PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, FR; Lemon-Mule, H; Bencharitiwong, R; Sampson, HA; Nowak-Wegrzyn, AH				Huang, F. R.; Lemon-Mule, H.; Bencharitiwong, R.; Sampson, H. A.; Nowak-Wegrzyn, A. H.			Effect of Heating and Food Matrix on Egg White (EW) Protein Allergenicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Huang, F. R.; Lemon-Mule, H.; Bencharitiwong, R.; Sampson, H. A.; Nowak-Wegrzyn, A. H.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai									0	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				689	S180	S180		10.1016/j.jaci.2008.12.680	http://dx.doi.org/10.1016/j.jaci.2008.12.680			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301162
J	Liu, AH; Sicherer, SH; Wood, RA; Bock, SA; Burks, AW; Jaramillo, R; Spruell, B; Massing, M; Zeldin, DC				Liu, A. H.; Sicherer, S. H.; Wood, R. A.; Bock, S. A.; Burks, A. W.; Jaramillo, R.; Spruell, B.; Massing, M.; Zeldin, D. C.			In the United States, Black Male Children have an Increased Risk of Food Allergy: Results from NHANES 2005-2006	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Liu, A. H.; Bock, S. A.] Natl Jewish Hlth, Denver, CO USA; [Liu, A. H.; Bock, S. A.] Univ Colorado, Sch Med, Aurora, CO USA; [Sicherer, S. H.] Mt Sinai Sch Med, Jaffe Food Allergy Inst, New York, NY USA; [Wood, R. A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Burks, A. W.] Duke Univ, Med Ctr, Durham, NC USA; [Jaramillo, R.; Spruell, B.; Massing, M.] SRA Int Inc, Durham, NC USA; [Zeldin, D. C.] Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Duke University; SRA International; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307					0	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				1037	S267	S267		10.1016/j.jaci.2008.12.1036	http://dx.doi.org/10.1016/j.jaci.2008.12.1036			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301509
J	Permaul, P; Stutius, LM; Sheehan, WJ; Rangsithienchai, PA; Walter, JE; Twarog, F; Schneider, LC; Phipatanakul, W				Permaul, P.; Stutius, L. M.; Sheehan, W. J.; Rangsithienchai, P. A.; Walter, J. E.; Twarog, F.; Schneider, L. C.; Phipatanakul, W.			Characterizing Sesame Allergy: Role of Specific IgE and Skin Prick Testing in Predicting Food Challenge Results	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Permaul, P.; Stutius, L. M.; Sheehan, W. J.; Walter, J. E.; Twarog, F.; Schneider, L. C.; Phipatanakul, W.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Rangsithienchai, P. A.] Northwestern Univ, Evanston Program, McGraw Med Ctr, Evanston, IL USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University					PHS HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512] Funding Source: NIH RePORTER	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	5	5	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				78	S24	S24		10.1016/j.jaci.2008.12.106	http://dx.doi.org/10.1016/j.jaci.2008.12.106			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR	21743756				2022-12-18	WOS:000263596300089
J	Turos, OI; Kovtunenko, IN; Markevych, YP; Drannik, GN; DuBuske, LM				Turos, O. I.; Kovtunenko, I. N.; Markevych, Y. P.; Drannik, G. N.; DuBuske, L. M.			Aeroallergen Monitoring in Ukraine Reveals the Presence of a Significant Ragweed Pollen Season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Turos, O. I.; Kovtunenko, I. N.; Markevych, Y. P.] Ukraine Acad Med Sci, O Marzeyev Inst Hyg & Med Ecol, Kiev, Ukraine; [Drannik, G. N.] Natl O Bohomolets Med Univ, Kiev, Ukraine; [DuBuske, L. M.] Immunol Res Inst New England, Gardner, MA USA	National Academy of Medical Sciences of Ukraine; O. M. MarzeIev Institute for Public Health of the National Academy of Medical Science of Ukraine			DuBuske, Lawrence/AAV-3402-2020						0	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				358	S95	S95		10.1016/j.jaci.2008.12.342	http://dx.doi.org/10.1016/j.jaci.2008.12.342			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300371
J	Apter, AJ				Apter, Andrea J.			Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; adults; genetics; inhaled corticosteroids; exhaled breath condensate; nitric oxide; chlorofluorocarbon; short-acting beta-agonists; health literacy	EXHALED NITRIC-OXIDE; EMERGENCY-DEPARTMENT VISITS; DELAYED ALLERGIC REACTIONS; OF-LIFE; AIR-POLLUTION; CHILDREN; EXPOSURE; CARE; ASSOCIATION; VALIDATION	In 2008 the Journal reported new findings in management of asthma. Dosing schedules of inhaled steroids have been modified and individualized. New, more costly propellants are replacing ozone-depleting chlorofluorocarbons. An association of asthma with pneumococcal disease has been observed. Smoking bans in public places are eliminating second-hand smoke and reducing asthma-related emergency department visits among adults. In contrast with these advances, however, disparity in asthma morbidity persists: black persons compared with white persons have a 4-fold greater risk of an asthma-related emergency department visit. (J Allergy Clin Immunol 2009;123:35-40.)	[Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu			National Heart, Lung, and Blood Institute [HL073932, HL0884691]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073932, K02HL088469] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Heart, Lung, and Blood Institute (HL073932, HL0884691).	Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P512, DOI 10.1016/j.jaci.2005.12.1353; Apter AJ, 2004, J ALLERGY CLIN IMMUN, V113, P407, DOI 10.1016/j.jaci.2003.12.002; APTER AJ, 2008, J GEN INTERN ME 1002; Apter AJ, 2008, J ALLERGY CLIN IMMUN, V121, P839, DOI 10.1016/j.jaci.2007.12.1176; Apter AJ, 2007, J ALLERGY CLIN IMMUN, V119, P563, DOI 10.1016/j.jaci.2007.01.001; Apter AJ, 2006, J ASTHMA, V43, P705, DOI 10.1080/02770900600925585; Apter Andrea J., 2003, Journal of Allergy and Clinical Immunology, V111, pS780, DOI 10.1067/mai.2003.153; Barr RG, 2007, AM J RESP CRIT CARE, V175, P120, DOI 10.1164/rccm.200603-411OC; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Barry PJ, 2008, J ALLERGY CLIN IMMUN, V121, P785, DOI 10.1016/j.jaci.2007.12.1184; Blais L, 2008, J ALLERGY CLIN IMMUN, V121, P1379, DOI 10.1016/j.jaci.2008.02.038; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; BUSSE WW, 2008, NEW ENGL J MED, V121, P1407; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Craig TJ, 2008, J ALLERGY CLIN IMMUN, V121, P671, DOI 10.1016/j.jaci.2007.12.1153; Cresswell KM, 2008, J ALLERGY CLIN IMMUN, V121, P1112, DOI 10.1016/j.jaci.2007.12.1180; Dijkstra A, 2008, J ALLERGY CLIN IMMUN, V121, P1510, DOI 10.1016/j.jaci.2008.04.015; Gaston B, 2006, J ALLERGY CLIN IMMUN, V118, P817, DOI 10.1016/j.jaci.2006.06.040; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; HARTERT T, 2008, NEW ENGL J MED, V122, P724; Hauswirth DW, 2008, J ALLERGY CLIN IMMUN, V122, P101, DOI 10.1016/j.jaci.2008.03.024; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; Holbrook JT, 2008, J ALLERGY CLIN IMMUN, V122, P828, DOI 10.1016/j.jaci.2008.07.012; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; *I MED, 2003, UN TREATM CONFR RAC; JUHN YJ, 2008, NEW ENGL J MED, V122, P719; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 2000, CLIN EXP ALLERGY, V30, P132; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Juniper EF, 2008, J ALLERGY CLIN IMMUN, V122, P654, DOI 10.1016/j.jaci.2008.05.003; Kumar R, 2008, J ALLERGY CLIN IMMUN, V122, P754, DOI 10.1016/j.jaci.2008.08.006; Leo HL, 2008, J ALLERGY CLIN IMMUN, V121, P776, DOI 10.1016/j.jaci.2007.12.1177; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P396, DOI 10.1016/j.jaci.2007.09.031; Limb SL, 2008, J ALLERGY CLIN IMMUN, V121, P786, DOI 10.1016/j.jaci.2007.12.1187; Limb SL, 2007, J ALLERGY CLIN IMMUN, V120, P1378, DOI 10.1016/j.jaci.2007.09.022; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P85, DOI [DOI 10.1016/HACI.2008.03.005, 10.1016/j.jaci.2008.03.005]; Litonjua AA, 2008, AM J RESP CRIT CARE, V178, P688, DOI 10.1164/rccm.200709-1363OC; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P1075, DOI 10.1016/j.jaci.2008.03.005; Marsden PA, 2008, J ALLERGY CLIN IMMUN, V122, P903, DOI 10.1016/j.jaci.2008.08.029; Mehra R, 2008, J ALLERGY CLIN IMMUN, V121, P1096, DOI 10.1016/j.jaci.2008.04.002; Menzies D, 2008, J ALLERGY CLIN IMMUN, V121, P1184, DOI 10.1016/j.jaci.2008.01.009; Miller TP, 2008, J ALLERGY CLIN IMMUN, V122, P328, DOI 10.1016/j.jaci.2008.05.021; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; *NAT CTR ED STAT I, 2003, NAT ASS AD LIT; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; NIELSONBOHLMAN L, 2004, HLTH LIT PRESCRIPTIO; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; Park SS, 2008, J ALLERGY CLIN IMMUN, V121, P1103, DOI 10.1016/j.jaci.2008.01.014; Patino CM, 2008, J ALLERGY CLIN IMMUN, V122, P936, DOI 10.1016/j.jaci.2008.08.027; Pedersen S, 2008, LANCET, V372, P1015, DOI 10.1016/S0140-6736(08)61420-8; Rabinovitch N, 2008, J ALLERGY CLIN IMMUN, V122, P542, DOI 10.1016/j.jaci.2008.07.016; Raby BA, 2004, J ALLERGY CLIN IMMUN, V113, P1071, DOI 10.1016/j.jaci.2004.03.035; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rand CS, 2008, J ALLERGY CLIN IMMUN, V122, P319, DOI 10.1016/j.jaci.2008.07.004; Rayens MK, 2008, J ALLERGY CLIN IMMUN, V122, P537, DOI 10.1016/j.jaci.2008.06.029; Riekert KA, 2008, J ALLERGY CLIN IMMUN, V121, P1181, DOI 10.1016/j.jaci.2008.03.023; Romieu I, 2008, J ALLERGY CLIN IMMUN, V121, P903, DOI 10.1016/j.jaci.2007.12.004; Salo PM, 2008, J ALLERGY CLIN IMMUN, V121, P678, DOI 10.1016/j.jaci.2007.12.1164; Shaker M, 2008, J ALLERGY CLIN IMMUN, V121, P81, DOI 10.1016/j.jaci.2007.06.047; Shin HW, 2007, J APPL PHYSIOL, V102, P1028, DOI 10.1152/japplphysiol.01012.2006; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Skinner Elizabeth A, 2004, Dis Manag, V7, P305, DOI 10.1089/dis.2004.7.305; Smith H, 2008, J ALLERGY CLIN IMMUN, V121, P770, DOI 10.1016/j.jaci.2007.09.035; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P470, DOI 10.1016/j.jaci.2004.12.1123; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Tantisira KG, 2008, PHARMACOGENET GENOM, V18, P733, DOI 10.1097/FPC.0b013e3282fe6ebf; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Taylor DR, 2008, J ALLERGY CLIN IMMUN, V122, P836, DOI 10.1016/j.jaci.2008.07.025; *UN ENV PROGR, 2007, EV MONTR PROT, V9, P2; *US DEP HHS NIH NA, 2007, 3 US DEP HLTH HUM SE; *US FDA CTR DRUG E, 2008, EARL COMM ONG SAF RE; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weiss BD, 1997, NEW ENGL J MED, V337, P272, DOI 10.1056/NEJM199707243370411; Williams MV, 1998, CHEST, V114, P1008, DOI 10.1378/chest.114.4.1008; Zeiger RS, 2008, J ALLERGY CLIN IMMUN, V121, P885, DOI 10.1016/j.jaci.2007.12.1178	84	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					35	40		10.1016/j.jaci.2008.11.017	http://dx.doi.org/10.1016/j.jaci.2008.11.017			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	399IP	19130925	Green Accepted			2022-12-18	WOS:000262793900006
J	Spector, SL; Tan, RA				Spector, Sheldon L.; Tan, Ricardo A.			Advances in allergic skin disease: Omalizumab is a promising therapy for urticaria and angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Spector, Sheldon L.; Tan, Ricardo A.] Calif Allergy & Asthma Med Grp, Los Angeles, CA USA		Spector, SL (corresponding author), Calif Allergy & Asthma Med Grp, Los Angeles, CA USA.	rtantan@aol.com						Boyce JA, 2006, J ALLERGY CLIN IMMUN, V117, P1415, DOI 10.1016/j.jaci.2006.04.003; Metz M, 2008, ALLERGY, V63, P247, DOI 10.1111/j.1398-9995.2007.01591.x; Sands MF, 2007, J ALLERGY CLIN IMMUN, V120, P979, DOI 10.1016/j.jaci.2007.07.041; Sicherer SH, 2008, J ALLERGY CLIN IMMUN, V121, P1351, DOI 10.1016/j.jaci.2008.01.032; Spector SL, 2007, ANN ALLERG ASTHMA IM, V99, P190, DOI 10.1016/S1081-1206(10)60644-8	5	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					273	274		10.1016/j.jaci.2008.07.033	http://dx.doi.org/10.1016/j.jaci.2008.07.033			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	18774168				2022-12-18	WOS:000262793900057
J	Raap, U; Schmid-Ott, G; Bruder, M; Wichmann, K; Kapp, A; Werfel, T				Raap, Ulrike; Schmid-Ott, Gerhard; Bruder, Manuela; Wichmann, Katja; Kapp, Alexander; Werfel, Thomas			The functional activity of basophil granulocytes is modulated by acute mental stress and sympathetic activation in vivo and in vitro	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNOLOGICAL RELEASE; ATOPIC-DERMATITIS; HUMAN-LUNG; FENOTEROL; HISTAMINE; LYMPHOCYTES; CELLS		[Raap, Ulrike; Bruder, Manuela; Kapp, Alexander] Hannover Med Sch, Dept Dermatol & Allergol, D-3000 Hannover, Germany; [Wichmann, Katja; Werfel, Thomas] Hannover Med Sch, Dept Immunodermatol & Allergy Res, D-3000 Hannover, Germany; [Schmid-Ott, Gerhard] Berolina Clin, Dept Psychosomat Med, Lohne, Germany	Hannover Medical School; Hannover Medical School	Raap, U (corresponding author), Hannover Med Sch, Dept Dermatol & Allergol, D-3000 Hannover, Germany.	raap.ulrike@mh-hannover.de	Werfel, Thomas/B-6921-2012	Kapp, Alexander/0000-0002-1748-6276				Dyke SM, 2008, CLIN EXP ALLERGY, V38, P86, DOI 10.1111/j.1365-2222.2007.02864.x; Gebhardt T, 2005, EUR J IMMUNOL, V35, P1124, DOI 10.1002/eji.200425869; HUGHES JM, 1983, EUR J PHARMACOL, V95, P239; MARONE G, 1984, INT ARCH ALLER A IMM, V74, P356, DOI 10.1159/000233573; MORR H, 1979, RESPIRATION, V38, P163, DOI 10.1159/000194074; Raap U, 2007, J INVEST ALLERG CLIN, V17, P199; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V107, P171, DOI 10.1067/mai.2001.111850; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V108, P455, DOI 10.1067/mai.2001.117800	8	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1227	1229		10.1016/j.jaci.2008.07.031	http://dx.doi.org/10.1016/j.jaci.2008.07.031			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	18789818				2022-12-18	WOS:000261711800027
J	Epstein, PR				Epstein, Paul R.			Fossil fuels, allergies, and a host of other ills	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						climate change; carbon dioxide; allergies	RAGWEED AMBROSIA-ARTEMISIIFOLIA; ELEVATED ATMOSPHERIC CO2; COMMON RAGWEED; POLLEN PRODUCTION; PUBLIC-HEALTH; RESPONSES; CARBON; ASTHMA		Harvard Univ, Sch Med, Ctr Hlth & Global Environm, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Epstein, PR (corresponding author), Harvard Univ, Sch Med, Ctr Hlth & Global Environm, 401 Pk Dr,2nd Floor E, Boston, MA 02215 USA.	paul_epstein@hms.harvard.edu						Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Epstein P.R., 2005, CLIMATE CHANGE FUTUR; Epstein Paul R., 2008, HLTH SOLUTIONS LOW C; HANSEN J, ATMOS CHEM PHYS, V7, P2287; IPCC, 2007, CONTRIBUTION WORKING; Klironomos JN, 1997, CAN J BOT, V75, P1670, DOI 10.1139/b97-880; Knox RB, 1997, CLIN EXP ALLERGY, V27, P246; LADEAU SL, 2006, FUNCT ECOL, V10, P1365; LINDROTH RL, 1996, CARBONDIOXIDE POPULA; Lovejoy Thomas E., 1993, P261; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103; Pimentel D., 2005, NATURAL RESOURCES RE, V14, P65, DOI [DOI 10.1007/s11053-005-4679-8, 10.1007/s11053-005-4679-8, DOI 10.1007/S11053-005-4679-8]; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Treseder KK, 2003, ECOSYSTEMS, V6, P786, DOI 10.1007/s10021-003-0182-4; Wayne P, 2002, ANN ALLERG ASTHMA IM, V80, P669; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P893; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	20	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2008	122	3					471	472		10.1016/j.jaci.2008.07.015	http://dx.doi.org/10.1016/j.jaci.2008.07.015			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	348TW	18774382	Bronze			2022-12-18	WOS:000259234000003
J	Bonini, S; Craig, T				Bonini, Sergio; Craig, Timothy			The elite athlete: Yes, with allergy we can	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; exercise; athlete; allergies; exercise-induced asthma; exercise-induced bronchospasm	BETA(2)-AGONISTS; OLYMPICS; AGONISTS; GAMES		[Bonini, Sergio] Univ Naples 2, I-00136 Rome, Italy; [Craig, Timothy] Penn State Univ, Hershey, PA USA	Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bonini, S (corresponding author), Univ Naples 2, Via Ugo Carolis 59, I-00136 Rome, Italy.	se.Bonini@gmail.com	Bonini, Sergio/T-6594-2019	Bonini, Sergio/0000-0003-0079-3031				Anderson SD, 2008, J ALLERGY CLIN IMMUN, V122, P225, DOI 10.1016/j.jaci.2008.05.001; Anderson SD, 2003, J ALLERGY CLIN IMMUN, V111, P45, DOI 10.1067/mai.2003.1; Fitch KD, 2006, CLIN REV ALLERG IMMU, V31, P259, DOI 10.1385/CRIAI:31:2:259; Katelaris CH, 2000, J ALLERGY CLIN IMMUN, V106, P260, DOI 10.1067/mai.2000.108603; Konig D, 2000, EXERC IMMUNOL REV, V6, P102; Lapucci G., 2003, Journal of Allergy and Clinical Immunology, V111, pS142, DOI 10.1016/S0091-6749(03)80450-5; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Nelson HS, 2006, J ALLERGY CLIN IMMUN, V117, P3, DOI 10.1016/j.jaci.2005.10.013; Pedersen BK, 1996, J SPORT MED PHYS FIT, V36, P236; Rundell KW, 2008, J ALLERGY CLIN IMMUN, V122, P238, DOI 10.1016/j.jaci.2008.06.014; *WADA, 2008, WORLD ANTIDOPING AG; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605; Weinberger M, 2008, J ALLERGY CLIN IMMUN, V122, P251, DOI 10.1016/j.jaci.2008.05.030	13	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2008	122	2					249	250		10.1016/j.jaci.2008.06.020	http://dx.doi.org/10.1016/j.jaci.2008.06.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	337HO	18619663	Bronze			2022-12-18	WOS:000258426300003
J	Jacobs, RL				Jacobs, Robert L.			Hypersensitivity pneumonitis may be home-induced by common domestic mold spores	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							LUNG-DISEASE; EXPOSURE		Biogen Res Inst, San Antonio, TX USA		Jacobs, RL (corresponding author), Biogen Res Inst, San Antonio, TX USA.	robert.jacobs7025@sbcglobal.net		Jacobs, Robert/0000-0002-2831-9086				Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; FINK JN, 1971, ANN INTERN MED, V74, P80, DOI 10.7326/0003-4819-74-1-80; Hanak V, 2007, MAYO CLIN PROC, V82, P812, DOI 10.4065/82.7.812; Jacobs RL, 2002, ANN ALLERG ASTHMA IM, V88, P30, DOI 10.1016/S1081-1206(10)63590-9; PATTERSON R, 1981, J ALLERGY CLIN IMMUN, V68, P128, DOI 10.1016/0091-6749(81)90171-8; Patterson R, 1998, CHEST, V114, P931, DOI 10.1378/chest.114.3.931; Temprano J, 2007, ANN ALLERG ASTHMA IM, V99, P562, DOI 10.1016/S1081-1206(10)60387-0	7	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2008	122	2					428	428		10.1016/j.jaci.2008.05.045	http://dx.doi.org/10.1016/j.jaci.2008.05.045			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	337HO	18602151				2022-12-18	WOS:000258426300039
J	Miller, TP; Oswald, FL; Reeves, MJ				Miller, Thomas P.; Oswald, Frederick L.; Reeves, Mathew J.			An exploration of factors underlying asthma care and morbidity: A factor analysis of clinical variables	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; factor analysis; emergency department; quality of care	QUALITY-OF-LIFE; EMERGENCY-DEPARTMENT VISITS; COMPUTER-BASED MODELS; CHILDHOOD ASTHMA; RISK-FACTORS; HOSPITALIZATION RATES; SOCIOECONOMIC-STATUS; SYSTEMS BIOLOGY; MANAGED CARE; CHILDREN	Background: Clinical risk models use recognized risk factors to identify patients at risk for future asthma morbidity. However, the low predictive values of these, models suggest an important need to,re-evaluate risk assessment strategies. Objective: To use exploratory factor analysis to define underlying factors operative in asthma treatment and morbidity, and characterize their interrelationships and association with 6-month morbidity. Methods: Children (n = 197) presenting to an emergency department for an acute asthma episode were followed for 6 months. (follow-up data available for 84%). Baseline data included demographics, asthma history, current and past symptoms, and current treatment and management. Factor analysis was used to summarize the underlying relationships between variables. Correlations between factors and 6-mouth morbidity were calculated. Results: Factor analysis revealed that 4 factors provided a parsimonious summary of the variables. The factors were labeled current symptom severity, quality of care indicators, previous severe disease, and sociodemographic factors. Positive correlations were observed between quality of care, current symptom severity, and previous severe disease. The factor describing sociodemographic factors was inversely related to current symptom severity and quality of care. Previous severe disease significantly predicted 6-month morbidity. Conclusion: Quality of care was better in subjects with increased current symptoms or previous severe disease, but poorer in individuals with adverse sociodemographic factors. Previous severe disease was the only factor associated with 6-month morbidity, suggesting that current assessment methods do not adequately account for all underlying factors likely operative in asthma morbidity.	[Miller, Thomas P.; Reeves, Mathew J.] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Oswald, Frederick L.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine; Michigan State University	Miller, TP (corresponding author), 360 E Beltline NE,Ste 100, Grand Rapids, MI 49506 USA.	millerjt@aol.com	Oswald, Frederick L/A-9995-2012					Adams RJ, 2001, PEDIATRICS, V107, P706, DOI 10.1542/peds.107.4.706; Adams RJ, 2000, THORAX, V55, P566, DOI 10.1136/thorax.55.7.566; Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; Bartlett SJ, 2001, ARCH PEDIAT ADOL MED, V155, P347, DOI 10.1001/archpedi.155.3.347; Barton C, 2003, RESP MED, V97, P747, DOI 10.1016/S0954-6111(03)00029-5; Berger WE, 2004, ANN ALLERG ASTHMA IM, V93, P538, DOI 10.1016/S1081-1206(10)61260-4; Blais L, 1998, AM J RESP CRIT CARE, V158, P126, DOI 10.1164/ajrccm.158.1.9707107; Boudreaux ED, 2003, CHEST, V124, P803, DOI 10.1378/chest.124.3.803; Boudreaux ED, 2003, PEDIATRICS, V111, pE615, DOI 10.1542/peds.111.5.e615; Calam R, 2003, J ALLERGY CLIN IMMUN, V112, P499, DOI 10.1067/mai.2003.1639; Cassino C, 1999, AM J RESP CRIT CARE, V159, P1773, DOI 10.1164/ajrccm.159.6.9809042; Cowie RL, 1997, CHEST, V112, P1534, DOI 10.1378/chest.112.6.1534; Cowie RL, 2001, J ASTHMA, V38, P179, DOI 10.1081/JAS-100000037; Dhar PK, 2004, IEEE T NANOBIOSCI, V3, P144, DOI 10.1109/TNB.2004.833699; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; Eggleston PA, 1998, IMMUNOL ALLERGY CLIN, V18, P75, DOI 10.1016/S0889-8561(05)70348-9; Federico MJ, 2003, PEDIATR CLIN N AM, V50, P655, DOI 10.1016/S0031-3955(03)00045-2; Fiese BH, 2005, J PEDIATR-US, V146, P171, DOI 10.1016/j.jpeds.2004.08.083; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P563, DOI 10.1001/archpedi.154.6.563; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; GOTTLIEB DJ, 1995, CHEST, V108, P28, DOI 10.1378/chest.108.1.28; Grana J, 1997, Am J Med Qual, V12, P113, DOI 10.1177/0885713X9701200205; Grazzini M, 2001, RESP MED, V95, P246, DOI 10.1053/rmed.2000.1017; GREENBERGER PA, 1993, ALLERGY PROC, V14, P321, DOI 10.2500/108854193778773994; Grus CL, 2001, J ASTHMA, V38, P99, DOI 10.1081/JAS-100000027; Hatcher L, 2013, STEP BY STEP APPROAC; Joseph CLM, 1998, J ALLERGY CLIN IMMUN, V101, P484, DOI 10.1016/S0091-6749(98)70355-0; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; LeSon S, 1996, J ASTHMA, V33, P27, DOI 10.3109/02770909609077760; Leung TF, 2005, THORAX, V60, P822, DOI 10.1136/thx.2004.039321; Lieu TA, 1998, AM J RESP CRIT CARE, V157, P1173, DOI 10.1164/ajrccm.157.4.9708124; Lieu TA, 1999, J ASTHMA, V36, P359, DOI 10.3109/02770909909068229; Lin S, 1999, J ASTHMA, V36, P239, DOI 10.3109/02770909909075407; MILLER TP, 1992, CHEST, V102, P515, DOI 10.1378/chest.102.2.515; *N2H, NIH PUBL; *NAT ASTHM ED PREV, 1997, NIH PUBL; *NAT CTR HLTH STAT, 2006, NAT HLTH INT SURV; National Center for Health Statistics, 2005, HLTH US 2005 CHARTB; Rand CS, 2000, J ALLERGY CLIN IMMUN, V105, P83, DOI 10.1016/S0091-6749(00)90182-9; Reeves MJ, 2006, PEDIATRICS, V117, pS118, DOI 10.1542/peds.2005-2000I; Rosi E, 1999, J ALLERGY CLIN IMMUN, V103, P232, DOI 10.1016/S0091-6749(99)70496-3; Schatz M, 2005, J ALLERGY CLIN IMMUN, V115, P1049, DOI 10.1016/j.jaci.2005.02.008; Schatz M, 2004, AM J MANAG CARE, V10, P25; Schatz M, 2003, AM J MANAG CARE, V9, P538; Schatz M, 2005, J ALLERGY CLIN IMMUN, V115, P564, DOI 10.1016/j.jaci.2004.12.005; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P995, DOI 10.1016/j.jaci.2006.01.053; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Strange K, 2005, AM J PHYSIOL-CELL PH, V288, pC968, DOI 10.1152/ajpcell.00598.2004; Sturdy PM, 2002, THORAX, V57, P1034, DOI 10.1136/thorax.57.12.1034; Sunyer J, 2000, AM J RESP CRIT CARE, V162, P930, DOI 10.1164/ajrccm.162.3.9911062; Taylor BW, 1999, J EMERG MED, V17, P953, DOI 10.1016/S0736-4679(99)00122-5; Thompson B, 2004, EXPLORATORY CONFIRMA; Tough S C, 1999, Can Respir J, V6, P429; Von Behren J, 1999, J ASTHMA, V36, P575, DOI 10.3109/02770909909087294; Wade S, 1997, PEDIATR PULM, V24, P263, DOI 10.1002/(SICI)1099-0496(199710)24:4<263::AID-PPUL5>3.0.CO;2-L; Yurk RA, 2004, AM J MANAG CARE, V10, P321; 1996, MORB MORTAL WKLY REP, V45, P350; 1997, MORB MORTAL WKLY REP, V46, P726	59	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2008	122	2					328	334		10.1016/j.jaci.2008.05.021	http://dx.doi.org/10.1016/j.jaci.2008.05.021			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	337HO	18572232				2022-12-18	WOS:000258426300019
J	Revicki, D; Brown, R; Dale, P				Revicki, Dennis; Brown, Ruth; Dale, Peter			Questioning the economic evaluation of omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA POLICY MODEL; QUALITY-OF-LIFE; COST-EFFECTIVENESS; ALLERGIC-ASTHMA; ADULTS; IGE		United BioSource Corp, Bethesda, MD USA; United BioSource Corp, London, England	United Biosource Corporation; United Biosource Corporation	Revicki, D (corresponding author), United BioSource Corp, Bethesda, MD USA.	dennis.revicki@unitedbiosource.com						Brown R, 2007, ALLERGY, V62, P149, DOI 10.1111/j.1398-9995.2006.01310.x; Louis R, 2004, ALLERGY, V59, P698, DOI 10.1111/j.1398-9995.2004.00548.x; Niebauer K, 2006, ANN ALLERG ASTHMA IM, V96, P316, DOI 10.1016/S1081-1206(10)61242-2; Paltiel AD, 2001, J ALLERGY CLIN IMMUN, V108, P39, DOI 10.1067/mai.2001.116289; PRESTA LG, 1993, J IMMUNOL, V151, P2623; REVICKI DA, 1993, QUAL LIFE RES, V2, P477, DOI 10.1007/BF00422222; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055	7	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2008	121	6					1514	1514		10.1016/j.jaci.2008.03.009	http://dx.doi.org/10.1016/j.jaci.2008.03.009			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	313WW	18395781	Bronze			2022-12-18	WOS:000256771700033
J	Nuijens, J; Verdonk, R; Giannetti, B; Visscher, S; van Doorn, M; Resink, T; Levi, M; Hack, C; Farkas, H; Obtulowicz, K; Caballero, T; Cicardi, M				Nuijens, J.; Verdonk, R.; Giannetti, B.; Visscher, S.; van Doorn, M.; Resink, T.; Levi, M.; Hack, C.; Farkas, H.; Obtulowicz, K.; Caballero, T.; Cicardi, M.			Clinical studies of recombinant human C1 inhibitor (rhC1INH) in patients with acute attacks of hereditary angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Nuijens, J.; Verdonk, R.; Giannetti, B.; Visscher, S.; Resink, T.] Pharming Technol BV, Leiden, Netherlands; [van Doorn, M.] Ctr Human Drug Res, Leiden, Netherlands; [Levi, M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Hack, C.] Crucell NV, Leiden, Netherlands; [Farkas, H.] Semmelweis Univ, H-1085 Budapest, Hungary; [Obtulowicz, K.] Jagiellonian Univ, Krakow, Poland; [Caballero, T.] Hosp Univ La Paz, Madrid, Spain; [Cicardi, M.] Luigi Sacco Hosp, Milan, Italy	University of Amsterdam; Academic Medical Center Amsterdam; Johnson & Johnson; Semmelweis University; Jagiellonian University; Hospital Universitario La Paz; University of Milan; Luigi Sacco Hospital			Levi, Marcel/AAZ-8559-2020; Caballero, Teresa/AAU-3982-2020	Caballero, Teresa/0000-0003-3005-9858					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3				LB25	797	797		10.1016/j.jaci.2008.01.061	http://dx.doi.org/10.1016/j.jaci.2008.01.061			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	273GR					2022-12-18	WOS:000253918900078
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma in 2007	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; asthma control; asthma impairment; asthma risk; asthma severity; early intervention in asthma; biomarkers; therapeutics	CHILDHOOD ASTHMA; MANAGEMENT PROGRAM; YOUNG-CHILDREN; PREVENTION; AIRWAY; RISK; EXACERBATIONS; FLUTICASONE; MONTELUKAST; PREVALENCE	This year's summary focuses on recent advances in pediatric asthma as reported in 2007 publications in the Journal. This past year, new National Asthma Education and Prevention Program asthma guidelines were released with a special emphasis on new information in pediatric asthma. Journal theme issues in 2007 included the revised National Asthma Education and Prevention Program asthma guidelines, the accomplishments of the National Institutes of Health asthma networks, and focused discussions on environmental allergens, neutrophils, eosinophils, T cells, and epithelial cells, all of which affect pediatric asthma. The new asthma guidelines emphasize several key terms including severity, control, impairment, risk, and responsiveness that are relevant for advancing the care of children with asthma. This review highlights Journal articles that relate to these guideline topics.	[Szefler, Stanley J.] Natl Jewish Med & Res Ctr, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Med & Res Ctr, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Szefler, SJ (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Room J304 Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njc.org			DIVISION OF LUNG DISEASES [N01HR016048] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081335, U10HL051834, U01HL075416, U10HL064288] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00051] Funding Source: Medline; NHLBI NIH HHS [HL075416, HL081335, HR-16048, HL64288, HL51834] Funding Source: Medline; NIAID NIH HHS [AI-25496] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P512, DOI 10.1016/j.jaci.2005.12.1353; Arshad SH, 2007, J ALLERGY CLIN IMMUN, V119, P307, DOI 10.1016/j.jaci.2006.12.621; Bacharier LB, 2007, J ALLERGY CLIN IMMUN, V119, P604, DOI 10.1016/j.jaci.2006.12.607; Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Busse WW, 2007, J ALLERGY CLIN IMMUN, V120, P1012, DOI 10.1016/j.jaci.2007.09.016; Busse WW, 2007, J ALLERGY CLIN IMMUN, V119, P43, DOI 10.1016/j.jaci.2006.10.021; Cazzoletti L, 2007, J ALLERGY CLIN IMMUN, V120, P1360, DOI 10.1016/j.jaci.2007.09.019; Chan-Yeung M, 2007, J ALLERGY CLIN IMMUN, V120, P1221, DOI 10.1016/j.jaci.2007.08.025; Chen WG, 2007, J ALLERGY CLIN IMMUN, V119, P529, DOI 10.1016/j.jaci.2007.01.004; Chipps BE, 2007, J ALLERGY CLIN IMMUN, V119, P1156, DOI 10.1016/j.jaci.2006.12.668; de Blic J, 2007, J ALLERGY CLIN IMMUN, V119, P808, DOI 10.1016/j.jaci.2006.12.657; Denlinger LC, 2007, J ALLERGY CLIN IMMUN, V119, P3, DOI 10.1016/j.jaci.2006.10.015; Drazen JM, 2007, J ALLERGY CLIN IMMUN, V119, P28, DOI 10.1016/j.jaci.2006.06.011; Federico MJ, 2007, J ALLERGY CLIN IMMUN, V119, P50, DOI 10.1016/j.jaci.2006.10.019; Gibson PG, 2007, J ALLERGY CLIN IMMUN, V119, P344, DOI 10.1016/j.jaci.2006.10.043; *GLOB STRAT ASTHM, 2007 GINA REP; Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Jones CA, 2007, J ALLERGY CLIN IMMUN, V119, P1445, DOI 10.1016/j.jaci.2007.02.031; Kelly HW, 2007, J ALLERGY CLIN IMMUN, V120, P989, DOI 10.1016/j.jaci.2007.01.035; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Krishnan JA, 2007, J ALLERGY CLIN IMMUN, V120, P1015, DOI 10.1016/j.jaci.2007.09.027; Lehtinen P, 2007, J ALLERGY CLIN IMMUN, V119, P570, DOI 10.1016/j.jaci.2006.11.003; Linehan MF, 2007, J ALLERGY CLIN IMMUN, V119, P1079, DOI 10.1016/j.jaci.2006.12.672; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Mai XM, 2007, J ALLERGY CLIN IMMUN, V120, P551, DOI 10.1016/j.jaci.2007.05.004; Mandhane PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1359, DOI 10.1016/j.jaci.2007.01.043; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; Martinez FD, 2007, J ALLERGY CLIN IMMUN, V119, P30, DOI 10.1016/j.jaci.2006.10.020; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; *NIH NAT HEART LUN, 2007, NIH PUBL; Oryszczyn MP, 2007, J ALLERGY CLIN IMMUN, V119, P57, DOI 10.1016/j.jaci.2006.09.026; Pajno GB, 2007, J ALLERGY CLIN IMMUN, V119, P796, DOI 10.1016/j.jaci.2007.01.009; Pedersen SE, 2007, J ALLERGY CLIN IMMUN, V120, P1036, DOI 10.1016/j.jaci.2007.07.016; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Scirica CV, 2007, J ALLERGY CLIN IMMUN, V119, P81, DOI 10.1016/j.jaci.2006.09.002; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stoloff SW, 2007, J ALLERGY CLIN IMMUN, V120, P1021, DOI 10.1016/j.jaci.2007.02.027; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Strunk RC, 2007, J ALLERGY CLIN IMMUN, V119, P36, DOI 10.1016/j.jaci.2006.09.038; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1043, DOI 10.1016/j.jaci.2007.08.063; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V119, P558, DOI 10.1016/j.jaci.2006.12.619; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V119, P24, DOI 10.1016/j.jaci.2006.10.036; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; van Gent R, 2007, J ALLERGY CLIN IMMUN, V119, P591, DOI 10.1016/j.jaci.2006.11.007; Weiler JM, 2007, J ALLERGY CLIN IMMUN, V119, P1349, DOI 10.1016/j.jaci.2007.02.041; Weinberger M, 2007, J ALLERGY CLIN IMMUN, V119, P567, DOI 10.1016/j.jaci.2006.12.641; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055	57	5	6	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					614	619		10.1016/j.jaci.2007.11.033	http://dx.doi.org/10.1016/j.jaci.2007.11.033			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18234318				2022-12-18	WOS:000253918900011
J	Alonso, E; Zapatero, L; Fuentes, V; Barranco, R; Davila, G; Martinez, M				Alonso, E.; Zapatero, L.; Fuentes, V.; Barranco, R.; Davila, G.; Martinez, M.			Specific oral tolerance induction in 39 children with IgE mediated persistent cow's milk allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Alonso, E.; Zapatero, L.; Fuentes, V.; Barranco, R.; Davila, G.; Martinez, M.] Hosp Materno Infantil Gregorio Maranon, Madrid, Spain										0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		951	S246	S246		10.1016/j.jaci.2007.12.976	http://dx.doi.org/10.1016/j.jaci.2007.12.976			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401415
J	Hoffman, DR; Peroutka, CM; Schmidt, M				Hoffman, D. R.; Peroutka, C. M.; Schmidt, M.			Imported fire ant venom phospholipase, Sol i 1, is a protein allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Hoffman, D. R.] E Carolina Univ, Brody Sch Med, Greenville, NC USA; [Peroutka, C. M.] E Carolina Univ, Greenville, NC USA; [Schmidt, M.] E Carolina Univ, Dept Biol, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		115	S30	S30		10.1016/j.jaci.2007.12.122	http://dx.doi.org/10.1016/j.jaci.2007.12.122			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400116
J	Kassab, D; Koterba, A; Jiang, Y; Akin, C				Kassab, D.; Koterba, A.; Jiang, Y.; Akin, C.			Elevated baseline tryptase levels in patients with mast cell activation syndromes without evidence mastocytosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Kassab, D.; Koterba, A.; Jiang, Y.; Akin, C.] Univ Michigan, Dept Med, Div Allergy & Clin Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		258	S67	S67		10.1016/j.jaci.2007.12.268	http://dx.doi.org/10.1016/j.jaci.2007.12.268			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400259
J	Lev-Tov, H; Josekutty, J; Kohlhoff, S; Norowitz, KB; Silverberg, JI; Chice, S; Nowakowski, M; Durkin, HG; Bluth, MH; Smith-Norowitz, TA				Lev-Tov, H.; Josekutty, J.; Kohlhoff, S.; Norowitz, K. B.; Silverberg, J. I.; Chice, S.; Nowakowski, M.; Durkin, H. G.; Bluth, M. H.; Smith-Norowitz, T. A.			IgE anti-varicella virus (VZV) and other immune responses before, during, and after shingles	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Lev-Tov, H.; Josekutty, J.; Kohlhoff, S.; Norowitz, K. B.; Silverberg, J. I.; Chice, S.; Nowakowski, M.; Durkin, H. G.; Bluth, M. H.; Smith-Norowitz, T. A.] Suny Downstate Med Ctr, Ctr Allergy & Asthma Res, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center			silverberg, jonathan/ABH-2765-2021	silverberg, jonathan/0000-0003-3686-7805					0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		796	S207	S207		10.1016/j.jaci.2007.12.773	http://dx.doi.org/10.1016/j.jaci.2007.12.773			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401260
J	Levy, R; McNeil, D; Li, H; Hsu, FI; Horn, P; Roberts, J				Levy, R.; McNeil, D.; Li, H.; Hsu, F. I.; Horn, P.; Roberts, J.			Results of a 2-stage, phase 3 pivotal trial, EDEMA3 (R): A study of subcutaneous DX-88 (ecallantide), a plasma kallikrein inhibitor, in patients with hereditary angioedema (HAE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Levy, R.] Family Allergy & Asthma Ctr, Atlanta, GA USA; [McNeil, D.] Optimed Res LLC, Optimed Infus Serv, Columbus, OH USA; [Li, H.] Inst Asthma & Allergy, Wheaton, IL USA; [Hsu, F. I.] Brigham & Womens Hosp, Allergy & Asthma Clin, Boston, MA 02115 USA; [Horn, P.; Roberts, J.] DYAX Corp, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		398A	S103	S103						1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400400
J	Teper, A; Ratner, PH				Teper, A.; Ratner, P. H.			Mometasone furoate nasal spray is safe and effective for one-year treatment of children with perennial allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Teper, A.] Schering Plough Res Inst, Kenilworth, NJ USA; [Ratner, P. H.] Sylvana Res Assoc, San Antonio, TX USA	Merck & Company; Schering-Plough Research Institute									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		204	S52	S53		10.1016/j.jaci.2007.12.213	http://dx.doi.org/10.1016/j.jaci.2007.12.213			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400205
J	Wantke, E; Moritz, K; Sesztak-Greinecker, G; Gtz, M; Hemmer, W; Moser, P; Jarisch, R				Wantke, E.; Moritz, K.; Sesztak-Greinecker, G.; Gtz, M.; Hemmer, W.; Moser, P.; Jarisch, R.			Histamine content in red and sparkling wine and relationship with wine quality	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Wantke, E.; Moritz, K.; Sesztak-Greinecker, G.; Gtz, M.; Hemmer, W.; Jarisch, R.] Floridsdorf Allergy Ctr, Vienna, Austria; [Moser, P.] Falstaff Magazine Publishers, Klosterneuburg, Austria										0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		746	S194	S194						1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401210
J	Matsumoto, K; Tamari, M; Saito, H				Matsumoto, Kenji; Tamari, Mayumi; Saito, Hirohisa			Involvement of eosinophils in the onset of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							SUBSEQUENT DEVELOPMENT; GENE POLYMORPHISMS; AIRWAY; INTERLEUKIN-5; IL-5		[Matsumoto, Kenji; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 1578535, Japan; [Tamari, Mayumi] Inst Phys & Chem Res, SNP Res Ctr, Lab Genet Allerrg Dis, Kanagawa, Japan	National Center for Child Health & Development - Japan; RIKEN	Matsumoto, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, 2-10-1 Okura, Tokyo 1578535, Japan.	kmatsumoto@nch.go.jp; hsaito@nch.go.jp	Tamari, Mayumi/N-5378-2015	Saito, Hirohisa/0000-0002-6630-8337				Bochner BS, 2004, J ALLERGY CLIN IMMUN, V113, P3, DOI 10.1016/j.jaci.2003.09.046; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Freidin M. B., 2002, Genetika, V38, P1710; Fukunaga K, 2001, EUR RESPIR J, V17, P59, DOI 10.1183/09031936.01.17100590; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JH, 2007, J ALLERGY CLIN IMMUN, V120, P1110, DOI 10.1016/j.jaci.2007.08.041; Matsumoto K, 2005, INT ARCH ALLERGY IMM, V137, P69, DOI 10.1159/000085435; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Pereira E, 1998, HUM MUTAT, V11, P51, DOI 10.1002/(SICI)1098-1004(1998)11:1<51::AID-HUMU8>3.0.CO;2-O; Petsky H. L., 2007, COCHRANE DB SYST REV, V18; Pifferi M, 2001, PEDIATR PULM, V31, P419, DOI 10.1002/ppul.1069; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Shin HD, 2003, HUM MOL GENET, V12, P1279, DOI 10.1093/hmg/ddg142; Wardlaw AJ, 1999, J ALLERGY CLIN IMMUN, V104, P917, DOI 10.1016/S0091-6749(99)70069-2	18	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2008	121	1					26	27		10.1016/j.jaci.2007.10.002	http://dx.doi.org/10.1016/j.jaci.2007.10.002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	251KM	18061649				2022-12-18	WOS:000252372000004
J	Cecioni, I; Fassio, F; Gori, S; Giudizi, MG; Romagnani, S; Almerigogna, F				Cecioni, Ilaria; Fassio, Filippo; Gori, Stefano; Giudizi, Maria Grazia; Romagnani, Sergio; Almerigogna, Fabio			Eosinophilia in cholesterol atheroembolic disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ENDOTHELIAL-CELLS; INTERLEUKIN-5		[Cecioni, Ilaria; Fassio, Filippo; Gori, Stefano; Giudizi, Maria Grazia; Romagnani, Sergio; Almerigogna, Fabio] Univ Florence, Dept Internal Med, Div Immunol & Cellular Therapies, AOUC Careggi, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi	Cecioni, I (corresponding author), Univ Florence, Dept Internal Med, Div Immunol & Cellular Therapies, AOUC Careggi, Florence, Italy.	f.almerigogna@dmi.unifi.it	Almerigogna, Fabio/AAL-4583-2020; Fassio, Filippo/K-1408-2018; Almerigogna, Fabio/A-4636-2012	Fassio, Filippo/0000-0002-0732-9090; 				COGAN E, 1995, J ALLERGY CLIN IMMUN, V96, P427, DOI 10.1016/S0091-6749(95)70065-X; Freidlin IS., 2006, HUM PHYSIOL+, V32, P124, DOI DOI 10.1134/S0362119706030170; KASINATH BS, 1987, ARCH INTERN MED, V147, P1384, DOI 10.1001/archinte.147.8.1384; Mohle R, 1997, BRIT J HAEMATOL, V99, P732, DOI 10.1046/j.1365-2141.1997.4713279.x; Ochiai K, 1999, INT ARCH ALLERGY IMM, V120, P2, DOI 10.1159/000053583; Sari I, 2007, J RHEUMATOL, V34, P229; Simon D, 2007, J ALLERGY CLIN IMMUN, V119, P1291, DOI 10.1016/j.jaci.2007.02.010	7	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1470	1471		10.1016/j.jaci.2007.07.014	http://dx.doi.org/10.1016/j.jaci.2007.07.014			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17697705				2022-12-18	WOS:000251653800037
J	French, AR; Kim, S; Fehniger, TA; Pratt, JR; Yang, L; Song, YJ; Caligiuri, MA; Yokoyama, WM				French, Anthony R.; Kim, Sungjin; Fehniger, Todd A.; Pratt, Jennifer R.; Yang, Liping; Song, Yun Jeong; Caligiuri, Michael A.; Yokoyama, Wayne M.			Chronic lymphocytosis of functionally immature natural killer cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						natural killer cells; lymphocytosis; chronic natural killer cell lymphocytosis; natural killer cell-deficient mice; IL-15; CD11b; Mac1	FATAL LEUKEMIA; NK CELLS; IL-15; INTERLEUKIN-15; LYMPHOMA; EXPRESSION; NEOPLASMS; RESPONSES; SURVIVAL	Background: The development of natural killer (NK) cells in the bone marrow is not well characterized. We recently described a mouse (referred to as an NK cell-deficient [NKD] mouse) with a selective deficiency in NK cells caused by the insertion of a transgene construct into the genetic locus for the basic leucine zipper transcription factor ATF-2. NK cells in this mouse were both phenotypically and functionally immature and accumulated in the bone marrow at a stage at which constitutive NK cell proliferation occurs in wild-type mice. Objective: We hypothesized that excess IL-15 could potentially overcome this developmental block, allowing normal emigration of mature NK cells from the bone marrow to the periphery. Methods: Double-transgenic mice were generated by crossing the NKD mice with transgenic mice overexpressing IL-15. Results: The double-transgenic mice had a dramatic accumulation of phenotypically immature NK cells in the bone marrow and subsequently in the blood, liver, and spleen. NK cells from these double-transgenic mice manifested functional deficits similar to those observed in NK cells from NKD mice, as assessed by decreased cytokine production and cytotoxicity. Conclusion: Rather than bypass the observed developmental defect in NKD mice, excess IL-15 drove a massive accumulation of phenotypically and functionally immature NK cells in the bone marrow and periphery. Clinical implications: We propose that these double-transgenic mice will serve as a murine model of chronic NK cell lymphocytosis in human patients.	Washington Univ, Sch Med, Dept Pediat, Div Pediat Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Hematol Oncol, St Louis, MO 63110 USA; Ohio State Univ, Dept Med, Div Hematol Oncol, Columbus, OH 43210 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University System of Ohio; Ohio State University; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	French, AR (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Pediat Rheumatol, Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	french_a@kids.wustl.edu		Fehniger, Todd/0000-0002-8705-2887	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033903, R37AI034385, R01AI051345] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI034385, R01 AI033903, R01 AI051345] Funding Source: Medline; PHS HHS [K08] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andrews DM, 2001, J IMMUNOL, V166, P1796, DOI 10.4049/jimmunol.166.3.1796; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blaser BW, 2005, BLOOD, V105, P894, DOI 10.1182/blood-2004-05-1687; Cheung MMC, 2003, SEMIN HEMATOL, V40, P221, DOI 10.1016/S0037-1963(03)00136-7; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Costello RT, 2004, TRENDS IMMUNOL, V25, P328, DOI 10.1016/j.it.2004.04.005; De Lord C, 1998, LEUKEMIA LYMPHOMA, V31, P417, DOI 10.3109/10428199809059236; Dokun AO, 2001, J IMMUNOL, V167, P5286, DOI 10.4049/jimmunol.167.9.5286; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Fahlen L, 1997, EUR J IMMUNOL, V27, P2057, DOI 10.1002/eji.1830270833; Farag SS, 2003, INT J HEMATOL, V78, P7, DOI 10.1007/BF02983234; Fehniger TA, 2001, BLOOD CELL MOL DIS, V27, P223, DOI 10.1006/bcmd.2001.0379; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; French AR, 2006, J IMMUNOL, V177, P4981, DOI 10.4049/jimmunol.177.8.4981; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Held W, 1996, J EXP MED, V184, P2037, DOI 10.1084/jem.184.5.2037; Huang Q, 2005, AM J SURG PATHOL, V29, P1540, DOI 10.1097/01.pas.0000168510.54867.9a; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2006, BLOOD, V107, P1024, DOI 10.1182/blood-2005-04-1493; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kwong YL, 2005, LEUKEMIA, V19, P2186, DOI 10.1038/sj.leu.2403955; Lamy T, 2003, SEMIN HEMATOL, V40, P185, DOI 10.1016/S0037-1963(03)00133-1; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lima M, 2004, AM J PATHOL, V165, P1117, DOI 10.1016/S0002-9440(10)63373-1; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Morice WG, 2001, LEUKEMIA LYMPHOMA, V41, P277, DOI 10.3109/10428190109057982; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Noguchi M, 2005, J NEUROL SCI, V232, P119, DOI 10.1016/j.jns.2005.01.013; OHNO Y, 1989, CANCER, V64, P63, DOI 10.1002/1097-0142(19890701)64:1<63::AID-CNCR2820640111>3.0.CO;2-#; Okuno SH, 1996, BRIT J HAEMATOL, V93, P810; Orange JS, 2001, CLIN IMMUNOL, V99, P53, DOI 10.1006/clim.2001.5002; Oshimi K, 2005, HEMATOLOGY, V10, P237, DOI 10.1080/10245330400026162; Oshimi K, 2003, INT J HEMATOL, V78, P18, DOI 10.1007/BF02983235; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ruskova AK, 2004, LEUKEMIA LYMPHOMA, V45, P2427, DOI 10.1080/10428190400004513; Suzuki R, 2004, LEUKEMIA, V18, P763, DOI 10.1038/sj.leu.2403262; TEFFERI A, 1994, BLOOD, V84, P2721; Wex H, 2005, J PEDIAT HEMATOL ONC, V27, P85, DOI 10.1097/01.mph.0000152571.06437.3f; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	45	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					924	931		10.1016/j.jaci.2007.05.022	http://dx.doi.org/10.1016/j.jaci.2007.05.022			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17604094	Bronze			2022-12-18	WOS:000250157700029
J	Kang, JB; Rothenberg, SS; Kravviec, ME; Sagel, SD				Kang, J. Brian; Rothenberg, Steven S.; Kravviec, Marzena E.; Sagel, Scott D.			Diagnosis of a symptomatic tracheal pouch by means of bronchoscopy after neonatal repair of a tracheoesophageal fistula	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						tracheal pouch,diverticulum; tracheoesophageal fistula; thoracoscopic surgery; recurrent pneumonias	CONGENITAL ESOPHAGEAL ATRESIA; COMPLICATIONS; DIVERTICULUM; MANAGEMENT		Childrens Hosp, Dept Pediat, Denver, CO 80218 USA; Rocky Mt Hosp Children, Dept Pediat Surg, Denver, CO USA; Natl Jewish Med & Res Ctr, Div Pediat Pulm Med, Denver, CO USA; Univ Colorado Denver & Hlth Sci Ctr, Denver, CO 80202 USA	Children's Hospital Colorado; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Sagel, SD (corresponding author), Childrens Hosp, Dept Pediat, 1056 E 19th Ave,Box B 395, Denver, CO 80218 USA.	sagel.scott@tchden.org						Agrawal L, 1999, ARCH DIS CHILD, V81, P404, DOI 10.1136/adc.81.5.404; Bhatnagar V, 1998, J PEDIATR SURG, V33, P1323, DOI 10.1016/S0022-3468(98)90181-6; CHETCUTI P, 1988, BRIT MED J, V297, P344, DOI 10.1136/bmj.297.6644.344; CHETCUTI P, 1993, ARCH DIS CHILD, V68, P167, DOI 10.1136/adc.68.2.167; DELIUS RE, 1992, SURGERY, V112, P527; Johnson LB, 2007, INT J PEDIATR OTORHI, V71, P527, DOI 10.1016/j.ijporl.2006.10.024; Kovesi T, 2004, CHEST, V126, P915, DOI 10.1378/chest.126.3.915; LEQUIEN P, 1978, ARCH FR PEDIATR, V35, P641	8	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2007	120	3					541	543		10.1016/j.jaci.2007.07.050	http://dx.doi.org/10.1016/j.jaci.2007.07.050			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	211DV	17765755				2022-12-18	WOS:000249505400010
J	Mjaanes, CM; Hendershot, RW; Quinones, RR; Gelfand, EW				Mjaanes, Christopher M.; Hendershot, Richard W.; Quinones, Ralph R.; Gelfand, Erwin W.			A novel mutation of intron 22 in Janus kinase 3-deficient severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DEFICIENCY		Natl Jewish Med & Res Ctr, Div Clin Immunol & Allergy, Dept Pediat, Denver, CO USA; Childrens Hosp, Div Pediat Hematol Oncol & Bone Marrow Transplant, Denver, CO 80218 USA	National Jewish Health; Children's Hospital Colorado	Mjaanes, CM (corresponding author), Natl Jewish Med & Res Ctr, Div Clin Immunol & Allergy, Dept Pediat, Denver, CO USA.	gelfande@njc.org						Bozzi F, 1998, BRIT J HAEMATOL, V102, P1363, DOI 10.1111/j.1365-2141.1998.tb08990.x; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; GLANZMANN E, 1950, ANN PAEDIAT, V174, P1; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Notorangelo LD, 2001, HUM MUTAT, V18, P255; Roberts JL, 2004, BLOOD, V103, P2009, DOI 10.1182/blood-2003-06-2104; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Schuler MK, 2003, UNFALLCHIRURG, V106, P73, DOI 10.1007/s00113-002-0499-z	10	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2007	119	6					1542	1545		10.1016/j.jaci.2007.03.004	http://dx.doi.org/10.1016/j.jaci.2007.03.004			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	178PO	17433830				2022-12-18	WOS:000247232800036
J	Pahwa, S; Muresan, P; Sleasman, J; Fenton, T; Moye, J; Deveikis, A; Wara, D; Van Dyke, R				Pahwa, Savita; Muresan, Petronella; Sleasman, John; Fenton, Terry; Moye, John; Deveikis, Audra; Wara, Diane; Van Dyke, Russ		AIDS Trials Study	Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: Results of Pediatric AIDS Clinical Trials Study 402	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HUMAN-IMMUNODEFICIENCY-VIRUS; T-LYMPHOCYTES; INTERLEUKIN-2; INFECTION; INDUCTION; THERAPY		Univ Miami, Miller Sch Med, Miami, FL 33152 USA; Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; Childrens Hosp, St Petersburg, FL USA; Univ S Florida, Tampa, FL USA; NICHD, Pediat Adolescent & Maternal AIDS Branch, Bethesda, MD USA; Long Beach Mem Med Ctr, Long Beach, CA USA; Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA; Tulane Univ Hosp, New Orleans, LA USA	University of Miami; Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco; Tulane University	Pahwa, S (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33152 USA.	spahwa@med.miami.edu	Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; moye, john/0000-0001-9976-8586	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033345, N01HD033162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041089] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI41089] Funding Source: Medline; NICHD NIH HHS [N01 HD 33345, N01 HD 33162] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adachi Y, 1996, J IMMUNOL, V157, P4184; Davey RT, 1997, J INFECT DIS, V175, P781, DOI 10.1086/513971; Hengge UR, 1998, AIDS, V12, pF225, DOI 10.1097/00002030-199817000-00003; Kovacs JA, 2005, J CLIN INVEST, V115, P2139, DOI 10.1172/JCI23196; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Starr SE, 2003, AIDS, V17, P2181, DOI 10.1097/00002030-200310170-00006; Steppan S, 2006, J INTERF CYTOK RES, V26, P171, DOI 10.1089/jir.2006.26.171	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2007	119	6					1538	1541		10.1016/j.jaci.2006.12.674	http://dx.doi.org/10.1016/j.jaci.2006.12.674			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	178PO	17418382				2022-12-18	WOS:000247232800034
J	Nolan, RC; de Leon, MP; Rolland, JM; Loh, RKS; O'Hehir, RE				Nolan, Richard C.; de Leon, Maria P.; Rolland, Jennifer M.; Loh, Richard K. S.; O'Hehir, Robyn E.			What's in a kiss: Peanut allergen transmission as a sensitizer?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXPOSURE		Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; Princess Margaret Hosp Children, Dept Immunol & Allergy, Perth, WA, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; University of Western Australia	Nolan, RC (corresponding author), Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia.	rich@perthnolans.com	O'Hehir, Robyn E/H-3627-2011; Rolland, Jennifer/E-7543-2011	O'Hehir, Robyn E/0000-0002-3489-7595; 				Fox AT, 2006, J ALLERGY CLIN IMMUN, V117, pS35, DOI 10.1016/j.jaci.2005.12.145; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Maloney JM, 2006, J ALLERGY CLIN IMMUN, V118, P719, DOI 10.1016/j.jaci.2006.05.017; Peeters KABM, 2004, J ALLERGY CLIN IMMUN, V113, P1000, DOI 10.1016/j.jaci.2004.03.005; Perry TT, 2004, J ALLERGY CLIN IMMUN, V113, P973, DOI 10.1016/j.jaci.2004.02.035; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x	7	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					755	755		10.1016/j.jaci.2006.10.027	http://dx.doi.org/10.1016/j.jaci.2006.10.027			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17141858				2022-12-18	WOS:000244925000036
J	Bielory, L; Danzig, M; Gates, D				Bielory, L.; Danzig, M.; Gates, D.			Ocular symptoms of seasonal allergic rhinitis can be treated effectively with an inhaled corticosteroid (Mometasone Furoate Nasal Spray)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					UMDNJ, New Jersey Med Sch, Newark, NJ USA; Schering Plough Res Inst, Kenilworth, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Merck & Company; Schering-Plough Research Institute									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		237	S61	S61		10.1016/j.jaci.2006.11.260	http://dx.doi.org/10.1016/j.jaci.2006.11.260			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400237
J	Bowie, KJ; Scarupa, MD; Li, HH				Bowie, K. J.; Scarupa, M. D.; Li, H. H.			Unnecessary abdominal surgeries secondary to undiagnosed Hereditary Angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Bowie, K. J.; Scarupa, M. D.; Li, H. H.] Inst Asthma & Allergy, Wheaton, IL USA										0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		1082	S276	S276		10.1016/j.jaci.2006.12.452	http://dx.doi.org/10.1016/j.jaci.2006.12.452			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401465
J	Chen, E; Oliver-Welker, T; Rodgers, D; Strunk, RC				Chen, Edith; Oliver-Welker, Tina; Rodgers, Denise; Strunk, Robert C.			Developing measures of symptom perception for children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD ASTHMA; DYSPNEA		Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Washington Univ, St Louis, MO USA	University of British Columbia; Washington University (WUSTL)	Chen, E (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	echen@psych.ubc.ca						Banzett RB, 2000, AM J RESP CRIT CARE, V162, P1178, DOI 10.1164/ajrccm.162.3.9909112; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Fritz GK, 1996, J PEDIATR PSYCHOL, V21, P153, DOI 10.1093/jpepsy/21.2.153; Julius SM, 2002, PEDIATR PULM, V34, P425, DOI 10.1002/ppul.10199; Rietveld S, 1998, PSYCHOL MED, V28, P407, DOI 10.1017/S0033291797006387; Rietveld S, 1996, J PEDIATR PSYCHOL, V21, P367, DOI 10.1093/jpepsy/21.3.367; SIMON PM, 1990, AM REV RESPIR DIS, V142, P1009, DOI 10.1164/ajrccm/142.5.1009; Wamboldt MZ, 2000, J ALLERGY CLIN IMMUN, V106, P1102; [No title captured]	9	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					248	250		10.1016/j.jaci.2006.08.031	http://dx.doi.org/10.1016/j.jaci.2006.08.031			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	127YL	17208610	Bronze			2022-12-18	WOS:000243622200036
J	Drazen, JM; Lenfant, C; Hurd, SS				Drazen, Jeffrey M.; Lenfant, Claude; Hurd, Suzanne S.			Acorns and inhalers: The Asthma Clinical Research Network	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						beta-agonists; albuterol; pharmacogenetics	ALBUTEROL		Brigham & Womens Hosp, Resp Dis Div, Boston, MA 02115 USA; Global Initiat Asthma, Gaithersburg, MD USA	Harvard University; Brigham & Women's Hospital	Drazen, JM (corresponding author), New England Journal Med, 10 Shattuck St, Boston, MA 02115 USA.	jdrazen@nejm.org	Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5	2	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					28	29		10.1016/j.jaci.2006.06.011	http://dx.doi.org/10.1016/j.jaci.2006.06.011			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	127YL	17137864				2022-12-18	WOS:000243622200004
J	Frigas, E				Frigas, E.			A pilot, prospective, double blind, placebo-controlled treatment trial with itraconazole orally in patients with chronic rhinosinusitis and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Frigas, E.] Mayo Clin, Rochester, MN USA	Mayo Clinic									0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		560	S142	S142		10.1016/j.jaci.2006.11.685	http://dx.doi.org/10.1016/j.jaci.2006.11.685			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400559
J	Gergen, PJ; Apter, AJ				Gergen, Peter J.; Apter, Andrea J.			Unconventional risk factors: Another pathway to understanding health disparities	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; disparities; adherence; morbidity	ASTHMA MORBIDITY; CHILDREN; ADHERENCE; CARE; NONCOMPLIANCE; DEPRESSION; OUTCOMES; IMPACT; ADULTS; POOR		NIAID, Div Allergy Immunol & Clin Immunol, NIH, Bethesda, MD 20892 USA; Univ Penn, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Gergen, PJ (corresponding author), NIAID, Div Allergy Immunol & Clin Immunol, NIH, 6610 Rockledge Dr,Rm 3067, Bethesda, MD 20892 USA.	pgergen@niaid.nih.gov			NHLBI NIH HHS [HL04337, HL073932] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004337, R01HL073932] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P512, DOI 10.1016/j.jaci.2005.12.1353; Apter AJ, 2006, J ALLERGY CLIN IMMUN, V117, P345, DOI 10.1016/j.jaci.2005.11.026; Barnes KC, 2006, J ALLERGY CLIN IMMUN, V117, P243, DOI 10.1016/j.jaci.2005.11.030; Bender BG, 2006, AM J RESP CRIT CARE, V173, P953, DOI 10.1164/rccm.200511-1706PP; Bonner S, 2002, J ASTHMA, V39, P167, DOI 10.1081/JAS-120002198; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Eschbach K, 2004, AM J PUBLIC HEALTH, V94, P1807, DOI 10.2105/AJPH.94.10.1807; Evans R, 1999, J PEDIATR-US, V135, P332, DOI 10.1016/S0022-3476(99)70130-7; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Gupta RS, 2006, J ALLERGY CLIN IMMUN, V117, P351, DOI 10.1016/j.jaci.2005.11.047; *I MED, 2003, UN TREATM CONFR RAC; Joseph CLM, 2006, J ALLERGY CLIN IMMUN, V117, P233, DOI 10.1016/j.jaci.2005.11.004; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; Lowe RA, 2005, MED CARE, V43, P792, DOI 10.1097/01.mlr.0000170413.60054.54; Matthews AK, 2002, J HEALTH COMMUN, V7, P205, DOI 10.1080/10810730290088094; McQuaid EL, 2003, J PEDIATR PSYCHOL, V28, P323, DOI 10.1093/jpepsy/jsg022; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; Ortega AN, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e1; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084; *US DEP HHS, 2005, PUBL US DEP HHS; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028; WILLIAMS LK, 2006, J ALLERGY CLIN IMMUN; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625	25	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					165	167		10.1016/j.jaci.2006.10.032	http://dx.doi.org/10.1016/j.jaci.2006.10.032			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	127YL	17141856				2022-12-18	WOS:000243622200023
J	Guo, JP; Myers, AC; Choi, O; Lee, HS; Zhu, Z; Hudson, SA; Brummet, M; Bovin, NV; Crocker, PR; Bochner, BS				Guo, J. P.; Myers, A. C.; Choi, O.; Lee, H. S.; Zhu, Z.; Hudson, S. A.; Brummet, M.; Bovin, N. V.; Crocker, P. R.; Bochner, B. S.			Ligands for Siglec-8 and Siglec-F: Binding characteristics and tissue distribution	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Guo, J. P.; Myers, A. C.; Choi, O.; Lee, H. S.; Zhu, Z.; Hudson, S. A.; Brummet, M.; Bochner, B. S.] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Bovin, N. V.] Russian Acad Sci, Moscow, Russia; [Crocker, P. R.] Univ Dundee, Dundee, Scotland	Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; University of Dundee			Bovin, Nicolai/P-2948-2017	Bovin, Nicolai/0000-0001-8669-4477					0	5	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		1170	S299	S299		10.1016/j.jaci.2006.12.542	http://dx.doi.org/10.1016/j.jaci.2006.12.542			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460401553
J	Howell, MD; Kim, BE; Boguniewicz, M; Leung, DYM				Howell, M. D.; Kim, B. E.; Boguniewicz, M.; Leung, D. Y. M.			Modulation of filaggrin by Th2 cytokines in the skin of atopic dermatitis (AD)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Howell, M. D.; Boguniewicz, M.; Leung, D. Y. M.] Natl Jewish Med & Res Ctr, Denver, CO USA; [Kim, B. E.] Inje Univ, Sanggye Paik Hosp, Seoul, South Korea	National Jewish Health; Inje University									0	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		1108	S283	S283		10.1016/j.jaci.2006.12.479	http://dx.doi.org/10.1016/j.jaci.2006.12.479			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460401491
J	Hungness, SI; Singer, AM; Akin, C				Hungness, S. I.; Singer, A. M.; Akin, C.			Food-dependent exercise-induced anaphylaxis associated with clonal mast cells carrying an activating c-kit mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		111	S29	S29		10.1016/j.jaci.2006.11.132	http://dx.doi.org/10.1016/j.jaci.2006.11.132			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400112
J	Jaffe, JS; Massanari, M				Jaffe, Jonathan S.; Massanari, Marc			In response to dosing omalizumab in allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIBODY OMALIZUMAB		Novartis Pharmaceut Corp, Exploratory Clin Dev, E Hanover, NJ USA; Novartis Pharmaceut Corp, US Clin Dev & Med Affairs, E Hanover, NJ USA	Novartis; Novartis	Jaffe, JS (corresponding author), Novartis Pharmaceut Corp, Exploratory Clin Dev, E Hanover, NJ USA.	jonathan.jaffe@novartis.com						Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; Rambasek T, 2006, J ALLERGY CLIN IMMUN, V117, P708, DOI 10.1016/j.jaci.2005.11.042; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101	4	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					255	256		10.1016/j.jaci.2006.10.026	http://dx.doi.org/10.1016/j.jaci.2006.10.026			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	127YL	17208614				2022-12-18	WOS:000243622200043
J	Keith, PK; Desrosiers, M; Waserman, S; Schellenberg, RR				Keith, P. K.; Desrosiers, M.; Waserman, S.; Schellenberg, R. R.			Burden of illness of allergic rhinitis in Canada	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Keith, P. K.] McMaster Univ, Hamilton, ON, Canada; [Desrosiers, M.] Univ Montreal, Montreal, PQ, Canada; [Waserman, S.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	McMaster University; Universite de Montreal; University of British Columbia									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		893	S227	S227		10.1016/j.jaci.2006.12.261	http://dx.doi.org/10.1016/j.jaci.2006.12.261			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460401277
J	Lommatzsch, M				Lommatzsch, Marek			The neural underpinnings of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Rostock, Dept Pneumol, Rostock, Germany	University of Rostock	Lommatzsch, M (corresponding author), Univ Rostock, Dept Pneumol, Rostock, Germany.	marek.lommatzsch@med.uni-rostock.de						Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Lommatzsch M, 2005, AM J RESP CRIT CARE, V171, P115, DOI 10.1164/rccm.200406-758OC; Nassenstein C, 2006, J ALLERGY CLIN IMMUN, V118, P597, DOI 10.1016/j.jaci.2006.04.052	3	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					254	255		10.1016/j.jaci.2006.10.004	http://dx.doi.org/10.1016/j.jaci.2006.10.004			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	127YL	17125824				2022-12-18	WOS:000243622200041
J	Nathan, R; Berger, W; Yang, W; Cheema, A; Silvey, MJ; Wu, W; Faris, M; Philpot, E				Nathan, R.; Berger, W.; Yang, W.; Cheema, A.; Silvey, M. J.; Wu, W.; Faris, M.; Philpot, E.			Once daily fluticasone furoate* nasal spray (FFNS), a novel enhanced affinity steroid, provides 24-hour relief for the nasal symptoms of perennial allergic rhinitis (PAR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Nathan, R.] Asthma & Allergy Assoc PC, Colorado Springs, CO USA; [Berger, W.] So Calif Res, Mission Viejo, CA USA; [Yang, W.] Asthma & Allergy Ctr, Ottawa, ON, Canada; [Cheema, A.] Private Practice, Mississauga, ON, Canada; [Silvey, M. J.; Wu, W.; Faris, M.; Philpot, E.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	GlaxoSmithKline									0	5	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		254	S65	S65		10.1016/j.jaci.2006.11.278	http://dx.doi.org/10.1016/j.jaci.2006.11.278			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400254
J	Pacharu, P; Visitsunthorn, N; Jirapongsananuruk, O; Vichyanond, P				Pacharu, P.; Visitsunthorn, N.; Jirapongsananuruk, O.; Vichyanond, P.			Vernal keratoconjunctivitis (vkc) treated with 0.1% Fk-506 ophthalmic ointment: Result of a three years follow-up	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Pacharu, P.; Visitsunthorn, N.; Jirapongsananuruk, O.; Vichyanond, P.] Siriraj Hosp, Bangkok, Thailand	Mahidol University									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		602	S153	S153		10.1016/j.jaci.2006.11.536	http://dx.doi.org/10.1016/j.jaci.2006.11.536			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400601
J	Torres, MJ; Blanca-Lopez, N; Martin, E; Mayorga, C; Rodriguez-Bada, JL; Dona, I; Cauto, G; Antunez, C; Romerol, JJ; Blanca, M				Torres, M. J.; Blanca-Lopez, N.; Martin, E.; Mayorga, C.; Rodriguez-Bada, J. L.; Dona, I.; Cauto, G.; Antunez, C.; Romerol, J. J.; Blanca, M.			Cross-reactivity between penicillins and cephalosporins with the same side chain: Amoxicillin and cefadroxil	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					Carlos Haya Hosp, Allergy Serv, Malaga, Spain; Doce Octubre Hosp, Allergy Serv, Madrid, Spain; Carlos Haya Hosp, Fdn IMABIS, Res Lab, Malaga, Spain	Hospital Carlos Haya; Hospital Universitario 12 de Octubre; FIMABIS; Hospital Carlos Haya			Torres, Maria/GVU-3391-2022; Mayorga, Cristobalina/D-7167-2018; Mayorga, Lina/FBO-7730-2022	Mayorga, Cristobalina/0000-0001-8852-8077; 					0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		145	S38	S38		10.1016/j.jaci.2006.11.166	http://dx.doi.org/10.1016/j.jaci.2006.11.166			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460400146
J	Tripathy, I; Sterling, R; Clements, D; Wu, W; Faris, M; Philpot, E				Tripathy, I.; Sterling, R.; Clements, D.; Wu, W.; Faris, M.; Philpot, E.			Lack of effect on hypothalamic-pituitary-adrenal (HPA) axis function by once-daily fluticasone furoate* nasal spray (FFNS) 110 mcg in children with perennial allergic rhinitis (PAR) *USAN approved name	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Tripathy, I.] Clin Res Ozarks, Rolla, MO USA; [Sterling, R.] Carolina Res, Orangeburg, NY USA; [Clements, D.; Wu, W.; Faris, M.; Philpot, E.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	GlaxoSmithKline									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		909	S232	S232		10.1016/j.jaci.2006.12.277	http://dx.doi.org/10.1016/j.jaci.2006.12.277			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401293
J	Zingale, LC; Bork, K; Farkas, H; Bygum, A; Bouillet, L; Caballero, T; Longhurst, H; Nielsen, EW; Bilo, B; Bucher, C; Perricone, R; Cicardi, M				Zingale, L. C.; Bork, K.; Farkas, H.; Bygum, A.; Bouillet, L.; Caballero, T.; Longhurst, H.; Nielsen, E. Waage; Bilo, B.; Bucher, C.; Perricone, R.; Cicardi, M.			The European register of Hereditary Angioedema: Experience and preliminary results	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Zingale, L. C.; Cicardi, M.] Univ Milan, Milan, Italy; [Bork, K.] Johannes Gutenberg Univ Mainz, D-6500 Mainz, Germany; [Farkas, H.] Semmelweis, Budapest, Hungary; [Bygum, A.] Odense Univ, Odense, Denmark; [Bouillet, L.] CHU Grenoble, F-38043 Grenoble, France; [Caballero, T.] Univ Hosp La Paz, Madrid, Spain; [Longhurst, H.] St Bartholomews Hosp, London, England; [Nielsen, E. Waage] Dept Anesthesiol, Bodo, Norway; [Bilo, B.] Univ Cracow, Krakow, Poland; [Bucher, C.] Univ Zurich, Zurich, Switzerland; [Perricone, R.] Univ Roma Tor Vergata, Rome, Italy	University of Milan; Johannes Gutenberg University of Mainz; University of Southern Denmark; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Hospital Universitario La Paz; University of London; Queen Mary University London; Jagiellonian University; University of Zurich; University of Rome Tor Vergata			Zingale, Lorenza Chiara/AAB-8598-2020; Bork, Konrad/AAE-4985-2022; Caballero, Teresa/AAU-3982-2020	Bork, Konrad/0000-0002-6084-4577; Caballero, Teresa/0000-0003-3005-9858; Bygum, Anette/0000-0002-3004-0180					0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		1079	S276	S276		10.1016/j.jaci.2006.12.449	http://dx.doi.org/10.1016/j.jaci.2006.12.449			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401462
J	Frank, MM; Atkinson, JP				Frank, Michael M.; Atkinson, John P.			Homozygous C1 inhibitor deficiency: The conclusion of a long search	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							INCREASED VASCULAR-PERMEABILITY; HEREDITARY ANGIONEUROTIC EDEMA; INHIBITOR; COMPLEMENT; ANGIOEDEMA; ACTIVATION; COMPONENT; PATHWAY; MICE		Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Duke University; Duke University; Duke University; Washington University (WUSTL)	Frank, MM (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Box 3352, Durham, NC 27710 USA.	frank007@mc.duke.edu		Atkinson, John/0000-0002-2514-3441				Agostoni A, 1999, IMMUNOPHARMACOLOGY, V44, P21, DOI 10.1016/S0162-3109(99)00107-1; ALSENZ J, 1989, J CLIN INVEST, V83, P1794, DOI 10.1172/JCI114084; Blanch A, 2006, J ALLERGY CLIN IMMUN, V118, P1330, DOI 10.1016/j.jaci.2006.07.035; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Davis A. E., 1998, HUMAN COMPLEMENT SYS, P455; Davis A R, 2001, J Pediatr Adolesc Gynecol, V14, P3, DOI 10.1016/S1083-3188(00)00076-0; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; FOLKERD EJ, 1980, IMMUNOLOGY, V41, P179; Frank MM, 1976, ANN INTERN MED, V84, P589; GELFAND JA, 1979, MEDICINE, V58, P321, DOI 10.1097/00005792-197907000-00004; Hack CE, 2004, J ALLERGY CLIN IMM S, V114, pS75; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Lee EDH, 2003, IMMUNOL LETT, V89, P155, DOI 10.1016/S0165-2478(03)00130-5; Osler W, 1888, AM J MED SCI, V95, P362; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; Petersen SV, 2000, MOL IMMUNOL, V37, P803, DOI 10.1016/S0161-5890(01)00004-9; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; Verpy E, 1996, AM J HUM GENET, V59, P308; Wong NKH, 1999, MOL IMMUNOL, V36, P853, DOI 10.1016/S0161-5890(99)00106-6; ZAHEDI R, 1995, J CLIN INVEST, V95, P1299, DOI 10.1172/JCI117780; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2505	22	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2006	118	6					1327	1329		10.1016/j.jaci.2006.08.040	http://dx.doi.org/10.1016/j.jaci.2006.08.040			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	117NP	17157664				2022-12-18	WOS:000242880300019
J	Steinke, JW; Negri, J; Enelow, R; Baramski, DF; Borish, L				Steinke, John W.; Negri, Julie; Enelow, Richard; Baramski, Dawn F.; Borish, Larry			Proinflammatory effects of IL-4 antagonism	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTERLEUKIN-4; ASTHMA; ALPHA		Univ Virginia, Asthma & Allerg Dis Ctr, Beirne Carter Ctr Immunol Res, Dept Med,Hlth Syst, Charlottesville, VA 22901 USA; Yale Univ, Sch Med, New Haven, CT USA	University of Virginia; Yale University	Steinke, JW (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, Beirne Carter Ctr Immunol Res, Dept Med,Hlth Syst, Charlottesville, VA 22901 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047737, K24AI001793] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00847] Funding Source: Medline; NIAID NIH HHS [AI01793, AI47737] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; CHANEZ P, 1994, J ALLERGY CLIN IMMUN, V94, P997, DOI 10.1016/0091-6749(94)90118-X; Enelow R, 2004, J ALLERGY CLIN IMMUN, V113, P560, DOI 10.1016/j.jaci.2003.12.004; SONE S, 1992, EUR RESPIR J, V5, P174; Steinke JW, 2004, IMMUNOL ALLERGY CLIN, V24, P599, DOI 10.1016/j.iac.2004.06.008	6	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					756	758		10.1016/j.jaci.2006.05.002	http://dx.doi.org/10.1016/j.jaci.2006.05.002			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950298	Bronze			2022-12-18	WOS:000240649000034
J	Strickland, MHV				Strickland, Maurice H. V.			How solid is the academy position paper on mold exposure?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MACROCYCLIC TRICHOTHECENE MYCOTOXINS; FUNGAL FRAGMENTS		Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Kansas; University of Kansas Medical Center	Strickland, MHV (corresponding author), Univ Kansas, Sch Med, Wichita, KS 67214 USA.							Brasel TL, 2005, APPL ENVIRON MICROB, V71, P7376, DOI 10.1128/AEM.71.11.7376-7388.2005; Brasel TL, 2005, APPL ENVIRON MICROB, V71, P114, DOI 10.1128/AEM.71.1.114-122.2005; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Cho SH, 2005, ATMOS ENVIRON, V39, P5454, DOI 10.1016/j.atmosenv.2005.05.042; Gorny RL, 2002, APPL ENVIRON MICROB, V68, P3522, DOI 10.1128/AEM.68.7.3522-3531.2002	5	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					763	764		10.1016/j.jaci.2006.07.008	http://dx.doi.org/10.1016/j.jaci.2006.07.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950305	Bronze			2022-12-18	WOS:000240649000041
J	Weidinger, S; Rodriguez, E; Zhao, YW; Jenneck, C; Ring, J; Illig, T; Diaz-Lacava, A; Liao, HH; Maintz, L; Nothen, MM; Baurecht, H; Klopp, N; Lee, SP; Hagemann, T; McLean, WHI; Irvine, AD; Wagenpfeil, S; Palmer, CNA; Behrendt, M; Novak, N				Weidinger, S.; Rodriguez, E.; Zhao, Y. W.; Jenneck, C.; Ring, J.; Illig, T.; Diaz-Lacava, A.; Liao, H. H.; Maintz, L.; Nothen, M. M.; Baurecht, H.; Klopp, N.; Lee, S. P.; Hagemann, T.; McLean, W. H. I.; Irvine, A. D.; Wagenpfeil, S.; Palmer, C. N. A.; Behrendt, M.; Novak, N.			Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations (vol 118, pg 152, 2006)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction													McLean, William HI/C-6352-2009; Weidinger, Stephan/C-8461-2011; Baurecht, Hansjoerg/C-4035-2013; Irvine, Alan D/A-3982-2008; Ring, Johannes/GLN-4341-2022	Weidinger, Stephan/0000-0003-3944-252X; Baurecht, Hansjoerg/0000-0002-9265-5594; Irvine, Alan D/0000-0002-9048-2044; Ring, Johannes/0000-0001-8236-3152				Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004	1	5	5	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					724	724						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV					2022-12-18	WOS:000240649000029
J	Tcheurekdjian, H; Gundling, K				Tcheurekdjian, Haig; Gundling, Katherine			Continuous hydromorphone infusion for opioid intolerance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MAST-CELLS; HISTAMINE; MORPHINE; FENTANYL; RELEASE		Univ Calif San Francisco, Div Allergy & Immunol, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tcheurekdjian, H (corresponding author), Univ Calif San Francisco, Div Allergy & Immunol, Dept Med, San Francisco, CA 94143 USA.							EBERTZ JM, 1986, AGENTS ACTIONS, V18, P455, DOI 10.1007/BF01964946; Grammer LC, 2005, ALLERGY ASTHMA PROC, V26, P76; HERMENS JM, 1985, ANESTHESIOLOGY, V62, P124, DOI 10.1097/00000542-198502000-00005; *JOINT COUNC ALL A, 1999, ANN ALLERG ASTHMA IM, V83, pS665; Nasser SMS, 2001, CLIN EXP ALLERGY, V31, P1014, DOI 10.1046/j.1365-2222.2001.01090.x; REIDENBERG MM, 1988, CLIN PHARMACOL THER, V44, P376, DOI 10.1038/clpt.1988.167; *THOMS HEALTHC INC, 1974, THOMPS MICR HEALCH S; Veien M, 2000, ANESTHESIOLOGY, V92, P1074, DOI 10.1097/00000542-200004000-00026; WHITE PF, 1983, ANESTHESIOLOGY, V59, P294, DOI 10.1097/00000542-198310000-00005	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2006	118	1					282	284		10.1016/j.jaci.2006.03.026	http://dx.doi.org/10.1016/j.jaci.2006.03.026			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	065UH	16815169				2022-12-18	WOS:000239184800037
J	Bush, RK; Peden, DB				Bush, RK; Peden, DB			Advances in environmental and occupational disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						environment; allergens; asthma; occupational diseases; environmental controls	AIR-POLLUTION; ALLERGEN AVOIDANCE; MAJOR ALLERGEN; PUBLIC-HEALTH; IN-VIVO; ASTHMA; CHILDREN; IGE; EXPOSURE; ENDOTOXIN	As with the previous year, 2005 was a very active year for investigation of the effect of environmental agents on allergic disease, be they allergens, pollutants, bioaerosols, or occupationally encountered agents. There were a large number of articles on the prevalence of allergic disease in the United States, identification and characterization of a number of allergens, and the role of indoor allergens and potential mitigation of the effect of such allergens, as well as the hygiene hypothesis, air pollution, and the effect of these agents on airway disease. The Journal of Allergy and Clinical Immunology also saw very interesting case reports and mechanistic studies examining the causes of occupational immune-mediated disease. There were also reports on gene-environment interactions, highlighting the importance of such interactions in modulating the risk for development of allergic disease. That these interactions have proved to be remarkably complex comes as no surprise to the allergy and immunology community because allergists and immunologists have long appreciated the role of environmental influences on disease.	William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; Univ Wisconsin, Dept Med, Sect Allergy Pulm & Crit Care Med, Madison, WI 53706 USA; Univ N Carolina, Sch Med, Div Pediat Immunol & Infect Dis, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bush, RK (corresponding author), William S Middleton Mem Vet Adm Med Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	Robert.Bush@med.va.gov		Peden, David/0000-0003-4526-4627				Adler A, 2005, J ALLERGY CLIN IMMUN, V115, P67, DOI 10.1016/j.jaci.2004.10.008; Alday E, 2005, J ALLERGY CLIN IMMUN, V115, P634, DOI 10.1016/j.jaci.2004.10.052; Alexis NE, 2005, J ALLERGY CLIN IMMUN, V115, P345, DOI 10.1016/j.jaci.2004.11.040; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P133, DOI 10.1016/j.jaci.2005.04.022; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Asturias JA, 2005, J ALLERGY CLIN IMMUN, V115, P1210, DOI 10.1016/j.jaci.2005.02.012; Barderas R, 2005, J ALLERGY CLIN IMMUN, V115, P351, DOI 10.1016/j.jaci.2004.10.001; Boasen J, 2005, J ALLERGY CLIN IMMUN, V116, P185, DOI 10.1016/j.jaci.2005.03.015; Brisbon N, 2005, J ALLERGY CLIN IMMUN, V115, P1024, DOI 10.1016/j.jaci.2005.02.020; Cho JY, 2005, J ALLERGY CLIN IMMUN, V116, P1116, DOI 10.1016/j.jaci.2005.08.015; Dreborg S, 2005, J ALLERGY CLIN IMMUN, V116, P620, DOI 10.1016/j.jaci.2005.06.027; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Eggleston PA, 2005, J ALLERGY CLIN IMMUN, V116, P122, DOI 10.1016/j.jaci.2005.04.012; Elliott L, 2005, J ALLERGY CLIN IMMUN, V116, P127, DOI 10.1016/j.jaci.2005.03.038; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Green BJ, 2005, J ALLERGY CLIN IMMUN, V115, P1043, DOI 10.1016/j.jaci.2005.02.009; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Hilger C, 2005, J ALLERGY CLIN IMMUN, V115, P617, DOI 10.1016/j.jaci.2004.11.052; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Karisola P, 2005, J ALLERGY CLIN IMMUN, V115, P598, DOI 10.1016/j.jaci.2004.09.015; Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P1056, DOI 10.1016/j.jaci.2005.02.006; Martyny JW, 2005, J ALLERGY CLIN IMMUN, V116, P630, DOI 10.1016/j.jaci.2005.05.008; Matsui EC, 2005, J ALLERGY CLIN IMMUN, V115, P358, DOI 10.1016/j.jaci.2004.11.007; Meyers DA, 2005, J ALLERGY CLIN IMMUN, V115, P1169, DOI 10.1016/j.jaci.2005.01.070; Michel O, 2005, J ALLERGY CLIN IMMUN, V115, P1143, DOI 10.1016/j.jaci.2005.01.067; O'Connor GT, 2005, J ALLERGY CLIN IMMUN, V116, P26, DOI 10.1016/j.jaci.2005.02.013; Pate AD, 2005, J ALLERGY CLIN IMMUN, V116, P844, DOI 10.1016/j.jaci.2005.06.016; Peden DB, 2005, J ALLERGY CLIN IMMUN, V115, P213, DOI 10.1016/j.jaci.2004.12.003; Platts-Mills JA, 2005, J ALLERGY CLIN IMMUN, V116, P384, DOI 10.1016/j.jaci.2005.05.012; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Pott GB, 2005, J ALLERGY CLIN IMMUN, V115, P1036, DOI 10.1016/j.jaci.2005.01.019; Rabinovitch N, 2005, J ALLERGY CLIN IMMUN, V116, P1053, DOI 10.1016/j.jaci.2005.08.045; Rautava S, 2005, J ALLERGY CLIN IMMUN, V116, P31, DOI 10.1016/j.jaci.2005.02.010; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Ryan PH, 2005, J ALLERGY CLIN IMMUN, V116, P279, DOI 10.1016/j.jaci.2005.05.014; Salo PM, 2005, J ALLERGY CLIN IMMUN, V116, P623, DOI 10.1016/j.jaci.2005.05.030; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Silkoff PE, 2005, J ALLERGY CLIN IMMUN, V115, P337, DOI 10.1016/j.jaci.2004.11.035; Singh J, 2005, J ALLERGY CLIN IMMUN, V115, P330, DOI 10.1016/j.jaci.2004.11.021; Takai T, 2005, J ALLERGY CLIN IMMUN, V115, P555, DOI 10.1016/j.jaci.2004.11.024; Tovey ER, 2005, J ALLERGY CLIN IMMUN, V116, P119, DOI 10.1016/j.jaci.2005.04.037; Trasande L, 2005, J ALLERGY CLIN IMMUN, V115, P689, DOI 10.1016/j.jaci.2005.01.056; Vandenberg JJ, 2005, J ALLERGY CLIN IMMUN, V115, P334, DOI 10.1016/j.jaci.2004.11.038; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024; Yacoub MR, 2005, J ALLERGY CLIN IMMUN, V116, P462, DOI 10.1016/j.jaci.2005.04.015; Zambelli-Weiner A, 2005, J ALLERGY CLIN IMMUN, V115, P1203, DOI 10.1016/j.jaci.2005.03.001	48	5	5	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2006	117	6					1367	1373		10.1016/j.jaci.2006.04.009	http://dx.doi.org/10.1016/j.jaci.2006.04.009			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	053UX	16750999	Green Accepted			2022-12-18	WOS:000238332300024
J	Kim, HB; Lee, SY; Shim, JY; Kim, JH; Hong, SJ				Kim, Hyo-Bin; Lee, So-Yeon; Shim, Jung Yeon; Kim, Ja-Hyung; Hong, Soo-Jong			The leukotriene C4 synthase (A-444C) promoter polymorphism is associated with the severity of exercise-induced asthma in Korean children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENE		Univ Ulsan, Coll Med, Dept Pediat, Asan Med Ctr, Seoul, South Korea; SungKyunKwan Univ, Sch Med, Dept Pediat, Kangbuk Samsung Hosp, Seoul, South Korea; Hallym Univ, Coll Med, Hallym Med Ctr, Dept Pediat, Seoul, South Korea; Univ Ulsan, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University; University of Ulsan	Kim, HB (corresponding author), Univ Ulsan, Coll Med, Dept Pediat, Asan Med Ctr, Seoul, South Korea.		Hong, Soo-Jong/AAR-1788-2020	Hong, Soo-Jong/0000-0003-1409-2113				Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Brauer JE, 1999, AM J RESP CRIT CARE, V159, pA650; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Isidoro-Garcia M, 2005, J ALLERGY CLIN IMMUN, V115, P206, DOI 10.1016/j.jaci.2004.08.033; Kawagishi Y, 2002, J ALLERGY CLIN IMMUN, V109, P936, DOI 10.1067/mai.2002.124466; Kedda MA, 2004, J ALLERGY CLIN IMMUN, V113, P889, DOI 10.1016/j.jaci.2004.02.008; Sampson AP, 2000, THORAX, V55, pS28, DOI 10.1136/thorax.55.suppl_2.S28; Sayers I, 2003, THORAX, V58, P417, DOI 10.1136/thorax.58.5.417	8	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2006	117	5					1191	1192		10.1016/j.jaci.2005.12.1361	http://dx.doi.org/10.1016/j.jaci.2005.12.1361			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	041EM	16675353				2022-12-18	WOS:000237436300037
J	Cavuoto, MA; Bonagura, VR				Cavuoto, MA; Bonagura, VR			A case of adult-onset PFAPA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					N Shore Long Isl Jewish Hlth Syst, Great Neck, NY USA	Northwell Health									0	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		819	S212	S212		10.1016/j.jaci.2005.12.838	http://dx.doi.org/10.1016/j.jaci.2005.12.838			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301316
J	Chipps, BE				Chipps, BE			Attaining optimal asthma control: A practice parameter (vol 116, pg S3, 2005)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		CHIPPS BE, 2005, J ALLERGY CLIN IMMUN, V116, pS3	1	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2					262	262						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IM					2022-12-18	WOS:000235687300005
J	Furlong, TJ; Maloney, JM; Sicherer, SH				Furlong, TJ; Maloney, JM; Sicherer, SH			Seafood allergic reactions in restaurants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Food Allergy Network, Fairfax, VA USA; Mt Sinai Med Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai									0	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		163	S41	S41		10.1016/j.jaci.2005.12.169	http://dx.doi.org/10.1016/j.jaci.2005.12.169			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300163
J	Ghaffari, G; Craig, T; Golden, D; Chegini, S				Ghaffari, G; Craig, T; Golden, D; Chegini, S			Delayed and recurrent anaphylactic reaction to yellow jacket sting	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; Johns Hopkins Univ, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Johns Hopkins University									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1194	S309	S309		10.1016/j.jaci.2005.12.1221	http://dx.doi.org/10.1016/j.jaci.2005.12.1221			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865302272
J	Goetz, DW				Goetz, DW			Harmonia axyridis ladybug hypersensitivity in clinical allergy practice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Exemplar Allergy & Asthma, Morgantown, WV USA										0	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		116	S29	S29		10.1016/j.jaci.2005.12.121	http://dx.doi.org/10.1016/j.jaci.2005.12.121			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300116
J	Kamchaisatian, W; Kosalaraksa, P; Benjaponpitak, S; Hongeng, S; Direkwattanachai, C; Lumbiganon, P; Wiangnon, S				Kamchaisatian, W; Kosalaraksa, P; Benjaponpitak, S; Hongeng, S; Direkwattanachai, C; Lumbiganon, P; Wiangnon, S			Penicillosis in patients with X-linked hyperimmunoglobulin M syndrome (XHIGM), case reports from Thailand	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Div Allergy Immunol, Bangkok, Thailand; Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen 40002, Thailand	Mahidol University; Khon Kaen University									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1089	S282	S282		10.1016/j.jaci.2005.12.1166	http://dx.doi.org/10.1016/j.jaci.2005.12.1166			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865302167
J	Morisset, M; Lee, T; Codreanu, F; Cordebar, V; Fremont, S; Guenard, L; Kanny, G; Moneret-Vautrin, D				Morisset, M; Lee, T; Codreanu, F; Cordebar, V; Fremont, S; Guenard, L; Kanny, G; Moneret-Vautrin, D			Allergy to an amino-acid formula in infants: Residual soy allergens in soybean oil are incriminated	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Univ Hosp, Dept Internal Med Clin Immunol & Allergol, Nancy, France; Genclis, Mol & Therapeut Med, Vandoeuvre Les Nancy, France; Nancy Univ Hosp, Biochem Lab, Cent Hosp, Nancy, France	CHU de Nancy; CHU de Nancy			Kanny, Gisèle/AHA-8910-2022						0	5	6	0	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		157	S40	S40		10.1016/j.jaci.2005.12.163	http://dx.doi.org/10.1016/j.jaci.2005.12.163			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300157
J	Nayak, AS; Tripathy, I; Levitt, D				Nayak, AS; Tripathy, I; Levitt, D			Novel Amb a 1 CpG oligodeoxyribonucleotide conjugate ragweed vaccine administered to children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Illinois State Univ, Peoria Sch Med, Normal, IL 61761 USA; Ozarks Inc, Clin Res, Rolla, MO USA; Dynavax Tchnol Inc, Berkeley, CA USA	Illinois State University									0	5	5	1	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		620	S159	S159		10.1016/j.jaci.2005.12.635	http://dx.doi.org/10.1016/j.jaci.2005.12.635			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301117
J	Gold, DR				Gold, DR			Allergy: The price paid for longevity and social wealth?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						allergy; asthma; children; childhood infection; hygiene hypothesis; Finland; Russia	INFECTIOUS-DISEASES; ATOPY; CHILDREN; ASTHMA; DISPARITIES; PREVALENCE; RESPONSES; EXPOSURE; GERMANY; LIFE		Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gold, DR (corresponding author), Brigham & Womens Hosp, Channing Lab, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	diane.gold@channing.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035786] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI/ES 35786] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belanger K, 2003, AM J EPIDEMIOL, V158, P195, DOI 10.1093/aje/kwg148; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Britton J, 2003, AM J RESP CRIT CARE, V168, P266, DOI 10.1164/rccm.2305011; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Grjibovski A, 2004, ACTA OBSTET GYN SCAN, V83, P1159, DOI 10.1111/j.0001-6349.2004.00443.x; Holt PG, 1997, PEDIATR ALLERGY IMMU, V8, P53, DOI 10.1111/j.1399-3038.1997.tb00145.x; Holt PG, 1999, ENVIRON HEALTH PERSP, V107, P485, DOI 10.1289/ehp.99107s3485; Jahns L, 2004, J NUTR, V134, P3114, DOI 10.1093/jn/134.11.3114; Matricardi PM, 1999, LANCET, V354, P430, DOI 10.1016/S0140-6736(05)75853-0; Netesov SV, 2001, EMERG INFECT DIS, V7, P1, DOI 10.3201/eid0701.010101; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; SHUSTOV AV, 2000, VOPROSI VIRUSOLOGII, V6, P22; TATOCHENKO V, 1999, MED GAZETA, V87, P8; Thomason MJ, 2000, THORAX, V55, P785, DOI 10.1136/thorax.55.9.785; von Hertzen L, 2006, J ALLERGY CLIN IMMUN, V117, P151, DOI 10.1016/j.jaci.2005.07.028; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x	22	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2006	117	1					148	150		10.1016/j.jaci.2005.09.021	http://dx.doi.org/10.1016/j.jaci.2005.09.021			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IK	16387598	Bronze			2022-12-18	WOS:000235687100023
J	Ozdemir, O				Ozdemir, O			Type 2 natural killer cells in asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							LYMPHOKINE-ACTIVATED KILLER; SURFACE-MARKERS; NK CELL; CRYOPRESERVATION; EXPRESSION; SEVERITY; FRESH		LSUHSC NO, Dept Pediat, Div Allergy Immunol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Ozdemir, O (corresponding author), LSUHSC NO, Dept Pediat, Div Allergy Immunol, 1542 Tulane Ave,T8-1, New Orleans, LA 70112 USA.							Aktas E, 2005, CLIN EXP IMMUNOL, V140, P301, DOI 10.1111/j.1365-2249.2005.02777.x; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; CALLERY CD, 1980, J IMMUNOL METHODS, V35, P213, DOI 10.1016/0022-1759(80)90248-3; Deneys V, 1999, J IMMUNOL METHODS, V228, P13, DOI 10.1016/S0022-1759(99)00089-7; Hussell T, 2000, J IMMUNOL, V165, P7109, DOI 10.4049/jimmunol.165.12.7109; KAWAI H, 1988, TRANSFUSION, V28, P531, DOI 10.1046/j.1537-2995.1988.28689059025.x; Lanza F, 1999, HAEMATOLOGICA, V84, P969; Lee YC, 2001, J ASTHMA, V38, P665, DOI 10.1081/JAS-100107544; LETELLIER C, 1991, VOX SANG, V61, P90, DOI 10.1111/j.1423-0410.1991.tb00252.x; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; MIYATAKE H, 1991, CHEST, V99, P670, DOI 10.1378/chest.99.3.670; Perussia B, 2005, MOL IMMUNOL, V42, P385, DOI 10.1016/j.molimm.2004.07.017; ROMEU MA, 1992, J IMMUNOL METHODS, V154, P7; Wei HM, 2005, J ALLERGY CLIN IMMUN, V115, P841, DOI 10.1016/j.jaci.2004.11.026; Wingett D, 2003, J LEUKOCYTE BIOL, V74, P531, DOI 10.1189/jlb.0303103	16	5	5	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2005	116	5					1165	1166		10.1016/j.jaci.2005.08.007	http://dx.doi.org/10.1016/j.jaci.2005.08.007			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IG	16275396				2022-12-18	WOS:000235686700037
J	Lemiere, C; Blais, L				Lemiere, C; Blais, L			Are inhaled corticosteroids taken during pregnancy harmless?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; pregnancy; corticosteroids	ASTHMA; ADHERENCE; PATIENT		Univ Montreal, Hop Sacre Coeur, Dept Chest Med, Montreal, PQ H4J 1C5, Canada	Universite de Montreal	Lemiere, C (corresponding author), Univ Montreal, Hop Sacre Coeur, Dept Chest Med, 5400 W Gouin, Montreal, PQ H4J 1C5, Canada.	catherine.lemiere@umontreal.ca						Bakhireva LN, 2005, J ALLERGY CLIN IMMUN, V116, P503, DOI 10.1016/j.jaci.2005.05.027; Campbell LA, 2001, AM J RESP CRIT CARE, V163, P1051, DOI 10.1164/ajrccm.163.5.16353; Cochrane MG, 2000, CHEST, V117, P542, DOI 10.1378/chest.117.2.542; Dorais M, 2005, J ASTHMA, V42, P385, DOI 10.1081/JAS-200063007; Jones C, 2003, J ASTHMA, V40, P93, DOI 10.1081/JAS-120017212; Lipkowitz MA, 1998, ANN ALLERG ASTHMA IM, V81, P30; Nelson-Piercy C, 2001, THORAX, V56, P325, DOI 10.1136/thorax.56.4.325; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Schatz M, 1997, DRUG SAFETY, V16, P342, DOI 10.2165/00002018-199716050-00005; Tan KS, 2000, AM J MED, V109, P727, DOI 10.1016/S0002-9343(00)00615-X; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028	11	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2005	116	3					501	502		10.1016/j.jaci.2005.06.009	http://dx.doi.org/10.1016/j.jaci.2005.06.009			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IE	16159615				2022-12-18	WOS:000235686500004
J	Beeren, IMJ; de Bruin-Weller, MS; Ra, C; Kok, I; Bruinzeel-Koomen, CAFM; Knol, EF				Beeren, IMJ; de Bruin-Weller, MS; Ra, C; Kok, I; Bruinzeel-Koomen, CAFM; Knol, EF			Expression of Fc epsilon Rl on dendritic cell subsets in peripheral blood of patients with atopic dermatitis and allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RI-ALPHA; RECEPTOR; SUBUNIT; IGE		Univ Utrecht, Med Ctr, Dept Dermatol Allergol, NL-3584 CX Utrecht, Netherlands; Nihon Univ, Sch Med, Dept Mol Cell Immunol & Allergol, Tokyo, Japan; Asthma Ctr Heideheuvel, NL-3584 CX Utrecht, Netherlands	Utrecht University; Nihon University	Beeren, IMJ (corresponding author), Univ Utrecht, Med Ctr, Dept Dermatol Allergol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.			Knol, Edward/0000-0001-7368-9820				de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; Hijnen DJ, 2004, J ALLERGY CLIN IMMUN, V113, P334, DOI 10.1016/j.jaci.2003.12.007; Maurer D, 1996, J IMMUNOL, V157, P607; Novak N, 2004, J ALLERGY CLIN IMMUN, V114, P364, DOI 10.1016/j.jaci.2004.05.038; TunonDeLara JM, 1996, CLIN EXP ALLERGY, V26, P648, DOI 10.1046/j.1365-2222.1996.1095481.x; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; 1987, AM REV RESP DIS, V136, P225	10	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					228	229		10.1016/j.jaci.2005.02.039	http://dx.doi.org/10.1016/j.jaci.2005.02.039			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990802				2022-12-18	WOS:000235686300037
J	Hoekstra, MO; Niers, LEM; Steenhuis, TJ; Rovers, M; Knol, EF; Uiterwaal, CSPM				Hoekstra, MO; Niers, LEM; Steenhuis, TJ; Rovers, M; Knol, EF; Uiterwaal, CSPM			Is randomization of breast-feeding feasible?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		Wilhelmina Childrens Hosp, Pediat Allergol Clin, NL-3508 AB Utrecht, Netherlands; Univ Utrecht, Med Ctr, Med Eth Comm, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Julius Ctr Epidemiol, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Dermatol & Allergol, Utrecht, Netherlands	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University; Utrecht University	Hoekstra, MO (corresponding author), Wilhelmina Childrens Hosp, Pediat Allergol Clin, POB 85090, NL-3508 AB Utrecht, Netherlands.		Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X; Knol, Edward/0000-0001-7368-9820				Chulada PC, 2003, J ALLERGY CLIN IMMUN, V111, P328, DOI 10.1067/mai.2003.127; Edwards SJ., 1998, HEALTH TECHNOL ASSES, V2, P1; Kull I, 2004, J ALLERGY CLIN IMMUN, V114, P755, DOI 10.1016/j.jaci.2004.07.036	3	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2005	115	6					1324	1324		10.1016/j.jaci.2005.03.012	http://dx.doi.org/10.1016/j.jaci.2005.03.012			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	935WZ	15940160				2022-12-18	WOS:000229815400039
J	Estelle, F; Simons, R				Estelle, F; Simons, R			Apparent lack of response to epinephrine in anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Manitoba, Dept Pediat & Child Hlth, Sect Allergy & Clin Immunol, Winnipeg, MB R3A 1R9, Canada; Univ Manitoba, Dept Immunol, Natl Training Program Asthma & Allergy, Winnipeg, MB R3A 1R9, Canada	University of Manitoba; University of Manitoba	Estelle, F (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Sect Allergy & Clin Immunol, 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.							Bernstein DI, 2004, J ALLERGY CLIN IMMUN, V113, P1129, DOI 10.1016/j.jaci.2004.02.006; LIEBERMAN P, 2003, MIDDLETONS ALLERGY P, P1497; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P837, DOI 10.1016/j.jaci.2004.01.079	3	5	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					640	640		10.1016/j.jaci.2005.01.023	http://dx.doi.org/10.1016/j.jaci.2005.01.023			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753921	Bronze			2022-12-18	WOS:000227687000037
J	Miller, TP				Miller, TP			Lack of cost-effectiveness of omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Michigan State Univ, Coll Human Med, Dept Internal Med, Grand Rapids, MI 49509 USA; Michigan State Univ, Coll Human Med, Dept Epidemiol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Miller, TP (corresponding author), Michigan State Univ, Coll Human Med, Dept Internal Med, Grand Rapids, MI 49509 USA.							Gold MR, 1996, COST EFFECTIVENESS H; Oba Y, 2004, J ALLERGY CLIN IMMUN, V114, P265, DOI 10.1016/j.jaci.2004.05.049; Petitti DB., 2000, META ANAL DECISION A; Sullivan S, 1996, AM J RESP CRIT CARE, V154, pS84, DOI 10.1164/ajrccm/154.3_Pt_2.S84; Sullivan SD, 2002, J ALLERGY CLIN IMMUN, V110, P576, DOI 10.1067/mai.2002.128009	5	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2005	115	2					429	430		10.1016/j.jaci.2004.10.049	http://dx.doi.org/10.1016/j.jaci.2004.10.049			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	897YU	15696113	Bronze			2022-12-18	WOS:000227043600046
J	San-Juan, S; Garces, M; Caballero, ML; Monzon, S; Moneo, I				San-Juan, S; Garces, M; Caballero, ML; Monzon, S; Moneo, I			Occupational asthma caused by shark cartilage dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COLLAGEN		Univ Hosp Lozano Blesa, Dept Allergy, Zaragoza 50009, Spain; Hosp Carlos III, Dept Immunol, Zaragoza, Spain	Lozano Blesa University Clinical Hospital; Hospital Carlos III	San-Juan, S (corresponding author), Univ Hosp Lozano Blesa, Dept Allergy, Planta 1, Zaragoza 50009, Spain.							Bardana Emil J., 2003, Journal of Allergy and Clinical Immunology, V111, pS530; KIMURA S, 1986, COMP BIOCHEM PHYS B, V84, P305, DOI 10.1016/0305-0491(86)90081-7; Ortega HG, 2002, AM J IND MED, V42, P50, DOI 10.1002/ajim.10088; RAMA S, 1984, CONNECT TISSUE RES, V12, P111, DOI 10.3109/03008208408992776; Shaw D, 1997, DRUG SAFETY, V17, P342, DOI 10.2165/00002018-199717050-00006	5	5	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2004	114	5					1227	1228		10.1016/j.jaci.2004.07.057	http://dx.doi.org/10.1016/j.jaci.2004.07.057			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	870HI	15536437	Bronze			2022-12-18	WOS:000225047800036
J	Holt, S; Masoli, M; Beasley, R				Holt, S; Masoli, M; Beasley, R			Increasing compliance with inhaled corticosteroids through the use of combination therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							FLUTICASONE PROPIONATE; PATIENT COMPLIANCE; ASTHMA; PREVENTION; SALMETEROL; MEDICATION		Med Res Inst New Zealand, Perth, WA 6001, Australia; P3 Res, Wellington, New Zealand; Univ Southampton, Southampton, Hants, England	University of Southampton	Beasley, R (corresponding author), Med Res Inst New Zealand, POB 10055, Perth, WA 6001, Australia.		Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X				Baraniuk JN, 1997, AM J RESP CRIT CARE, V155, P704, DOI 10.1164/ajrccm.155.2.9032216; Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202; BOSLEY CM, 1994, EUR RESPIR J, V7, P504, DOI 10.1183/09031936.94.07030504; Chapman KR, 2000, RESP MED, V94, P2, DOI 10.1053/rmed.1999.0667; CHMELIK F, 1994, ANN ALLERGY, V73, P527; COUTTS JAP, 1992, ARCH DIS CHILD, V67, P332, DOI 10.1136/adc.67.3.332; MAK JCW, 1995, AM J PHYSIOL-LUNG C, V268, pL41, DOI 10.1152/ajplung.1995.268.1.L41; Michael Y, 2001, INT J PHARM, V221, P165, DOI 10.1016/S0378-5173(01)00678-0; National Institutes of Health: National Heart Lung and Blood Institute, 2002, NIH PUBLICATION, V02-5215; Nelson HS, 2003, J ALLERGY CLIN IMMUN, V112, P29, DOI 10.1067/mai.2003.1558; RAND CS, 1992, AM REV RESPIR DIS, V146, P1559, DOI 10.1164/ajrccm/146.6.1559; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; Simmons MS, 1998, J ALLERGY CLIN IMMUN, V102, P409, DOI 10.1016/S0091-6749(98)70128-9; Stoloff SW, 2004, J ALLERGY CLIN IMMUN, V113, P245, DOI 10.1016/j.jaci.2003.10.011; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; YEUNG M, 1994, RESP MED, V88, P31, DOI 10.1016/0954-6111(94)90171-6	17	5	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2004	113	2					219	220		10.1016/j.jaci.2003.11.022	http://dx.doi.org/10.1016/j.jaci.2003.11.022			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	773EX	14767433				2022-12-18	WOS:000188885700005
J	Rieker, J; Ruzicka, T; Neumann, NJ; Homey, B				Rieker, J; Ruzicka, T; Neumann, NJ; Homey, B			Protein contact dermatitis to asparagus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGY; ASTHMA		Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Rieker, J (corresponding author), Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany.							Amin S., 1997, CONTACT URTICARIA SY; Anibarro B, 1997, J ALLERGY CLIN IMMUN, V100, P734, DOI 10.1016/S0091-6749(97)70266-5; Asero R, 2001, J ALLERGY CLIN IMMUN, V108, P309, DOI 10.1067/mai.2001.116983; Cadot P, 2001, ALLERGY, V56, P192, DOI 10.1034/j.1398-9995.2001.056002192.x; Escribano MM, 1998, ALLERGY, V53, P622, DOI 10.1111/j.1398-9995.1998.tb03942.x; MCFADDEN JP, 1992, CONTACT DERMATITIS, V27, P333, DOI 10.1111/j.1600-0536.1992.tb03297.x; Pires G, 2002, ALLERGY, V57, P957, DOI 10.1034/j.1398-9995.2002.23832_2.x; Sanchez-Hernandez MC, 2000, ALLERGY, V55, P297, DOI 10.1034/j.1398-9995.2000.00460.x	8	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2004	113	2					354	355		10.1016/j.jaci.2003.10.066	http://dx.doi.org/10.1016/j.jaci.2003.10.066			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	773EX	14767455				2022-12-18	WOS:000188885700028
J	Airaghi, L; Tedeschi, A				Airaghi, L; Tedeschi, A			Results of the US Third National Health and Nutrition Examination Survey support the hygiene hypothesis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		Osped Maggiore Policlin, IRCCS, Div Internal Med 1, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Airaghi, L (corresponding author), Osped Maggiore Policlin, IRCCS, Div Internal Med 1, I-20122 Milan, Italy.		; Airaghi, Lorena/K-1274-2018; Smeeth, Liam/X-5862-2018	Sheikh, Aziz/0000-0001-7022-3056; Airaghi, Lorena/0000-0001-5466-8151; Smeeth, Liam/0000-0002-9168-6022				Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8	3	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					179	180		10.1016/j.jaci.2003.06.001	http://dx.doi.org/10.1016/j.jaci.2003.06.001			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713930				2022-12-18	WOS:000187837900029
J	Hamid, Q				Hamid, Q			Eosinophils in allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada	McGill University	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.								0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					182	184		10.1016/j.jaci.2003.10.058	http://dx.doi.org/10.1016/j.jaci.2003.10.058			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713933	Bronze			2022-12-18	WOS:000187837900032
J	Cohen, SG				Cohen, SG			Pioneers and milestones - Loveless on wasp venom allergy and immunity - Part 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item						loveless; hymenoptera; wasp venom; allergy; immunity	IMMUNOTHERAPY		NIAID, Natl Lib Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Library of Medicine (NLM)	Cohen, SG (corresponding author), NIAID, Natl Lib Med, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							*AM ASS IMM, 1991, ALLERGY PROC, V12, P357; BUSSE WW, 1975, JAMA-J AM MED ASSOC, V231, P1154, DOI 10.1001/jama.231.11.1154; COHEN SG, 1995, ANN ALLERGY, V74, P1; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; HUNT KJ, 1976, ANN INTERN MED, V85, P56, DOI 10.7326/0003-4819-85-1-56; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; Levine MI, 1986, MONOGRAPH INSECT ALL; LICHTENSTEIN LM, 1974, NEW ENGL J MED, V290, P1223, DOI 10.1056/NEJM197405302902204; LOVELESS MH, PULBLICATION LIST; REISMAN RE, 1978, ALLERGY PRINCIPLES P, V2, P1100; THOMAS D, 1985, CHILDS CHRISTMAS WAL, P24; VALENTINE MD, 1978, IMMUNOLOGICAL DIS, V2, P917; 1977, NEWSWEEK        0411, P66; 1963, LIFE            0809, P67; 1992, CTR FOCUS, P9	15	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2003	112	6					1248	1252		10.1016/j.jaci.2003.09.043	http://dx.doi.org/10.1016/j.jaci.2003.09.043			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	752HC	14657895				2022-12-18	WOS:000187154200038
J	Tarlo, SM; Liss, GM				Tarlo, SM; Liss, GM			Practical implications of studies in occupational rhinoconjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						occupational rhinitis; occupational conjunctivitis; antimal allergy; occupational asthma	LABORATORY-ANIMAL ALLERGY; WORK-RELATED SYMPTOMS; RESPIRATORY SYMPTOMS; ESTIMATED EXPOSURE; SENSITIZATION; ASTHMA; DETERMINANTS; RHINITIS; COHORT; FLOUR		Toronto Western Hosp, Gage Occupat & Environm Hlth Unit, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Ontario Minist Labor, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Tarlo, SM (corresponding author), Toronto Western Hosp, Gage Occupat & Environm Hlth Unit, EC4-009,399 Bathurst St, Toronto, ON M5T 2S8, Canada.			Tarlo, Susan/0000-0002-4746-5310				Archambault S, 2001, J ALLERGY CLIN IMMUN, V107, P921; CULLINAN P, 1994, OCCUP ENVIRON MED, V51, P589, DOI 10.1136/oem.51.9.589; Cullinan P, 1999, EUR RESPIR J, V13, P1139, DOI 10.1034/j.1399-3003.1999.13e33.x; CULLINAN P, 1994, OCCUP ENVIRON MED, V51, P579, DOI 10.1136/oem.51.9.579; Dykewicz MS, 1998, ANN ALLERG ASTHMA IM, V81, P478, DOI 10.1016/S1081-1206(10)63155-9; Fisher R, 1998, J OCCUP ENVIRON MED, V40, P609, DOI 10.1097/00043764-199807000-00005; Gautrin D, 2002, ALLERGY, V57, P913, DOI 10.1034/j.1398-9995.2002.23636.x; Gautrin D, 2001, EUR RESPIR J, V17, P904, DOI 10.1183/09031936.01.17509040; Karjalainen A, 2003, CHEST, V123, P283, DOI 10.1378/chest.123.1.283; Kruize H, 1997, OCCUP ENVIRON MED, V54, P830, DOI 10.1136/oem.54.11.830; Liss GM, 2003, OCCUP ENVIRON MED, V60, P254, DOI 10.1136/oem.60.4.254; Malo JL, 1997, EUR RESPIR J, V10, P1513, DOI 10.1183/09031936.97.10071513; Monso E, 2000, AM J RESP CRIT CARE, V161, P1508, DOI 10.1164/ajrccm.161.5.9906113; MUSK AW, 1989, BRIT J IND MED, V46, P636; Reeb-Whitaker C, 1999, J ALLERGY CLIN IMMUN, V103, P139, DOI 10.1016/S0091-6749(99)70537-3; RENSTROM A, 1994, ALLERGY, V49, P548, DOI 10.1111/j.1398-9995.1994.tb01127.x; Rodier F, 2003, J ALLERGY CLIN IMMUN, V112, P1105, DOI 10.1016/j.jaci.2003.08.011; Saary MJ, 2002, J ALLERGY CLIN IMMUN, V109, P131, DOI 10.1067/mai.2002.120557; Slater JE, 1998, J ALLERGY CLIN IMMUN, V102, P977, DOI 10.1016/S0091-6749(98)70336-7; VEDAL S, 1986, ARCH ENVIRON HEALTH, V41, P179, DOI 10.1080/00039896.1986.9935774	20	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2003	112	6					1047	1049		10.1016/j.jaci.2003.09.017	http://dx.doi.org/10.1016/j.jaci.2003.09.017			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	752HC	14657855				2022-12-18	WOS:000187154200003
J	Nafstad, P; Jaakkola, JJK				Nafstad, P; Jaakkola, JJK			Breast-feeding, passive smoking, and asthma and wheeze in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RESPIRATORY-TRACT INFECTIONS		Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; Univ Birmingham, Birmingham, W Midlands, England	Norwegian Institute of Public Health (NIPH); University of Birmingham	Nafstad, P (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.		Jaakkola, Jouni J.K./G-4314-2012	Jaakkola, Jouni/0000-0003-4168-4683				Chulada PC, 2003, J ALLERGY CLIN IMMUN, V111, P328, DOI 10.1067/mai.2003.127; Nafstad P, 1996, EUR RESPIR J, V9, P2623, DOI 10.1183/09031936.96.09122623; Nystad W, 2002, SCAND J PUBLIC HEALT, V30, P70, DOI 10.1177/14034948020300010201; WOODWARD A, 1990, J EPIDEMIOL COMMUN H, V44, P224, DOI 10.1136/jech.44.3.224	4	5	6	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2003	112	4					807	808		10.1016/S0091-6749(03)02018-9	http://dx.doi.org/10.1016/S0091-6749(03)02018-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730LA	14564371				2022-12-18	WOS:000185831200028
J	Isidoro-Garcia, M; Roa-Gomez, S; Davila, I; Lorente, F; Gonzalez-Sarmiento, R				Isidoro-Garcia, M; Roa-Gomez, S; Davila, I; Lorente, F; Gonzalez-Sarmiento, R			Lack of association between the 7888 C/T polymorphism in the AID gene and atopy in a Spanish population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Salamanca, Dept Med, Mol Med Unit, Salamanca 37008, Spain; Univ Hosp Salamanca, Dept Allergy, Salamanca, Spain	University of Salamanca; University of Salamanca	Isidoro-Garcia, M (corresponding author), Univ Salamanca, Dept Med, Mol Med Unit, Campus Unamuno, Salamanca 37008, Spain.		Roa, Sergio/H-9293-2015; Dávila, Ignacio/K-4453-2012; Gonzalez-Sarmiento, Rogelio/V-5526-2019	Roa, Sergio/0000-0003-1095-0715; Dávila, Ignacio/0000-0001-8485-5513; Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; ISIDORO-GARCIA, MARIA/0000-0002-9013-9422				Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Noguchi E, 2001, J ALLERGY CLIN IMMUN, V108, P382, DOI 10.1067/mai.2001.117456; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9	3	5	5	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					460	460		10.1067/mai.2003.1642	http://dx.doi.org/10.1067/mai.2003.1642			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY	12897760				2022-12-18	WOS:000184650600038
J	Kelsen, SG				Kelsen, SG			Asthma and pregnancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; asthma morbidity; pregnancy	GLUCOCORTICOID RECEPTOR; OUTCOMES; GROWTH; WOMEN		Temple Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kelsen, SG (corresponding author), Temple Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19140 USA.							Demissie K, 1998, AM J RESP CRIT CARE, V158, P1091, DOI 10.1164/ajrccm.158.4.9802053; FOSTER PS, 1983, BRIT J PHARMACOL, V78, P441, DOI 10.1111/j.1476-5381.1983.tb09409.x; GAENSLER EA, 1965, RESP HDB PHYSL, P1623; Heinonen OP, 1977, BIRTH DEFECTS DRUGS; JUNIPER EF, 1989, AM REV RESPIR DIS, V140, P924, DOI 10.1164/ajrccm/140.4.924; KONTULA K, 1983, BIOCHEM PHARMACOL, V32, P1511, DOI 10.1016/0006-2952(83)90474-4; Liu SL, 2001, AM J OBSTET GYNECOL, V184, P90, DOI 10.1067/mob.2001.108073; *MAN ASTHM PREGN, 1993, NIH PUBL; MILNE JA, 1977, BRIT J OBSTET GYNAEC, V84, P448, DOI 10.1111/j.1471-0528.1977.tb12621.x; REINISCH JM, 1978, SCIENCE, V202, P436, DOI 10.1126/science.705336; SCHATZ M, 1990, CHEST, V98, P389, DOI 10.1378/chest.98.2.389; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516; Schatz M, 1997, J ALLERGY CLIN IMMUN, V100, P301, DOI 10.1016/S0091-6749(97)70241-0; SteniusAarniala BSM, 1996, THORAX, V51, P411, DOI 10.1136/thx.51.4.411; SVEC F, 1980, ENDOCRINOLOGY, V107, P566, DOI 10.1210/endo-107-2-566	16	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					268	270		10.1067/mai.2003.1675	http://dx.doi.org/10.1067/mai.2003.1675			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY	12897731				2022-12-18	WOS:000184650600009
J	Lange, JH; Rylander, R; Fedeli, U; Mastrangelo, G				Lange, JH; Rylander, R; Fedeli, U; Mastrangelo, G			Extension of the "hygiene hypothesis" to the association of occupational endotoxin exposure with lower lung cancer risk	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COTTON DUST; MORTALITY; WORKERS; ASTHMA		Envirosafe Training & Consultants Inc, Pittsburgh, PA 15239 USA; Univ Gothenburg, Dept Environm Med, Gothenburg, Sweden; Univ Padua, Dept Environm Med & Publ Hlth, Sect Occupat Hlth, Padua, Italy	University of Gothenburg; University of Padua	Lange, JH (corresponding author), Envirosafe Training & Consultants Inc, POB 114022, Pittsburgh, PA 15239 USA.			Fedeli, Ugo/0000-0002-9939-3398				Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; DAUM SM, 1975, 997271 HSM NIOSH; ENTERLINE PE, 1985, LANCET, V2, P934; ENTERLINE PE, 1965, NEW YORK ACAD SCI, V132, P156; Henderson V, 1973, J Occup Med, V15, P717; Kalliomaki M., 2002, Current Drug Targets - Infectious Disorders, V2, P193; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lange JH, 2003, OCCUP ENVIRON MED, V60, P144, DOI 10.1136/oem.60.2.144; LANGE JH, 1992, J ENVIRON SCI HEAL A, VA27, P505, DOI 10.1080/10934529209375741; LANGE JH, 1988, P 12 COTT DUST RES C, P124; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Mastrangelo G, 1996, AM J IND MED, V30, P601; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MERCHANT JA, 1981, CHEST, V79, pS6; Pance A, 2002, J INVEST MED, V50, P173, DOI 10.2310/6650.2002.33430; Rylander R, 2002, J ENDOTOXIN RES, V8, P241, DOI 10.1179/096805102125000452; RYLANDER R, 1994, ORGANIC DUSTS EXPOSU, P73; Weiss ST, 2002, NEW ENGL J MED, V347, P930, DOI 10.1056/NEJMe020092; Yamakido M, 1996, ENVIRON HEALTH PERSP, V104, P485, DOI 10.2307/3432809	19	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2003	112	1					219	220		10.1067/mai.2003.1601	http://dx.doi.org/10.1067/mai.2003.1601			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	698QQ	12847509	Bronze			2022-12-18	WOS:000184010600040
J	Stempel, DA				Stempel, DA			Assessing the economic burden of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Univ Washington, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Stempel, DA (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.	econmed@msn.com						*CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; Drummond MF, 1997, JAMA-J AM MED ASSOC, V277, P1552, DOI 10.1001/jama.277.19.1552; Legorreta AP, 1998, ARCH INTERN MED, V158, P457, DOI 10.1001/archinte.158.5.457; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Stempel DA, 2002, J ALLERGY CLIN IMMUN, V109, P433, DOI 10.1067/mai.2002.121953; Weiss KB, 2000, J ALLERGY CLIN IMMUN, V106, P493, DOI 10.1067/mai.2000.109426	8	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2003	111	6					1203	1204		10.1067/mai.2003.1553	http://dx.doi.org/10.1067/mai.2003.1553			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	688FZ	12789217				2022-12-18	WOS:000183424700005
J	Hamelmann, E; Schleimer, RP				Hamelmann, E; Schleimer, RP			Corticosteroid treatment in bronchial asthma: For better or for worse?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						corticosteroids; apoptosis; bronchial asthma	AIRWAY INFLAMMATION; EPITHELIAL-CELLS; LUNG-TISSUE; APOPTOSIS; PROLIFERATION; BUDESONIDE; EXPRESSION; GAMMA		Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA; Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, Berlin, Germany	Johns Hopkins University; Johns Hopkins Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schleimer, RP (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle,Room 3A62, Baltimore, MD 21224 USA.							AXELROD L, 1989, ANTIINFLAMMATORY STE, P377; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; Benayoun L, 2001, AM J RESP CRIT CARE, V164, P1487, DOI 10.1164/ajrccm.164.8.2101070; CARAYOL N, 2002, AM J RESP CRIT CARE, V165, pA65; CHOPRA DP, 1987, J CELL PHYSIOL, V130, P173, DOI 10.1002/jcp.1041300202; CLAMAN HN, 1975, J ALLERGY CLIN IMMUN, V55, P145, DOI 10.1016/0091-6749(75)90010-X; COYLE AJ, 1994, AM J RESP CRIT CARE, V150, pS63, DOI 10.1164/ajrccm/150.5_Pt_2.S63; Davies DE, 2003, J ALLERGY CLIN IMMUN, V111, P215, DOI 10.1067/mai.2003.128; Dorscheid DR, 2003, J ALLERGY CLIN IMMUN, V111, P360, DOI 10.1067/mai.2003.117; Dorscheid DR, 2001, AM J RESP CRIT CARE, V164, P1939, DOI 10.1164/ajrccm.164.10.2103013; Esmailpour N, 1997, EUR RESPIR J, V10, P1496, DOI 10.1183/09031936.97.10071496; FENG ZW, 1995, J CELL BIOL, V131, P1095, DOI 10.1083/jcb.131.4.1095; FRAENKEL A, 1898, Z KLIN MED, V35, P559; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; KAWADA H, 1988, BIOCHIM BIOPHYS ACTA, V972, P152, DOI 10.1016/0167-4889(88)90114-0; LAITINEN LA, 1991, AM REV RESPIR DIS, V143, P423, DOI 10.1164/ajrccm/143.2.423; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; MYGIND G, 1982, EUR J RESPIR DIS, V122, P229; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; *NIH, 2002, J ALLERGY CLIN IMMUN, V110, pS141; Prosperini G, 2002, J ALLERGY CLIN IMMUN, V110, P855, DOI 10.1067/mai.2002.130050; Van den Berge M, 2001, AM J RESP CRIT CARE, V164, P1127, DOI 10.1164/ajrccm.164.7.2102135; VANDENBOSCH JMM, 1993, BIOPHARM DRUG DISPOS, V14, P455, DOI 10.1002/bdd.2510140511; Vignola AM, 2001, J ALLERGY CLIN IMMUN, V108, P738, DOI 10.1067/mai.2001.119160; Wen LP, 1997, AM J PHYSIOL-LUNG C, V273, pL921, DOI 10.1152/ajplung.1997.273.5.L921; WU R, 1985, J CELL PHYSIOL, V125, P167, DOI 10.1002/jcp.1041250202	27	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2003	111	2					248	250		10.1067/mai.2003.156	http://dx.doi.org/10.1067/mai.2003.156			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	644WF	12589340				2022-12-18	WOS:000180942700004
J	Morell, F; Roger, A; Cruz, MJ				Morell, F; Roger, A; Cruz, MJ			Usefulness of specific skin tests in the diagnosis of hypersensitivity pneumonitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Hosp Univ Vall Hebron, Serv Pneumol, Barcelona, Spain; Hosp Univ Vall Hebron, Unitat Invest Pneumol, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Morell, F (corresponding author), Hosp Univ Vall Hebron, Serv Pneumol, Barcelona, Spain.		Roger, Albert/AAF-3042-2020; Roger, Albert/AAY-9876-2021; Cruz, Maria Jesus/I-9073-2014	Munoz, Xavier/0000-0002-8693-022X; Morell Brotad, Ferran/0000-0002-7206-4543; Cruz, Maria Jesus/0000-0001-9759-5466				MORELL F, 1985, CHEST, V87, P202, DOI 10.1378/chest.87.2.202; MORELL F, 1986, THORAX, V41, P538, DOI 10.1136/thx.41.7.538; Patel AM, 2001, J ALLERGY CLIN IMMUN, V108, P661	3	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2002	110	6					939	939		10.1067/mai.2002.128801	http://dx.doi.org/10.1067/mai.2002.128801			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	624TL	12464966				2022-12-18	WOS:000179777400022
J	Hall, K				Hall, K			Endotoxin from synthetic and feather pillows	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DUST MITE ALLERGEN; HOUSE; ASTHMA		Wellington Sch Med & Hlth Sci, Wellington Asthma Res Grp, Wellington, New Zealand	University of Otago	Hall, K (corresponding author), Wellington Sch Med & Hlth Sci, Wellington Asthma Res Grp, POB 7343, Wellington, New Zealand.			Oldfield, Karen/0000-0003-4734-8488				Custovic A, 2000, PEDIATR ALLERGY IMMU, V11, P71, DOI 10.1034/j.1399-3038.2000.00072.x; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; DOUWES J, 1995, APPL ENVIRON MICROB, V61, P1763, DOI 10.1128/AEM.61.5.1763-1769.1995; Kemp TJ, 1996, BMJ-BRIT MED J, V313, P916, DOI 10.1136/bmj.313.7062.916; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Rains N, 1999, CLIN EXP ALLERGY, V29, P182, DOI 10.1046/j.1365-2222.1999.00470.x; SIEBERS R, 2002, IN PRESS CLIN EXP AL	7	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2002	110	5					811	811		10.1067/mai.2002.128530	http://dx.doi.org/10.1067/mai.2002.128530			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	612NN	12417893				2022-12-18	WOS:000179082500019
J	Claman, HN				Claman, HN			Glucocorticoids in herbal formulas?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Colorado, Sch Med, Dept Med, Denver, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Claman, HN (corresponding author), Univ Colorado, Sch Med, Dept Med, Denver, CO 80202 USA.							Li XM, 2001, J ALLERGY CLIN IMMUN, V108, P639, DOI 10.1067/mai.2001.118787	1	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2002	109	6					1038	1038		10.1067/mai.2002.125261	http://dx.doi.org/10.1067/mai.2002.125261			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	566RU	12063540	Bronze			2022-12-18	WOS:000176442700027
J	Fritz, SB; Singer, AM; Revan, VB; Baker, JR				Fritz, SB; Singer, AM; Revan, VB; Baker, JR			Bioterrorism: Relevance to allergy and immunology in clinical practice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bioterrorism; biowarfare; immunosuppressed; anthrax; smallpox; plague; tularemia; botulism; hemorrhagic fever viruses; immunodeficiency; atopic dermatitis	NECROSIS-FACTOR-ALPHA; BIOLOGICAL WEAPON; FRANCISELLA-TULARENSIS; ANTHRAX; VACCINIA; IMMUNIZATION; TOXIN	It has become clear in recent months that the threat of bioterrorism is very real. All physicians need to be aware of the presenting signs and symptoms of the most likely agents. Allergists and immunologists care for a unique population of patients with several alterations of their immune system that might change the expected course of illnesses from biologic terror agents. In this review, we discuss specific bioterrorisin agents, focusing on their presentation, pathogenesis, and immunology. In addition, we describe how these illnesses might differ in the population of patients followed by allergists and immunologists.	Univ Michigan, Dept Internal Med, Ctr Biol Nanotechnol,Hlth Syst, Div Clin Immunol & Allergy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fritz, SB (corresponding author), Taubman Ctr 3918, Box 0380, Ann Arbor, MI 48109 USA.							ABBAS AK, 2000, CELLULAR MOL IMMUNOL, P240; Alibek Ken., 1999, BIOHAZARD; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; DAPLAN E, 1996, CULT END WORLD; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DiGiovanni C, 1999, AM J PSYCHIAT, V156, P1500, DOI 10.1176/ajp.156.10.1500; DIXON CW, 1948, J HYG-CAMBRIDGE, V46, P351, DOI 10.1017/S0022172400036536; DOGANAY M, 1991, SCAND J INFECT DIS, V23, P333, DOI 10.3109/00365549109024319; Evans ME, 1997, MED ASPECTS CHEM BIO, P503; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FRIEDLANDER AM, 1992, MED ASPECTS CHEM BIO, P467; GESHELIN P, 1974, J MOL BIOL, V88, P785, DOI 10.1016/0022-2836(74)90399-4; GOODMAN LS, 2001, GOODMAN GILLMANS PHA, P1655; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; HANNA PC, 1994, MOL MED, V1, P7; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HOOVER DL, 1994, INFECT IMMUN, V62, P4432, DOI 10.1128/IAI.62.10.4432-4439.1994; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Kortepeter M., 2001, USAMRIIDS MED MANAGE; KOSKELA P, 1985, J CLIN MICROBIOL, V22, P973, DOI 10.1128/JCM.22.6.973-979.1985; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; LITTAURA RA, 1992, J VIROL, V66, P2274, DOI 10.1128/JVI.66.4.2274-2280.1992; MCCLAIN DJ, 1992, MED ASPECTS CHEM BIO, P539; MCGOVERN TW, 1992, MED ASPECTS CHEM BIO, P479; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; MIDDLEBROOK JL, 1992, MED ASPECTS CHEM BIO, P643; MODULIN JF, 2000, CLIN TOXICOL, V39, P85; PEELER RN, 1965, ANN INTERN MED, V63, P44, DOI 10.7326/0003-4819-63-1-44; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; Saslaw S, 1961, ARCH INTERN MED, V107, P134, DOI DOI 10.1001/ARCHINTE.1961.03620050068007; TURNBULL PCB, 1986, INFECT IMMUN, V52, P356, DOI 10.1128/IAI.52.2.356-363.1986; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; WHITE CS, 1974, ANN INTERN MED, V81, P594, DOI 10.7326/0003-4819-81-5-594; *WHO EXP COMM SMAL, 1972, WHO TECH REP SER, V493	37	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2002	109	2					214	228		10.1067/mai.2002.121947	http://dx.doi.org/10.1067/mai.2002.121947			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	528EZ	11842289				2022-12-18	WOS:000174232600004
J	Dama, AR; Liccardi, G; Lobefalo, G; Bonadonna, P; Schiappoli, M; Crivellaro, M; Senna, G				Dama, AR; Liccardi, G; Lobefalo, G; Bonadonna, P; Schiappoli, M; Crivellaro, M; Senna, G			Colecoxib, a new selective COX 2 inhibitor, is a safe alternative drug in highly NSAIDs-intolerant patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Verona Hosp, Allergy Unit, Verona, Italy; Dept Chest Dis Cardarelli, Naples, Italy				Schiappoli, Michele/J-5054-2012; Schiappoli, Michele/M-5590-2019	Schiappoli, Michele/0000-0002-4718-5984; Schiappoli, Michele/0000-0002-4718-5984					0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		411	S141	S141		10.1016/S0091-6749(02)81547-0	http://dx.doi.org/10.1016/S0091-6749(02)81547-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800410
J	Hamilton, RG; Biagini, R; Mackenzie, B; Yeang, HY; Arija, S; Bernstein, DI				Hamilton, RG; Biagini, R; Mackenzie, B; Yeang, HY; Arija, S; Bernstein, DI			FDA-cleared immunoassays for latex-specific IgE are missing allergenic epitopes from multiple Hevb allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Sch Med, Baltimore, MD USA; NIOSH, Cincinnati, OH 45226 USA; Rubber Res Inst Malaysia, Kuala Lumpur, Malaysia; Univ Cincinnati, Cincinnati, OH 45221 USA	Johns Hopkins University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Institute Penyelidikan Getah Malaysia; University System of Ohio; University of Cincinnati									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		790	S259	S259		10.1016/S0091-6749(02)81925-X	http://dx.doi.org/10.1016/S0091-6749(02)81925-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800787
J	Hayden, ML; Dolan, CM; Johnson, C; Morris, SM; Bleecker, ER				Hayden, ML; Dolan, CM; Johnson, C; Morris, SM; Bleecker, ER			High level health care utilization in severe and difficult-to-treat asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Virginia Adult & Pediat Allergy & Asthma, Richmond, VA USA; Genentech Inc, San Francisco, CA 94080 USA; Wake Forest Univ, Winston Salem, NC 27109 USA	Roche Holding; Genentech; Wake Forest University									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		897	S293	S293		10.1016/S0091-6749(02)82032-2	http://dx.doi.org/10.1016/S0091-6749(02)82032-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX		Bronze			2022-12-18	WOS:000173744800894
J	Polmar, SH; Yong, CL; Wood, CC; Staehle, H; Gupta, A				Polmar, SH; Yong, CL; Wood, CC; Staehle, H; Gupta, A			Safety and pharmacokinetics of an oral p38 MAP kinase inhibitor (BIRB 796 BS), administered twice daily for 14 days to healthy volunteers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; Boehringer Ingelheim Pharmaceut Inc, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim									0	5	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		157	S66	S66		10.1016/S0091-6749(02)81293-3	http://dx.doi.org/10.1016/S0091-6749(02)81293-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX		Bronze			2022-12-18	WOS:000173744800156
J	Rangaraj, S; Tuthill, D; Burr, M; Alfaham, M				Rangaraj, S; Tuthill, D; Burr, M; Alfaham, M			Childhood epidemiology of anaphylaxis and epinephrine prescriptions in Wales: 1994-1999	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Llandough Hosp, Cardiff, S Glam, Wales										0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		187	S75	S75		10.1016/S0091-6749(02)81323-9	http://dx.doi.org/10.1016/S0091-6749(02)81323-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800186
J	Togias, A; Bieneman, A; Bloom, DI; Schleimer, R; Iezzoni, D; Harris, A; Schroeder, JT				Togias, A; Bieneman, A; Bloom, DI; Schleimer, R; Iezzoni, D; Harris, A; Schroeder, JT			Changes in blood leukocyte cytokine expression following repeated nasal allergen provocation: Evidence for systemic manifestations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Baltimore, MD 21218 USA; Schering Plough Corp, Kenilworth, NJ 07033 USA	Johns Hopkins University; Merck & Company; Schering Plough Corporation									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		799	S262	S262		10.1016/S0091-6749(02)81934-0	http://dx.doi.org/10.1016/S0091-6749(02)81934-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800796
J	Ying, S; Kikuchi, Y; Meng, Q; Kay, AB; Kaplan, AP				Ying, S; Kikuchi, Y; Meng, Q; Kay, AB; Kaplan, AP			Th1/Th2 cytokines and cell infiltration in skin from chronic idiopathic urticaria: Comparison with allergen-induced skin late-phase reactions and normal controls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ London Imperial Coll Sci & Technol, Fac Med, NHLI Div, London, England; Med Univ S Carolina, Charleston, SC 29425 USA	Imperial College London; Medical University of South Carolina									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		231	S88	S88		10.1016/S0091-6749(02)81367-7	http://dx.doi.org/10.1016/S0091-6749(02)81367-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800230
J	Peters, S; Crane, J; Fitzharris, P				Peters, S; Crane, J; Fitzharris, P			Fel d 1 levels in domestic living rooms are not related to cat color or hair length	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Wellington Sch Med & Hlth Sci, Wellington Asthma Res Grp, Wellington, New Zealand	University of Otago	Peters, S (corresponding author), Wellington Sch Med & Hlth Sci, Wellington Asthma Res Grp, POB 7343, Wellington, New Zealand.			Healy, Bridget/0000-0002-7159-354X; Siebers, Robert/0000-0002-6359-3144				CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Hussain S, 2000, J ALLERGY CLIN IMMUN, V105, pS5, DOI 10.1016/S0091-6749(00)90443-3; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Ramaker DE, 1998, J PHYS-CONDENS MAT, V10, P8753, DOI 10.1088/0953-8984/10/39/013; Sawyer G, 1998, J ALLERGY CLIN IMMUN, V102, P765, DOI 10.1016/S0091-6749(98)70016-8	5	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2001	108	4					652	653		10.1067/mai.2001.118788	http://dx.doi.org/10.1067/mai.2001.118788			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	485NK	11590399	Bronze			2022-12-18	WOS:000171760300032
J	Brito, FF; Mur, P; Bartolome, B; Galindo, PA; Gomez, E; Borja, J; Martinez, A				Brito, FF; Mur, P; Bartolome, B; Galindo, PA; Gomez, E; Borja, J; Martinez, A			Rhinoconjunctivitis and occupational asthma caused by Diplotaxis erucoides (wall rocket)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Diplotaxis erucoides; occupational allergy; pollen allergy; Cruciferae allergy	SUNFLOWER POLLEN; ALLERGY; INHALATION	Wall rocket (Diplotaxis erucoides) is a common Crucifera plant that grows in European and American vineyards and olive groves. We present the cases of 2 farmers with rhinoconjunctivitis and asthma related to wine-growing tasks during D erucoides pollination (March-April). The aim of this work was to demonstrate that occupational symptoms were caused by D erucoides pollen sensitization. Cutaneous tests, specific IgE measurements, conjunctival and bronchial provocation tests, and peak-flow measurements during working days were performed.	Sect Allergy, Ciudad Real, Spain; Hosp Santa Barbara, Allergy Unit, Puertolano, Spain; Bial Aristegui, Dept Res & Dev, Bilbao, Spain		Brito, FF (corresponding author), Gen Aguilera,17-2A, Ciudad Real 13001, Spain.			Feo-Brito, Francisco/0000-0003-1886-9620				BOUSQUET J, 1985, J ALLERGY CLIN IMMUN, V75, P70, DOI 10.1016/0091-6749(85)90015-6; BUCUR I, 1978, SCAND J RESPIR DIS, V59, P222; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHATHAM M, 1982, CHEST, V82, P15, DOI 10.1378/chest.82.1.15; Feo F, 1997, ALLERGY, V52, P633, DOI 10.1111/j.1398-9995.1997.tb01042.x; HINOJOSA M, 1984, J ALLERGY CLIN IMMUN, V74, P782, DOI 10.1016/0091-6749(84)90179-9; JIMENEZ A, 1994, INT ARCH ALLERGY IMM, V105, P297, DOI 10.1159/000236772; LOSADA E, 1992, J ALLERGY CLIN IMMUN, V89, P118, DOI 10.1016/S0091-6749(05)80048-X; MOLLER C, 1994, ALLERGY, V1, P37; SOUTAR A, 1995, OCCUP ENVIRON MED, V52, P575, DOI 10.1136/oem.52.9.575	10	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2001	108	1					125	127		10.1067/mai.2001.115756	http://dx.doi.org/10.1067/mai.2001.115756			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	458AN	11447393	Bronze			2022-12-18	WOS:000170171200018
J	Cueva, B; Izquierdo, G; Crespo, JF; Rodriguez, J				Cueva, B; Izquierdo, G; Crespo, JF; Rodriguez, J			Unexpected spice allergy in the meat industry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Hosp Univ Doce Octubre, Serv Alergia, Madrid, Spain	Hospital Universitario 12 de Octubre	Cueva, B (corresponding author), Hosp Univ Doce Octubre, Serv Alergia, Madrid, Spain.							DREBORG S, 1983, ALLERGY, V38, P167, DOI 10.1111/j.1398-9995.1983.tb01602.x; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; STAGER J, 1991, ALLERGY, V46, P475, DOI 10.1111/j.1398-9995.1991.tb04228.x; VANTOORENENBERGEN AW, 1985, J ALLERGY CLIN IMMUN, V76, P477, DOI 10.1016/0091-6749(85)90730-4; VETTER E, 1988, ALLERGOLOGIE, V5, P165	5	5	5	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2001	108	1					144	144		10.1067/jmai.2001.116003	http://dx.doi.org/10.1067/jmai.2001.116003			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	458AN	11447400				2022-12-18	WOS:000170171200024
J	Bohm, M; Bunselmeyer, B; Luger, TA; Brehler, R				Bohm, M; Bunselmeyer, B; Luger, TA; Brehler, R			Food intolerance due to wine gums: Identification of copper chlorophyll (E141) as a possible pseudoallergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Munster, Dept Dermatol, D-48149 Munster, Germany	University of Munster	Bohm, M (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-48149 Munster, Germany.							DEWECK AL, 1992, PROGR ALLERGY CLIN I, V2, P197; HUMPHREY AM, 1980, FOOD CHEM, V5, P57, DOI 10.1016/0308-8146(80)90064-3; KAGI MK, 1994, LANCET, V344, P60, DOI 10.1016/S0140-6736(94)91083-9; STEVENSON DD, 1986, J ALLERGY CLIN IMMUN, V78, P182, DOI 10.1016/0091-6749(86)90011-4	4	5	6	0	5	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2					393	394						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	403YV	11174213				2022-12-18	WOS:000167071400033
J	Carrozzi, FM; Katelaris, CH; Burke, TV; Byth, K				Carrozzi, FM; Katelaris, CH; Burke, TV; Byth, K			An open study examining the effects of intranasal budesonide on quality of life and performance in elite athletes with allergic rhinoconjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Westmead Hosp, Sydney, NSW, Australia	University of Sydney									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		510	S154	S155						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300509
J	Epton, MJ; Malainual, N; Smith, WA; Thomas, WR				Epton, MJ; Malainual, N; Smith, WA; Thomas, WR			Vitellogenin-apoplipophorin like allergen Der p 14 is a major specificity in house dust mite sensitisation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									TVW Telethon Inst Child Hlth Res, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		45	S14	S14						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300046
J	Frank, E; Williams, A; Cromwell, O; Atkinson, P; Rajakulasingam, K				Frank, E; Williams, A; Cromwell, O; Atkinson, P; Rajakulasingam, K			Effectiveness of a pre-seasonal allergoid immunotherapy in patients with seasonal allergic rhinitis due to grass pollen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Allergopharma Joachim Ganzer KG, Reinbeck, Germany; Homerton Hosp NHS Trust, London, England; Diagen Ltd, Newark, Notts, England	Allergopharma									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		851	S260	S260						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300847
J	Frick, OL; Buchanan, BB; Delval, G; Umetsu, DT				Frick, OL; Buchanan, BB; Delval, G; Umetsu, DT			Allergen Immunotherapy with Heat-killed Listeria monocytogenes (HKL) as adjuvant prevents allergic reactions in highly foodsensitized dogs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Stanford University									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		763	S232	S232						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300759
J	Horowitz, E; Diemer, FB; Poyser, J; Rice, V; Jean, LG; Britt, V; Knight, M; Togias, A				Horowitz, E; Diemer, FB; Poyser, J; Rice, V; Jean, LG; Britt, V; Knight, M; Togias, A			Asthma and rhinosinusitis prevalence in a Baltimore City public housing complex	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Baltimore, MD USA; Housing Author Baltimore City, Baltimore, MD USA	Johns Hopkins University									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		918	S280	S280						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300914
J	Kim, HY; Park, HS; Kim, YK; Son, JW; Kim, HA; Suh, JH; Nahm, DH; Cho, SH; Min, KU; Kim, YY				Kim, HY; Park, HS; Kim, YK; Son, JW; Kim, HA; Suh, JH; Nahm, DH; Cho, SH; Min, KU; Kim, YY			Identification of IgE-binding components of citrus red mite in sera of patients with citrus red mite-induced asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						citrus red mite; IgE-binding component; major allergen; amino acid sequencing	PANONYCHUS-CITRI; HOUSE DUST; ALLERGEN; FARINAE; FARMERS	Background: Our previous investigations demonstrated that citrus red mite (CRM) antigen could cause IgE-mediated bronchoconstriction in exposed farmers working on citrus farms. Objective: This study was performed to confirm IgE-binding components and major allergens within the CRM antigens. Methods: Ten subjects who had been diagnosed as having CRM-induced asthma were enrolled. Serum-specific IgE antibodies to CRM antigens were measured by using an ELISA. To identify IgE-binding components and major allergens, SDS-PAGE, 2-dimensional PAGE, IgE-immunoblot analysis, and amino acid sequencing of major allergens were performed. Results: All the asthmatic subjects had high specific IgE antibodies to CRMs. Twelve percent SDS-PAGE analysis showed more than 10 protein bands ranging from 6 to 64 kd. SDS-PAGE and IgE-immunoblot analysis with each individual serum showed 5 IgE-binding components (11, 24, 35, 40, and 64 kd), with 2 (24 and 35 kd) of them bound in more than 50% of the study subjects. Two-dimensional PAGE and IgE-immunoblot analysis demonstrated that the major allergen at 24 kd had 2 bands with different isoelectric points of 1.75 and 5.1. Thirty-five kilodaltons had one band with an isoelectric point of 4.75. All amino acid sequencing of the 2 major allergens was performed, which was not homologous with any previously characterized allergens. Conclusion: Five IgE-binding components and 2 major allergens (24 and 35 kd) were identified within the CRM antigen. The N-terminal amino acid sequence of the 2 major allergens (24 and 35 kd) was determined.	Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 442749, South Korea; Seoul Natl Univ, Dept Med, Seoul, South Korea	Ajou University; Seoul National University (SNU)	Park, HS (corresponding author), Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Paldalgu Wonchondong San-5, Suwon 442749, South Korea.		Park, Hae-Sim/S-7974-2019; Min, Kyung-Up/J-5468-2012; Cho, Sang Heon/J-2793-2012	Park, Hae-Sim/0000-0003-2614-0303				ARLIAN LG, 1984, J ALLERGY CLIN IMMUN, V74, P172, DOI 10.1016/0091-6749(84)90282-3; Ashida T, 1995, Arerugi, V44, P1290; BRUCHES E, 1996, CLIN ECP ALLERGY, V26, P1262; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P534; HONG C-S, 1991, Yonsei Medical Journal, V32, P24; Kim HY, 1999, ANN ALLERG ASTHMA IM, V82, P174, DOI 10.1016/S1081-1206(10)62593-8; Kim YK, 1999, CLIN EXP ALLERGY, V29, P1102, DOI 10.1046/j.1365-2222.1999.00607.x; Kim YK, 1999, ANN ALLERG ASTHMA IM, V82, P223, DOI 10.1016/S1081-1206(10)62601-4; Park DC, 1996, ADV COMPOS MATER, V6, P1, DOI 10.1163/156855196X00167; PLATTSMILLS TAE, 1986, J ALLERGY CLIN IMMUN, V78, P398, DOI 10.1016/0091-6749(86)90024-2; REUNALA T, 1983, CLIN ALLERGY, V13, P383, DOI 10.1111/j.1365-2222.1983.tb02612.x	11	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2					244	248		10.1067/mai.2001.112123	http://dx.doi.org/10.1067/mai.2001.112123			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	403YV	11174189				2022-12-18	WOS:000167071400009
J	Kirshenbaum, AS; Hettinger, B; Day, YJ; Gilfillan, AM; Metcalfe, DD; Kim, YC; Linden, J; Jacobson, KA				Kirshenbaum, AS; Hettinger, B; Day, YJ; Gilfillan, AM; Metcalfe, DD; Kim, YC; Linden, J; Jacobson, KA			MRS 1754, a selective A2B adenosine receptor antagonist, inhibits degranulation of cultured human butnotmurine mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NIH, Bethesda, MD 20892 USA; Univ Virginia, Charlottesville, VA USA	National Institutes of Health (NIH) - USA; University of Virginia			Jacobson, Kenneth Alan/A-1530-2009	Jacobson, Kenneth Alan/0000-0001-8104-1493					0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		922	S281	S281						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300918
J	Philip, G; Malmstrom, K; Nayak, AS; Malice, MP; Reiss, TF				Philip, G; Malmstrom, K; Nayak, AS; Malice, MP; Reiss, TF		Montelukast Fall Rhinitis Investig	Improvement in rhinoconjunctivitis quality of life outcomes in the treatment of fall allergic rhinitis by montelukast alone or in combination with loratadine in a multicenter, double-blind, randomized, placebo-controlled study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Merck & Co Inc, Rahway, NJ 07065 USA; Clin Studies Bloomington Normal, Normal, IL USA	Merck & Company									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		521	S158	S158						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300519
J	Ren, SL; Kambe, N; Du, ZM; Li, YL; Xia, HZ; Kambe, M; Bieberich, E; Pozez, A; Grimes, M; Yu, RK; Irani, AM; Schwartz, LB				Ren, SL; Kambe, N; Du, ZM; Li, YL; Xia, HZ; Kambe, M; Bieberich, E; Pozez, A; Grimes, M; Yu, RK; Irani, AM; Schwartz, LB			Disialoganglioside GD3 is selectively expressed by developing and mature human mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						GD3; mast cells; tryptase; Kit	MOUSE MONOCLONAL-ANTIBODY; BASOPHILIC LEUKEMIA-CELLS; HUMAN T-LYMPHOCYTES; PHASE-I TRIAL; GANGLIOSIDE EXPRESSION; SIGNAL-TRANSDUCTION; DIFFERENTIATION; MELANOMA; TRYPTASE; CHYMASE	Background: Disialoganggioside GD3 is expressed on the surface of selected cell types, Anti-GD3 mAb administered to human subjects with malignant melanoma produces signs and symptoms of immediate hypersensitivity reactions. Objective: The expression of GD3 by human mast cells was assessed during mast cell development in vitro and in samples of lung and skin. Methods: GD3 on tissue- and in vitro-derived mast cells was analyzed after double labeling of cells for tryptase (G3 mAb) or Kit (YB5.B8 mAb) and GD3 (R24 mAb). Glycolipids in extracts of fetal liver-derived mast cells were examined by using high-performance thin-layer chromatography. Results: Flow cytometry showed that the percentage of GD3(+) cells increased in parallel to Kit(+) cells during the recombinant human stem cell factor-dependent development of fetal liver-derived mast cells. Double-labeling experiments showed that GD3(+) cells were also surface Kit(+) and granule tryptase positive, identifying them as mast cells in preparations of lung-, skin-, fetal liver-, and cord blood-derived cells. The major acidic glycolipid detected was NeuAc alpha2-8NeuAc alpha2-3Gal beta1-4Glc beta1-1'Cer (GD3). Among peripheral blood leukocytes, only basophils and about 10% of the T cells were labeled with anti-GD3 mAb. Anti-GD3 mAb-conjugated magnetic beads were used to purify mast cells to greater than 90% purity from dispersed skin cells enriched to approximately 12% purity by means of density-dependent sedimentation but were less proficient for dispersed human lung mast cells, most likely because of other cell types that express GD3. Conclusion: GD3 is expressed on the surface of developing human mast cells in parallel to tryptase in secretory granules and, like Kit, can serve as a target for their enrichment by immunoaffinity techniques.	Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pediat, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Schwartz, LB (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, POB 980263, Richmond, VA 23298 USA.		Kambe, Naotomo/H-3987-2017	Kambe, Naotomo/0000-0001-9610-4952	NIAID NIH HHS [AI27517, AI20487] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027517, R21AI020487, R37AI020487, R01AI020487] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boussiotis VA, 1996, EUR J IMMUNOL, V26, P2149, DOI 10.1002/eji.1830260928; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; CASPER ES, 1994, CANCER INVEST, V12, P20, DOI 10.3109/07357909409021389; CLAUS C, 1994, EUR J IMMUNOL, V24, P1208, DOI 10.1002/eji.1830240530; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; DIPPOLD W, 1994, EUR J CANCER, V30A, P137, DOI 10.1016/0959-8049(94)90073-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuentes R, 1997, LUNG CANCER-J IASLC, V18, P21, DOI 10.1016/S0169-5002(97)00049-4; FUJIMAKI H, 1995, INT ARCH ALLERGY IMM, V107, P527, DOI 10.1159/000237095; Goldman JE, 1996, GLIA, V16, P291, DOI 10.1002/(SICI)1098-1136(199604)16:4<291::AID-GLIA1>3.0.CO;2-3; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; IRANI AMA, 1992, BLOOD, V80, P3009; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; KEPLEY C, 1994, J IMMUNOL METHODS, V175, P1, DOI 10.1016/0022-1759(94)90326-3; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; KNIEP B, 1995, J BIOL CHEM, V270, P30173; KOJIMA N, 1994, J BIOL CHEM, V269, P30451; LERNER NB, 1991, BLOOD, V77, P1876; LICHEY J, 1994, INT ARCH ALLERGY IMM, V103, P252, DOI 10.1159/000236636; Merritt WD, 1996, CELL IMMUNOL, V173, P131, DOI 10.1006/cimm.1996.0259; MERRITT WD, 1991, LEUKEMIA, V5, P1087; MINASIAN LM, 1995, CANCER, V75, P2251, DOI 10.1002/1097-0142(19950501)75:9<2251::AID-CNCR2820750910>3.0.CO;2-F; MINOGUCHI K, 1994, J BIOL CHEM, V269, P5249; NAKAKUMA H, 1992, JPN J CLIN ONCOL, V22, P308; NILSSON G, 1993, IMMUNOLOGY, V79, P325; NORIHISA Y, 1994, J IMMUNOL, V152, P485; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Ortaldo JR, 1996, J LEUKOCYTE BIOL, V60, P533, DOI 10.1002/jlb.60.4.533; Oskeritzian CA, 1999, J IMMUNOL, V163, P5105; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; REAMAN GH, 1990, CANCER RES, V50, P202; REN S, 1989, CANCER RES, V49, P7051; SCHLAAK JF, 1995, SCAND J IMMUNOL, V41, P475, DOI 10.1111/j.1365-3083.1995.tb03595.x; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Stephan V, 1997, MOL IMMUNOL, V34, P227, DOI 10.1016/S0161-5890(97)00026-6; Swailes S, 1999, INT J SELECT ASSESS, V7, P1, DOI 10.1111/1468-2389.00099; URMACHER C, 1989, AM J DERMATOPATH, V11, P577, DOI 10.1097/00000372-198912000-00013; VADHANRAJ S, 1988, J CLIN ONCOL, V6, P1636, DOI 10.1200/JCO.1988.6.10.1636; Xia HZ, 1997, J IMMUNOL, V159, P2911; XIA HZ, 1995, J IMMUNOL, V154, P5472; YU RK, 1994, PROG BRAIN RES, V101, P31; ZENG GC, 1995, P NATL ACAD SCI USA, V92, P8670, DOI 10.1073/pnas.92.19.8670; ZUBERBIER T, 1995, BBA-MOL CELL RES, V1269, P79, DOI 10.1016/0167-4889(95)00103-Y; Zuberbier T, 1999, EXP DERMATOL, V8, P380, DOI 10.1111/j.1600-0625.1999.tb00386.x	45	5	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2					322	330		10.1067/mai.2001.112272	http://dx.doi.org/10.1067/mai.2001.112272			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	403YV	11174200				2022-12-18	WOS:000167071400020
J	Schmidt, M; Hoffman, DR				Schmidt, M; Hoffman, DR			Expression of recombinant fire ant venom allergen Sol i 4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									E Carolina Univ, Greenville, NC USA; Brody Sch Med, Greenville, NC USA	University of North Carolina; East Carolina University									0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		374	S112	S113						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300373
J	Shapiro, GG				Shapiro, GG		Desloratadine Study Grp	Decongestant effects of desloratadine in patients with seasonal allergic rhinitis and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Asthma Inc, Seattle, WA USA; Desloratadine Study Grp, Seattle, WA USA										0	5	5	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		530	S161	S161						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300528
J	Sicherer, SH; Desimone, J; Furlong, TJ				Sicherer, SH; Desimone, J; Furlong, TJ			Peanut and tree nut allergic reactions in restaurants and food establishments	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Mt Sinai Sch Med, Jaffe Food Allergy Inst, New York, NY USA; Food Allergy Network, Fairfax, VA USA	Icahn School of Medicine at Mount Sinai									0	5	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		759	S231	S231						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300755
J	Giacoia, GP				Giacoia, GP			Incentive to study drugs in children and other governmental initiatives: Will patients with asthma benefit?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						pediatric drug trials; pediatric labeling; Pediatric Pharmacology Research Unit Network; Pediatric Rule of 1998; biomarkers	CHILDHOOD; GENE	This article summarizes current regulations that have been developed to facilitate the performance of pediatric drug trials and their impact on children, particularly those children affected with asthma, in addition, other initiatives that have been developed by the federal government in response to the unexplained increase of asthma occurrence during the last 15 years will be reviewed. In the face of an asthma epidemic, a comprehensive approach is needed to determine the causes for the increase in the prevalence rate and the role of aeroallergens and other environmental and genetic factors and to identify effective preventive measures. Clearly, facilitating drug trials to prove the safety and effectiveness of drugs is of paramount importance.	NICHHD, Pediat Pharmacol Res Unit Network, Bethesda, MD 20892 USA; Georgetown Univ, Dept Pediat, Washington, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Giacoia, GP (corresponding author), NICHHD, Ctr Res Mothers & Children, Room 4B11B,6100 Executive Blvd, Bethesda, MD 20892 USA.							ADAMS PF, 1995, VITAL HLTH STAT, V10, P94; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burney P, 1996, EUR RESPIR J, V9, P687; BURNEY PGJ, 1997, ASTHMA, P35; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1022; Eggleston PA, 1998, PEDIATRICS, V101, P349, DOI 10.1542/peds.101.3.349; Farquhar I, 1998, RES HUM CAP, V12, P35; *FDA, 1970, PINK SHEET, V32, P17; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GILMAN JT, 1992, CLIN PHARMACOKINET, V23, P1, DOI 10.2165/00003088-199223010-00001; Jarvis D, 1998, BRIT MED J, V316, P607, DOI 10.1136/bmj.316.7131.607; MANNINO DM, 1998, MOR MORTAL WKLY REP, V477, P1; Martinez FD, 1998, CLIN EXP ALLERGY, V28, P21; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V103, P355, DOI 10.1016/S0091-6749(99)70456-2; MASTERS S, 1985, EPIDEMIOL REV, V7, P49, DOI 10.1093/oxfordjournals.epirev.a036285; Meijer GG, 1998, CLIN EXP ALLERGY, V28, P921; *NAT CTR HLTH STAT, 1996, UND CAUS DEATH DAT; *NAT CTR HLTH STAT, 1996, 227 NAT CTR HLTH STA; Omlor GJ, 1996, PEDIATR PULM, V22, P255, DOI 10.1002/(SICI)1099-0496(199610)22:4<255::AID-PPUL5>3.0.CO;2-L; SHIRKEY H, 1968, J PEDIATR-US, V72, P119, DOI 10.1016/S0022-3476(68)80414-7; TAYLOR WR, 1992, PEDIATRICS, V90, P657; *US DEP HHS, 1999, ACT ASTHM STRAT PLAN; WEISS KB, 1992, NEW ENGL J MED, V326, P862, DOI 10.1056/NEJM199203263261304; Weiss Scott T., 1994, Comprehensive Therapy, V20, P606; Weiss ST, 1999, CLIN EXP ALLERGY, V29, P96, DOI 10.1046/j.1365-2222.1999.00017.x; WILSON JT, 1972, J PEDIATR-US, V80, P855; WOOLCOCK AJ, 1997, EVIDENCE INCREASE AS, P122; YUNNINGER JW, 1992, AM REV RESPIR DIS, V146, P888; 1998, FED REG 277733, V63	29	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2000	106	3		S			S118	S124		10.1067/mai.2000.109417	http://dx.doi.org/10.1067/mai.2000.109417			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	357XB	10984391				2022-12-18	WOS:000089525400002
J	Djukanovic, R				Djukanovic, R			Induced sputum - A tool with great potential but not without problems	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						induced sputum; asthma	BRONCHOALVEOLAR LAVAGE; AIRWAY INFLAMMATION; ASTHMATIC SUBJECTS; INDUCTION; BRONCHITIS; CHILDREN; ALLERGEN; HEALTHY; SAMPLES; HYPERRESPONSIVENESS		Univ Med, Southampton Gen Hosp, Div Resp & Cell Biol, Southampton, Hants, England	University of Southampton	Djukanovic, R (corresponding author), Univ Med, Southampton Gen Hosp, Div Resp Cell & Mol Biol, Level D,Ctr Block, Southampton SO16 6YD, Hants, England.			Djukanovic, Ratko/0000-0001-6039-5612				Cai Y, 1998, EUR RESPIR J, V11, P848, DOI 10.1183/09031936.98.11040848; CLAMAN DM, 1994, J ALLERGY CLIN IMMUN, V94, P861, DOI 10.1016/0091-6749(94)90154-6; de la Fuente PT, 1998, AM J RESP CRIT CARE, V157, P1127, DOI 10.1164/ajrccm.157.4.9610008; Ennis M, 1999, CLIN EXP ALLERGY, V29, P362; Fahy JV, 1998, EUR RESPIR J, V11, P1240, DOI 10.1183/09031936.98.11061240; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P53, DOI 10.1164/ajrccm.152.1.7599862; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Fujimoto K, 1999, CHEST, V115, P697, DOI 10.1378/chest.115.3.697; Gershman NH, 1999, J ALLERGY CLIN IMMUN, V104, P322, DOI 10.1016/S0091-6749(99)70374-X; GIBSON PG, 1989, THORAX, V44, P693, DOI 10.1136/thx.44.9.693; GIBSON PG, 1995, CLIN EXP ALLERGY, V25, P127, DOI 10.1111/j.1365-2222.1995.tb01017.x; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Grootendorst DC, 1997, CLIN EXP ALLERGY, V27, P769, DOI 10.1111/j.1365-2222.1997.tb01211.x; Holz O, 1998, CLIN EXP ALLERGY, V28, P284; Jarjour NN, 1998, AM J RESP CRIT CARE, V157, P692, DOI 10.1164/ajrccm.157.3.9705020; Keatings VM, 1997, J ALLERGY CLIN IMMUN, V99, P693, DOI 10.1016/S0091-6749(97)70032-0; KELLY CA, 1988, AM REV RESPIR DIS, V138, P81, DOI 10.1164/ajrccm/138.1.81; Kips JC, 1998, EUR RESPIR J, V11, p9S; Louis R, 1999, EUR RESPIR J, V13, P660, DOI 10.1183/09031936.99.13366099; Louis R, 1997, AM J RESP CRIT CARE, V155, P466, DOI 10.1164/ajrccm.155.2.9032180; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Pizzichini E, 1998, AM J RESP CRIT CARE, V158, P1511, DOI 10.1164/ajrccm.158.5.9804028; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Stevenson EC, 1997, CLIN EXP ALLERGY, V27, P1027, DOI 10.1111/j.1365-2222.1997.tb01254.x; Teran LM, 1996, J IMMUNOL, V157, P1806; Twaddell SH, 1996, EUR RESPIR J, V9, P2104, DOI 10.1183/09031936.96.09102104; Wong HH, 1997, AM J RESP CRIT CARE, V156, P299, DOI 10.1164/ajrccm.156.1.9610114	27	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2000	105	6	1				1071	1073		10.1067/mai.2000.107042	http://dx.doi.org/10.1067/mai.2000.107042			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	327EX	10856137				2022-12-18	WOS:000087781800004
J	Demoly, P; Messaad, D; Reynes, J; Faucherre, V; Bousquet, J				Demoly, P; Messaad, D; Reynes, J; Faucherre, V; Bousquet, J			Trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients: Long-term follow-up regarding efficacy and safety	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									CHU Montpellier, Hop Amaud de Villeneuve, INSERM, U454,IFR3, F-34295 Montpellier 5, France; CHU Montpellier, Hop Guy de Chauliac, F-34295 Montpellier 5, France; CHU Montpellier, Hop St Eloi, F-34295 Montpellier 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Demoly, P (corresponding author), CHU Montpellier, Hop Amaud de Villeneuve, INSERM, U454,IFR3, F-34295 Montpellier 5, France.		Demoly, Pascal/Y-9938-2019; Bousquet, Jean/O-4221-2019	Demoly, Pascal/0000-0001-7827-7964; 				ALSADR WM, 1998, NEW ENGL J MED, V339, P1889; Caumes E, 1996, CLIN INFECT DIS, V23, P1313, DOI 10.1093/clinids/23.6.1313; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; Demoly P, 1998, J ALLERGY CLIN IMMUN, V102, P1033, DOI 10.1016/S0091-6749(98)70343-4; Ioannidis JPA, 1996, ARCH INTERN MED, V156, P177, DOI 10.1001/archinte.156.2.177	5	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2000	105	3					588	589		10.1067/mai.2000.104781	http://dx.doi.org/10.1067/mai.2000.104781			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	347UC	10719313				2022-12-18	WOS:000088946700030
J	Page, C				Page, C			The role of proteoglycans regulation of airways inflammation and airways remodelling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						proteoglycans; airways remodeling; glycosaminoglycans; airways inflammation	INDUCED EOSINOPHIL INFILTRATION; INHALED HEPARIN; ULCERATIVE-COLITIS; GUINEA-PIGS; INHIBITION; ASTHMA; ALLERGEN; CELLS; GLYCOSAMINOGLYCANS; ANTIGEN	Proteoglycans such as heparin have been recognized as useful anticoagulant drugs for a long time. However, it is now apparent that proteoglycans possess a wide array of biologic activities that are of potential interest in our understanding of the regulation of airways inflammation and remodelling in addition to their anticoagulant effects.(1) A proteoglycan is any glycoprotein that consists of a protein core and has glycosaminoglycan side chains. Glycosaminoglycans are polysaccharides that have a simple repeating disaccharide unit and are highly anionic in nature because of the presence of many sulphate and carboxyl groups.(2) Heparin is found exclusively in mast cell granules in mammals,(3) whereas heparan sulphate is ubiquitous, being found on the surface of must cell types, particularly on the surface of vascular endothelial cells.(1) However, although we have known for some time that heparin is present in mast cell granules, where it binds histamine and the mast cell enzymes, tryptase, and chymase,(3) little is known about the role of endogenous heparin. It is now clear that after the exposure of human lung mast cells to house dust-mite allergen, heparin can be released into the extracellular environment.(4) This article will review the biologic activities of heparin and related proteoglycans that are of interest in the context of our understanding of airway inflammation and remodelling.	Kings Coll London, Sackler Inst Pulm Pharmacol, GKT Sch Biomed Sci, Div Pharmaceut & Therapeut, London SE1 9RT, England	University of London; King's College London	Page, C (corresponding author), Kings Coll London, Sackler Inst Pulm Pharmacol, GKT Sch Biomed Sci, Div Pharmaceut & Therapeut, 5th Floor,Hodgkin Bldg,Guys Campus, London SE1 9RT, England.			Page, Clive Peter/0000-0002-9358-3799				AHMED T, 1994, J APPL PHYSIOL, V76, P893, DOI 10.1152/jappl.1994.76.2.893; BOWLER SD, 1993, AM REV RESPIR DIS, V147, P160, DOI 10.1164/ajrccm/147.1.160; COYLE AJ, 1995, J CLIN INVEST, V95, P1735, DOI 10.1172/JCI117850; Crimi N., 1995, European Respiratory Journal, V8, p10S; Diamant Z, 1996, AM J RESP CRIT CARE, V153, P1790, DOI 10.1164/ajrccm.153.6.8665036; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; EKRE HPT, 1986, INT J IMMUNOPHARMACO, V8, P277, DOI 10.1016/0192-0561(86)90109-8; Erickson DR, 1997, J UROLOGY, V157, P61, DOI 10.1016/S0022-5347(01)65280-7; EVANGELISTA V, 1992, EUR J PHARMACOL, V216, P401, DOI 10.1016/0014-2999(92)90437-9; Folwaczny C, 1997, AM J GASTROENTEROL, V92, P911; FRYER A, 1997, J PHARMACOL EXP THER, V282, P209; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; GAFFNEY PR, 1995, AM J GASTROENTEROL, V90, P220; GORSKI A, 1991, FASEB J, V5, P2287, DOI 10.1096/fasebj.5.9.1860620; GRAHAM MF, 1987, GASTROENTEROLOGY, V93, P801, DOI 10.1016/0016-5085(87)90443-4; GREEN WF, 1993, AM J RESP CELL MOL, V8, P518, DOI 10.1165/ajrcmb/8.5.518; HOWELL RE, 1993, PULM PHARMACOL, V6, P237, DOI 10.1006/pulp.1993.1031; ITOH K, 1995, EUR SURG RES, V27, P184, DOI 10.1159/000129398; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; JOHNSON N, 1995, ENVIRON PLANN D, V13, P51, DOI 10.1068/d130051; JONES CA, 1995, BIOL REPROD, V52, P839, DOI 10.1095/biolreprod52.4.839; KARNOVSKY MJ, 1994, AIRWAY VASCULAR REMO, P41; KILFEATHER SA, 1995, BRIT J PHARMACOL, V114, P1442, DOI 10.1111/j.1476-5381.1995.tb13367.x; KINHARDT RJ, 1990, BIOMIMETIC POLYM, P135; KUNA P, 1996, J ALLERGY CLIN IMMUN, V365, P274; LAMBERT RK, 1993, J APPL PHYS, V74, P2711; LEVER R, 1997, AM J RESP CRIT CARE, V155, pA874; LIDER O, 1990, EUR J IMMUNOL, V20, P493, DOI 10.1002/eji.1830200306; LUNGREN R, 1988, EUR RESPIR J, V1, P883; METZGER WJ, 1995, SPRINGER SEMIN IMMUN, V16, P467; METZGER WJ, 1992, J ALLERGY CLIN IMMUN, V89, pA235; MOTOJIMA S, 1989, AM REV RESPIR DIS, V139, P801, DOI 10.1164/ajrccm/139.3.801; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; NELSON RM, 1993, BLOOD, V82, P3253; PAGE CP, 1991, LANCET, V337, P717, DOI 10.1016/0140-6736(91)90289-2; Pavord I, 1996, EUR RESPIR J, V9, P217, DOI 10.1183/09031936.96.09020217; PREUSS JMH, 1996, AM J HOSP CRIT CARE, V153, pA627; REDINI F, 1988, BIOCHEM J, V252, P515, DOI 10.1042/bj2520515; ROCHE WR, 1989, LANCET, V1, P520; SANANTONIO JD, 1992, J CELL PHYSIOL, V150, P8; SASAKI M, 1993, BRIT J PHARMACOL, V110, P107, DOI 10.1111/j.1476-5381.1993.tb13778.x; SCHWARTZ LB, 1981, J IMMUNOL, V126, P2071; SEEDS EAM, 1993, J LIPID MEDIATOR, V7, P269; Seeds EAM, 1995, PULM PHARMACOL, V8, P97, DOI 10.1006/pulp.1995.1012; SHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; STUCKEY JA, 1992, PROTEINS, V14, P3119; SY MS, 1983, CELL IMMUNOL, V82, P23, DOI 10.1016/0008-8749(83)90137-5; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; THOMPSON BT, 1994, AM J RESP CRIT CARE, V149, P1512, DOI 10.1164/ajrccm.149.6.8004307; TYRRELL DJ, 1995, TRENDS PHARMACOL SCI, V16, P198, DOI 10.1016/S0165-6147(00)89022-7; TYRRELL DJ, 1993, J BIOL CHEM, V268, P4684; Van de Carr FR, 1928, J IMMUNOL, V15, P13; WEILER JM, 1992, J IMMUNOL, V148, P3210; WILLENBORG DO, 1988, J IMMUNOL, V140, P3401; WRIGHT TC, 1989, J BIOL CHEM, V264, P1534	55	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	2	S			S518	S521		10.1016/S0091-6749(00)90054-X	http://dx.doi.org/10.1016/S0091-6749(00)90054-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286JG	10669535				2022-12-18	WOS:000085439600012
J	Wiesch, DG; Meyers, DA				Wiesch, DG; Meyers, DA			Strategies for analyzing genotype-phenotype relationships in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						genotype; phenotype; asthma; complex disease; mendelian disease; breast cancer; cystic fibrosis; case-control study; gene-environment interaction	CYSTIC-FIBROSIS PATIENTS; OVARIAN-CANCER; BRCA2; MUTATIONS; FREQUENCY; FAMILIES; BREAST	Asthma is a genetically complex disease with a multifaceted phenotype, Different approaches including population-based and family-based methods for evaluating genotype-phenotype relationships in asthma are discussed as well as the problems that may obscure these determinations. Examples of similar efforts in cystic fibrosis and breast cancer are considered in addition to interaction between causative genes and etiologically relevant environmental exposure.	Univ Maryland, Sch Med, Ctr Genet Asthma & Complex Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Meyers, DA (corresponding author), Univ Maryland, Sch Med, Ctr Genet Asthma & Complex Dis, 108 N Greene St,Suite 119, Baltimore, MD 21201 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049602, R01HL048341] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL48341, U01 HL/AI49602] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; EASTON DF, 1993, AM J HUM GENET, V52, P678; Ferrari M, 1996, ANN BIOL CLIN-PARIS, V54, P235; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hubert D, 1996, EUR RESPIR J, V9, P2207, DOI 10.1183/09031936.96.09112207; Kahn P, 1996, SCIENCE, V274, P497, DOI 10.1126/science.274.5287.497; Khoury MJ, 1993, FUNDAMENTALS GENETIC, P383; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; MANGE EJ, 1994, BASIC HUMAN GENETICS; Marsh DG, 1997, NAT GENET, V15, P389; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Szabo CI, 1997, AM J HUM GENET, V60, P1013; WIESCH DG, 1996, GENETICS ASTHMA, P421; XU J, 1996, GENETICS ASTHMA, P351; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	18	5	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	2	S			S482	S486		10.1016/S0091-6749(00)90047-2	http://dx.doi.org/10.1016/S0091-6749(00)90047-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286JG	10669528				2022-12-18	WOS:000085439600005
J	Assa'ad, A; Lierl, M				Assa'ad, A; Lierl, M			Effect of acellular pertussis vaccine on the development of allergic sensitization to environmental allergens in adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						adult; allergens; Bordetella pertussis; hypersensitivity; IgE; hospital personnel; pertussis toxin; pertussis vaccine; RAST; vaccines	IMMUNE-RESPONSE; IGE RESPONSES; TOXIN; IMMUNIZATION; MICE; POPULATION; INFECTION; STAFF	Background: Exposure of children to pertussis antigens caused by infection or vaccination with whole-cell pertussis vaccine may increase the serum IgE level and predispose to sensitization to the prevalent environmental allergens. Acellular pertussis vaccine (APV) that may be given to adults may have a similar effect. Objective: The purpose of this study was to determine whether APV will cause an increase in environmental sensitization measured by an increase of serum-specific IgE to the allergens to which adults are exposed during the vaccination period. Methods: One hundred adult hospital employees were randomized to receive either a a component APV composed of pertussis toxin and filamentous hemagglutinin or a meningococcal vaccine as a control, Serum-specific IgE level to 2 indoor allergens, cat and dust mite, and 2 outdoor allergens prevalent during the immunization season, Alternaria species and ragweed, was measured by an RIA on sera collected before and 1 month after vaccination. Results: The group that received the APV had no significant change in their serum-specific IgE levels to cat, dust Alternaria species, or ragweed 1 month after vaccination. Conclusion: A 2-component APV did not predispose to an increase of allergen-specific IgE in an adult population.	Childrens Hosp, Med Ctr, Div Pulm Med Allergy & Clin Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Assa'ad, A (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Med Allergy & Clin Immunol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.							AOYAMA T, 1992, AM J DIS CHILD, V146, P163, DOI 10.1001/archpedi.1992.02160140029015; ARARA S, 1970, INT ARCH ALLER A IMM, V37, P357; Ausiello CM, 1998, J INFECT DIS, V178, P466, DOI 10.1086/515628; Blumenthal JB, 1996, IMMUNOL ALLERGY CLIN, V16, P517, DOI 10.1016/S0889-8561(05)70259-9; CHRISTIE CDC, 1995, INFECT CONT HOSP EP, V16, P556; CLINE MG, 1989, THORAX, V44, P425, DOI 10.1136/thx.44.5.425; EDWARDS KM, 1993, JAMA-J AM MED ASSOC, V269, P53, DOI 10.1001/jama.269.1.53; Lin TY, 1997, VACCINE, V15, P1917, DOI 10.1016/S0264-410X(97)00127-8; LINDSAY DSJ, 1994, INT ARCH ALLERGY IMM, V105, P281, DOI 10.1159/000236770; MU HH, 1994, IMMUNOLOGY, V83, P639; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; Nilsson L, 1998, ARCH PEDIAT ADOL MED, V152, P734; Odelram H, 1994, Pediatr Allergy Immunol, V5, P118, DOI 10.1111/j.1399-3038.1994.tb00228.x; PARFENTJEV IA, 1948, J PHARMACOL EXP THER, V92, P411; REDHEAD K, 1993, INFECT IMMUN, V61, P3190, DOI 10.1128/IAI.61.8.3190-3198.1993; Samore MH, 1996, VACCINE, V14, P290, DOI 10.1016/0264-410X(95)00201-B; SCHUSTER A, 1993, CLIN INVESTIGATOR, V71, P208; SEN DK, 1974, J ALLERGY CLIN IMMUN, V54, P25, DOI 10.1016/S0091-6749(74)80005-9; SHEFER A, 1995, J INFECT DIS, V171, P1053, DOI 10.1093/infdis/171.4.1053; TORRE D, 1990, AM J DIS CHILD, V144, P290, DOI 10.1001/archpedi.1990.02150270040022; VANDERPOUWKRAAN CTM, 1995, CLIN EXP IMMUNOL, V99, P473; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; WRIGHT SW, 1994, ANN EMERG MED, V24, P413, DOI 10.1016/S0196-0644(94)70177-6	23	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	1				170	175		10.1016/S0091-6749(00)90193-3	http://dx.doi.org/10.1016/S0091-6749(00)90193-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	278LW	10629468				2022-12-18	WOS:000084992100023
J	Beck, G; Mansur, A; Afzal, M; Wang, SF; Dellavecchia, D; Moll, B; Cardenas, P; Frieri, M				Beck, G; Mansur, A; Afzal, M; Wang, SF; Dellavecchia, D; Moll, B; Cardenas, P; Frieri, M			Effect of azelastine nasal spray on mediators of inflammation in patients with seasonal allergic rhinitis (SAR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Nassau Cty Med Ctr, E Meadow, NY 11554 USA										0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		607	S203	S203		10.1016/S0091-6749(00)91035-2	http://dx.doi.org/10.1016/S0091-6749(00)91035-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100603
J	Dixit, A; Kwilinski, K				Dixit, A; Kwilinski, K			Cladosporium sphaerospermum - A new allergenic species	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL)									0	5	5	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		969	S328	S328		10.1016/S0091-6749(00)91395-2	http://dx.doi.org/10.1016/S0091-6749(00)91395-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100963
J	Glass, TA; Hutcheson, PS; Dykewicz, MS; Borts, MR; Sacha, RF; Slavin, RG				Glass, TA; Hutcheson, PS; Dykewicz, MS; Borts, MR; Sacha, RF; Slavin, RG			Clinical spectrum of ladybug hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									St Louis Univ, Sch Med, St Louis, MO USA	Saint Louis University									0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		384	S128	S128		10.1016/S0091-6749(00)90813-3	http://dx.doi.org/10.1016/S0091-6749(00)90813-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100381
J	Glue, P; Banfield, C; Affrime, MB; Statkevich, P; Reyderman, L; Padhi, D				Glue, P; Banfield, C; Affrime, MB; Statkevich, P; Reyderman, L; Padhi, D			Desloratadine and erythromycin: Pharmacokinetics and electrocardiographic pharmacodynamic effects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Res Inst, Kenilworth, NJ USA	Merck & Company; Schering-Plough Research Institute									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1130	S387	S387		10.1016/S0091-6749(00)91556-2	http://dx.doi.org/10.1016/S0091-6749(00)91556-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530101124
J	Guyton, S; Tsay, A; Chapman, M; Eggleston, P				Guyton, S; Tsay, A; Chapman, M; Eggleston, P			Performance evaluation of a rapid test for dust mite allergen detection in the home	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University									0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		848	S289	S289		10.1016/S0091-6749(00)91276-4	http://dx.doi.org/10.1016/S0091-6749(00)91276-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100844
J	Hey, J; Anthes, J; Barnett, A; Tozzi, S; Kreutner, W				Hey, J; Anthes, J; Barnett, A; Tozzi, S; Kreutner, W			Preclinical cardiovascular and CNS safety profile of desloratadine, a selective and nonsedating histamine H-1-receptor antagonist	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA	Merck & Company; Schering Plough Corporation									0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1120	S383	S383		10.1016/S0091-6749(00)91546-X	http://dx.doi.org/10.1016/S0091-6749(00)91546-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530101114
J	Jorge, PPO; Tobias, KRC; Ferriani, VPL; Smith, AM; Chapman, MD; Arruda, LK				Jorge, PPO; Tobias, KRC; Ferriani, VPL; Smith, AM; Chapman, MD; Arruda, LK			Recombinant allergens for diagnosis of mite allergy in children with asthma and/or rhinitis: Comparison with commercial extracts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Sch Med Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil; USP, Sch Med Ribeiro Preto, Ribeirao Preto, Brazil; Univ Virginia, Charlottesville, VA 22903 USA	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; University of Virginia			Arruda, L. Karla/D-5845-2013; Ferriani, Virginia PL/E-2209-2012	Arruda, L. Karla/0000-0002-7505-210X; 					0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		515	S169	S169		10.1016/S0091-6749(00)90943-6	http://dx.doi.org/10.1016/S0091-6749(00)90943-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100511
J	Martin, DF; Gardner, KH; Gruchalla, RS				Martin, DF; Gardner, KH; Gruchalla, RS			Preparation and analysis of Penicilloic Acid and Penilloic Acid using high resolution nuclear magnetic resonance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Texas, SW Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556					0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1021	S346	S346		10.1016/S0091-6749(00)91447-7	http://dx.doi.org/10.1016/S0091-6749(00)91447-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530101015
J	Matz, J; Kalberg, C; Emmett, A; Yancey, S; Dorinsky, P; Rickard, K				Matz, J; Kalberg, C; Emmett, A; Yancey, S; Dorinsky, P; Rickard, K			The combination of salmeterol and low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Atlantic Asthma & Allergy Ctr, Baltimore, MD USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		494	S162	S162		10.1016/S0091-6749(00)90923-0	http://dx.doi.org/10.1016/S0091-6749(00)90923-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100491
J	Pomes, A; Chapman, MD; Blundell, TL; Dhanaraj, V				Pomes, A; Chapman, MD; Blundell, TL; Dhanaraj, V			Comparative modeling of Bla g 2, a cockroach allergen and inactive aspartic proteinase	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Cambridge, Cambridge CB2 1TN, England; Univ Virginia, Charlottesville, VA USA	University of Cambridge; University of Virginia			Pomés, Anna/H-7010-2019	Pomés, Anna/0000-0002-8729-1829					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		510	S168	S168		10.1016/S0091-6749(00)90938-2	http://dx.doi.org/10.1016/S0091-6749(00)90938-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100506
J	Sellers, CL; Teuber, SS; Buchanan, BB; Chen, L				Sellers, CL; Teuber, SS; Buchanan, BB; Chen, L			Peanut protein digestibility: A gastric and intestinal model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Cerro Cosos Coll, Ridgecrest, CA USA; Univ Calif Davis, Sch Med, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Davis									0	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		425	S140	S140		10.1016/S0091-6749(00)90854-6	http://dx.doi.org/10.1016/S0091-6749(00)90854-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100422
J	Vaughan, JW; McGee, H; Squillace, SP; Sporik, R; Platts-Mills, TAE				Vaughan, JW; McGee, H; Squillace, SP; Sporik, R; Platts-Mills, TAE			Exposure to high concentrations of cat allergen at home is associated with increased IgG and IgG4 ab but not IgE ab to Fel d 1: IgG4 as a marker for a modified T(H)2 response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA USA; Inst Resp Med, Sydney, NSW, Australia	University of Virginia									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1067	S363	S363		10.1016/S0091-6749(00)91493-3	http://dx.doi.org/10.1016/S0091-6749(00)91493-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530101061
J	Wasserman, SI				Wasserman, SI			The allergist in the new millennium	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy and immunology; clinical practice and research challenges; training in allergy		Allergy and immunology emerged as a distinct research area and clinical specialty in the early 20th century. As the 21st century approaches, the evolution of clinical and academic life in American medicine produces unique challenges for this field and its practitioners, educators, and investigators. How we reached our current state and a personal view of the future for the clinician and the academician in this field are discussed.	Univ Calif San Diego, Ctr Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	Wasserman, SI (corresponding author), Univ Calif San Diego, Ctr Med, 402 Dickinson St, San Diego, CA 92103 USA.							American Board of Medical Specialties, 1999, ANN REP REF HDB; Cohen SG, 1992, EXCERPTS CLASSICS AL; Dale HH, 1910, J PHYSIOL-LONDON, V41, P318; HOLGATE S, 1997, SRS A LEUKOTRIENES D; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; JOHANSSON SGO, 1967, J IMMUNOL, V98, P381; Kellaway CH, 1940, Q J EXP PHYSIOL CMS, V30, P121; METCALFE DD, 1995, PRIMARY CARE, V25, P885; Moy E, 1997, JAMA-J AM MED ASSOC, V278, P217, DOI 10.1001/jama.278.3.217; Pirquet Clemens von, 1906, MUNCHEN MED WOCHEN, V30, P1457; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; RILEY JF, 1953, J PHYSIOL-LONDON, V120, P528, DOI 10.1113/jphysiol.1953.sp004915; Schultz W. H., 1909, J PHARMACOL EXP THER, V1, P566	13	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	1				3	8		10.1016/S0091-6749(00)90170-2	http://dx.doi.org/10.1016/S0091-6749(00)90170-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	278LW	10629446				2022-12-18	WOS:000084992100001
J	Williams, G				Williams, G			Moisture transport into chlorofluorocarbon-free metered dose inhalers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						aerosols; moisture		Moisture is known to affect the stability of some metered dose inhalers (MDIs). Hydrofluoroalkanes such as tetrafluoroethane (134a) and heptafluoropropane (227) are known to have higher affinity for moisture than the currently used chlorofluorocarbon propellents, An initial study was conducted to determine the water vapor transmission rates of various elastomers that may be used as gaskets in MDIs. A further study was conducted to measure the moisture ingress rates of various chlorofluorocarbon-free MDIs. The data indicate that moisture transport into chlorofluorocarbon-free MDIs is influenced by the elastomeric nature of the gaskets used and the type of hydrofluoroalkane formulation and storage conditions used.	Valois Pharm, R&D Lab, F-27100 Le Vaudreuil, France		Williams, G (corresponding author), Valois Pharm, R&D Lab, Route Falaise, F-27100 Le Vaudreuil, France.							*COMM EUR COMM, 1993, COMM EUR COMM PUBL; *CTR PROF ADV, 1997, PHARM AER TECHN TRAI; *INT ORG STAND, ISO25281974E INT ORG; KIM Y, 1992, DRUG DEV IND PHARM, V18, P185; Miller N.C., 1990, RESP DRUG DELIVERY, P249; Reynolds JM, 1996, PHARMACEUT RES, V13, P809, DOI 10.1023/A:1016028423118	6	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1999	104	6					S227	S229		10.1016/S0091-6749(99)70035-7	http://dx.doi.org/10.1016/S0091-6749(99)70035-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266FD	10588979				2022-12-18	WOS:000084289200035
J	Vaswani, SK; Sampson, HA; Chang, BW; Hamilton, RG				Vaswani, SK; Sampson, HA; Chang, BW; Hamilton, RG			Adult-onset sensitization to casein after occupational exposure to aerosolized Tryptone powder	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FOOD ALLERGY; ASTHMA		Johns Hopkins Univ, Sch Med, Mt Sinai Sch Med, Mid Atlantic Permanente Med Grp, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Permanente Medical Groups	Vaswani, SK (corresponding author), Allergy & Asthma Clin Ctr, Ellicott City, MD 21043 USA.							Bernstein DI, 1998, ALLERGY PRINCIPLES P; CHANYEUNG M, 1995, NEW ENGL J MED, V333, P107, DOI 10.1056/NEJM199507133330207; JAMES JM, 1991, J ALLERGY CLIN IMMUN, V88, P402, DOI 10.1016/0091-6749(91)90104-V; JANSEN JJN, 1994, J ALLERGY CLIN IMMUN, V93, P446; Sampson HA, 1997, JAMA-J AM MED ASSOC, V278, P1888, DOI 10.1001/jama.278.22.1888; Vaswani SK, 1996, ALLERGY, V51, P266, DOI 10.1111/j.1398-9995.1996.tb04604.x	6	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					1108	1109		10.1016/S0091-6749(99)70097-7	http://dx.doi.org/10.1016/S0091-6749(99)70097-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550761				2022-12-18	WOS:000083778400040
J	Barranco, P; Moreno-Ancillo, A; Robles, MLM; Alvarez-Sala, R; De Terreros, LG; Martin-Esteban, M; Vicente, J; Lopez-Serrano, MC				Barranco, P; Moreno-Ancillo, A; Robles, MLM; Alvarez-Sala, R; De Terreros, LG; Martin-Esteban, M; Vicente, J; Lopez-Serrano, MC			Hypersensitivity pneumonitis in a worker exposed to tiger nut dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ Hosp La Paz, Serv Allergy, Madrid, Spain; Univ Hosp La Paz, Serv Pneumol, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz	Barranco, P (corresponding author), Hosp Gen La Paz, Secc Alergia, P Castellana 261, Madrid 28046, Spain.			Alvarez-Sala, Rodolfo/0000-0002-3442-670X				CISTEROBAHIMA A, 1994, ALLERGY CLIN IMMUN S, V2, P449; FINK JN, 1978, ALLERGY PRINCIPLES P, P855; PARKES WR, 1982, OCCUPATIONAL LUNG DI, P359; RICHERSON HB, 1989, J ALLERGY CLIN IMMUN, V84, P839, DOI 10.1016/0091-6749(89)90349-7; SALVAGGIO JE, 1980, HOSP PRACT, V15, P93, DOI 10.1080/21548331.1980.11946685	5	5	5	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				500	501		10.1016/S0091-6749(99)70401-X	http://dx.doi.org/10.1016/S0091-6749(99)70401-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452779	Bronze			2022-12-18	WOS:000082364800050
J	Gershman, NH; Fahy, JV				Gershman, NH; Fahy, JV			The effect of methacholine challenge on the cellular composition of induced sputum	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; FLUID		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fahy, JV (corresponding author), Univ Calif San Francisco, Dept Med, Box 0111, San Francisco, CA 94143 USA.							Diamant Z, 1997, AM J RESP CRIT CARE, V155, P1247, DOI 10.1164/ajrccm.155.4.9105062; Gershman NH, 1996, EUR RESPIR J, V9, P2448, DOI 10.1183/09031936.96.09122448; KRAFT M, 1995, EUR RESPIR J, V8, P1966, DOI 10.1183/09031936.95.08111966; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; SODERBERG M, 1993, ALLERGY, V48, P173, DOI 10.1111/j.1398-9995.1993.tb00709.x	5	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				957	959		10.1016/S0091-6749(99)70448-3	http://dx.doi.org/10.1016/S0091-6749(99)70448-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329838	Bronze			2022-12-18	WOS:000080470200039
J	van der Zee, JS; de Jager, KSN; Kuipers, BF; Stapel, SO				van der Zee, JS; de Jager, KSN; Kuipers, BF; Stapel, SO			Outbreak of occupational allergic asthma in a Stephanotis floribunda nursery	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1100 DE Amsterdam, Netherlands; STIGAS, Occupat Hlth Serv, Leeuwarden, Netherlands; Dr Weezenlanden Hosp, Dept Pulmonol, Zwolle, Netherlands; Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Allergy, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van der Zee, JS (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, F4-208,POB 22700, NL-1100 DE Amsterdam, Netherlands.		van der Zee, Jaring S/M-8462-2013; van der Zee, Jaring/HGU-9235-2022; van der Zee, Jaring/AAQ-6669-2021	van der Zee, Jaring S/0000-0002-8698-6039; 				AXELSSON IGK, 1987, ALLERGY, V42, P161, DOI 10.1111/j.1398-9995.1987.tb02193.x; AXELSSON JGK, 1987, ALLERGY, V42, P46, DOI 10.1111/j.1398-9995.1987.tb02186.x; Delbourg MF, 1995, ANN ALLERG ASTHMA IM, V75, P496; van der Veen MJ, 1998, J ALLERGY CLIN IMMUN, V102, P24, DOI 10.1016/S0091-6749(98)70051-X; VANDERVEEN MJ, 1996, J ALLERGY CLIN IMMUN, V98, P10024	5	5	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				950	952		10.1016/S0091-6749(99)70444-6	http://dx.doi.org/10.1016/S0091-6749(99)70444-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329834	Bronze			2022-12-18	WOS:000080470200035
J	Spector, S				Spector, S			Pathophysiology and pharmacotherapy of allergic rhinitis - Foreword	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Calif Allergy & Asthma, Los Angeles, CA 90025 USA		Spector, S (corresponding author), Calif Allergy & Asthma, 11645 Wilshire Blvd,Suite 1090, Los Angeles, CA 90025 USA.								0	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1999	103	3	2	S			S377	S377		10.1016/S0091-6749(99)70214-9	http://dx.doi.org/10.1016/S0091-6749(99)70214-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	179CL	10069895	Bronze			2022-12-18	WOS:000079305900001
J	Ayuso, R; Reese, G; Lehrer, SB				Ayuso, R; Reese, G; Lehrer, SB			IgE-antibody recognition of Pen a 1 (shrimp tropomyosin): Localization of continuous, antigenic sites by synthetic, overlapping peptides.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		254	S66	S66						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000261
J	Frieri, M; Therattil, J; Than, S; Wang, SF; Huang, CY; Rockitter, S; Wang, YC				Frieri, M; Therattil, J; Than, S; Wang, SF; Huang, CY; Rockitter, S; Wang, YC			Montelukast inhibits IL-5 mRNA expression and cysteinyl leukotriene (CysLT) production in ragweed and mite stimulated mononuclear cells (MNC) from asthmatics.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Nassau Cty Med Ctr, E Meadow, NY 11554 USA; Adv Biosci Labs Inc, Kensington, MD USA										0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		781	S203	S203						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000783
J	Hjelmroos, M; Burkhead, T; Egen, NB; Spangfort, M; Schumacher, MJ				Hjelmroos, M; Burkhead, T; Egen, NB; Spangfort, M; Schumacher, MJ			Effects of automobile pollution and sunlight on variation of Bet v I content of birch pollen.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Arizona, Coll Med, Tucson, AZ 85721 USA	University of Arizona									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		347	S91	S91						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000353
J	Huang, CK; Schofield, BH; Burks, AW; Bannon, GA; Huang, SK; Sampson, HA; Li, XM				Huang, CK; Schofield, BH; Burks, AW; Bannon, GA; Huang, SK; Sampson, HA; Li, XM			Strain-dependent protection from allergic reactions by peanut allergen plasmid DNA immunization in mice.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CUNY Mt Sinai Sch Med, New York, NY 10029 USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Arkansas, Little Rock, AR 72204 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		915	S238	S238						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000917
J	Ichikawa, K; Sun, W; Wu, Z; Vailes, LD; Guyre, P; Chapman, MD				Ichikawa, K; Sun, W; Wu, Z; Vailes, LD; Guyre, P; Chapman, MD			Fully immunoreactive recombinant CAT allergen, Fel d1, expressed in baculovirus.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Dartmouth Med Sch, Lebanon, NH USA; Univ Virginia, Charlottesville, VA 22903 USA	Dartmouth College; University of Virginia									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		704	S184	S184						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000707
J	Jackola, D; Pierson-Mullany, L; Corazalla, E; Daniels, L; Rosenberg, A; Blumenthal, M				Jackola, D; Pierson-Mullany, L; Corazalla, E; Daniels, L; Rosenberg, A; Blumenthal, M			Pathophysiological states associated with asthma and atopy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		678	S177	S177						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000681
J	Profita, M; Vignola, AM; Mirabella, A; Siena, L; Sala, A; Gjomarkaj, M; Bousquet, J; Bonsignore, G				Profita, M; Vignola, AM; Mirabella, A; Siena, L; Sala, A; Gjomarkaj, M; Bousquet, J; Bonsignore, G			IL-4 and IgE-anti-IgE modulation of 15(S)-hydroxyeicosatetraenoic acid release by mononuclear phagocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						monocytes; asthma; IL-4; IgE; 15(S)-)Hydroxyeicosatetraenoic acid	PERIPHERAL-BLOOD; HUMAN-MONOCYTES; T-CELL; 15-HYDROXYEICOSATETRAENOIC ACID; ALVEOLAR MACROPHAGES; ARACHIDONIC-ACID; CD23 EXPRESSION; MESSENGER-RNA; HUMAN AIRWAYS; 15-LIPOXYGENASE	Background: IL-4 modulates the synthesis of IgE, the expression of CD23, and the release of 15(S)-hydroxyeicosatetraenoic (15[S]-HETE). Objective: We evaluated the release of 15(S)-HETE by IL-4-stimulated monocytes and verified whether the observed increase in 15(S)-HETE release after passive sensitization and anti-IgE challenge of IL-4-treated monocytes was secondary to an increased CD23 expression. Methods: Human monocytes were incubated for 24, 48, and 72 hours with IL-4 (10 ng/mL) with or without an Ige-anti-IgE stimulation. We evaluated CD23 expression by immunocytochemistry and 15(S)-HETE release by HPLC and RIA. To prove that the increase in 15(S)-HETE release was due to the effect of IL-4 on CD23, we performed experiments with an anti-CDW blocking mAb. Results: CD23 expression and 15(S)-HETE release were significantly increased by IL-4, reaching a peak after 72 hours (P < .02). After passive sensitization with human IgE and anti-IgE challenge, IL-4-stimulated monocytes released higher amounts of 15(S)-HETE than IL-4-unstimulated monocytes (P < .02). Pretreatment with the anti-human B-cell CD23 MHM6 mAb caused a dose-dependent inhibition of 15(S)-HETE release. Conclusions: This study shows that immunologic challenge of IL-4-treated, passively sensitized monocytes results in a CD23-dependent additional increase of 15(S)-HETE release, indicating the presence of a synergistic effect of IL-4 on CD23 expression and 1`5(S)-HETE production.	CNR, Ist Fisiopatol Resp, I-90146 Palermo, Italy; Univ Palermo, Ist Med Gen & Pneumol, Palermo, Italy; Univ Milan, Ctr Farmacol Cardiopolmonare, Milan, Italy; INSERM, Clin Malattie Resp, Montpellier, France; INSERM, CJF 92 10, Montpellier, France	Consiglio Nazionale delle Ricerche (CNR); University of Palermo; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Vignola, AM (corresponding author), CNR, Ist Fisiopatol Resp, Via Trabucco 180, I-90146 Palermo, Italy.		Profita, Mirella/D-8957-2018; Sala, Angelo/H-5478-2019; Profita, Mirella/AAY-3165-2020; Bousquet, Jean/O-4221-2019	Profita, Mirella/0000-0002-7821-8283; Sala, Angelo/0000-0001-9290-0257; SIENA, LIBORIA/0000-0002-3182-9503				BONNEFOY JY, 1987, J IMMUNOL, V138, P2970; BORGEAT P, 1983, BIOCHEM PHARMACOL, V32, P381, DOI 10.1016/0006-2952(83)90515-4; Bousquet J, 1997, Curr Opin Pulm Med, V3, P42, DOI 10.1097/00063198-199701000-00007; BRADDING P, 1995, AM J RESP CRIT CARE, V151, P1201; BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248; CAMPBELL AM, 1993, AM REV RESPIR DIS, V147, P529, DOI 10.1164/ajrccm/147.3.529; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; DAHLEN SE, 1983, ACTA PHYSIOL SCAND, V118, P415, DOI 10.1111/j.1748-1716.1983.tb07291.x; DEL PG, 1988, J IMMUNOL, V140, P4193; DEMOLY P, 1994, J ALLERGY CLIN IMMUN, V93, P108, DOI 10.1016/0091-6749(94)90239-9; FERRERI NR, 1986, J IMMUNOL, V136, P4188; HAMBERG M, 1980, ACTA PHYSIOL SCAND, V110, P219, DOI 10.1111/j.1748-1716.1980.tb06656.x; HART PH, 1989, BLOOD, V74, P1222; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; JOHNSON HG, 1985, AM REV RESPIR DIS, V131, P917; KUMLIN M, 1991, ADV PROSTAGLANDIN TH, P441; LAI CKW, 1990, EUR RESPIR J, V3, P38; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; PAULEUGENE N, 1995, J LEUKOCYTE BIOL, V57, P160, DOI 10.1002/jlb.57.1.160; PENE J, 1988, J IMMUNOL, V141, P1218; RANKIN JA, 1989, J ALLERGY CLIN IMMUN, V83, P722, DOI 10.1016/0091-6749(89)90005-5; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SALARI H, 1991, PULM PHARMACOL, V4, P1, DOI 10.1016/0952-0600(91)90033-Y; SIGAL E, 1993, J LIPID MEDIATOR, V6, P75; Sihra BS, 1997, J ALLERGY CLIN IMMUN, V99, P699, DOI 10.1016/S0091-6749(97)70033-2; TEVELDE AA, 1988, J IMMUNOL, V140, P1548; VANDERHOEK J, 1983, J BIOL CHEM, V255, P10064; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WILLIAMS J, 1992, J IMMUNOL, V149, P2823; WONG HL, 1992, J IMMUNOL, V148, P2118; YANAGAWA H, 1991, MICROBIOL IMMUNOL, V35, P879, DOI 10.1111/j.1348-0421.1991.tb02028.x	34	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	1				159	164		10.1016/S0091-6749(99)70540-3	http://dx.doi.org/10.1016/S0091-6749(99)70540-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	158JM	9893200	Bronze			2022-12-18	WOS:000078112300024
J	Skalky, CS; Edelman, JM; Polis, A; Bird, S; Gormley, GJ; Israel, E				Skalky, CS; Edelman, JM; Polis, A; Bird, S; Gormley, GJ; Israel, E			Montelukast sodium (MK) compared to inhaled beclomethasone dipropionate (BD) in adult asthmatics: A randomized clinical trial.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Brigham & Womens Hosp, Boston, MA 02115 USA; Merck & Co Inc, W Point, PA USA	Harvard University; Brigham & Women's Hospital; Merck & Company									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		880	S228	S228						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000882
J	Tomazic-Jezic, VJ; Woolhizer, MR; Beezhold, DH				Tomazic-Jezic, VJ; Woolhizer, MR; Beezhold, DH			Quantification of latex proteins by inhibition ELISA.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NIOSH, HELD, Morgantown, WV USA; US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA; GRI, Sayre, PA USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); US Food & Drug Administration (FDA)									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		619	S162	S162						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000622
J	Dicpinigaitis, PV; Dobkin, JB				Dicpinigaitis, PV; Dobkin, JB			Effect of angiotensin II receptor blockade on bronchial responsiveness in asthmatic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ANTAGONISTS; LOSARTAN		Albert Einstein Coll Med, Dept Med, Div Pulm, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Dicpinigaitis, PV (corresponding author), Albert Einstein Hosp, 1825 Eastchester Rd, Bronx, NY 10461 USA.							Csajka C, 1997, CLIN PHARMACOKINET, V32, P1, DOI 10.2165/00003088-199732010-00001; Dicpinigaitis PV, 1996, J ALLERGY CLIN IMMUN, V98, P1128, DOI 10.1016/S0091-6749(96)80205-3; Goodfriend TL, 1996, NEW ENGL J MED, V334, P1649, DOI 10.1056/NEJM199606203342507; MILLAR E, 1995, EUR RESPIR J, V8, P1838, DOI 10.1183/09031936.95.08111838; MILLAR EA, 1994, THORAX, V49, P492, DOI 10.1136/thx.49.5.492; Sasaki M, 1996, J CLIN PHARMACOL, V36, P403, DOI 10.1002/j.1552-4604.1996.tb05026.x	6	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1998	102	3					521	522		10.1016/S0091-6749(98)70143-5	http://dx.doi.org/10.1016/S0091-6749(98)70143-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	124ZN	9768596				2022-12-18	WOS:000076212800030
J	Mazer, BD; Toledano, B; Saririan, M; Bastien, Y				Mazer, BD; Toledano, B; Saririan, M; Bastien, Y			Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						platelet-activating factor; lipid mediators; B lymphocytes; immunoglobulin production; apoptosis	FACTOR RECEPTOR; CELL-LINE; ENDOTHELIAL-CELLS; HUMAN-LEUKOCYTES; PAF-ACETHER; MAST-CELL; 1-ACYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE; PHOSPHORYLATION; EXPRESSION; DESENSITIZATION	Background: Platelet activating-factor (PAF), an ether-linked phospholipid, is a potent activator of B lymphocyte cell lines. The related ester-linked phospholipid, 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine (PAGPC), is synthesized by tissues important in B-cell development. Objectives: We examined whether PAGPC was capable of influencing immunoglobulin synthesis in B lymphocytes and compared its action with that of PAF. We also examined the interaction of the two mediators as agonists or competitive antagonists. Methods: Ramos, an IgM-secreting immature B-cell line that expresses PAF receptor, was used in these experiments. The effect of PAF, PAGPC, or both mediators together on IBM secretion and anti-IgM-mediated apoptosis was measured. Results: Both PAF and PAGPC stimulated IgM production in Ramos cells in a dose-dependent fashion, with PAC-PC being approximately three logs less potent than PAF. The effect of both mediators was inhibited by specific PAF receptor antagonists. Preincubation with suboptimal concentrations of PAGPC inhibited the ability of PAF to increase IgM secretion by Ramos cells. Additionally, preincubation with low concentrations of PAGPC prevented PAF from rescuing Ramos cells from apoptosis induced by cross-linking the B-cell receptor with anti-IgM antibodies, PAGPC caused PAF receptor desensitization because displacement of bound PAGPC with high concentrations of bovine serum albumin did not reverse its PAF antagonist effect. Conclusions: PAF and PAGPC are biologically active phospholipids, but PAF is approximately 1000 times more potent, At high concentrations, PAGPC acts similarly to PAF, whereas at lower concentrations, PAGPC acts as a functional PAF antagonist. Because it is secreted at sites of inflammation and allergic reactions, PAGPC may be an endogenous regulator of the effects of PAF.	Montreal Childrens Hosp, Div Clin Immunol & Allergy, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University	Mazer, BD (corresponding author), Montreal Childrens Hosp, Div Clin Immunol & Allergy, 2300 Tupper St, Montreal, PQ H3H 1P3, Canada.		Saririan, Mehrdad/AAF-7664-2019					BARNES PJ, 1991, RES CLIN FORUMS, V13, P61; BARTHELSON R, 1990, J ALLERGY CLIN IMMUN, V86, P193, DOI 10.1016/S0091-6749(05)80066-1; BASTIEN Y, 1994, BIOCHEM BIOPH RES CO, V202, P1373, DOI 10.1006/bbrc.1994.2082; CLAY KL, 1991, BIOCHIM BIOPHYS ACTA, V1094, P43, DOI 10.1016/0167-4889(91)90024-R; COLUMBO M, 1993, J ALLERGY CLIN IMMUN, V92, P325, DOI 10.1016/0091-6749(93)90176-G; DARYZYNKIEWICZ Z, 1995, METHOD CELL BIOL, V46, P27; DENIZOT Y, 1995, BBA-MOL CELL RES, V1265, P55, DOI 10.1016/0167-4889(94)00193-I; DERYCKX S, 1992, J IMMUNOL, V148, P1465; FRANKLIN RA, 1993, J IMMUNOL, V151, P1802; HILLIQUIN P, 1995, INFLAMM RES, V44, P313, DOI 10.1007/BF01796260; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Janeway C., 1996, IMMUNOBIOLOGY; KOLTAI M, 1993, J LIPID MEDIATOR, V6, P183; KOVAR J, 1986, METHOD ENZYMOL, V121, P277; KURUVILLA A, 1994, J IMMUNOL, V153, P5433; MAZER B, 1990, J IMMUNOL, V145, P2602; MAZER B, 1991, J IMMUNOL, V146, P1914; MCMANUS LM, 1993, LAB INVEST, V69, P639; MUELLER HW, 1991, BIOCHEM BIOPH RES CO, V176, P1557, DOI 10.1016/0006-291X(91)90465-J; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; Nguer CM, 1996, LIPIDS, V31, P1051, DOI 10.1007/BF02522462; NORVELL A, 1995, J IMMUNOL, V154, P4404; OFLAHERTY JT, 1994, BIOCHIM BIOPHYS ACTA, V210, P209; PINCKARD RN, 1992, J IMMUNOL, V148, P3528; ROSSKOPF D, 1995, HYPERTENSION, V26, P432, DOI 10.1161/01.HYP.26.3.432; SCHULAM PG, 1991, J IMMUNOL, V146, P1642; SHIMIZU T, 1995, BIOCHIM BIOPHYS ACTA, V1259, P317; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; TAKANO T, 1994, J BIOL CHEM, V269, P22453; Toledano BJ, 1997, J IMMUNOL, V158, P3705; TORDAI A, 1994, J IMMUNOL, V152, P566; TRIGGIANI M, 1991, BIOCHIM BIOPHYS ACTA, V1084, P41, DOI 10.1016/0005-2760(91)90053-K; TRIGGIANI M, 1991, J IMMUNOL, V147, P660; TRIGGIANI M, 1990, J IMMUNOL, V144, P4773; TRIGGIANI M, 1992, BIOCHEM J, V286, P497, DOI 10.1042/bj2860497; Tuscano JM, 1996, BLOOD, V88, P1359, DOI 10.1182/blood.V88.4.1359.bloodjournal8841359; VALONE FH, 1987, PLATELET ACTIVATING, P137; VENABLE ME, 1993, J LIPID RES, V34, P691; ZHOU WG, 1992, J IMMUNOL, V149, P1763; ZIMMERMAN GA, 1992, IMMUNOL TODAY, V13, P93, DOI 10.1016/0167-5699(92)90149-2	40	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1998	102	2					231	237		10.1016/S0091-6749(98)70091-0	http://dx.doi.org/10.1016/S0091-6749(98)70091-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	113EH	9723666	Bronze			2022-12-18	WOS:000075537100014
J	Peng; Li; Simons				Peng; Li; Simons			Immunoblot analysis of salivary allergens in 10 mosquito species with worldwide distribution and the human IgE responses to these allergens (vol 101, pg 498, 1998)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4	1	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1998	101	6	1				746	746						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZW470					2022-12-18	WOS:000074414200006
J	Moraes, PSA				Moraes, PSA			Allergic vulvovaginitis induced by house dust mites: A case report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Hosp Mater Dei, Belo Horizonte, MG, Brazil		Moraes, PSA (corresponding author), Rua Levindo Lopes 36-601, BR-30140170 Belo Horizonte, MG, Brazil.							DHALIWAL A, 1995, J ALLERGY CLIN IMMUN, V95, P781; MITCHELL WM. F., 1948, ANN ALLERGY, V6, P144; MORAES PSA, 1996, REV BRAS ALERG IMUNO, V19, P51; Tupker RA, 1996, J ALLERGY CLIN IMMUN, V97, P1064, DOI 10.1016/S0091-6749(96)70259-2; WITKIN SS, 1988, J ALLERGY CLIN IMMUN, V81, P412, DOI 10.1016/0091-6749(88)90909-8	5	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	1				557	558		10.1016/S0091-6749(98)70366-5	http://dx.doi.org/10.1016/S0091-6749(98)70366-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZH469	9564812	Bronze			2022-12-18	WOS:000073113500022
J	Wein, M				Wein, M			Sting anaphylaxis and urticaria pigmentosa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Allergy Asthma & Sinus Dis, Ft Pierce, FL 34950 USA		Wein, M (corresponding author), Allergy Asthma & Sinus Dis, 1900 Nebraska Ave 7, Ft Pierce, FL 34950 USA.							WEIN M, 1995, ANN ALLERGY, V74, P84	1	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1998	101	3					432	432						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZC570	9525467	Bronze			2022-12-18	WOS:000072593900028
J	Storms, WW				Storms, WW			A comprehensive diagnostic approach to upper airway disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, ILLINOIS				ALLERGIC RHINITIS; EPIDEMIOLOGY		Univ Colorado, Hlth Sci Ctr, Colorado Springs, CO 80907 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado at Colorado Springs	Storms, WW (corresponding author), Asthma & Allergy Associates PC, 2709 N Tejon St, Colorado Springs, CO 80907 USA.							BASOMBA A, 1993, ALLERGY, V48, P71; BOUSQUET J, 1994, J ALLERGY CLIN IMMUN, V94, P182, DOI 10.1016/0091-6749(94)90038-8; CRETICOS PS, 1995, ASTHMA RHINITIS, P1394; FIREMAN P, 1996, ATLAS ALLERGIES, P141; *INT RHIN MAN WORK, 1994, ALLERGY S19, V49, pS5; MILLER SD, 1991, RHINITIS, P283; Sanz ML, 1996, J INVEST ALLERG CLIN, V6, P152; SIBBALD B, 1991, THORAX, V46, P895, DOI 10.1136/thx.46.12.895; SIBBALD B, 1995, ASTHMA RHINITIS, P32; SMITH JM, 1991, RHINITIS, P151; VANCAUWENBERGE PB, 1995, ASTHMA RHINITIS, P6; WRIGHT AL, 1994, PEDIATRICS, V94, P895	12	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S361	S363		10.1016/S0091-6749(98)70220-9	http://dx.doi.org/10.1016/S0091-6749(98)70220-9			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZA245	9500728				2022-12-18	WOS:000072343900004
J	Balcer, SL; Baker, TW; Bugos, CL; Zimmerman, LS; McKenzie, DR; Meeves, SG; Norman, PS; Creticos, PS				Balcer, SL; Baker, TW; Bugos, CL; Zimmerman, LS; McKenzie, DR; Meeves, SG; Norman, PS; Creticos, PS			Comparison of fexofenadine (F), terfenadine (T), loratadine (L) and placebo (P) in a double-blind crossover trial utilizing a skin test model to examine suppression of histamine-induced wheal and flare.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Baltimore, MD 21218 USA; Hoechst Mar Roussel, Kansas City, MO USA	Johns Hopkins University									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			1009	S243	S243						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924801005
J	Beck, L; Brummet, M; Bickel, C; Leiferman, K; Andresen, C; Gilman, S; Gladue, R; Milici, AJ; Schleimer, R				Beck, L; Brummet, M; Bickel, C; Leiferman, K; Andresen, C; Gilman, S; Gladue, R; Milici, AJ; Schleimer, R			Cutaneous injections with C-C chemokines; a comparative study in cynomologous macaques.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Pfizer Inc, Groton, CT 06340 USA	Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic; Pfizer									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			158	S36	S36						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800159
J	Custovic, A; Simpson, BM; Simpson, A; Woodcock, A				Custovic, A; Simpson, BM; Simpson, A; Woodcock, A			Low allergen environment can be achieved and maintained throughout pregnancy and in early life.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital			Custovic, Adnan/A-2435-2012	Custovic, Adnan/0000-0001-5218-7071					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			341	S81	S81						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800342
J	Hauk, PJ; Wenzel, SE; Trumble, AE; Strickland, I; Szefler, SJ; Leung, DYM				Hauk, PJ; Wenzel, SE; Trumble, AE; Strickland, I; Szefler, SJ; Leung, DYM			Increased T cell receptor (TCR)-BV8+ T cells in bronchoalveolar lavage (BAL) of poorly controlled (PC) asthmatics: A potential role for microbial superantigens.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Jewish Med & Res Ctr, Denver, CO USA	National Jewish Health									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			977	S236	S236						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800973
J	Kurtz, KM; Schaefer, JA; Hamilton, RG; Adkinson, NF				Kurtz, KM; Schaefer, JA; Hamilton, RG; Adkinson, NF			Conjunctival, nasal and bronchial provocation of latex allergic subjects employing the hooded exposure chamber (HEC).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			841	S204	S204						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800840
J	Lack, G; Fos, DES; Golding, J				Lack, G; Fos, DES; Golding, J			Risk factors for the development of peanut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			431	S104	S104						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800431
J	Levy, DA; Allouache, S; Brion, M; Valantin, C; Wolikow, M; Buck, D; Roth, F; Burney, P; Leynadier, F				Levy, DA; Allouache, S; Brion, M; Valantin, C; Wolikow, M; Buck, D; Roth, F; Burney, P; Leynadier, F			Effect of powdered vs nonpowdered latex gloves on the prevalence of latex allergy in dental student.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Hop Rothschild, F-75571 Paris, France; Fac Chirurg Dent, Paris, France; St Thomas Hosp, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Guy's & St Thomas' NHS Foundation Trust				Burney, Peter/0000-0001-8635-5678					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			662	S160	S161						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800662
J	Muller, UR; Soldatova, L; Weber, M				Muller, UR; Soldatova, L; Weber, M			Bee venom allergy: Comparison of IgE-binding capacity of purified natural and recombinant-synthetic venom allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Zieglerspital, Bern, Switzerland										0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			143	S33	S33						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800144
J	Ostinelli, J; Bousquet, J				Ostinelli, J; Bousquet, J		French Rhinocort Study Grp	Effect of nasal steroids on general quality of life in seasonal allergic rhinitis.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Labs Astra France, Rueil Malmaison, France; Hop A de Villeneuve, Montpellier, France	Universite de Montpellier; CHU de Montpellier			Bousquet, Jean/O-4221-2019						0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			1007	S243	S243						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924801003
J	Sercombe, JK; Pavlicek, PK; Xavier, ML; Lea, SA; Graham, JAH; Tovey, ER				Sercombe, JK; Pavlicek, PK; Xavier, ML; Lea, SA; Graham, JAH; Tovey, ER			Assessment of nasal and pocket air samplers.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Sydney, Inst Resp Med, Sydney, NSW 2006, Australia	University of Sydney			Tovey, Euan R/G-8604-2017	Tovey, Euan R/0000-0002-1802-7266					0	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			337	S80	S80						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800338
J	Srebro, SH; Weber, HH; Rogenes, PR; Edwards, L				Srebro, SH; Weber, HH; Rogenes, PR; Edwards, L		FP Clinical Study Grp	Comparison of fluticasone propionate with flunisolide in patients with mild to moderate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Glaxo Wellcome, Res Triangle Pk, NC USA; Glaxo Wellcome, Hamburg, Germany	GlaxoSmithKline; GlaxoSmithKline									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			27	S6	S7						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800028
J	Zweiman, B; Moskovitz, AR; von Allmen, C				Zweiman, B; Moskovitz, AR; von Allmen, C			Comparison of inflammatory events in skin sites with and without cutaneous late-phase reactions after prominent immediate IgE-mediated responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						late-phase reactions; IgE-mediated responses; cytokines; inflammatory cells	MESSENGER-RNA EXPRESSION; ATOPIC INDIVIDUALS; ALLERGIC REACTIONS; CHALLENGE; RELEASE; INFILTRATION; ACTIVATION; CYTOKINES; HISTAMINE	Background: A number of inflammatory events have been detected in skin chambers overlying sites of developing late-phase reactions (LPR) to pollen antigens in sensitive subjects. However, the pathogenic significance of such events is still unclear. Objective: We sought to compare inflammatory responses and cytokine levels in skin chambers that overlie sites of antigen challenge in individuals with and individuals without LPRs after immediate wheal responses of similar intensity. Results: Early histamine releases at antigen sites were similar in eight subjects with LPR (+/+ group) and eight subjects without LPR (+/- group), However, histamine releases during hours 2 through 5 of antigen challenge were significantly greater in the +/+ subjects than in the +/- subjects. Total exuding leukocytes; percent eosinophils; and levels of eosinophil cationic protein, lactoferrin, and IL-8 were significantly greater at antigen versus buffer control challenge sites in both the +/+ and +/- groups, with no significant differences between the groups, IL-1 and L-6 levels were not greater at antigen sites than at buffer sites. Conclusions: The only significantly greater antigen-induced response detected in +/+ subjects than in +/- subjects was in later histamine release, which is possibly a marker of other inflammatory responses because histamine itself does not induce LPRs, Other inflammatory events assessed may be somewhat greater in +/+ subjects, but not significantly so.	Univ Penn, Sch Med, Dept Med, Div Allergy & Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania	Zweiman, B (corresponding author), Univ Penn, Sch Med, Dept Med, Div Allergy & Immunol, 512 Johnson Pavil, Philadelphia, PA 19104 USA.							ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; ATKINS PC, 1992, J ALLERGY CLIN IMMUN, V89, P552, DOI 10.1016/0091-6749(92)90322-S; ATKINS PC, 1995, J ALLERGY CLIN IMMUN, V95, P742, DOI 10.1016/S0091-6749(95)70180-X; BOCHNER BS, 1990, J ALLERGY CLIN IMMUN, V86, P830, DOI 10.1016/S0091-6749(05)80143-5; Charlesworth EN, 1996, J ALLERGY CLIN IMMUN, V98, pS291, DOI 10.1016/S0091-6749(96)80114-X; CHARLESWORTH EN, 1995, CHEM IMMUNOL, V62, P84; DESHAZO RD, 1979, J IMMUNOL, V122, P692; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; LEE CE, 1992, J ALLERGY CLIN IMMUN, V89, P1010, DOI 10.1016/0091-6749(92)90224-P; Lemanske RF, 1993, ALLERGY PRINCIPLES P, P320; Martin LB, 1996, INT ARCH ALLERGY IMM, V109, P207, DOI 10.1159/000237239; MASSEY WA, 1993, ANN ALLERGY, V71, P578; Schroeder JT, 1997, J ALLERGY CLIN IMMUN, V99, P429, DOI 10.1016/S0091-6749(97)70065-4; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V50, P41; TabordaBarata L, 1996, CLIN EXP ALLERGY, V26, P68, DOI 10.1111/j.1365-2222.1996.tb00058.x; TALBOT SF, 1985, J CLIN INVEST, V76, P650, DOI 10.1172/JCI112018; TSICOPOULOS A, 1994, J ALLERGY CLIN IMMUN, V94, P764, DOI 10.1016/0091-6749(94)90185-6; ZENG L, 1997, J ALLERGY CLIN IMMUN, V99, pS37; ZSWIMAN B, 1997, J ALLERGY CLIN IMMUN, V100, P341; Zweiman B, 1997, J ALLERGY CLIN IMMUN, V100, P104, DOI 10.1016/S0091-6749(97)70201-X; ZWEIMAN B, 1993, CURR OPIN IMMUNOL, V5, P950, DOI 10.1016/0952-7915(93)90111-5; ZWEIMAN B, 1991, J ALLERGY CLIN IMMUN, V87, P984, DOI 10.1016/0091-6749(91)90421-J; ZWEIMAN B, 1990, J IMMUNOL, V144, P3953	24	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				110	115		10.1016/S0091-6749(98)70201-5	http://dx.doi.org/10.1016/S0091-6749(98)70201-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449509	hybrid			2022-12-18	WOS:000071539800017
J	Chen, SF; Teoh, SC; Porter, M				Chen, SF; Teoh, SC; Porter, M			A false-positive result with the American Society for Testing and Materials D5712-95 test method for protein given by a common vulcanization accelerator	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									LONDON INT GRP,RES & DEV,UNIT 205,CAMBRIDGE CB4 4GZ,ENGLAND; LONDON INT GRP,RES & DEV,KEDAH,MALAYSIA				Chen, Seong Fong/AAX-9641-2020					*ASTM, 1995, D571295 ASTM; BEEZHOLD D, 1992, GUTHRIE J, V61, P77; *FDA, 1995, INT GUID PROT CONT L; VANHAGEHAMSTEN M, 1987, CLIN ALLERGY, V17, P23; 1992, I LAT C SENS LAT MED	5	5	5	1	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1997	100	5					713	714		10.1016/S0091-6749(97)70179-9	http://dx.doi.org/10.1016/S0091-6749(97)70179-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YG202	9389305	Bronze			2022-12-18	WOS:A1997YG20200022
J	Metcalfe, DD; Anderson, J; Shearer, WT; Blaiss, MS; Liu, A; Rosenwasser, LJ; Terr, AI; Wray, B; Ballow, M				Metcalfe, DD; Anderson, J; Shearer, WT; Blaiss, MS; Liu, A; Rosenwasser, LJ; Terr, AI; Wray, B; Ballow, M			The future of the subspecialty of allergy and immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							US PHYSICIAN WORKFORCE; ASTHMA; SPECIALTY; NEEDS				Metcalfe, DD (corresponding author), AAAAI EXECUT OFF, 611 E WELLS ST, MILWAUKEE, WI 53202 USA.			Shearer, William/0000-0002-2483-2130				Anderson J. A., 1997, Journal of Allergy and Clinical Immunology, V99, pS146; ANDERSON JA, 1994, J ALLERGY CLIN IMMUN, V93, P803; ANDERSON JA, 1991, J ALLERGY CLIN IMMUN, V88, P17, DOI 10.1016/0091-6749(91)90296-Z; FOWELS J, 1990, J ALLERGY CLIN IMMUN, V85, P195; FREUND DA, 1989, J ALLERGY CLIN IMMUN, V84, P401, DOI 10.1016/0091-6749(89)90428-4; Goodman DC, 1996, JAMA-J AM MED ASSOC, V276, P1811, DOI 10.1001/jama.276.22.1811; MAHR TA, 1993, ANN ALLERGY, V71, P115; MULLALLY DI, 1983, J ALLERGY CLIN IMMUN, V72, P252, DOI 10.1016/0091-6749(83)90028-3; Storms B, 1995, ANN ALLERG ASTHMA IM, V75, P491; Weinber JP, 1994, JAMA-J AM MED ASSOC, V272, P222; ZEIGER RS, 1991, J ALLERGY CLIN IMMUN, V87, P1160, DOI 10.1016/0091-6749(91)92162-T	11	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1997	100	4					441	443						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YA529	9338534				2022-12-18	WOS:A1997YA52900002
J	Farinas, E; Honig, P				Farinas, E; Honig, P			Upper gastrointestinal obstruction associated with claritin-D 24 hour extended release tablets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									US FDA,CTR DRUG EVALUAT & RES,DIV PULM DRUG PROD,ROCKVILLE,MD 20857; US FDA,CTR DRUG EVALUAT & RES,DIV PHARMACOVIGILANCE & EPIDEMIOL,ROCKVILLE,MD 20857	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)									0	5	5	1	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1997	100	3					427	428		10.1016/S0091-6749(97)70260-4	http://dx.doi.org/10.1016/S0091-6749(97)70260-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XX479	9314359				2022-12-18	WOS:A1997XX47900024
J	Wood, RA				Wood, RA			Indoor allergens: Thrill of victory or agony of defeat?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							FEL-D-I; BRONCHIAL HYPERREACTIVITY; ENVIRONMENTAL-CONTROL; CAT; AVOIDANCE; DUST		JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,DIV IMMUNOL & ALLERGY,BALTIMORE,MD 21218	Johns Hopkins University								Avner DB, 1997, J ALLERGY CLIN IMMUN, V100, P307, DOI 10.1016/S0091-6749(97)70242-2; Bjornsdottir U. S., 1997, Journal of Allergy and Clinical Immunology, V99, pS389; Cloosterman SGM, 1997, J ALLERGY CLIN IMMUN, V100, P313, DOI 10.1016/S0091-6749(97)70243-4; DEBLAY F, 1991, AM REV RESPIR DIS, V143, P1334, DOI 10.1164/ajrccm/143.6.1334; EHNERT B, 1992, J ALLERGY CLIN IMMUN, V90, P135, DOI 10.1016/S0091-6749(06)80024-2; Hide DW, 1996, ALLERGY, V51, P89, DOI 10.1111/j.1398-9995.1996.tb04563.x; HUSS RW, 1994, J ALLERGY CLIN IMMUN, V94, P27, DOI 10.1016/0091-6749(94)90067-1; KLUCKA CV, 1995, J ALLERGY CLIN IMMUN, V95, P1164, DOI 10.1016/S0091-6749(95)70072-2; KOREN LGH, 1995, J ALLERGY CLIN IMMUN, V95, P322; LAUSCHADENDORF S, 1991, J ALLERGY CLIN IMMUN, V87, P41, DOI 10.1016/0091-6749(91)90211-6; OBMAN JL, 1983, J ALLERGY CLIN IMMUN, V72, P288; PERONI DG, 1994, AM J RESP CRIT CARE, V149, P1442, DOI 10.1164/ajrccm.149.6.8004296; Perzanowski MS, 1997, J ALLERGY CLIN IMMUN, V100, P428, DOI 10.1016/S0091-6749(97)70261-6; PLATTSMILLS TAE, 1982, LANCET, V2, P675; SOLDATOV D, 1995, J ALLERGY CLIN IMMUN, V95, P263; WENTZ PE, 1990, J ALLERGY CLIN IMMUN, V85, P94, DOI 10.1016/0091-6749(90)90228-V; Wood Robert A., 1997, Journal of Allergy and Clinical Immunology, V99, pS388; WOODFOLK JA, 1995, J ALLERGY CLIN IMMUN, V96, P325, DOI 10.1016/S0091-6749(95)70051-X	18	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1997	100	3					290	292		10.1016/S0091-6749(97)70239-2	http://dx.doi.org/10.1016/S0091-6749(97)70239-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XX479	9314338	hybrid			2022-12-18	WOS:A1997XX47900003
J	Catapani, WR; Pinto, PLS; AmatoNeto, V; Mendes, E				Catapani, WR; Pinto, PLS; AmatoNeto, V; Mendes, E			Prevalence of allergic diseases in patients with schistosomiasis mansoni	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									ADOLFO LUTZ INST,BR-04038990 SAO PAULO,BRAZIL; UNIFESP,DISCIPLINA IMUNOL,BR-04038990 SAO PAULO,BRAZIL	Instituto Adolfo Lutz; Universidade Federal de Sao Paulo (UNIFESP)	Catapani, WR (corresponding author), UNIV FED SAO PAULO,UNIFESP,BR-04038990 SAO PAULO,BRAZIL.		CATAPANI, WILSON R/I-5192-2012; Pinto, Pedro Luiz LS Silva/B-5225-2016	Pinto, Pedro Luiz LS Silva/0000-0002-3727-596X				GOUNNI AS, 1994, J ALLERGY CLIN IMMUN, V94, P1214, DOI 10.1016/0091-6749(94)90334-4; LARRICK JW, 1983, J ALLERGY CLIN IMMUN, V71, P184, DOI 10.1016/0091-6749(83)90097-0; LYNCH NR, 1984, J ALLERGY CLIN IMMUN, V73, P229, DOI 10.1016/S0091-6749(84)80012-3	3	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1997	100	1					142	142						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XP428	9257801				2022-12-18	WOS:A1997XP42800023
J	Zellweger, JP				Zellweger, JP			Alcohol-induced asthma: Not only in Asians	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Zellweger, JP (corresponding author), UNIV LAUSANNE,MED POLICLIN,RUE CESAR ROUX 9,CH-1005 LAUSANNE,SWITZERLAND.							GEPPERT EF, 1975, AM REV RESPIR DIS, V112, P423; SHIMODA, 1996, J ALLERGY CLIN IMMUN, V97, P74; ZELLWEGER JP, 1982, SCHWEIZ MED WSCHR, V112, P212	3	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				860	860		10.1016/S0091-6749(97)80027-9	http://dx.doi.org/10.1016/S0091-6749(97)80027-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215261	Bronze			2022-12-18	WOS:A1997XH19300026
J	Gordon, S; Tee, RD; Newman, AJ				Gordon, S; Tee, RD; Newman, AJ			Analysis of rat serum allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											Gordon, S (corresponding author), UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,NATL HEART & LUNG INST,DEPT ENVIRONM & OCCUPAT MED,LONDON SW3 6LR,ENGLAND.							GORDON S, 1993, J ALLERGY CLIN IMMUN, V92, P298, DOI 10.1016/0091-6749(93)90173-D; OHMAN JL, 1975, J ALLERGY CLIN IMMUN, V55, P16, DOI 10.1016/S0091-6749(75)80004-2; PRICE JA, 1986, ALLERGY, V41, P603, DOI 10.1111/j.1398-9995.1986.tb00353.x; Spitzauer S, 1995, J ALLERGY CLIN IMMUN, V96, P951, DOI 10.1016/S0091-6749(95)70233-4; WAHN U, 1980, J IMMUNOL, V125, P2544	5	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1997	99	5					716	717		10.1016/S0091-6749(97)70036-8	http://dx.doi.org/10.1016/S0091-6749(97)70036-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WY600	9155841	Bronze			2022-12-18	WOS:A1997WY60000022
J	Boeck, A; Buckley, RH; Schiff, RI				Boeck, A; Buckley, RH; Schiff, RI			Gastroesophageal reflux and severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						gastroesophageal reflux; severe combined immunodeficiency; Nissen fundoplication	DISEASE; DIAGNOSIS; ASTHMA	Background: Gastrointestinal and respiratory symptoms and failure to thrive not associated with infections or medications were noted in patients with severe combined immunodeficiency. Objective: The aim of our study was to determine the frequency of gastroesophageal reflux in patients with severe combined immunodeficiency. Methods: We studied the case histories of 73 pediatric patients who had been treated at Duke University Medical Center for severe combined immunodeficiency between 1982 and 1995. Charts were reviewed for documentation of gastroesophageal reflux on the basis of clinical course and results of barium swallow esophageal pH probe monitoring, or endoscopy. To compare the incidence of gastroesophageal reflux in patients with severe combined immunodeficiency to known high-risk populations, we additionally tabulated the underlying diagnoses in an age-matched group of patients who underwent Nissen fundoplication from 1990 to 1995. Results: We found clinically significant gastroesophageal reflux in 15 of the 73 patients (20.5%), much higher than has been reported in the normal population (0.1% to 0.3%, p < 0.001). Of patients treated between 1990 and the present, 10 of 36 (27.7%) had significant gastroesophageal reflux compared with five of 37 patients (13.5%) in the previous years. Thus with greater recognition and improved methods for diagnosis, the observed incidence of gastroesophageal reflux has increased greatly. The clinical presentations were not different from those of patients with other well-documented underlying diagnoses. Seven of the 15 patients (46.6%) did not respond to medical treatment with antacids, H-2-blockers, and prokinetic agents and underwent surgical treatment. Indications for surgery included persistent esophagitis, vomiting, pneumonia, and growth failure. Conclusions: The reason for the high incidence of gastroesophageal reflux in patients with severe T-cell disorders remains unclear. Considering the frequency of this association, early recognition and treatment is important to enable adequate nutrition and prevent damage to the esophagus and lungs.			Boeck, A (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT,DIV ALLERGY & IMMUNOL,365 JONES BLDG,BOX 2898,DURHAM,NC 27710, USA.		Buckley, Rebecca/AAB-1578-2019		NIAID NIH HHS [5RO1AI128414] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOOTH IW, 1992, ARCH DIS CHILD, V67, P1325, DOI 10.1136/adc.67.11.1325; BUCKLEY RH, 1994, PEDIATR CLIN N AM, V41, P665; BYRNE WJ, 1989, J PEDIATR GASTR NUTR, V8, P283, DOI 10.1097/00005176-198904000-00002; CASTELL DO, 1995, CHEST, V108, P1186, DOI 10.1378/chest.108.5.1186; FISCHER A, 1992, Immunodeficiency Reviews, V3, P83; HILLEMEIER AC, 1981, J PEDIATR-US, V98, P190, DOI 10.1016/S0022-3476(81)80633-6; IANOCO G, 1996, J ALLERGY CLIN IMMUN, V97, P822; NELSON WE, 1992, TXB PEDIAT, P943; ROY CC, 1995, PEDIAT CLIN GASTROEN, P163; SONDHEIMER JM, 1988, PEDIATR CLIN N AM, V35, P103; SONDHEIMER JM, 1979, J PEDIATR-US, V94, P710, DOI 10.1016/S0022-3476(79)80135-3; Stephan J L, 1993, Immunodeficiency, V4, P87; SUTPHEN JL, 1990, GASTROENTEROL CLIN N, V19, P617; WASHINGTON K, 1991, MODERN PATHOL, V4, P707; WILCOX CM, 1992, AM J MED, V92, P412, DOI 10.1016/0002-9343(92)90272-D; ZALOGA GP, 1983, AM SURGEON, V49, P403; 1995, CLIN EXP IMMUNOL, V99, P1	17	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1997	99	3					420	424		10.1016/S0091-6749(97)70062-9	http://dx.doi.org/10.1016/S0091-6749(97)70062-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WM422	9058700				2022-12-18	WOS:A1997WM42200021
J	Burks, AW; King, N; West, CM; Stanley, JS; Cockrell, G; Helm, R; Huang, SK; Sampson, HA; Bannon, GA				Burks, AW; King, N; West, CM; Stanley, JS; Cockrell, G; Helm, R; Huang, SK; Sampson, HA; Bannon, GA			Cloning, epitope mapping, and mutual analysis of Ara h 2, a major peanut allergen.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV ARKANSAS,SCH MED,LITTLE ROCK,AR 72204; JOHNS HOPKINS UNIV,BALTIMORE,MD	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Johns Hopkins University									0	5	5	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			569	569						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200567
J	DelaFuente, G; Moll, B; Raju, L; Lin, J; Frieri, M				DelaFuente, G; Moll, B; Raju, L; Lin, J; Frieri, M			Immunohistologic analysis in autopsy specimens from asthma patients.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NASSAU CTY MED CTR,E MEADOW,NY 11554										0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1679	1679						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201675
J	Grayson, MH; VanderVieren, M; Gallatin, WM; Hoffman, PA; Bochner, BS				Grayson, MH; VanderVieren, M; Gallatin, WM; Hoffman, PA; Bochner, BS			Expression of a novel beta 2 integrin (alpha d beta 2) on human leukocytes and mast cells.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Grayson, Mitchell/AAX-3674-2020	Grayson, Mitchell/0000-0002-4673-2122					0	5	5	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1576	1576						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201572
J	Lebel, B; Bousquet, J; Czarlewski, W; Campbell, AM				Lebel, B; Bousquet, J; Czarlewski, W; Campbell, AM			Loratadine (L) reduces RANTES release by an epithelial cell line.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1802	1802						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201796
J	Siebers, R; Rains, N; Fitzharris, P; Crane, J				Siebers, R; Rains, N; Fitzharris, P; Crane, J			A worldwide external quality control program for the house dust mite allergen, Der p 1.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									WELLINGTON SCH MED,WELLINGTON ASTHMA RES GRP,WELLINGTON,NEW ZEALAND	University of Otago			Siebers, Robert/A-4102-2009	Siebers, Robert/0000-0002-6359-3144					0	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1596	1596						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201592
J	Slater, JE; Zhang, YJ; ArthurSmith, A; ColbergPoley, A				Slater, JE; Zhang, YJ; ArthurSmith, A; ColbergPoley, A			A DNA vaccine inhibits IgE responses to the latex allergen Hev b 5 in mice.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									CHILDRENS NATL MED CTR,CHILDRENS RES INST,WASHINGTON,DC 20010	Children's National Health System									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			2037	2037						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14202031
J	Yamaguchi, M; Lantz, CS; Oettgen, HC; Katona, IM; Fleming, T; Yano, K; Miyajima, I; Kinet, JP; Galli, SJ				Yamaguchi, M; Lantz, CS; Oettgen, HC; Katona, IM; Fleming, T; Yano, K; Miyajima, I; Kinet, JP; Galli, SJ			IgE enhances mouse and human mast cell Fc epsilon RI expression, which in turn enhances IgE-dependent mast cell mediator release.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									BETH ISRAEL DEACONESS MED CTR, DEPT PATHOL, BOSTON, MA USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; CHILDRENS HOSP, DIV IMMUNOL, BOSTON, MA 02115 USA; UNIFORMED SERV UNIV HLTH SCI, DEPT MED, BETHESDA, MD 20814 USA; UNIFORMED SERV UNIV HLTH SCI, DEPT PEDIAT, BETHESDA, MD 20814 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			422	422						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200420
J	KoyanoNakagawa, N; Arai, KI				KoyanoNakagawa, N; Arai, KI			Specific versus cooperative regulatory mechanisms of the cytokine genes that are clustered on the same chromosome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						genes for IL-2; IL-3; IL-4; IL-5; IL-13; and GM-CSF; nuclear factor of activated T cells (NF-AT); NF-kappa B; T helper cells; enhancer; coordinated expression; transcriptional regulation	NF-KAPPA-B; T-CELL ACTIVATION; HUMAN IL-3 GENE; GM-CSF GENE; NUCLEAR FACTOR; TRANSCRIPTIONAL REGULATION; INTERLEUKIN-3 EXPRESSION; PRECURSOR P105; PROTEIN; BINDING	The genes for IL-3, IL-4, IL-5, IL-9, IL-13, and granulocyte-macrophage colony-stimulating factor (GM-CSF) are known to be clustered on human chromosome 5q and on mouse chromosome 11. IL-2 and interferon gamma (IFN-gamma) genes are located on separate chromosome. It is well known that upon stimulation by antigen presentation, T-H1 and T-H2 subsets of T helper cells start to transcribe distinct sets of cytokine genes. Thus mechanisms should exist that transmit extracellular signals into the nucleus, thereby coordinately turning on transcriptional machinery in cell type-specific manners. Several different mechanism exist in which specific as well as coordinated expression of cytokines are regulated at the transcriptional level. These include (1) regulation by proximal cis-elements, to which specific transcription factors bind (2) regulation by distal cis-elements, such as enhancers or locus controlling elements, especially those located several kilobases away from the target gene, and (3) enhancement of transcription by viral trans-activators in a pathologic state. In this article, we review the recent studies on the above issues, with particular emphasis on our own results that support the presence of different modes of control mechanisms. We also discuss the possible approaches to the thorough understanding of the coordinated and specific regulation of cytokines.	UNIV TOKYO, INST MED SCI, DEPT MOL & DEV BIOL, MINATO KU, TOKYO 108, JAPAN	University of Tokyo								ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DAVIES K, 1993, BLOOD, V81, P928; FRASER JD, 1992, MOL CELL BIOL, V12, P4357, DOI 10.1128/MCB.12.10.4357; FUJII M, 1992, GENE DEV, V6, P2066, DOI 10.1101/gad.6.11.2066; GOTTSCHALK LR, 1993, J EXP MED, V178, P1681, DOI 10.1084/jem.178.5.1681; HIRAI H, 1992, ONCOGENE, V7, P1737; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099, DOI 10.1128/MCB.14.8.5099; KOYANONAKAGAWA N, 1993, INT IMMUNOL, V5, P345, DOI 10.1093/intimm/5.4.345; Lederer JA, 1996, J IMMUNOL, V156, P56; LEE HJ, 1995, J BIOL CHEM, V270, P17541, DOI 10.1074/jbc.270.29.17196; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MASUDA ES, 1993, IMMUNOLOGIST, V1, P198; MATHEYPREVOT B, 1990, P NATL ACAD SCI USA, V87, P5046, DOI 10.1073/pnas.87.13.5046; MATSUDA I, 1994, BIOCHEM BIOPH RES CO, V199, P439, DOI 10.1006/bbrc.1994.1248; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naito Y, 1996, CYTOKINE, V8, P346, DOI 10.1006/cyto.1996.0048; NISHIDA J, 1991, INT IMMUNOL, V3, P245, DOI 10.1093/intimm/3.3.245; OSBORNE CS, 1995, J IMMUNOL, V155, P226; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; RIEGEL JS, 1992, CHEM IMMUNOL, V51, P266; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; SHOEMAKER SG, 1990, P NATL ACAD SCI USA, V87, P9650, DOI 10.1073/pnas.87.24.9650; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; SZABO SJ, 1993, MOL CELL BIOL, V13, P5928; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; TSUBOI A, 1991, INT IMMUNOL, V3, P807, DOI 10.1093/intimm/3.8.807; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; WATANABE M, 1993, ONCOGENE, V8, P2949; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; WU C, 1989, METHOD ENZYMOL, V170, P269; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	39	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	2	S			S174	S182		10.1016/S0091-6749(96)70064-7	http://dx.doi.org/10.1016/S0091-6749(96)70064-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WC447	8977525	Bronze			2022-12-18	WOS:A1996WC44700002
J	Steinberg, P; Pheley, A; Peterson, PK				Steinberg, P; Pheley, A; Peterson, PK			Influence of immediate hypersensitivity skin reactions on delayed reactions in patients with chronic fatigue syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CELL-MEDIATED-IMMUNITY		HENNEPIN CTY MED CTR,DIV CLIN IMMUNOL & ALLERGY,MINNEAPOLIS,MN; HENNEPIN CTY MED CTR,DEPT MED,DIV INFECT DIS,MINNEAPOLIS,MN	Hennepin County Medical Center; Hennepin County Medical Center								ASKENASE PW, 1993, ALLERGY PRINCIPLES P, P362; FAIRSHTER RD, 1980, J ALLERGY CLIN IMMUN, V66, P452, DOI 10.1016/0091-6749(80)90005-6; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; HUNZIKER N, 1980, ARCH DERMATOL, V116, P1266, DOI 10.1001/archderm.116.11.1266; LLOYD AR, 1989, MED J AUSTRALIA, V151, P122, DOI 10.5694/j.1326-5377.1989.tb139594.x; Marcussen PV, 1937, ARCH DERMATOL SYPH, V36, P494, DOI 10.1001/archderm.1937.01480030021003; PETERSON PK, 1991, MINN MED, V74, P21; Steinberg P, 1996, J ALLERGY CLIN IMMUN, V97, P119, DOI 10.1016/S0091-6749(96)70290-7; Woodfolk JA, 1996, J IMMUNOL, V156, P1695	9	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	1				1126	1128		10.1016/S0091-6749(96)80204-1	http://dx.doi.org/10.1016/S0091-6749(96)80204-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WB378	8977518				2022-12-18	WOS:A1996WB37800022
J	Garcia, R; Feijoo, E; Guerrero, MF; deGorgolas, M; MunozFernandez, MA				Garcia, R; Feijoo, E; Guerrero, MF; deGorgolas, M; MunozFernandez, MA			Immune complexes from HIV-1+ patients contain infectious virus able to infect normal lymphocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HIV; AIDS; immune complexes; infectivity; p24 antigen; PCR	AIDS; TYPE-1	It has been suggested that circulating immune complexes containing HIV-1 could be involved in enhancement of the infection through Fc receptors. To test this hypothesis, immune complexes precipitated from the sera of 25 HIV-1-seropositive individuals, at different stages of the disease, were assayed for the presence of infectious virus. When added to phytohemagglutinin-activated peripheral blood lymphocytes, seven of 25 complexes were able to sustain a productive infection. This was demonstrated by release of HIV-p24 antigens in the supernatant of activated brit not resting peripheral blood lymphocytes after several days of culture. Moreover, peripheral blood lymphocytes cultured with complexes from HIV-1+ patients but not from control subject, contained integrated HIV-1 provirus in their DNA. These results demonstrated the presence of infectious virus in immune complexes from HIV-1+ patients.	UNIV COMPLUTENSE MADRID,HOSP GEN GREGORIO MARANON,DIV IMMUNOL,E-28040 MADRID,SPAIN; FDN JIMENEZ DIAZ,DEPT INFECT DIS,E-28040 MADRID,SPAIN	Complutense University of Madrid; General University Gregorio Maranon Hospital	Garcia, R (corresponding author), FDN JIMENEZ DIAZ,DEPT IMMUNOL,REYES CATOLICOS 2,E-28040 MADRID,SPAIN.			Munoz-Fernandez/0000-0002-0813-4500				ALBERT J, 1990, J CLIN MICROBIOL, V28, P1560, DOI 10.1128/JCM.28.7.1560-1564.1990; BOLOGNESI DP, 1989, NATURE, V340, P431, DOI 10.1038/340431a0; FEIJOO E, 1995, INT ARCH ALLERGY IMM, V106, P366, DOI 10.1159/000236868; KARPATKIN S, 1988, SEMIN HEMATOL, V25, P219; KESTENS L, 1991, J VIROL METHODS, V31, P67, DOI 10.1016/0166-0934(91)90145-P; KOBAYASHI K, 1993, J INFECT DIS, V168, P729, DOI 10.1093/infdis/168.3.729; LAURENCE J, 1990, IMMUNOLOGY, V70, P338; MCDOUGAL JS, 1985, J CLIN IMMUNOL, V5, P130, DOI 10.1007/BF00915011; MORROW WJW, 1986, CLIN IMMUNOL IMMUNOP, V40, P515, DOI 10.1016/0090-1229(86)90196-0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SREEPADA TO, 1985, NEW ENGL J MED, V10, P669; 1993, MMWR-MORBID MORTAL W, V41, P1	12	5	5	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					827	830		10.1016/S0091-6749(96)70132-X	http://dx.doi.org/10.1016/S0091-6749(96)70132-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876559	Bronze			2022-12-18	WOS:A1996VM66500016
J	Musmand, JJ; Helbling, A; Lehrer, SB				Musmand, JJ; Helbling, A; Lehrer, SB			Surimi: Something fishy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PRODUCTS		TULANE UNIV,SCH MED,DEPT MED,ALLERGY & CLIN IMMUNOL SECT,NEW ORLEANS,LA 70112	Tulane University								AAS K, 1966, INT ARCH ALLER A IMM, V29, P346, DOI 10.1159/000229716; BERNHISELBROADBENT J, 1992, J ALLERGY CLIN IMMUN, V90, P622, DOI 10.1016/0091-6749(92)90135-O; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; ELSAYED S, 1971, INT ARCH ALLER A IMM, V40, P428, DOI 10.1159/000230425; HELBLING A, 1992, INT ARCH ALLERGY IMM, V99, P452, DOI 10.1159/000236310; KIRATSOUS AS, 1990, FLAVORS OFF FLAVORS, P659; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LANIER TC, 1985, FISH PROTEIN PROCESS; LEE CM, 1986, FOOD TECHNOL-CHICAGO, V40, P115; MARTIN R, 1992, ADV SEAFOOD BIOCH CO, P377; MATA E, 1994, ALLERGY, V49, P442, DOI 10.1111/j.1398-9995.1994.tb00837.x; ONEIL C, 1993, CLIN REV ALLERG, V11, P183; *US DEP COMM, 1992, NAT DAT BOOK, P132; YUNGINGER JW, 1988, JAMA-J AM MED ASSOC, V260, P1450, DOI 10.1001/jama.260.10.1450; 1993, JAMA-J AM MED ASSOC, V269, P3015	15	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1996	98	3					697	699		10.1016/S0091-6749(96)70104-5	http://dx.doi.org/10.1016/S0091-6749(96)70104-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VJ428	8828548				2022-12-18	WOS:A1996VJ42800027
J	Waisel, Y; GellerBernstein, C				Waisel, Y; GellerBernstein, C			Reliability of olive pollen extracts for skin prick tests	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									ZAMENHOFF ALLERGY CLIN,KUPAT HOLIM,IL-64373 TEL AVIV,ISRAEL		Waisel, Y (corresponding author), TEL AVIV UNIV,IL-69978 TEL AVIV,ISRAEL.							CAUNEAUPIGOT A, 1990, P 4 INT C AER AUG 31, P116; GELLERBERNSTEIN C, IN PRESS ALLERGY; KOSMAN E, 1994, ALLERGY, V49, P502, DOI 10.1111/j.1398-9995.1994.tb01120.x; WAISEL Y, 1995, ALLERGY PISTACIA, P665; WHEELER AW, 1990, MOL IMMUNOL, V27, P631, DOI 10.1016/0161-5890(90)90005-K	5	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1996	98	3					715	716		10.1016/S0091-6749(96)70113-6	http://dx.doi.org/10.1016/S0091-6749(96)70113-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VJ428	8828555				2022-12-18	WOS:A1996VJ42800036
J	Samet, JM; Fonteh, AN; Galli, SJ; Tsai, M; Fasano, MB; Chilton, FH				Samet, JM; Fonteh, AN; Galli, SJ; Tsai, M; Fasano, MB; Chilton, FH			Alterations in arachidonic acid metabolism in mouse mast cells induced to undergo maturation in vitro in response to stem cell factor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mast cell; stem cell factor; phospholipase A(2); arachidonic acid; eicosanoids	GROUP-II PHOSPHOLIPASE-A2; C-KIT LIGAND; 2ND MESSENGER; SIGNAL TRANSDUCTION; PANCREATIC-ISLETS; HUMAN-NEUTROPHILS; HUMAN-PLATELETS; PROTEIN-KINASE; ACYL RESIDUES; FATTY-ACIDS	We studied arachidonic acid (AA) metabolism during the maturation of bone marrow-derived cultured mast cells (BMCMCs) into mast cells with phenotypic characteristics, which were more similar to those of connective tissue-type mast cells. BMCMCs were maintained in medium containing 100 ng/ml recombinant mt stein cell factor (SCF) for 1 to 6 weeks. After 3 to 4 weeks in SCF, BMCMCs acquired many phenotypic characteristics of maturation including enlarged size, numerous electron-dense cytoplasmic granules, and a 50-fold elevation in histamine content. Maintenance in SCF for 6 week did not significantly alter the amounts or species of eicosanoids that were produced by BMCMCs stimulated with calcium ionophore A23187. However, SCF-treated mast cells released 2.6 +/- 0.13 limes more free AA and accumulated 6.4 +/- 1.0 times higher levels of intracellular free AA than did immature BMCMCs not exposed to SCF. There was no increase in the mobilization of other fatty acids (e.g., linoleic or oleic acid), indicating specificity for AA. Moreover, there were no differences between the 5-lipoxygenase activities of SCF-treated or untreated cells, as assayed in cell homogenates prepared by nitrogen cavitation. Although the total AA content in SCF-treated cells was significantly elevated, the distribution of AA in phospholipid and neutral lipid classes was not altered by SCF treatment. Total phospholipase (PL)A(2) activity increased 85% +/- 11.5% in SCF-treated cells. In homogenates of immature BMCMCs, 51.0% +/- 13.7% of the PLA(2) activity was inhibited by 0.5 mmol/L dithiothreitol, whereas the same concentration of dithiothreitol caused only a 2.2% +/- 10.7% reduction in the PLA(2) activity in homogenates of SCF-treated BMCMCs (p less than or equal to 0.05, n = 4). These findings suggest that SCF treatment induces a dithiothreitol-resistant PLA(2) and that this PLA(2) may contribute to the mobilization of AA that is not further metabolized to eicosanoids.	WAKE FOREST UNIV,BOWMAN GRAY SCH MED,PULM & CRIT CARE MED SECT,WINSTON SALEM,NC 27154; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,WINSTON SALEM,NC 27103; HARVARD UNIV,SCH MED,DEPT PATHOL,CAMBRIDGE,MA; BETH ISRAEL HOSP,CAMBRIDGE,MA; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,INFECT DIS SECT,WINSTON SALEM,NC	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Wake Forest University; Wake Forest Baptist Medical Center				Fasano, Mary/0000-0001-8468-1605; Tsai, Mindy/0000-0002-8421-4721	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026771, R29AI024985, R01AI024985] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 26771, AI 24985, AI 22674] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAMSON SB, 1991, J IMMUNOL, V147, P231; ANTOINE C, 1992, BIOCHIM BIOPHYS ACTA, V1128, P139, DOI 10.1016/0005-2760(92)90299-B; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; COFFEY M, 1992, J BIOL CHEM, V267, P570; FONTEH A, 1994, JIMMUNOL, V105, P5348; FONTEH AN, 1992, J IMMUNOL, V148, P1784; FONTEH AN, 1993, J IMMUNOL, V150, P563; FUJIMORI Y, 1992, J BIOCHEM-TOKYO, V111, P54, DOI 10.1093/oxfordjournals.jbchem.a123718; GALLI SJ, 1990, LAB INVEST, V62, P5; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; GORDON JR, 1990, IMMUNOL TODAY, V11, P458, DOI 10.1016/0167-5699(90)90176-A; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; HENDERSON WR, 1991, AM REV RESPIR DIS, V143, pS86, DOI 10.1164/ajrccm/143.5_Pt_2.S86; HUBBARD WC, 1987, PROSTAGLANDIN LIPID, P365; KALINER M, 1987, CHEST, V91, pS171, DOI 10.1378/chest.91.6.171S; KAY AB, 1987, AM REV RESPIR DIS, V135, P1200; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KRAMER RM, 1990, ADV PROSTAG THROMB L, V20, P79; LAPOSATA M, 1988, J BIOL CHEM, V263, P3266; LEWIS JC, 1982, LAB INVEST, V46, P123; LIHLING L, 1992, P NATL ACAD SCI USA, V89, P6147; MALAVIYA R, 1993, J BIOL CHEM, V268, P4939; MARTINEK R G, 1970, Journal of the American Medical Technologists, V32, P337; MATSSON L, 1992, ARCH ORAL BIOL, V37, P445, DOI 10.1016/0003-9969(92)90098-S; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MUELLER HW, 1984, J LIPID RES, V25, P383; MUELLER HW, 1983, LIPIDS, V18, P814, DOI 10.1007/BF02534641; MURAKAMI M, 1991, FEBS LETT, V294, P247, DOI 10.1016/0014-5793(91)81440-J; MURAKAMI M, 1992, J BIOCHEM-TOKYO, V111, P175, DOI 10.1093/oxfordjournals.jbchem.a123733; MURAKAMI M, 1992, EUR J BIOCHEM, V209, P257, DOI 10.1111/j.1432-1033.1992.tb17284.x; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; NAOR Z, 1991, MOL CELL ENDOCRINOL, V80, pC181, DOI 10.1016/0303-7207(91)90135-F; PETERS SP, 1987, AM REV RESPIR DIS, V135, P1196; SCHLEIMER RP, 1983, CLIN REV ALLERG, V1, P327; SCHWARTZ L, 1993, CLIN ASPECTS IMMUNOL, P549; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Snedecor G.W., 1978, STAT METHODS, V6th; SUGUIRA T, 1983, LIPIDS, V18, P125; SUMIDA C, 1993, PROSTAG LEUKOTR ESS, V48, P117, DOI 10.1016/0952-3278(93)90019-S; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WOLF BA, 1986, J BIOL CHEM, V261, P3501	44	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1329	1341		10.1016/S0091-6749(96)70202-6	http://dx.doi.org/10.1016/S0091-6749(96)70202-6			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648030				2022-12-18	WOS:A1996VD60700022
J	Arima, M; Plitt, JR; Stellato, C; Schwiebert, LM; Schleimer, RP				Arima, M; Plitt, JR; Stellato, C; Schwiebert, LM; Schleimer, RP			The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Stellato, Cristiana/P-3001-2015; Arima, Masafumi/L-1951-2018	Stellato, Cristiana/0000-0002-1294-8355; Arima, Masafumi/0000-0002-5169-7536					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				443	443						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600443
J	Klemm, DJ; Surs, W; Spahn, JD; Szefler, SJ; Leung, DYM				Klemm, DJ; Surs, W; Spahn, JD; Szefler, SJ; Leung, DYM			Alterations in glucocorticoid(GC) receptor(R) binding to DNA contributes to steroid resistant (SR) asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				716	716						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600716
J	LaRosa, M; Romeo, MA; DiGregorio, F; Russo, G				LaRosa, M; Romeo, MA; DiGregorio, F; Russo, G			Desensitization treatment for anaphylactoid reactions to desferrioxamine in a pediatric patient with thalassemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RAPID DESENSITIZATION				LaRosa, M (corresponding author), UNIV CATANIA,DEPT PEDIAT,VIALE A DORIA 6,I-95125 CATANIA,ITALY.							ATHANASIOU A, 1977, LANCET, V2, P616; BOUSQUET J, 1983, LANCET, V2, P859; DAVIS SC, 1983, LANCET, V1, P181; MILLER KB, 1981, LANCET, V1, P1059; ROMEO MA, 1984, J INHERIT METAB DIS, V7, P121, DOI 10.1007/BF01801768	5	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	1				127	128		10.1016/S0091-6749(96)70291-9	http://dx.doi.org/10.1016/S0091-6749(96)70291-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TR947	8568125	Bronze			2022-12-18	WOS:A1996TR94700016
J	VanSchoor, J; Toogood, JH; Pauwels, RA				VanSchoor, J; Toogood, JH; Pauwels, RA			Short courses of high-dose inhaled budesonide and serum IgG subclass levels in healthy volunteers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgC subclasses; inhaled glucocorticosteroids; budesonide; asthma	OBSTRUCTIVE PULMONARY-DISEASE; MONOCLONAL-ANTIBODIES; RESPIRATORY-TRACT; IMMUNOGLOBULIN-G; ASTHMA; CORTICOSTEROIDS; BECLOMETHASONE; SPECIFICITY; DEFICIENCY; THERAPY	Background: The incidence of systemic side effects of inhaled budesonide increases at doses exceeding 2000 mu g/day. Objective: This study was carried out to investigate whether high-dose inhaled budesonide affects serum IgG subclass concentrations in healthy adult volunteers. Methods: Two groups of 10 subjects each inhaled 2.4 mg of budesonide per day in a double-blind crossover study of morning (8:00 AM and noon, group A) and diurnal (8:00 AM and 8:00 PM, group B) dosing schedules for 4 weeks each, separated by a 2-week washout period. The budesonide was inhaled through a pressurized metered-dose inhaler, mounted on a 750 ml Nebuhaler (ASTRA Pharmaceuticals, Lund Sweden). The IgG subclass levels were determined at baseline and every 2 weeks until the end of the study period (10 weeks). Results: There were no statistically significant changes in the serum IgG subclass concentrations over the 10-week study period in group A, group B, or groups A and B combined. Conclusion: Inhalation of budesonide, 2.4 mg/day, through a large-volume spacer for repented 1-month periods does not influence serum IgG subclass concentrations in healthy adults, suggesting that budesonide does nor cause systemic humoral immunosuppression when given at therapeutic doses.	UNIV WESTERN ONTARIO,DEPT MED,LONDON,ON,CANADA	Western University (University of Western Ontario)	VanSchoor, J (corresponding author), STATE UNIV GHENT HOSP,DEPT RESP DIS,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.							ANDERSON CJ, 1980, J ALLERGY CLIN IMMUN, V65, P140, DOI 10.1016/0091-6749(80)90199-2; British Thoracic Society (BTS), 1993, THORAX, V48, pS1; BROGDEN RN, 1992, DRUGS, V44, P375, DOI 10.2165/00003495-199244030-00007; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; DECOTIIS BA, 1980, J ALLERGY CLIN IMMUN, V65, P218; DUKES MNG, 1994, EUR RESPIR J, V7, P830, DOI 10.1183/09031936.94.07040830; FRANK A, 1985, RESPIRATION, V48, P122, DOI 10.1159/000194811; HAMILOS DL, 1992, ANN ALLERGY, V68, P472; HORTON DJ, 1977, CHEST, V71, P540, DOI 10.1378/chest.71.4.540; JEFFERIS R, 1985, IMMUNOL LETT, V10, P223, DOI 10.1016/0165-2478(85)90082-3; JEFFERIS R, 1990, CLIN EXP IMMUNOL, V81, P357; JEFFERIS R, 1992, IMMUNOL LETT, V31, P143, DOI 10.1016/0165-2478(92)90141-A; KLAUSTERMEYER WB, 1992, CHEST, V102, P1137, DOI 10.1378/chest.102.4.1137; KLAUSTERMEYER WB, 1989, ANN ALLERGY, V63, P327; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; OKEEFFE S, 1991, EUR RESPIR J, V4, P932; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; PAUWELS RA, 1992, EUR RESPIR J, V5, P1254; POSEY WC, 1978, J ALLERGY CLIN IMMUN, V62, P340, DOI 10.1016/0091-6749(78)90134-3; REYNOLDS HY, 1988, MAYO CLIN PROC, V63, P161, DOI 10.1016/S0025-6196(12)64949-0; SETTIPANE GA, 1978, J ALLERGY CLIN IMMUN, V62, P162, DOI 10.1016/0091-6749(78)90101-X; SHAIKH WA, 1992, ALLERGY, V47, P327, DOI 10.1111/j.1398-9995.1992.tb02063.x; SZCZEKLIK A, 1992, CLIN EXP ALLERGY, V22, P283, DOI 10.1111/j.1365-2222.1992.tb03084.x; TARLO S, 1979, CLIN ALLERGY, V9, P293, DOI 10.1111/j.1365-2222.1979.tb01556.x; TOOGOOD JH, 1980, J ALLERGY CLIN IMMUN, V65, P145, DOI 10.1016/0091-6749(80)90200-6; TOOGOOD JH, 1984, AM REV RESPIR DIS, V129, P723, DOI 10.1164/arrd.1984.129.5.723; TOOGOOD JH, 1991, J ALLERGY CLIN IMMUN, V88, P572, DOI 10.1016/0091-6749(91)90150-M; TRUHAN AP, 1989, ANN ALLERGY, V62, P375; WEDZICHA JA, 1993, THORAX, V48, P305, DOI 10.1136/thx.48.4.305; 1992, EUR RESPIR J, V5, P601	30	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	1				113	118		10.1016/S0091-6749(96)70289-0	http://dx.doi.org/10.1016/S0091-6749(96)70289-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TR947	8568123				2022-12-18	WOS:A1996TR94700014
J	Karaz, SS; Moeckli, JK; Davis, W; Craig, TJ				Karaz, SS; Moeckli, JK; Davis, W; Craig, TJ			Effect of topical doxepin cream on skin testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242	University of Iowa								BERNSTEIN JE, 1981, J AM ACAD DERMATOL, V5, P582, DOI 10.1016/S0190-9622(81)70120-8; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P613, DOI 10.1016/S0190-9622(94)70225-X; GUPTA MA, 1987, ARCH DERMATOL, V123, P647, DOI 10.1001/archderm.123.5.647; RICHELSON E, 1983, MAYO CLIN PROC, V58, P40; 1994, ZONALON CREAM DOXEPI	5	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	1				997	998		10.1016/S0091-6749(95)70238-5	http://dx.doi.org/10.1016/S0091-6749(95)70238-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN124	8543759				2022-12-18	WOS:A1995TN12400018
J	Kosugi, H; Nakagawa, Y; Arai, K; Yokota, T				Kosugi, H; Nakagawa, Y; Arai, K; Yokota, T			Gene structures of the alpha subunits of human IL-3 and granulocyte-macrophage colony-stimulating factor receptors: Comparison with the cytokine receptor superfamily	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	New Trends in Immunopharmacology 1994 Conference	JUL   23, 1994	TOKYO, JAPAN	Sandoz Pharm Ltd		cytokine receptor; gene structure; gene evolution; IL-3; GM-CSF; cytokine receptor superfamily	Y PSEUDOAUTOSOMAL REGION; GENOMIC ORGANIZATION; EXPRESSION CLONING; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; GROWTH-HORMONE; X-CHROMOSOME; CHAIN GENE; EVOLUTION; DOMAIN	Recently, many genes encoding the members of the cytokine receptor superfamily (CRSF), which have common structural features, have been characterized. Analyses on the structures of the genes encoding the alpha subunits of human IL-3 (hIL-3R alpha) and granulocyte-macrophage colony-stimulating factor receptors (hGMR alpha) revealed that they have the structural features common to all members of the CRSF (i.e., conservation of the intron phase pattern as ''1-2-1-0-1'' rule in the fibronectin type III domains located in extracellular segments of type I cytokine receptor subunits. This finding led us to propose a possible model for gene evolution for the CRSF. We pointed out that the CRSF genes derived from a putative common ancestral gene. In addition to these common features, we found an additional intron that is unique to the IL-3R alpha and the GMR alpha genes. This additional intron suggests that the IL-3R alpha and the GMR alpha genes evolved closely in the evolution process of the CRSF genes. This evidence and results of recent studies on the evolution of mammalian X chromosome make it tempting to speculate that a putative common ancestral gene of the subfamily including IL-3R alpha GMR alpha, and IL-5R alpha emerged in an autosome at least before the divergence of marsupials and eutherian mammals early in the 200 million-year history of mammals.	UNIV TOKYO,INST MED SCI,DEPT MOLEC & DEV BIOL,MINATO KU,TOKYO 108,JAPAN; NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 1,NAGOYA,AICHI 466,JAPAN	University of Tokyo; Nagoya University			Yokota, Takashi/F-6021-2011; Yokota, Takashi/J-8483-2015					ASHWORTH A, 1990, NUCLEIC ACIDS RES, V18, P7178, DOI 10.1093/nar/18.23.7178; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; CROSIER KE, 1991, P NATL ACAD SCI USA, V88, P7744, DOI 10.1073/pnas.88.17.7744; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DURIEZ B, 1993, MOL ENDOCRINOL, V7, P806, DOI 10.1210/me.7.6.806; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; EITAN S, 1992, P NATL ACAD SCI USA, V89, P5442, DOI 10.1073/pnas.89.12.5442; EITAN S, 1993, SCIENCE, V261, P106, DOI 10.1126/science.8100369; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GORMAN DM, 1992, J BIOL CHEM, V267, P15842; Graves JAM, 1992, CURR OPIN GENET DEV, V2, P890, DOI 10.1016/S0959-437X(05)80112-1; HOHAUS S, 1994, BLOOD S1, V84, pA150; IMAMURA F, 1994, DNA CELL BIOL, V13, P283, DOI 10.1089/dna.1994.13.283; ITO Y, 1994, EUR J BIOCHEM, V220, P881, DOI 10.1111/j.1432-1033.1994.tb18691.x; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KOSUGI H, 1995, BIOCHEM BIOPH RES CO, V208, P360, DOI 10.1006/bbrc.1995.1346; KREMER E, 1993, BLOOD, V82, P22, DOI 10.1182/blood.V82.1.22.bloodjournal82122; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; LEUTZ A, 1989, EMBO J, V8, P175, DOI 10.1002/j.1460-2075.1989.tb03362.x; LYON MF, 1990, NATURE, V348, P585, DOI 10.1038/348585a0; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; MIGNOTTE V, 1994, GENOMICS, V20, P5, DOI 10.1006/geno.1994.1120; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; MITCHELL MJ, 1992, NATURE, V359, P528, DOI 10.1038/359528a0; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MIYAJIMA A, 1993, BLOOD, V82, P1960; MIYAJIMA I, 1995, IN PRESS BLOOD; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; NAKAGAWA Y, 1994, J BIOL CHEM, V269, P10905; NOGUCHI M, 1993, J BIOL CHEM, V268, P13601; PATTHY L, 1994, CURR OPIN STRUC BIOL, V4, P383, DOI 10.1016/S0959-440X(94)90108-2; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; PENNY LA, 1991, GENOMICS, V11, P974, DOI 10.1016/0888-7543(91)90022-7; RAINES MA, 1991, P NATL ACAD SCI USA, V88, P8203, DOI 10.1073/pnas.88.18.8203; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; SEKELLICK MJ, 1994, J INTERFERON RES, V14, P71, DOI 10.1089/jir.1994.14.71; SETO Y, 1992, J IMMUNOL, V148, P259; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; SHIBUYA H, 1990, NUCLEIC ACIDS RES, V18, P3697, DOI 10.1093/nar/18.13.3697; SIPES JM, 1993, J CELL BIOL, V121, P469, DOI 10.1083/jcb.121.2.469; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; SPENCER JA, 1991, GENOMICS, V11, P339, DOI 10.1016/0888-7543(91)90141-Z; TAMAI T, 1993, BIOCHIM BIOPHYS ACTA, V1174, P182, DOI 10.1016/0167-4781(93)90112-Q; TANAKA M, 1992, BIOCHEM BIOPH RES CO, V188, P490, DOI 10.1016/0006-291X(92)91082-2; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109; Wrighton N, 1992, GROWTH FACTORS, V6, P103, DOI 10.3109/08977199209011014; YOSHIMURA A, 1992, J BIOL CHEM, V267, P11619	54	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	2	S			1115	1125		10.1016/S0091-6749(95)70196-6	http://dx.doi.org/10.1016/S0091-6749(95)70196-6			11	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ509	8543768				2022-12-18	WOS:A1995TQ50900007
J	Sekizawa, K; Nakazawa, H; Morikawa, M; Yamauchi, K; Maeyama, K; Watanabe, T; Sasaki, H				Sekizawa, K; Nakazawa, H; Morikawa, M; Yamauchi, K; Maeyama, K; Watanabe, T; Sasaki, H			Histamine N-methyltransferase inhibitor potentiates histamine- and antigen-induced airway microvascular leakage in guinea pigs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						plasma extravasation; bronchial asthma; histamine; allergic rhinitis; mucosal edema	BRONCHOALVEOLAR LAVAGE FLUID; VASCULAR-PERMEABILITY; ENDOTHELIAL-CELLS; NASAL-MUCOSA; CHALLENGE; DEGRADATION; MEDIATORS; PROTEINS; TISSUES; INVIVO	Background: Histamine N-methyltransferase (HMT) modulates histamine- and antigen-induced bronchoconstriction. However, it is unclear whether vascular permeability evoked by an allergic reaction can be exaggerated by inhibition of HMT activity. Methods: We studied the effects of intravenously injected SKF 91488, a specific HMT inhibitor, on increases in plasma extravasation induced by intravenously injected histamine in unsensitized guinea pigs and by intravenously injected ovalbumin antigen in guinea pigs sensitized to ovalbumin in vivo with Evans blue dye as a maker. Results: Pretreatment with SKF 91488 shifted, in a dose-dependent fashion, the dose-response curves of the leakage of dye to histamine to lower concentrations in the trachea, main bronchi, and nasal mucosa. Likewise, pretreatment with SKF 91488 (20 mg/kg intravenously) significantly increased the leakage of dye induced by ovalbumin antigen (200 mu g/kg intravenously) in three parts of the airway (p<0.05). In contrast to SKF 91488, intravenously injected aminoguanidine, a specific inhibitor of diamine oxidase (16 mg/kg intravenously), did not alter the leakage of dye induced by histamine (from 0.001 mu g/kg to 10 mu g/kg intravenously) (p>0.20). HMT activities were observed in the nasal mucosa, as well as in the trachea and main bronchi, as shown in a previous study. Conclusion: These findings suggest that HMT modulates the effect of exogenous histamine and endogenously released histamine induced by antigen challenge on plasma extravasation in the airway in guinea pigs in vivo.	TOHOKU UNIV,SCH MED,DEPT GERIATR MED,AOBA KU,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,SCH MED,DEPT INTERNAL MED 1,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,SCH MED,DEPT PHARMACOL,SENDAI,MIYAGI 980,JAPAN	Tohoku University; Tohoku University; Tohoku University			Yamauchi, Kohei/N-2749-2016					ABE Y, 1993, CLIN EXP ALLERGY, V23, P512, DOI 10.1111/j.1365-2222.1993.tb03239.x; ABE Y, 1993, CLIN EXP ALLERGY, V23, P132, DOI 10.1111/j.1365-2222.1993.tb00308.x; BEAVEN MA, 1979, BIOCHEM PHARMACOL, V28, P183, DOI 10.1016/0006-2952(79)90500-8; BEAVEN MA, 1979, AGENTS ACTIONS, V9, P455, DOI 10.1007/BF01968110; BEAVEN MA, 1978, HDB EXPT PHARM, P151; BECKER CG, 1973, AM J PATHOL, V71, P1; BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; BERTACCINI G, 1979, BRIT J PHARMACOL, V66, P13, DOI 10.1111/j.1476-5381.1979.tb16091.x; BROGAN TD, 1975, THORAX, V30, P72, DOI 10.1136/thx.30.1.72; CASALE TB, 1987, J CLIN INVEST, V79, P1197, DOI 10.1172/JCI112937; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; EVANS TW, 1988, AM REV RESPIR DIS, V138, P395, DOI 10.1164/ajrccm/138.2.395; FUKUDA H, 1991, J CHROMATOGR-BIOMED, V567, P459, DOI 10.1016/0378-4347(91)80152-3; GULBENKIAN AR, 1990, AM REV RESPIR DIS, V142, P680, DOI 10.1164/ajrccm/142.3.680; HADDOCK RC, 1987, J BIOL CHEM, V262, P10220; JORIS I, 1982, STAIN TECHNOL, V57, P177, DOI 10.3109/10520298209066611; LAITINEN LA, 1988, EUR RESPIR J, V1, P488; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; NAKAZAWA H, 1992, AM REV RESPIR DIS, V145, P377; OHRUI T, 1992, J PHARMACOL EXP THER, V261, P1268; OHRUI T, 1992, J ALLERGY CLIN IMMUN, V89, P933, DOI 10.1016/0091-6749(92)90215-N; PARSONS ME, 1977, AGENTS ACTIONS, V7, P31, DOI 10.1007/BF01964878; PHILLIPS MJ, 1983, J IMMUNOL, V131, P906; PROUD D, 1983, J CLIN INVEST, V72, P1678, DOI 10.1172/JCI111127; RYLEY HC, 1968, BRIT J EXP PATHOL, V49, P625; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; SEKIZAWA K, 1993, AM REV RESPIR DIS, V147, P92, DOI 10.1164/ajrccm/147.1.92; UDAKA K, 1970, P SOC EXP BIOL MED, V133, P1384; WHITE MV, 1992, J ALLERGY CLIN IMMUN, V90, P699, DOI 10.1016/0091-6749(92)90155-U; WHITE MV, 1990, J ALLERGY CLIN IMMUN, V86, P599, DOI 10.1016/S0091-6749(05)80223-4; WHITE MV, 1991, LUNG SCI F, P927	33	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	1				910	916		10.1016/S0091-6749(95)70228-8	http://dx.doi.org/10.1016/S0091-6749(95)70228-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN124	8543749				2022-12-18	WOS:A1995TN12400008
J	NAVARRO, JA; DELPOZO, MD; GASTAMINZA, G; MONEO, I; AUDICANA, MT; DECORRES, LF				NAVARRO, JA; DELPOZO, MD; GASTAMINZA, G; MONEO, I; AUDICANA, MT; DECORRES, LF			ALLIUM-CEPA SEEDS - A NEW OCCUPATIONAL ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							INHALATION		INST SALUD CARLOS 3, CTR INVEST CLIN, SERV IMMUNOL, MADRID, SPAIN	Instituto de Salud Carlos III	NAVARRO, JA (corresponding author), HOSP SANTIAGO APOSTOL, SERV ALERGOL, C OLAGUIBEL 29, E-01004 VITORIA, SPAIN.							BERNSTEIN ID, 1993, ASTHMA WORKPLACE, P29; LYBARGER JA, 1982, J ALLERGY CLIN IMMUN, V69, P448, DOI 10.1016/0091-6749(82)90120-8; PETIT C, 1989, METHOD ENZYMOL, V178, P144; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOWNLEY RJ, 1987, J ALLERGY CLIN IMMUN, V80, P111, DOI 10.1016/0091-6749(87)90116-3	5	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1995	96	5	1				690	693		10.1016/S0091-6749(95)70269-5	http://dx.doi.org/10.1016/S0091-6749(95)70269-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TG528	7499687				2022-12-18	WOS:A1995TG52800016
J	AALBERSE, RC; DANNEMAN, A; VANREE, R; WAHN, U				AALBERSE, RC; DANNEMAN, A; VANREE, R; WAHN, U			THE HUMAN IGE RESPONSE TO DIPHTHERIA TETANUS IN-VIVO IS SUPPRESSED RATHER THAN ENHANCED BY CO-VACCINATION WITH BORDETELLA-PERTUSSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				361	361						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400879
J	ADKINSON, F; EGGLESTON, P; GOLDSTEIN, E; SCHUBERTH, K; ENEY, D; BACON, J; WEISS, M; HAMILTON, R; WHEELER, B; ARSHAD, H; MEINERT, C; TONASCIA, J				ADKINSON, F; EGGLESTON, P; GOLDSTEIN, E; SCHUBERTH, K; ENEY, D; BACON, J; WEISS, M; HAMILTON, R; WHEELER, B; ARSHAD, H; MEINERT, C; TONASCIA, J			TRIAL OF IMMUNOTHERAPY FOR ALLERGIC-ASTHMA IN CHILDREN .1. DESIGN AND METHODS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				189	189						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400193
J	ADKINSON, F; EGGELESTON, P; GOLDSTEIN, E; SCHUBERTH, K; ENEY, D; BACON, J; WEISS, M; HAMILTON, R; WHEELER, B; ARSHAD, H; MEINERT, C; TONASCIA, J				ADKINSON, F; EGGELESTON, P; GOLDSTEIN, E; SCHUBERTH, K; ENEY, D; BACON, J; WEISS, M; HAMILTON, R; WHEELER, B; ARSHAD, H; MEINERT, C; TONASCIA, J			TRIAL OF IMMUNOTHERAPY FOR ALLERGIC-ASTHMA IN CHILDREN .2. OUTCOMES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				189	189						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400194
J	ADKISON, F; EGGLESTON, P; GOLDSTEIN, E; SCHUBERTH, K; ENEY, D; BACON, J; WEISS, M; HAMILTON, R; WHEELER, B; ARSHAD, H; MEINERT, C; TONASCIA, J				ADKISON, F; EGGLESTON, P; GOLDSTEIN, E; SCHUBERTH, K; ENEY, D; BACON, J; WEISS, M; HAMILTON, R; WHEELER, B; ARSHAD, H; MEINERT, C; TONASCIA, J			TRIAL OF IMMUNOTHERAPY FOR ALLERGIC-ASTHMA IN CHILDREN .3. CONSIDERATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				189	189						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400195
J	ANTCZAK, M; KUNA, P				ANTCZAK, M; KUNA, P			HEPARIN INHIBITS ALLERGEN-INDUCED AIRWAY RESPONSE IN ASTHMATICS - RESULTS OF A DOUBLE-BLIND PLACEBO-CONTROLLED, CROSSOVER STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				386	386						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400982
J	BURGE, H; CHEW, G; MUILENBERG, M; GOLD, D				BURGE, H; CHEW, G; MUILENBERG, M; GOLD, D			ROLE OF FUNGI IN-HOUSE DUST ECOSYSTEMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health									0	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				167	167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400108
J	COSACHOV, J; ZITT, M; BOUBOULIS, D; FANG, S; FRIERI, M				COSACHOV, J; ZITT, M; BOUBOULIS, D; FANG, S; FRIERI, M			SULFIDOLEUKOTRIENES (SLT) IN ALLERGEN-SPECIFIC MONONUCLEAR-CELLS IN ATOPIC ASTHMATICS DURING IMMUNOTHERAPY (IT)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				259	259						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400475
J	HOFFMAN, KM; HO, D; SAMPSON, HA				HOFFMAN, KM; HO, D; SAMPSON, HA			IN-VIVO ALLERGENIC CROSS-REACTIVITY OF COW MILK AND GOAT MILK	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				330	330						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400757
J	HOVANECBURNS, D; ORDONEZ, M; CORRAO, M; ENJAMURI, S; UNVER, E				HOVANECBURNS, D; ORDONEZ, M; CORRAO, M; ENJAMURI, S; UNVER, E			IDENTIFICATION OF ANOTHER LATEX-CROSS-REACTIVE FOOD ALLERGEN - PEANUT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ünver, Edhem/ABF-8926-2020						0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				150	150						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400040
J	JAGGI, KJ; HOVANECBURNS, D; UNVER, E				JAGGI, KJ; HOVANECBURNS, D; UNVER, E			EXISTENCE OF PROFILIN IN LATEX ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ünver, Edhem/ABF-8926-2020						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				212	212						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400286
J	KITA, H; KANEKO, M; FRIGAS, E; BARTEMES, KR; WEILER, DA; GLEICH, GJ				KITA, H; KANEKO, M; FRIGAS, E; BARTEMES, KR; WEILER, DA; GLEICH, GJ			EOSINOPHILS FROM HAY-FEVER PATIENTS DEGRANULATE IN RESPONSE TO IGG, BUT NOT TO IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				339	339						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400791
J	MCCANN, SA; MCCANN, ML				MCCANN, SA; MCCANN, ML			SUDDEN-INFANT-DEATH-SYNDROME (SIDS) FROM COW MILK ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				330	330						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400755
J	MOQBEL, R; YING, S; BARKANS, J; WAKELIN, M; KIMMITT, P; CORRIGAN, CJ; DURHAM, SR; KAY, AB				MOQBEL, R; YING, S; BARKANS, J; WAKELIN, M; KIMMITT, P; CORRIGAN, CJ; DURHAM, SR; KAY, AB			EOSINOPHILS TRANSCRIBE AND TRANSLATE MESSENGER-RNA FOR IL-4	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				221	221						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400321
J	PAWANKAR, R; OKUDA, M; AZUMA, M; SUZUKI, KMS; YAGI, T; OKUMURA, K; RA, C				PAWANKAR, R; OKUDA, M; AZUMA, M; SUZUKI, KMS; YAGI, T; OKUMURA, K; RA, C			CHARACTERIZATION OF NASAL GAMMA-DELTA T-CELLS IN PERENNIAL ALLERGIC RHINITICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				190	190						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400200
J	REDINGTON, AE; MADDEN, J; DJUKANOVIC, R; ROCHE, WR; HOWARTH, PH; HOLGATE, ST				REDINGTON, AE; MADDEN, J; DJUKANOVIC, R; ROCHE, WR; HOWARTH, PH; HOLGATE, ST			TRANSFORMING GROWTH-FACTOR-BETA LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID ARE INCREASED IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				377	377						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400945
J	RUTELLA, S; BONINI, S; RUMI, C; ONORATI, P; LAMBIASE, A; BONINI, S				RUTELLA, S; BONINI, S; RUMI, C; ONORATI, P; LAMBIASE, A; BONINI, S			FLOW-CYTOMETRY OF PERIPHERAL-BLOOD LEUKOCYTES IN VERNAL KERATOCONJUNCTIVITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV CATTOLICA SACRO CUORE, ROME, ITALY; UNIV ROMA TOR VERGATA, DEPT OPHTHALMOL, ROME, ITALY; UNIV ROMA LA SAPIENZA, MED CLIN 1, ROME, ITALY; UNIV NAPLES 2, CHAIR CLIN IMMUNOL & ALLERGOL, NAPLES, ITALY	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Sapienza University Rome; Universita della Campania Vanvitelli			Bonini, Sergio/T-6594-2019; Rutella, Sergio/AAF-9210-2020; Rutella, Sergio/AAF-9187-2020; Bonini, Stefano/A-2250-2012	Bonini, Sergio/0000-0003-0079-3031; Rutella, Sergio/0000-0003-1970-7375; Bonini, Stefano/0000-0002-7787-2144					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				376	376						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400942
J	TOOGOOD, J; HODSMAN, A; BASKERVILLE, J; MARKOV, A				TOOGOOD, J; HODSMAN, A; BASKERVILLE, J; MARKOV, A			VERTEBRAL BONE-MINERAL DENSITY (VBMD) AMONG ELDERLY MEN AND WOMEN RECEIVING LONG-TERM INHALED (I-S) OR ORAL STEROIDS (O-S) FOR ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									VICTORIA HOSP,LONDON,ON N6A 4G5,CANADA; LAWSON RES INST,LONDON,ON,CANADA	University of Victoria; Western University (University of Western Ontario); Western University (University of Western Ontario)									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				310	310						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400679
J	ROBINSON, DA; MEYER, CF				ROBINSON, DA; MEYER, CF			PRIMARY SJOGRENS-SYNDROME ASSOCIATED WITH RECURRENT SINOPULMONARY INFECTIONS AND BRONCHIECTASIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							MANIFESTATIONS		MED COLL GEORGIA,AUGUSTA,GA 30912	University System of Georgia; Augusta University								BARDANA EJ, 1990, ANN ALLERGY, V64, P3; DANIELS TE, 1975, ORAL SURG ORAL MED O, V39, P875, DOI 10.1016/0030-4220(75)90108-5; FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P699; GRENIER P, 1986, RADIOLOGY, V161, P95, DOI 10.1148/radiology.161.1.3763889; STRIMLAN CV, 1976, CHEST, V70, P354, DOI 10.1378/chest.70.3.354	5	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2					263	264		10.1016/0091-6749(94)90050-7	http://dx.doi.org/10.1016/0091-6749(94)90050-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC926	8064080				2022-12-18	WOS:A1994PC92600019
J	ANDERSON, JA; COHEN, SG; FRICK, OL; FRIEDLAENDER, S; NORMAN, PS; RACHELEFSKY, GS; STRUNK, RC				ANDERSON, JA; COHEN, SG; FRICK, OL; FRIEDLAENDER, S; NORMAN, PS; RACHELEFSKY, GS; STRUNK, RC			WILL THE SUPPLY OF ALLERGISTS AND IMMUNOLOGISTS IN THE UNITED-STATES MEET FUTURE-NEEDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											ANDERSON, JA (corresponding author), AAAI,611 E WELLS,MILWAUKEE,WI 53202, USA.							ANDERSON JA, 1991, J ALLERGY CLIN IMMUN, V88, P17, DOI 10.1016/0091-6749(91)90296-Z; GRUMBACH K, 1993, NEW ENGL J MED, V328, P940, DOI 10.1056/NEJM199304013281308; LEVINSKY NG, 1993, NEW ENGL J MED, V328, P656, DOI 10.1056/NEJM199303043280913; SCHROEDER SA, 1992, ANN INTERN MED, V116, P583, DOI 10.7326/0003-4819-116-7-583; SCHROEDER SA, 1993, NEW ENGL J MED, V328, P961, DOI 10.1056/NEJM199304013281312; 1987, NATIONAL ALLERGY IMM; 1993, AAMC DATA BOOK STATI; 1992, FEB C TAK CHARG GRAD; 1993, JAMA-J AM MED ASSOC, V270, P1116; PPRC1992 GME ANN REP; 1981, GMENAC1980 US DEP HL	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1994	93	4					803	810						8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NH497					2022-12-18	WOS:A1994NH49700016
J	CROCKER, IC; TOWNLEY, RG; KHAN, MM				CROCKER, IC; TOWNLEY, RG; KHAN, MM			PHOSPHODIESTERASE INHIBITORS MODULATE CYTOKINE SECRETION AND PROLIFERATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				286	286						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700743
J	LANG, DM				LANG, DM			INHALED STEROIDS ARE UNDERUTILIZED IN URBAN AREAS OF HIGH ASTHMA MORTALITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				246	246						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700500
J	OHTA, K; SAWAMOTO, S; NAKAJIMA, M; NAGAI, A; TANAKA, Y; HIRAI, K; MANO, K; MIYASHITA, H				OHTA, K; SAWAMOTO, S; NAKAJIMA, M; NAGAI, A; TANAKA, Y; HIRAI, K; MANO, K; MIYASHITA, H			THEOPHYLLINE INDUCES APOPTOSIS IN EOSINOPHILS SURVIVING WITH INTERLEUKIN-5 IN-VITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				200	200						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700224
J	PHILIP, G; PROUD, D; NACLERIO, RM; TOGIAS, AG				PHILIP, G; PROUD, D; NACLERIO, RM; TOGIAS, AG			INCREASED RESPONSES TO CAPSAICIN NASAL CHALLENGE IN ALLERGIC VERSUS NONALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				217	217						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700325
J	QUINN, JM; TAJIRI, KS; MOTTA, P; FREEMAN, TM				QUINN, JM; TAJIRI, KS; MOTTA, P; FREEMAN, TM			LONG-TERM EFFICACY AFTER DISCONTINUATION OF IMPORTED FIRE ANT (SOLENOPSIS-INVICTA) IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				223	223						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700362
J	SAFADI, GS; MELTON, AL; WAGNER, WO				SAFADI, GS; MELTON, AL; WAGNER, WO			BANANA ANAPHYLAXIS IN LATEX HYPERSENSITIVE HEALTH-CARE WORKERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		MRAIHI L, 1991, J ALLERGY CLIN IMMUN, V87, P129, DOI 10.1016/0091-6749(91)90224-C	1	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				283	283						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700725
J	SANMARTIN, JE; QUINTERO, CH; MOSCICKI, RA; BLOCH, KJ				SANMARTIN, JE; QUINTERO, CH; MOSCICKI, RA; BLOCH, KJ			EQUIVALENCE OF BOVINE RENAL AND INNER-EAR EXTRACTS FOR THE DETECTION OF ANTIBODY TO A 68 KD PROTEIN ASSOCIATED WITH IDIOPATHIC, PROGRESSIVE, BILATERAL, SENSORINEURAL HEARING-LOSS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				204	204						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700249
J	SELNER, J; BANOV, C; BOLTANSKY, H; BRONSKY, E; CHERVINSKY, P; DRUCE, H; GEORGITIS, J; KAISER, H; LAFORCE, C; MELTZER, E; MUNK, Z; WEBB, D; FIELD, E; HAMEDANI, A; MILWEE, S				SELNER, J; BANOV, C; BOLTANSKY, H; BRONSKY, E; CHERVINSKY, P; DRUCE, H; GEORGITIS, J; KAISER, H; LAFORCE, C; MELTZER, E; MUNK, Z; WEBB, D; FIELD, E; HAMEDANI, A; MILWEE, S			FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY EFFECTIVELY TREATS PERENNIAL NONALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				165	165						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700017
J	WILLIAMS, PB; BUHR, MP; WEBER, RW; VOLZ, MA; KOEPKE, JW; SELNER, JC				WILLIAMS, PB; BUHR, MP; WEBER, RW; VOLZ, MA; KOEPKE, JW; SELNER, JC			AIR-POLLUTION, ASTHMA, LATEX AND TIRE FRAGMENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				284	284						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700730
J	FOULDS, RA				FOULDS, RA			AN OVERVIEW OF HUMAN SAFETY DATA WITH NEDOCROMIL SODIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FOULDS, RA (corresponding author), SMITHKLINE BEECHAM PHARMACEUT,WELWYN GARDEN CIT AL7 1EY,HERTS,ENGLAND.							CARRASCO E, 1988, J INT MED RES, V16, P394, DOI 10.1177/030006058801600509; LAL S, 1986, EUR J RESPIR DIS, V69, P136	2	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				202	204		10.1016/0091-6749(93)90109-S	http://dx.doi.org/10.1016/0091-6749(93)90109-S			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8393031				2022-12-18	WOS:A1993LQ35400015
J	HELBLING, A; HORNER, WE; LEHRER, SB				HELBLING, A; HORNER, WE; LEHRER, SB			COMPARISON OF PSILOCYBE-CUBENSIS SPORE AND MYCELIUM ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						FUNGAL ALLERGY; BASIDIOSPORE; PSILOCYBE-CUBENSIS; SPORE ALLERGEN; MYCELIUM ALLERGEN; INVITRO CULTURE	BASIDIOMYCETE ALLERGY; IGE ANTIBODIES; EXTRACTS; ALTERNARIA; POLLEN	Background: Basidiospores are an important cause of respiratory allergy in mold-sensitive atopic subjects. Collection of the large amounts of spores required for extract preparation is tedious and difficult. A destrable alternative could be mycelium grown in vitro if it is allergenically similar to spores. Methods: Therefore this study compared the allergen contents of Psilocybe cubensis spore and mycelium extracts by different techniques with the use of pooled sera from subjects who had skin test and RAST results that were positive to P. cubensis spores. Results: Isoelectric focusing immunoprints revealed six common IgE-binding bands at isoelectric points 4.7, 5.0, 5.5, 5.6, 8.7, and 9.3. Two additional bands at isoelectric points 3.9 and 5.7 were detected only in the spore extract. Sodium dodecylsulfate-polyacrylamide gel electrophoresis immunoblots exhibited six common IgE-binding bands at 16, 35, 487, 52, 62, and 76 kd; 20 and 40 kd bands were present only in the spore exact. Although RAST and isoelectric focusing inhibition demonstrated that P. cubensis spore and mycelium extracts share many allergens, spores were allergenically more potent than mycelium. Conclusion: The results indicate that mycelium is a useful source of P. cubensis allergen, even though several spore allergens were not detected in mycelium.	TULANE UNIV,SCH MED,DEPT MED,ALLERGY & CLIN IMMUNOL SECT,NEW ORLEANS,LA 70112	Tulane University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020331] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20331] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON JH, 1985, ANN ALLERGY, V54, P390; BAENACAGNANI CE, 1992, J ALLERGY CLIN IMMUN, V89, P285; BUTCHER BT, 1987, J ALLERGY CLIN IMMUN, V80, P803, DOI 10.1016/S0091-6749(87)80269-5; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1921; DEMEULEMESTER C, 1987, ELECTROPHORESIS, V8, P71, DOI 10.1002/elps.1150080113; DEZUBIRIA A, 1990, J ALLERGY CLIN IMMUN, V86, P26, DOI 10.1016/S0091-6749(05)80119-8; DIXIT AB, 1992, J ALLERGY CLIN IMMUN, V90, P11, DOI 10.1016/S0091-6749(06)80006-0; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; HELBLING A, IN PRESS INT ARCH AL; HOFFMAN DR, 1981, ANN ALLERGY, V46, P310; HOFFMAN DR, 1984, MOULD ALLERGY, P104; HORNER WE, 1988, J ALLERGY CLIN IMMUN, V82, P978, DOI 10.1016/0091-6749(88)90134-0; HORNER WE, 1989, INT ARCH ALLER A IMM, V90, P174; HORNER WE, IN PRESS ALLERGY; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SB, 1986, J ALLERGY CLIN IMMUN, V78, P478, DOI 10.1016/0091-6749(86)90036-9; Levetin E., 1990, Aerobiologia, V6, P177, DOI 10.1007/BF02539111; LOPEZ M, 1989, J ALLERGY CLIN IMMUN, V84, P242, DOI 10.1016/0091-6749(89)90331-X; LOPEZ M, 1976, J ALLERGY CLIN IMMUN, V57, P480, DOI 10.1016/0091-6749(76)90064-6; LOPEZ M, 1985, INT ARCH ALLER A IMM, V77, P169, DOI 10.1159/000233775; MISRA RP, 1987, PERSPECT MYCOL RES, V1, P243; ONEIL CE, 1988, INT ARCH ALLER A IMM, V85, P161, DOI 10.1159/000234496; PELTRE G, 1982, IMMUNOL LETT, V5, P127, DOI 10.1016/0165-2478(82)90096-7; SOLOMON WR, 1980, J ALLERGY CLIN IMMUN, V65, P229	24	5	5	1	9	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1993	91	5					1059	1066		10.1016/0091-6749(93)90220-A	http://dx.doi.org/10.1016/0091-6749(93)90220-A			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LC978	8491938	Bronze			2022-12-18	WOS:A1993LC97800014
J	AVJIOGLU, A; SINGH, M; KNOX, RB				AVJIOGLU, A; SINGH, M; KNOX, RB			SEQUENCE-ANALYSIS OF SOR-H-I, THE GROUP-I ALLERGEN OF JOHNSON GRASS-POLLEN AND ITS COMPARISON TO RYE-GRASS LOL-P-I	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				340	340						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100796
J	BRANDT, MA; GRUCHALLA, RS; SULLIVAN, TJ				BRANDT, MA; GRUCHALLA, RS; SULLIVAN, TJ			SKIN TESTING AND INVITRO TESTING TO DETECT IGE TO ANTIMICROBIAL DRUGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				263	263						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100490
J	CARDABA, B; HERNANDEZ, D; MARTIN, E; DEANDRES, B; DELPOZO, V; GALLARDO, S; FERNANDEZ, JC; RODRIGUEZ, R; VILLALBA, M; PALOMINO, P; BASOMBA, A; LAHOZ, C				CARDABA, B; HERNANDEZ, D; MARTIN, E; DEANDRES, B; DELPOZO, V; GALLARDO, S; FERNANDEZ, JC; RODRIGUEZ, R; VILLALBA, M; PALOMINO, P; BASOMBA, A; LAHOZ, C			ANTIBODY-RESPONSE TO OLIVE POLLEN ANTIGENS - ASSOCIATION BETWEEN HLA CLASS-II GENES AND IGE RESPONSE TO OLE-E-I	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									FDN JIMENEZ DIAZ,MADRID,SPAIN; UNIV COMPLUTENSE MADRID,DEPT BIOCHEM,MADRID 3,SPAIN; HOSP LA FE,VALENCIA,SPAIN	Complutense University of Madrid; Hospital Universitari i Politecnic La Fe			de Andres, Belen/D-4712-2016; RODRIGUEZ, ROSALIA/K-4993-2014; Martin-Orozco, Elena/C-2553-2008; Cárdaba, Blanca/S-3772-2019	RODRIGUEZ, ROSALIA/0000-0002-4280-3691; Martin-Orozco, Elena/0000-0002-6303-481X; 					0	5	7	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				338	338						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100789
J	KITA, H; HORIE, S; OKUBO, Y; WEILER, D; GLEICH, GJ				KITA, H; HORIE, S; OKUBO, Y; WEILER, D; GLEICH, GJ			PHARMACOLOGICAL MODULATION OF EOSINOPHIL DEGRANULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				332	332						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100765
J	LANE, SJ; SOUSA, AR; POSTON, RN; LEE, TH				LANE, SJ; SOUSA, AR; POSTON, RN; LEE, TH			INVIVO CUTANEOUS TUBERCULIN RESPONSE TO PREDNISOLONE IN CORTICOSTEROID-RESISTANT BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract														Lee, Tak/0000-0002-7554-4059					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				222	222						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100327
J	RAK, S; JACOBSON, MR; SUDDERICK, RM; MASUYAMA, K; KAY, AB; LOWHAGEN, O; DURHAM, SR				RAK, S; JACOBSON, MR; SUDDERICK, RM; MASUYAMA, K; KAY, AB; LOWHAGEN, O; DURHAM, SR			EFFECT OF TOPICAL FLUTICASONE PROPIONATE ON ALLERGEN-INDUCED EARLY AND LATE NASAL RESPONSES AND ASSOCIATED TISSUE EOSINOPHILIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				299	299						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100635
J	ROGERS, BL; POLLOCK, J; KLAPPER, DG; GRIFFITH, IJ				ROGERS, BL; POLLOCK, J; KLAPPER, DG; GRIFFITH, IJ			CLONING, COMPLETE SEQUENCE, AND RECOMBINANT EXPRESSION OF A NOVEL ALLERGEN FROM SHORT RAGWEED POLLEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				339	339						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100793
J	SCHULER, M; COSTABEL, U; VIRCHOW, JC; KORTSIK, C; HASSE, J; MATTHYS, H; KROEGEL, C				SCHULER, M; COSTABEL, U; VIRCHOW, JC; KORTSIK, C; HASSE, J; MATTHYS, H; KROEGEL, C			SERUM EOSINOPHIL CATIONING PROTEIN (ECP) LEVELS IN DISEASE - A PROSPECTIVE-STUDY ON 549 PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				179	179						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100156
J	IGARASHI, Y; LUNDGREN, JD; DOERFLER, ME; SHELHAMER, JH; KALINER, MA; WHITE, MV				IGARASHI, Y; LUNDGREN, JD; DOERFLER, ME; SHELHAMER, JH; KALINER, MA; WHITE, MV			HUMAN NEUTROPHIL-DERIVED HISTAMINE-RELEASING ACTIVITY (HRA-N) CAUSES THE RELEASE OF SEROTONIN BUT NOT ARACHIDONIC-ACID METABOLITES FROM RAT BASOPHILIC LEUKEMIA-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NEUTROPHIL; HISTAMINE-RELEASING FACTOR; BASOPHIL; RAT BASOPHILIC LEUKEMIA CELL; SEROTONIN; ARACHIDONIC ACID; PROSTAGLANDIN; LEUKOTRIENE	LUNG MAST-CELLS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; SLOW REACTING SUBSTANCE; HUMAN MONONUCLEAR-CELLS; MOUSE BONE-MARROW; LATE-PHASE; DIFFERENTIAL RELEASE; ANTIGEN CHALLENGE; LEUKOTRIENE C-4; HUMAN AIRWAYS	The effects of neutrophil-derived histamine-releasing activity (HRA-N) on arachidonic acid (AA) metabolism is unknown. Human basophils exposed to HRA-N released 25% of total histamine but no leukotriene C4 (LTC4). To confirm this phenomenon, rat basophilic leukemia (RBL) cells were exposed to HRA-N as well as anti-IgE, or calcium ionophore A23187. RBL cells incubated with A23187 released 44% of available serotonin and 59 and 124 pmol/10(6) cells of prostaglandin D2 (PGD2) and LTC4, respectively. Anti-IgE stimulation resulted in 34% serotonin release and the generation of 34 pmol PGD, per 10(6) cells and 72 pmol LTC4 per 10(6) cells. In contrast, HRA-N (2 U/ml) induced 20% serotonin release, 4 pmol PGD, per 10(6) cells, and 0.6 pmol LTC4 per 10(6) cells. Neither increasing the dose nor the incubation time of HRA-N enhanced the generation of AA metabolite. Additionally, the spectrum of AA metabolites generated by RBL cells in response to those agents was examined by reverse-phase high-performance liquid chromatography. RBL cells stimulated with A23187 released PGD2, LTB4, and its isomers, LTC4, and 5-hydroxyeicosatetraenoic acid. In contrast, HRA-N stimulation resulted in only minimal PGD2 generation and no other discernable AA metabolites. Thus, HRA-N causes selective release of serotonin without inducing AA metabolites. These data suggest that HRA-N activates mast cells through a unique pathway.	NIAID, CLIN INVEST LAB,ALLERG DIS SECT,BLDG 10, ROOM 11C207,9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Lundgren, Jens/AAE-6876-2019	Lundgren, Jens/0000-0001-8901-7850				ALLANSMITH MR, 1984, J ALLERGY CLIN IMMUN, V73, P49, DOI 10.1016/0091-6749(84)90483-4; ARZUBIAGA C, 1991, J ALLERGY CLIN IMMUN, V87, P88, DOI 10.1016/0091-6749(91)90216-B; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BERNSTROM K, 1981, J BIOL CHEM, V256, P9579; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; COHAN VL, 1991, BIOCHEM PHARMACOL, V41, P293, DOI 10.1016/0006-2952(91)90489-R; CRETICOS PS, 1984, NEW ENGL J MED, V310, P1626, DOI 10.1056/NEJM198406213102502; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; FITZPATRICK FA, 1982, J BIOL CHEM, V257, P4680; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; FREELAND HS, 1988, AM REV RESPIR DIS, V138, P389, DOI 10.1164/ajrccm/138.2.389; GOETZL EJ, 1984, IMMUNOLOGY, V53, P227; Granstrom E, 1978, Adv Prostaglandin Thromboxane Res, V5, P119; HEAVEY DJ, 1988, J IMMUNOL, V140, P1953; HOLGATE ST, 1984, J IMMUNOL, V133, P2138; JAKSCHIK BA, 1978, PROSTAGLANDINS, V16, P733, DOI 10.1016/0090-6980(78)90007-2; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; LEE CW, 1982, P NATL ACAD SCI-BIOL, V79, P4166, DOI 10.1073/pnas.79.13.4166; LEMANSKE R, 1982, CRC CRIT REV IMMUNOL, V1, P547; LEVISCHAFFER F, 1989, INT ARCH ALLER A IMM, V90, P352, DOI 10.1159/000235052; LEWIS RA, 1982, J IMMUNOL, V129, P1627; LEWIS RA, 1980, BIOCHEM BIOPH RES CO, V96, P271, DOI 10.1016/0006-291X(80)91210-3; LIU MC, 1986, J IMMUNOL, V136, P2588; MACGLASHAN DW, 1982, J CLIN INVEST, V70, P747, DOI 10.1172/JCI110670; MACGLASHAN DW, 1983, FED PROC, V42, P2504; MAROM Z, 1983, J CLIN INVEST, V72, P122, DOI 10.1172/JCI110949; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; MCBRIDE P, 1988, J ALLERGY CLIN IMMUN, V82, P638, DOI 10.1016/0091-6749(88)90977-3; MENCIAHUERTA JM, 1983, J IMMUNOL, V130, P1885; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; ORCHARD MA, 1986, J IMMUNOL, V136, P2240; ORNING L, 1980, P NATL ACAD SCI-BIOL, V77, P2014, DOI 10.1073/pnas.77.4.2014; ORTEGA E, 1989, EUR J IMMUNOL, V19, P2251, DOI 10.1002/eji.1830191211; PETERS SP, 1984, J IMMUNOL, V132, P1972; POWELL WS, 1985, ANAL BIOCHEM, V148, P59, DOI 10.1016/0003-2697(85)90628-1; RADMARK O, 1980, J BIOL CHEM, V255, P1828; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SCHLEIMER RP, 1986, FASEB J, V45, P1105; SEDGWICK JD, 1981, CLIN EXP IMMUNOL, V45, P409; SELDIN DC, 1985, P NATL ACAD SCI USA, V82, P3871, DOI 10.1073/pnas.82.11.3871; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; TANNENBAUM S, 1980, J IMMUNOL, V125, P325; THUESON DO, 1979, J IMMUNOL, V123, P626; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118; VERHAGEN J, 1986, J CHROMATOGR, V378, P208, DOI 10.1016/S0378-4347(00)80714-8; WARNER JA, 1989, J LEUKOCYTE BIOL, V45, P558, DOI 10.1002/jlb.45.6.558; WHITE MV, 1987, J IMMUNOL, V139, P1624; WHITE MV, 1988, J IMMUNOL, V141, P3575; WHITE MV, 1989, J ALLERGY CLIN IMMUN, V84, P773, DOI 10.1016/0091-6749(89)90308-4; ZHEUTLIN LM, 1984, J IMMUNOL, V133, P2180	54	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1992	89	6					1085	1097		10.1016/0091-6749(92)90292-A	http://dx.doi.org/10.1016/0091-6749(92)90292-A			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HZ748	1376734				2022-12-18	WOS:A1992HZ74800003
J	THIEN, FCK; ATKINSON, BA; KHAN, A; MENCIAHUERTA, JM; LEE, TH				THIEN, FCK; ATKINSON, BA; KHAN, A; MENCIAHUERTA, JM; LEE, TH			EFFECT OF DIETARY FISH OIL SUPPLEMENTATION ON THE ANTIGEN-INDUCED LATE-PHASE RESPONSE IN THE SKIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ALLERGENS; LATE-PHASE RESPONSE; EICOSAPENTAENOIC ACID; FISH OILS; EOSINOPHILS		We have studied the effect of dietary fish oil supplementation (3.2 gm/day of eicosapentaenoic acid and 2.2 gm/day of docosahexaenoic acid) for 10 weeks on the antigen-induced, cutaneous late-phase response (LPR) in 16 atopic individuals. All subjects developed an LPR to intradermal allergen injection. The mean +/- SEM area of induration at 6 hours was 1840 +/- 472 mm2. A biopsy was performed at the LPR site at 6 hours. Subjects were then randomized to receive fish oil or placebo olive oil in a double-blind, parallel fashion, for 10 weeks. After the diet, there were no significant differences between fish oil and placebo treatment in the size of the immediate wheal-and-flare response or the extent of induration at 4 and 6 hours, as compared with prediet values in each group. Histologically, at 6 hours, there was a significant infiltrate into the allergen site compared with that of the control diluent site of total inflammatory cells (p < 0.002) as well as of eosinophils (p < 0.001). However, there were no significant differences when pre- and postdiet values were compared. Hence, we conclude that dietary fish oil supplementation does not inhibit the cutaneous LPR clinically or histologically.	GUYS HOSP, DEPT ALLERGY & ALLIED RESP DISORDERS, 4TH FLOOR, HUNTS HOUSE, LONDON SE1 9RT, ENGLAND; GUYS HOSP, DEPT HISTOPATHOL, LONDON SE1 9RT, ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust			Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059				ARM JP, 1989, AM REV RESPIR DIS, V139, P1395, DOI 10.1164/ajrccm/139.6.1395; ATKINS PC, 1988, ANN ALLERGY, V60, P27; BERHRENS BL, 1991, LAB INVEST, V56, P101; Blackley CH., 1873, EXPT RES CAUSES NATU; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; BOULET LP, 1984, CLIN ALLERGY, V14, P379, DOI 10.1111/j.1365-2222.1984.tb02219.x; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; CHARLESWORTH EN, 1991, J IMMUNOL, V146, P671; Church M. RC. B. PH. R. MA. L., 1989, MAST CELL BASOPHIL D, P161; DIAZ P, 1989, AM REV RESPIR DIS, V139, P1383, DOI 10.1164/ajrccm/139.6.1383; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; DVORACEK JE, 1984, J ALLERGY CLIN IMMUN, V73, P363, DOI 10.1016/0091-6749(84)90409-3; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; FREW AJ, 1988, J IMMUNOL, V141, P4158; FREW AJ, 1988, J ALLERGY CLIN IMMUN, V81, P1117, DOI 10.1016/0091-6749(88)90878-0; LAI CKW, 1989, AM REV RESPIR DIS, V140, P917, DOI 10.1164/ajrccm/140.4.917; LEE TH, 1984, J CLIN INVEST, V74, P1922, DOI 10.1172/JCI111612; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; MEYDANI SM, 1991, ADV PROSTAGLANDIN TH, P245; MICHEL L, 1988, J ALLERGY CLIN IMMUN, V82, P101, DOI 10.1016/0091-6749(88)90058-9; PARM J, 1988, THORAX, V43, P84, DOI 10.1136/thx.43.2.84; PAUWELS R, 1985, J ALLERGY CLIN IMMUN, V76, P583, DOI 10.1016/0091-6749(85)90779-1; PAYAN DG, 1986, J CLIN IMMUNOL, V6, P402, DOI 10.1007/BF00915380; PRESCOTT SM, 1984, J BIOL CHEM, V259, P7615; PRICKETT JD, 1981, J CLIN INVEST, V68, P556, DOI 10.1172/JCI110288; RANGI SP, 1990, J ALLERGY CLIN IMMUN, V85, P484, DOI 10.1016/0091-6749(90)90159-2; REDIER H, 1991, ALLERGY CLIN IMMUN S, V1, P119; ROBERTSON DG, 1974, J ALLERGY CLIN IMMUN, V54, P244, DOI 10.1016/0091-6749(74)90067-0; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; SPERLING RI, 1987, J IMMUNOL, V139, P4186; TRIGGIANI M, 1990, J IMMUNOL, V145, P2241; VARNEY V, 1991, Journal of Allergy and Clinical Immunology, V87, P331, DOI 10.1016/0091-6749(91)92050-B; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WASSERFALLEN JB, 1991, ALLERGY CLIN IMMUN S, V1, P185; WENZEL SE, 1990, AM REV RESPIR DIS, V142, P112, DOI 10.1164/ajrccm/142.1.112; WENZEL SE, 1991, J ALLERGY CLIN IMMUN, V87, P540, DOI 10.1016/0091-6749(91)90013-E; ZUNICH KM, 1989, J ALLERGY CLIN IMMUN, V83, P428, DOI 10.1016/0091-6749(89)90129-2	40	5	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1992	89	4					829	835		10.1016/0091-6749(92)90438-8	http://dx.doi.org/10.1016/0091-6749(92)90438-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN860	1560166	Bronze			2022-12-18	WOS:A1992HN86000008
J	BOYER, G; AARONSON, D; MELTZER, E; LAFORCE, C; GROSSMAN, J; YANCEY, S				BOYER, G; AARONSON, D; MELTZER, E; LAFORCE, C; GROSSMAN, J; YANCEY, S			ENHANCEMENT OF A GENERAL QUALITY-OF-LIFE SCALE - VALIDATION OF A SLEEP SCALE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				186	186						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000117
J	BOYLE, KT; ANDERSON, MC; KENIMER, JG				BOYLE, KT; ANDERSON, MC; KENIMER, JG			SPECIFIC IGE TO LATEX EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				224	224						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000269
J	COHAN, VL; JOHNSON, KL; BRESLOW, R; CHENG, JB; SHOWELL, HJ				COHAN, VL; JOHNSON, KL; BRESLOW, R; CHENG, JB; SHOWELL, HJ			PDE-IV IS THE PREDOMINANT PDE ISOZYME REGULATING CHEMOTACTIC FACTOR-MEDIATED GUINEA-PIG EOSINOPHIL FUNCTIONS INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									PFIZER INC,GROTON,CT 06340	Pfizer									0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				310	310						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000614
J	DURHAM, SR; HAMID, Q; YING, S; VARNEY, V; JACOBSON, M; SUDDERICK, R; MACKAY, IS; KAY, AB				DURHAM, SR; HAMID, Q; YING, S; VARNEY, V; JACOBSON, M; SUDDERICK, R; MACKAY, IS; KAY, AB			CYTOKINE MESSENGER-RNA EXPRESSION FOR INTERLEUKIN-3 (IL-3), IL-4, IL-5 AND GM-CSF IN THE NASAL-MUCOSA AFTER ALLERGEN PROVOCATION - RELATIONSHIP TO TISSUE EOSINOPHILIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				239	239						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000332
J	FISH, L; WILSON, S; STARRSCHNEIDKRAUT, N; LOES, L; PAGE, A				FISH, L; WILSON, S; STARRSCHNEIDKRAUT, N; LOES, L; PAGE, A			AN ASTHMA EDUCATION-PROGRAM FOR PARENTS OF CHILDREN UNDER 7, USING VIDEO TECHNOLOGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				188	188						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000126
J	KELLY, KJ; KURUP, VP; RESNICK, A; FINK, JN; ROBERTS, M; GRAMMER, L; HAVENS, P				KELLY, KJ; KURUP, VP; RESNICK, A; FINK, JN; ROBERTS, M; GRAMMER, L; HAVENS, P			A CASE CONTROL STUDY OF HYPERSENSITIVITY TO LATEX (L), ETHYLENE-OXIDE (ETO) AND ALLERGIC FACTORS PREDICTING ANAPHYLAXIS IN PEDIATRIC-PATIENTS UNDERGOING GENERAL-ANESTHESIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				226	226						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000277
J	KWITTKEN, PL; PAWLOWSKI, NA; DOUGLAS, SD; CAMPBELL, DE				KWITTKEN, PL; PAWLOWSKI, NA; DOUGLAS, SD; CAMPBELL, DE			MEASUREMENT OF HUMAN IGE TO NATURAL LATEX PROTEINS - COMPARISON OF FLOW-CYTOMETRY AND ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				225	225						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000276
J	LIMMOMBAY, M; BAROODY, FM; TAYLOR, R; NACLERIO, RM				LIMMOMBAY, M; BAROODY, FM; TAYLOR, R; NACLERIO, RM			MUCOSAL CELLULAR-CHANGES AFTER NASAL ANTIGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				205	205						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000193
J	SIM, TC; ALAM, R; HILSMEIER, KA; GRANT, JA				SIM, TC; ALAM, R; HILSMEIER, KA; GRANT, JA			DETECTION OF INFLAMMATORY CYTOKINES IN NASAL SECRETIONS (NS) OF ALLERGIC SUBJECTS FOLLOWING ANTIGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				216	216						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000239
J	SLATER, JE; TRYBUL, DE				SLATER, JE; TRYBUL, DE			AFFINITY PURIFICATION OF LATEX (L) ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				226	226						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000279
J	SMITH, AM; HOFFMAN, DR				SMITH, AM; HOFFMAN, DR			FURTHER CHARACTERIZATION OF IMPORTED FIRE ANT VENOM ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				293	293						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000544
J	VERVLOET, D; DESFOUGERES, JL; CHARPIN, D				VERVLOET, D; DESFOUGERES, JL; CHARPIN, D			FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY VERSUS CETIRIZINE IN SEASONAL RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HOP ST MARGUERITE,SERV PNEUMOLALLERGOL,F-13009 MARSEILLE,FRANCE; GLAXO LABS,PARIS,FRANCE	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; GlaxoSmithKline									0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				304	304						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000591
J	VOUILLOT, C; DEBLAY, F; THIERRY, R; SIMON, B; MAHR, L; PAULI, G				VOUILLOT, C; DEBLAY, F; THIERRY, R; SIMON, B; MAHR, L; PAULI, G			CHICKEN ALBUMIN RESPONSIBLE FOR CROSS-SENSITIZATION BETWEEN EGGS AND CHICKEN LIVER AND FLESH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				194	194						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000149
J	WAGENMANN, M; BAROODY, FM; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NACLERIO, RM				WAGENMANN, M; BAROODY, FM; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NACLERIO, RM			EFFECTS OF H1-ANTAGONISM (H1-ANT) ON NASAL REFLEXES AFTER UNILATERAL NASAL ALLERGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Wagenman, Martin/B-2524-2012	Wagenman, Martin/0000-0002-9734-0241					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				205	205						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000196
J	WEYER, A; CZARLEWSKI, W; CARMILEROY, A; DAVID, B				WEYER, A; CZARLEWSKI, W; CARMILEROY, A; DAVID, B			INVITRO INHIBITION BY LORATADINE AND ITS ACTIVE METABOLITE OF ANTI-IGE INDUCED HISTAMINE-RELEASE FROM HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				222	222						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000264
J	ZACHARISEN, MC; KURUP, VP; RESNICK, A; CASTILLO, LJ; MURALI, PS; ROERIG, DL; KELLY, KJ; FINK, JN				ZACHARISEN, MC; KURUP, VP; RESNICK, A; CASTILLO, LJ; MURALI, PS; ROERIG, DL; KELLY, KJ; FINK, JN			CHARACTERIZATION OF LATEX ANTIGENS REACTING WITH IGE ANTIBODIES IN THE SERA OF PATIENTS WITH ALLERGY TO LATEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				225	225						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000275
J	CROMAR, BW; COLVIN, M; CASALE, TB				CROMAR, BW; COLVIN, M; CASALE, TB			VALIDITY OF SKIN-TESTS TO CYCLOPHOSPHAMIDE AND METABOLITES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							HYPERSENSITIVITY REACTION; CROSS-SENSITIVITY; URTICARIA; ANAPHYLAXIS		UNIV IOWA,COLL MED,IOWA CITY,IA 52242; JOHNS HOPKINS UNIV,BALTIMORE,MD 21218	University of Iowa; Johns Hopkins University			Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377				ANKU V, 1982, CANCER TREAT REP, V66, P2106; JONES JB, 1989, DICP ANN PHARMAC, V23, P88, DOI 10.1177/106002808902300125; KARCHMER RK, 1977, JAMA-J AM MED ASSOC, V237, P475, DOI 10.1001/jama.237.5.475; KIM HC, 1985, J ALLERGY CLIN IMMUN, V76, P591, DOI 10.1016/0091-6749(85)90780-8; KRUTCHIK AN, 1978, ARCH INTERN MED, V138, P1725, DOI 10.1001/archinte.138.11.1725; LAKIN JD, 1976, J ALLERGY CLIN IMMUN, V58, P160, DOI 10.1016/0091-6749(76)90151-2; LEGHA SS, 1978, CANCER TREAT REP, V62, P180; MURTI L, 1979, J PEDIATR-US, V94, P844, DOI 10.1016/S0022-3476(79)80178-X; SCHMIDT JD, 1979, J UROLOGY, V121, P185, DOI 10.1016/S0022-5347(17)56714-2; STARK BJ, 1986, J ALLERGY CLIN IMMUN, V78, P76, DOI 10.1016/0091-6749(86)90117-X	10	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1991	88	6					965	967		10.1016/0091-6749(91)90256-N	http://dx.doi.org/10.1016/0091-6749(91)90256-N			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GW262	1744368				2022-12-18	WOS:A1991GW26200020
J	GANCEDO, SQ; FREIRE, P; RIVAS, MF; DAVILA, I; LOSADA, E				GANCEDO, SQ; FREIRE, P; RIVAS, MF; DAVILA, I; LOSADA, E			URTICARIA FROM CAFFEINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							AMINOPHYLLINE		HOSP RAMON & CAJAL,DEPT DERMATOL,MADRID,SPAIN	Hospital Universitario Ramon y Cajal	GANCEDO, SQ (corresponding author), HOSP RAMON & CAJAL,DEPT ALLERGY,SERV ALERGIA,CTRA COLMENAR KM 9 1,E-28034 MADRID,SPAIN.		Dávila, Ignacio/K-4453-2012	Dávila, Ignacio/0000-0001-8485-5513				BOOTH BH, 1979, ANN ALLERGY, V43, P289; CURATOLO PW, 1983, ANN INTERN MED, V98, P641, DOI 10.7326/0003-4819-98-5-641; LICHTENS.LM, 1968, SCIENCE, V161, P902, DOI 10.1126/science.161.3844.902; POLA J, 1988, ANN ALLERGY, V60, P207; WONG D, 1971, J ALLERGY CLIN IMMUN, V48, P165, DOI 10.1016/0091-6749(71)90012-1	5	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1991	88	4					680	681		10.1016/0091-6749(91)90163-I	http://dx.doi.org/10.1016/0091-6749(91)90163-I			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GL049	1918734				2022-12-18	WOS:A1991GL04900018
J	SWART, SJ; VANDERBAAN, S; STEENBERGEN, JJE; NAUTA, JJP; VANKAMP, GJ; BIEWENGA, J				SWART, SJ; VANDERBAAN, S; STEENBERGEN, JJE; NAUTA, JJP; VANKAMP, GJ; BIEWENGA, J			IMMUNOGLOBULIN CONCENTRATIONS IN NASAL SECRETIONS DIFFER BETWEEN PATIENTS WITH AN IGE-MEDIATED RHINOPATHY AND A NON-IGE-MEDIATED RHINOPATHY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IGE-MEDIATED RHINOPATHY; NON-IGE-MEDIATED RHINOPATHY; NASAL SECRETION; IMMUNOGLOBULINS	DISEASE	Nasal secretions from patients with an IgE-mediated rhinopathy, patients with a non-IgE-mediated rhinopathy, and healthy control subjects were collected with a newly developed direct aspiration system. Total protein, albumin, secretory IgA (sIgA), IgE, IgG, and IgM concentrations were measured in the nasal secretions to detect whether the nasal pathology is reflected in nasal secretion protein concentrations. It was found that protein and immunoglobulin concentrations in nasal secretions were inversely related to amount of secretion in the nasal cavity. Both patients' groups had a significantly higher sIgA to protein ratio than the healthy control subjects. Furthermore, patients with an IgE-mediated rhinopathy had significantly higher sIgA and IgM to total protein ratios in their nasal secretions than patients with a non-IgE-mediated rhinopathy. Probably these differences are due to changes in immunoregulation.	FREE UNIV AMSTERDAM,FAC MED,DEPT CELL BIOL,DIV HISTOL,VANDERBOECHORSTSTR 7,1081 BT AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM,ACAD HOSP,DEPT OTORHINOLARYNGOL HEAD & NECK SURG,1007 MC AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM,ACAD HOSP,DEPT CLIN CHEM,1007 MC AMSTERDAM,NETHERLANDS	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam								BACHERT C, 1989, ARCH OTO-RHINO-LARYN, V246, P173, DOI 10.1007/BF00453657; BIEWENGA J, 1991, ANN CLIN BIOCHEM, V28, P260, DOI 10.1177/000456329102800311; BRANDTZAEG P, 1987, INT ARCH ALLER A IMM, V82, P483, DOI 10.1159/000234260; Brandtzaeg P., 1984, IMMUNOLOGY LUNG UPPE, P28; EICHNER H, 1983, Rhinology (Utrecht), V21, P223; HOBDAY JD, 1971, CLIN EXP IMMUNOL, V9, P577; HOLT JJ, 1986, OTOLARYNGOL HEAD NEC, V3, P403; ILLUM P, 1978, ACTA OTO-LARYNGOL, V86, P135; KORSRUD F R, 1983, Rhinology (Utrecht), V21, P203; MIADONNA A, 1983, CLIN ALLERGY, V13, P155, DOI 10.1111/j.1365-2222.1983.tb02583.x; MYGIND N, 1976, ACTA OTO-LARYNGOL, V82, P219, DOI 10.3109/00016487609120888; MYGIND N, 1976, ACTA OTO-LARYNGOL, V82, P216, DOI 10.3109/00016487609120887; PULIDO V, 1983, Rhinology (Utrecht), V21, P29; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RICHARDSON P S, 1987, European Journal of Respiratory Diseases Supplement, V71, P43; ROSSEN RD, 1966, J CLIN INVEST, V5, P768; RUSSELL MW, 1988, REV INFECT DIS S2, V10, P440; SNEDECOR GW, 1980, STATISTICAL METHODS, pCH12; VANKAMP GJ, 1989, ANN CLIN BIOCHEM, V26, P427, DOI 10.1177/000456328902600509; VANKAMP GJ, 1989, CLIN CHIM ACTA, V183, P295, DOI 10.1016/0009-8981(89)90363-X	20	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1991	88	4					612	619		10.1016/0091-6749(91)90155-H	http://dx.doi.org/10.1016/0091-6749(91)90155-H			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GL049	1918727				2022-12-18	WOS:A1991GL04900010
J	SEGGEV, JS				SEGGEV, JS			SPONTANEOUS REMISSION OF COMMON VARIABLE IMMUNODEFICIENCY OF 20 YEARS DURATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN; CIMETIDINE		UNIV MISSOURI,HLTH SCI CTR,DEPT MED,COLUMBIA,MO 65201	University of Missouri System; University of Missouri Columbia								HERMANS PE, 1976, AM J MED, V61, P221, DOI 10.1016/0002-9343(76)90173-X; ROSEN FS, 1984, NEW ENGL J MED, V311, P235, DOI 10.1056/NEJM198407263110406; SEGAL R, 1989, J ALLERGY CLIN IMMUN, V84, P753, DOI 10.1016/0091-6749(89)90305-9; WHITE WB, 1985, NEW ENGL J MED, V312, P198, DOI 10.1056/NEJM198501243120402; WRIGHT JJ, 1987, NEW ENGL J MED, V317, P1516, DOI 10.1056/NEJM198712103172406; ZIELINSKI CC, 1983, ARCH INTERN MED, V143, P1937, DOI 10.1001/archinte.143.10.1937	6	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1991	88	3	1				418	420		10.1016/0091-6749(91)90108-Z	http://dx.doi.org/10.1016/0091-6749(91)90108-Z			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GG126	1890273				2022-12-18	WOS:A1991GG12600040
J	ANDERSON, JA				ANDERSON, JA			THE MOST IMPORTANT ISSUE FACING THE SPECIALTY OF ALLERGY AND IMMUNOLOGY TODAY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											ANDERSON, JA (corresponding author), HENRY FORD HOSP, DEPT INTERNAL MED, DIV ALLERGY & IMMUNOL, 2799 W GRAND BLVD, DETROIT, MI 48202 USA.							ANDERSON J, 1990, NATIONAL ALLERGY IMM; ANDERSON JA, 1987, J ALLERGY CLIN IMMUN, V80, P202, DOI 10.1016/0091-6749(87)90130-8; FRICK OL, 1978, J ALLERGY CLIN IMMUN, V62, P1, DOI 10.1016/0091-6749(78)90063-5; MULLALLY DI, 1983, J ALLERGY CLIN IMMUN, V72, P252, DOI 10.1016/0091-6749(83)90028-3; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V62, P314, DOI 10.1016/0091-6749(78)90164-1; TOSTESON DC, 1990, SUPPLYING PHYSICIANS, P3; 1989, 1989 DERM F ANN REP; 1990, PREPARATION NEEDS BA, P1; 1980, SUMMARY REPORT GRADU, P10	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1991	88	1					17	26		10.1016/0091-6749(91)90296-Z	http://dx.doi.org/10.1016/0091-6749(91)90296-Z			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY204	2071782	Bronze			2022-12-18	WOS:A1991FY20400002
J	AMBRUS, JL; HANEIWICH, S; CHESKY, L; MCFARLAND, P; PETERS, MG; ENGLER, RJ				AMBRUS, JL; HANEIWICH, S; CHESKY, L; MCFARLAND, P; PETERS, MG; ENGLER, RJ			ABNORMAL RESPONSE TO A HUMAN B-CELL GROWTH-FACTOR IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY (CVI)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							NECROSIS FACTOR-ALPHA; T-T HYBRIDOMA; LYMPHOCYTES-B; INOSITOL 1,4,5-TRISPHOSPHATE; HUMORAL IMMUNODEFICIENCY; VARIED IMMUNODEFICIENCY; INTERLEUKIN-2 RECEPTORS; FACTOR BCGF; DIFFERENTIATION; HYPOGAMMAGLOBULINEMIA	Patients with common variable immunodeficiency (CVI) generally fail to produce antigen-specific IgG. We have identified a lymphokine called high molecular weight B cell growth factor (HMW BCGF) that expands an IgG-producing subpopulation of B cells. The B cells from 15 of 16 patients with CVI evaluated in this study failed to proliferate to HMW BCGF, although they proliferated normally to another BCGF, low molecular weight BCGF (LMW BCGF). Nevertheless, 11 patients had more than normal numbers of B cells expressing HMW BCGF receptors. The HMW BCGF receptors on the B cells of three patients with CVI studied were the same molecular weight as the normal HMW BCGF receptor. Examination of B cells from four patients with CVI for intracellular signals produced in normal B cells after stimulation with HMW BCGF revealed that B cells from patients with CVI failed to developed significant increases in cyclic adenosine monophosphate or phosphoinositides after HMW BCGF stimulation. However, cytoplasmic phosphoinositides in the B cells from all four patients with CVI were already increased above what is observed in normal B cells before stimulation with HMW BCGF (either freshly isolated or Staphylococcus aureus Cowan I-activated B cell). Thus, the failure of B cells from patients with CVI to respond to HMW BCGF may be related to their abnormal activation in vivo. Since HMW BCGF expands a subpopulation of memory B cells, the inability of CVI B cells to respond to HMW BCGF may contribute to their abnormal secondary responses to antigens.	NIAID, BETHESDA, MD 20892 USA; MED UNIV S CAROLINA, CHARLESTON, SC 29425 USA; WASHINGTON UNIV, SCH MED, DEPT INTERNAL MED, DIV GASTROENTEROL, ST LOUIS, MO 63110 USA; WALTER REED ARMY MED CTR, DIV ALLERGY & IMMUNIZAT, WASHINGTON, DC 20307 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Medical University of South Carolina; Washington University (WUSTL); United States Department of Defense; United States Army; Walter Reed National Military Medical Center	AMBRUS, JL (corresponding author), WASHINGTON UNIV, JEWISH HOSP ST LOUIS,SCH MED,DEPT MED, DIV RHEUMATOL,660 S EUCLID, CAMPUS BOX 8045, ST LOUIS, MO 63110 USA.							ALMERIGOGNA F, 1989, IMMUNOLOGY, V67, P244; AMBRUS JL, 1988, J IMMUNOL, V141, P861; AMBRUS JL, 1988, J IMMUNOL, V140, P2382; AMBRUS JL, 1985, J CLIN INVEST, V75, P732, DOI 10.1172/JCI111754; AMBRUS JL, 1990, J IMMUNOL, V145, P3949; AMBRUS JL, 1985, J EXP MED, V162, P1319, DOI 10.1084/jem.162.4.1319; AMBRUS JL, IN PRESS CELLULAR IM; AMBRUS JL, 1974, MOL BASIS LYMPHOKINE, P137; AMBRUS JL, 1988, LYMPHOCYTE ACTIVATIO, P73; AMBRUS JL, 1987, MECHANISMS LYMPHOCYT, P163; AMBRUS JL, IN PRESS J BIOL CHEM; BUCKLEY RH, 1986, CLIN IMMUNOL IMMUNOP, V40, P13, DOI 10.1016/0090-1229(86)90065-6; BUTLER JL, 1984, J IMMUNOL, V133, P251; CARTER A, 1987, P NATL ACAD SCI USA, V84, P7266, DOI 10.1073/pnas.84.20.7266; CHESKY L, 1989, FASEB J, V3, P1091; CUNNINGHAMRUNDLES C, 1989, J CLIN IMMUNOL, V9, P22, DOI 10.1007/BF00917124; DEFRANCE T, 1987, J IMMUNOL, V139, P1135; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DELFRAISSY JF, 1986, EUR J IMMUNOL, V16, P1251, DOI 10.1002/eji.1830161011; DURANDY A, 1990, J IMMUNOL, V144, P60; ESKOLA J, 1989, J CLIN LAB IMMUNOL, V28, P55; FALKOFF RM, 1982, J IMMUNOL METHODS, V50, P39, DOI 10.1016/0022-1759(82)90302-7; FARFEL Z, 1981, P NATL ACAD SCI-BIOL, V78, P3098, DOI 10.1073/pnas.78.5.3098; FARRANT J, 1989, CLIN IMMUNOL IMMUNOP, V51, P196, DOI 10.1016/0090-1229(89)90019-6; GENOT E, 1989, CELL IMMUNOL, V122, P424, DOI 10.1016/0008-8749(89)90089-0; IRVINE RF, 1985, BIOCHEM J, V229, P505, DOI 10.1042/bj2290505; IUDICONE P, 1989, HAEMATOLOGICA, V74, P359; JELINEK DF, 1987, J IMMUNOL, V139, P2970; JELINEK DF, 1987, ADV IMMUNOL, V40, P1, DOI 10.1016/S0065-2776(08)60237-0; KEHRL JH, 1987, J EXP MED, V166, P786, DOI 10.1084/jem.166.3.786; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; LEVINE MA, 1983, J CLIN INVEST, V72, P316, DOI 10.1172/JCI110971; MAYER L, 1984, J CLIN INVEST, V74, P2115, DOI 10.1172/JCI111636; MEHTA SR, 1985, J IMMUNOL, V135, P3298; MURAGUCHI A, 1985, J EXP MED, V161, P181, DOI 10.1084/jem.161.1.181; NAKAGAWA T, 1988, J IMMUNOL, V140, P465; PERRI RT, 1985, BLOOD, V66, P345; PETERS MG, 1988, J EXP MED, V168, P1225, DOI 10.1084/jem.168.4.1225; RANSOM JT, 1986, J IMMUNOL, V137, P708; SAIKI O, 1984, J IMMUNOL, V133, P1920; SAIKI O, 1982, P NATL ACAD SCI-BIOL, V79, P6008, DOI 10.1073/pnas.79.19.6008; SAXON A, 1989, J ALLERGY CLIN IMMUN, V84, P44, DOI 10.1016/0091-6749(89)90177-2; SEGAL R, 1989, J ALLERGY CLIN IMMUN, V84, P753, DOI 10.1016/0091-6749(89)90305-9; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SPICKETT GP, 1989, IMMUNOL TODAY, V10, P192, DOI 10.1016/0167-5699(89)90323-X; STOHL W, 1988, CLIN IMMUNOL IMMUNOP, V49, P273, DOI 10.1016/0090-1229(88)90117-1; THOMPSON LF, 1986, J IMMUNOL, V137, P2496; UCKUN FM, 1987, BLOOD, V70, P1020; UCKUN FM, 1989, J CLIN INVEST, V84, P1595, DOI 10.1172/JCI114337; VAZQUEZ A, 1986, EUR J IMMUNOL, V16, P1503, DOI 10.1002/eji.1830161206; VOLKMAN DJ, 1981, P NATL ACAD SCI-BIOL, V78, P2528, DOI 10.1073/pnas.78.4.2528; WALDMANN TA, 1986, CLIN IMMUNOL IMMUNOP, V40, P25, DOI 10.1016/0090-1229(86)90066-8; WALDMANN TA, 1974, LANCET, V2, P609; WALDMANN TA, 1984, J EXP MED, V160, P1450, DOI 10.1084/jem.160.5.1450	54	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1991	87	6					1138	1149		10.1016/0091-6749(91)92160-3	http://dx.doi.org/10.1016/0091-6749(91)92160-3			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR066	1646248				2022-12-18	WOS:A1991FR06600014
J	BOUSQUET, J; PUJOL, JL; BARNEON, G; HEJJAOUI, A; NARDOUX, J; AUSSEIL, M; GODARD, P; JOYEUX, H; MICHEL, FB				BOUSQUET, J; PUJOL, JL; BARNEON, G; HEJJAOUI, A; NARDOUX, J; AUSSEIL, M; GODARD, P; JOYEUX, H; MICHEL, FB			SKIN-TEST REACTIVITY IN PATIENTS SUFFERING FROM LUNG AND BREAST-CANCER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MAST-CELLS; ALLERGY; SENSITIVITY; HISTAMINE; EXTRACT	Mast cells and histamine-mediated reactions may be altered in patients with cancer. In an attempt to characterize the possible skin defects in patients with cancer, we tested 22 patients suffering from lung cancers, 30 from breast cancers, and 30 age-matched normal individuals, using several compounds, in investigating the pathophysiology of the skin response. Histamine hydrochloride (10 and 100 mg/ml) and codeine phosphate (9%) were tested by prick test. Substance P (50 and 500 ng per injection site), phentolamine (20-mu-g per injection site), and carbachol (1-mu-g per injection site) were tested by intradermal skin tests. Skin mast cells were also microscopically examined in 10 patients with lung cancer, five with breast cancer, and 10 normal subjects. The mean wheal sizes induced by all the tested substances were similar in patients with cancer and chronic bronchitis and in normal individuals. The flare to histamine, codeine phosphate, and substance P was completely abolished in 7/22 patients with lung cancer, but the lack of flare was not related to the age of the patients, nor to the staging of cancer, nor to metastasis. The mean numbers of alcian blue-stained or toluidine blue-stained positive mast cells were similar in normal subjects and in subjects with cancer. This study does not confirm the skin hyporeactivity of patients with cancer.	HOP GUY CHAULIAC, ANAT PATHOL LAB, MONTPELLIER, FRANCE; CTR PAUL LAMARQUE, CTR LUTTE CONTRE CANC, F-34033 MONTPELLIER, FRANCE	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	BOUSQUET, J (corresponding author), CHU MONTPELLIER, HOP AIGUELONGUE, MALAD RESP CLIN, AVE MAJOR FLANDRE, F-34059 MONTPELLIER, FRANCE.		Bousquet, Jean/O-4221-2019					[Anonymous], 1982, Am J Clin Pathol, V77, P123; [Anonymous], 1989, ALLERGY S10, V10, P1; BLOOM HG, 1974, FRONT RAD THER ONCOL, V9, P112; BOUSQUET J, 1985, J ALLERGY CLIN IMMUN, V76, P734, DOI 10.1016/0091-6749(85)90680-3; BOUSQUET J, 1985, CLIN ALLERGY, V15, P29, DOI 10.1111/j.1365-2222.1985.tb02251.x; BOUSQUET J, 1988, ALLERGY PRINCIPLES P, P419; BUCKLEY CE, 1982, J ALLERGY CLIN IMMUN, V69, P25, DOI 10.1016/0091-6749(82)90083-5; BURTIN C, 1986, ANN INST PASTEUR IMM, VD137, P289; BURTIN C, 1986, J ALLERGY CLIN IMMUN, V78, P83, DOI 10.1016/0091-6749(86)90118-1; CARNEY DN, 1987, CANCER RES, V47, P821; CROWLE PK, 1989, MAST CELL BASOPHIL D, P307; DREBORG S, 1987, THESIS U LINKOPING; EHRLICH P, 1916, COLLECTED PAPERS P E; FISHER ER, 1989, HUM PATHOL, V20, P159, DOI 10.1016/0046-8177(89)90180-9; FISHER ER, 1985, BREAST CANCER RES TR, V5, P285, DOI 10.1007/BF01806023; FOREMAN JC, 1987, ALLERGY, V42, P1, DOI 10.1111/j.1398-9995.1987.tb02180.x; HALONEN M, 1982, J ALLERGY CLIN IMMUN, V69, P221, DOI 10.1016/0091-6749(82)90103-8; HARTZELL S, 1989, American Review of Respiratory Disease, V139, pA119; LINBGREN BR, 1987, J ALLERGY CLIN IMMUN, V79, P941; LUNDBLAD L, 1987, ALLERGY, V2, P12; MARSHALL JS, 1987, BRIT J DERMATOL, V117, P29, DOI 10.1111/j.1365-2133.1987.tb04087.x; NELEMS B, 1987, B C MED J, V29, P591; NORMAN PS, 1983, ALLERGY PRINCIPLES P, P295; PRESLOW TP, 1984, AM J PATHOL, V116, P207; Scarff RW, 1938, LANCET, V2, P582; SCARFF RW, 1986, HISTOLOGICAL TYPING; SKASSABROCIEK W, 1987, J ALLERGY CLIN IMMUN, V80, P711, DOI 10.1016/0091-6749(87)90292-2; Sobin LH, 1987, TNM CLASSIFICATION M; STANLEY KE, 1986, CANCER DETECT PREV, V9, P83; SWAIN HH, 1952, J ALLERGY, V23, P441, DOI 10.1016/0021-8707(52)90008-7; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087	31	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1991	87	6					1066	1072		10.1016/0091-6749(91)92151-P	http://dx.doi.org/10.1016/0091-6749(91)92151-P			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR066	1710631				2022-12-18	WOS:A1991FR06600005
J	CAVANAH, DK; CASALE, TB				CAVANAH, DK; CASALE, TB			CUTANEOUS RESPONSE TO ANTICHOLINERGICS - EVIDENCE FOR MUSCARINIC RECEPTOR SUBTYPE PARTICIPATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RAT MAST-CELLS; HISTAMINE; ANTAGONISTS; RELEASE	We conducted a series of experiments to determine if anticholinergics induce immediate cutaneous wheal-and-flare responses in normal volunteers. We performed intradermal skin testing in seven healthy volunteers (three atopic and four nonatopic) with 20 nmol of atropine. All subjects had an immediate wheal-and-flare response to atropine. To determine if this cutaneous response was due to anticholinergics in general, skin testing was also performed to scopolamine and ipratropium. These agents also produced immediate wheal-and-flare responses in all subjects, but they less potent than atropine. Pretreatment with antihistamines equivalently inhibited wheal-and-flare responses to both histamine and atropine, indicating a possible mast cell role. The potential role of M1, M2, and M3 muscarinic receptor subtypes was evaluated by use of the selective antagonists, pirenzepine (M1), 11[[2-1[(diethylamino)methyl]-1-piperidinyl]-acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepine-6-one (AFDX-116) (M2), and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP) (M3). Cutaneous wheal responses induced by pirenzepine and 4-DAMP were relatively equivalent and larger than responses induced by AFDX-116 at doses < 200 nmol. At 200 nmol, all three muscarinic receptor subtype antagonists induced equivalent wheal formation. We then compared the cutaneous wheal responses to these specific muscarinic receptor antagonists based on their relative affinity for their respective muscarinic receptor subtype. This comparison suggested that M1 or M2, but not M3, muscarinic receptor subtypes may be important in anticholinergic-induced cutaneous wheal-and-flare responses. We propose that there may be an M1 or M2 muscarinic autoreceptor that inhibits the release of acetylcholine and other neurotransmitters. Anticholinergic-induced cutaneous wheal-and-flare responses may then result from inhibition of this autoreceptor, thereby allowing release of acetylcholine and other neurotransmitters leading to an immediate wheal-and-flare response.	VET AFFAIRS MED CTR,DEPT INTERNAL MED,IOWA CITY,IA; UNIV IOWA,COLL MED,IOWA CITY,IA 52242	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa			Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI019093] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 19093] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AQUILERA L, 1988, ANAESTHESIA, V43, P955; AYALA LE, 1989, CHEST, V96, P1285, DOI 10.1378/chest.96.6.1285; BARNES PJ, 1989, CHEST, V96, P1220, DOI 10.1378/chest.96.6.1220; BIRDSALL NJM, 1983, TRENDS PHARMACOL SCI, V4, P459, DOI 10.1016/0165-6147(83)90493-5; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P775, DOI 10.1016/0091-6749(84)90447-0; CASALE TB, 1984, J ALLERGY CLIN IMMUN, V73, P837, DOI 10.1016/0091-6749(84)90456-1; CASALE TB, 1989, ALLERGY PRINCIPLES P, P1; DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257; FANTOZZI R, 1978, NATURE, V273, P473, DOI 10.1038/273473a0; GOYAL RK, 1989, NEW ENGL J MED, V321, P1022; KUNYSZ EL, 1988, BRIT J PHARMACOL, V93, P491, DOI 10.1111/j.1476-5381.1988.tb10303.x; MASINI E, 1985, AGENTS ACTIONS, V16, P152, DOI 10.1007/BF01983125; MEI L, 1989, LIFE SCI, V45, P1831, DOI 10.1016/0024-3205(89)90537-7; RAO C P, 1990, Annals of Allergy, V64, P94; SOKOLOVSKY M, 1989, ADV DRUG RES, V18, P431	15	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1991	87	5					971	976		10.1016/0091-6749(91)90419-O	http://dx.doi.org/10.1016/0091-6749(91)90419-O			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FM095	2026847				2022-12-18	WOS:A1991FM09500009
J	PORTNOY, J; PACHECO, F; BALLAM, Y; BARNES, C				PORTNOY, J; PACHECO, F; BALLAM, Y; BARNES, C			SEPARATION OF ALTERNARIA INTO PROTEIN AND CARBOHYDRATE FRACTIONS WITH PHENYL SEPHAROSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASPERGILLUS-FUMIGATUS ANTIGENS; BIOLOGIC ACTIVITY; ALLERGENS; ASSAY	To evaluate the contribution of high carbohydrate-containing fractions to the allergen content of Alternaria, samples of an Alternaria extract were bound to a phenyl Sepharose column and eluted with Tris buffer containing 4, 2, and 1 mol/L of NaCl and then distilled water. The fractions were dialyzed and lyophilized. The 4 mol/L fraction accounted for 79% of the dry weight and most of the carbohydrate content. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the fractions demonstrated significant interfraction differences with the largest number of silver-stained bands in the H2O fraction. Although individual differences in skin reactivity to the fractions were present, geometric means of histamine equivalent pricks were approximately the same with only a 0.5 log dilution higher potency for the 1 mol/L and H2O fractions. The 50% IgE ELISA-inhibition concentration was 100-mu-g/ml for the 1 mol/L and distilled water fractions and 10-mu-g/ml for the other fractions. Since the 4 mol/L fraction accounted for most of the dry weight and had the highest carbohydrate to protein ratio (5.8), purification of Alternaria extracts by removal of carbohydrate fractions may result in significant loss of allergenic material.	UNIV MISSOURI,KANSAS CITY,MO 64110	University of Missouri System; University of Missouri Kansas City	PORTNOY, J (corresponding author), CHILDRENS MERCY HOSP,ALLERGY IMMUNOL SECT,KANSAS CITY,MO 64108, USA.							BJORKSTEN F, 1984, J ALLERGY CLIN IMMUN, V73, P324, DOI 10.1016/0091-6749(84)90404-4; BUDD TW, 1983, J ALLERGY CLIN IMMUN, V71, P277, DOI 10.1016/0091-6749(83)90081-7; BUSH R, 1985, J ALLERGY CLIN IMMUN, V75, P52; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; HORNER WE, 1988, J ALLERGY CLIN IMMUN, V82, P978, DOI 10.1016/0091-6749(88)90134-0; KARR RM, 1981, J ALLERGY CLIN IMMUN, V67, P194, DOI 10.1016/0091-6749(81)90061-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILES RM, 1983, J ALLERGY CLIN IMMUN, V71, P36, DOI 10.1016/0091-6749(83)90544-4; PORTNOY J, 1990, ANN ALLERGY, V65, P109; SCHAFFER NATHAN, 1959, ANN ALLERGY, V17, P380; SCHONHEYDER H, 1984, INT ARCH ALLER A IMM, V74, P262, DOI 10.1159/000233555; SCHONHEYDER H, 1984, INT ARCH ALLER A IMM, V73, P231, DOI 10.1159/000233473; SORENSON WG, 1974, ANN ALLERGY, V33, P131; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	15	5	5	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1991	87	4					789	793		10.1016/0091-6749(91)90124-7	http://dx.doi.org/10.1016/0091-6749(91)90124-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FG059	2013674	Bronze			2022-12-18	WOS:A1991FG05900007
J	BUSH, RK				BUSH, RK			OCCUPATIONAL ASTHMA FROM VEGETABLE GUMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV WISCONSIN,SCH MED,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	BUSH, RK (corresponding author), WILLIAM S MIDDLETON MEM VET ADM MED CTR,2500 OVERLOOK TERR,MADISON,WI 53705, USA.							BARDY JD, 1987, AM REV RESPIR DIS, V135, P1033; BUSH RK, 1989, J ALLERGY CLIN IMMUN, V84, P814, DOI 10.1016/0091-6749(89)90344-8; CLOUTIER Y, 1989, EUR RESPIR J, V2, P769; Feinberg SM, 1935, JAMA-J AM MED ASSOC, V105, P505; GELFAND HH, 1943, J ALLERGY, V14, P203; LAGIER F, 1990, J ALLERGY CLIN IMMUN, V85, P785, DOI 10.1016/0091-6749(90)90199-E; MALO JL, 1990, J ALLERGY CLIN IMMUN, V86, P562, DOI 10.1016/S0091-6749(05)80213-1; Montgomery R., 1959, CHEM PLANT GUMS MUCI; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; SPIELMAN AD, 1933, JAMA-J AM MED ASSOC, V101, P466	10	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	1				443	444		10.1016/S0091-6749(05)80197-6	http://dx.doi.org/10.1016/S0091-6749(05)80197-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EG454	2229807				2022-12-18	WOS:A1990EG45400001
J	EPSTEIN, M; WRIGHT, JM				EPSTEIN, M; WRIGHT, JM			SEVERE MULTISYSTEM DISEASE CAUSED BY TRIMETHOPRIM-SULFAMETHOXAZOLE - POSSIBLE ROLE OF AN INVITRO LYMPHOCYTE ASSAY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									ST PAULS HOSP,DEPT MED & PHARMACOL & THERAPEUT,VANCOUVER V6Z 1Y6,BC,CANADA; UNIV BRITISH COLUMBIA,VANCOUVER V6T 1W5,BC,CANADA	St. Paul's Hospital; University of Saskatchewan; University of British Columbia				Epstein, Michelle/0000-0002-4755-0224				BLANCHARD A J, 1958, Can Med Assoc J, V79, P627; DUFF GL, 1943, AM J MED, V205, P439; DUJOVNE CA, 1967, NEW ENGL J MED, V277, P785, DOI 10.1056/NEJM196710122771503; EVANS WE, 1975, DRUG INTEL CLIN PHAR, V9, P660, DOI 10.1177/106002807500901205; HOIGNE R, 1984, MEYLERS SIDE EFFECTS, P538; MACSEARRAIGH ET, 1968, BMJ-BRIT MED J, V3, P33, DOI 10.1136/bmj.3.5609.33; RIEDER MJ, 1988, J PHARMACOL EXP THER, V244, P724; RIEDER MJ, 1989, ANN INTERN MED, V110, P286, DOI 10.7326/0003-4819-110-4-286; SHEAR NH, 1986, ANN INTERN MED, V105, P179, DOI 10.7326/0003-4819-105-2-179	9	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1990	86	3	1				416	417		10.1016/S0091-6749(05)80108-3	http://dx.doi.org/10.1016/S0091-6749(05)80108-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EA859	2212414				2022-12-18	WOS:A1990EA85900019
J	KERREBIJN, KF				KERREBIJN, KF			KETOTIFEN FOR LONG-TERM CONTROL OF ASTHMA IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											KERREBIJN, KF (corresponding author), SOPHIA CHILDRENS UNIV HOSP,GORDELWEG 160,POB 70029,3000 LL ROTTERDAM,NETHERLANDS.							CHUNG KF, 1988, J ALLERGY CLIN IMMUN, V81, P1192, DOI 10.1016/0091-6749(88)90890-1; HARGREAVE FE, IN PRESS J ALLERGY C; HSU K, 1988, J FORMOS MED ASSOC, V87, P939; KAKUTA Y, 1988, J ALLERGY CLIN IMMUN, V81, P469, DOI 10.1016/0091-6749(88)90919-0; RACKHAM A, 1989, J ALLERGY CLIN IMMUN, V84, P286, DOI 10.1016/0091-6749(89)90410-7; WARNER JO, 1989, ARCH DIS CHILD, V64, P1065, DOI 10.1136/adc.64.7.1065	6	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1990	86	2					274	275		10.1016/S0091-6749(05)80078-8	http://dx.doi.org/10.1016/S0091-6749(05)80078-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DV316	2132736	Bronze			2022-12-18	WOS:A1990DV31600022
J	LUCZYNSKA, CM; HUTCHCROFT, BJ; HARRISON, MA; DORNAN, JD; TOPPING, MD				LUCZYNSKA, CM; HUTCHCROFT, BJ; HARRISON, MA; DORNAN, JD; TOPPING, MD			OCCUPATIONAL ASTHMA AND SPECIFIC IGE TO A DIAZONIUM SALT INTERMEDIATE USED IN THE POLYMER INDUSTRY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									OCCUPAT MED & HYG LABS HLTH & SAFETY EXECUT,403 EDGWARE RD,LONDON NW2 6LN,ENGLAND; NO GEN HOSP,DEPT RESP MED,SHEFFIELD S5 7AU,S YORKSHIRE,ENGLAND; EMPLOYMENT MED ADVISORY SERV,DARLINGTON,ENGLAND; EMPLOYMENT MED ADVISORY SERV,SHEFFIELD,ENGLAND	Northern General Hospital								ARMELI G, 1986, MED LAV, V59, P463; BUTCHER BT, 1980, J ALLERGY CLIN IMMUN, V66, P213, DOI 10.1016/0091-6749(80)90041-X; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; DEWAIR MA, 1982, J CLIN CHEM CLIN BIO, V26, P337; GRAHAM VAL, 1981, THORAX, V36, P950, DOI 10.1136/thx.36.12.950; HOWE W, 1983, J ALLERGY CLIN IMMUN, V71, P5, DOI 10.1016/0091-6749(83)90539-0; KAROL MH, 1978, AM IND HYG ASSOC J, V39, P454, DOI 10.1080/0002889778507789; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCZYNSKA CM, 1986, J IMMUNOL METHODS, V95, P177, DOI 10.1016/0022-1759(86)90404-7; Pepys J, 1972, Clin Allergy, V2, P391, DOI 10.1111/j.1365-2222.1972.tb01303.x; TOPPING MD, 1986, J ALLERGY CLIN IMMUN, V77, P834, DOI 10.1016/0091-6749(86)90381-7; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZOLLINGER H, 1961, AZO DIAZO DYE CHEM, P210	13	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1990	85	6					1076	1082		10.1016/0091-6749(90)90053-7	http://dx.doi.org/10.1016/0091-6749(90)90053-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DK509	2355154				2022-12-18	WOS:A1990DK50900014
J	MALONE, DG; DOLAN, PW				MALONE, DG; DOLAN, PW			DROPERIDOL-FENTANYL INHIBITS MAST-CELL HISTAMINE-RELEASE IN RAT SYNOVIUM, BUT NOT SKIN, AFTER IMMUNOLOGICAL ACTIVATION - EVIDENCE FOR MAST-CELL HETEROGENEITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MALONE, DG (corresponding author), UNIV WISCONSIN, DEPT MED, RHEUMAT DIS SECT, 600 HIGHLAND AVE, ROOM H6-367, MADISON, WI 53792 USA.							BARRETT KE, 1984, J CLIN IMMUNOL, V4, P253, DOI 10.1007/BF00915292; BEIL W, 1987, Alimentary Pharmacology and Therapeutics, V1, P141; BEIL W, 1988, PHARMACOLOGY, V36, P198, DOI 10.1159/000138384; BIENENSTOCK J, 1988, J ALLERGY CLIN IMMUN, V81, P763, DOI 10.1016/0091-6749(88)90929-3; CODERRE TJ, 1989, J NEUROPHYSIOL, V62, P48, DOI 10.1152/jn.1989.62.1.48; DOUGLAS WW, 1985, PHARMACOL BASIS THER, P616; ELLIS HV, 1970, J PHARMACOL EXP THER, V175, P627; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P303, DOI 10.1111/apm.1966.66.3.303; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P313, DOI 10.1111/apm.1966.66.3.313; FLACKE JW, 1987, ANESTH ANALG, V66, P723; GROSMAN N, 1981, AGENTS ACTIONS, V11, P196, DOI 10.1007/BF01967614; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; HERMENS JM, 1985, ANESTHESIOLOGY, V62, P124, DOI 10.1097/00000542-198502000-00005; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; LOPICKYBURD JA, 1988, J RHEUMATOL, V9, P1326; LOWMAN MA, 1988, J ALLERGY CLIN IMMUN, V81, P574, DOI 10.1016/0091-6749(88)90199-6; MALONE DG, 1986, ARTHRITIS RHEUM, V29, P956, DOI 10.1002/art.1780290803; MALONE DG, 1988, ARTHRITIS RHEUM, V31, P1063, DOI 10.1002/art.1780310820; MALONE DG, 1987, ARTHRITIS RHEUM, V30, P130, DOI 10.1002/art.1780300202; MALONE DG, UNPUB DYNAMIC MONITO; PEARCE FL, 1984, J ALLERGY CLIN IMMUN, V73, P819, DOI 10.1016/0091-6749(84)90453-6; PEARCE FL, 1982, J IMMUNOL, V128, P2481; ROSOW CE, 1984, ANESTHESIOLOGY, V60, P489, DOI 10.1097/00000542-198405000-00020; ROSOW CE, 1982, ANESTHESIOLOGY, V56, P93, DOI 10.1097/00000542-198202000-00003; SHANAHAN F, 1986, INT ARCH ALLER A IMM, V80, P424, DOI 10.1159/000234092; THARP MD, 1987, J ALLERGY CLIN IMMUN, V79, P646, DOI 10.1016/S0091-6749(87)80162-8; TODA N, 1977, ANESTHESIOLOGY, V46, P411, DOI 10.1097/00000542-197706000-00007; TOMICHECK RC, 1983, ANESTH ANALG, V62, P881	29	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1990	85	5					821	827		10.1016/0091-6749(90)90063-A	http://dx.doi.org/10.1016/0091-6749(90)90063-A			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DD959	1692046				2022-12-18	WOS:A1990DD95900001
J	XUAN, ATD; REGNARD, J; SIMILOWSKI, T; REY, J; MARSAC, J; LOCKHART, A				XUAN, ATD; REGNARD, J; SIMILOWSKI, T; REY, J; MARSAC, J; LOCKHART, A			EFFECTS OF SK AND F-104353, A LEUKOTRIENE RECEPTOR ANTAGONIST, ON THE BRONCHIAL RESPONSES TO HISTAMINE IN SUBJECTS WITH ASTHMA - A COMPARATIVE-STUDY WITH TERFENADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOP COCHIN, DEPT MALAD RESP, F-75674 PARIS 14, FRANCE; FAC MED COCHIN, PHYSIOL LAB, F-75674 PARIS 14, FRANCE; SK&F LABS, DEPT RES & DEV, PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite			DINH-XUAN, Anh Tuan/A-9691-2008	DINH-XUAN, Anh Tuan/0000-0001-8651-5176				ARM JP, 1988, J ALLERGY CLIN IMMUN, V82, P654, DOI 10.1016/0091-6749(88)90979-7; AUGSTEIN J, 1973, NATURE-NEW BIOL, V245, P215, DOI 10.1038/newbio245215a0; BARNES N, 1987, J ALLERGY CLIN IMMUN, V79, P816, DOI 10.1016/0091-6749(87)90215-6; BARNES NC, 1986, ASTHMA CLIN PHARM TH, P194; BLACK P N, 1988, American Review of Respiratory Disease, V137, P427; BRITTON JR, 1987, J ALLERGY CLIN IMMUN, V79, P811, DOI 10.1016/0091-6749(87)90214-4; CIAPPI G, 1988, EUR RESPIR J S, V1, pS9; COOKSON WOCM, 1987, BRIT J CLIN PHARMACO, V24, P120, DOI 10.1111/j.1365-2125.1987.tb03150.x; CREESE BR, 1983, PROSTA LEUKOTR MED, V11, P161, DOI 10.1016/0262-1746(83)90016-1; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1983, P NATL ACAD SCI-BIOL, V80, P1712, DOI 10.1073/pnas.80.6.1712; DBROT J, 1988, J APPL PHYSIOL, V65, P194, DOI 10.1152/jappl.1988.65.1.194; EISER NM, 1983, B EUR PHYSIOPATH RES, V19, P495; EISER NM, 1989, THORAX, V44, pP334; EVANS JM, 1988, BRIT J CLIN PHARMACO, V26, pP677; FENNESSY MR, 1986, BRIT J PHARMACOL, V87, P741, DOI 10.1111/j.1476-5381.1986.tb14592.x; FISH JE, 1981, J APPL PHYSIOL, V50, P1079, DOI 10.1152/jappl.1981.50.5.1079; FRIEDMAN MM, 1987, AM REV RESPIR DIS, V135, P1157; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HAY DWP, 1987, J PHARMACOL EXP THER, V243, P474; HOLGATE ST, 1987, CLIN SCI, V73, P561, DOI 10.1042/cs0730561; HOLROYDE MC, 1981, LANCET, V2, P17; ISRAEL E, 1988, American Review of Respiratory Disease, V137, P27; JOOS GF, 1989, J ALLERGY CLIN IMMUN, V83, P187; LEWIS RA, 1980, P NATL ACAD SCI-BIOL, V77, P3710, DOI 10.1073/pnas.77.6.3710; MANN JS, 1986, THORAX, V41, P746, DOI 10.1136/thx.41.10.746; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; POPA VT, 1977, J ALLERGY CLIN IMMUN, V59, P54, DOI 10.1016/0091-6749(77)90177-4; PUUSTINEN T, 1984, PROSTA LEUKOTR MED, V14, P161, DOI 10.1016/0262-1746(84)90197-5; RAFFERTY P, 1987, AM REV RESPIR DIS, V135, P181; SCHILD HO, 1951, LANCET, V261, P376; SMITH LJ, 1985, AM REV RESPIR DIS, V131, P368; XUAN ATD, 1988, EUR RESPIR J, V1, P345	33	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1990	85	5					865	871		10.1016/0091-6749(90)90070-K	http://dx.doi.org/10.1016/0091-6749(90)90070-K			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DD959					2022-12-18	WOS:A1990DD95900008
J	HINOJOSA, M; QUIRCE, S; PUYANA, J; CODINA, J; RULL, SG				HINOJOSA, M; QUIRCE, S; PUYANA, J; CODINA, J; RULL, SG			BRONCHIAL HYPERREACTIVITY AND COUGH INDUCED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									HOSP RAMON & CAJAL,DEPT CARDIOL,E-28034 MADRID,SPAIN; HOSP RAMON & CAJAL,DEPT PNEUMOL,SERV ALERGIA,E-28034 MADRID,SPAIN	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	HINOJOSA, M (corresponding author), HOSP RAMON & CAJAL,DEPT ALLERGY,CARRETERA COLMENAR KM 91,E-28034 MADRID,SPAIN.		s, q/AAD-7171-2020					BUCKNALL CE, 1988, BRIT MED J, V296, P86, DOI 10.1136/bmj.296.6615.86; COULTER DM, 1987, BRIT MED J, V294, P1521, DOI 10.1136/bmj.294.6586.1521; FERNER RE, 1987, BRIT MED J, V294, P1119, DOI 10.1136/bmj.294.6580.1119; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; FULLER RW, 1987, BMJ-BRIT MED J, V295, P1025, DOI 10.1136/bmj.295.6605.1025-a; KAUFMAN J, 1989, CHEST, V95, P544, DOI 10.1378/chest.95.3.544; MORICE AH, 1987, LANCET, V2, P1116; SEMPLE PF, 1986, NEW ENGL J MED, V314, P61; SESOKO S, 1985, ARCH INTERN MED, V145, P1524; TOWN GI, 1987, NEW ZEAL MED J, V100, P161; 1988, LANCET, V1, P447	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					818	819		10.1016/0091-6749(90)90206-J	http://dx.doi.org/10.1016/0091-6749(90)90206-J			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2324421				2022-12-18	WOS:A1990DA43700023
J	ROSARIO, NA				ROSARIO, NA			POLLINOSIS IN BRAZIL - CHANGING CONCEPTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											ROSARIO, NA (corresponding author), FED UNIV PARANA,PEDIATR,CURITIBA,BRAZIL.		rosario, nelson/K-7205-2012	rosario, nelson/0000-0002-8550-8051				Lima A. Oliveira, 1946, ANN ALLERGY, V4, P13; ROSARIO NA, 1983, REV BRAS ALERG IMUNO, V6, P12; ROSARIO NA, 1987, REV BRAS ALERG IMUNO, V10, P25	3	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					819	820		10.1016/0091-6749(90)90207-K	http://dx.doi.org/10.1016/0091-6749(90)90207-K			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2324422				2022-12-18	WOS:A1990DA43700024
J	HILL, HR; SHIGEOKA, AO; GONZALES, LA; CHRISTENSEN, RD				HILL, HR; SHIGEOKA, AO; GONZALES, LA; CHRISTENSEN, RD			INTRAVENOUS IMMUNE GLOBULIN USE IN NEWBORNS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV UTAH,DEPT PEDIAT,DIV CLIN IMMUNOL & ALLERGY & HUMAN DEV AGING,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019094, R01AI013150] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19094, AI13150] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHIRICO G, 1987, J PEDIATR-US, V110, P437, DOI 10.1016/S0022-3476(87)80514-0; CHRISTENSEN RD, 1983, PEDIATR RES, V17, P795, DOI 10.1203/00006450-198310000-00005; CHRISTENSEN RD, 1982, PEDIATR RES, V16, P549, DOI 10.1203/00006450-198207000-00011; CHRISTENSEN RD, IN PRESS PERINATOLOG; CLAPP DW, 1988, PEDIATR RES, V23, P471; EIBL MM, 1988, NEW ENGL J MED, V319, P1, DOI 10.1056/NEJM198807073190101; HAQUE KN, 1986, PEDIATR INFECT DIS J, V5, P622, DOI 10.1097/00006454-198611000-00004; HARPER TE, 1986, REV INFECT DIS, V8, pS401; HEMMING VG, 1976, J CLIN INVEST, V58, P1379, DOI 10.1172/JCI108593; HILL HR, 1986, REV INFECT DIS, V8, pS396; SANTOS JI, 1981, J PEDIATR-US, V99, P873, DOI 10.1016/S0022-3476(81)80009-1; SHIGEOKA AO, 1978, LANCET, V1, P636; SHIGEOKA AO, 1983, J INFECT DIS, V147, P857, DOI 10.1093/infdis/147.5.857; SHIGEOKA AO, 1988, AM J PATHOL, V133, P623; SIDIROPOULOS D, 1986, PEDIATR INFECT DIS J, V5, pS193; SIDIROPOULOS D, 1986, J PEDIATR-US, V109, P505, DOI 10.1016/S0022-3476(86)80132-9; STABILE A, 1988, ARCH DIS CHILD, V63, P441, DOI 10.1136/adc.63.4.441; YANG KD, 1989, J INFECT DIS, V159, P701, DOI 10.1093/infdis/159.4.701; YANG KD, 1988, J INFECT DIS, V185, P823	19	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1989	84	4	2	S			617	624		10.1016/0091-6749(89)90200-5	http://dx.doi.org/10.1016/0091-6749(89)90200-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZ398	2677096				2022-12-18	WOS:A1989AZ39800009
J	LURIE, A; CHAUSSAIN, M; RAYNAUD, F; DEMONTIS, G; STRAUCH, G; LOCKHART, A; MARSAC, J; DARDENNE, M				LURIE, A; CHAUSSAIN, M; RAYNAUD, F; DEMONTIS, G; STRAUCH, G; LOCKHART, A; MARSAC, J; DARDENNE, M			SERUM THYMIC HORMONE THYMULIN ACTIVITY IS NORMAL IN CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOP COCHIN,INST RECH THERAPEUT ECPIMED,F-75674 PARIS 14,FRANCE; HOP ST VINCENT DE PAUL,F-75674 PARIS 14,FRANCE; HOP ENFANTS MALADES PARIS,INSERM,U25,F-75730 PARIS 15,FRANCE; HOP ENFANTS MALADES PARIS,CNRS,UA122,F-75730 PARIS 15,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	LURIE, A (corresponding author), HOP COCHIN,DEPT PNEUMOL,27 RUE FAUBOURG ST JACQUES,F-75674 PARIS 14,FRANCE.							AAS K, 1971, J ALLERGY CLIN IMMUN, V48, P134, DOI 10.1016/0091-6749(71)90008-X; BACH JF, 1973, IMMUNOLOGY, V25, P353; BACH JF, 1972, LANCET, V2, P1056; BACH JF, 1983, CLIN IMMUNOL ALLERGY, V3, P133; BLAYLOCK WK, 1976, J ALLERGY CLIN IMMUN, V57, P62, DOI 10.1016/0091-6749(76)90080-4; BUCKLEY RH, 1978, IMMUNOL REV, V41, P288, DOI 10.1111/j.1600-065X.1978.tb01469.x; COOPER KD, 1980, CLIN RES, V28, P566; DARDENNE M, 1975, BIOL ACTIVITY THYMIC, P235; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DURHAM SR, 1984, NEW ENGL J MED, V311, P1398, DOI 10.1056/NEJM198411293112202; GARACI E, 1978, J ALLERGY CLIN IMMUN, V62, P357, DOI 10.1016/0091-6749(78)90136-7; GERBLICH AA, 1985, CHEST, V87, P45; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; GREIDING L, 1986, 12 P INT C ALL CLIN, P341; HALPERN G M, 1980, Allergie et Immunologie (Paris), V12, P21; HANIFIN JM, 1977, ARCH DERMATOL, V113, P663, DOI 10.1001/archderm.113.5.663; HARPER TB, 1980, CLIN ALLERGY, V10, P555, DOI 10.1111/j.1365-2222.1980.tb02137.x; HSIEH KH, 1982, ANN ALLERGY, V48, P345; HWANG KC, 1985, CLIN ALLERGY, V15, P67, DOI 10.1111/j.1365-2222.1985.tb02257.x; ILFIELD D, 1985, CLIN EXP IMMUNOL, V61, P360; KANG K, 1983, J AM ACAD DERMATOL, V8, P372, DOI 10.1016/S0190-9622(83)70042-3; KANG K, 1983, SEMIN DERMATOL, V2, P59; KAY AB, 1984, ASTHMA PHYSL IMMUNOP, P211; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; LEUNG DYM, 1981, J ALLERGY CLIN IMMUN, V67, P450, DOI 10.1016/0091-6749(81)90098-1; LEWIS VM, 1978, J CLIN ENDOCR METAB, V47, P145, DOI 10.1210/jcem-47-1-145; MILLER JFAP, 1975, ANN NY ACAD SCI, V249, P9, DOI 10.1111/j.1749-6632.1975.tb29052.x; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; Ringel KP, 1982, LABORATORIUMSBLATTER, V32, P26; RIVLIN J, 1981, CLIN ALLERGY, V11, P353, DOI 10.1111/j.1365-2222.1981.tb01605.x; ROCKLIN RE, 1980, NEW ENGL J MED, V302, P1213, DOI 10.1056/NEJM198005293022201; ROLAPLESZCZYNSKI M, 1981, INT ARCH ALLER A IMM, V64, P361, DOI 10.1159/000232717; SAXON A, 1980, J CLIN INVEST, V65, P1457, DOI 10.1172/JCI109810; SCHREIBER RD, 1983, J IMMUNOL, V131, P826; WARNER JO, 1976, ARCH DIS CHILD, V51, P297; WIDE L, 1967, LANCET, V2, P1105	36	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1989	84	3					386	390		10.1016/0091-6749(89)90425-9	http://dx.doi.org/10.1016/0091-6749(89)90425-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AR199	2674264				2022-12-18	WOS:A1989AR19900018
J	ADOLPHSON, RL; CHESTNUT, JC; THUESON, DO; CONROY, MC				ADOLPHSON, RL; CHESTNUT, JC; THUESON, DO; CONROY, MC			A NEW ANTI-ALLERGY COMPOUND, CI-959 POTENTLY INHIBITS MEDIATOR RELEASE FROM HUMAN (HU) AND GUINEA-PIG (GP) LUNG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					205	205						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900157
J	BLANCA, M; MIRANDA, A; GARCIA, J; CARMONA, MJ; VEGA, JM; TERRADOS, S; AVILA, M; JUAREZ, C				BLANCA, M; MIRANDA, A; GARCIA, J; CARMONA, MJ; VEGA, JM; TERRADOS, S; AVILA, M; JUAREZ, C			ALLERGY TO AMOXYCILLIN WITH GOOD TOLERANCE TO BENZYLENICILLIN STUDY IN A GROUP OF PATIENTS ALLERGIC TO BETALACTAMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					270	270						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900417
J	GIBSON, PG; MANNING, PJ; GIRGISGABARDO, A; HARGREAVE, FE; OBYRNE, PM; DOLOVICH, J; DENBURG, J				GIBSON, PG; MANNING, PJ; GIRGISGABARDO, A; HARGREAVE, FE; OBYRNE, PM; DOLOVICH, J; DENBURG, J			PROGENITORS DURING THE LATE ASTHMATIC RESPONSE TO ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					233	233						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900266
J	JANCELOWICZ, Z; SUSSMAN, G; TARLO, S; DOLOVICH, J				JANCELOWICZ, Z; SUSSMAN, G; TARLO, S; DOLOVICH, J			CLINICAL PRESENTATION OF 5 PATIENTS ALLERGIC TO LATEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					267	267						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900403
J	KERSTEN, W; MUSKEN, H				KERSTEN, W; MUSKEN, H			A CLINICAL-STUDY ON THE EFFECTIVENESS OF THE ACARICIDE ACAROSAN IN TREATING HOUSE-DUST MITE ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					263	263						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900388
J	LAU, S; RUSCHE, A; WEBER, A; BISCHOFF, E; WAHN, U				LAU, S; RUSCHE, A; WEBER, A; BISCHOFF, E; WAHN, U			SHORT-TERM EFFICACY OF BENZYLBENZOATE ON MITE ALLERGEN CONCENTRATIONS IN HOUSE DUST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					263	263						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900386
J	LESLIE, CA; MATHE, AA				LESLIE, CA; MATHE, AA			MODIFICATION OF GUINEA-PIG LUNG ANAPHYLAXIS BY CENTRAL NERVOUS-SYSTEM (CNS) PERTURBATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BOSTON UNIV,SCH MED,BOSTON,MA 02118; KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT PSYCHIAT,S-11281 STOCKHOLM,SWEDEN	Boston University; Karolinska Institutet	LESLIE, CA (corresponding author), EN ROGERS MEM VET ADM HOSP,GERIATR RES EDUC & CLIN CTR,200 SPRINGS RD,BEDFORD,MA 01730, USA.				NHLBI NIH HHS [HL-19717, HL-22011] Funding Source: Medline; NIADDK NIH HHS [AM-32588] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM032588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019717] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COSCINA DV, 1977, SCIENCE, V195, P416, DOI 10.1126/science.831288; FILIPP G, 1952, ORVOSI HETILAP, V16, P465; FREEDMAN DX, 1958, ARCH NEURO PSYCHIATR, V79, P164, DOI 10.1001/archneurpsyc.1958.02340020044008; GARDINER PJ, 1980, PROSTAGLANDINS, V19, P819, DOI 10.1016/0090-6980(80)90116-1; GOL'DSHTEIN M M, 1976, Byulleten' Eksperimental'noi Biologii i Meditsiny, V82, P977; GOODMAN WB, 1976, SURG FORUM, V27, P472; GRYGLEWSKI RJ, 1975, PROSTAGLANDINS, V10, P343, DOI 10.1016/S0090-6980(75)80087-6; HAKANSON R, 1974, ANAL BIOCHEM, V60, P560, DOI 10.1016/0003-2697(74)90267-X; HAMBERG M, 1976, ADV PROSTAG THROMB R, V1, P495; HITCHCOCK M, 1978, J PHARMACOL EXP THER, V207, P630; KARAKASH C, 1977, AM J PHYSIOL, V232, pE286, DOI 10.1152/ajpendo.1977.232.3.E286; LESLIE CA, 1985, J EXP MED, V162, P1336, DOI 10.1084/jem.162.4.1336; LESLIE CA, 1973, BIOCHEM BIOPH RES CO, V52, P715; LESLIE CA, 1982, 5 PROST INT C; LUPARELLO TJ, 1964, AM J PHYSIOL, V207, P911, DOI 10.1152/ajplegacy.1964.207.4.911; MACRIS NT, 1970, AM J PHYSIOL, V219, P1205, DOI 10.1152/ajplegacy.1970.219.5.1205; MAO CC, 1974, ANAL BIOCHEM, V59, P63, DOI 10.1016/0003-2697(74)90009-8; MARCHEVSKY AM, 1984, LUNG, V162, P281, DOI 10.1007/BF02715658; MATHE AA, 1977, BIOCHEM PHARMACOL, V26, P181, DOI 10.1016/0006-2952(77)90300-8; MATHE AA, 1977, NEW ENGL J MED, V296, P910, DOI 10.1056/NEJM197704212961605; MATHE AA, 1977, NEW ENGL J MED, V296, P850, DOI 10.1056/NEJM197704142961505; MATHE AA, 1978, PHARMACOLOGY, V16, P30, DOI 10.1159/000136743; MATHE AA, 1976, ACTA PHYSIOL SC S441, V98, P1; MATHE AA, 1979, 7TH P INT C PHARM, P77; NATHAN MA, 1975, CIRC RES, V37, P226, DOI 10.1161/01.RES.37.2.226; PARROT JL, 1961, J PHYSIOL-PARIS, V53, P441; RONDEAU DB, 1978, PHARMACOL BIOCHEM BE, V9, P43, DOI 10.1016/0091-3057(78)90011-4; ROSENTHA.ME, 1969, P SOC EXP BIOL MED, V130, P339; ROSENTHALE ME, 1971, J PHARMACOL EXP THER, V178, P541; SCHIAVI RC, 1966, AM J PHYSIOL, V211, P1269, DOI 10.1152/ajplegacy.1966.211.5.1269; Snedecor G.W., 1982, STAT METHODS, V507, P53; SOHN RJ, 1977, LIFE SCI, V21, P1365, DOI 10.1016/0024-3205(77)90020-0; STEIN M, 1976, SCIENCE, V191, P435; STEINER AL, 1972, J BIOL CHEM, V247, P1114; SZENTIVANYI A, 1952, ORVOSI HETILAP, V19, P1193; SZENTIVANYI ANDOR, 1958, ANN ALLERGY, V16, P143; TIMA L, 1975, ACTA BIOL ACAD SCI H, V26, P237; TISHER PW, 1978, BIOCHEM PHARMACOL, V27, P117, DOI 10.1016/0006-2952(78)90267-8; TWIGGS DG, 1978, SCIENCE, V200, P1414, DOI 10.1126/science.663624; TYREY L, 1972, AM J PHYSIOL, V222, P185; WAGNER JE, 1976, BIOL GUINEA PIG, P228	41	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					94	101		10.1016/0091-6749(89)90482-X	http://dx.doi.org/10.1016/0091-6749(89)90482-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419	2464017				2022-12-18	WOS:A1989T041900013
J	LI, JT; YUNGINGER, JW; REED, CE; NELSON, DR; JAFFE, H; HALLAGAN, J; BLOMGREN, J; GLEICH, GJ				LI, JT; YUNGINGER, JW; REED, CE; NELSON, DR; JAFFE, H; HALLAGAN, J; BLOMGREN, J; GLEICH, GJ			RECOMBINANT INTERFERON-GAMMA IN THE TREATMENT OF ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					307	307						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900564
J	TRUETT, AP; SNYDERMAN, R; MURRAY, JJ				TRUETT, AP; SNYDERMAN, R; MURRAY, JJ			EVIDENCE FOR PHOSPHATIDYLCHOLINE (PC) - SPECIFIC PHOSPHOLIPASE-D ACTIVATION IN STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES (PMNS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					311	311						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900578
J	ARKINSTALL, WW; HOPKINSON, M; RIVINGTON, RN; CALCUTT, L; AITKEN, T; STEWART, JH				ARKINSTALL, WW; HOPKINSON, M; RIVINGTON, RN; CALCUTT, L; AITKEN, T; STEWART, JH			THE CLINICAL-SIGNIFICANCE OF FOOD-INDUCED CHANGES IN THE ABSORPTION OF THEOPHYLLINE FROM UNIPHYL TABLETS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									PURDUE FREDERICK INC,DEPT SCI,TORONTO,ONTARIO,CANADA; UNIV OTTAWA,OTTAWA CIVIC HOSP,DIV RESPIROL,OTTAWA K1N 6N5,ONTARIO,CANADA	University of Ottawa; Ottawa Hospital Research Institute	ARKINSTALL, WW (corresponding author), KELOWNA GEN HOSP,DIV RES MED,2268 PANDOSY ST,KELOWNA V1Y 1T2,BC,CANADA.							ARKINSTALL WW, 1987, AM REV RESPIR DIS, V135, P316; ARKINSTALL WW, 1984, INT C S SERIES, V78, P39; CLARK TJH, 1977, BRIT J DIS CHEST, V71, P87, DOI 10.1016/0007-0971(77)90087-0; COHEN BM, 1984, J ASTHMA, V21, P305, DOI 10.3109/02770908409077441; COIFMAN RE, 1983, NEW ENGL J MED, V309, P557; DEDERICH RA, 1981, J ALLERGY CLIN IMMUN, V67, P465, DOI 10.1016/0091-6749(81)90100-7; FAIRSHTER RD, 1986, J ALLERGY CLIN IMMUN, V77, P646, DOI 10.1016/0091-6749(86)90361-1; FINK JN, 1985, AM J MED, V79, P58, DOI 10.1016/0002-9343(85)90090-7; FOX ZR, 1984, INT C S SERIES, V78, P29; GOLDBERG P, 1980, AM J DIS CHILD, V134, P596, DOI 10.1001/archpedi.1980.02130180054016; HENDELES L, 1985, CHEST, V87, P758, DOI 10.1378/chest.87.6.758; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; KARIM A, 1985, CLIN PHARMACOL THER, V38, P77, DOI 10.1038/clpt.1985.138; KARIM A, 1985, CLIN PHARM THER, V39, P598; KATZ RM, 1983, ANN ALLERGY, V50, P23; KLEIN JJ, 1983, AM REV RESPIR DIS, V127, P413, DOI 10.1164/arrd.1983.127.4.413; LASSETER KC, 1984, INT C S SERIES, V78, P141; LOREN ML, 1980, ANN ALLERGY, V44, P200; MANGURA BT, 1986, CHEST, V90, P566, DOI 10.1378/chest.90.4.566; MASELLI R, 1970, J PEDIATR, V76, P777, DOI 10.1016/S0022-3476(70)80305-5; MILAVETZ G, 1984, PHARMACOTHERAPY, V4, P216; OGILVIE RI, 1978, CLIN PHARMACOKINET, V3, P267, DOI 10.2165/00003088-197803040-00002; PEDERSON S, 1984, PEDIATRICS, P534; RACHELEFSKY GS, 1978, ANN ALLERGY, V40, P252; Rall T. W., 1980, PHARMACOL BASIS THER, P592; RIVERACALIMLIM L, 1986, J ASTHMA, V23, P113, DOI 10.3109/02770908609077485; RIVINGTON RN, 1985, AM J MED, V79, P67, DOI 10.1016/0002-9343(85)90092-0; RIVINGTON RN, 1984, INT C S SERIES, V78, P197; ROGERS RJ, 1985, J PEDIATR-US, V106, P496, DOI 10.1016/S0022-3476(85)80690-9; ROULEAU MY, 1984, INT C S SERIES, P129; SBARBARO J, 1985, AM J MED S6A, V7, P34; SCOTT PH, 1981, J PEDIATR-US, V99, P476, DOI 10.1016/S0022-3476(81)80354-X; SPECTOR SL, 1985, J ALLERGY CLIN IMMUN, V76, P302, DOI 10.1016/0091-6749(85)90646-3; THOMPSON PJ, 1983, BRIT J DIS CHEST, V77, P293; THOMPSON PJ, 1983, NEW ENGL J MED, V309, P558; TINKELMAN DG, 1985, ANN ALLERGY, V55, P571; TURNERWARWICK M, 1977, BRIT J DIS CHEST, V71, P73, DOI 10.1016/0007-0971(77)90086-9; WALKER SE, 1983, BRIT J CLIN PRACT, V37, P23; WALKER SE, 1985, DRUG INTEL CLIN PHAR, V19, P468; WARREN JB, 1985, BRIT J CLIN PHARMACO, V19, P707, DOI 10.1111/j.1365-2125.1985.tb02701.x; WELSH PW, 1986, AM J MED, V80, P1098, DOI 10.1016/0002-9343(86)90671-6; 1985, US PHARMACOPEIA, V21, P1042	43	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					155	164		10.1016/0091-6749(88)90994-3	http://dx.doi.org/10.1016/0091-6749(88)90994-3			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	3273483				2022-12-18	WOS:A1988P874100004
J	BOCK, SA; ATKINS, FM; SAMPSON, HA				BOCK, SA; ATKINS, FM; SAMPSON, HA			ALLERGENIC CROSS-REACTIVITY AMONG LEGUME FOODS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									JOHNS HOPKINS UNIV HOSP,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine	BOCK, SA (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,1400 JACKSON ST,DENVER,CO 80206, USA.							ATKINS FM, 1985, J ALLERGY CLIN IMMUN, V75, P356, DOI 10.1016/0091-6749(85)90072-7; BARNETT D, 1987, J ALLERGY CLIN IMMUN, V79, P433, DOI 10.1016/0091-6749(87)90359-9; BERNSTEIN M, 1982, J ALLERGY CLIN IMMUN, V70, P205, DOI 10.1016/0091-6749(82)90043-4; BOCK SA, 1986, J ALLERGY CLIN IMMUN, V78, P165, DOI 10.1016/0091-6749(86)90009-6; SAMPSON HA, 1984, J ALLERGY CLIN IMMUN, V74, P26, DOI 10.1016/0091-6749(84)90083-6; SAMPSON HA, 1983, J ALLERGY CLIN IMMUN, V71, P473, DOI 10.1016/0091-6749(83)90464-5	6	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					310	311		10.1016/0091-6749(88)91021-4	http://dx.doi.org/10.1016/0091-6749(88)91021-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	3403872				2022-12-18	WOS:A1988P874100031
J	CARPENTER, N; DBROT, J; KIM, CS; ABRAHAM, WM; AHMED, T				CARPENTER, N; DBROT, J; KIM, CS; ABRAHAM, WM; AHMED, T			EFFECT OF GALLOPAMIL, A CALCIUM-CHANNEL BLOCKER, ON CARBACHOL-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN SHEEP	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MIAMI,MT SINAI MED CTR,SCH MED,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140	Mount Sinai Medical Center; University of Miami					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033897] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 33897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMED T, 1985, CHEST, V88, P176, DOI 10.1378/chest.88.2.176; AHMED T, 1980, J APPL PHYSIOL, V49, P826, DOI 10.1152/jappl.1980.49.5.826; AHMED T, 1986, CHEST, V89, pS535; BARNES PJ, 1981, THORAX, V36, P726, DOI 10.1136/thx.36.10.726; BRINK C, 1982, J PHARM PHARMACOL, V34, P199, DOI 10.1111/j.2042-7158.1982.tb04224.x; BRUGMAN TM, 1983, AM REV RESPIR DIS, V127, P14, DOI 10.1164/arrd.1983.127.1.14; CARPENTER N, 1986, AM REV RESPIR DIS, V133, pA14; CHENG JB, 1983, ARCH INT PHARMACOD T, V263, P228; COBURN RF, 1977, FED PROC, V36, P2692; COOK CD, 1957, J CLIN INVEST, V36, P440, DOI 10.1172/JCI103441; DEAL EC, 1984, CHEST, V86, P762, DOI 10.1378/chest.86.5.762; FANTA CH, 1983, AM REV RESPIR DIS, V127, P673; FANTA CH, 1982, AM REV RESPIR DIS, V125, P61; FARLEY JM, 1978, J PHARMACOL EXP THER, V207, P340; FLECKENSTEIN A, 1977, ANNU REV PHARMACOL, V17, P149, DOI 10.1146/annurev.pa.17.040177.001053; FLECKENSTEINGRU.G, 1984, GALLOPAMIL PHARM CLI, P33; GONZALEZ JM, 1983, AM REV RESPIR DIS, V127, P155; HENDERSON AF, 1983, AM REV RESPIR DIS, V127, P549, DOI 10.1164/arrd.1983.127.5.549; HIMORI N, 1980, BRIT J PHARMACOL, V68, P595, DOI 10.1111/j.1476-5381.1980.tb10848.x; KIM C S, 1984, American Review of Respiratory Disease, V129, pA110; MALO PE, 1982, J PHARMACOL EXP THER, V221, P410; MARTHAN R, 1987, AM REV RESPIR DIS, V135, P185; MCINTYRE E, 1983, J ALLERGY CLIN IMMUN, V71, P375, DOI 10.1016/0091-6749(83)90065-9; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; NEUSS H, 1984, GALLOPAMIL PHARM CLI, P99; PATEL KR, 1981, CLIN ALLERGY, V11, P441, DOI 10.1111/j.1365-2222.1981.tb01617.x; POPA VT, 1984, AM REV RESPIR DIS, V130, P1006; RUSSI EW, 1983, AM REV RESPIR DIS, V127, P675; RUSSI EW, 1985, CHEST, V88, P74, DOI 10.1378/chest.88.1.74; SHORE S, 1985, J APPL PHYSIOL, V59, P1355, DOI 10.1152/jappl.1985.59.5.1355; WANNER A, 1978, J APPL PHYSIOL, V44, P479, DOI 10.1152/jappl.1978.44.3.479; WILLIAMS DO, 1981, BRIT MED J, V283, P348, DOI 10.1136/bmj.283.6287.348; YOUSIF FB, 1986, CAN J PHYSIOL PHARM, V64, P273, DOI 10.1139/y86-044; YU CP, 1983, J AEROSOL SCI, V14, P599, DOI 10.1016/0021-8502(83)90065-4; Zar JH, 1974, BIOSTATISTICAL ANAL	35	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	1				859	866		10.1016/0091-6749(88)90943-8	http://dx.doi.org/10.1016/0091-6749(88)90943-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7036	3372909				2022-12-18	WOS:A1988N703600015
J	SAXON, A; CAMPEN, V				SAXON, A; CAMPEN, V			AIDS - STATE OF THE ART, SPRING 1988	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,CTR AIDS,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	SAXON, A (corresponding author), UNIV CALIF LOS ANGELES,MED CTR,SCH MED,DIV CLIN IMMUNOL ALLERGY,10833 LECONTE AVE,RM 52-175 CHS,LOS ANGELES,CA 90024, USA.							Broder S, 1987, AIDS MODERN CONCEPTS; BRUNVEZINET F, 1987, LANCET, V1, P128; CHURCH JA, 1987, IMMUNOL ALLERGY PRAC, V9, P25; CLAVEL F, 1987, NEW ENGL J MED, V316, P1180, DOI 10.1056/NEJM198705073161903; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; CLUMECK N, 1984, NEW ENGL J MED, V310, P492, DOI 10.1056/NEJM198402233100804; COFFIN J, 1986, SCIENCE, V232, P697, DOI 10.1126/science.3008335; DULSTAD R, 1986, AIDS PAPERS SCI 1982; FRIEDLAND GH, 1986, NEW ENGL J MED, V314, P344, DOI 10.1056/NEJM198602063140604; GALLO RC, 1987, SCI AM, V256, P46; GOEDERT JJ, 1986, ANN INTERN MED, V105, P609, DOI 10.7326/0003-4819-105-4-609; HENDERSON DK, 1986, ANN INTERN MED, V104, P644, DOI 10.7326/0003-4819-104-5-644; HO DD, 1985, ANN INTERN MED, V103, P880, DOI 10.7326/0003-4819-103-6-880; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; MARGOLICK JB, 1987, J IMMUNOL, V138, P1719; MAYER KH, 1986, ANN INTERN MED, V104, P194, DOI 10.7326/0003-4819-104-2-194; MURRAY JF, 1984, NEW ENGL J MED, V310, P1682, DOI 10.1056/NEJM198406213102529; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; SHAW GM, 1985, SCIENCE, V227, P117; VINCENT TD, 1985, AIDS ETIOLOGY DIAGNO; YARCHOAN R, 1987, NEW ENGL J MED, V316, P557, DOI 10.1056/NEJM198702263160925; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4	22	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	1				796	802		10.1016/0091-6749(88)90934-7	http://dx.doi.org/10.1016/0091-6749(88)90934-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	N7036	3286719				2022-12-18	WOS:A1988N703600006
J	BLANCA, M; MIRANDA, A; GARCIA, J; FERNANDEZ, J; PERALTA, V; PELAEZ, A; BENSABAT, S; NEGRO, J; BORRAS, J				BLANCA, M; MIRANDA, A; GARCIA, J; FERNANDEZ, J; PERALTA, V; PELAEZ, A; BENSABAT, S; NEGRO, J; BORRAS, J			DISTRIBUTION OF THE SENSITIVITY TO VESPIDS IN SOUTH EUROPE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					170	170						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400030
J	CHEEMA, A; SUSSMAN, GL; JANCELEWICZ, Z; DOLOVICH, J; EVANS, S				CHEEMA, A; SUSSMAN, GL; JANCELEWICZ, Z; DOLOVICH, J; EVANS, S			PENTOTHAL ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					220	220		10.1016/0091-6749(88)90443-5	http://dx.doi.org/10.1016/0091-6749(88)90443-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400230
J	CONNELL, JT; LINZMAYER, MI				CONNELL, JT; LINZMAYER, MI			STUDIES OF REBOUND PHENOMENA AND OXYMETAZOLINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					179	179		10.1016/0091-6749(88)90278-3	http://dx.doi.org/10.1016/0091-6749(88)90278-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400065
J	DURHAM, SR; COOKSON, WOCM; CRADDOCK, CF; BENSON, MK				DURHAM, SR; COOKSON, WOCM; CRADDOCK, CF; BENSON, MK			FALLS IN EOSINOPHILS PARALLEL THE LATE ASTHMATIC RESPONSE AND ASSOCIATED INCREASES IN AIRWAY RESPONSIVENESS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Cookson, William/HHC-1790-2022						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					249	249		10.1016/0091-6749(88)90559-3	http://dx.doi.org/10.1016/0091-6749(88)90559-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400346
J	HAAKFRENDSCHO, M; ARAI, N; ARAI, KI; BAEZA, ML; FINN, A; KAPLAN, AP				HAAKFRENDSCHO, M; ARAI, N; ARAI, KI; BAEZA, ML; FINN, A; KAPLAN, AP			HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 CAUSE BASOPHIL HISTAMINE-RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					224	224		10.1016/0091-6749(88)90460-5	http://dx.doi.org/10.1016/0091-6749(88)90460-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Green Submitted			2022-12-18	WOS:A1988M027400247
J	JOOS, GF; PAUWELS, RA; VANDERSTRAETEN, ME				JOOS, GF; PAUWELS, RA; VANDERSTRAETEN, ME			THE EFFECT OF NEDOCROMIL SODIUM ON THE BRONCHO-CONSTRICTOR EFFECT OF NEUROKININ-A IN ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									STATE UNIV GHENT HOSP,DEPT RESP DIS,B-9000 GHENT,BELGIUM	Ghent University; Ghent University Hospital									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					276	276		10.1016/0091-6749(88)90667-7	http://dx.doi.org/10.1016/0091-6749(88)90667-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400454
J	LANTIN, JP; HUGUENOT, C; PECOUD, AR				LANTIN, JP; HUGUENOT, C; PECOUD, AR			EFFECT OF ASTEMIZOLE ON SKIN-TESTS WITH HISTAMIN, CODEIN AND ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					213	213		10.1016/0091-6749(88)90416-2	http://dx.doi.org/10.1016/0091-6749(88)90416-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400203
J	MELTZER, EO; ELLIS, EF; ROSEN, JP; SHAPIRO, GG; SIEGEL, SC; TINKELMAN, DG; VALERO, RN; ROMAN, IJ				MELTZER, EO; ELLIS, EF; ROSEN, JP; SHAPIRO, GG; SIEGEL, SC; TINKELMAN, DG; VALERO, RN; ROMAN, IJ			A COMPARISON OF LORATADINE, CHLORPHENIRAMINE AND PLACEBO SUSPENSIONS IN CHILDREN WITH SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					177	177		10.1016/0091-6749(88)90270-9	http://dx.doi.org/10.1016/0091-6749(88)90270-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400057
J	RING, J; KRAUS, K; FROSCHL, M; BURG, G				RING, J; KRAUS, K; FROSCHL, M; BURG, G			AIDS, HIV INFECTION AND ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					216	216		10.1016/0091-6749(88)90427-7	http://dx.doi.org/10.1016/0091-6749(88)90427-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400214
J	ZILLIOX, AP; HUTCHESON, PS; DOMOTO, DT; SLAVIN, RG				ZILLIOX, AP; HUTCHESON, PS; DOMOTO, DT; SLAVIN, RG			HENOCH-SCHONLEIN PURPURA ASSOCIATED WITH STREPTOKINASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					224	224		10.1016/0091-6749(88)90458-7	http://dx.doi.org/10.1016/0091-6749(88)90458-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400245
J	ZURAW, BL; CHRISTIANSEN, SC; SUGIMOTO, SL; LANG, DL				ZURAW, BL; CHRISTIANSEN, SC; SUGIMOTO, SL; LANG, DL			RADIOGRAPHIC CONTRAST-MEDIA (RCM) REACTIONS ASSOCIATED WITH HYPOTENSION ARE ACCOMPANIED BY CLEAVAGE OF HIGH MOLECULAR-WEIGHT KININOGEN (HMWK) IN PLASMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					223	223		10.1016/0091-6749(88)90453-8	http://dx.doi.org/10.1016/0091-6749(88)90453-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400240
J	FUJIWARA, K; SAITA, T; SHIMODA, T; ASAI, S; HARA, K				FUJIWARA, K; SAITA, T; SHIMODA, T; ASAI, S; HARA, K			ISONICOTINIC-ACID HYDRAZIDE AS AN ANTIGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NAGASAKI UNIV,SCH MED,DEPT INTERNAL MED 2,NAGASAKI 852,JAPAN	Nagasaki University	FUJIWARA, K (corresponding author), NAGASAKI UNIV,FAC PHARMACEUT SCI,BUNKYO MACHI 1-14,NAGASAKI 852,JAPAN.							AALBERSE RC, 1973, IMMUNOCHEMISTRY, V10, P295, DOI 10.1016/0019-2791(73)90025-6; ASAI S, 1987, J ALLERGY CLIN IMMUN, V80, P578, DOI 10.1016/0091-6749(87)90010-8; ASAI S, 1977, JPN J ALLERGOLOGY, V26, P731; CUTHBERTSON WFJ, 1953, BIOCHEM J, V55, P669, DOI 10.1042/bj0550669; DEHAAN P, 1979, ALLERGY, V34, P111; FOX HH, 1953, J ORG CHEM, V18, P1375, DOI 10.1021/jo50016a018; FUJIWARA K, 1984, CANCER RES, V44, P4172; FUJIWARA K, 1982, CANCER RES, V42, P1487; LORAND L, 1972, BIOCHEMISTRY-US, V11, P434, DOI 10.1021/bi00753a021; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; SHIMODA T, 1986, THESIS NAGASAKI U NA; SPATH P, 1979, ALLERGY, V34, P405, DOI 10.1111/j.1398-9995.1979.tb02010.x; TSE KS, 1976, J IMMUNOL, V116, P965	13	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1987	80	4					582	585		10.1016/0091-6749(87)90011-X	http://dx.doi.org/10.1016/0091-6749(87)90011-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5224	3668122	Bronze			2022-12-18	WOS:A1987K522400011
J	EARL, HS; STARK, BJ; SULLIVAN, TJ				EARL, HS; STARK, BJ; SULLIVAN, TJ			PENICILLIN INDUCED IGE RE-SENSITIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					200	200						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000323
J	FREELAND, HS; SCHLEIMER, RP; ALGER, M; PETERS, SP				FREELAND, HS; SCHLEIMER, RP; ALGER, M; PETERS, SP			LEUKOTRIENE B4 (LTB4) GENERATION BY HUMAN-PMNS IS NOT INHIBITED BY GLUCOCORTICOIDS INVIVO OR INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					157	157						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000154
J	GEHA, RS; HELM, B; WOOD, N; MARSH, P; GOULD, H				GEHA, RS; HELM, B; WOOD, N; MARSH, P; GOULD, H			IGE SITES RELEVANT FOR BINDING TO TYPE-1 FC EPSILON (FCER) RECEPTORS ON MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					129	129						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000042
J	PLATTSMILLS, T; POLLART, S; FIOCCO, G; ROSE, G; CHAPMAN, M				PLATTSMILLS, T; POLLART, S; FIOCCO, G; ROSE, G; CHAPMAN, M			EPIDEMIOLOGY OF ADULT ASTHMA IN AN EMERGENCY ROOM (ER) .2.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV VIRGINIA,CHARLOTTESVILLE,VA 22903	University of Virginia									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					184	184						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000259
J	TSAI, JJ; MAESTRELLI, P; FITZHARRIS, P; PARISH, N; KNIGHT, RA; KAY, AB				TSAI, JJ; MAESTRELLI, P; FITZHARRIS, P; PARISH, N; KNIGHT, RA; KAY, AB			A LYMPHOCYTE-DERIVED ACTIVITY WHICH ENHANCES IGG-DEPENDENT RELEASE OF LEUKOTRIENE B4 (LTB4) FROM HUMAN-NEUTROPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									BROMPTON HOSP,INST CARDIOTHORAC,LONDON SW3 6HP,ENGLAND	Royal Brompton Hospital									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					167	167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000191
J	BJORKSTEN, F				BJORKSTEN, F			EARLY ALLERGEN CONTACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BJORKSTEN, F (corresponding author), HELSINKI UNIV,CENT HOSP,HOSP ALLERG DIS,MEILAHDENTIE 2,SF-00250 HELSINKI,FINLAND.							ALANKO K, 1978, CLIN ALLERGY, V8, P25, DOI 10.1111/j.1365-2222.1978.tb00444.x; BACKMAN A, 1984, ALLERGY, V39, P309, DOI 10.1111/j.1398-9995.1984.tb00867.x; BJORKSTEN B, 1983, IMMUNOL TODAY, V4, P215, DOI 10.1016/0167-5699(83)90029-4; BJORKSTEN F, 1978, LANCET, V2, P624; BJORKSTEN F, 1980, CLIN ALLERGY, V10, P585, DOI 10.1111/j.1365-2222.1980.tb02140.x; BJORKSTEN F, 1981, ACTA MED SCAND, V209, P299; BJORKSTEN F, 1976, CLIN ALLERGY, V6, P165, DOI 10.1111/j.1365-2222.1976.tb01894.x; CROMWELL O, 1979, CLIN ALLERGY, V9, P109, DOI 10.1111/j.1365-2222.1979.tb01529.x; FRICK OL, 1979, J ALLERGY CLIN IMMUN, V63, P228, DOI 10.1016/0091-6749(79)90106-4; KAJOSAARI M, 1983, ACTA PAEDIATR SCAND, V72, P411, DOI 10.1111/j.1651-2227.1983.tb09738.x; KEMP AS, 1979, MED J AUSTRALIA, V1, P263, DOI 10.5694/j.1326-5377.1979.tb112072.x; KJELLMAN NIM, 1978, ACTA PAEDIATR SCAND, V67, P717, DOI 10.1111/j.1651-2227.1978.tb16249.x; MARSH DG, 1975, ANTIGENS, V3, P271; MURRAY AB, 1980, ANN ALLERGY, V45, P347; PEARSON DJ, 1977, CLIN ALLERGY, V7, P29, DOI 10.1111/j.1365-2222.1977.tb01421.x; Smith J. M., 1978, ALLERGY PRINCIPLES P, P633; SMITH JM, 1979, CLIN ALLERGY, V9, P153, DOI 10.1111/j.1365-2222.1979.tb01536.x; SUONIEMI I, 1981, ALLERGY, V36, P263, DOI 10.1111/j.1398-9995.1981.tb01573.x; VANTO T, 1983, ACTA PAEDIATR SCAND, V72, P571, DOI 10.1111/j.1651-2227.1983.tb09773.x	19	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1010	1012		10.1016/0091-6749(86)90294-0	http://dx.doi.org/10.1016/0091-6749(86)90294-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782662	Bronze			2022-12-18	WOS:A1986E971900015
J	WEI, BY; CARTER, BG; HOLFORDSTREVENS, V; SEHON, AH				WEI, BY; CARTER, BG; HOLFORDSTREVENS, V; SEHON, AH			SUPPRESSION OF IGE AND NON-IGE ANTIBODIES TO INDUSTRIAL-CHEMICALS BY CONJUGATES OF POLYVINYL-ALCOHOL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											WEI, BY (corresponding author), UNIV MANITOBA,DEPT IMMUNOL,MRC,ALLERGY RES GRP,WINNIPEG R3E 0W3,MANITOBA,CANADA.							BOYD AW, 1980, J EXP MED, V151, P1436, DOI 10.1084/jem.151.6.1436; BUTCHER BT, 1979, J ALLERGY CLIN IMMUN, V64, P146, DOI 10.1016/0091-6749(79)90049-6; DAVIES RJ, 1977, J ALLERGY CLIN IMMUN, V60, P93, DOI 10.1016/0091-6749(77)90032-X; HOLT PG, 1981, INT ARCH ALLER A IMM, V66, P357, DOI 10.1159/000232844; HOLT PG, 1983, INT ARCH ALLER A IMM, V71, P188, DOI 10.1159/000233387; HUBBARD DA, 1981, J IMMUNOL, V126, P407; KAROL MH, 1979, J OCCUP ENVIRON MED, V21, P354; KELLY KA, 1980, J IMMUNOL METHODS, V39, P317, DOI 10.1016/0022-1759(80)90232-X; LEE WY, 1980, INT ARCH ALLER A IMM, V63, P1; LEE WY, 1981, J IMMUNOL, V126, P414; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; OKUDAIRA H, 1981, CELL IMMUNOL, V58, P188, DOI 10.1016/0008-8749(81)90160-X; PATTERSON R, 1979, AM REV RESPIR DIS, V120, P1259; PEETERS SH, 1981, IMMUNOLOGY, V43, P25; SALVAGGIO JE, 1982, J ALLERGY CLIN IMMUN, V70, P5, DOI 10.1016/0091-6749(82)90193-2; SCHRADER JW, 1974, J EXP MED, V139, P1582, DOI 10.1084/jem.139.6.1582; SCHRADER JW, 1975, EUR J IMMUNOL, V5, P808, DOI 10.1002/eji.1830051203; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; WATANABE MR, 1983, CELL IMMUNOL, V79, P345, DOI 10.1016/0008-8749(83)90076-X; WEI BY, 1984, IMMUNOLOGY, V51, P687; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZHENG SS, UNPUB DETERMINATIONS	22	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1066	1070		10.1016/0091-6749(86)90307-6	http://dx.doi.org/10.1016/0091-6749(86)90307-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782669				2022-12-18	WOS:A1986E971900028
J	POPA, V				POPA, V			THE RELATIONSHIP BETWEEN ACETYLCHOLINE-INDUCED AND HISTAMINE-INDUCED CONSTRICTION OF LARGE AIRWAYS IN NORMAL SUBJECTS AND SUBJECTS WITH ASTHMA - A POSSIBLE ROLE FOR POSTRECEPTOR MECHANISMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL OHIO,PULM SECT,TOLEDO,OH 43699						NHLBI NIH HHS [HL-23679] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTOUNYAN R. E. C., 1964, THORAX, V19, P406, DOI 10.1136/thx.19.5.406; ANTONISSEN LA, 1980, J PHARMACOL EXP THER, V213, P150; ANUNLAKSHANA O, 1959, BRIT J PHARMACOL, V14, P48; BANDOUVAKIS J, 1981, BRIT J DIS CHEST, V75, P295, DOI 10.1016/0007-0971(81)90009-7; BEAKEY JF, 1969, ANN ALLERGY, V7, P113; BRINK C, 1980, BRIT J PHARMACOL, V69, P383, DOI 10.1111/j.1476-5381.1980.tb07026.x; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; CASTERLINE CL, 1976, J ALLERGY CLIN IMMUN, V58, P607, DOI 10.1016/0091-6749(76)90207-4; CHUNG KF, 1982, AM REV RESPIR DIS, V126, P849; COCKCROFT DW, 1977, THORAX, V32, P429, DOI 10.1136/thx.32.4.429; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; CROPP GJA, 1980, AM THORACIC SOC NEWS, V6, P11; CURRY JJ, 1946, J CLIN INVEST, V25, P792, DOI 10.1172/JCI101765; DEKOCK M, 1960, J APPL PHYSL, V21, P185; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; DURON B, 1970, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V164, P1086; EISER NM, 1981, CLIN RES PROC, V17, P427; EISER NM, 1983, B EUR PHYSIOPATH RES, V19, P495; EISER NM, 1982, B EUR PHYSIOPATH RES, V18, P449; FINNEY MJB, 1984, EUR J RESPIR DIS, V65, P447; FISH JE, 1979, J ALLERGY CLIN IMMUN, V64, P592, DOI 10.1016/0091-6749(79)90019-8; FURCHGOTT RF, 1970, FED PROC, V29, P1352; GHELANI AM, 1980, BRIT J PHARMACOL, V71, P107, DOI 10.1111/j.1476-5381.1980.tb10915.x; GOLD WM, 1967, J APPL PHYSIOL, V23, P433, DOI 10.1152/jappl.1967.23.4.433; GUYATT AR, 1968, J APPL PHYSIOL, V24, P310, DOI 10.1152/jappl.1968.24.3.310; HABIB MP, 1978, J APPL PHYSL, V17, P51; HIGGENBOTTAM T, 1980, J APPL PHYSIOL, V49, P403; HOLTZMAN MJ, 1979, AM REV RESPIR DIS, V120, P1059; HOLTZMAN MJ, 1980, AM REV RESPIR DIS, V122, P17; ITKIN IH, 1970, J ALLERGY, V45, P178, DOI 10.1016/0021-8707(70)90126-7; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; KALSER SC, 1971, ANN NY ACAD SCI, V179, P667, DOI 10.1111/j.1749-6632.1971.tb46943.x; Laitinen L A, 1979, Scand J Respir Dis Suppl, V103, P215; MACKLEM PT, 1975, NEW ENGL J MED, V293, P339, DOI 10.1056/NEJM197508142930706; MAKINO S, 1966, J APPL PHYSL, V49, P869; MULLER N, 1980, J APPL PHYSIOL, V49, P869, DOI 10.1152/jappl.1980.49.5.869; MURLAS C, 1982, J APPL PHYSIOL, V52, P1084, DOI 10.1152/jappl.1982.52.4.1084; NADEL J A, 1973, P29; OREHEK J, 1981, AM REV RESPIR DIS, V123, P269; PAK CCF, 1982, AM REV RESPIR DIS, V125, P331; PEGELOW KO, 1974, ACTA ALLERGOL, V29, P365, DOI 10.1111/j.1398-9995.1974.tb01472.x; PERSSON CGA, 1976, AGENTS ACTIONS, V6, P389, DOI 10.1007/BF01973208; POPA V, 1984, American Review of Respiratory Disease, V129, pA29; POPA V, 1974, J LAB CLIN MED, V84, P225; POPA V, 1981, CLIN RES, V29, P774; POPA V, J PHARM EXP THER; POPA VT, 1984, AM REV RESPIR DIS, V130, P1006; POPA VT, 1980, CHEST, V78, P442, DOI 10.1378/chest.78.3.442; SHEPPARD D, 1984, J ALLERGY CLIN IMMUN, V73, P82, DOI 10.1016/0091-6749(84)90488-3; SIMONSSON BG, 1967, J CLIN INVEST, V46, P1812, DOI 10.1172/JCI105671; STANESCU DC, 1973, SCAND J RESPIR DIS, V54, P333; STEEL R, 1980, PRINCIPLES PROCEDURE, P100; THOMSON NC, 1979, CLIN SCI, V56, P235, DOI 10.1042/cs0560235; Tiffeneau R, 1958, Acta Allergol Suppl (Copenh), V5, P187; VINCENC KS, 1983, AM REV RESPIR DIS, V128, P875; WOENNE R, 1978, J ALLERGY CLIN IMMUN, V62, P119, DOI 10.1016/0091-6749(78)90089-1; 1962, AM REV RESPIR DIS, V85, P762; 1979, AM REV RESPIR DIS, V19, P831	58	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	1				601	613		10.1016/0091-6749(86)90077-1	http://dx.doi.org/10.1016/0091-6749(86)90077-1			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5682	3771952				2022-12-18	WOS:A1986E568200008
J	DAMELIO, R; PERRICONE, R; DECAROLIS, C; PONTESILLI, O; MATRICARDI, PM; FONTANA, L				DAMELIO, R; PERRICONE, R; DECAROLIS, C; PONTESILLI, O; MATRICARDI, PM; FONTANA, L			IMMUNE-COMPLEXES IN HEREDITARY ANGIONEUROTIC-EDEMA (HANE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									UNIV ROME LA SAPIENZA,MED CLIN 6,I-00100 ROME,ITALY	Sapienza University Rome	DAMELIO, R (corresponding author), UNIV ROME LA SAPIENZA,DEPT ALLERGOL & CLIN IMMUNOL,I-00100 ROME,ITALY.			De Carolis, Caterina/0000-0002-6597-6253; Perricone, Roberto/0000-0002-2368-9766; D'Amelio, Raffaele/0000-0003-0669-2629				BARNET M, 1980, 4TH INT C IMM PAR, P21; CASALI P, 1977, CLIN EXP IMMUNOL, V29, P342; DOEKES G, 1983, IMMUNOLOGY, V49, P215; HAY FC, 1976, CLIN EXP IMMUNOL, V24, P396; MIGLIORINI P, 1984, CLIN IMMUNOL IMMUNOP, V32, P298, DOI 10.1016/0090-1229(84)90274-5; SCHIFFERLI JA, 1983, LANCET, V2, P957; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2500	7	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				486	487		10.1016/0091-6749(86)90037-0	http://dx.doi.org/10.1016/0091-6749(86)90037-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3760406	Bronze			2022-12-18	WOS:A1986E114800018
J	MUNRO, IC				MUNRO, IC			THE INGREDIENTS OF FOODS - HOW THEY ARE TESTED AND WHY THEY ARE SELECTED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MUNRO, IC (corresponding author), CANADIAN CTR TOXICOL,645 GORDON ST,GUELPH N1G 1Y3,ONTARIO,CANADA.							TANNAHILL R, 1973, FOOD HIST, P1; 1982, CONSUMER PRODUCTS EN; 1984, CURRENT ISSUES TOXIC; 1981, GUIDELINES TESTING C; 1975, TESTING CHEM CARCINO; 1978, ENV HLTH CRITERIA, V6; 1967, WHO TECHNICAL REPORT, V426; 1978, FOOD COSMET TOXICO S, V16, P1; 1982, TOXICOLOGICAL PRINCI; 1982, TOXIC SUBSTANCES HLT	10	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	2	S			133	139		10.1016/0091-6749(86)90003-5	http://dx.doi.org/10.1016/0091-6749(86)90003-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2997	3722640				2022-12-18	WOS:A1986D299700003
J	VYSZENSKIMOHER, DL; ARLIAN, LG; BERNSTEIN, IL; GALLAGHER, JS				VYSZENSKIMOHER, DL; ARLIAN, LG; BERNSTEIN, IL; GALLAGHER, JS			PREVALENCE OF HOUSE DUST MITES IN NURSING-HOMES IN SOUTHWEST OHIO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Discussion									WRIGHT STATE UNIV, COLL SCI & ENGN, DEPT BIOL SCI, DAYTON, OH 45435 USA; UNIV CINCINNATI, MED CTR, DEPT MED, DIV ALLERGY, CINCINNATI, OH 45267 USA; WRIGHT STATE UNIV, COLL SCI & ENGN, DEPT PHYSIOL & BIOPHYS, DAYTON, OH 45435 USA; WRIGHT STATE UNIV, SCH MED, DAYTON, OH 45435 USA	Wright State University Dayton; University of Cincinnati; Wright State University Dayton; Wright State University Dayton					NIAID NIH HHS [R01 AI 13702] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARLIAN LG, 1982, J ALLERGY CLIN IMMUN, V69, P527, DOI 10.1016/0091-6749(82)90178-6; ARLIAN LG, 1981, J MED ENTOMOL, V18, P351, DOI 10.1093/jmedent/18.4.351; ARLIAN LG, 1978, J MED ENTOMOL, V15, P35, DOI 10.1093/jmedent/15.1.35; ARLIAN LG, UNPUB J ALLERGY CLIN; BLYTHE ME, 1975, BRIT MED J, V1, P62, DOI 10.1136/bmj.1.5949.62; CUNNINGTON AM, 1968, NATURE, V217, P1271, DOI 10.1038/2171271a0; LIND P, 1983, SCAND J IMMUNOL, V17, P263, DOI 10.1111/j.1365-3083.1983.tb00789.x; LUSTGRAAF BVD, 1977, ACTA ALLERGOL, V32, P406, DOI 10.1111/j.1398-9995.1977.tb01364.x; PLATTSMILLS TAE, 1982, LANCET, V2, P675; RAO V R M, 1975, Clinical Allergy, V5, P209, DOI 10.1111/j.1365-2222.1975.tb01854.x; SARSFIELD JK, 1974, ARCH DIS CHILD, V49, P711, DOI 10.1136/adc.49.9.711; SESAY HR, 1972, ACAROLOGIA, V14, P3; Van Bronswijk J.E.M.H., 1971, Researches Popul Ecol, V13, P67, DOI 10.1007/BF02522014; VANBRONS.JE, 1973, J MED ENTOMOL, V10, P63, DOI 10.1093/jmedent/10.1.63; VANBRONS.JE, 1974, ENTOMOL EXP APPL, V17, P199, DOI 10.1007/BF00335876; VANBRONSWIJK JE, 1971, J ALLERGY, V47, P31, DOI 10.1016/S0091-6749(71)80315-9	16	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1986	77	5					745	748		10.1016/0091-6749(86)90423-9	http://dx.doi.org/10.1016/0091-6749(86)90423-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	C3903	3700901				2022-12-18	WOS:A1986C390300021
J	AMEISEN, JC; FOURNIER, E; VORNG, H; TONNEL, AB; JOSEPH, M; CAPRON, A				AMEISEN, JC; FOURNIER, E; VORNG, H; TONNEL, AB; JOSEPH, M; CAPRON, A			ASPIRIN-SENSITIVE ASTHMA - SERUM FROM ASPIRIN DESENSITIZED PATIENTS INHIBITS THE ABNORMAL PLATELET RESPONSE TO NSAIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			182	182						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800241
J	BARSELA, S; BENZVI, A; RUBINOFF, A				BARSELA, S; BENZVI, A; RUBINOFF, A			CROSS-REACTIVITY OF GRASS-POLLEN AND CEREAL ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			196	196						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800297
J	BJORKANDER, J; BENGTSSON, U; OXELIUS, VA; HANSON, LA				BJORKANDER, J; BENGTSSON, U; OXELIUS, VA; HANSON, LA			SYMPTOMS AND EFFECTS OF IMMUNOGLOBULIN PROPHYLAXIS IN PATIENTS WITH LOW SERUM LEVELS OF THE IGG SUBCLASSES 1, 2 AND/OR 3	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			124	124						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800013
J	BUSH, R; OLSEN, E; MEIERDAVIS, S; CZLAPINSKI, D				BUSH, R; OLSEN, E; MEIERDAVIS, S; CZLAPINSKI, D			CHARACTERIZATION OF AN ALLERGEN IN A CASE OF SNOW CRAB ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			121	121						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800001
J	FADEL, R; PARIS, S; FITTING, C; RASSEMONT, R; DAVID, B				FADEL, R; PARIS, S; FITTING, C; RASSEMONT, R; DAVID, B			A COMPARISON OF EXTRACTS FROM ALTERNARIA SPORES AND MYCELIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			242	242						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800481
J	FIOCCO, GP; WILKINS, SR; HAYDEN, ML; GUERRANT, JL; PLATTSMILLS, TAE				FIOCCO, GP; WILKINS, SR; HAYDEN, ML; GUERRANT, JL; PLATTSMILLS, TAE			ANAPHYLAXIS AND SEVERE ANGIOEDEMA ASSOCIATED WITH IMMEDIATE HYPERSENSITIVITY TO TRICHOPHYTON INFECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			189	189						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800272
J	JUNIPER, EF; HARGREAVE, FE				JUNIPER, EF; HARGREAVE, FE			AIRWAY RESPONSIVENESS ASSESSED BY AEROSOL INHALATION TESTS - VARIABILITY IN RESULTS DUE TO UNEXPECTED DIFFERENCES BETWEEN CALIBRATED NEBULIZERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			171	171						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800198
J	LEE, RJ; BRAMAN, SS; SETTIPANE, GA				LEE, RJ; BRAMAN, SS; SETTIPANE, GA			REPRODUCIBILITY OF METABISULFITE CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			157	157						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800142
J	STEINACKER, A				STEINACKER, A			A SUGGESTED MECHANISM OF ACTION FOR SULFITE SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											STEINACKER, A (corresponding author), WASHINGTON UNIV,SCH MED,DEPT OTOLARYNGOL,517 S EUCLID AVE,ST LOUIS,MO 63110, USA.							[Anonymous], 1973, CHEM BIOCH SULFHYDRY; ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; BAKER GJ, 1981, MED J AUSTRALIA, V2, P614, DOI 10.5694/j.1326-5377.1981.tb113018.x; DEMBIEC D, 1977, J NEUROCHEM, V28, P1125, DOI 10.1111/j.1471-4159.1977.tb10677.x; DEMBIEC D, 1976, BIOCHEM PHARMACOL, V25, P1369, DOI 10.1016/0006-2952(76)90106-4; FREEDMAN BJ, 1977, CLIN ALLERGY, V7, P407, DOI 10.1111/j.1365-2222.1977.tb01471.x; GERBER DA, 1967, BIOCHEM PHARMACOL, V16, P115, DOI 10.1016/0006-2952(67)90192-X; KURATOMI K, 1957, J BIOCHEM-TOKYO, V44, P183, DOI 10.1093/oxfordjournals.jbchem.a126743; LUKAS RJ, 1980, J BIOL CHEM, V255, P5573; MEANS GE, 1971, CHEM MODIFICATIONS P; NADEL JA, 1965, J APPL PHYSIOL, V20, P164, DOI 10.1152/jappl.1965.20.1.164; SCHWARTZ HJ, 1983, J ALLERGY CLIN IMMUN, V71, P487, DOI 10.1016/0091-6749(83)90466-9; SHEPPARD D, 1980, AM REV RESPIR DIS, V122, P873; SIMON R, 1984, J ALLERGY CLIN IMMUN, V73, P109; STEINACKER A, 1982, J NEUROSCI RES, V7, P313, DOI 10.1002/jnr.490070309; STEINACKER A, 1981, P NATL ACAD SCI-BIOL, V78, P7806, DOI 10.1073/pnas.78.12.7806; STEINACKER A, 1979, NATURE, V278, P353; STENIUS BSM, 1976, CLIN ALLERGY, V6, P119, DOI 10.1111/j.1365-2222.1976.tb01889.x; STEVENSON DD, 1981, J ALLERGY CLIN IMMUN, V68, P26, DOI 10.1016/0091-6749(81)90119-6; TWAROG FJ, 1982, JAMA-J AM MED ASSOC, V248, P2030, DOI 10.1001/jama.248.16.2030; WERTH GR, 1982, J ALLERGY CLIN IMMUN, V70, P143, DOI 10.1016/0091-6749(82)90243-3; ZUAZAGA DC, 1985, PR HLTH SCI J, V3, P125	22	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				116	117		10.1016/0091-6749(86)90334-9	http://dx.doi.org/10.1016/0091-6749(86)90334-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	3944370				2022-12-18	WOS:A1986AZD3600022
J	TURCOTTE, H; LEGRIS, C; BOULET, LP				TURCOTTE, H; LEGRIS, C; BOULET, LP			NONSPECIFIC BRONCHIAL RESPONSIVENESS TO HISTAMINE AFTER REPEATED EXERCISE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			164	164						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800171
J	WALKER, SB; BIERMAN, CW; PIERSON, WE; SHAPIRO, GG; FURUKAWA, CT; MINGO, TS				WALKER, SB; BIERMAN, CW; PIERSON, WE; SHAPIRO, GG; FURUKAWA, CT; MINGO, TS			BITOLTEROL MESYLATE IN EXERCISE-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ASTHMA INC,SEATTLE,WA; UNIV WASHINGTON,CHILDRENS ORTHOPED HOSP & MED CTR,SCH MED,DEPT PEDIAT,DIV ALLERGY,SEATTLE,WA 98105	University of Washington; University of Washington Seattle								BIERMAN CW, 1985, J ALLERGY CLIN IMMUN, V75, P161, DOI 10.1016/0091-6749(85)90362-8; BIERMAN CW, 1983, CLIN REV ALLERG, V1, P87; COCKCROFT DW, 1981, CURR THER RES CLIN E, V30, P817; EGGLESTON PA, 1981, CLIN PHARMACOL THER, V29, P505, DOI 10.1038/clpt.1981.70; EGGLESTON PA, 1979, J ALLERGY CLIN IMMUN, V63, P104, DOI 10.1016/0091-6749(79)90199-4; GODFREY S, 1975, PEDIATRICS, V56, P851; KIVILOOG J, 1975, PEDIATRICS, V56, P908; OLSEN CR, 1968, AM REV RESPIR DIS, V98, P301; Schild H, 1937, Q J EXP PHYSIOL, V26, P165; SCHLEIMER RP, 1984, J ALLERGY CLIN IMMUN, V74, P473, DOI 10.1016/0091-6749(84)90381-6; SCHOEFFEL RE, 1981, ANN ALLERGY, V46, P273; SLY RM, 1984, J ALLERGY CLIN IMMUN, V73, P680, DOI 10.1016/0091-6749(84)90305-1; SLY RM, 1968, ANN ALLERGY, V26, P258; TINKELMAN DG, 1983, J ALLERGY CLIN IMMUN, V71, P126, DOI 10.1016/0091-6749(83)90274-9; WINER BJ, 1971, STATISTICAL PRINCIPL, P514	15	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				32	36		10.1016/0091-6749(86)90318-0	http://dx.doi.org/10.1016/0091-6749(86)90318-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	3944373				2022-12-18	WOS:A1986AZD3600006
J	YOUNG, C; TOOGOOD, JH				YOUNG, C; TOOGOOD, JH			DO BETA-BLOCKERS INCREASE THE RISK OF IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			225	225						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800415
J	ZIMMERMAN, B; UNDERDOWN, BJ; ELLIS, J; JAMES, O				ZIMMERMAN, B; UNDERDOWN, BJ; ELLIS, J; JAMES, O			CLONED HELPER T-CELL FOR IGE - CHARACTERIZATION OF T-CELLS CLONED FROM AN ATOPIC DONOR WITH A HIGH SERUM IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TORONTO,SUNNYBROOK HOSP,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	ZIMMERMAN, B (corresponding author), HOSP SICK CHILDREN,DIV ALLERGY,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							BUCKLEY RH, 1982, ANN ALLERGY, V49, P67; FISER PM, 1979, J ALLERGY CLIN IMMUN, V63, P145; GEHA RS, 1984, J ALLERGY CLIN IMMUN, V74, P109, DOI 10.1016/0091-6749(84)90270-7; HEMADY Z, 1983, J ALLERGY CLIN IMMUN, V71, P324, DOI 10.1016/0091-6749(83)90087-8; HENDERSON LE, 1983, J IMMUNOL, V131, P810; HIRASHIMA M, 1980, J IMMUNOL, V125, P1442; ISHIZAKA K, 1976, ADV IMMUNOL, V23, P1, DOI 10.1016/S0065-2776(08)60318-1; LANZAVECCHIA A, 1984, CLIN EXP IMMUNOL, V55, P197; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P733, DOI 10.1002/eji.1830130908; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; MINGARI MC, 1982, EUR J IMMUNOL, V12, P900, DOI 10.1002/eji.1830121019; NONAKA M, 1981, J EXP MED, V153, P1574, DOI 10.1084/jem.153.6.1574; ROMAGNANI S, 1983, CLIN EXP IMMUNOL, V52, P85; ROMAGNANI S, 1980, CLIN EXP IMMUNOL, V42, P167; SAMPSON HA, 1981, J IMMUNOL, V127, P829; SARFATI M, 1984, IMMUNOLOGY, V53, P187; SARYAN JA, 1983, J IMMUNOL, V130, P242; SAXON A, 1980, J CLIN INVEST, V65, P1457, DOI 10.1172/JCI109810; SAXON A, 1979, CLIN IMMUNOL IMMUNOP, V14, P974; SPIEGELBERG HL, 1983, J IMMUNOL, V131, P3001; SUEMURA M, 1980, J IMMUNOL, V125, P148; TADA T, 1975, PROG ALLERGY, V19, P122, DOI 10.1159/000313387; TJIO AH, 1979, J IMMUNOL, V122, P2131; TSUI F, 1984, CELL IMMUNOL, V85, P34, DOI 10.1016/0008-8749(84)90275-2; TURNER KJ, 1981, CLIN EXP IMMUNOL, V43, P458; UNDERDOWN BJ, 1977, IMMUNOCHEMISTRY, V14, P111, DOI 10.1016/0019-2791(77)90289-0; UNDERDOWN BJ, 1983, J ALLERGY CLIN IMMUN, V71, P122, DOI 10.1016/0091-6749(83)90258-0; UNDERDOWN BJ, 1983, 6TH P ICACI SAT M RE, P67; YOUNG M C, 1984, Journal of Allergy and Clinical Immunology, V73, P172; ZURAW BL, 1981, J IMMUNOL, V127, P1169	30	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				70	79		10.1016/0091-6749(86)90326-X	http://dx.doi.org/10.1016/0091-6749(86)90326-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	2935568				2022-12-18	WOS:A1986AZD3600014
J	CHAN, TB; SHELTON, D; EISER, N				CHAN, TB; SHELTON, D; EISER, N			EFFECTS OF AN ORAL ANTIHISTAMINE ON ANTIGEN-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									GUYS HOSP,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					141	141		10.1016/0091-6749(85)90281-7	http://dx.doi.org/10.1016/0091-6749(85)90281-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200146
J	COGEN, FC; GOLDSTEIN, M; ZWEIMAN, B				COGEN, FC; GOLDSTEIN, M; ZWEIMAN, B			SKIN TESTING IN CHYMOPAPAIN ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,PHILADELPHIA,PA 19104	University of Pennsylvania								BAUR X, 1982, CLIN ALLERGY, V12, P9, DOI 10.1111/j.1365-2222.1982.tb03121.x; BERNSTEIN D I, 1984, Journal of Allergy and Clinical Immunology, V73, P180; DiMaio V J, 1976, J Forensic Sci, V21, P187; HAVERLY R W, 1984, Journal of Allergy and Clinical Immunology, V73, P179; MANSFIELD LE, 1983, J ALLERGY CLIN IMMUN, V71, P371, DOI 10.1016/0091-6749(83)90064-7; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; SMITH L, 1972, J BONE JOINT SURG AM, VA 54, P1795; TARLO SM, 1978, CLIN ALLERGY, V8, P207, DOI 10.1111/j.1365-2222.1978.tb03216.x; Watts C, 1977, Neurosurgery, V1, P2; 1983, S SKIN TESTING CHEMO; 1973, JAMA, V224, P613	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	6					728	730		10.1016/0091-6749(85)90101-0	http://dx.doi.org/10.1016/0091-6749(85)90101-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ALA84	3891824	Bronze			2022-12-18	WOS:A1985ALA8400016
J	DURHAM, SR; LOEGERING, DA; GLEICH, GJ; KAY, AB				DURHAM, SR; LOEGERING, DA; GLEICH, GJ; KAY, AB			EOSINOPHILS, NON-SPECIFIC BRONCHIAL RESPONSIVENESS, AND ALLERGEN-INDUCED LATE-PHASE ASTHMATIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					148	148		10.1016/0091-6749(85)90308-2	http://dx.doi.org/10.1016/0091-6749(85)90308-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200173
J	GOLDSTEIN, MF; KORNSTEIN, MJ; TALBOT, S; LEVINSON, AI				GOLDSTEIN, MF; KORNSTEIN, MJ; TALBOT, S; LEVINSON, AI			ACQUIRED HYPER-IGM SYNDROME WITH NECROTIZING GRANULOMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104	University of Pennsylvania	LEVINSON, AI (corresponding author), UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,515 JOHNSON PAVILION,36TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.							BEALL GN, 1980, J ALLERGY CLIN IMMUN, V65, P471, DOI 10.1016/0091-6749(80)90242-0; BHAN AK, 1981, J EXP MED, V154, P737, DOI 10.1084/jem.154.3.737; BRONSKY D, 1965, AM J MED SCI, V11, P18; BUCKLEY RH, 1983, J ALLERGY CLIN IMMUN, V72, P627, DOI 10.1016/0091-6749(83)90619-X; DELELLIS RA, 1979, AM J CLIN PATHOL, V71, P483; FRIEDMAN R, 1983, AM J DIS CHILD, V137, P774, DOI 10.1001/archpedi.1983.02140340054015; GEHA RS, 1979, J CLIN INVEST, V64, P385, DOI 10.1172/JCI109473; GRANOWICZ E, 1976, EUR J IMMUNOL, V6, P588; HERROD HG, 1978, PEDIATR RES, V12, P480, DOI 10.1203/00006450-197804001-00707; HINZ CF, 1963, NEW ENGL J MED, V269, P1329, DOI 10.1056/NEJM196312192692501; HOBBS JR, 1967, CLIN EXP IMMUNOL, V2, P581; HOFFMAN FM, 1983, BLOOD, V62, P775; KOATTINEN YT, 1983, CLIN IMMUNOL IMMUNOP, V26, P380; KORNSTEIN MJ, 1983, CANCER RES, V43, P2749; KRANTMAN HJ, 1980, CLIN EXP IMMUNOL, V40, P147; KYONG CU, 1978, PEDIATR RES, V12, P1024, DOI 10.1203/00006450-197810000-00015; LEVINSON AI, 1981, J CLIN LAB IMMUNOL, V5, P17; LEVITT D, 1983, J CLIN INVEST, V72, P1650, DOI 10.1172/JCI111124; LEVITT D, 1981, CLIN IMMUNOL IMMUNOP, V21, P50, DOI 10.1016/0090-1229(81)90194-X; MITSUYA H, 1979, J CLIN LAB IMMUNOL, V2, P337; MODLIN RL, 1983, CLIN EXP IMMUNOL, V51, P430; MORRIS HB, 1983, HISTOPATHOLOGY, V7, P809, DOI 10.1111/j.1365-2559.1983.tb02298.x; NARAYANAN RB, 1983, CLIN EXP IMMUNOL, V51, P421; PASCUALSALCEDO D, 1979, J CLIN LAB IMMUNOL, V2, P337; POPPEMA S, 1981, J EXP MED, V153, P30, DOI 10.1084/jem.153.1.30; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; ROSEN FS, 1961, PEDIATRICS, V28, P182; ROSEN FS, 1963, NEW ENGL J MED, V269, P1336, DOI 10.1056/NEJM196312192692502; RUCO LP, 1984, CLIN IMMUNOL IMMUNOP, V30, P337, DOI 10.1016/0090-1229(84)90020-5; SHARMA OP, 1971, AM REV RESPIR DIS, V104, P228; STIEHM ER, 1966, AM J MED, V40, P805, DOI 10.1016/0002-9343(66)90163-X; 1979, CLIN IMMUNOL IMMUNOP, V13, P297	32	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					472	478		10.1016/S0091-6749(85)80020-8	http://dx.doi.org/10.1016/S0091-6749(85)80020-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3980882				2022-12-18	WOS:A1985AFY4400007
J	LOCKEY, R; BENEDICT, LM; TURKELTAUB, P				LOCKEY, R; BENEDICT, LM; TURKELTAUB, P			FATALITIES (F) FROM IMMUNOTHERAPY (IT) AND SKIN TESTING (ST)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/U-7729-2019; turkeltaub, paul/AAG-6160-2019						0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					166	166		10.1016/0091-6749(85)90381-1	http://dx.doi.org/10.1016/0091-6749(85)90381-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200246
J	MCCALL, MK; NAIR, N; WONG, S; TOWNLEY, RG; LANG, D; WEISS, SJ				MCCALL, MK; NAIR, N; WONG, S; TOWNLEY, RG; LANG, D; WEISS, SJ			DOUBLE-BLIND CONTROLLED SAFETY AND EFFICACY TRIAL OF SK-AND-F 93944	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					168	168		10.1016/0091-6749(85)90391-4	http://dx.doi.org/10.1016/0091-6749(85)90391-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200256
J	MCGETTIGAN, MC; SCHULMAN, ES; POST, TJ; VIGDERMAN, RJ				MCGETTIGAN, MC; SCHULMAN, ES; POST, TJ; VIGDERMAN, RJ			HISTAMINE RELEASING (HR) FACTOR FROM CULTURED HUMAN MONOCYTE-MACROPHAGES (M-M)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		THUESON, 1979, J IMMUNOL, V123, P626	1	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					110	110		10.1016/0091-6749(85)90156-3	http://dx.doi.org/10.1016/0091-6749(85)90156-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200021
J	NORDVALL, SL; JOHANSSON, SGO; LEDFORD, DK; LOCKEY, RF				NORDVALL, SL; JOHANSSON, SGO; LEDFORD, DK; LOCKEY, RF			ALLERGENS OF IMPORTED FIRE ANT (IFA), SOLENOPSIS-INVICTA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					122	122		10.1016/0091-6749(85)90207-6	http://dx.doi.org/10.1016/0091-6749(85)90207-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200072
J	RANDOLPH, CC; REISMAN, RE				RANDOLPH, CC; REISMAN, RE			FURTHER EVALUATION OF DECLINE IN VENOM-SPECIFIC IGE AS A CRITERION FOR DISCONTINUING VENOM IMMUNOTHERAPY (VIT)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					151	151		10.1016/0091-6749(85)90320-3	http://dx.doi.org/10.1016/0091-6749(85)90320-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200185
J	SCHATZ, M; WASSERMAN, S; OCONNOR, RD; HARDEN, K; FORSYTHE, A; CHILINGAR, L; HOFFMAN, C; SPERLING, W; ZEIGER, RS				SCHATZ, M; WASSERMAN, S; OCONNOR, RD; HARDEN, K; FORSYTHE, A; CHILINGAR, L; HOFFMAN, C; SPERLING, W; ZEIGER, RS			DISTINGUISHING CLINICAL AND BIOCHEMICAL CHARACTERISTICS ASSOCIATED WITH IMPROVEMENT OR DETERIORATION OF ASTHMA DURING PREGNANCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					133	133		10.1016/0091-6749(85)90250-7	http://dx.doi.org/10.1016/0091-6749(85)90250-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200115
J	SCHELLENBERG, RR; FOSTER, A; DUFF, MJ				SCHELLENBERG, RR; FOSTER, A; DUFF, MJ			ANTI-IGE INDUCED CONTRACTION OF HUMAN BRONCHUS INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV BRITISH COLUMBIA,PULM RES LAB,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia			Foster, Aidan/F-7530-2011	Foster, Aidan/0000-0003-2531-8640					0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					126	126		10.1016/0091-6749(85)90223-4	http://dx.doi.org/10.1016/0091-6749(85)90223-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200088
J	SCHOENWETTER, WF				SCHOENWETTER, WF			ANAPHYLAXIS IN NURSES CAUSED BY INHALED PSYLLIUM SEED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					209	209		10.1016/0091-6749(85)90555-X	http://dx.doi.org/10.1016/0091-6749(85)90555-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200420
J	SKASSABROCIEK, W; BOUSQUET, J; MENARDO, JL; MICHEL, FB				SKASSABROCIEK, W; BOUSQUET, J; MENARDO, JL; MICHEL, FB			VARIATION OF SKIN-TESTS ACCORDING TO THE AGE OF THE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					195	195		10.1016/0091-6749(85)90497-X	http://dx.doi.org/10.1016/0091-6749(85)90497-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200362
J	SMITH, CM; ANDERSON, SD				SMITH, CM; ANDERSON, SD			HYPEROSMOLARITY AS THE STIMULUS TO HYPERVENTILATION ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		ANDERSON SD, 1983, THORAX, V38, P284, DOI 10.1136/thx.38.4.284; ROSENTHAL, 1984, JACI, V73, P676; 1984, JACI, V73, P660	3	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					143	143		10.1016/0091-6749(85)90288-X	http://dx.doi.org/10.1016/0091-6749(85)90288-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200153
J	WARDLAW, AJ; FITZHARRIS, P; CROMWELL, O; COLLINS, JV; KAY, AB				WARDLAW, AJ; FITZHARRIS, P; CROMWELL, O; COLLINS, JV; KAY, AB			HISTAMINE-RELEASE FROM MUCOSAL-TYPE HUMAN-LUNG MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					193	193		10.1016/0091-6749(85)90489-0	http://dx.doi.org/10.1016/0091-6749(85)90489-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200354
J	BRASH, AR; MAAS, RL; OATES, JA				BRASH, AR; MAAS, RL; OATES, JA			ON THE MECHANISM OF BIOSYNTHESIS OF 5-SERIES AND 15-SERIES LEUKOTRIENES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BRASH, AR (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,DIV CLIN PHARMACOL,NASHVILLE,TN 37232, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 15431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRASH AR, UNPUB INVESTIGATION; COREY EJ, 1980, J AM CHEM SOC, V102, P4278, DOI 10.1021/ja00532a059; FEE JA, 1980, METAL ION ACTIVATION, P209; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HAMBERG M, 1980, BIOCHEM BIOPH RES CO, V95, P1090, DOI 10.1016/0006-291X(80)91584-3; HAMBERG M, 1971, ANAL BIOCHEM, V43, P515, DOI 10.1016/0003-2697(71)90282-X; HAMILTON GA, 1974, MOL MECHANISMS OXYGE, P410; HAMMARSTROM S, 1983, J BIOL CHEM, V258, P1427; JUBIZ W, 1981, BIOCHEM BIOPH RES CO, V99, P976, DOI 10.1016/0006-291X(81)91258-4; MAAS RL, 1981, P NATL ACAD SCI-BIOL, V78, P5523, DOI 10.1073/pnas.78.9.5523; MAAS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2884, DOI 10.1073/pnas.80.10.2884; MAAS RL, 1982, J BIOL CHEM, V257; MAAS RL, UNPUB INVESTIGATION; PANOSSIAN A, 1982, FEBS LETT, V150, P511, DOI 10.1016/0014-5793(82)80801-6; RADMARK O, 1982, ADV PROSTAG THROMB L, V9, P61; ROOT RK, 1975, J CLIN INVEST, V55, P945, DOI 10.1172/JCI108024; SOK DE, 1982, BIOCHEM BIOPH RES CO, V104, P1363, DOI 10.1016/0006-291X(82)91400-0; SOK DE, 1983, BIOCHEM BIOPH RES CO, V110, P273, DOI 10.1016/0006-291X(83)91291-3	18	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					316	323		10.1016/0091-6749(84)90123-4	http://dx.doi.org/10.1016/0091-6749(84)90123-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6088609				2022-12-18	WOS:A1984TQ63300003
J	FRASER, CM; VENTER, JC				FRASER, CM; VENTER, JC			ANTI-RECEPTOR ANTIBODIES IN HUMAN-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FRASER, CM (corresponding author), NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT MOLEC IMMUNOL,BUFFALO,NY 14263, USA.			Fraser, Claire/0000-0003-1462-2428				Adams D., 1956, P U OTAGO MED SCH, V34, P11; ANHOLT R, 1984, ENZYMES BIOL MEMBRAN; BLECHER M, 1984, J ALLERGY CLIN IMMUN, V74, P246, DOI 10.1016/0091-6749(84)90253-7; BUSSE WW, 1976, J ALLERGY CLIN IMMUN, V58, P586, DOI 10.1016/0091-6749(76)90205-0; CAMPBELL AK, 1979, FEBS LETT, V107, P55, DOI 10.1016/0014-5793(79)80462-7; CHANGEUX JP, 1981, HARVEY LECT, V75, P85; CLEVELAND WL, 1983, NATURE, V305, P56, DOI 10.1038/305056a0; CONNOLLY ME, 1976, J CLIN INVEST, V58, P1307; CONTITRONCONI BM, 1982, ANNU REV BIOCHEM, V51, P491, DOI 10.1146/annurev.bi.51.070182.002423; DORRINGTON KJ, 1966, CLIN PHARMACOL THER, V7, P788; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; ENDO K, 1978, J CLIN ENDOCR METAB, V46, P734, DOI 10.1210/jcem-46-5-734; ENGEL AG, 1979, NEUROLOGY, V29, P179, DOI 10.1212/WNL.29.2.179; ENGEL AG, 1977, NEUROLOGY, V27, P307, DOI 10.1212/WNL.27.4.307; ENGEL AG, 1976, J NEUROPATH EXP NEUR, V35, P569, DOI 10.1097/00005072-197609000-00008; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FLIER JS, 1976, J CLIN INVEST, V58, P1442, DOI 10.1172/JCI108600; FLIER JS, 1975, SCIENCE, V190, P63, DOI 10.1126/science.170678; FRASER CM, 1981, NEW ENGL J MED, V305, P1165, DOI 10.1056/NEJM198111123052001; HARRISON L, 1980, MEMBRANE RECEPTORS I, P109; HARRISON LC, 1979, SCIENCE, V203, P544, DOI 10.1126/science.83675; HARRISON LC, 1979, J CLIN ENDOCR METAB, V48, P59, DOI 10.1210/jcem-48-1-59; HARRISON LC, 1982, RECEPTORS ANTIBODIES, P248; HEINEMANN S, 1977, P NATL ACAD SCI USA, V74, P3090, DOI 10.1073/pnas.74.7.3090; HENDERSON WR, 1979, NEW ENGL J MED, V300, P642, DOI 10.1056/NEJM197903223001203; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KAHN CR, 1977, J CLIN INVEST, V60, P1094, DOI 10.1172/JCI108861; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; KAHN CR, 1976, NEW ENGL J MED, V294, P739, DOI 10.1056/NEJM197604012941401; KAHN CR, 1982, RECEPTORS ANTIBODIES, P91; KARLSSON FA, 1979, P NATL ACAD SCI USA, V76, P809, DOI 10.1073/pnas.76.2.809; KASUGA M, 1978, J CLIN ENDOCR METAB, V47, P66, DOI 10.1210/jcem-47-1-66; KENDALLTAYLOR P, 1973, BMJ-BRIT MED J, V3, P72; KOHN LD, 1984, RECEPTOR BIOCH METHO, V4; KOHN LD, 1982, MEMBRANES TUMOR GROW, P389; Lindstrom J, 1979, Adv Immunol, V27, P1, DOI 10.1016/S0065-2776(08)60261-8; LINDSTROM J, 48TH COLD SPRING HAR; LINDSTROM J, 1983, MYOLOGY; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MAKINO S, 1977, J ALLERGY CLIN IMMUN, V59, P348, DOI 10.1016/0091-6749(77)90016-1; MANLEY SW, 1974, J ENDOCRINOL, V61, P419, DOI 10.1677/joe.0.0610419; NITSCH L, 1980, P NATL ACAD SCI-BIOL, V77, P2743, DOI 10.1073/pnas.77.5.2743; OCHI Y, 1977, ACTA ENDOCRINOL-COP, V85, P791, DOI 10.1530/acta.0.0850791; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; PATRICK J, 1973, P NATL ACAD SCI USA, V70, P3334, DOI 10.1073/pnas.70.12.3334; PETERSEN VB, 1977, FEBS LETT, V83, P63, DOI 10.1016/0014-5793(77)80642-X; ROITT IM, 1982, RECEPTOR ANTIBODIES, P22; SCHREIBER AB, 1980, P NATL ACAD SCI-BIOL, V77, P7385, DOI 10.1073/pnas.77.12.7385; SHECHTER Y, 1982, SCIENCE, V216, P542, DOI 10.1126/science.7041258; SHELHAMER JH, 1980, J ALLERGY CLIN IMMUN, V66, P52, DOI 10.1016/0091-6749(80)90138-4; SMITH BR, 1974, LANCET, V2, P427; SMITH BR, 1971, BIOCHIM BIOPHYS ACTA, V229, P649, DOI 10.1016/0005-2795(71)90281-9; SMITH BR, 1977, J ENDOCRINOL, V75, P401, DOI 10.1677/joe.0.0750401; SMITH BR, 1969, BIOCHIM BIOPHYS ACTA, V192, P277, DOI 10.1016/0304-4165(69)90366-3; SMITH LJ, 1980, J ALLERGY CLIN IMMUN, V66, P374, DOI 10.1016/0091-6749(80)90116-5; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TZARTOS SJ, 1982, P NATL ACAD SCI-BIOL, V79, P188, DOI 10.1073/pnas.79.1.188; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; TZARTOS SJ, 1980, P NATL ACAD SCI-BIOL, V77, P755, DOI 10.1073/pnas.77.2.755; VALENTE WA, 1982, P NATL ACAD SCI-BIOL, V79, P6680, DOI 10.1073/pnas.79.21.6680; VALENTE WA, 1983, NEW ENGL J MED, V309, P1028, DOI 10.1056/NEJM198310273091705; VANOBBERGHEN E, 1979, NATURE, V280, P500, DOI 10.1038/280500a0; VENTER JC, 1980, SCIENCE, V207, P1361, DOI 10.1126/science.6153472; VENTER JC, 1983, TRENDS PHARMACOL SCI, V4, P256; VITTI P, 1982, P NATL ACAD SCI-BIOL, V79, P1525, DOI 10.1073/pnas.79.5.1525	65	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	5					661	673		10.1016/0091-6749(84)90227-6	http://dx.doi.org/10.1016/0091-6749(84)90227-6			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TT169	6209320				2022-12-18	WOS:A1984TT16900002
J	KLEMAWESCH, SJ; BUCKLEY, CE				KLEMAWESCH, SJ; BUCKLEY, CE			THE LECTIN REACTIVITY AND LECTIN-LIKE ACTIVITY OF ALLERGENIC POLLEN EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,DEPT MICROBIOL IMMUNOL,DURHAM,NC 27706	Duke University; Duke University								BROWN A, 1933, J ALLERGY, V4, P468; BUCKLEY RH, 1977, J ALLERGY CLIN IMMUN, V59, P70, DOI 10.1016/0091-6749(77)90180-4; BURGER MM, 1970, NATURE, V228, P512, DOI 10.1038/228512a0; CLARKE AE, 1978, Q REV BIOL, V53, P3, DOI 10.1086/410333; Coca AF, 1925, J IMMUNOL, V10, P555; FRANCUS T, 1983, P NATL ACAD SCI-BIOL, V80, P3430, DOI 10.1073/pnas.80.11.3430; GOLDSTEIN IJ, 1974, ANN NY ACAD SCI, V234, P283, DOI 10.1111/j.1749-6632.1974.tb53040.x; GOLDSTEIN IJ, 1972, METHODS CARBOHYD CHE, V6, P106; INBAR M, 1969, NATURE, V223, P710, DOI 10.1038/223710a0; KABAT EA, 1961, KABAT MAYERS EXPT IM, P609; KARLSTAM B, 1982, J IMMUNOL METHODS, V99, P119; KNOX RB, 1976, P NATL ACAD SCI USA, V73, P2788, DOI 10.1073/pnas.73.8.2788; Ouchterlony O., 1964, IMMUNOLOGICAL METHOD, P55; PEREIRA MEA, 1979, CRC CRIT REV IMMUNOL, V12, P133; POWELL AE, 1970, EXP CELL RES, V62, P315, DOI 10.1016/0014-4827(70)90560-4; SHOHAM J, 1970, NATURE, V227, P1244, DOI 10.1038/2271244a0; Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936; VANLIS JMJ, 1975, BRIT J DERMATOL, V92, P27; WATSON L, 1974, NATURE, V249, P574, DOI 10.1038/249574a0; WILLOUGHBY WF, 1979, LAB INVEST, V40, P399; WINDHOLZ M, 1976, MERCK INDEX, P25	21	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					619	627		10.1016/0091-6749(84)90521-9	http://dx.doi.org/10.1016/0091-6749(84)90521-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS045	6425389	Bronze			2022-12-18	WOS:A1984SS04500014
J	MAHAN, LK				MAHAN, LK			NUTRITION AND THE ALLERGIC ATHLETE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WASHINGTON, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	MAHAN, LK (corresponding author), CHILDRENS ORTHOPED HOSP & MED CTR, CTR PEDIAT PULM DIS, SEATTLE, WA 98105 USA.							AHLMAN K, 1961, J SPORTS MED PHYSICA, V1, P58; BERGSTROM J, 1967, SCAND J CLIN LAB INV, V19, P218, DOI 10.3109/00365516709090629; CELEJOWA I, 1970, NUTR METAB, V12, P259; COHEN SH, 1979, J ALLERGY CLIN IMMUN, V64, P270, DOI 10.1016/0091-6749(79)90143-X; COOTER GR, 1978, RES QUART, V49, P114, DOI 10.1080/10671315.1978.10615515; COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155; COSTILL DL, 1982, AM J CLIN NUTR, V36, P266, DOI 10.1093/ajcn/36.2.266; COSTILL DL, 1981, AM J CLIN NUTR, V34, P1831, DOI 10.1093/ajcn/34.9.1831; COSTILL DL, 1975, AVIAT SPACE ENVIR MD, V46, P795; de Wijn J F, 1971, J Sports Med Phys Fitness, V11, P42; DECOMBAZ J, 1979, EUR J APPL PHYSIOL O, V41, P61, DOI 10.1007/BF00424469; DILLARD CJ, 1978, J APPL PHYSIOL, V45, P927, DOI 10.1152/jappl.1978.45.6.927; Dressendorfer Rudolph H, 1982, Phys Sportsmed, V10, P113, DOI 10.1080/00913847.1982.11947250; Edwards HT, 1935, NEW ENGL J MED, V213, P532, DOI 10.1056/NEJM193509122131108; Evans WJ, 1983, PHYSICIAN SPORTSMED, V11, P63, DOI DOI 10.1080/00913847.1983.11708585; EVANS WJ, MED SCI SPORTS EXERC; FELDMAN CH, 1980, PEDIATRICS, V66, P956; FINCH CA, 1979, J CLIN INVEST, V64, P129, DOI 10.1172/JCI109431; HARRISON MH, 1974, J APPL PHYSIOL, V44, P69; HAYMES EM, 1983, ERGOGENIC AIDS SPORT, P27; Houston M E, 1981, Phys Sportsmed, V9, P73, DOI 10.1080/00913847.1981.11711208; Hunt HB, 1938, BMJ-BRIT MED J, V1938, P726; KAPPAS A, 1976, CLIN PHARMACOL THER, V20, P643; KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203; KREISMAN H, 1977, LUNG, V154, P223; LARITCHEVA KA, 1978, NUTRITION PHYSICAL F, P155; LAWRENCE JD, 1975, AM J CLIN NUTR, V28, P205, DOI 10.1093/ajcn/28.3.205; LEMON PWR, 1980, J APPL PHYSIOL, V48, P624, DOI 10.1152/jappl.1980.48.4.624; LEMON PWR, 1981, MED SCI SPORT EXER, V13, P141; MANSFIELD LE, 1981, ANN ALLERGY, V47, P154; Mirkin G, 1973, JAMA, V223, P1511; MOSHENIN V, 1983, AM REV RESPIR DIS, V27, P143; NELSON RA, 1982, PHYSICIAN SPORTSMED, V10, P55; NOVEY HS, 1977, J ALLERGY CLIN IMMUN, V59, P359, DOI 10.1016/0091-6749(77)90018-5; OGILVY CS, 1981, J ALLERGY CLIN IMMUN, V67, P363, DOI 10.1016/0091-6749(81)90081-6; OSEID S, 1984, COMMUNICATION; Pate R R, 1983, Phys Sportsmed, V11, P115, DOI 10.1080/00913847.1983.11708460; Pate Russell R, 1979, Phys Sportsmed, V7, P81, DOI 10.1080/00913847.1979.11948486; PUGLIESE MT, 1983, NEW ENGL J MED, V309, P513, DOI 10.1056/NEJM198309013090901; REFSUM HE, 1979, SCAND J CLIN LAB INV, V39, P407, DOI 10.3109/00365517909106125; SALTIN B, 1964, J APPL PHYSIOL, V19, P1125, DOI 10.1152/jappl.1964.19.6.1125; SALTIN B, 1964, J APPL PHYSIOL, V19, P1114, DOI 10.1152/jappl.1964.19.6.1114; SCHACHTER EN, 1982, ANN ALLERGY, V49, P146; SHERMAN WM, 1981, INT J SPORTS MED, V2, P114, DOI 10.1055/s-2008-1034594; SMITH NJ, 1980, PEDIATRICS, V66, P139; STEWART GA, 1972, MED J AUSTRALIA, V2, P1339, DOI 10.5694/j.1326-5377.1972.tb92925.x; Strydom N B, 1966, S Afr Med J, V40, P539; WILLIAMS MH, 1976, NUTRITIONAL ASPECTS, P113; Yoshimura H, 1980, World Rev Nutr Diet, V35, P1; ZUSKIN E, 1973, J ALLERGY CLIN IMMUN, V51, P218, DOI 10.1016/0091-6749(73)90141-3; 1967, JAMA, V201, P541; [No title captured]	52	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					728	734		10.1016/0091-6749(84)90315-4	http://dx.doi.org/10.1016/0091-6749(84)90315-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS046	6715737				2022-12-18	WOS:A1984SS04600022
J	OSEID, S				OSEID, S			DOPING AND ATHLETES - PREVENTION AND COUNSELING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV HOSP OSLO,CHILDRENS ASTHMA & ALLERGY INST,N-1000 OSLO,NORWAY	University of Oslo	OSEID, S (corresponding author), NORWEGIAN COLL PHYS EDUC & SPORT,OSLO,NORWAY.							LAMB DR, 1983, AM J SPORTS MED, V12, P31; PROKOP L, 1975, AM J SPORTS MED, V3, P85	2	5	5	0	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					735	739		10.1016/0091-6749(84)90316-6	http://dx.doi.org/10.1016/0091-6749(84)90316-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	SS046	6715738				2022-12-18	WOS:A1984SS04600023
J	PARKER, CW				PARKER, CW			LIPOXYGENASES AND LEUKOTRIENES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST LAB,ST LOUIS,MO 63110	Washington University (WUSTL)	PARKER, CW (corresponding author), WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,ST LOUIS,MO 63110, USA.							BAILEY DM, 1981, ANNU REP MED CHEM, V16, P213; BOCKMAN RS, 1981, PROSTAGLANDINS, V21, P9, DOI 10.1016/0090-6980(81)90192-1; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P3213, DOI 10.1073/pnas.76.7.3213; BORGEAT P, 1976, J BIOL CHEM, V251, P7816; BORGEAT P, 1979, J BIOL CHEM, V254, P2643; BORGEAT P, 1982, LEUKOTRIENES OTHER L, P45; CHILTON FH, 1982, J BIOL CHEM, V257, P5402; FALKENHEIN SF, 1980, J IMMUNOL, V125, P163; FEINMARK SJ, 1981, FEBS LETT, V136, P141, DOI 10.1016/0014-5793(81)81233-1; FORDHUTCHINSON AW, 1981, PROSTAGLANDINS, V21, P143, DOI 10.1016/0090-6980(81)90204-5; FORDHUTCHINSON AW, 1981, J ROY SOC MED, V74, P831, DOI 10.1177/014107688107401111; FORDHUTCHINSON AW, 1982, BRIT J PHARMACOL, V76, P215, DOI 10.1111/j.1476-5381.1982.tb09209.x; GALLIARD T, 1975, BIOCH PLANTS, P335; GIBIAN MJ, 1978, BIOORGANIC CHEM, P117; GOETZL EJ, 1979, J EXP MED, V150, P406, DOI 10.1084/jem.150.2.406; GOETZL EJ, 1981, MED CLIN N AM, V65, P809, DOI 10.1016/S0025-7125(16)31499-7; GOLDMAN DW, 1982, J IMMUNOL, V129, P1600; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; HAMMARSTROM S, 1979, J INVEST DERMATOL, V73, P180, DOI 10.1111/1523-1747.ep12581645; HAMMARSTROM S, 1979, BIOCHEM BIOPH RES CO, V91, P1266, DOI 10.1016/0006-291X(79)91203-8; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; JAKSCHIK BA, 1977, J IMMUNOL, V119, P618; JAKSCHIK BA, 1977, P NATL ACAD SCI USA, V74, P4577, DOI 10.1073/pnas.74.10.4577; JAKSCHIK BA, 1982, LEUKOTRIENES OTHER L, P127; JOUBIZ W, 1982, J BIOL CHEM, V257, P6106; KENNERLY DA, 1979, J IMMUNOL, V122, P152; KENNERLY DA, 1979, J EXP MED, V150, P1039, DOI 10.1084/jem.150.4.1039; KREISLE RA, 1983, J EXP MED, V157, P628, DOI 10.1084/jem.157.2.628; LEWIS RA, 1980, P NATL ACAD SCI-BIOL, V77, P3710, DOI 10.1073/pnas.77.6.3710; MAAS RL, 1982, J BIOL CHEM, V257, P7056; MAAS RL, 1982, LEUKOTRIENES OTHER L, P29; MORRIS HR, 1980, NATURE, V285, P104, DOI 10.1038/285104a0; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; NUGTEREN DH, 1977, PROSTAGLANDINS HEMAT, P11; ORNING L, 1980, P NATL ACAD SCI USA, V77, P2012; PARKER CW, 1979, PROSTAGLANDINS, V18, P673, DOI 10.1016/0090-6980(79)90088-1; PARKER CW, 1980, P NATL ACAD SCI-BIOL, V77, P6870, DOI 10.1073/pnas.77.11.6870; PARKER CW, 1982, BIOCHEM BIOPH RES CO, V109, P1011, DOI 10.1016/0006-291X(82)92040-X; PARKER CW, 1980, PROSTAGLANDINS, V20, P863, DOI 10.1016/0090-6980(80)90139-2; PARKER CW, 1980, BIOCH BIOPHYS RES CO, V96, P1037; PARKER CW, 1980, 4TH P INT S BIOCH AC, P23; PARKER CW, 1983, IMMUNOPHARMACOLOGY L, P5; RITTENHOUSESIMMONS S, 1979, J CLIN INVEST, V63, P580, DOI 10.1172/JCI109339; ROUZER CA, 1980, P NATL ACAD SCI-BIOL, V77, P4928, DOI 10.1073/pnas.77.8.4928; SAMUELSSON B, 1980, ADV PROSTAGLANDIN TH, P1; STENSON WF, 1979, PROSTAGLANDINS, V18, P285, DOI 10.1016/0090-6980(79)90115-1; STENSON WF, 1979, J CLIN INVEST, V64, P1457, DOI 10.1172/JCI109604; STENSON WF, 1980, BIOCHEM BIOPH RES CO, V96, P1045, DOI 10.1016/0006-291X(80)90058-3; VERHUE WM, 1972, BIOCHIM BIOPHYS ACTA, V284, P43, DOI 10.1016/0005-2744(72)90044-7; WHITE AA, 1982, BIOCHEM J, V204, P383, DOI 10.1042/bj2040383	50	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					343	348		10.1016/0091-6749(84)90127-1	http://dx.doi.org/10.1016/0091-6749(84)90127-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633	6432876				2022-12-18	WOS:A1984TQ63300007
J	SHAPIRO, GG				SHAPIRO, GG			METHACHOLINE CHALLENGE - RELEVANCE FOR THE ALLERGIC ATHLETE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SHAPIRO, GG (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195, USA.							ANDERTON RC, 1979, J ALLERGY CLIN IMMUN, V63, P315, DOI 10.1016/0091-6749(79)90125-8; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHATHAM M, 1982, AM REV RESPIR DIS, V126, P235; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; CURNY JJ, 1947, J CLIN INVEST, V26, P430; EGGLESTON PA, 1979, J ALLERGY CLIN IMMUN, V63, P104, DOI 10.1016/0091-6749(79)90199-4; FELARCA AB, 1966, J ALLERGY, V37, P223, DOI 10.1016/0021-8707(66)90117-1; FISH JE, 1976, AM REV RESPIR DIS, V113, P579; HARGREAVE FE, 1983, SEMIN RESPIR MED, V4, P224, DOI 10.1055/s-2007-1012487; HOPP R, 1983, AM ACADEMY PEDIAT AI; ITKIN IH, 1967, J ALLERGY, V40, P245, DOI 10.1016/0021-8707(67)90087-1; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; KIVILOOG J, 1973, SCAND J RESPIR DIS, V54, P347; MAKINO S, 1966, J ALLERGY, V38, P127, DOI 10.1016/0021-8707(66)90036-0; MALO JL, 1983, AM REV RESPIR DIS, V128, P8, DOI 10.1164/arrd.1983.128.1.8; MELLIS CM, 1978, AM REV RESPIR DIS, V117, P911; MUITTARI A, 1968, Annales Medicinae Internae Fenniae, V57, P197; MYERS JR, 1981, JAMA-J AM MED ASSOC, V246, P225, DOI 10.1001/jama.246.3.225; OREHEK J, 1977, AM REV RESPIR DIS, V115, P937; PARKER CD, 1965, ARCH INTERN MED, V115, P452, DOI 10.1001/archinte.1965.03860160078013; PRATTER MR, 1983, CHEST, V84, P42, DOI 10.1378/chest.84.1.42; RYAN G, 1981, AM REV RESPIR DIS, V123, P195; SCHILLER L, 1947, ANN ALLERGY, V5, P564; SHAPIRO GG, 1982, J ALLERGY CLIN IMMUN, V69, P365, DOI 10.1016/0091-6749(82)90147-6; SPECTOR SL, 1975, J ALLERGY CLIN IMMUN, V56, P308, DOI 10.1016/0091-6749(75)90105-0; TIFFENEAU R, 1955, ANN MED, V56, P582; TOWNLEY RG, 1965, J ALLERGY, V36, P121, DOI 10.1016/0021-8707(65)90161-9; TOWNLEY RG, 1975, J ALLERGY CLIN IMMUN, V56, P429	28	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					670	675		10.1016/0091-6749(84)90303-8	http://dx.doi.org/10.1016/0091-6749(84)90303-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS046	6371105				2022-12-18	WOS:A1984SS04600010
J	BORIS, M; SCHIFF, M; WEINDORF, S; INSELMAN, L				BORIS, M; SCHIFF, M; WEINDORF, S; INSELMAN, L			BRONCHOPROVOCATION BLOCKED BY NEUTRALIZATION THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					92	92		10.1016/0091-6749(83)90140-9	http://dx.doi.org/10.1016/0091-6749(83)90140-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200017
J	CHANG, JL; JOHNSON, J; KANG, B				CHANG, JL; JOHNSON, J; KANG, B			CHARACTERIZATION OF COCKROACH ANTIGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					161	161		10.1016/0091-6749(83)90413-X	http://dx.doi.org/10.1016/0091-6749(83)90413-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200290
J	CLARK, NM				CLARK, NM			THE APPLICATION OF THEORY IN CHILDHOOD ASTHMA SELF-HELP PROGRAMS - RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CLARK, NM (corresponding author), UNIV MICHIGAN, SCH PUBL HLTH, DEPT HLTH BEHAV & HLTH EDUC, ANN ARBOR, MI 48109 USA.							[Anonymous], 1974, Health Education Monograph, V2, P324; BECKER MH, 1975, INT J HEALTH EDUC, V18, P173; BECKER MH, 1972, J PEDIATR-US, V81, P843, DOI 10.1016/S0022-3476(72)80118-5; BECKER MH, 1978, PUBLIC HEALTH REP, V93, P268; BRUHN JG, 1982, HLTH ED Q, V9, P142; CLARK NM, 1980, HEALTH EDUC QUART, V7, P278, DOI 10.1177/109019818000700403; CLARK NM, 1981, HEALTH EDUC QUART, V8, P166, DOI 10.1177/109019818100800203; CREER T, 1981, SELF MANAGEMENT ED P, V2; DAVIS MS, 1968, AM J PUBLIC HEALTH N, V58, P274, DOI 10.2105/AJPH.58.2.274; Haynes RB., 1979, COMPLIANCE HLTH CARE; LEWIS CE, 1977, PEDIATRICS, V60, P499; LEWIS CE, 1982, HLTH ED Q, V9, P129; NATAPOFF J, 1982, HLTH ED Q, V9, P34; Parcel G.S., 1981, HLTH ED          MAY, P14; STECKEL SB, 1977, HOSPITALS, V51, P81; WALLSTON BS, 1978, HEALTH EDUC QUART, V6, P107; WILSON SR, 1982, AM PUBLIC HLTH ASS M	17	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					578	580		10.1016/0091-6749(83)90484-0	http://dx.doi.org/10.1016/0091-6749(83)90484-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RS163	6643864				2022-12-18	WOS:A1983RS16300010
J	CLAYTON, WF; GEORGITIS, JW; REISMAN, RE				CLAYTON, WF; GEORGITIS, JW; REISMAN, RE			INSECT STING ANAPHYLAXIS IN PATIENTS WITHOUT DETECTABLE SERUM VENOM-SPECIFIC IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					141	141		10.1016/0091-6749(83)90335-4	http://dx.doi.org/10.1016/0091-6749(83)90335-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200212
J	CRETICOS, PS; ADKINSON, NF; SOBOTKA, AK; MEIER, HL; LICHTENSTEIN, LM; MARSH, DG; NORMAN, PS				CRETICOS, PS; ADKINSON, NF; SOBOTKA, AK; MEIER, HL; LICHTENSTEIN, LM; MARSH, DG; NORMAN, PS			CHARACTERIZATION OF RAGWEED SENSITIVE PATIENTS BY NASAL CHALLENGE WITH POLLEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					90	90		10.1016/0091-6749(83)90129-X	http://dx.doi.org/10.1016/0091-6749(83)90129-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200006
J	DAY, JH; LEES, REM; CLARKE, RH				DAY, JH; LEES, REM; CLARKE, RH			RESPIRATORY EFFECTS OF FORMALDEHYDE AND UFFI OFF-GAS FOLLOWING CONTROLLED EXPOSURE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									QUEENS UNIV,KINGSTON K7L 3N6,ONTARIO,CANADA	Queens University - Canada									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					159	159		10.1016/0091-6749(83)90407-4	http://dx.doi.org/10.1016/0091-6749(83)90407-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200284
J	EMMETT, EA				EMMETT, EA			OCCUPATIONAL SKIN-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											EMMETT, EA (corresponding author), JOHNS HOPKINS MED INST, CTR OCCUPAT & ENVIRONM HLTH, DIV OCCUPAT MED, BLDG 6, 3100 WYMAN PK DR, BALTIMORE, MD 21211 USA.			Emmett, Edward/0000-0002-3731-7197				Adams R. M., 1983, OCCUPATIONAL SKIN DI; BAER RL, 1981, IMMUNODERMATOLOGY CO, V7; BAGINSKY E, 1982, OCCUPATIONAL SKIN DI; BAGINSKY E, 1973, OCCUPATIONAL DISEASE; BLEEHEN SS, 1968, J INVEST DERMATOL, V50, P103, DOI 10.1038/jid.1968.13; BRONAUGH RL, 1983, DERMATOTOXICOLOGY; BURROWS D, 1972, BRIT J DERMATOL, V87, P145, DOI 10.1111/j.1365-2133.1972.tb16189.x; CHANG KJ, 1981, TOXICOL APPL PHARM, V61, P58, DOI 10.1016/0041-008X(81)90007-7; EMMETT EA, 1978, INT J DERMATOL, V17, P370, DOI 10.1111/ijd.1978.17.5.370; EMMETT EA, 1979, PHOTOCHEM PHOTOBIOL, V30, P429, DOI 10.1111/j.1751-1097.1979.tb07159.x; EMMETT EA, 1975, J OCCUP ENVIRON MED, V1, P44, DOI 10.1097/00043764-197501000-00011; EMMETT EA, 1979, DERMATOLOGY GENERAL; EPSTEIN J, 1981, IMMUNODERMATOLOGY; FELDMANN RJ, 1967, J INVEST DERMATOL, V48, P181, DOI 10.1038/jid.1967.29; Figard W H, 1982, Occup Health Saf, V51, P32; FISHER MS, 1978, J IMMUNOL, V121, P1139; Foussereau J, 1982, OCCUPATIONAL CONTACT; Fregert S, 1975, Contact Dermatitis, V1, P96, DOI 10.1111/j.1600-0536.1975.tb05334.x; Fregert S., 1981, MANUAL CONTACT DERMA, V2nd ed.; GELLIN GA, 1970, JOM-J OCCUP MED, V12, P386; GELLIN GA, 1982, OCCUPATIONAL IND DER; HEISEL EB, 1978, ARCH ENV HLTH, V17, P705; HELLIER FF, 1958, BRIT MED J, V1, P196, DOI 10.1136/bmj.1.5064.196; Hjorth N., 1977, DERMATOTOXICOLOGY PH, P344; JIMBOW K, 1974, J INVEST DERMATOL, V62, P436, DOI 10.1111/1523-1747.ep12701679; KAHN G, 1970, ARCH DERMATOL, V102, P177; KONZEN JK, 1982, OCCUPATIONAL IND DER; Kripke M L, 1981, Adv Cancer Res, V34, P69, DOI 10.1016/S0065-230X(08)60239-0; Maibach HI, 1982, OCCUPATIONAL IND DER; Mathias C. G. t., 1983, DERMATOTOXICOLOGY, P167; MCGUIRE J, 1971, J INVEST DERMATOL, V57, P256, DOI 10.1111/1523-1747.ep12261579; MITCHELL JG, 1974, CONTACT DERMATITIS, V1, P193; PHILLIPS L, 1972, TOXICOL APPL PHARM, V21, P369, DOI 10.1016/0041-008X(72)90157-3; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POSSICK PA, 1970, AM IND HYG ASSOC J, V31, P12, DOI 10.1080/0002889708506201; ROTHENBORG HW, 1977, CONTACT DERMATITIS, V3, P37, DOI 10.1111/j.1600-0536.1977.tb03584.x; SCHEVPLEIN RJ, 1981, PHYSIOL REV, V51, P702; SCHWARTZ L, 1957, OCCUPATIONAL DISEASE; STEINBERG M, 1975, ANIMAL MODELS DERMAT, P1; STINGL G, 1980, J INVEST DERMATOL, V74, P315, DOI 10.1111/1523-1747.ep12543548; SUKANTO H, 1981, CONTACT DERMATITIS, V7, P180, DOI 10.1111/j.1600-0536.1981.tb04038.x; Taylor J S, 1979, Ann N Y Acad Sci, V320, P295, DOI 10.1111/j.1749-6632.1979.tb13155.x; TAYLOR JS, 1982, CHLORINATED DIOXINS; VOS JG, 1980, HALOGENATED BIPHENYL; WESTER RC, 1983, DERMATOTOXICOLOGY; 1979, REPORT OSHA ADVISORY; 1977, ENCY BRITANNICA	47	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	6					649	656		10.1016/0091-6749(83)90624-3	http://dx.doi.org/10.1016/0091-6749(83)90624-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RW048	6227649	Bronze			2022-12-18	WOS:A1983RW04800003
J	FINDLAY, S; STOSKY, E; LIETERMANN, K; HEMEDY, Z; OHMAN, J				FINDLAY, S; STOSKY, E; LIETERMANN, K; HEMEDY, Z; OHMAN, J			AIRBORNE CAT-ASSOCIATED ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					160	160		10.1016/0091-6749(83)90412-8	http://dx.doi.org/10.1016/0091-6749(83)90412-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200289
J	GRAFT, DF; SCHUBERTH, KC; KAGEYSOBOTKA, A; KWITEROVICH, KA; LICHTENSTEIN, LM; VALENTINE, MD				GRAFT, DF; SCHUBERTH, KC; KAGEYSOBOTKA, A; KWITEROVICH, KA; LICHTENSTEIN, LM; VALENTINE, MD			IMMUNOLOGICAL EFFECTS OF PROLONGED VENOM IMMUNOTHERAPY IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					140	140		10.1016/0091-6749(83)90331-7	http://dx.doi.org/10.1016/0091-6749(83)90331-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200208
J	HEWITT, B; BOUSQUET, J; GUERIN, B; MICHEL, FB				HEWITT, B; BOUSQUET, J; GUERIN, B; MICHEL, FB			CROSS ALLERGENICITY AMONG URTICACEAE POLLENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bousquet, Jean/O-4221-2019						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					105	105		10.1016/0091-6749(83)90192-6	http://dx.doi.org/10.1016/0091-6749(83)90192-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200069
J	HINDIALEXANDER, MC				HINDIALEXANDER, MC			EDUCATIONAL SELF-HELP APPROACHES IN CHILDHOOD ASTHMA - RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY BUFFALO,DEPT MED,DIV ALLERGY,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								ALEXANDER AB, 1981, MED PSYCHOL CONTRIBU, P373; [Anonymous], 1977, STRESS COPING ANTHOL; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BURDON JGW, 1982, AM REV RESPIR DIS, V126, P825; CLARK NM, 1980, HEALTH EDUC QUART, V7, P278, DOI 10.1177/109019818000700403; CREER T, SELF MANAGEMENT CHRO; Creer T L, 1976, Rehabil Lit, V37, P226; CREER TL, 1982, J CONSULT CLIN PSYCH, V50, P912, DOI 10.1037/0022-006X.50.6.912; CREER TL, 1979, SPRINGER SERIES BEHA; DIRKS JF, 1982, J RESPIR DIS, V38, P24; DOLOVICH J, 1982, CAN MED ASSOC J, V126, P613; DUMONT MP, 1974, AM J PSYCHIAT, V131, P631; FIREMAN P, 1981, PEDIATRICS, V68, P341; FISCHBACH RL, 1980, PATIENT COUNS HLTH E, V1, P1; Green L. W., 1980, HLTH ED PLANNING DIA; HINDIALEXANDER M, 1981, ANN ALLERGY, V46, P143; HOCHSTADT NJ, 1980, J PEDIATR-US, V97, P1012, DOI 10.1016/S0022-3476(80)80449-5; HUDGEL DW, 1982, AM REV RESPIR DIS, V126, P121; KING NJ, 1981, J BEHAV MED, V3, P169; KINSMAN RA, 1980, PSYCHOSOM MED, V42, P397, DOI 10.1097/00006842-198007000-00002; Kotses H, 1981, Biofeedback Self Regul, V6, P573, DOI 10.1007/BF00998741; Levin L., 1976, SELF CARE LAY INITIA; MAIMAN LA, 1979, JAMA-J AM MED ASSOC, V241, P1919; MCELHENNEY TK, 1981, HUMAN VALUES TEACHIN; NEWHOUSE MT, 1982, CHEST, V1, pS39; NORMAN GR, 1982, MED CARE, V20, P263; PARCEL GS, 1978, HEALTH EDUC QUART, V6, P149, DOI 10.1177/109019817800600106; REBUCK AS, 1982, CHEST S, V1, pS28; RUBINFELD AR, 1976, LANCET, V1, P882; RUBINFELD AR, 1977, CHEST, V72, P154, DOI 10.1378/chest.72.2.154; SEATON A, 1978, THORAX, V33, P1, DOI 10.1136/thx.33.1.1-a; SQUYRES WD, 1980, SPRINGER SERIES HLTH, V4; STAUDENMAYER H, 1981, J ASTHMA, V18, P1, DOI 10.3109/02770908109118301; TAPLIN PS, 1978, J ASTHMA RES, V16, P15, DOI 10.3109/02770907809106608; VERBRUGGE LM, 1980, MED CARE, V18, P73, DOI 10.1097/00005650-198001000-00006; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; WINDSOR RA, 1980, J CHRON DIS, V33, P5, DOI 10.1016/0021-9681(80)90080-6; 1977, P NATIONAL HEART LUN; 1979, US DHEW R2480 REP; 1981, SELF MANAGEMENT PROG; 1978, P WORKSHOP COMMONALI; 1982, STRATEGIES PROMOTE S	42	5	5	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					555	560		10.1016/0091-6749(83)90482-7	http://dx.doi.org/10.1016/0091-6749(83)90482-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RS163	6358326				2022-12-18	WOS:A1983RS16300008
J	JALOWAYSKI, AA; MAES, TE; WASSERMAN, SI; ZEIGER, RS				JALOWAYSKI, AA; MAES, TE; WASSERMAN, SI; ZEIGER, RS			PROGRAM AND ABSTRACTS OF PAPERS TO BE PRESENTED AT THE AMERICAN-ACADEMY-OF-ALLERGY-AND-IMMUNOL 39TH ANNUAL-MEETING, 19-23, MARCH 1983	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					89	89		10.1016/0091-6749(83)90125-2	http://dx.doi.org/10.1016/0091-6749(83)90125-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200001
J	JALOWAYSKI, AA; MAES, TE; WASSERMAN, SI; ZEIGER, RS				JALOWAYSKI, AA; MAES, TE; WASSERMAN, SI; ZEIGER, RS			HISTOCHEMICAL-DIFFERENTIATION OF HUMAN NASAL-MUCOSA MAST-CELLS FROM BASOPHIL LEUKOCYTES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					89	89		10.1016/0091-6749(83)90125-2	http://dx.doi.org/10.1016/0091-6749(83)90125-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200002
J	KOEPKE, JW; SELNER, JC; DUNHILL, AL				KOEPKE, JW; SELNER, JC; DUNHILL, AL			SO2 DERIVED FROM BRONCHODILATOR SOLUTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					147	147		10.1016/0091-6749(83)90357-3	http://dx.doi.org/10.1016/0091-6749(83)90357-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200234
J	LITTLER, S; WYPYCH, JI; NOBLE, RE; REISMAN, RE				LITTLER, S; WYPYCH, JI; NOBLE, RE; REISMAN, RE			ALLERGENIC COMPONENTS OF BALD-FACED HORNET (V-MACULATA) VENOM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					120	120		10.1016/0091-6749(83)90250-6	http://dx.doi.org/10.1016/0091-6749(83)90250-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200127
J	NACLERIO, RM; MEIER, HL; ADKINSON, NF; KAGEYSOBOTKA, A; NORMAN, PS; LICHTENSTEIN, LM				NACLERIO, RM; MEIER, HL; ADKINSON, NF; KAGEYSOBOTKA, A; NORMAN, PS; LICHTENSTEIN, LM			MEDIATOR RELEASE FOLLOWING ANTIGENIC NASAL CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					89	89		10.1016/0091-6749(83)90128-8	http://dx.doi.org/10.1016/0091-6749(83)90128-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200005
J	ODRISCOLL, BR; LEE, TH; CROMWELL, O; KAY, AB				ODRISCOLL, BR; LEE, TH; CROMWELL, O; KAY, AB			RELEASE OF HIGH MOLECULAR-WEIGHT NEUTROPHIL CHEMOTACTIC ACTIVITY (NCA) FROM IMMUNOLOGICALLY CHALLENGED HUMAN-LUNG FRAGMENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059				1982, NEW ENGL J MED, V306, P497; 1982, J CLIN INVEST, V69, P889	2	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					146	146		10.1016/0091-6749(83)90353-6	http://dx.doi.org/10.1016/0091-6749(83)90353-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200230
J	PEPPE, BC; LOCKEY, RF; MADDEN, J; BAIRD, I; TURKELTAUB, P				PEPPE, BC; LOCKEY, RF; MADDEN, J; BAIRD, I; TURKELTAUB, P			HYMENOPTERA VENOM STUDY (HVS), TREATMENT RESULTS, 9/30/82	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									AAAI COMM INSECTS,TAMPA,FL				turkeltaub, paul/AAG-6160-2019; turkeltaub, paul/U-7729-2019						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					120	120		10.1016/0091-6749(83)90249-X	http://dx.doi.org/10.1016/0091-6749(83)90249-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200126
J	PLATTSMILLS, TAE; LONGBOTTOM, JL; WILKINS, SR				PLATTSMILLS, TAE; LONGBOTTOM, JL; WILKINS, SR			AIRBORNE ALLERGENS ASSOCIATED WITH ASTHMA - COMPARISON OF DUST MITE AND RAT URINARY ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					157	157		10.1016/0091-6749(83)90398-6	http://dx.doi.org/10.1016/0091-6749(83)90398-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200275
J	SCHAEFER, PA; LITTLER, SJ; DRZEWIECKI, G; MIDDLETON, E				SCHAEFER, PA; LITTLER, SJ; DRZEWIECKI, G; MIDDLETON, E			ISOLATION AND PURIFICATION OF HUMAN SEROSAL MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					134	134		10.1016/0091-6749(83)90307-X	http://dx.doi.org/10.1016/0091-6749(83)90307-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200184
J	STEVENSON, DD; PLESKOW, WW; SIMON, RA; MATHISON, DA; LUMRY, WR; SCHATZ, M; ZEIGER, RS				STEVENSON, DD; PLESKOW, WW; SIMON, RA; MATHISON, DA; LUMRY, WR; SCHATZ, M; ZEIGER, RS			TREATMENT OF ASPIRIN SENSITIVE ASTHMA RHINOSINUSITIS WITH ASPIRIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					156	156		10.1016/0091-6749(83)90396-2	http://dx.doi.org/10.1016/0091-6749(83)90396-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200273
J	WARING, NP; DESHAZO, R; SALVAGGIO, JE; DAUL, C; LEHRER, SB				WARING, NP; DESHAZO, R; SALVAGGIO, JE; DAUL, C; LEHRER, SB			SKIN AND RAST REACTIONS TO SHELLFISH ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									TULANE UNIV,SCH MED,NEW ORLEANS,LA 70112	Tulane University									0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					111	111		10.1016/0091-6749(83)90213-0	http://dx.doi.org/10.1016/0091-6749(83)90213-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200090
J	BUSSE, WW; ANDERSON, CL; COOPER, W				BUSSE, WW; ANDERSON, CL; COOPER, W			CORTISOL PROTECTION OF THE GRANULOCYTE RESPONSE TO ISOPROTERENOL DURING AN INVITRO INFLUENZA-VIRUS INCUBATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BUSSE, WW (corresponding author), UNIV WISCONSIN, CTR CLIN SCI, DEPT MED, MADISON, WI 53792 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015685, P50AI010404] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-15685, AI-10404] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BUSH RK, 1978, J ALLERGY CLIN IMMUN, V61, P80, DOI 10.1016/0091-6749(78)90229-4; BUSSE W, 1979, AM REV RESPIR DIS, V119, P62; BUSSE WW, 1976, J ALLERGY CLIN IMMUN, V58, P586, DOI 10.1016/0091-6749(76)90205-0; BUSSE WW, 1979, AM REV RESPIR DIS, V119, P561; BUSSE WW, 1977, J CLIN INVEST, V59, P1080, DOI 10.1172/JCI108731; BUSSE WW, 1976, SCIENCE, V194, P737, DOI 10.1126/science.185696; BUSSE WW, 1977, AM REV RESPIR DIS, V115, P783; BUSSE WW, 1981, J ALLERGY CLIN IMMUN, V67, P70, DOI 10.1016/0091-6749(81)90048-8; ELLULMICALLEF R, 1975, LANCET, V2, P1269; FISHMAN WH, 1967, CLIN CHIM ACTA, V15, P435, DOI 10.1016/0009-8981(67)90008-3; HENSON P, 1974, J IMMUNOL, V107, P1535; HORN MEC, 1979, THORAX, V34, P23, DOI 10.1136/thx.34.1.23; IGNARRO LJ, 1973, SCIENCE, V180, P1181, DOI 10.1126/science.180.4091.1181; KLEINERMAN ES, 1976, AM J PATHOL, V85, P373; LEE TP, 1977, J ALLERGY CLIN IMMUN, V59, P408, DOI 10.1016/0091-6749(77)90002-1; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MANO K, 1979, J ALLERGY CLIN IMMUN, V63, P147; MCINTOSH K, 1973, J PEDIATR-US, V82, P578, DOI 10.1016/S0022-3476(73)80582-7; MINOR TE, 1974, JAMA-J AM MED ASSOC, V227, P292, DOI 10.1001/jama.227.3.292; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; SHEPPARD H, 1973, P235; SZENTIVANYI A, 1980, J ALLERGY CLIN IMMUN, V65, P5, DOI 10.1016/0091-6749(80)90170-0; WEISSMANN G, 1971, J EXP MED, V134, pS149; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550; ZURIER RB, 1973, P NATL ACAD SCI USA, V70, P844, DOI 10.1073/pnas.70.3.844	26	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	3					178	184		10.1016/0091-6749(81)90058-0	http://dx.doi.org/10.1016/0091-6749(81)90058-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LG778	7462534				2022-12-18	WOS:A1981LG77800003
J	ONEIL, RM; GOODMAN, FR				ONEIL, RM; GOODMAN, FR			RESPIRATORY RESPONSES TO ASCARIS ANTIGEN IN RHESUS AND CYNOMOLGUS MONKEYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									DOW CHEM USA, DEPT PHARMACOL, INDIANAPOLIS, IN 46268 USA	Dow Chemical Company								ALARIE Y, 1971, ARCH ENVIRON HEALTH, V22, P643, DOI 10.1080/00039896.1971.10665918; BERENDT RF, 1968, LAB ANIM CARE, V18, P391; GOLD WM, 1972, J APPL PHYSIOL, V33, P496, DOI 10.1152/jappl.1972.33.4.496; HOGARTHS.RS, 1967, IMMUNOLOGY, V13, P535; HOGARTHSCOTT RS, 1967, INT ARCH ALLER A IMM, V32, P201, DOI 10.1159/000229928; KELLY JF, 1974, J LAB CLIN MED, V83, P738; MUNSON ES, 1970, J APPL PHYSIOL, V28, P108, DOI 10.1152/jappl.1970.28.1.108; OGILVIE BM, 1967, IMMUNOLOGY, V12, P113; OGILVIE BM, 1964, NATURE, V204, P91, DOI 10.1038/204091a0; PARE PD, 1976, J APPL PHYSIOL, V41, P668, DOI 10.1152/jappl.1976.41.5.668; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V61, P261, DOI 10.1016/0091-6749(78)90201-4; PATTERSON R, 1960, J ALLERGY, V31, P351, DOI 10.1016/0021-8707(60)90071-X; PATTERSON R, 1976, J CLIN INVEST, V57, P586, DOI 10.1172/JCI108314; PATTERSON R, 1975, INT ARCH ALLER A IMM, V48, P412, DOI 10.1159/000231326; PATTERSON R, 1972, J ALLERGY CLIN IMMUN, V49, P292, DOI 10.1016/0091-6749(72)90097-8; PATTERSON R, 1969, J LAB CLIN MED, V73, P924; PATTERSON R, 1978, J LAB CLIN MED, V92, P283; PATTERSON R, 1974, ANNU REV MED, V25, P53, DOI 10.1146/annurev.me.25.020174.000413; STRANDBE.K, 1971, ACTA PHYSIOL SCAND, V82, P358, DOI 10.1111/j.1748-1716.1971.tb04977.x; Svedberg T, 1926, J AM CHEM SOC, V48, P3081, DOI 10.1021/ja01691a008; WEISSBERG RM, 1979, INT ARCH ALLER A IMM, V59, P85, DOI 10.1159/000232243; WEISZER I, 1968, J ALLERGY, V41, P14, DOI 10.1016/0021-8707(68)90004-X	22	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	3					229	236		10.1016/0091-6749(81)90066-X	http://dx.doi.org/10.1016/0091-6749(81)90066-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LG778	7462539				2022-12-18	WOS:A1981LG77800011
J	VANARSDEL, PP				VANARSDEL, PP			ASTHMA-TREATMENT - A NEGLECTED OPTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	VANARSDEL, PP (corresponding author), UNIV WASHINGTON HOSP,DEPT MED,SEATTLE,WA 98195, USA.							[Anonymous], 1960, ANN RHEUM DIS, V19, P95; Burns Amberson J., 1931, AM REV TUBERC, V24, P401; DAVIS P, 1979, J RHEUMATOL, V6, P1; Forestier J, 1934, LANCET, V2, P646; MCCORMICK J, 1980, AM REV RESPIR DIS, V122, P145; MURANAKA M, 1974, J ALLERGY CLIN IMMUN, V54, P32, DOI 10.1016/S0091-6749(74)80006-0; MURANAKA M, 1978, ANN ALLERGY, V40, P132; PENNEYS NS, 1979, J AM ACAD DERMATOL, V1, P315, DOI 10.1016/S0190-9622(79)80020-1; WELLS H, 1932, CHEM TUBERCULOSIS, P426; 1979, BRIT MED J, V1, P289	10	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	5					348	349		10.1016/0091-6749(81)90078-6	http://dx.doi.org/10.1016/0091-6749(81)90078-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ563	7229223				2022-12-18	WOS:A1981LQ56300003
J	BRODER, S				BRODER, S			CELLULAR-REGULATION OF IMMUNE FUNCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											BRODER, S (corresponding author), NCI,METAB BRANCH,BETHESDA,MD 20205, USA.							BENACERRAF B, 1978, IMMUNOL REV, V38, P70, DOI 10.1111/j.1600-065X.1978.tb00385.x; Binz H, 1977, Contemp Top Immunobiol, V7, P113; BRODER S, 1978, NEW ENGL J MED, V298, P66, DOI 10.1056/NEJM197801122980202; BRODER S, 1978, NEW ENGL J MED, V299, P1281, DOI 10.1056/NEJM197812072992305; BRODSKY FM, 1979, IMMUNOL REV, V47, P47; CANTOR H, 1979, FED PROC, V38, P2058; DOSCH HM, 1978, J IMMUNOL, V121, P2097; FELDMANN M, 1977, J EXP MED, V145, P793, DOI 10.1084/jem.145.4.793; FELDMANN M, 1977, Z IMMUNITATSFORSCH, V153, P217, DOI 10.1016/S0340-904X(77)80003-1; GATHINGS WE, 1977, EUR J IMMUNOL, V7, P804, DOI 10.1002/eji.1830071112; HERROD HG, 1979, J CLIN INVEST, V63, P868, DOI 10.1172/JCI109386; PEARL ER, 1978, J IMMUNOL, V120, P1169; Rajewsky K, 1977, Contemp Top Immunobiol, V7, P69; REINHERZ EL, 1979, NEW ENGL J MED, V301, P1018, DOI 10.1056/NEJM197911083011902; SIEGAL FP, 1976, J CLIN INVEST, V58, P109, DOI 10.1172/JCI108439; TADA T, 1977, PROG IMMUNOL, V3, P369; UYTDEHAAG F, 1979, J IMMUNOL, V123, P646; WALDMANN TA, 1974, LANCET, V2, P609; WALDMANN TA, 1978, ANN INTERN MED, V88, P226, DOI 10.7326/0003-4819-88-2-226; WITEMEYER SB, 1976, CLIN IMMUNOL IMMUNOP, V6, P312, DOI 10.1016/0090-1229(76)90084-2	20	5	5	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					239	241		10.1016/0091-6749(80)90150-5	http://dx.doi.org/10.1016/0091-6749(80)90150-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	6965680				2022-12-18	WOS:A1980JN54800001
J	ELIAS, JA				ELIAS, JA			SYSTEMIC REACTION TO RADIOCONTRAST MEDIA DURING HYSTEROSALPINGOGRAPHY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											ELIAS, JA (corresponding author), UNIV PENN,SCH MED,ALLERGY & IMMUNOL SECT,PHILADELPHIA,PA 19104, USA.							BARNET E, 1976, COMPLICATIONS DIAGNO; Cogen F C, 1978, Compr Ther, V4, P50; FISHER MS, 1966, AMER J ROENTGENOL RA, V98, P233, DOI 10.2214/ajr.98.1.233; Holt B B, 1970, Tex Med, V66, P44; INGERSOLL FM, 1947, AM J OBSTET GYNECOL, V53, P307, DOI 10.1016/0002-9378(47)90352-9; KIKA K, 1954, AM J OBSTET GYNECOL, V67, P56, DOI 10.1016/0002-9378(54)90195-7; MARSHAK RH, 1950, SURG GYNECOL OBSTET, V91, P182; MEADSDAY B, 1960, J OBSTET GYNAECOL, V67, P663; SANFILIPPO JS, 1978, FERTIL STERIL, V30, P636; SCHATZ M, 1975, J ALLERGY CLIN IMMUN, V55, P538; SHAPIRO JH, 1957, AMER J ROENTGENOL RA, V77, P1055; YUNE HY, 1977, RADIOGRAPHIC CONTRAS, P307; ZWEIMAN B, 1975, ANN INTERN MED, V83, P159, DOI 10.7326/0003-4819-83-2-159	13	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	3					242	243		10.1016/0091-6749(80)90046-9	http://dx.doi.org/10.1016/0091-6749(80)90046-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KH358					2022-12-18	WOS:A1980KH35800012
J	HENDRIX, S; ZEISS, C; SUSZKO, I; LIEBERMAN, P; MCQUEEN, R; MILLER, M; SLAVIN, R; SHEFFER, A; PATTERSON, R				HENDRIX, S; ZEISS, C; SUSZKO, I; LIEBERMAN, P; MCQUEEN, R; MILLER, M; SLAVIN, R; SHEFFER, A; PATTERSON, R			POLYMERIZED RAGWEED ALLERGENS - MULTI-INSTITUTIONAL STUDY OF THE SAFETY AND EFFICACY OF AN IMPROVED FORM OF IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					164	164						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000004
J	LIGHT, WC; WORTLEY, G				LIGHT, WC; WORTLEY, G			EFFECT OF MATERNAL ASTHMA ON NEWBORN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					204	204						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000132
J	PARKER, JL; SANTRACH, PJ; YUNGINGER, JW				PARKER, JL; SANTRACH, PJ; YUNGINGER, JW			DIAGNOSIS OF HYMENOPTERA STING SENSITIVITY WITH DELIBERATE INSECT STING CHALLENGES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					198	199						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000115
J	REISMAN, RE; WICHER, K; WYPYCH, J; MUELLER, U; LAZELL, M; ARBESMAN, CE				REISMAN, RE; WICHER, K; WYPYCH, J; MUELLER, U; LAZELL, M; ARBESMAN, CE			COMPARISON OF THE ALLERGENICITY AND ANTIGENICITY OF YELLOW JACKET AND HORNET VENOMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					200	200						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000121
J	SANO, Y; BEGLEY, M; WATT, G; TOWNLEY, R				SANO, Y; BEGLEY, M; WATT, G; TOWNLEY, R			CORTICOSTEROID INCREASES LEUKOCYTE BETA-ADRENERGIC RECEPTORS INVIVO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					223	224						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000196
J	SCHULMAN, ES; ADKINSON, NF; ADAMS, K; LICHTENSTEIN, LM; NEWBALL, HH				SCHULMAN, ES; ADKINSON, NF; ADAMS, K; LICHTENSTEIN, LM; NEWBALL, HH			ANAPHYLACTIC RELEASE OF THROMBOXANE-A-2 FROM HUMAN BRONCHI AND PARENCHYMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000234
J	STROM, GB; BOSWELL, RN; JACOBS, RL				STROM, GB; BOSWELL, RN; JACOBS, RL			IMPORTED FIRE ANT (IFA) STING SENSITIVITY - CORRELATION INVIVO BETWEEN VENOM AND WHOLE-BODY EXTRACT (WBE) TESTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					202	203						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000128
J	WEINBERGER, M; HENDELES, L; WONG, L				WEINBERGER, M; HENDELES, L; WONG, L			FLUCTUATIONS IN SERUM THEOPHYLLINE CONCENTRATION (FSTC) DURING 8-HOUR AND 12-HOUR DOSING WITH A SLOWLY ABSORBED FORMULATION COMPARED WITH 6-HOUR DOSING WITH CONVENTIONAL TABLETS (CT)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					177	178						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000048
J	WELSH, W; ZIMMERMANN, EM; YUNGINGER, JW; KERN, EB; GLEICH, GJ				WELSH, W; ZIMMERMANN, EM; YUNGINGER, JW; KERN, EB; GLEICH, GJ			INTRANASAL RAGWEED IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					191	192						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000092
J	WYPYCH, J; REISMAN, RE; LAZELL, M; ARBESMAN, CE; STEGER, R; ELLIOTT, W				WYPYCH, J; REISMAN, RE; LAZELL, M; ARBESMAN, CE; STEGER, R; ELLIOTT, W			STUDIES IN ALLERGIC INDIVIDUALS OF SERUM IGE AND IGG ANTIBODIES TO PURIFIED BEE VENOM FRACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					201	201						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000123
J	AKIYAMA, K; MIYAMOTO, T; HORIUCHI, Y				AKIYAMA, K; MIYAMOTO, T; HORIUCHI, Y			NEW METHOD OF ALLERGEN STANDARDIZATION - PASSIVE CUTANEOUS ANAPHYLAXIS INHIBITION IN A MOUSE-TO-RAT SYSTEM IN COMPARISON WITH OTHER METHODS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											AKIYAMA, K (corresponding author), UNIV TOKYO,FAC MED,DEPT MED & PHYS THERAPY,BUNKYO KU,TOKYO 113,JAPAN.							AAS K, 1966, INT ARCH ALLER A IMM, V30, P1; Arbesman C E, 1975, Dev Biol Stand, V29, P249; ARBESMAN CE, 1975, J ALLERGY CLIN IMMUN, V55, P84; ARBESMAN CE, 1977, INT ARCH ALLER A IMM, V53, P310, DOI 10.1159/000231767; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; CHIORAZZI N, 1976, J IMMUNOL, V117, P1629; CHIORAZZI N, 1977, J IMMUNOL, V118, P48; Cooke RA, 1915, LARYNGOSCOPE, V25, P108; GLEICH GJ, 1976, J ALLERGY CLIN IMMUN, V58, P31, DOI 10.1016/0091-6749(76)90104-4; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; KLINMAN NR, 1969, CLIN EXP IMMUNOL, V4, P473; KUDO K, 1978, J ALLERGY CLIN IMMUN, V61, P1, DOI 10.1016/0091-6749(78)90466-9; LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156, DOI 10.1159/000230343; LICHTENSTEIN LM, 1966, J ALLERGY, V38, P174, DOI 10.1016/0021-8707(66)90040-2; MIYAMOTO T, 1976, EXCERPTA MED INT 414, P209; Noon L, 1911, LANCET, V1, P1572; PERKINS FT, 1975, DEV BIOL STAND, V29, P413; SHEARD P, 1967, NATURE, V216, P283, DOI 10.1038/216283a0; STULL ARTHUR, 1933, JOUR ALLERGY, V4, P455, DOI 10.1016/S0021-8707(33)90098-2; VAZ EM, 1971, IMMUNOLOGY, V21, P11; YUNGINGER JW, 1976, J ALLERGY CLIN IMMUN, V58, P405, DOI 10.1016/0091-6749(76)90121-4; YUNGINGER JW, 1976, J ALLERGY CLIN IMMUN, V57, P293, DOI 10.1016/0091-6749(76)90085-3	23	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	5					354	360		10.1016/0091-6749(79)90131-3	http://dx.doi.org/10.1016/0091-6749(79)90131-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GU943	429715				2022-12-18	WOS:A1979GU94300010
J	CHOUDHURY, AM; DELCARPIO, J; GOODFRIEND, L				CHOUDHURY, AM; DELCARPIO, J; GOODFRIEND, L			RA5(G), A HOMOLOG OF RA5 IN GIANT RAGWEED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		LAPKOFF CB, 1974, INT ARCH ALLER A IMM, V46, P215, DOI 10.1159/000231125	1	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					194	194						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400203
J	COHEN, HI; HARRIS, C; GREEN, HW; GOODRIENDRESNIK, S				COHEN, HI; HARRIS, C; GREEN, HW; GOODRIENDRESNIK, S			COST-BENEFIT-ANALYSIS OF ASTHMA SELF-MANAGEMENT EDUCATIONAL-PROGRAM IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					155	156						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400070
J	FINK, JN				FINK, JN			USE OF BRONCHOPROVOCATION IN THE DIAGNOSIS OF HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,DEPT MED,ALLERGY SECT,MILWAUKEE,WI 53233	Medical College of Wisconsin	FINK, JN (corresponding author), VET ADM HOSP,RES SERV,WOOD,WI 53193, USA.							FINK JN, 1973, J ALLERGY CLIN IMMUN, V52, P309, DOI 10.1016/0091-6749(73)90051-1; PEPYS J, 1969, HYPERSENSITIVITY DIS, P69; RODEY GE, 1979, AM REV RESPIR DIS, V119, P755; SCHATZ M, 1979, NEW ENGL J MED, V300, P1310, DOI 10.1056/NEJM197906073002305	4	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					590	591		10.1016/0091-6749(79)90018-6	http://dx.doi.org/10.1016/0091-6749(79)90018-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	512251				2022-12-18	WOS:A1979HX84300006
J	FISER, PM; BUCKLEY, RH				FISER, PM; BUCKLEY, RH			HUMAN IGE BIOSYNTHESIS INVITRO - STUDIES OF LYMPHOCYTE SUB-POPULATIONS AND CELL-CELL INTERACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Buckley, Rebecca/AAB-1578-2019						0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					145	145						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400034
J	FORD, L; BUI, T; WATT, G; BURKE, K; BEWTRA, A; TOWNLEY, R				FORD, L; BUI, T; WATT, G; BURKE, K; BEWTRA, A; TOWNLEY, R			EFFECTS OF INJECTED, INHALED, AND INGESTED LODOXAMIDE TROMETHAMINE ON ALLERGEN SKIN-TEST AND INHALATION CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					160	160						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400086
J	HUSSAIN, R; MARSH, DG				HUSSAIN, R; MARSH, DG			ALLERGENIC ACTIVITY OF A RAPIDLY RELEASED BASIC COMPONENT OF SHORT RAGWEED, RA6	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Hussain, Rabia/M-6649-2015	Hussain, Rabia/0000-0001-9995-8742					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					193	194						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400201
J	IMBEAU, S; NICHOLS, D; DICKIE, H; REED, CE				IMBEAU, S; NICHOLS, D; DICKIE, H; REED, CE			DO ALL PATIENTS NEED CHRONIC STEROID-THERAPY FOR ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					203	204						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400237
J	JACOBS, RL; FREEDMAN, PM; BOSWELL, RN				JACOBS, RL; FREEDMAN, PM; BOSWELL, RN			NON-ALLERGIC RHINITIS WITH NASAL EOSINOPHILIA - CLINICAL CHARACTERIZATION OF 52 PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					202	202						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400231
J	LEUNG, P; MCINTOSH, K; CHAI, H				LEUNG, P; MCINTOSH, K; CHAI, H			AMANTADINE PROPHYLAXIS AGAINST INFLUENZA A-USSR IN CHILDREN WITH CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					140	141						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400019
J	MATHIAS, CG; FRICK, OL				MATHIAS, CG; FRICK, OL			IMMUNOTHERAPY IN SEMINAL FLUID ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					173	173						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400131
J	MULLARKEY, MF; HILL, JS; WEBB, DR				MULLARKEY, MF; HILL, JS; WEBB, DR			EOSINOPHILIC NON-ALLERGIC RHINITIS - PREVALENCE AND THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					201	202						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400230
J	ONG, KS; GRIECO, MH; GOEL, Z				ONG, KS; GRIECO, MH; GOEL, Z			RESPONSES INVITRO TO ANTIGEN-E BY LYMPHOCYTES-T OF SUBJECTS SENSITIVE AND NON-SENSITIVE TO RAGWEED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					149	149						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400047
J	SAMTER, M				SAMTER, M			ALLERGY AND CLINICAL IMMUNOLOGY - 50 YEARS FROM NOW	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									UNIV ILLINOIS,MED CTR,ABRAHAM LINCOLN SCH MED,CHICAGO,IL 60680	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital								[Anonymous], 1929, J ALLERGY, V1, P1; ASEBER MA, 1976, TRANSFER FACTOR BASI; BACH FH, 1979, COMMUNICATION; BECKER RH, 1979, COMMUNICATION; BURNET, 1958, ENZYME ANTIGEN VIRUS; COMROE JH, 1978, HLTH CARE REGULATION, P120; CONFUCIUS, CITED INDIRECTLY; CURTIS CP, 1953, PRACTICAL COGITATOR, P233; FAHEY J, 1971, WHO496 TECHN REP SER, P42; Freeman J, 1914, LANCET, V1, P1178; FREEMAN J, 1959, HAY FEVER KEY ALLERG, P306; GIRARD RA, 1979, ANN INTERN MED, V90, P965, DOI 10.7326/0003-4819-90-6-965; GOTTLIEB GL, 1972, COMPUT BIOMED RES, V5, P99, DOI 10.1016/0010-4809(72)90073-0; HABERMAN S, 1979, COMMUNICATION; HAMBURGER RN, 1976, AM SCI, V64, P157; HAMBURGER RN, 1979, COMMUNICATION; ISHIZAKA K, 1975, J IMMUNOL, V114, P110; JERNE NK, 1977, ORIGINS LYMPHOCYTE D; LEVINE RJ, 1979, HASTINGS CENT REP, V9, P21, DOI 10.2307/3560793; MATHEWS KP, 1965, J ALLERGY, V36, P219, DOI 10.1016/0021-8707(65)90078-X; MATHEWS KP, 1979, COMMUNICATION; MAUGH THH, 1973, SCIENCE, V192, P270; MAY CD, 1960, AM J DIS CHILD, V100, P661, DOI 10.1001/archpedi.1960.04020040663005; MAY CD, 1979, COMMUNICATION; MEDAWAR P, 1978, SCIENCES, V18, P14; MICKLEM HS, 1977, ENCYCLOPEDIA IGNORAN, P305; OSLER W, CITED INDIRECTLY; PATTERSON R, 1976, NEW ENGL J MED, V295, P277, DOI 10.1056/NEJM197607292950512; PEABODY FW, 1953, PRACTICAL COGITATOR, P259; PEPYS J, 1971, Clinical Allergy, V1, P1, DOI 10.1111/j.1365-2222.1971.tb02443.x; PEPYS J, 1979, COMMUNICATION; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; REISER SJ, 1978, SCIENCES         DEC, P7; ROWLEY DA, 1979, COMMUNICATION; SAMTER M, 1978, IMMUNOLOGICAL DISEAS, pR12; SCHNABEL TG, 1937, AM F, V1; SCHNABEL TG, AM F, V2; SHEDD F, 1975, HASTINGS CTR REPORT, V5, P6; STENT G, 1978, PARADOXES PROGR; STERLING A, 1929, J ALLERGY, V1, P542; THOMAS L, 1977, DAEDALUS         SUM, P163; VAUGHAN JH, 1978, IMMUNOLOGICAL DISEAS, P1029; VEREECKEN JLT, 1968, HYPOSENSITIZATION PR, P31; WAGNER R, 1968, PIRQUET HIS LIFE WOR; WHITE A, 1979, COMMUNICATION; WHITE AF, UNPUBLISHED; WHITEHEAD AN, 1968, FAMILIAR MEDICAL QUO, P463; 1979, NIH79387 DHEW NIAID	48	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	5					321	330		10.1016/0091-6749(79)90003-4	http://dx.doi.org/10.1016/0091-6749(79)90003-4			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HT520	385672				2022-12-18	WOS:A1979HT52000003
J	SPECTOR, SL; KINSMAN, RA				SPECTOR, SL; KINSMAN, RA			MORE IMPLICATIONS OF REACTIVITY CHARACTERISTICS TO METHACHOLINE AND HISTAMINE IN ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SPECTOR, SL (corresponding author), NATL JEWISH HOSP & RES CTR,DEPT MED,DENVER,CO 80206, USA.							HORTON DJ, 1978, AM REV RESPIR DIS, V117, P1029; LUPARELLO T, 1968, PSYCHOSOM MED, V30, P819, DOI 10.1097/00006842-196811000-00002; MCNICHOL KN, 1973, BRIT MED J, V4, P12, DOI 10.1136/bmj.4.5883.12; MCNICOL KN, 1973, BRIT MED J, V4, P7, DOI 10.1136/bmj.4.5883.7; NATHAN RA, RELATIONSHIP AIRWAYS; REED CE, 1975, NEW DIRECTIONS ASTHM, P291; SPECTOR S, 1976, AM REV RESPIR DIS, V113, P43; SPECTOR SL, 1979, ALLERGY, V34, P167, DOI 10.1111/j.1398-9995.1979.tb01564.x; SPECTOR SL, 1975, J ALLERGY CLIN IMMUN, V56, P308, DOI 10.1016/0091-6749(75)90105-0; SPECTOR SL, 1974, MED CLIN N AM, V58, P71, DOI 10.1016/S0025-7125(16)32178-2; STAUDENMAYER H, 1978, PSYCHOSOM MED, V41, P109	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					587	589		10.1016/0091-6749(79)90017-4	http://dx.doi.org/10.1016/0091-6749(79)90017-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	512250				2022-12-18	WOS:A1979HX84300005
J	SPECTOR, SL				SPECTOR, SL			USE OF PROVOCATION TECHNIQUES FOR THE EVALUATION OF DRUG EFFICACY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SPECTOR, SL (corresponding author), NATL JEWISH HOSP & RES CTR,DEPT MED,DENVER,CO 80206, USA.							CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHIPPS BE, 1978, J ALLERGY CLIN IMMUN, V61, P171, DOI 10.1016/0091-6749(78)90382-2; CLAMAN HN, 1975, J ALLERGY CLIN IMMUN, V55, P145, DOI 10.1016/0091-6749(75)90010-X; Farr RS, 1973, CHEST, V63, p64S; GALANT SP, 1953, J ALLERGY CLIN IMMUN, V51, P11; GERVAIS P, 1977, J ALLERGY CLIN IMMUN, V59, P207, DOI 10.1016/0091-6749(77)90151-8; GIMENO F, 1972, AM REV RESPIR DIS, V105, P68; GOLDBERG I, 1965, AM REV RESPIR DIS, V91, P13, DOI 10.1164/arrd.1965.91.1.13; HALPERN BN, 1963, BRIT J PHARM CHEMOTH, V20, P389, DOI 10.1111/j.1476-5381.1963.tb01477.x; HUME K. M., 1957, THORAX, V12, P276, DOI 10.1136/thx.12.3.276; IMBEAU SA, 1978, J ALLERGY CLIN IMMUN, V62, P193, DOI 10.1016/0091-6749(78)90207-5; MAY C D, 1973, Clinical Allergy, V3, P319, DOI 10.1111/j.1365-2222.1973.tb01340.x; MILLER MM, 1977, J ALLERGY CLIN IMMUN, V60, P116, DOI 10.1016/0091-6749(77)90036-7; MILLER MM, 1977, INT ARCH ALLER A IMM, V53, P349, DOI 10.1159/000231771; MUTTARI A, 1978, CLIN ALLERGY, V8, P281; PEPYS J, 1974, CLIN ALLERGY, V4, P13, DOI 10.1111/j.1365-2222.1974.tb01358.x; PERPER RJ, 1972, INT ARCH ALLER A IMM, V43, P837, DOI 10.1159/000230901; PIERSON DJ, 1976, CHEST, V70, P17, DOI 10.1378/chest.70.1.17; ROSENTHAL RR, 1977, J APPL PHYSIOL, V42, P600, DOI 10.1152/jappl.1977.42.4.600; SPECTOR S, 1976, AM REV RESPIR DIS, V113, P43; SPECTOR SL, 1975, J ALLERGY CLIN IMMUN, V56, P308, DOI 10.1016/0091-6749(75)90105-0; SPECTOR SL, 1976, BRONCHIAL ASTHMA MEC, P639; SPECTOR SL, 1978, CHEST, V735, P9765; SPECTOR SL, 1978, CHEST              S, V73, pS976	24	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					677	684		10.1016/0091-6749(79)90038-1	http://dx.doi.org/10.1016/0091-6749(79)90038-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	512264				2022-12-18	WOS:A1979HX84300026
J	ZIERING, RW; OCONNOR, R; MELLON, M; COOK, D; TOMASZEWSKI, M; STREET, DH; HAMBURGER, RN				ZIERING, RW; OCONNOR, R; MELLON, M; COOK, D; TOMASZEWSKI, M; STREET, DH; HAMBURGER, RN			UNIVERSITY-OF-CALIFORNIA IN SAN-DIEGO PROPHYLAXIS OF ALLERGY IN INFANCY STUDY - INTERIM-REPORT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					199	199						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400222
J	BLOOM, FL; SPANGLER, DL; WITTIG, HJ; RHOADES, RB				BLOOM, FL; SPANGLER, DL; WITTIG, HJ; RHOADES, RB			IMPORTED FIRE ANT (IFA) RAPID HYPOSENSITIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					134	134		10.1016/0091-6749(78)90256-7	http://dx.doi.org/10.1016/0091-6749(78)90256-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300017
J	BRADY, R; GLOVSKY, M; HUGLI, T				BRADY, R; GLOVSKY, M; HUGLI, T			COMPLEMENT (C) ACTIVATION BY HOUSE DUST EXTRACT - IMPLICATIONS IN IMMEDIATE HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					187	188		10.1016/0091-6749(78)90436-0	http://dx.doi.org/10.1016/0091-6749(78)90436-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300197
J	BUI, T; BURKE, K; WATT, G; BEWTRA, A; TOWNLEY, R				BUI, T; BURKE, K; WATT, G; BEWTRA, A; TOWNLEY, R			EFFECT OF SINGLE DOSES OF IODOXAMIDE TROMETHAMINE ON ALLERGEN INHALATION PROVOCATION TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					189	189		10.1016/0091-6749(78)90441-4	http://dx.doi.org/10.1016/0091-6749(78)90441-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300202
J	GOLDSTEIN, RA				GOLDSTEIN, RA			CELLULAR IMMUNE-RESPONSES IN ASPERGILLOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									GEORGE WASHINGTON MED CTR,WASHINGTON,DC	George Washington University	GOLDSTEIN, RA (corresponding author), VET ADM HOSP,WASHINGTON,DC 20422, USA.								0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					229	230		10.1016/0091-6749(78)90190-2	http://dx.doi.org/10.1016/0091-6749(78)90190-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	632466	Bronze			2022-12-18	WOS:A1978EV08000015
J	HARGREAVE, FE; COCKCROFT, D; RUFFIN, R; DOLOVICH, J				HARGREAVE, FE; COCKCROFT, D; RUFFIN, R; DOLOVICH, J			PREDICTION OF DOSE OF INHALED ALLERGEN REQUIRED TO PRODUCE A THRESHOLD EXPERIMENTAL ASTHMATIC RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					194	194		10.1016/0091-6749(78)90457-8	http://dx.doi.org/10.1016/0091-6749(78)90457-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300218
J	KALINER, M; PLATSHON, L				KALINER, M; PLATSHON, L			EFFECT OF HISTAMINE ON HUMAN LUNG ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					130	130		10.1016/0091-6749(78)90243-9	http://dx.doi.org/10.1016/0091-6749(78)90243-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300004
J	KELLY, JF; PATTERSON, R; STEVENSON, D; MATHISON, D				KELLY, JF; PATTERSON, R; STEVENSON, D; MATHISON, D			RADIOGRAPHIC CONTRAST-MEDIA STUDIES IN HIGH-RISK PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					146	146		10.1016/0091-6749(78)90298-1	http://dx.doi.org/10.1016/0091-6749(78)90298-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300059
J	KOOISTRA, JB; CLARK, JW; YUNGINGER, JW				KOOISTRA, JB; CLARK, JW; YUNGINGER, JW			INVITRO STUDIES OF HUMAN SEMINAL FLUID ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					181	182		10.1016/0091-6749(78)90416-5	http://dx.doi.org/10.1016/0091-6749(78)90416-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300177
J	LACEY, J				LACEY, J			THERMOPHILIC ACTINOMYCETES - CHARACTERISTICS AND IDENTIFICATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											LACEY, J (corresponding author), ROTHAMSTED EXPTL STN,HARPENDEN AL5 2JQ,HERTFORDSHIRE,ENGLAND.								0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					231	232		10.1016/0091-6749(78)90192-6	http://dx.doi.org/10.1016/0091-6749(78)90192-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	632468				2022-12-18	WOS:A1978EV08000017
J	MCLEAN, JA; MATHEWS, KP; BRAYTON, PR; BAYNE, NK; SOLOMON, WR				MCLEAN, JA; MATHEWS, KP; BRAYTON, PR; BAYNE, NK; SOLOMON, WR			INTRANASAL EFFECTS OF PHARMACOLOGIC AGENTS IN HAY-FEVER AND VASOMOTOR RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					191	192		10.1016/0091-6749(78)90450-5	http://dx.doi.org/10.1016/0091-6749(78)90450-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300211
J	RACHELEFSKY, G; BYRNE, W; STROBEL, C; AMENT, M; KATZ, R; SIEGEL, S; EULER, A				RACHELEFSKY, G; BYRNE, W; STROBEL, C; AMENT, M; KATZ, R; SIEGEL, S; EULER, A			GASTROESOPHAGEAL REFLUX AND RECURRENT PULMONARY-DISEASE IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					138	138		10.1016/0091-6749(78)90270-1	http://dx.doi.org/10.1016/0091-6749(78)90270-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300031
J	SCHWARTZ, SA; GOOD, RA				SCHWARTZ, SA; GOOD, RA			CLASS-SPECIFIC SUPPRESSION OF IMMUNOGLOBULIN-SYNTHESIS AND SECRETION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Schwartz, Stanley A./AAP-8852-2021	Schwartz, Stanley A./0000-0002-8664-1380					0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					144	144		10.1016/0091-6749(78)90291-9	http://dx.doi.org/10.1016/0091-6749(78)90291-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300052
J	SIEGEL, S; KATZ, R; RACHELEFSKY, G; CREPEA, S				SIEGEL, S; KATZ, R; RACHELEFSKY, G; CREPEA, S			FLUNISOLIDE AEROSOL TREATMENT OF PERENNIAL ALLERGIC RHINITIS IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					152	152		10.1016/0091-6749(78)90317-2	http://dx.doi.org/10.1016/0091-6749(78)90317-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300078
J	SLAVIN, RG				SLAVIN, RG			WHAT DOES A FUNGUS AMONG US REALLY MEAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									ST LOUIS UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63103	Saint Louis University	SLAVIN, RG (corresponding author), ST LOUIS UNIV,SCH MED,ALLERGY & IMMUNOL SECT,ST LOUIS,MO 63103, USA.							[Anonymous], COMMUNICATION; HOEHNE JH, 1973, CHEST, V63, P177, DOI 10.1378/chest.63.2.177; McCarthy DS, 1971, CLIN ALLERGY, V1, P261, DOI DOI 10.1111/J.1365-2222.1971.TB; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; NOBLE WC, 1963, J GEN MICROBIOL, V32, P397, DOI 10.1099/00221287-32-3-397; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; SCHWARTZ HJ, 1978, J ALLERGY CLIN IMMUN, V62, P9, DOI 10.1016/0091-6749(78)90065-9; SLAVIN RG, 1977, ANN ALLERGY, V38, P215; SOLOMON WR, 1978, J ALLERGY CLIN IMMUN, V62, P56, DOI 10.1016/0091-6749(78)90073-8; SOLOMON WR, 1976, J ALLERGY CLIN IMMUN, V57, P46, DOI 10.1016/0091-6749(76)90078-6; SOLOMON WR, 1975, J ALLERGY CLIN IMMUN, V55, P90	11	5	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	62	1					7	8		10.1016/0091-6749(78)90064-7	http://dx.doi.org/10.1016/0091-6749(78)90064-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FG870	350935				2022-12-18	WOS:A1978FG87000002
J	WEBB, DR				WEBB, DR			CLINICAL CHARACTERISTICS AND THERAPY OF NASAL POLYPS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					185	185		10.1016/0091-6749(78)90427-X	http://dx.doi.org/10.1016/0091-6749(78)90427-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300188
J	BLOCH, KJ				BLOCH, KJ			EXPANDING ROLE OF ALLERGIST IN CLINICAL IMMUNOLOGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MASSACHUSETTS GEN HOSP,MED SERV,CLIN IMMUNOL UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,MED SERV,ALLERGY UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School								NATVIG JB, 1975, VOX SANG, V28, P329, DOI 10.1111/j.1423-0410.1975.tb02778.x; REEVES, 1976, LANCET, V2, P459; VAUGHAN JH, 1972, J ALLERGY CLIN IMMUN, V50, P294, DOI 10.1016/0091-6749(72)90028-0; WHITTINGHAM S, 1971, CLIN EXP IMMUNOL, V8, P857; 1972, WHO496 TECHN REP SER; 1975, J IMMUNOL, V115, P609; 1975, CLIN EXP IMMUNOL, V22, P550	7	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	60	2					144	148		10.1016/0091-6749(77)90041-0	http://dx.doi.org/10.1016/0091-6749(77)90041-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR448	301530				2022-12-18	WOS:A1977DR44800010
J	RING, J; SEIFERT, J; BRENDEL, W				RING, J; SEIFERT, J; BRENDEL, W			HIGH INCIDENCE OF HORSE SERUM-PROTEIN ALLERGY IN VARIOUS AUTOIMMUNE DISORDERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MUNICH,CHIRURG KLIN,D-8000 MUNICH 2,FED REP GER	University of Munich			Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152				AAS K, 1971, J ALLERGY CLIN IMMUN, V48, P134, DOI 10.1016/0091-6749(71)90008-X; Assem E S, 1972, Clin Allergy, V2, P325, DOI 10.1111/j.1365-2222.1972.tb01297.x; BALNER H, 1974, PROGR IMMUNOL II, V5, P401; BERG T, 1971, INT ARCH ALLER A IMM, V40, P770, DOI 10.1159/000230461; BOYDEN SV, 1951, J EXP MED, V93, P107, DOI 10.1084/jem.93.2.107; BRENDEL W, 1971, TRANSPLANT P, V3, P280; BRENDEL W, 1974, PROGR IMMUNOLOGY 2, V5, P245; DELAPAVA S, 1962, ARCH INTERN MED, V109, P391, DOI 10.1001/archinte.1962.03620160017003; DIXON FJ, 1958, ARCH PATHOL, V65, P18; GELL PGH, 1975, CLINICAL ASPECTS IMM; GLYNN LE, 1965, AUTOIMMUNE DISEASE; Halpern B, 1967, Presse Med, V75, P461; HOLLAND P, 1964, LANCET, V1, P1368; HOPF U, 1970, KLIN WOCHENSCHR, V48, P906, DOI 10.1007/BF01487629; IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; ISHIZAKA K, 1963, PROG ALLERGY, V7, P32, DOI 10.1159/000314085; JONES VE, 1976, POSTGRAD MED J, V52, P136; JONES VE, 1975, CLIN EXP IMMUNOL, V21, P13; JUNGE U, 1970, CLIN EXP IMMUNOL, V7, P431; KARLINER JS, 1965, J AMER MED ASSOC, V193, P359, DOI 10.1001/jama.1965.03090050035009; KASHIWAGI N, 1968, ANN INTERN MED, V68, P275, DOI 10.7326/0003-4819-68-2-275; Kojis FG, 1942, AM J DIS CHILD, V64, P93, DOI 10.1001/archpedi.1942.02010070094011; KOLIN A, 1966, J IMMUNOL, V97, P621; LANCE EM, 1975, CLIN EXP IMMUNOL, V21, P1; LANCE EM, 1973, ADV IMMUNOL, V17, P1; OUCHTERLONY O, 1962, PROG ALLERGY, V6, P30, DOI 10.1159/000313795; PEPYS J, 1975, CLINICAL ASPECTS IMM; RING J, 1976, INT ARCH ALLER A IMM, V50, P103, DOI 10.1159/000231486; RING J, 1973, KLIN WOCHENSCHR, V51, P487, DOI 10.1007/BF01467826; RING J, 1974, LANCET, V2, P1093; RING J, 1974, STUDIES NEUROMUSCULA; RING J, 1973, EXCERPTA MED, V300, P77; RING J, 1974, ALLERGOLOGIA IMMUNPA, V2, P3; SAMTER M, 1964, ANNU REV PHARMACOL, V4, P265, DOI 10.1146/annurev.pa.04.040164.001405; SEIFERT J, 1975, DEUT MED WOCHENSCHR, V100, P1078, DOI 10.1055/s-0028-1106341; SEIFERT J, 1974, NATURE, V249, P776, DOI 10.1038/249776a0; TRINCA JC, 1967, LANCET, V1, P76; VAISHNAV.H, 1966, LANCET, V2, P1371; WEIGLE WO, 1971, CLIN EXP IMMUNOL, V9, P437; WEIGLE WO, 1958, P SOC EXP BIOL MED, V99, P226; WEIR DM, 1974, HDB EXPT IMMUNOLOGY; WIDE L, 1967, LANCET, V2, P1105; WITEBSKY LE, 1959, 1958 IMM S BAS	43	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	3					185	189		10.1016/0091-6749(77)90148-8	http://dx.doi.org/10.1016/0091-6749(77)90148-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CZ249	320246				2022-12-18	WOS:A1977CZ24900001
J	SOBOTKA, AK				SOBOTKA, AK			DIAGNOSIS OF INSECT HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									GOOD SAMARITAN HOSP,BALTIMORE,MD 21239									ADKINSON NF, 1971, NEW ENGL J MED, V285, P22, DOI 10.1056/NEJM197107012850104; BENSON RL, 1930, J ALLERGY, V1, P105; BERNTON HS, 1965, J ALLERGY, V36, P315, DOI 10.1016/0021-8707(65)90038-9; CONROY MC, 1977, FED PROC, V36, P1216; FOUBERT EL, 1958, J ALLERGY, V29, P13, DOI 10.1016/0021-8707(58)90050-9; HUNT KH, TO BE PUBLISHED; HUNT KJ, 1976, ANN INTERN MED, V85, P56, DOI 10.7326/0003-4819-85-1-56; KERN F, 1976, J ALLERGY CLIN IMMUN, V57, P554, DOI 10.1016/0091-6749(76)90006-3; KING TS, COMMUNICATION; LEVINE BB, 1969, J ALLERGY, V43, P231, DOI 10.1016/0021-8707(69)90066-5; LOVELESS MARY HEWITT, 1956, ANN ALLERGY, V14, P347; LOVELESS MH, 1962, J IMMUNOL, V89, P204; OCONNOR R, 1965, ANN ALLERGY, V23, P151; ORDMAN D, 1965, INT ARCH ALLER A IMM, V28, P366, DOI 10.1159/000229682; SCHWARTZ HJ, 1965, J AMER MED ASSOC, V194, P703, DOI 10.1001/jama.194.7.703; SHULMAN S, 1966, J IMMUNOL, V96, P29; SOBOTKA AK, 1974, J ALLERGY CLIN IMMUN, V53, P170, DOI 10.1016/0091-6749(74)90005-0; TORSNEY PJ, 1973, J ALLERGY CLIN IMMUN, V52, P303, DOI 10.1016/0091-6749(73)90049-3; ZELEZNICK LD, 1977, J ALLERGY CLIN IMMUN, V59, P2, DOI 10.1016/0091-6749(77)90169-5; 1965, JAMA, V193, P109	20	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	60	4					213	214		10.1016/0091-6749(77)90131-2	http://dx.doi.org/10.1016/0091-6749(77)90131-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DX458	71309				2022-12-18	WOS:A1977DX45800001
J	BURGE, HA; SOLOMON, WR; BOISE, JR				BURGE, HA; SOLOMON, WR; BOISE, JR			APPRAISAL OF IMPREGON AS A DETERRENT OF DOMESTIC FUNGUS GROWTH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MICHIGAN,SCH MED,DEPT INTERN MED,DIV ALLERGY,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan								HAMILTON WA, 1968, J GEN MICROBIOL, V50, P441, DOI 10.1099/00221287-50-3-441; HERMAN PS, 1972, SOAP PHOTODERMATITIS; LEMKE PA, 1968, MYCOPATHOL MYCOL APP, V38, P49; SLIFKIN MK, 1973, MYCOPATH MYCOL APPL, V50, P233, DOI 10.1007/BF02053372; WILLIAMSON RL, 1967, SCIENCE, V158, P1694, DOI 10.1126/science.158.3809.1694; WOODROFFE RC, 1966, J GEN MICROBIOL, V44, P343, DOI 10.1099/00221287-44-3-343	6	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	4					491	499		10.1016/0091-6749(76)90193-7	http://dx.doi.org/10.1016/0091-6749(76)90193-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH210	787049				2022-12-18	WOS:A1976CH21000006
J	EHTESSABIAN, R; CASSIDY, JT; THOMAS, MR; MATHEWS, KP; TUBERGEN, DG				EHTESSABIAN, R; CASSIDY, JT; THOMAS, MR; MATHEWS, KP; TUBERGEN, DG			COMMON VARIABLE IMMUNODEFICIENCY WITH PERNICIOUS-ANEMIA, ASTHMA, AND REACTIONS TO GAMMA-GLOBULIN - TREATMENT WITH PLASMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MICHIGAN, SCH MED, DEPT INTERN MED, ALLERGY SECT, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, SCH MED, DEPT PEDIAT & COMMUN DIS, ANN ARBOR, MI 48104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan								AIUTI F, 1973, CLIN EXP IMMUNOL, V15, P43; AULT KA, 1973, J CLIN INVEST, V52, P2507, DOI 10.1172/JCI107441; BARANDUN S, 1962, VOX SANG, V7, P157, DOI 10.1111/j.1423-0410.1962.tb03240.x; BUCKLEY RH, 1975, J CLIN INVEST, V55, P157, DOI 10.1172/JCI107906; BUCKLEY RH, 1972, AM J DIS CHILD, V124, P376, DOI 10.1001/archpedi.1972.02110150074014; CONN HO, 1968, ANN INTERN MED, V68, P603, DOI 10.7326/0003-4819-68-3-603; COOPER MD, 1973, TRANSPLANT REV-DENMA, V16, P51; COOPER MD, 1971, LANCET, V2, P791; CRAIN JD, 1969, VOX SANG, V17, P77; CROWDER RV, 1959, ARCH INTERN MED, V103, P445, DOI 10.1001/archinte.1959.00270030101010; DOUGLAS SD, 1970, AM J MED, V48, P48, DOI 10.1016/0002-9343(70)90097-5; FREEDMAN SO, 1958, AM J MED, V25, P961, DOI 10.1016/0002-9343(58)90067-6; FUDENBERG H, 1971, PEDIATRICS, V47, P927; FUDENBERG HH, 1972, AM J PATHOL, V69, P529; FUDENBERG HH, 1970, IMMUNOGLOBULINS, P211; GEHA RS, 1973, J CLIN INVEST, V52, P1726, DOI 10.1172/JCI107354; GEHA RS, 1974, NEW ENGL J MED, V291, P1, DOI 10.1056/NEJM197407042910101; GHORY J E, 1971, Journal of Asthma Research, V9, P37, DOI 10.3109/02770907109105036; GOLDFARB AA, 1961, NEW YORK STATE J MED, V61, P2721; GOOD RA, 1960, AM J MED, V29, P804, DOI 10.1016/0002-9343(60)90114-5; GOOD RA, 1962, PROG ALLERGY, V6, P187, DOI 10.1159/000313800; GOODMAN DH, 1967, J ALLERGY, V40, P131, DOI 10.1016/0021-8707(67)90001-9; GREY HM, 1971, J CLIN INVEST, V50, P2368, DOI 10.1172/JCI106735; GROVE DI, 1975, J ALLERGY CLIN IMMUN, V55, P152, DOI 10.1016/0091-6749(75)90011-1; HEINER DC, 1970, J IMMUNOL, V104, P691; HENNEY CS, 1968, NEW ENGL J MED, V278, P1144, DOI 10.1056/NEJM196805232782104; HOLLINGER FB, 1973, NEW ENGL J MED, V289, P385, DOI 10.1056/NEJM197308232890801; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; KLAYMAN MI, 1955, NEW ENGL J MED, V253, P808, DOI 10.1056/NEJM195511102531903; LOBO PI, 1975, J IMMUNOL, V114, P116; MACKENZIE DL, 1974, NEW ENGL J MED, V290, P749; NICOD I, 1973, CLIN EXP IMMUNOL, V15, P365; PAINTER TS, 1959, NEW ENGL J MED, V260, P15, DOI 10.1056/NEJM195901012600104; POLMAR SH, 1972, AM J PATHOL, V69, P499; PREUDHOMME J, 1975, J IMMUNOL, V114, P481; ROPARS C, 1974, VOX SANG, V27, P294, DOI 10.1111/j.1423-0410.1974.tb02422.x; ROSENTHAL SH, 1974, J LAB CLIN MED, V83, P584; ROWLANDS DT, 1975, NEW ENGL J MED, V293, P26, DOI 10.1056/NEJM197507032930108; SCHIFF RI, 1974, J IMMUNOL, V112, P376; SGOURIS JT, 1967, VOX SANG, V13, P71; SOOTHILL JF, 1971, MEDICAL RESEARCH COU, V130; STIEHM ER, 1966, BLOOD-J HEMATOL, V28, P918, DOI 10.1182/blood.V28.6.918.918; STJERNSW.J, 1972, LANCET, V1, P1352; TWOMEY JJ, 1970, ANN INTERN MED, V72, P499, DOI 10.7326/0003-4819-72-4-499; TWOMEY JJ, 1969, AM J MED, V47, P340, DOI 10.1016/0002-9343(69)90218-6; WALDMANN TA, 1974, LANCET, V2, P609	46	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	2					337	350		10.1016/0091-6749(76)90140-8	http://dx.doi.org/10.1016/0091-6749(76)90140-8			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA661					2022-12-18	WOS:A1976CA66100012
J	FIELD, J; ALLEGRA, J; TRAUTLEIN, J; GILLIN, M; ZELIS, R				FIELD, J; ALLEGRA, J; TRAUTLEIN, J; GILLIN, M; ZELIS, R			EVALUATION OF EXERCISE-INDUCED BRONCHOSPASM IN ADULT ASTHMATIC	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									PENN STATE UNIV,MILTON S HERSHEY MED CTR,DIV INTERN MED,HERSHEY,PA 17033; PENN STATE UNIV,MILTON S HERSHEY MED CTR,DIV CARDIOL,HERSHEY,PA 17033; PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT MED,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health								BIERMAN CW, 1975, JAMA-J AM MED ASSOC, V234, P295; BUTLER J, 1960, J CLIN INVEST, V39, P584, DOI 10.1172/JCI104071; FITCH KD, 1971, BRIT MED J, V4, P577, DOI 10.1136/bmj.4.5787.577; GODFREY S, 1975, J ALLERGY CLIN IMMUN, V56, P1, DOI 10.1016/0091-6749(75)90029-9; MCNEILL RS, 1966, Q J MED, V35, P55; PIERSON WE, 1969, J ALLERGY, V43, P136, DOI 10.1016/S0021-8707(69)80004-3; WILMOR JH, 1974, HEART LUNGS WORK PRI	7	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	5					575	580		10.1016/0091-6749(76)90203-7	http://dx.doi.org/10.1016/0091-6749(76)90203-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CL088	977864				2022-12-18	WOS:A1976CL08800005
J	FINE, SR; FOGARTY, M; LINZ, A				FINE, SR; FOGARTY, M; LINZ, A			FRESH FROZEN PLASMA FOR PROPHYLAXIS IN HEREDITARY ANGIOEDEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									ROOSEVELT HOSP RA COOKE INST ALLERGY,NEW YORK,NY 10019										0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	6					624	625		10.1016/0091-6749(76)90017-8	http://dx.doi.org/10.1016/0091-6749(76)90017-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BV054	932345				2022-12-18	WOS:A1976BV05400017
J	GLEICH, GJ; JACOB, GL; YUNGINGER, JW				GLEICH, GJ; JACOB, GL; YUNGINGER, JW			EFFECT OF IMMUNOTHERAPY ON SEASONAL-CHANGES IN IGE ANTIBODY TO RAGWEED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					203	203						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000034
J	HARNETT, J; SPECTOR, SL				HARNETT, J; SPECTOR, SL			BLOCKING EFFECT OF SCH 1000, ISOPROTERENOL, AND COMBINATION ON METHACHOLINE AND HISTAMINE INHALATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					261	261						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000174
J	KELLER, KF; DOYLE, RJ				KELLER, KF; DOYLE, RJ			MECHANISM FOR TOBACCO SMOKE-INDUCED ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV LOUISVILLE,SCH MED,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,LOUISVILLE,KY 40201	University of Louisville								ARMEN RN, 1959, DIS CHEST, V35, P663; BLUE JA, 1970, ANN ALLERGY, V28, P110; CHU YM, 1970, AM REV RESPIR DIS, V102, P118; COLLIER HOJ, 1965, J PHYSIOL, V180, P13; DOCKHORN RJ, 1971, ANN ALLERGY, V29, P539; FISHEL CW, 1962, J IMMUNOL, V89, P8; Friedlander M, 1936, P SOC EXP BIOL MED, V34, P156; GRIECO MH, 1970, B NY ACAD MED, V46, P601; HARKAVY J, 1968, ANN ALLERGY, V26, P447; LIMA A O, 1949, Ann Allergy, V7, P528; MUNOZ J, 1968, BACTERIOL REV, V32, P103, DOI 10.1128/MMBR.32.2.103-126.1968; OUELLETTE J J, 1967, Journal of Allergy, V39, P160, DOI 10.1016/0021-8707(67)90033-0; ROSEN F L, 1954, J Med Soc N J, V51, P109; SILVETTE H, 1957, AM J MED SCI, V234, P561, DOI 10.1097/00000441-195711000-00008; SZENTIVANYI A, 1968, J ALLERGY, V42, P202; TOWNLEY RG, 1967, J ALLERGY, V39, P177, DOI 10.1016/0021-8707(67)90036-6	16	5	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					278	282		10.1016/0091-6749(76)90047-6	http://dx.doi.org/10.1016/0091-6749(76)90047-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240	2631				2022-12-18	WOS:A1976BJ24000188
J	MORRIS, HG; BARZEN, K; CARO, C; RUSNAK, SL				MORRIS, HG; BARZEN, K; CARO, C; RUSNAK, SL			EFFECT OF ADRENERGIC THERAPY ON LEUKOCYTE CYCLIC ADENOSINE-MONOPHOSPHATE (CAMP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					264	264						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000182
J	NELSON, HS; BROWN, G; OBARR, TP; BRANCH, LB; SPAULDING, H; BLACK, JW				NELSON, HS; BROWN, G; OBARR, TP; BRANCH, LB; SPAULDING, H; BLACK, JW			CLINICAL AND IMMUNOLOGICAL STUDIES OF TIMOTHY ANTIGEN D IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,SERV ALLERGY IMMUNOL,DENVER,CO 80240									AMIES CR, 1959, J PATHOL BACTERIOL, V77, P435, DOI 10.1002/path.1700770214; FRANKLAND AW, 1954, LANCET, V1, P1055; GIRARD JP, 1970, INT ARCH ALLER A IMM, V37, P561, DOI 10.1159/000230245; GORDON J, 1958, J EXP MED, V108, P37, DOI 10.1084/jem.108.1.37; JAROS SH, 1964, ANN ALLERGY, V22, P173; MALLEY A, 1970, J ALLERGY, V45, P14, DOI 10.1016/0021-8707(70)90013-4; MALLEY A, 1969, J ALLERGY, V43, P59, DOI 10.1016/0021-8707(69)90126-9; MALLEY A, 1971, J ALLERGY CLIN IMMUN, V48, P267, DOI 10.1016/0091-6749(71)90027-3; MALLEY A, 1964, J IMMUNOL, V93, P420; MALLEY A, 1967, J IMMUNOL, V99, P825; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	5					463	472		10.1016/0091-6749(76)90062-2	http://dx.doi.org/10.1016/0091-6749(76)90062-2			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BR201	57131				2022-12-18	WOS:A1976BR20100010
J	SCHATZ, M; PATTERSON, R; DESWARTE, R				SCHATZ, M; PATTERSON, R; DESWARTE, R			NONORGANIC ADVERSE REACTIONS TO AEROALLERGEN IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University								BOOTH BH, 1972, ALLERGIC DISEASES DI, P63; CRAMER B, 1971, ARCH GEN PSYCHIAT, V24, P573; HAWKINGS JR, 1956, BMJ-BRIT MED J, V1, P361, DOI 10.1136/bmj.1.4963.361; HOLLENDER MH, 1973, SOUTH MED J, V66, P1279, DOI 10.1097/00007611-197311000-00020; KELLY JF, 1974, JAMA-J AM MED ASSOC, V227, P1431, DOI 10.1001/jama.1974.03230250055038; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; MELAM H, 1972, ALLERGIC DISEASES, P293; MOORE GL, 1973, PSYCHIAT MED, V4, P301; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; PATTERSON R, 1975, J ALLERGY CLIN IMMUN, V56, P152, DOI 10.1016/0091-6749(75)90120-7; PATTERSON R, 1974, CLIN ALLERGY, V4, P309; PETERSDORF RG, 1957, ANN INTERN MED, V46, P1039, DOI 10.7326/0003-4819-46-6-1039; ROSE E, 1969, ANN INTERN MED, V71, P309, DOI 10.7326/0003-4819-71-2-309; SERVICE KJ, 1974, ARCH INTERN MED, V134, P336; Sheldon JM, 1967, MANUAL CLINICAL ALLE, P98	15	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	1					198	203		10.1016/0091-6749(76)90155-X	http://dx.doi.org/10.1016/0091-6749(76)90155-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BX744	956556				2022-12-18	WOS:A1976BX74400009
J	SEABURY, J; BECKER, B; SALVAGGIO, J				SEABURY, J; BECKER, B; SALVAGGIO, J			HOME HUMIDIFIER THERMOPHILIC ACTINOMYCETE ISOLATES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									TULANE UNIV MED CTR, NEW ORLEANS, LA 70118 USA	Tulane University								BANASZAK EF, 1974, AM REV RESPIR DIS, V110, P585; BECKER B, 1965, APPL MICROBIOL, V13, P236, DOI 10.1128/AEM.13.2.236-243.1965; BECKER B, 1964, APPL MICROBIOL, V12, P421, DOI 10.1128/AEM.12.5.421-423.1964; BERD D, 1973, APPL MICROBIOL, V25, P665, DOI 10.1128/AEM.25.4.665-681.1973; LECHEVALIER HA, 1967, ANNU REV MICROBIOL, V21, P76; LECHEVALIER MP, 1968, J LAB CLIN MED, V71, P934; SEABURY J, 1973, J ALLERGY CLIN IMMUN, V51, P161, DOI 10.1016/0091-6749(73)90021-3; SEABURY J, 1969, P SOC EXP BIOL MED, V129, P361	8	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	2					174	176		10.1016/0091-6749(76)90037-3	http://dx.doi.org/10.1016/0091-6749(76)90037-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BE952	1078519	Bronze			2022-12-18	WOS:A1976BE95200010
J	SOIFER, MM; BARBORIAK, JJ; CHRYSSANTHOPOULOS, C; FINK, JN; FUNAHASHI, A; HAMILTON, LH; MAKSUD, MG				SOIFER, MM; BARBORIAK, JJ; CHRYSSANTHOPOULOS, C; FINK, JN; FUNAHASHI, A; HAMILTON, LH; MAKSUD, MG			METABOLIC CHANGES IN EXERCISE-INDUCED AND METHACHOLINE-INDUCED BRONCHOCONSTRICTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,DEPT PHYSIOL,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT PHARMACOL,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53233; VET ADM CTR,SERV RES,BIOCHEM SECT,WOOD,WI 53193	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin								ANDERSON SD, 1971, THORAX, V26, P396, DOI 10.1136/thx.26.4.396; BARBORIAK J J, 1973, Clinical Allergy, V3, P83, DOI 10.1111/j.1365-2222.1973.tb01312.x; Barker SB, 1941, J BIOL CHEM, V138, P535; CARLSON LA, 1967, NUTRITION PHYSICAL A, P16; GODFREY S, 1973, J ALLERGY CLIN IMMUN, V52, P199, DOI 10.1016/0091-6749(73)90058-4; GODFREY S, 1973, CHEST, V63, P36; GRIFFITHS J, 1972, Chest, V62, P527; ISSEKUTZ B, 1964, FAT TISSUE, pCH11; KO H, 1967, ANAL BIOCHEM, V20, P205, DOI 10.1016/0003-2697(67)90026-7; KORY RC, 1963, AM REV RESPIR DIS, V87, P228; MATHE AA, 1969, NEW ENGL J MED, V281, P234, DOI 10.1056/NEJM196907312810503; MCNEILL RS, 1964, LANCET, V2, P1101; SUTHERLAND EW, 1968, CIRCULATION, V37, P279, DOI 10.1161/01.CIR.37.2.279; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; YU DYC, 1972, J APPL PHYSIOL, V32, P823, DOI 10.1152/jappl.1972.32.6.823	15	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	6					577	581		10.1016/0091-6749(76)90009-9	http://dx.doi.org/10.1016/0091-6749(76)90009-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BV054					2022-12-18	WOS:A1976BV05400009
J	BRANCH, LB; NELSON, HS; LIPTAK, R				BRANCH, LB; NELSON, HS; LIPTAK, R			SERUM IGA AND DELAYED-HYPERSENSITIVITY SKIN-TESTS IN ALLERGIC PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					113	114						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800112
J	FERRARESI, RW; ROOKS, WH; NAKANO, GM; RINGOLD, HJ; KIDSON, C				FERRARESI, RW; ROOKS, WH; NAKANO, GM; RINGOLD, HJ; KIDSON, C			SELECTIVE INHIBITOR OF ELICITATION OF IMMUNE-MEDIATED REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									INST BIOL SCI, SYNTEX RES, STANFORD IND PK, PALO ALTO, CA 94304 USA	Syntex Corporation								BAILEY DW, 1960, TRANSPLAN B, V25, P424; BLOMGREN H, 1969, EXP CELL RES, V57, P185, DOI 10.1016/0014-4827(69)90140-2; COHEN JJ, 1970, J IMMUNOL, V105, P1146; CROWLE AJ, 1968, J ALLERGY, V42, P140, DOI 10.1016/0021-8707(68)90087-7; DORFMAN RI, 1961, ENDOCRINOLOGY, V68, P616, DOI 10.1210/endo-68-4-616; DORFMAN RI, 1961, ENDOCRINOLOGY, V68, P43, DOI 10.1210/endo-68-1-43; DORFMAN RI, 1961, ENDOCRINOLOGY, V68, P17, DOI 10.1210/endo-68-1-17; DORFMAN RI, 1962, P SOC EXP BIOL MED, V111, P441; FREEDMAN HH, 1972, P SOC EXP BIOL MED, V139, P909; GLENN EM, 1959, METABOLISM, V8, P265; GREIG ME, 1970, J PHARMACOL EXP THER, V173, P85; HAINES RF, 1967, FED PROC, V26, P934; HULKA JF, 1965, ENDOCRINOLOGY, V77, P897, DOI 10.1210/endo-77-5-897; Jerne N.K., 1963, CELL BOUND ANTIBODIE, P109; KINCL FA, 1965, J REPROD FERTIL, V10, P105; LEE JM, 1955, P SOC EXP BIOL MED, V89, P263; LEVINE MA, 1970, SCIENCE, V167, P1515, DOI 10.1126/science.167.3924.1515; MATHEWS JH, 1970, J CLIN ENDOCR METAB, V30, P653, DOI 10.1210/jcem-30-5-653; McPhail MK, 1934, J PHYSIOL-LONDON, V83, P145, DOI 10.1113/jphysiol.1934.sp003217; MISHELL RI, 1966, SCIENCE, V153, P1004, DOI 10.1126/science.153.3739.1004; PELNER L, 1965, J AM GERIATR SOC, V13, P765, DOI 10.1111/j.1532-5415.1965.tb00634.x; ROSZKOWSKI AP, 1971, J PHARMACOL EXP THER, V179, P114; SHIPLEY EG, 1962, METHOD HORMONE RES, V2, pCH5; SILVER E, 1971, FED PROC, V30, pA601; TOIVANEN P, 1967, MED PHARMACOL EXP, V17, P33; TURCOTTE JG, 1968, TRANSPLANTATION, V6, P248, DOI 10.1097/00007890-196803000-00010; WARNER NL, 1964, AUST J EXP BIOL MED, V42, P401, DOI 10.1038/icb.1964.38; WINER BJ, 1962, STATISTICAL PRINCIPL; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	29	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	1					25	34		10.1016/S0091-6749(75)80005-4	http://dx.doi.org/10.1016/S0091-6749(75)80005-4			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V2344	45926	Bronze			2022-12-18	WOS:A1975V234400004
J	LEFFERT, F; MAY, CD				LEFFERT, F; MAY, CD			UNRESPONSIVE BASOPHILS IN A HIGHLY POLLEN-SENSITIVE SUBJECT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					85	85						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800041
J	LEVINSON, A; ZWEIMAN, B; LISAK, R; ABDOU, N				LEVINSON, A; ZWEIMAN, B; LISAK, R; ABDOU, N			T-LYMPHOCYTES AND B-LYMPHOCYTES IN MULTIPLE-SCLEROSIS (MS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					100	100						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800078
J	RAJTORA, D; KAMMERMEYER, JK; ANURAS, J; RICHERSON, HB				RAJTORA, D; KAMMERMEYER, JK; ANURAS, J; RICHERSON, HB			CLINICAL EVALUATION OF TOPICAL FLUNISOLIDE IN ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					121	121						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800129
J	RUBINSTEIN, E; REISMAN, RE; SOKAL, JE; ARBESMAN, CE				RUBINSTEIN, E; REISMAN, RE; SOKAL, JE; ARBESMAN, CE			RELATIONSHIP OF SERUM TOTAL IGE AND CELL-MEDIATED-IMMUNITY IN PATIENTS WITH HODGKINS-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					115	115						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800115
J	SNYDERMAN, R; BUCKLEY, RH				SNYDERMAN, R; BUCKLEY, RH			DEFECTS OF MONOCYTE CHEMOTAXIS IN PATIENTS WITH HYPERIMMUNOGLOBULINEMIA-E AND UNDUE SUSCEPTIBILITY TO INFECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Buckley, Rebecca/AAB-1578-2019					SNYDERMAN R, 1972, J IMMUNOL, V108, P857	1	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					102	103						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800084
J	TUFFIASH, WA; MCLEAN, JA				TUFFIASH, WA; MCLEAN, JA			TRIAL OF 4 PERCENT CROMOLYN SODIUM IN SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					116	117						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800119
J	VERVLOET, D; OKAZAKI, T; ILEA, VS; REISMAN, RE; ARBESMAN, CE				VERVLOET, D; OKAZAKI, T; ILEA, VS; REISMAN, RE; ARBESMAN, CE			HISTAMINE-RELEASE FROM HUMAN LEUKOCYTES - MODULATION BY CADMIUM ION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY Buffalo, DEPT MED, BUFFALO, NY USA; SUNY Buffalo, DEPT MICROBIOL, BUFFALO, NY USA; SUNY Buffalo, BUFFALO GEN HOSP, ALLERGY RES LAB, BUFFALO, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								ANTUNESMADEIRA MC, 1971, MEM ESTUD MUSEU ZOOL, V312, P5; BELMONTE AA, 1972, LIPIDS, V7, P490, DOI 10.1007/BF02533167; BLUM JJ, 1972, ARCH BIOCHEM BIOPHYS, V97, P309; BRISSON GR, 1972, J CLIN INVEST, V51, P232, DOI 10.1172/JCI106808; CHAKRAVARTY N, 1960, ACTA PHYSIOL SCAND, V48, P146, DOI 10.1111/j.1748-1716.1960.tb01854.x; EFENDIC S, 1970, Hormone and Metabolic Research, V2, P287; FOREMAN JC, 1972, J PHYSIOL-LONDON, V224, P753, DOI 10.1113/jphysiol.1972.sp009921; GILLESPI.E, 1974, J ALLERGY CLIN IMMUN, V53, P73; GILLESPIE E, 1972, J CLIN INVEST, V51, P2941, DOI 10.1172/JCI107118; GILLESPIE E, 1971, J CELL BIOL, V50, P544, DOI 10.1083/jcb.50.2.544; GREAVES MW, 1968, IMMUNOLOGY, V15, P743; HAUSER H, 1967, EUR J BIOCHEM, V1, P61, DOI 10.1111/j.1432-1033.1967.tb00044.x; HOGBERG B, 1960, ACTA PHYSIOL SCAND, V48, P133, DOI 10.1111/j.1748-1716.1960.tb01853.x; ILLU E, 1971, ELECTROPHYSIOLOGY, V29, P41; KALINER M, 1974, J IMMUNOL, V112, P664; LICHTENS.LM, 1968, SCIENCE, V161, P902, DOI 10.1126/science.161.3844.902; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LICHTENSTEIN LM, 1971, J IMMUNOL, V107, P1131; LICHTENSTEIN LM, 1973, ASTHMA PHYSIOLOGY IM, P99; LIPKAN GN, 1970, SB5 TOKS RES PUB MEZ, P191; MAIZELS M, 1956, J PHYSIOL-LONDON, V132, P414, DOI 10.1113/jphysiol.1956.sp005535; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; MONGAR JL, 1958, J PHYSIOL-LONDON, V140, P272, DOI 10.1113/jphysiol.1958.sp005933; MONGAR JL, 1973, INT ARCH ALLER A IMM, V45, P70, DOI 10.1159/000231004; ORANGE RP, 1973, BIOLOGIC ROLE IMMUNO; RASMUSSEN, 1970, SCIENCE, V170, P404; Sato H., 1966, Biological Bulletin Marine Biological Laboratory Woods Hole, V131, P405; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; STECHSCHULTE DJ, 1974, J IMMUNOL, V112, P970; THIND GS, 1970, AM J PHYSIOL, V219, P577, DOI 10.1152/ajplegacy.1970.219.3.577; TODA N, 1973, J PHARMACOL EXP THER, V184, P357; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104	32	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	4					262	272		10.1016/0091-6749(75)90100-1	http://dx.doi.org/10.1016/0091-6749(75)90100-1			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AS523	51863				2022-12-18	WOS:A1975AS52300003
J	VLAGOPOULOS, T; TOWNLEY, R; GHAZANSHAHI, S; BEWTRA, A; BURKE, K				VLAGOPOULOS, T; TOWNLEY, R; GHAZANSHAHI, S; BEWTRA, A; BURKE, K			COMPARISON OF ONSET OF ACTION AND BRONCHODILATION EFFECTS OF ANTICHOLINERGIC AGENT SCH-1000 WITH ISOPROTERENOL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					99	99						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800075
J	ARBESMAN, CE; RUBINSTE.E; FUJITA, Y; BUREK, CL; OKAZAKI, T; REISMAN, RE				ARBESMAN, CE; RUBINSTE.E; FUJITA, Y; BUREK, CL; OKAZAKI, T; REISMAN, RE			IN-VIVO AND IN-VITRO MEASUREMENT OF RAGWEED SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					81	81						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000041
J	CHARAVEJ.CC; WYPYCH, JI; REISMAN, RE; ARBESMAN, CE				CHARAVEJ.CC; WYPYCH, JI; REISMAN, RE; ARBESMAN, CE			STINGING INSECT HYPERSENSITIVITY .2. STUDIES OF BEE VENOM ANTIGENICITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					104	104						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000098
J	CHMELIK, F; FLAHERTY, D; REED, CE				CHMELIK, F; FLAHERTY, D; REED, CE			PREVALENCE OF PRECIPITINS TO ANTIGENS ASSOCIATED WITH HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					86	86						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000053
J	FUJITA, Y; WYPYCH, JI; WICHER, K; REISMAN, RE; ARBESMAN, CE				FUJITA, Y; WYPYCH, JI; WICHER, K; REISMAN, RE; ARBESMAN, CE			INHIBITORY EFFECT OF NONREAGINIC ANTIBODY ON RAST DETERMINATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					80	81						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000040
J	LEE, TP; BUSSE, WW; REED, CE				LEE, TP; BUSSE, WW; REED, CE			EPIDERMAL ADENYL-CYCLASE OF HUMAN AND MOUSE - STUDY OF ATOPIC STATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN, MED SCH,DEPT MED,ALLERGY LAB,433 SMI, 1300 UNIV AVE, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison								BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; BULLOUGH WS, 1962, BIOL REV, V37, P307, DOI 10.1111/j.1469-185X.1962.tb01615.x; BULLOUGH WS, 1955, EXP CELL RES, V9, P108, DOI 10.1016/0014-4827(55)90164-6; CARR RH, 1973, J ALLERGY CLIN IMMUN, V51, P255, DOI 10.1016/0091-6749(73)90127-9; HOLLA SWJ, 1972, BRIT J DERMATOL, V86, P147, DOI 10.1111/j.1365-2133.1972.tb16077.x; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MIER PD, 1970, BRIT J DERMATOL, V83, P364, DOI 10.1111/j.1365-2133.1970.tb15717.x; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; POWELL JA, 1971, ARCH DERMATOL, V104, P359, DOI 10.1001/archderm.104.4.359; REED CE, 1968, YALE J BIOL MED, V40, P507; SZENTIVANYI A, 1971, IMMUNOLOGICAL DISEAS; VOORHEES JJ, 1972, ARCH DERMATOL, V105, P384, DOI 10.1001/archderm.105.3.384	12	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	5					283	287		10.1016/0091-6749(74)90107-9	http://dx.doi.org/10.1016/0091-6749(74)90107-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S9114	4362674				2022-12-18	WOS:A1974S911400005
J	RIEGER, CHL; KRAFT, SC; ROTHBERG, RM				RIEGER, CHL; KRAFT, SC; ROTHBERG, RM			T CELL FUNCTION IN PATIENTS WITH EARLY THYMIC IRRADIATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					76	76						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000029
J	SLY, RM				SLY, RM			EFFECT OF DIETHYLCARBAMAZINE PAMOATE UPON EXERCISE-INDUCED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					82	83						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000045
J	SOLOMON, WR				SOLOMON, WR			ASSESSING FUNGUS PREVALENCE IN DOMESTIC INTERIORS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					71	71						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000016
J	VONMAUR, K; TURK, A; STEVENS, MB; ADKINSON, NF; LICHTENS.LM				VONMAUR, K; TURK, A; STEVENS, MB; ADKINSON, NF; LICHTENS.LM			LACK OF INCREASED HYPERSENSITIVITY TO PENICILLIN IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					68	68						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000008
J	WEINBERG.MM; BRONSKY, EA				WEINBERG.MM; BRONSKY, EA			ORAL BRONCHODILATOR THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					78	79						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000035
J	BERNSTEIN, RA; LINARELLI, L; FRIDAY, GA; DRASH, A; FIREMAN, P				BERNSTEIN, RA; LINARELLI, L; FRIDAY, GA; DRASH, A; FIREMAN, P			EFFECT OF EPHEDRINE SULFATE ON URINARY CYCLIC ADENOSINE-MONOPHOSPHATE (AMP) IN NORMALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		NELSON HS, 1972, J ALLERGY CLIN IMMUN, V49, P105	1	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					89	89		10.1016/S0091-6749(73)80025-9	http://dx.doi.org/10.1016/S0091-6749(73)80025-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300025
J	GROSSMAN, J; BAUM, J; GLUCKMAN, J; FUSNER, J; CONDEMI, JJ				GROSSMAN, J; BAUM, J; GLUCKMAN, J; FUSNER, J; CONDEMI, JJ			EFFECT OF AGING AND ACUTE ILLNESS ON DELAYED-HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					127	128		10.1016/S0091-6749(73)80105-8	http://dx.doi.org/10.1016/S0091-6749(73)80105-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913		Bronze			2022-12-18	WOS:A1973O791300105
J	MCCONNEL.LH; ARKINS, JA; FINK, JN				MCCONNEL.LH; ARKINS, JA; FINK, JN			INDUCED HOMOCYTOTROPIC ANTIBODY TO BOVINE SERUM-ALBUMIN IN NONATOPIC DOGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WOOD VET ADM HOSP,RES SERV,MILWAUKEE,WI 53226; MED COLL WISCONSIN,DEPT MED,ALLERGY SECT,MILWAUKEE,WI 53226	Medical College of Wisconsin								ARKINS JA, 1967, J ALLERGY, V40, P50, DOI 10.1016/0021-8707(67)90059-7; BALE WF, 1966, P SOC EXP BIOL MED, V122, P407; BECKER GL, 1966, J EXP MED, V124, P379; Ovary Z, 1964, IMMUNOLOGICAL METHOD; PATTERSON R, 1969, J IMMUNOL, V102, P466; PATTERSON R, 1968, J IMMUNOL, V101, P687; PATTERSON R, 1963, J IMMUNOL, V91, P129; PATTERSON R, 1964, J IMMUNOL, V93, P51; PRUZANSKY JJ, 1964, J ALLERGY, V35, P1, DOI 10.1016/0021-8707(64)90042-5; STAVITSKY AB, 1954, J IMMUNOL, V72, P360; SUNTHONP.P, 1971, CLIN EXP IMMUNOL, V8, P825	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	1					47	54		10.1016/0091-6749(73)90120-6	http://dx.doi.org/10.1016/0091-6749(73)90120-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q1826	4197605				2022-12-18	WOS:A1973Q182600006
J	OROURKE, JN; BOOTH, BH; PATTERSO.R				OROURKE, JN; BOOTH, BH; PATTERSO.R			ANAPHYLACTIC REACTION TO PARATHYROID-HORMONE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV, MED SCH, DEPT MED, SECT ALLERGY IMMUNOL, CHICAGO, IL 60611 USA	Northwestern University								AURBACH GD, 1964, ENDOCRINOLOGY, V75, P290, DOI 10.1210/endo-75-2-290; AUSTEN KF, 1965, J AMER MED ASSOC, V192, P108, DOI 10.1001/jama.1965.03080150038007; KABAT EA, 1961, EXPTL IMMUNOCHEMISTR; LIEBERMAN P, 1971, Journal of the American Medical Association, V215, P1106, DOI 10.1001/jama.215.7.1106; MAHON WE, 1967, THORAX, V22, P13, DOI 10.1136/thx.22.1.13; PATTERSON R, 1969, J IMMUNOL, V103, P1061; Patterson Richard W., IN PRESS; Pepys J, 1966, Clin Exp Immunol, V1, P377; POTTS JT, 1965, PARATHYROID GLANDS; PURNELL DC, 1970, J CLIN ENDOCRINOL, V46, P507; RASMUSSEN H, 1964, J BIOL CHEM, V239, P2852; RIDOLFO AS, PERSONAL COMMUNICATI; ROSENBLUM AH, 1964, J PEDIATR-US, V64, P387, DOI 10.1016/S0022-3476(64)80191-8; SALMON SE, 1969, J IMMUNOL, V103, P129; ZEISS CR, IN PRESS	15	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	1					55	59		10.1016/0091-6749(73)90121-8	http://dx.doi.org/10.1016/0091-6749(73)90121-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q1826	4736677	Bronze			2022-12-18	WOS:A1973Q182600007
J	SPITZER, RH; CALLAGHAN, OH; KAPLAN, MA; LEIJA, JG; DAMUS, AJ				SPITZER, RH; CALLAGHAN, OH; KAPLAN, MA; LEIJA, JG; DAMUS, AJ			PROPERTIES OF RABBIT ANTI-RAGWEED AND ANTI-HORSERADISH PEROXIDASE HOMOCYTOTROPIC ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHICAGO MED SCH, DEPT BIOCHEM, 2020 W OGDEN AVE, CHICAGO, IL 60612 USA	Chicago Medical School								AVRAMEAS S, 1970, J EXP MED, V131, P1137, DOI 10.1084/jem.131.6.1137; BECKER EL, 1968, TEXTBOOK IMMUNOPATHO, V1; CALLAGHAN OH, 1962, J IMMUNOL, V89, P612; CONNELL JT, 1964, J ALLERGY, V35, P18, DOI 10.1016/0021-8707(64)90045-0; DHALIWAL KS, 1971, J ALLERGY CLIN IMMUN, V48, P161, DOI 10.1016/0091-6749(71)90011-X; FREEMAN MJ, 1969, INT ARCH ALLER A IMM, V36, P530, DOI 10.1159/000230773; HENSON P, 1968, FED PROC, V27, P479; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; ISHIZAKA K, 1966, J IMMUNOL, V97, P840; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; ISHIZAKA K, 1967, J IMMUNOL, V99, P610; ISHIZAKA K, 1969, J IMMUNOL, V102, P69; ISHIZAKA K, 1970, IMMUNOCHEMISTRY, V7, P515, DOI 10.1016/0019-2791(70)90273-9; KINDT TJ, 1970, J IMMUNOL, V104, P1491; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; LINDQVIST KJ, 1968, IMMUNOCHEMISTRY, V5, P525, DOI 10.1016/0019-2791(68)90089-X; ONOUE K, 1966, J EXP MED, V123, P173, DOI 10.1084/jem.123.1.173; PERELMUTTER L, 1962, INT ARCH ALLER A IMM, V21, P1; PERELMUTTER L, 1962, INT ARCH ALLER A IMM, V20, P355, DOI 10.1159/000229277; PINCKARD RN, 1971, J IMMUNOL, V106, P1602; REISMAN ROBERT E., 1964, J ALLERGY, V35, P227, DOI 10.1016/0021-8707(64)90005-X; REVOLTELLA R, 1969, INT ARCH ALLER A IMM, V36, P282, DOI 10.1159/000230749; RICHERSON HB, 1968, J IMMUNOL, V101, P1291; ROBBINS KC, 1963, J IMMUNOL, V91, P354; SPITZER RH, 1968, INT ARCH ALLER A IMM, V34, P488, DOI 10.1159/000230142; SPITZER RH, 1964, INT ARCH ALLER A IMM, V25, P335, DOI 10.1159/000229536; STRANNEGARD O, 1969, IMMUNOLOGY, V16, P387; STRAUS W, 1969, METHODS ACHIEVEMENTS, V4; STREJAN G, 1970, J IMMUNOL, V105, P1264; SUNTHONP.P, 1971, CLIN EXP IMMUNOL, V8, P825; ZVAIFLER NJ, 1969, J IMMUNOL, V102, P947; ZVAIFLER NJ, 1967, INT ARCH ALLER A IMM, V31, P465, DOI 10.1159/000229892; ZVAIFLER NJ, 1967, EXP PARASITOL, V20, P278, DOI 10.1016/0014-4894(67)90050-1; ZVAIFLER NJ, 1966, J EXP MED, V123, P935, DOI 10.1084/jem.123.5.935; [No title captured]	35	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	2					63	72		10.1016/0091-6749(73)90078-X	http://dx.doi.org/10.1016/0091-6749(73)90078-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q4190					2022-12-18	WOS:A1973Q419000001
J	STEINBERG, P; ISHIZAKA, K; NORMAN, PS				STEINBERG, P; ISHIZAKA, K; NORMAN, PS			IS IMMUNOGLOBULIN-E A GATEKEEPER FOR OTHER ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					109	109		10.1016/S0091-6749(73)80067-3	http://dx.doi.org/10.1016/S0091-6749(73)80067-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300067
J	KAWAI, T; ARQUEMBOURG, P; SALVAGGIO, J; MARSH, D				KAWAI, T; ARQUEMBOURG, P; SALVAGGIO, J; MARSH, D			DETECTION OF ANTI-HOUSE DUST PRECIPITINS IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					134	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700104
J	MCINTOSH, K; ELLIS, EF; ELLER, JJ; FULGINIT.VA; HOFFMAN, LS; LYBASS, TG				MCINTOSH, K; ELLIS, EF; ELLER, JJ; FULGINIT.VA; HOFFMAN, LS; LYBASS, TG			ASSOCIATION OF VIRAL AND BACTERIAL RESPIRATORY-INFECTION WITH EXACERBATIONS OF WHEEZING IN YOUNG ASTHMATIC CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					131	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700097
J	PERELMUTTER, L; PHILLS, JA; BERNSTEIN, IL; MICHAELS, G; JOHANSSON, SG				PERELMUTTER, L; PHILLS, JA; BERNSTEIN, IL; MICHAELS, G; JOHANSSON, SG			SOME QUANTITATIVE ASPECTS OF RAT MAST-CELL TECHNIQUE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					113	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700059
J	ZEITZ, SJ; VANARSDE.PP; OSTROW, JH				ZEITZ, SJ; VANARSDE.PP; OSTROW, JH			IMMUNOLOGICAL FEATURES OF ANERGIC TUBERCULOSIS PATIENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					93	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700019
J	DHALIWAL, KS; ARKINS, JA; BERGER, S				DHALIWAL, KS; ARKINS, JA; BERGER, S			PRODUCTION OF ANAPHYLAXIS WITH RAGWEED IN NONATOPIC DOGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		ARBESMAN CE, 1960, J ALLERGY, V31, P317, DOI 10.1016/0021-8707(60)90068-X; ARKINS JA, 1967, J ALLERGY, V40, P50, DOI 10.1016/0021-8707(67)90059-7; BUKOSKY RJ, 1968, J LAB CLIN MED, V72, P383; DAVIS BE, 1967, MICROBIOLOGY, P526; DEAN HR, 1962, J PATH BACT, V27, P51; KABAT E, 1961, EXPERIMENTAL IMMUNOC; PATTERSON R, 1968, J IMMUNOL, V101, P687; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; STAVITSKY AB, 1954, J IMMUNOL, V72, P360; SUNTHONPALIN P, IN PRESS; TENNENBAUM JI, 1963, SCIENCE, V142, P589, DOI 10.1126/science.142.3592.589	11	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	3					161	&		10.1016/0091-6749(71)90011-X	http://dx.doi.org/10.1016/0091-6749(71)90011-X			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K3234	5284940				2022-12-18	WOS:A1971K323400005
J	TAYLOR, FB; GREEN, GR; TOMAR, RH				TAYLOR, FB; GREEN, GR; TOMAR, RH			SEPARATION OF A MATERIAL IN STREPTOKINASE-STREPOTODORNASE WHICH INDUCES DELAYED SKIN REACTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; LAWRENCE HS, 1952, J IMMUNOL, V68, P159; TAYLOR FB, 1968, BIOCHEMISTRY-US, V7, P232, DOI 10.1021/bi00841a028	3	5	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	1					23	&		10.1016/0091-6749(71)90051-0	http://dx.doi.org/10.1016/0091-6749(71)90051-0			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	J8503	5282885				2022-12-18	WOS:A1971J850300004
J	Dai, RX; Miliku, K; Gaddipati, S; Choi, J; Ambalavanan, A; Tran, MM; Reyna, M; Sbihi, H; Lou, W; Parvulescu, P; Lefebvre, DL; Becker, AB; Azad, MB; Mandhane, PJ; Turvey, SE; Duan, QL; Moraes, J; Sears, MR; Subbarao, P				Dai, Ruixue; Miliku, Kozeta; Gaddipati, Sirisha; Choi, Jihoon; Ambalavanan, Amirthagowri; Tran, Maxwell M.; Reyna, Myrtha; Sbihi, Hind; Lou, Wendy; Parvulescu, Paula; Lefebvre, Diana L.; Becker, Allan B.; Azad, Meghan B.; Mandhane, Piush J.; Turvey, Stuart E.; Duan, Qingling; Moraes, J.; Sears, Malcolm R.; Subbarao, Padmaja			Wheeze trajectories: Determinants and outcomes in the CHILD Cohort Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Wheeze trajectories; asthma; lung function; pediatrics; CHILD Cohort Study; early-life determinants; genetic risk	1ST 6 YEARS; LUNG-FUNCTION; RISK-FACTORS; MATERNAL TRANSMISSION; AIRWAY RESPONSIVENESS; YOUNG-CHILDREN; ASTHMA; PHENOTYPES; BIRTH; ASSOCIATIONS	Background: Wheezing in early life is associated with asthma in adulthood; however, the determinants of wheezing trajectories and their associations with asthma and lung function in childhood remain poorly understood. Objective: In the CHILD Cohort Study, we aimed to identify wheezing trajectories and examine the associations between these trajectories, risk factors, and clinical outcomes at age 5 years.Methods: Wheeze data were collected at 8 time points from 3 months to 5 years of age. We used group-based trajectory models to derive wheeze trajectories among 3154 children. Associations with risk factors and clinical outcomes were analyzed by weighted regression models.Results: We identified 4 trajectories: a never/infrequent trajectory, transient wheeze, intermediate-onset (preschool) wheeze, and persistent wheeze. Higher body mass index was a common risk factor for all wheeze trajectories compared with that in the never/infrequent group. The unique predictors for specific wheeze trajectories included male sex, lower respiratory tract infections, and day care attendance for transient wheeze; paternal history of asthma, atopic sensitization, and child genetic risk score of asthma for intermediate wheeze; and maternal asthma for persistent wheeze. Blood eosinophil counts were higher in children with the intermediate wheeze trajectory than in those children with the other trajectories at the ages of 1 and 5 years. All wheeze trajectories were associated with decreased lung function and increased risk of asthma at age 5 years.Conclusions: We identified 4 distinct trajectories in children from 3 months to 5 years of age, reflecting different phenotypes of early childhood wheeze. These trajectories were characterized by different biologic and physiologic traits and risk factors. (J Allergy Clin Immunol 2022;149:2153-65.)	[Dai, Ruixue; Miliku, Kozeta; Tran, Maxwell M.; Reyna, Myrtha; Subbarao, Padmaja] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Lefebvre, Diana L.; Sears, Malcolm R.; Subbarao, Padmaja] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Gaddipati, Sirisha] Univ Miami, Miller Sch Med, Coral Gables, FL USA; [Choi, Jihoon; Ambalavanan, Amirthagowri] Queens Univ, Sch Comp, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Sbihi, Hind] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Lou, Wendy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Parvulescu, Paula] Liverpool City Council, Publ Hlth Dept, Liverpool, England; [Becker, Allan B.; Azad, Meghan B.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Mandhane, Piush J.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Miami; Queens University - Canada; University of British Columbia; University of Toronto; University of Manitoba; University of Alberta	Subbarao, P (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Subbarao, P (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	padmaja.subbarao@sickkids.ca	Turvey, Stuart/HGV-1191-2022	Turvey, Stuart/0000-0003-1599-1065; Dai, Ruixue/0000-0001-5485-2725; Tran, Maxwell/0000-0001-5503-613X	Canadian Institutes of Health Research (CIHR); Allergy, Genes and Environment Network of Centers of Excellence (AllerGen NCE, Inc); Allergy, Genes and Environment Network of the Networks of Centres of Excellence (AllerGen NCE, Inc); Health Canada; Environment Canada; Canada Mortgage and Housing Corporation; Sick Children's Hospital Foundation; Silver Thread Foundation; Childhood Asthma Foundation; Canada Research Chairs program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Allergy, Genes and Environment Network of Centers of Excellence (AllerGen NCE, Inc); Allergy, Genes and Environment Network of the Networks of Centres of Excellence (AllerGen NCE, Inc); Health Canada; Environment Canada(CGIAR); Canada Mortgage and Housing Corporation; Sick Children's Hospital Foundation; Silver Thread Foundation; Childhood Asthma Foundation; Canada Research Chairs program(Canada Research Chairs)	Supported by the Canadian Institutes of Health Research (CIHR) and Allergy, Genes and Environment Network of Centers of Excellence (AllerGen NCE, Inc). CHILD was initially funded by the Canadian Institutes of Health Research (CIHR) and the Allergy, Genes and Environment Network of the Networks of Centres of Excellence (AllerGen NCE, Inc). Additional support has been provided by Health Canada, Environment Canada, Canada Mortgage and Housing Corporation, the Sick Children's Hospital Foundation, Don and Debbie Morrison, the Silver Thread Foundation, and the Childhood Asthma Foundation. P.S., S.E.T., and M.B.A. are supported by the Canada Research Chairs program. We also acknowledge the generosity of ALK-Abell (Mississauga, Ontario, Canada) in supplying all allergens for the study, and Lincoln Diagnostics, Inc (Decatur, Ill), for providing the Duotip-Test II devices and skin testing kits. The funders had no role in the design and analysis of the study. PM2.5 metrics, indexed to DMTI Spatial, Inc, postal codes, were provided by CANUE (Canadian Urban Environmental Health Research Consortium). Visit CHILD at www.childstudy.ca.	Ambalavanan A, 2020, AUTHOREA; Azad MB, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02019-2016; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Belgrave DCM, 2013, EXPERT REV CLIN IMMU, V9, P921, DOI 10.1586/1744666X.2013.836450; Belgrave DCM, 2013, J ALLERGY CLIN IMMUN, V132, P575, DOI 10.1016/j.jaci.2013.05.041; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cano-Garcinuno A, 2014, PRIM CARE RESP J, V23, P60, DOI 10.4104/pcrj.2014.00008; Caudri D, 2013, CLIN EXP ALLERGY, V43, P1395, DOI 10.1111/cea.12173; Clifton VL, 2019, LANCET RESP MED, V7, P485, DOI 10.1016/S2213-2600(19)30149-3; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; Coverstone AM, 2020, J ALLER CL IMM-PRACT, V8, P442, DOI 10.1016/j.jaip.2019.11.020; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Dezateux C, 1999, AM J RESP CRIT CARE, V159, P403, DOI 10.1164/ajrccm.159.2.9712029; Granell R, 2016, J ALLERGY CLIN IMMUN, V138, P1060, DOI 10.1016/j.jaci.2016.01.046; Granell R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048359; Guilbert TW, 2007, AM J RESP CRIT CARE, V176, P843, DOI 10.1164/rccm.200610-1507OC; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Howard R, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0542-0; Jackson DJ, 2021, THORAX, V76, P220, DOI 10.1136/thoraxjnl-2020-215168; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Lee KI, 1997, COMMUN STAT-SIMUL C, V26, P559, DOI 10.1080/03610919708813397; Leme AS, 2006, J IMMUNOL, V176, P762, DOI 10.4049/jimmunol.176.2.762; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Lim RH, 2009, AM J REPROD IMMUNOL, V61, P1, DOI 10.1111/j.1600-0897.2008.00671.x; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miliku K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080995; Moraes TJ, 2015, PAEDIATR PERINAT EP, V29, P84, DOI 10.1111/ppe.12161; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Neuman A, 2014, PEDIAT ALLERG IMM-UK, V25, P380, DOI 10.1111/pai.12223; Oksel C, 2019, ANN AM THORAC SOC, V16, P868, DOI 10.1513/AnnalsATS.201811-837OC; Oksel C, 2019, J ALLERGY CLIN IMMUN, V143, P1783, DOI 10.1016/j.jaci.2018.10.059; Owora AH, 2021, PEDIAT ALLERG IMM-UK, V32, P34, DOI 10.1111/pai.13313; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raby BA, 2005, AM J RESP CRIT CARE, V172, P552, DOI 10.1164/rccm.200501-010OC; Roth DE, 2015, TROP MED INT HEALTH, V20, P1607, DOI 10.1111/tmi.12592; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sbihi H, 2015, ENVIRON HEALTH PERSP, V123, P902, DOI 10.1289/ehp.1408700; Schmiedel BJ, 2016, 17Q21 ASTHMA RISK VA, V7, P1; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Sonnappa S, 2010, J ALLERGY CLIN IMMUN, V126, P519, DOI 10.1016/j.jaci.2010.04.018; Sordillo JE, 2020, J ALLERGY CLIN IMMUN, V145, P716, DOI 10.1016/j.jaci.2019.10.026; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; Stick SM, 1996, LANCET, V348, P1060, DOI 10.1016/S0140-6736(96)04446-7; Subbarao P, 2015, THORAX, V70, P998, DOI 10.1136/thoraxjnl-2015-207246; Tagiyeva N, 2016, AM J RESP CRIT CARE, V193, P23, DOI 10.1164/rccm.201505-0870OC; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Tse SM, 2016, J ALLERGY CLIN IMMUN, V138, P1561, DOI 10.1016/j.jaci.2016.04.005; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO Child Growth Standards, 2006, LENGTH HEIGHT AG WEI; Wright AL, 1999, J ALLERGY CLIN IMMUN, V104, P589, DOI 10.1016/S0091-6749(99)70328-3	55	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2153	2165		10.1016/j.jaci.2021.10.039	http://dx.doi.org/10.1016/j.jaci.2021.10.039			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2E6QP	34974064				2022-12-18	WOS:000812351900009
J	Maetzel, A; Smith, MD; Duckworth, EJ; Hampton, SL; De Donatis, GM; Murugesan, N; Rushbrooke, LJ; Li, L; Francombe, D; Feener, EP; Yea, CM				Maetzel, Andreas; Smith, Michael D.; Duckworth, Edward J.; Hampton, Sally L.; De Donatis, Gian Marco; Murugesan, Nivetha; Rushbrooke, Louise J.; Li, Lily; Francombe, Danielle; Feener, Edward P.; Yea, Christopher M.			KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hereditary angioedema; plasma kallikrein; clinical trial	C1 INHIBITOR CONCENTRATE; ATTACKS; ICATIBANT; EDEMA	Background: Attacks of hereditary angioedema are attributed to excessive plasma kallikrein (PKa) activity, which cleaves high-molecular-weight kininogen to generate the proinflammatory hormone bradykinin. Objective: We evaluated the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of KVD900, an orally administered inhibitor of PKa in healthy adults. Methods: KVD900 was administered in 2 clinical studies. In the first study, healthy adult men received single ascending doses (5-600 mg) of KVD900 capsule or placebo, single 100 mg doses of KVD900 tablet and KVD900 capsule (crossover), and single 600 mg doses of KVD900 (6 x 100 mg tablets) under fed and fasting conditions (crossover). In a second study, 3 cohorts of healthy adults were provided 600 mg of KVD900 tablets at 8-, 4-, and 2-hour intervals. Results: Overall, 98 healthy participants received KVD900. All adverse events (AEs) were mild, except for a single moderate AE (headache). Exposure to KVD900 was proportional to dose. The PK parameters for KVD900 600 mg in tablet form under fasted conditions were mean (coefficient of variation) maximum plasma concentration of 6460 (22.0) ng/mL, mean (coefficient of variation) area under the curve (AUC(0-24)) of 18,600 (22.5) h$ng/mL, and median (range) time to maximum plasma concentration of 0.5 (0.33-1.5) hours. Mean PKa inhibition was essentially complete (>98%) between 20 minutes and 3 hours, and >90% inhibition was maintained for at least 8 hours after dosing. High-molecular-weight kininogen cleavage protection at the 600 mg dose was attained within 20 minutes and maintained for 8 to 10 hours. Conclusion: These phase 1 studies evaluated the PK/PD profile of KVD900, showing that KVD900 rapidly achieves nearcomplete PKa inhibition and is generally safe and well tolerated.	[Maetzel, Andreas; Smith, Michael D.; Duckworth, Edward J.; Hampton, Sally L.; De Donatis, Gian Marco; Murugesan, Nivetha; Rushbrooke, Louise J.; Li, Lily; Feener, Edward P.; Yea, Christopher M.] KalVista Pharmaceut, Salisbury, Wilts, England; [Maetzel, Andreas; Smith, Michael D.; Duckworth, Edward J.; Hampton, Sally L.; De Donatis, Gian Marco; Murugesan, Nivetha; Rushbrooke, Louise J.; Li, Lily; Feener, Edward P.; Yea, Christopher M.] KalVista Pharmaceut, Cambridge, England; [Maetzel, Andreas] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Francombe, Danielle] Simbec Orion Ltd, Merthyr Tydfil, M Glam, Wales	University of Toronto	Feener, EP (corresponding author), KalVista Pharmaceut Inc, 55 Cambridge Pkwy,Ste 901E, Cambridge, MA 02142 USA.	epf@kalvisa.com		Hampton, Sally/0000-0002-4305-5461	KalVista Pharmaceuticals Ltd.	KalVista Pharmaceuticals Ltd.	The study was sponsored by KalVista Pharmaceuticals Ltd. The sponsor participated in the design and conduct of the study, including data collection, data management, data analysis, interpretation of the data, preparation, and review and approval of the report.	Aberer W, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0203-z; [Anonymous], 2018, VOICE PATIENT HEREDI; [Anonymous], 2011, FIRAZYR PACKAGE INSE; [Anonymous], 2018, TAKHZYRO PACKAGE INS; [Anonymous], 2020, ORLADEYO PACKAGE INS; [Anonymous], 2008, CINRYZE PACKAGE INSE; [Anonymous], 2014, RUCONEST PACKAGE INS; [Anonymous], 2009, BERINERT PACKAGE INS; Banerji A, 2017, NEW ENGL J MED, V376, P717, DOI 10.1056/NEJMoa1605767; Banerji A, 2018, JAMA-J AM MED ASSOC, V320, P2108, DOI 10.1001/jama.2018.16773; Betschel S, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0376-8; Bork K, 2001, ARCH INTERN MED, V161, P714, DOI 10.1001/archinte.161.5.714; Busse PJ, 2020, NEW ENGL J MED, V382, P1136, DOI 10.1056/NEJMra1808012; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; Hofman ZLM, 2016, J ALLERGY CLIN IMMUN, V138, P359, DOI 10.1016/j.jaci.2016.02.041; Kalbitor, 2009, KALBITOR PACKAGE INS; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; Martinez-Saguer I, 2014, TRANSFUSION, V54, P1552, DOI 10.1111/trf.12501; Maurer M, 2018, ALLERGY, V73, P1575, DOI 10.1111/all.13384; Zanichelli A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0233-x; Zuraw B, 2021, J ALLERGY CLIN IMMUN, V148, P164, DOI 10.1016/j.jaci.2020.10.015; Zuraw B, 2010, J ALLERGY CLIN IMMUN, V126, P821, DOI 10.1016/j.jaci.2010.07.021; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	24	4	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2034	2042		10.1016/j.jaci.2021.10.038	http://dx.doi.org/10.1016/j.jaci.2021.10.038			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35086692	hybrid			2022-12-18	WOS:000833525500026
J	Redhu, D; Franke, K; Aparicio-Soto, M; Kumari, V; Pazur, K; Illerhaus, A; Hartmann, K; Worm, M; Babina, M				Redhu, Davender; Franke, Kristin; Aparicio-Soto, Marina; Kumari, Vandana; Pazur, Kristijan; Illerhaus, Anja; Hartmann, Karin; Worm, Margitta; Babina, Magda			Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: Relevance of the tryptase/protease-activated receptor 2 axis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; interleukin 1; keratinocytes; mast cells; PAR-2; TSLP; tryptase	HUMAN EPITHELIAL-CELLS; ATOPIC-DERMATITIS; HUMAN SKIN; TSLP; INFLAMMATION; EXPRESSION; PROTEASES; HISTAMINE; ALPHA; INDUCTION	Background: Thymic stromal lymphopoietin (TSLP) promotes TH2 inflammation and is deeply intertwined with inflammatory dermatoses like atopic dermatitis. The mechanisms regulating TSLP are poorly defined. Objective: We investigated whether and by what mechanisms mast cells (MCs) foster TSLP responses in the cutaneous environment. Methods: Ex vivo and in vivo skin MC degranulation was induced by compound 48/80 in wild-type protease-activated receptor 2 (PAR -2)-and MC-deficient mice in the presence or absence of neutralizing antibodies, antagonists, or exogenous mouse MC protease 6 (mMCP6). Primary human keratinocytes and murine skin explants were stimulated with lysates/supernatants of human skin MCs, purified tryptase, or MC lysate diminished of tryptase. Chymase and histamine were also used. TSLP was quantified by ELISA, real-time quantitative PCR, and immunofluorescence staining. Results: Mas-related G protein-coupled receptor X2 (Mrgprb2) activation elicited TSLP in intact skin, mainly in the epidermis. Responses were strictly MC dependent and relied on PAR-2. Complementarily, TSLP was elicited by tryptase in murine skin explants. Exogenous mMCP6 could fully restore responsiveness in MC-deficient murine skin explants. Conversely, PAR-2 knockout mice were unresponsive to mMCP6 while displaying increased responsiveness to other inflammatory pathways, such as IL-1a. Indeed, IL-1a acted in concert with tryptase. In primary human keratinocytes, MC-elicited TSLP generation was likewise abolished by tryptase inhibition or elimination. Chymase and histamine did not affect TSLP production, but histamine triggered IL-6, IL 8, and stem cell factor. Conclusion: MCs communicate with kerationocytes more broadly than hitherto suspected. The tryptase/PAR-2 axis is a crucial component of this cross talk, underlying MC-dependent stimulation of TSLP in neighboring kerationocytes. Interference specifically with MC tryptase may offer a treatment option for disorders initiated or perpetuated by aberrant TSLP, such as atopic dermatitis.	[Redhu, Davender; Franke, Kristin; Aparicio-Soto, Marina; Kumari, Vandana; Pazur, Kristijan; Worm, Margitta; Babina, Magda] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergy Ctr Charite, Berlin, Germany; [Redhu, Davender; Franke, Kristin; Aparicio-Soto, Marina; Kumari, Vandana; Pazur, Kristijan; Worm, Margitta; Babina, Magda] Free Univ Berlin, Berlin, Germany; [Redhu, Davender; Franke, Kristin; Aparicio-Soto, Marina; Kumari, Vandana; Pazur, Kristijan; Worm, Margitta; Babina, Magda] Humboldt Univ, Berlin, Germany; [Redhu, Davender; Franke, Kristin; Aparicio-Soto, Marina; Kumari, Vandana; Pazur, Kristijan; Worm, Margitta; Babina, Magda] Berlin Inst Hlth, Berlin, Germany; [Illerhaus, Anja] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany; [Hartmann, Karin] Univ Hosp Basel, Dept Dermatol, Div Allergy, Basel, Switzerland; [Hartmann, Karin] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Hartmann, Karin] Univ Basel, Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; University of Cologne; University of Basel; University of Basel; University of Basel	Babina, M (corresponding author), Univ Med Berlin, Dept Dermatol & Allergy, Div Allergy & Immunol, Charite Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.	margitta.worm@charite.de	Hartmann, Karin/N-4865-2015	Hartmann, Karin/0000-0002-4595-8226; Redhu, Davender/0000-0002-8423-0844; Dr. Franke, Kristin/0000-0002-7402-4211; Pazur, Kristijan/0000-0002-3959-6986; Babina, Magda/0000-0002-4500-7615	Deutsche Forschungsgemeinschaft (DFG),Germany [WO-541/13-2, TRR130]	Deutsche Forschungsgemeinschaft (DFG),Germany(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG),Germany to M.W. (WO-541/13-2 and TRR130)	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Artuc M, 2002, J INVEST DERMATOL, V119, P411, DOI 10.1046/j.1523-1747.2002.01838.x; Babina M, 2004, J LEUKOCYTE BIOL, V75, P244, DOI 10.1189/jlb.0403157; Babina M., 2020, ITCH, V5, DOI [DOI 10.1097/ITX.0000000000000032, 10.1097/itx.0000000000000032]; Babina M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010102; Babina M, 2021, J INVEST DERMATOL, V141, P1286, DOI 10.1016/j.jid.2020.09.017; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buhl T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01740; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Cianferoni A, 2014, EXPERT REV CLIN IMMU, V10, P1463, DOI 10.1586/1744666X.2014.967684; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Corren J, 2019, NAT IMMUNOL, V20, P1603, DOI 10.1038/s41590-019-0524-9; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Derian CK, 1997, CELL GROWTH DIFFER, V8, P743; Dewas C, 2015, J IMMUNOL, V194, P1372, DOI 10.4049/jimmunol.1400519; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; DVORAK AM, 1991, J LEUKOCYTE BIOL, V49, P197, DOI 10.1002/jlb.49.2.197; Franke K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073580; Fu ZR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205147; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Fyfe M, 2005, CYTOKINE, V31, P358, DOI 10.1016/j.cyto.2005.06.004; Gouin O, 2018, J INVEST DERMATOL, V138, P1564, DOI 10.1016/j.jid.2018.01.034; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hazzan T, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080829; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Indra AK, 2013, EXPERT REV PROTEOMIC, V10, P309, DOI 10.1586/14789450.2013.814881; Jarvikallio A, 2003, ARCH DERMATOL RES, V295, P2, DOI 10.1007/s00403-002-0378-z; Kanda N, 2004, J INVEST DERMATOL, V122, P863, DOI 10.1111/j.0022-202X.2004.22432.x; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kohda F, 2002, J DERMATOL SCI, V28, P34, DOI 10.1016/S0923-1811(01)00147-5; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Kumari V, 2015, BRIT J DERMATOL, V172, P951, DOI 10.1111/bjd.13465; Lansu K, 2017, NAT CHEM BIOL, V13, P529, DOI [10.1038/NCHEMBIO.2334, 10.1038/nchembio.2334]; Maun HR, 2019, CELL, V179, P417, DOI 10.1016/j.cell.2019.09.009; Maurer M, 1997, J DERMATOL SCI, V16, P79, DOI 10.1016/S0923-1811(97)00043-1; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Nattkemper LA, 2018, J INVEST DERMATOL, V138, P1311, DOI 10.1016/j.jid.2017.12.029; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Okayama Y, 2009, EUR RESPIR J, V34, P425, DOI 10.1183/09031936.00121008; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00685-2019; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Rattenholl A, 2008, DRUG NEWS PERSPECT, V21, P369, DOI 10.1358/dnp.2008.21.7.1255294; Redhu D, 2020, BRIT J DERMATOL, V182, P119, DOI 10.1111/bjd.17940; Rukwied R, 2000, BRIT J DERMATOL, V142, P1114, DOI 10.1046/j.1365-2133.2000.03535.x; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Siiskonen H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00422; Simpson EL, 2019, J AM ACAD DERMATOL, V80, P1013, DOI 10.1016/j.jaad.2018.11.059; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Steinhoff M, 2018, IMMUNOL REV, V282, P248, DOI 10.1111/imr.12635; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Trivedi NN, 2010, AM J RESP CELL MOL, V42, P257, DOI 10.1165/rcmb.2009-0324RT; Wang Z, 2020, EXP DERMATOL, V29, P1104, DOI 10.1111/exd.14182; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Yamada Y, 2018, EXP DERMATOL, V27, P418, DOI 10.1111/exd.13322; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	69	4	4	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2053	+		10.1016/j.jaci.2022.01.029	http://dx.doi.org/10.1016/j.jaci.2022.01.029			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2E6QP	35240143	Bronze			2022-12-18	WOS:000812351900001
J	Steinhoff, M; Ahmad, F; Pandey, A; Datsi, A; AlHammadi, A; Al-Khawaga, S; Al-Malki, A; Meng, JH; Alam, M; Buddenkotte, J				Steinhoff, Martin; Ahmad, Fareed; Pandey, Atul; Datsi, Angeliki; AlHammadi, Ayda; Al-Khawaga, Sara; Al-Malki, Aysha; Meng, Jianghui; Alam, Majid; Buddenkotte, Joerg			Neuroimmune communication regulating pruritus in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Atopic eczema; pruritus; itch; pathophysiology; eczema; cytokine; neuropeptide; neuroimmunology; therapy	GENE-RELATED PEPTIDE; PROTEINASE-ACTIVATED RECEPTOR-2; THYMIC STROMAL LYMPHOPOIETIN; ITCH-ASSOCIATED RESPONSE; VASOACTIVE INTESTINAL POLYPEPTIDE; MAST-CELL DEGRANULATION; PRIMARY SENSORY NEURONS; HUMAN EPITHELIAL-CELLS; NERVE GROWTH-FACTOR; P-INDUCED ITCH	Atopic dermatitis (AD) is a common, chronic-relapsing inflammatory skin disease with significant disease burden. Genetic and environmental trigger factors contribute to AD, activating 2 of our largest organs, the nervous system and the immune system. Dysregulation of neuroimmune circuits plays a key role in the pathophysiology of AD, causing inflammation, pruritus, pain, and barrier dysfunction. Sensory nerves can be activated by environmental or endogenous trigger factors, transmitting itch stimuli to the brain. On stimulation, sensory nerve endings also release neuromediators into the skin, contributing again to inflammation, barrier dysfunction, and itch. In addition, dysfunctional peripheral and central neuronal structures contribute to neuroinflammation, sensitization, nerve elongation, and neuropathic itch, thus chronification and therapy resistance. Consequently, neuroimmune circuits in skin and central nervous system may be targets to treat pruritus in AD. Cytokines, chemokines, proteases, lipids, opioids, and ions excite/sensitize sensory nerve endings, which not only induces itch but further aggravates/perpetuates inflammation, skin barrier disruption, and pruritus as well. Thus, targeted therapies for neuroimmune circuits as well as pathway inhibitors (eg, kinase inhibitors) may be beneficial to control pruritus in AD either in systemic and/or in topical form. Understanding neuroimmune circuits and neuronal signaling will optimize our approach to control all pathological mechanisms in AD, inflammation, barrier dysfunction, and pruritus.	[Steinhoff, Martin; AlHammadi, Ayda; Al-Khawaga, Sara; Al-Malki, Aysha; Buddenkotte, Joerg] Hamad Med Corp, Dept Dermatol & Venereol, Doha, Qatar; [Steinhoff, Martin; Ahmad, Fareed; Pandey, Atul; Alam, Majid; Buddenkotte, Joerg] Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar; [Steinhoff, Martin; Ahmad, Fareed; Pandey, Atul; Alam, Majid; Buddenkotte, Joerg] Hamad Med Corp, Acad Hlth Syst, Dermatol Inst, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med Qatar, Dept Dermatol, Ar Rayyan, Qatar; [Steinhoff, Martin] Qatar Univ, Coll Med, Doha, Qatar; [Steinhoff, Martin] Weill Cornell Med, Dept Dermatol, New York, NY USA; [Datsi, Angeliki] Univ Hosp Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany; [Meng, Jianghui] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland	Hamad Medical Corporation; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar University; Cornell University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Dublin City University	Steinhoff, M; Buddenkotte, J (corresponding author), Hamad Med Corp, Dept Dermatol & Venereol, Doha, Qatar.; Steinhoff, M; Buddenkotte, J (corresponding author), Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar.	MSteinhoff@hamad.qa; JBuddenkotte@hamad.qa	Datsi, Angeliki/N-1778-2016	Datsi, Angeliki/0000-0001-5022-8087; Alam, Majid/0000-0002-5783-6605	National Priorities Research Program of the Qatar National Research Fund of Qatar Foundation [NPRP11S-0117-180326]; Internal Research Grand Competition of the MRC Fund, Hamad Medical Corporation, Qatar [IRGC-04-SI-17-151, IRGC-07-JI-20-725]	National Priorities Research Program of the Qatar National Research Fund of Qatar Foundation(Qatar National Research Fund (QNRF)); Internal Research Grand Competition of the MRC Fund, Hamad Medical Corporation, Qatar(Qatar National Research Fund (QNRF))	This study was supported by the National Priorities Research Program (grant no. NPRP11S-0117-180326 [to M.S. and J.B.] ) of the Qatar National Research Fund, Member of Qatar Foundation, and the Internal Research Grand Competition (grant no. IRGC-04-SI-17-151 [to M.S. and J.B.] and IRGC-07-JI-20-725 [to M.S., J.B., F.A., and M.A.] ) of the MRC Fund, Hamad Medical Corporation, Qatar.	Abboud D, 2017, DRUG DISCOV TODAY, V22, P702, DOI 10.1016/j.drudis.2016.11.023; ACKERMANN A, 1949, Dermatologica, V98, P370; Agache I, 2021, ALLERGY, V76, P45, DOI 10.1111/all.14510; Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Akiyama T, 2015, ACTA DERM-VENEREOL, V95, P147, DOI 10.2340/00015555-1879; Akiyama T, 2009, J PHARMACOL EXP THER, V329, P945, DOI 10.1124/jpet.109.152256; Aktar MK, 2015, ALLERGY, V70, P846, DOI 10.1111/all.12633; Alam M, 2021, DRUGS, V81, P621, DOI 10.1007/s40265-021-01478-1; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Altunbulakli C, 2018, J ALLERGY CLIN IMMUN, V142, P1643, DOI 10.1016/j.jaci.2018.07.005; Andersen HH, 2017, PAIN, V158, P1780, DOI 10.1097/j.pain.0000000000000980; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Andoh T, 2017, ACTA DERM-VENEREOL, V97, P922, DOI 10.2340/00015555-2697; Andoh T, 2015, EXP DERMATOL, V24, P978, DOI 10.1111/exd.12828; Antunez C, 2009, BRIT J DERMATOL, V161, P547, DOI 10.1111/j.1365-2133.2009.09318.x; Arai I, 2013, EXP DERMATOL, V22, P669, DOI 10.1111/exd.12222; Asfaha S, 2007, BRIT J PHARMACOL, V150, P176, DOI 10.1038/sj.bjp.0706975; Ayasse MT, 2020, EXP DERMATOL, V29, P414, DOI 10.1111/exd.14071; Azimi E, 2017, J ALLERGY CLIN IMMUN, V140, P447, DOI 10.1016/j.jaci.2016.12.980; Bagci IS, 2018, J ALLERGY CLIN IMMUN, V141, P858, DOI 10.1016/j.jaci.2017.10.045; Baral P, 2016, CELL HOST MICROBE, V19, P755, DOI 10.1016/j.chom.2016.05.010; Barr TP, 2019, J INVEST DERMATOL, V139, P412, DOI 10.1016/j.jid.2018.08.019; Baurecht H, 2018, J ALLERGY CLIN IMMUN, V141, P1668, DOI 10.1016/j.jaci.2018.01.019; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Beck KM, 2019, JAMA DERMATOL, V155, P118, DOI 10.1001/jamadermatol.2018.3912; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Belzberg M, 2021, J INVEST DERMATOL, V141, P2208, DOI 10.1016/j.jid.2021.02.749; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2022, NAT REV DRUG DISCOV, V21, P21, DOI 10.1038/s41573-021-00266-6; Bigliardi-Qi M, 2005, DERMATOLOGY, V210, P91, DOI 10.1159/000082563; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Bin LH, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0158-5; Bitton A, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2938; BORELLI S, 1971, HAUTARZT, V22, P450; BRAIN SD, 1986, J INVEST DERMATOL, V87, P533, DOI 10.1111/1523-1747.ep12455620; Braz JM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021386118; Brocq L., 1903, ANN DERMATOL SYPHIL, V4, P172; Brunner PM, 2018, ANN ALLERG ASTHMA IM, V120, P34, DOI 10.1016/j.anai.2017.09.055; Brunner PM, 2017, J ALLERGY CLIN IMMUN, V139, pS65, DOI 10.1016/j.jaci.2017.01.011; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Buddenkotte J, 2010, ALLERGY, V65, P805, DOI 10.1111/j.1398-9995.2010.01995.x; Buddenkotte J, 2010, ADV EXP MED BIOL, V709, P73; Buhl T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01740; Burbach GJ, 2001, J INVEST DERMATOL, V117, P1075, DOI 10.1046/j.0022-202x.2001.01498.x; Campion M, 2019, EXP DERMATOL, V28, P1501, DOI 10.1111/exd.14034; Cao T, 2017, J EUR ACAD DERMATOL, V31, pE191, DOI 10.1111/jdv.13919; Cartron AM, 2021, CLIN EXP DERMATOL, V46, P820, DOI 10.1111/ced.14567; Castro J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131712; Cevikbas F, 2007, CURR OPIN ALLERGY CL, V7, P365, DOI 10.1097/ACI.0b013e3282a644d2; Cevikbas F, 2020, PHYSIOL REV, V100, P945, DOI 10.1152/physrev.00017.2019; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Cevikbas F, 2012, J INVEST DERMATOL, V132, P1326, DOI 10.1038/jid.2012.66; Cevikbas F, 2011, CNS NEUROSCI THER, V17, P742, DOI 10.1111/j.1755-5949.2010.00201.x; Chan LS, 2001, J INVEST DERMATOL, V117, P977, DOI 10.1046/j.0022-202x.2001.01484.x; Chen XJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16859-5; Chen YL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax2945; Chen ZF, 2021, NAT REV NEUROSCI, V22, P758, DOI 10.1038/s41583-021-00526-9; Chiricozzi A, 2020, IMMUNOTARGETS THER, V9, P151, DOI 10.2147/ITT.S260370; Chovatiya R, 2021, J ALLERGY CLIN IMMUN, V148, P927, DOI 10.1016/j.jaci.2021.08.009; Clarysse K, 2019, J EUR ACAD DERMATOL, V33, P367, DOI 10.1111/jdv.15301; Coavoy-Sanchez SA, 2016, PHARMACOL RES, V113, P686, DOI 10.1016/j.phrs.2016.09.030; Cornelissen C, 2011, BRIT J DERMATOL, V165, P966, DOI 10.1111/j.1365-2133.2011.10487.x; Cornelissen C, 2012, J ALLERGY CLIN IMMUN, V129, P426, DOI 10.1016/j.jaci.2011.10.042; Corren J, 2021, J ASTHMA ALLERGY, V14, P1, DOI 10.2147/JAA.S286036; Corren J, 2019, NAT IMMUNOL, V20, P1603, DOI 10.1038/s41590-019-0524-9; Czarnowicki T, 2019, J ALLERGY CLIN IMMUN, V143, P1, DOI 10.1016/j.jaci.2018.10.032; Dabek M, 2009, AM J PATHOL, V175, P207, DOI 10.2353/ajpath.2009.080986; Dai XJ, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165719; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Datsi A, 2021, ALLERGY, V76, P2982, DOI 10.1111/all.14791; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Ding WH, 2008, J IMMUNOL, V181, P6020, DOI 10.4049/jimmunol.181.9.6020; Ding W, 2018, MOLECULES, V23, DOI 10.3390/molecules23071665; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; Du LX, 2019, GLIA, V67, P1680, DOI 10.1002/glia.23639; Dubin C, 2021, EXPERT REV CLIN IMMU, V17, P835, DOI 10.1080/1744666X.2021.1940962; Dvorak AM, 1998, CELL TISSUE RES, V293, P1, DOI 10.1007/s004410051093; Eichenfield LF, 2021, JAMA DERMATOL, V157, P1165, DOI 10.1001/jamadermatol.2021.2830; EKBLOM A, 1993, SKIN PHARMACOL, V6, P215; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013; Fang ZF, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.720393; Fatima M, 2019, PAIN, V160, P1166, DOI 10.1097/j.pain.0000000000001499; Feld M, 2016, J ALLERGY CLIN IMMUN, V138, P500, DOI 10.1016/j.jaci.2016.02.020; Feng J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01056-8; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Furue M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10091906; Furue M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113741; Gao PS, 2010, J ALLERGY CLIN IMMUN, V125, P1403, DOI 10.1016/j.jaci.2010.03.016; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gilhar A, 2021, EXP DERMATOL, V30, P319, DOI 10.1111/exd.14270; Gokin AP, 2001, J NEUROSCI, V21, P5358, DOI 10.1523/JNEUROSCI.21-14-05358.2001; Goswami SC, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-44; Griesenauer B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00475; Groneberg DA, 2005, J NEUROIMMUNOL, V161, P87, DOI 10.1016/j.jneuroim.2004.12.019; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V144, P482, DOI 10.1016/j.jaci.2018.11.053; Hanel KH, 2016, J IMMUNOL, V196, P3233, DOI 10.4049/jimmunol.1402943; HAGERMARK O, 1979, ACTA DERM-VENEREOL, V59, P297; Hagstromer L, 2006, EXP DERMATOL, V15, P950, DOI 10.1111/j.1600-0625.2006.00487.x; Han HW, 2017, IMMUNOL REV, V278, P116, DOI 10.1111/imr.12546; Han HW, 2013, J IMMUNOL, V190, P904, DOI 10.4049/jimmunol.1201808; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Hasannejad H, 2007, J ALLERGY CLIN IMMUN, V120, P69, DOI 10.1016/j.jaci.2007.04.010; Hashimoto T, 2021, J INVEST DERMATOL, V141, P2338, DOI 10.1016/j.jid.2021.03.009; Hashimoto T, 2019, ALLERGY, V74, P1727, DOI 10.1111/all.13870; Hashimoto Y, 2005, J PHARMACOL SCI, V98, P90, DOI 10.1254/jphs.SC0040209; Hassler SN, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137393; Hawro T, 2014, ALLERGY, V69, P113, DOI 10.1111/all.12316; He H, 2021, J ALLERGY CLIN IMMUN, V147, P1369, DOI 10.1016/j.jaci.2020.08.041; He HE, 2021, J ALLERGY CLIN IMMUN, V147, P199, DOI 10.1016/j.jaci.2020.05.048; Henehan M, 2019, EXP DERMATOL, V28, P877, DOI 10.1111/exd.13936; Hermans MAW, 2018, CLIN EXP ALLERGY, V48, P1412, DOI 10.1111/cea.13217; Herro R, 2018, J EXP MED, V215, P415, DOI 10.1084/jem.20170536; HORIO T, 1991, METABOLISM, V40, P999, DOI 10.1016/0026-0495(91)90119-H; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Huang J, 2018, NAT NEUROSCI, V21, P707, DOI 10.1038/s41593-018-0119-z; HUGHES SR, 1991, BRIT J PHARMACOL, V104, P738, DOI 10.1111/j.1476-5381.1991.tb12497.x; Husein-ElAhmed H, 2022, J DERMATOL TREAT, V33, P1547, DOI 10.1080/09546634.2020.1853024; Ikeda-Miyagawa Y, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0004-7; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ikoma A, 2003, ARCH DERMATOL, V139, P1475, DOI 10.1001/archderm.139.11.1475; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imai Y, 2019, J DERMATOL SCI, V96, P2, DOI 10.1016/j.jdermsci.2019.08.006; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Inan S, 2019, EUR J PHARMACOL, V864, DOI 10.1016/j.ejphar.2019.172702; Inan S, 2011, PEPTIDES, V32, P286, DOI 10.1016/j.peptides.2010.11.022; Irani AMA, 1998, J ALLERGY CLIN IMMUN, V101, P354, DOI 10.1016/S0091-6749(98)70248-9; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jang H, 2016, J INVEST DERMATOL, V136, P127, DOI 10.1038/JID.2015.363; JANISZEWSKI J, 1994, AM J PHYSIOL, V267, pC138, DOI 10.1152/ajpcell.1994.267.1.C138; Jaquet L., 1904, TRAITEDE DERMATOLOGI, V5, P341; Jiang HW, 2019, BRAIN BEHAV IMMUN, V80, P464, DOI 10.1016/j.bbi.2019.04.026; Jing PB, 2018, NEUROSCI BULL, V34, P54, DOI 10.1007/s12264-017-0128-z; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Kabashima K, 2020, NEW ENGL J MED, V383, P141, DOI 10.1056/NEJMoa1917006; Kabashima K, 2018, J ALLERGY CLIN IMMUN, V142, P1121, DOI 10.1016/j.jaci.2018.03.018; Kamei J, 2001, EUR J PHARMACOL, V418, P141, DOI 10.1016/S0014-2999(01)00941-4; Kanda N, 2003, J INVEST DERMATOL, V121, P570, DOI 10.1046/j.1523-1747.2003.12428.x; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kasraie S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/942375; Kato A, 2014, J DERMATOL SCI, V74, P229, DOI 10.1016/j.jdermsci.2014.02.009; Kay AB, 2011, J ALLERGY CLIN IMMUN, V127, P232, DOI 10.1016/j.jaci.2010.10.028; Kee Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01249; Kelsen SG, 2021, J ALLERGY CLIN IMMUN, V148, P790, DOI 10.1016/j.jaci.2021.03.044; Kempkes C, 2014, FRONT NEUROSCI, P193; Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029; Kesterson K, 2018, J ALLER CL IMM-PRACT, V6, P2130, DOI 10.1016/j.jaip.2018.03.002; Kido-Nakahara M, 2014, J CLIN INVEST, V124, P2683, DOI 10.1172/JCI67323; Kim BS, 2020, J AM ACAD DERMATOL, V82, P1305, DOI 10.1016/j.jaad.2020.02.009; Kim BS, 2020, J ALLERGY CLIN IMMUN, V145, P572, DOI 10.1016/j.jaci.2019.08.042; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim HS, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041190; Kim KH, 2003, J DERMATOL SCI, V32, P115, DOI 10.1016/S0923-1811(03)00070-7; Kim S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1047; Kim WK, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00092; Kinoshita H, 2009, J ALLERGY CLIN IMMUN, V123, P179, DOI 10.1016/j.jaci.2008.10.008; Kishibe M, 2019, J DERMATOL SCI, V95, P50, DOI 10.1016/j.jdermsci.2019.06.007; Klaeschen AS, 2021, J ALLERGY CLIN IMMUN, V147, P2202, DOI 10.1016/j.jaci.2020.11.041; Klein A, 2021, ELIFE, V10, DOI 10.7554/eLife.64506; Kolkhir P, 2022, NAT REV IMMUNOL, V22, P294, DOI 10.1038/s41577-021-00622-y; Komai-Koma M, 2012, ALLERGY, V67, P1118, DOI 10.1111/j.1398-9995.2012.02859.x; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; KURIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P1435, DOI 10.1016/0006-291X(89)92270-5; L'Herondelle K, 2021, J INVEST DERMATOL, V141, P648, DOI 10.1016/j.jid.2020.07.020; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Larkin C, 2021, J ALLERGY CLIN IMMUN, V147, P1110, DOI 10.1016/j.jaci.2020.09.028; Lay M, 2020, ANNU REV NEUROSCI, V43, P187, DOI 10.1146/annurev-neuro-083019-024537; Lee EB, 2010, PEDIAT ALLERG IMM-UK, V21, pE457, DOI 10.1111/j.1399-3038.2009.00919.x; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Li W, 2020, AM J CLIN DERMATOL, V21, P44, DOI 10.1007/s40257-020-00538-8; Li XK, 2021, J ALLERGY CLIN IMMUN, V147, P2236, DOI 10.1016/j.jaci.2020.12.626; Liu BY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124497; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Liu Q, 2015, HANDB EXP PHARMACOL, V226, P71, DOI 10.1007/978-3-662-44605-8_5; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Lonndahl L, 2018, ACTA DERM-VENEREOL, V98, P324, DOI 10.2340/00015555-2852; LOWMAN MA, 1988, J ALLERGY CLIN IMMUN, V81, P574, DOI 10.1016/0091-6749(88)90199-6; Luo YM, 2021, J ALLERGY CLIN IMMUN, V148, P911, DOI 10.1016/j.jaci.2021.08.004; Mack MR, 2018, TRENDS IMMUNOL, V39, P980, DOI 10.1016/j.it.2018.10.001; Maier E, 2014, J IMMUNOL, V193, P645, DOI 10.4049/jimmunol.1301836; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; McQueen DS, 2007, BRIT J PHARMACOL, V151, P278, DOI 10.1038/sj.bjp.0707216; Meixiong J, 2017, ANNU REV GENET, V51, P103, DOI 10.1146/annurev-genet-120116-024723; Meller S, 2007, J ALLERGY CLIN IMMUN, V119, P1470, DOI 10.1016/j.jaci.2006.12.654; Melo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33620-7; MENDELSOHN HV, 1946, ARCH DERMATOL SYPH, V53, P656; Meng J, 2016, CURR RES TRANSL MED, V64, P203, DOI 10.1016/j.retram.2016.08.006; Meng JH, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.696784; Meng JH, 2020, BRIT J PHARMACOL, V177, P1025, DOI 10.1111/bph.14952; Meng JH, 2019, J INVEST DERMATOL, V139, P2324, DOI 10.1016/j.jid.2019.04.017; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Meng JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21226; Mishra SK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.036; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mitamura Y, 2018, ALLERGY, V73, P1881, DOI 10.1111/all.13437; MITCHELL EB, 1983, CLIN REV ALLERG, V1, P427; Miyamoto T, 2002, JPN J PHARMACOL, V88, P351, DOI 10.1254/jjp.88.351; Mobus L, 2021, J ALLERGY CLIN IMMUN, V147, P213, DOI 10.1016/j.jaci.2020.06.012; Mochizuki H, 2017, ALLERGOL INT, V66, P14, DOI 10.1016/j.alit.2016.08.013; MOLANDER C, 1987, NEUROSCI LETT, V74, P37, DOI 10.1016/0304-3940(87)90047-4; Mommert S, 2021, ALLERGY, V76, P2886, DOI 10.1111/all.14979; Moormann C, 2006, J INVEST DERMATOL, V126, P746, DOI 10.1038/sj.jid.5700169; Moyle M, 2019, EXP DERMATOL, V28, P756, DOI 10.1111/exd.13911; Murai-Yamamura M, 2021, ALLERGY, V76, P3534, DOI 10.1111/all.15035; Murota H, 2016, EUR J PAIN, V20, P47, DOI 10.1002/ejp.777; Murota H, 2012, J ALLERGY CLIN IMMUN, V130, P671, DOI 10.1016/j.jaci.2012.05.027; Nakagawa H, 2021, J AM ACAD DERMATOL, V85, P854, DOI 10.1016/j.jaad.2021.06.014; Nakagawa H, 2020, J AM ACAD DERMATOL, V82, P823, DOI 10.1016/j.jaad.2019.12.015; Nakagawa H, 2019, J ALLERGY CLIN IMMUN, V144, P1575, DOI 10.1016/j.jaci.2019.08.004; Nakahara T, 2018, ALLERGY, V73, P511, DOI 10.1111/all.13322; Nakamura K, 2008, J DERMATOL, V35, P546, DOI 10.1111/j.1346-8138.2008.00518.x; Napolitano M, 2020, DERMATITIS, V31, P81, DOI 10.1097/DER.0000000000000517; Nattkemper LA, 2018, J INVEST DERMATOL, V138, P1311, DOI 10.1016/j.jid.2017.12.029; Navines-Ferrer A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29965-8; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Neisius U, 2002, J AM ACAD DERMATOL, V47, P28, DOI 10.1067/mjd.2002.120462; Nemmer JM, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.639097; Nemoto O, 2016, BRIT J DERMATOL, V174, P296, DOI 10.1111/bjd.14207; Neurodermatitis Folster-Holst F_, 2017, OPHTHALMOLOGE, V114, P498; Nguyen E, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc3774; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Novak N, 2010, J ALLERGY CLIN IMMUN, V125, P50, DOI 10.1016/j.jaci.2009.11.019; Nygaard U, 2016, J EUR ACAD DERMATOL, V30, P1930, DOI 10.1111/jdv.13679; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Oetjen LK, 2018, FEBS J, V285, P3138, DOI 10.1111/febs.14465; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Oh MH, 2013, J IMMUNOL, V191, P5371, DOI 10.4049/jimmunol.1300300; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Paller AS, 2017, J ALLERGY CLIN IMMUN, V140, P633, DOI 10.1016/j.jaci.2017.07.006; Palmer CB, 2022, PHARMACOL THERAPEUT, V233, DOI 10.1016/j.pharmthera.2021.108014; Panzer R, 2014, EXP DERMATOL, V23, P364, DOI 10.1111/exd.12383; Park CW, 2022, J ALLERGY CLIN IMMUN, V149, P1340, DOI 10.1016/j.jaci.2021.09.024; Patricio ES, 2015, J INVEST DERMATOL, V135, P2484, DOI 10.1038/jid.2015.183; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Pavel AB, 2019, J ALLERGY CLIN IMMUN, V144, P1011, DOI 10.1016/j.jaci.2019.07.013; Pellefigues C, 2021, J ALLERGY CLIN IMMUN, V148, P799, DOI 10.1016/j.jaci.2021.02.018; Perner C, 2020, IMMUNITY, V53, P1063, DOI 10.1016/j.immuni.2020.10.001; Pincelli C, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P31, DOI 10.1038/jidsymp.1997.8; Pojawa-Golab M, 2019, DERMATOLOGY THER, V9, P391, DOI 10.1007/s13555-019-0305-2; Pongcharoen P, 2016, EUR J PAIN, V20, P24, DOI 10.1002/ejp.766; Popovic B, 2017, J MOL BIOL, V429, P208, DOI 10.1016/j.jmb.2016.12.005; Purwar R, 2006, J INVEST DERMATOL, V126, P1043, DOI 10.1038/sj.jid.5700085; Qu LT, 2017, J NEUROPHYSIOL, V118, P619, DOI 10.1152/jn.00187.2017; Quan PL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094421; Raap U, 2005, J ALLERGY CLIN IMMUN, V115, P1268, DOI 10.1016/j.jaci.2005.02.007; Raap U, 2017, CLIN EXP ALLERGY, V47, P499, DOI 10.1111/cea.12875; Ratchataswan T, 2021, J ALLER CL IMM-PRACT, V9, P1053, DOI 10.1016/j.jaip.2020.11.034; Reddy VB, 2018, J INVEST DERMATOL, V138, P461, DOI 10.1016/j.jid.2017.05.042; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Redhu D, 2020, BRIT J DERMATOL, V182, P119, DOI 10.1111/bjd.17940; Renert-Yuval Y, 2021, J ALLERGY CLIN IMMUN, V148, P148, DOI 10.1016/j.jaci.2021.01.001; Roesch S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020436; Roesner LM, 2019, CURR OPIN ALLERGY CL, V19, P319, DOI 10.1097/ACI.0000000000000553; Roggenkamp D, 2013, J INVEST DERMATOL, V133, P1620, DOI 10.1038/jid.2012.464; Rogoz K, 2014, J NEUROSCI, V34, P14055, DOI 10.1523/JNEUROSCI.1722-14.2014; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Rosenblad C, 2000, MOL CELL NEUROSCI, V15, P199, DOI 10.1006/mcne.1999.0817; Roy S, 2021, J ALLERGY CLIN IMMUN, V148, P293, DOI 10.1016/j.jaci.2021.03.049; Rukwied R, 1998, ARCH DERMATOL RES, V290, P198, DOI 10.1007/s004030050290; Rukwied R, 1999, EXP DERMATOL, V8, P39, DOI 10.1111/j.1600-0625.1999.tb00346.x; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Ryu WI, 2018, J DERMATOL SCI, V90, P313, DOI 10.1016/j.jdermsci.2018.02.017; Sakata D, 2019, J ALLERGY CLIN IMMUN, V144, P1130, DOI 10.1016/j.jaci.2019.06.031; Salamon P, 2008, J ALLERGY CLIN IMMUN, V121, P448, DOI 10.1016/j.jaci.2007.08.054; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Satoh T, 2011, ACTA DERM-VENEREOL, V91, P371, DOI 10.2340/00015555-1052; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schmelz M, 2002, J DERMATOL SCI, V28, P91, DOI 10.1016/S0923-1811(01)00167-0; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schmelz M, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.643006; Schmelz M, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00167; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Seeliger S, 2010, AM J PATHOL, V177, P2563, DOI 10.2353/ajpath.2010.090941; Seidl B, 2009, J ALLERGY CLIN IMMUN, V124, P862, DOI 10.1016/j.jaci.2009.07.028; Seltmann J, 2015, J ALLERGY CLIN IMMUN, V135, P1659, DOI 10.1016/j.jaci.2015.01.048; Seo SH, 2020, J INVEST DERMATOL, V140, P2199, DOI 10.1016/j.jid.2020.02.028; Serhan N, 2021, NEUROSCI LETT, V749, DOI 10.1016/j.neulet.2021.135724; Shi BC, 2016, J ALLERGY CLIN IMMUN, V138, P1233, DOI 10.1016/j.jaci.2016.04.053; Shiraishi H, 2012, ALLERGOL INT, V61, P563, DOI 10.2332/allergolint.10-OA-0297; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Siiskonen H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00422; Silverberg JI, 2021, J EUR ACAD DERMATOL, V35, P1562, DOI 10.1111/jdv.17218; Silverberg JI, 2020, J ALLERGY CLIN IMMUN, V145, P173, DOI 10.1016/j.jaci.2019.08.013; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson EL, 2019, J AM ACAD DERMATOL, V80, P1013, DOI 10.1016/j.jaad.2018.11.059; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Slager RE, 2012, J ALLERGY CLIN IMMUN, V130, P516, DOI 10.1016/j.jaci.2012.03.030; Smith TP, 2014, J PAIN RES, V7, P531, DOI 10.2147/JPR.S65923; Solinski HJ, 2019, CELL REP, V26, P3561, DOI 10.1016/j.celrep.2019.02.089; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stander S, 2006, EUR J PAIN, V10, P473, DOI 10.1016/j.ejpain.2006.03.005; Stander S, 2020, NEW ENGL J MED, V382, P706, DOI 10.1056/NEJMoa1908316; Stander S, 2019, J AM ACAD DERMATOL, V80, P1395, DOI 10.1016/j.jaad.2019.01.052; Stander S, 2003, ARCH DERMATOL, V139, P1463, DOI 10.1001/archderm.139.11.1463; Stantcheva KK, 2016, EMBO REP, V17, P585, DOI 10.15252/embr.201540983; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Steinhoff M, 2003, ARCH DERMATOL, V139, P1479, DOI 10.1001/archderm.139.11.1479; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Steinhoff M, 2006, J INVEST DERMATOL, V126, P1705, DOI 10.1038/sj.jid.5700231; Steinhoff M, 2018, LANCET NEUROL, V17, P709, DOI 10.1016/S1474-4422(18)30217-5; Steinhoff M, 2018, IMMUNOL REV, V282, P248, DOI 10.1111/imr.12635; Steinhoff M, 2012, J ALLERGY CLIN IMMUN, V130, P1015, DOI 10.1016/j.jaci.2012.08.006; Steinhoff M, 2009, J INVEST DERMATOL, V129, P531, DOI 10.1038/jid.2008.440; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Storan ER, 2015, HANDB EXP PHARMACOL, V226, P163, DOI 10.1007/978-3-662-44605-8_9; Stott B, 2013, J ALLERGY CLIN IMMUN, V132, P446, DOI 10.1016/j.jaci.2013.03.050; Su WL, 2020, MOL PAIN, V16, DOI 10.1177/1744806920926426; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Szegedi K, 2018, EXP DERMATOL, V27, P393, DOI 10.1111/exd.13438; Szollosi AG, 2019, J INVEST DERMATOL, V139, P2393, DOI 10.1016/j.jid.2019.04.018; Takaoka A, 2007, EXP DERMATOL, V16, P331, DOI 10.1111/j.1600-0625.2006.00540.x; Togashi Y, 2002, EUR J PHARMACOL, V435, P259, DOI 10.1016/S0014-2999(01)01588-6; Tominaga M, 2007, J INVEST DERMATOL, V127, P2228, DOI 10.1038/sj.jid.5700942; Totsuka A, 2017, EUR J DERMATOL, V27, P247, DOI 10.1684/ejd.2017.2985; Tran BW, 2010, ACTA DERM-VENEREOL, V90, P354, DOI 10.2340/00015555-0890; Tsianakas A, 2019, ACTA DERM-VENEREOL, V99, P379, DOI 10.2340/00015555-3120; Tsoi LC, 2022, J ALLERGY CLIN IMMUN, V149, P1329, DOI 10.1016/j.jaci.2021.10.004; TSUBOI R, 1995, FEBS LETT, V371, P188, DOI 10.1016/0014-5793(95)00912-S; Tsuda M, 2018, NEUROSCI BULL, V34, P178, DOI 10.1007/s12264-017-0129-y; Tsybikov NN, 2015, ALLERGY ASTHMA PROC, V36, P320, DOI 10.2500/aap.2015.36.3846; Ultsch M, 2013, J MOL BIOL, V425, P1330, DOI 10.1016/j.jmb.2013.01.024; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Virtanen AT, 2019, BIODRUGS, V33, P15, DOI 10.1007/s40259-019-00333-w; Voisin T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022087118; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Walsh CM, 2019, ELIFE, V8, DOI [10.7554/elife.48448, 10.7554/eLife.48448]; Wang F, 2021, CELL, V184, P422, DOI 10.1016/j.cell.2020.12.033; Wang W, 2018, J IMMUNOL, V201, P2221, DOI 10.4049/jimmunol.1800709; Wedi B, 2020, ALLERGY, V75, P2229, DOI 10.1111/all.14213; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Weigelt N, 2010, J CUTAN PATHOL, V37, P578, DOI 10.1111/j.1600-0560.2009.01484.x; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Wolf K, 2021, J ALLERGY CLIN IMMUN, V148, P506, DOI 10.1016/j.jaci.2020.12.655; WUTHRICH B, 1972, ARCH DERMATOL FORSCH, V244, P327, DOI 10.1007/BF00600201; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Xu JJ, 2020, IMMUNITY, V53, P371, DOI 10.1016/j.immuni.2020.06.023; Yamada Y, 2017, INT ARCH ALLERGY IMM, V173, P84, DOI 10.1159/000473700; Yamamoto Y, 2020, J DERMATOL SCI, V97, P161, DOI 10.1016/j.jdermsci.2019.12.008; Yamamura K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13946; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082867; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yoshimoto T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00716; Yosipovitch G, 2020, J EUR ACAD DERMATOL, V34, P239, DOI 10.1111/jdv.15973; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6; Yu YQ, 2017, SCIENCE, V355, DOI 10.1126/science.aak9748; Yun JW, 2011, J INVEST DERMATOL, V131, P1576, DOI 10.1038/jid.2011.87; Zeng D, 2021, LIFE SCI, V266, DOI 10.1016/j.lfs.2020.118906; Zhang CL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100749118; Zhao JH, 2020, J INVEST DERMATOL, V140, P1524, DOI 10.1016/j.jid.2020.01.012; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou Y, 2019, J CELL MOL MED, V23, P4819, DOI 10.1111/jcmm.14392; Zhu Y, 2015, INT IMMUNOPHARMACOL, V28, P507, DOI 10.1016/j.intimp.2015.04.047	382	4	4	7	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1875	1898		10.1016/j.jaci.2022.03.010	http://dx.doi.org/10.1016/j.jaci.2022.03.010			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35337846	hybrid			2022-12-18	WOS:000833525500007
J	Kato, A; Schleimer, RP; Bleier, BS				Kato, Atsushi; Schleimer, Robert P.; Bleier, Benjamin S.			Mechanisms and pathogenesis of chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Chronic rhinosinusitis; endotype; epithelial dysfunction; eosinophils; nasal polyps; neutrophils	AIRWAY EPITHELIAL-CELLS; INNATE LYMPHOID-CELLS; THYMIC STROMAL LYMPHOPOIETIN; P-GLYCOPROTEIN INHIBITION; TASTE RECEPTOR T2R38; TOLL-LIKE RECEPTORS; NASAL POLYPS; MAST-CELLS; STAPHYLOCOCCUS-AUREUS; BARRIER DYSFUNCTION	Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by local inflammation of the upper airways and is historically divided into 2 main phenotypes: CRS with nasal polyps and CRS without nasal polyps. Inflammation in CRS is mainly characterized by 3 endotypes based on elevation of canonical lymphocyte cytokines: type (T) 1 (T1) by T(H)1 cytokine IFN-gamma, T2 by T(H)2 cutokines IL-4, IL-5, and IL-13, and T3 by T(H)17 cytokines including IL-17. Inflammation in both CRS without nasal polyps and CRS with nasal polyps is highly heterogeneous, and the frequency of various endotypes varies geographically around the world. This finding complicates establishment of a unified understanding of the mechanisms of pathogenesis in CRS. Sinonasal epithelium acts as a passive barrier, and epithelial barrier dysfunction is a common feature in CRS induced by endotype-specific cytokines directly and indirectly. The sinonasal epithelium also participates in both innate immunity via recognition by innate pattern-recognition receptors and promotes and regulates adaptive immunity via release of chemokines and innate cytokines including thymic stromal lymphopoietin. The purpose of this review was to discuss the contribution of the epithelium to CRS pathogenesis and to update the field regarding endotypic heterogeneity and various mechanisms for understanding pathogenesis in CRS.	[Kato, Atsushi; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Div Allergy & Immunol, Dept Med, Chicago, IL 60611 USA; [Kato, Atsushi; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA; [Bleier, Benjamin S.] Harvard Med Sch, Massachusetts Eye & Ear, Dept Otolaryngol Head & Neck Surg, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Kato, A (corresponding author), Northwestern Univ, Div Allergy & Immunol, Feinberg Sch Med, 240 E Huron,Rm M304, Chicago, IL 60611 USA.	a-kato@northwestern.edu		Kato, Atsushi/0000-0001-9144-3138	National Institutes of Health [R01 AI137174, R01 NS108968, P01 AI145818]; Ernest S. Bazley Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Foundation	This research was supported in part by the National Institutes of Health (grant nos. R01 AI137174, R01 NS108968, and P01 AI145818) and by a grant from the Ernest S. Bazley Foundation.	Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bertschi NL, 2021, INT ARCH ALLERGY IMM, V182, P365, DOI 10.1159/000515144; Bleier BS, 2015, INT FORUM ALLERGY RH, V5, P10, DOI 10.1002/alr.21436; Bleier BS, 2014, INT FORUM ALLERGY RH, V4, P488, DOI 10.1002/alr.21316; Bleier BS, 2012, INT FORUM ALLERGY RH, V2, P122, DOI 10.1002/alr.21004; Bochner BS, 2021, ALLERGY ASTHMA IMMUN, V13, P8, DOI 10.4168/aair.2021.13.1.8; Brusilovsky M, 2021, NAT IMMUNOL, V22, P1316, DOI 10.1038/s41590-021-01011-2; Buchheit KM, 2020, J ALLERGY CLIN IMMUN, V145, P1574, DOI 10.1016/j.jaci.2020.02.035; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Cao YJ, 2019, CLIN EXP ALLERGY, V49, P990, DOI 10.1111/cea.13408; Chen B, 2006, AM J RHINOL, V20, P325, DOI 10.2500/ajr.2006.20.2870; Chen CL, 2020, J ALLERGY CLIN IMMUN, V146, P677, DOI 10.1016/j.jaci.2020.02.010; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Delemarre T, 2021, J ALLERGY CLIN IMMUN, V148, P327, DOI 10.1016/j.jaci.2021.03.024; Delemarre T, 2021, J ALLERGY CLIN IMMUN, V147, P179, DOI 10.1016/j.jaci.2020.08.036; Derycke L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097581; Dwyer DF, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb7221; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Feldman RE, 2013, INT FORUM ALLERGY RH, V3, P684, DOI 10.1002/alr.21176; Feldman S, 2017, CLIN EXP ALLERGY, V47, P457, DOI 10.1111/cea.12878; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gabazza EC, 2004, INT J HEMATOL, V79, P117, DOI 10.1532/IJH97.03165; Gevaert E, 2020, J ALLERGY CLIN IMMUN, V145, P427, DOI 10.1016/j.jaci.2019.08.027; Gevaert E, 2017, J ALLERGY CLIN IMMUN, V139, P1849, DOI 10.1016/j.jaci.2017.01.019; Gevaert P, 2022, J ALLERGY CLIN IMMUN, V149, P957, DOI 10.1016/j.jaci.2021.07.045; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Gudis D, 2012, AM J RHINOL ALLERGY, V26, P1, DOI 10.2500/ajra.2012.26.3716; Gudis DA, 2010, OTOLARYNG CLIN N AM, V43, P461, DOI 10.1016/j.otc.2010.02.007; Hirschberg A, 2016, EUR ARCH OTO-RHINO-L, V273, P1779, DOI 10.1007/s00405-015-3816-1; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, P1075, DOI 10.1016/j.jaci.2013.01.043; Hupin C, 2014, ALLERGY, V69, P1540, DOI 10.1111/all.12503; Hwang CS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44627-z; Imoto Y, 2018, CLIN EXP ALLERGY, V48, P544, DOI 10.1111/cea.13119; Imoto Y, 2019, J ALLERGY CLIN IMMUN, V144, P1566, DOI 10.1016/j.jaci.2019.08.040; Jang YJ, 2002, EUR ARCH OTO-RHINO-L, V259, P465, DOI 10.1007/s00405-002-0500-z; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kato A, 2022, ALLERGY, V77, P812, DOI 10.1111/all.15074; Kato A, 2019, CHEST, V156, P141, DOI 10.1016/j.chest.2019.04.101; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Kato Y, 2018, AM J RESP CELL MOL, V59, P448, DOI 10.1165/rcmb.2017-0325OC; Katotomichelakis M, 2013, AM J RHINOL ALLERGY, V27, P354, DOI 10.2500/ajra.2013.27.3922; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Kim DY, 2015, ALLERGY ASTHMA IMMUN, V7, P421, DOI 10.4168/aair.2015.7.5.421; Kim SJ, 2013, OTOLARYNG HEAD NECK, V149, P431, DOI 10.1177/0194599813495363; Klingler AI, 2021, J ALLERGY CLIN IMMUN, V147, P1306, DOI 10.1016/j.jaci.2020.11.037; Kocharyan A, 2014, INT FORUM ALLERGY RH, V4, P734, DOI 10.1002/alr.21361; Kohanski MA, 2018, J ALLERGY CLIN IMMUN, V142, P460, DOI 10.1016/j.jaci.2018.03.019; Kouzaki H, 2017, AM J RESP CRIT CARE, V195, P737, DOI 10.1164/rccm.201603-0529OC; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Koyama T, 2019, ALLERGOL INT, V68, P216, DOI 10.1016/j.alit.2018.09.002; Krysko O, 2011, ALLERGY, V66, P396, DOI 10.1111/j.1398-9995.2010.02498.x; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Lane AP, 2006, AM J RHINOL, V20, P117, DOI 10.1177/194589240602000122; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lou HF, 2018, INT FORUM ALLERGY RH, V8, P1218, DOI 10.1002/alr.22214; Lou HF, 2016, RHINOLOGY, V54, P150, DOI [10.4193/Rhin15.271, 10.4193/Rhino15.271]; Ma JJ, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6356; Malik Z, 2015, INT FORUM ALLERGY RH, V5, P551, DOI 10.1002/alr.21517; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082373; Menzies-Gow A, 2021, NEW ENGL J MED, V384, P1800, DOI 10.1056/NEJMoa2034975; Miyake MM, 2017, J ALLERGY CLIN IMMUN, V140, P271, DOI 10.1016/j.jaci.2016.11.014; Miyata J, 2019, ALLERGY, V74, P1113, DOI 10.1111/all.13726; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mueller SK, 2019, INT FORUM ALLERGY RH, V9, P1212, DOI 10.1002/alr.22407; Mueller SK, 2019, INT FORUM ALLERGY RH, V9, P177, DOI 10.1002/alr.22226; Murphy RC, 2021, NAT IMMUNOL, V22, P1207, DOI 10.1038/s41590-021-01005-0; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Nakayama T, 2022, J ALLERGY CLIN IMMUN, V149, P1296, DOI 10.1016/j.jaci.2021.11.017; Ninomiya T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29612-2; Nocera AL, 2019, J ALLERGY CLIN IMMUN, V143, P1525, DOI 10.1016/j.jaci.2018.08.046; Nocera AL, 2017, LARYNGOSCOPE, V127, pE295, DOI 10.1002/lary.26614; Nomura K, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-21; Ogasawara N, 2020, MUCOSAL IMMUNOL, V13, P86, DOI 10.1038/s41385-019-0215-8; Ogasawara N, 2018, ALLERGY, V73, P2251, DOI 10.1111/all.13552; Okada N, 2018, INT FORUM ALLERGY RH, V8, P592, DOI 10.1002/alr.22083; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Orlandi RR, 2021, INT FORUM ALLERGY RH, V11, P213, DOI 10.1002/alr.22741; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Perez-Novo CA, 2005, J ALLERGY CLIN IMMUN, V115, P1189, DOI 10.1016/j.jaci.2005.02.029; Persson EK, 2019, SCIENCE, V364, P751, DOI 10.1126/science.aaw4295; Peterson S, 2012, J ALLERGY CLIN IMMUN, V129, P119, DOI 10.1016/j.jaci.2011.08.021; Plager DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011450; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Poposki JA, 2022, J ALLERGY CLIN IMMUN, V149, P1666, DOI 10.1016/j.jaci.2021.11.023; Poposki JA, 2017, IMMUN INFLAMM DIS, V5, P233, DOI 10.1002/iid3.161; Poposki JA, 2017, J ALLERGY CLIN IMMUN, V139, P1559, DOI 10.1016/j.jaci.2016.08.040; Poposki JA, 2016, J ALLERGY CLIN IMMUN, V137, P1274, DOI 10.1016/j.jaci.2015.09.029; Pothoven KL, 2017, J ALLERGY CLIN IMMUN, V139, P1966, DOI 10.1016/j.jaci.2016.10.039; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Rogers GA, 2011, INT FORUM ALLERGY RH, V1, P50, DOI 10.1002/alr.20014; Ryu G, 2019, ALLERGY ASTHMA IMMUN, V11, P664, DOI 10.4168/aair.2019.11.5.664; Schleimer RP, 2017, J ALLERGY CLIN IMMUN, V139, P1752, DOI 10.1016/j.jaci.2017.04.010; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Seshadri S, 2012, ALLERGY, V67, P920, DOI 10.1111/j.1398-9995.2012.02848.x; Seshadri S, 2015, J ALLERGY CLIN IMMUN, V136, P1548, DOI 10.1016/j.jaci.2015.05.024; Seshadri S, 2013, J ALLERGY CLIN IMMUN, V132, P1227, DOI 10.1016/j.jaci.2013.05.042; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Shahana S, 2006, RESP MED, V100, P2018, DOI 10.1016/j.rmed.2006.02.012; Shi LL, 2014, AM J RESP CRIT CARE, V190, P628, DOI 10.1164/rccm.201402-0234OC; Shimizu S, 2000, AM J PHYSIOL-LUNG C, V279, pL503, DOI 10.1152/ajplung.2000.279.3.L503; Shimizu S, 2008, CLIN IMMUNOL, V129, P365, DOI 10.1016/j.clim.2008.07.020; Shimizu S, 2017, AM J RHINOL ALLERGY, V31, pE13, DOI 10.2500/ajra.2017.31.4400; Shimizu S, 2015, AM J RHINOL ALLERGY, V29, P235, DOI 10.2500/ajra.2015.29.4183; Shimizu S, 2011, AM J RHINOL ALLERGY, V25, P7, DOI 10.2500/ajra.2011.25.3535; Shin SH, 2006, ACTA OTO-LARYNGOL, V126, P1286, DOI 10.1080/00016480500395179; Shin SH, 2004, J ALLERGY CLIN IMMUN, V114, P1369, DOI 10.1016/j.jaci.2004.08.012; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Stevens WW, 2021, J ALLERGY CLIN IMMUN, V148, P439, DOI 10.1016/j.jaci.2021.02.045; Stevens WW, 2021, ANN ALLERG ASTHMA IM, V126, P110, DOI 10.1016/j.anai.2020.08.001; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Succar EF, 2020, ALLERGY, V75, P713, DOI 10.1111/all.14071; Sun Y, 2012, AM J RHINOL ALLERGY, V26, P104, DOI 10.2500/ajra.2012.26.3718; Taha MS, 2021, RHINOLOGY, V59, P205, DOI 10.4193/Rhin20.551; Takabayashi T, 2020, J ALLERGY CLIN IMMUN, V145, P740, DOI 10.1016/j.jaci.2020.01.027; Takabayashi T, 2017, ALLERGOL INT, V66, P594, DOI 10.1016/j.alit.2017.03.007; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Takabayashi T, 2012, J ALLERGY CLIN IMMUN, V130, P410, DOI 10.1016/j.jaci.2012.02.046; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Tarran R, 2014, INT J BIOCHEM CELL B, V52, P130, DOI 10.1016/j.biocel.2014.03.002; Tieu DD, 2010, J ALLERGY CLIN IMMUN, V125, P667, DOI 10.1016/j.jaci.2009.11.045; Tojima I, 2016, CLIN IMMUNOL, V170, P1, DOI 10.1016/j.clim.2016.07.010; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Turner CT, 2021, J INVEST DERMATOL, V141, P36, DOI 10.1016/j.jid.2020.05.095; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Roey GA, 2017, J ALLERGY CLIN IMMUN, V140, P89, DOI 10.1016/j.jaci.2016.11.015; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020; Varricchi G, 2018, IMMUNOL REV, V282, P8, DOI 10.1111/imr.12627; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wang H, 2019, CLIN EXP OTORHINOLAR, V12, P337, DOI 10.21053/ceo.2019.00654; Wang LF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-85; Wang WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26604; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Wang ZC, 2022, J ALLERGY CLIN IMMUN, V149, P610, DOI 10.1016/j.jaci.2021.06.023; Workman AD, 2014, AM J RHINOL ALLERGY, V28, P454, DOI 10.2500/ajra.2014.28.4092; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zaravinos A, 2008, ONCOL REP, V19, P385; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang YN, 2016, J ALLERGY CLIN IMMUN, V137, P462, DOI 10.1016/j.jaci.2015.07.025; Zhang Y, 2019, ALLERGY ASTHMA IMMUN, V11, P156, DOI 10.4168/aair.2019.11.2.156; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhong B, 2021, ALLERGY, V76, P582, DOI 10.1111/all.14571; Zuckerman JD, 2008, AM J RHINOL, V22, P589, DOI 10.2500/ajr.2008.22.3235	168	4	4	7	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1491	1503		10.1016/j.jaci.2022.02.016	http://dx.doi.org/10.1016/j.jaci.2022.02.016			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3W0TR	35245537				2022-12-18	WOS:000842068800001
J	Berin, MC; Agashe, C; Burks, AW; Chiang, D; Davidson, WF; Dawson, P; Grishin, A; Henning, AK; Jones, SM; Kim, EH; Leung, DYM; Masilamani, M; Scurlock, AM; Sicherer, SH; Wood, RA; Sampson, HA				Berin, M. Cecilia; Agashe, Charuta; Burks, A. Wesley; Chiang, David; Davidson, Wendy F.; Dawson, Peter; Grishin, Alexander; Henning, Alice K.; Jones, Stacie M.; Kim, Edwin H.; Leung, Donald Y. M.; Masilamani, Madhan; Scurlock, Amy M.; Sicherer, Scott H.; Wood, Robert A.; Sampson, Hugh A.			Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T(H)2 cells; T-FH cells; basophil activation test; immunoglobulins; oral immunotherapy; epicutaneous immunotherapy; double-blind placebo-controlled food challenge	PEANUT ALLERGY; EPICUTANEOUS IMMUNOTHERAPY; CHILDREN; TOLERANCE; SUBPOPULATION; EXPRESSION; RESPONSES; REVEALS; DEFINES	Background: Allergen-specific IL-4(+) and IL-13(+) CD4(+) cells (type 2 cells) are essential for helping B cells to class-switch to IgE and establishing an allergic milieu in the gastrointestinal tract. The role of T cells in established food allergy is less clear. Objective: We examined the food allergen-specific T-cell response in participants of 2 food allergen immunotherapy trials to assess the relationship of the T-cell response to clinical phenotypes, including response to immunotherapy. Methods: Blood was obtained from 84 participants with peanut allergy and 142 participants with egg allergy who underwent double-blind placebo-controlled food challenges. Peanut- and egg-responsive T cells were identified by CD154 upregulation after stimulation with the respective extract. Intracellular cytokines and chemokine receptors were also detected. The response to peanut epicutaneous immunotherapy (Peanut Epicutaneous Phase II Immunotherapy Clinical Trial [CoFAR6]; 49 participants receiving epicutaneous immunotherapy) and egg oral immunotherapy or a baked egg diet (Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy [CoFAR7]; 92 participants) was monitored over time. Results: Peanut-specific type 2 and CCR6(+) T cells were negatively correlated with each other and differently associated with immune parameters, including specific IgE level and basophil activation test result. At baseline, type 2 cells, but not CCR61 cells, were predictive of clinical parameters, including a successfully consumed dose of peanut and baked egg tolerance. Exposure to peanut or egg immunotherapy was associated with a decrease in type 2 cell frequency. At baseline, high egg-specific type 2 cell frequency was the immune feature most predictive of oral immunotherapy failure. Conclusion: Food-specific type 2 T cells at baseline are informative of threshold of reactivity and response to immunotherapy.	[Berin, M. Cecilia; Agashe, Charuta; Chiang, David; Grishin, Alexander; Masilamani, Madhan; Sicherer, Scott H.; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Burks, A. Wesley; Kim, Edwin H.] Univ N Carolina, Sch Med, Dept Med & Pediat, Chapel Hill, NC 27515 USA; [Davidson, Wendy F.; Dawson, Peter] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Henning, Alice K.] Emmes, Rockville, MD USA; [Jones, Stacie M.; Scurlock, Amy M.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Jones, Stacie M.; Scurlock, Amy M.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; National Jewish Health; Johns Hopkins University	Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	cecilia.berin@mssm.edu	Agashe, Charuta/AAF-3847-2020	Agashe, Charuta/0000-0001-8820-8655; berin, cecilia/0000-0002-9051-9249	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [U19AI066738, U01AI066560, UM2AI130836]; University of Arkansas for Medical Sciences - NIH-NIAID [UM1AI130781]; University of North Carolina - NIH-NIAID [UM1AI30936]; Mount Sinai University - NIH-NIAID [UM1AI130570]; National Jewish Health - NIH-NIAID [UM1AI130780]; Johns Hopkins University School of Medicine - NIH-NIAID [UM1AI30838]; University of Arkansas for Medical Sciences - National Center for Research Resources (NCRR), a component of the NIH [UM1AI130781]; University of North Carolina - National Center for Research Resources (NCRR), a component of the NIH [UL1TR001111]; Mount Sinai University - National Center for Research Resources (NCRR), a component of the NIH [UL1TR000067]; National Jewish Health - National Center for Research Resources (NCRR), a component of the NIH [UL1TR002535]; Johns Hopkins University School of Medicine - National Center for Research Resources (NCRR), a component of the NIH [UL1TR000424]; DBV Technologies, Inc (Montrouge, France)	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Arkansas for Medical Sciences - NIH-NIAID; University of North Carolina - NIH-NIAID; Mount Sinai University - NIH-NIAID; National Jewish Health - NIH-NIAID; Johns Hopkins University School of Medicine - NIH-NIAID; University of Arkansas for Medical Sciences - National Center for Research Resources (NCRR), a component of the NIH; University of North Carolina - National Center for Research Resources (NCRR), a component of the NIH; Mount Sinai University - National Center for Research Resources (NCRR), a component of the NIH; National Jewish Health - National Center for Research Resources (NCRR), a component of the NIH; Johns Hopkins University School of Medicine - National Center for Research Resources (NCRR), a component of the NIH; DBV Technologies, Inc (Montrouge, France)	Supported by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (grants U19AI066738, U01AI066560, and UM2AI130836). Also supported by the University of Arkansas for Medical Sciences (grant UM1AI130781), the University of North Carolina (grant UM1AI30936), Mount Sinai University (grant UM1AI130570), National Jewish Health (grant UM1AI130780), and Johns Hopkins University School of Medicine (grant UM1AI30838), which were supported by the NIH-NIAID, and by the University of Arkansas for Medical Sciences (grant UL1TR003107), the University of North Carolina (grant UL1TR001111), Mount Sinai University (grant UL1TR000067), National Jewish Health (grant UL1TR002535), and Johns Hopkins University School of Medicine (grant UL1TR000424), which were supported by the National Center for Research Resources (NCRR), a component of the NIH. The study's contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or the NIH. Support for this trial was also provided by DBV Technologies, Inc (Montrouge, France), through funds provided to the Consortium for Food Allergy Research. Protocol development, study conduct, data analysis, and article development were conducted independently of DBV. The decision and approval to publish this article was made by the authors, as investigators in CoFAR, Emmes, and the NIH/NIAID leadership.	Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Asrat S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav8402; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Berin MC, 2018, J ALLERGY CLIN IMMUN, V142, P149, DOI 10.1016/j.jaci.2018.01.044; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P1329, DOI 10.1016/j.jaci.2014.06.032; Bruton K, 2021, J ALLERGY CLIN IMMUN, V147, P1381, DOI 10.1016/j.jaci.2020.11.042; Chiang D, 2018, J ALLERGY CLIN IMMUN, V141, P2107, DOI 10.1016/j.jaci.2017.11.060; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Jimenez-Saiz R, 2017, J ALLERGY CLIN IMMUN, V140, P1604, DOI 10.1016/j.jaci.2017.01.018; Jones SM, 2017, J ALLERGY CLIN IMMUN, V139, P1242, DOI 10.1016/j.jaci.2016.08.017; Jones SM, 2009, J ALLERGY CLIN IMMUN, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Kim EH, 2020, J ALLERGY CLIN IMMUN, V146, P851, DOI 10.1016/j.jaci.2020.05.040; Kosoy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163831; Lee JB, 2016, J ALLERGY CLIN IMMUN, V137, P1216, DOI 10.1016/j.jaci.2015.09.019; Lin YL, 2019, MUCOSAL IMMUNOL, V12, P1304, DOI 10.1038/s41385-019-0204-y; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Noah TK, 2019, J ALLERGY CLIN IMMUN, V144, P1058, DOI 10.1016/j.jaci.2019.04.030; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Ruiter B, 2020, J ALLERGY CLIN IMMUN, V145, P270, DOI 10.1016/j.jaci.2019.09.033; Scurlock AM, 2021, J ALLERGY CLIN IMMUN, V147, P992, DOI 10.1016/j.jaci.2020.11.027; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Tortola L, 2020, IMMUNITY, V53, P597, DOI 10.1016/j.immuni.2020.07.001; Turcanu V, 2003, J CLIN INVEST, V111, P1065, DOI 10.1172/JCI200316142; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Weissler KA, 2018, J ALLERGY CLIN IMMUN, V141, P1699, DOI 10.1016/j.jaci.2018.01.035; Wisniewski JA, 2015, CLIN EXP ALLERGY, V45, P1201, DOI 10.1111/cea.12537; Xie JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045377	35	4	4	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1373	+		10.1016/j.jaci.2021.09.029	http://dx.doi.org/10.1016/j.jaci.2021.09.029			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34653515				2022-12-18	WOS:000820784100004
J	Dantzer, J; Dunlop, J; Psoter, KJ; Keet, C; Wood, R				Dantzer, Jennifer; Dunlop, Joan; Psoter, Kevin J.; Keet, Corinne; Wood, Robert			Efficacy and safety of baked milk oral immunotherapy in children with severe milk allergy: A randomized, double-blind, placebo-controlled phase 2 trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Milk allergy; food allergy; oral immunotherapy; baked milk; desensitization; IgE; IgG(4); quality of life	QUALITY-OF-LIFE; FOOD ALLERGY; EOSINOPHILIC ESOPHAGITIS; QUESTIONNAIRE; IGE; VALIDATION; DIAGNOSIS	Background: Cow's milk allergy is the most common food allergy in young children and has no current treatment. Oral immunotherapy studies to date have shown efficacy but high rates of adverse reactions. Objective: We sought to evaluate the safety and efficacy of baked milk oral immunotherapy (BMOIT) in children allergic to baked milk. Methods: Participants (3-18 years) were randomized to receive BMOIT or placebo for 12 months. Efficacy was assessed by double-blind placebo-controlled food challenge after 12 months of treatment. Safety, quality of life, and mechanistic parameters were also evaluated. Results: Eleven of 15 (73%) BMOIT participants reached the primary end point, tolerating 4044 mg of baked milk protein after 12 months of oral immunotherapy, compared with 0 of 15 (0%) on placebo. The median maximum tolerated dose and median change from baseline was significantly higher in the BMOIT group than in the placebo group (median maximum tolerated dose, 4044 mg vs 144 mg; P = .001; median change in maximum tolerated dose of 3900 mg vs 0 mg, P - .0001). Dose-related reactions were common, but more than 95% in both groups were mild. There was no significant change in cow's milk- or beta lactoglobulin-IgE from baseline for either group. Cow's milk-sIgG4 did significantly increase and casein IgE decreased in the BMOIT group. For proxy-reported food allergy quality of life, there was a significant difference in the emotional impact domain only, with more improving while on placebo compared with BMOIT. Most children and adolescents in the BMOIT group directly reported improvement in at least 1 domain. Conclusions: BMOIT was well tolerated and induced a substantial level of desensitization after 12 months of treatment.	[Dantzer, Jennifer; Dunlop, Joan; Wood, Robert] Div Pediat Allergy & Immunol, Baltimore, MD USA; [Psoter, Kevin J.] Dept Pediat, Gen Pediat, Baltimore, MD USA; [Keet, Corinne] Dept Pediat, Div Allergy & Immunol, Chapel Hill, NC USA		Dantzer, J (corresponding author), 600 N Wolfe St,Blalock 453, Baltimore, MD 21287 USA.	jwrubel1@jhmi.edu			Myra Reinhard Family Foundation	Myra Reinhard Family Foundation	Funding was received from the Myra Reinhard Family Foundation.	Blok BMJF, 2008, J ALLERGY CLIN IMMUN, V122, P139, DOI 10.1016/j.jaci.2008.05.008; Boyce JA, 2011, NUTR RES, V31, P61, DOI 10.1016/j.nutres.2011.01.001; Burbank AJ, 2016, IMMUNOL ALLERGY CLIN, V36, P55, DOI 10.1016/j.iac.2015.08.007; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; Dantzer J, 2020, ALLERGENS ALLERGEN I, P515; Dantzer JA, 2020, J ALLERGY CLIN IMMUN, V146, DOI 10.1016/j.jaci.2020.03.030; De Schryver S, 2019, J ALLER CL IMM-PRACT, V7, P1912, DOI 10.1016/j.jaip.2019.02.007; DunnGalvin A, 2008, CLIN EXP ALLERGY, V38, P977, DOI 10.1111/j.1365-2222.2008.02978.x; Echeverria-Zudaire LA, 2016, ALLERGOL IMMUNOPATH, V44, P531, DOI 10.1016/j.aller.2016.05.002; Flokstra-de Blok BMJ, 2010, ALLERGY, V65, P238, DOI 10.1111/j.1398-9995.2009.02121.x; Flokstra-de Blok BMJ, 2009, CLIN EXP ALLERGY, V39, P127, DOI [10.1111/j.1365-2222.2008.03120.x, 10.1111/j.1365-2222.2009.03376.x]; Flokstra-de Blok BMJ, 2009, ALLERGY, V64, P1209, DOI 10.1111/j.1398-9995.2009.01968.x; Goldberg MR, 2015, J ALLERGY CLIN IMMUN, V136, P1601, DOI 10.1016/j.jaci.2015.05.040; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hobbs CB, 2015, J ALLER CL IMM-PRACT, V3, P133, DOI 10.1016/j.jaip.2014.11.004; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P448, DOI 10.1016/j.jaci.2011.10.023; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Kim J, 2013, NUTR RES PRACT, V7, P488, DOI 10.4162/nrp.2013.7.6.488; Lucendo AJ, 2014, ANN ALLERG ASTHMA IM, V113, P624, DOI 10.1016/j.anai.2014.08.004; Calatayud CM, 2014, J INVEST ALLERG CLIN, V24, P298; Narisety SD, 2009, J ALLERGY CLIN IMMUN, V124, P610, DOI 10.1016/j.jaci.2009.06.025; Nowak-Wegrzyn A, 2008, J ALLERGY CLIN IMMUN, V122, P342, DOI 10.1016/j.jaci.2008.05.043; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P234, DOI 10.1097/ACI.0b013e32832b88e7; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Pajno GB, 2010, ANN ALLERG ASTHMA IM, V105, P376, DOI 10.1016/j.anai.2010.03.015; Petroni D, 2018, ANN ALLERG ASTHMA IM, V120, P237, DOI 10.1016/j.anai.2017.11.016; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Vazquez-Ortiz M, 2013, CLIN EXP ALLERGY, V43, P92, DOI 10.1111/cea.12012; Wood RA, 2017, J INVEST ALLERG CLIN, V27, P151, DOI 10.18176/jiaci.0143	33	4	4	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1383	+		10.1016/j.jaci.2021.10.023	http://dx.doi.org/10.1016/j.jaci.2021.10.023			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34740607				2022-12-18	WOS:000820784100005
J	Mendez-Enriquez, E; Salomonsson, M; Eriksson, J; Janson, C; Malinovschi, A; Sellin, ME; Hallgren, J				Mendez-Enriquez, Erika; Salomonsson, Maya; Eriksson, Jens; Janson, Christer; Malinovschi, Andrei; Sellin, Mikael E.; Hallgren, Jenny			IgE cross-linking induces activation of human and mouse mast cell progenitors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Activation; allergic airway inflammation; IgE cross-linking; mast cells; mast cell progenitors; phosphorylation	ADULT	Background: The concept of innate and adaptive effector cells that are repleted by maturing inert progenitor cell populations is changing. Mast cells develop from rare mast cell progenitors populating peripheral tissues at homeostatic conditions, or as a result of induced recruitment during inflammatory conditions. Objective: Because FceRI-expressing mast cell progenitors are the dominating mast cell type during acute allergic lung inflammation in vivo, we hypothesized that they are activated by IgE cross-linking. Methods: Mouse peritoneal and human peripheral blood cells were sensitized and stimulated with antigen, or stimulated with anti-IgE, and the mast cell progenitor population analyzed for signs of activation by flow cytometry. Isolated peritoneal mast cell progenitors were studied before and after anti-IgE stimulation at single-cell level by time-lapse fluorescence microscopy. Lung mast cell progenitors were analyzed for their ability to produce IL-13 by intracellular flow cytometry in a mouse model of ovalbumin-induced allergic airway inflammation. Results: Sensitized mouse peritoneal mast cell progenitors demonstrate increased levels of phosphorylation of tyrosines on intracellular proteins (total tyrosine phosphorylation), and spleen tyrosine kinase (Syk) phosphorylation after antigen exposure. Anti-IgE induced cell surface-associated lysomal-associated membrane protein-1 (LAMP-1) in naive mast cell progenitors, and prompted loss of fluorescence signal and altered morphology of isolated cells loaded with lysotracker. In human mast cell progenitors, anti-IgE increased total tyrosine phosphorylation, cell surface-associated LAMP-1, and CD63. Lung mast cell progenitors from mice with ovalbumin-induced allergic airway inflammation produce IL-13. Conclusions: Mast cell progenitors become activated by IgE cross-linking and may contribute to the pathology associated with acute allergic airway inflammation.	[Mendez-Enriquez, Erika; Salomonsson, Maya; Hallgren, Jenny] Uppsala Univ, BMC, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Eriksson, Jens; Sellin, Mikael E.] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Hallgren, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	Jenny.hallgren@imbim.uu.se	Hallgren Martinsson, Jenny/AAZ-5937-2021; Hallgren Martinsson, Jenny/AAZ-6356-2021	Hallgren Martinsson, Jenny/0000-0002-3685-5364; Eriksson, Jens/0000-0002-8945-2665; Sellin, Mikael/0000-0002-8355-0803	Swedish Research Council [2014-03293, 2016-00803]; Swedish Heart and Lung Foundation [20150379, 20170479]; Knut and Alice Wallenberg Foundation [2017.0022]; Malin and Lennart Philipson Foundation; Konsul ThC Bergh's Foundation; Ruth och Nils-Erik Stenback Foundation; Mats Kleberg's Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Malin and Lennart Philipson Foundation; Konsul ThC Bergh's Foundation; Ruth och Nils-Erik Stenback Foundation; Mats Kleberg's Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Swedish Research Council (grant nos. 2014-03293 and 2016-00803 to J.H.), the Swedish Heart and Lung Foundation (grant nos. 20150379 and 20170479 to J.H.), Knut and Alice Wallenberg Foundation (grant no. 2017.0022 to J.H.), Malin and Lennart Philipson Foundation, Konsul ThC Bergh's Foundation, Ruth och Nils-Erik Stenback Foundation, and Mats Kleberg's Foundation, and Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico, estancia postdoctoral en el extranjero (E.M.-E.).	Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Bahri R, 2018, J ALLERGY CLIN IMMUN, V142, P485, DOI 10.1016/j.jaci.2018.01.043; Bujanover N, 2018, LEUKEMIA, V32, P2016, DOI 10.1038/s41375-018-0220-z; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; Dahdah A, 2014, J CLIN INVEST, V124, P4577, DOI 10.1172/JCI75212; Dahlin JS, 2013, ALLERGY, V68, P1333, DOI 10.1111/all.12223; Dahlin JS, 2016, BLOOD, V127, P383, DOI 10.1182/blood-2015-06-650648; Dahlin JS, 2015, STEM CELLS DEV, V24, P1703, DOI 10.1089/scd.2014.0553; Derakhshan T, 2021, J EXP MED, V218, DOI 10.1084/jem.20200321; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; Liu AY, 2013, J IMMUNOL, V190, P1758, DOI 10.4049/jimmunol.1202567; Mendez-Enriquez E, 2021, ALLERGY, V76, P2057, DOI 10.1111/all.14748; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Radinger M, 2009, PHARMACOL THERAPEUT, V121, P174, DOI 10.1016/j.pharmthera.2008.10.008; Salomonsson M, 2020, ALLERGY, V75, P456, DOI 10.1111/all.14004; Salomonsson M, 2019, CLIN EXP ALLERGY, V49, P874, DOI 10.1111/cea.13388; Santos AF, 2014, J ALLERGY CLIN IMMUN, V134, P645, DOI 10.1016/j.jaci.2014.04.039; Shen DT, 2006, J LEUKOCYTE BIOL, V80, P827, DOI 10.1189/jlb.0603298; Siraganian RP, 2010, FEBS LETT, V584, P4933, DOI 10.1016/j.febslet.2010.08.006; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Vadillo E, 2014, EXP HEMATOL, V42, P562, DOI 10.1016/j.exphem.2014.03.008; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005	25	4	4	4	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1458	1463		10.1016/j.jaci.2021.08.019	http://dx.doi.org/10.1016/j.jaci.2021.08.019			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34492259	hybrid, Green Published			2022-12-18	WOS:000820784100012
J	Olin, JT; Shaffer, M; Nauman, E; Durso, CS; Fan, EM; Staudenmayer, H; Christopher, KL; Gartner-Schmidt, J				Olin, James Tod; Shaffer, Monica; Nauman, Emily; Durso, Catherine S.; Fan, Elizabeth M.; Staudenmayer, Herman; Christopher, Kent L.; Gartner-Schmidt, Jackie			Development and validation of the Exercise-Induced Laryngeal Obstruction Dyspnea Index (EILODI)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Exercise-induced laryngeal obstruction; EILO; Exercise-Induced Laryngeal Obstruction Dyspnea Index; EILODI; continuous laryngoscopy during exercise; CLE; vocal cord dysfunction; VCD; paradoxical vocal fold motion; patient-reported outcome measure; questionnaire	SURGICAL-TREATMENT; LARYNGOSCOPY; PREVALENCE; DYSFUNCTION	Background: Exercise-induced laryngeal obstruction (EILO) causes exertional dyspnea and is important for its effect on quality of life, diagnostic confusion with exercise-induced asthma, and health care resource utilization. There is no validated patient-reported outcome measure specific to EILO. Objective: We sought to develop, validate, and define a minimal clinically important difference for a patient-reported outcome measure to be used with adolescents and young adults with EILO. Methods: A multidisciplinary group created a preliminary measure, modified by a 10-member participant focus group, with 20 items scored along a 5-point Likert scale. A subsequent cohort of participants recruited from a clinic, aged 12 to 21 years, with confirmed EILO by continuous laryngoscopy during exercise testing (1) completed the measure at 3 points in time over 28 days and (2) provided anchoring data in the form of a daily exercise log and categorical self-assessments of clinical improvement. Thirty additional participants without exertional dyspnea served as controls. Results: Two hundred nineteen subjects with mild to severe EILO participated in the exploratory factor analysis, which identified 7 factors within the preliminary outcome measure. After a process of item reduction, a 12-item metric with a total score ranging from 0 to 48 was developed. Mean scores of patients with EILO and healthy controls at baseline were 28.8 +/- 7.4 and 4.5 +/- 7.4, respectively. A minimal clinically important difference of 6 was determined by comparison of index change with changes in categorical self-assessments of improvement. Conclusions: This is the first patient-reported outcome measure specifically designed for adolescents and young adults with EILO.	[Olin, James Tod; Fan, Elizabeth M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Olin, James Tod] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Shaffer, Monica; Nauman, Emily] Natl Jewish Hlth, Dept Rehabil, Denver, CO 80206 USA; [Durso, Catherine S.] Univ Denver, Dept Comp Sci, Denver, CO USA; [Staudenmayer, Herman] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Christopher, Kent L.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Gartner-Schmidt, Jackie] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olin, JT (corresponding author), Natl Jewish Hlth, Div Pediat Pulmonol, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	olint@njhealth.org						Albaum G, 1997, J MARKET RES SOC, V39, P331; Chiang T, 2013, LARYNGOSCOPE, V123, P727, DOI 10.1002/lary.23654; Christensen PM, 2015, EUR RESPIR REV, V24, P445, DOI 10.1183/16000617.00006513; Christensen PM, 2013, PRIM CARE RESP J, V22, P306, DOI 10.4104/pcrj.2013.00067; Christensen PM, 2011, EUR ARCH OTO-RHINO-L, V268, P1313, DOI 10.1007/s00405-011-1612-0; Costello AB., 2005, PRACT ASSESS RES EVA, V10, P7, DOI DOI 10.1037/0021-9010.78.1; Efron B., 1994, INTRO BOOTSTRAP; Fowler SJ, 2015, CLIN EXP ALLERGY, V45, P1406, DOI 10.1111/cea.12550; Gartner-Schmidt JL, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.12.017; Halvorsen T, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02221-2016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heimdal JH, 2006, LARYNGOSCOPE, V116, P52, DOI 10.1097/01.mlg.0000184528.16229.ba; Hilland M, 2016, ARCH DIS CHILD, V101, P443, DOI 10.1136/archdischild-2015-308450; Johansson H, 2015, THORAX, V70, P57, DOI 10.1136/thoraxjnl-2014-205738; Johnston KL, 2018, J VOICE, V32, P698, DOI 10.1016/j.jvoice.2017.08.020; LAKIN RC, 1984, CHEST, V86, P499, DOI 10.1378/chest.86.3.499; Maat RC, 2007, EUR ARCH OTO-RHINO-L, V264, P401, DOI 10.1007/s00405-006-0216-6; Maat RC, 2011, EUR ARCH OTO-RHINO-L, V268, P1485, DOI 10.1007/s00405-011-1656-1; Maat RC, 2009, EUR ARCH OTO-RHINO-L, V266, P1929, DOI 10.1007/s00405-009-1030-8; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; NEWMAN KB, 1995, AM J RESP CRIT CARE, V152, P1382, DOI 10.1164/ajrccm.152.4.7551399; Nielsen EW, 2013, MED SCI SPORT EXER, V45, P2030, DOI 10.1249/MSS.0b013e318298b19a; Norlander K, 2015, ACTA OTO-LARYNGOL, V135, P1152, DOI 10.3109/00016489.2015.1062548; Olin JT, 2017, PEDIATR PULM, V52, P813, DOI 10.1002/ppul.23634; Olin JT, 2016, EUR RESPIR J, V48, P1192, DOI 10.1183/13993003.00160-2016; Roksund OD, 2009, RESP MED, V103, P1911, DOI 10.1016/j.rmed.2009.05.024; Rundell KW, 2003, CHEST, V123, P468, DOI 10.1378/chest.123.2.468; Shaffer M, 2018, IMMUNOL ALLERGY CLIN, V38, P293, DOI 10.1016/j.iac.2018.01.003; Traister RS, 2014, J ALLER CL IMM-PRACT, V2, P65, DOI 10.1016/j.jaip.2013.09.002; Walsted ES, 2017, J ASTHMA, V54, P77, DOI 10.1080/02770903.2016.1195843	30	4	4	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1437	1444		10.1016/j.jaci.2021.09.027	http://dx.doi.org/10.1016/j.jaci.2021.09.027			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34619181				2022-12-18	WOS:000820784100010
J	Shin, JW; Kim, J; Ham, S; Choi, SM; Lee, CH; Lee, JC; Kim, JH; Cho, SH; Kang, HR; Kim, YM; Chung, DH; Chung, Y; Bae, YS; Bae, YS; Roh, TY; Kim, T; Kim, HY				Shin, Jae Woo; Kim, Jihyun; Ham, Seokjin; Choi, Sun Mi; Lee, Chang-Hoon; Lee, Jung Chan; Kim, Ji Hyung; Cho, Sang-Heon; Kang, Hye Ryun; Kim, You-Me; Chung, Doo Hyun; Chung, Yeonseok; Bae, Yoe-Sik; Bae, Yong-Soo; Roh, Tae-Young; Kim, Taesoo; Kim, Hye Young			A unique population of neutrophils generated by air pollutant-induced lung damage exacerbates airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Diesel exhaust particles; granulocytes; SiglecF; ATP; DAMP; neutrophil extracellular traps; leukotrienes; asthma	EXTRACELLULAR TRAPS; ASTHMA PHENOTYPES; CELLS; MECHANISMS; MOUSE; DISEASE; DNA; HYPERRESPONSIVENESS; LEUKOTRIENES; ACTIVATION	Background: Diesel exhaust particles (DEPs) are the main component of traffic-related air pollution and have been implicated in the pathogenesis and exacerbation of asthma. However, the mechanism by which DEP exposure aggravates asthma symptoms remains unclear. Objective: This study aimed to identify a key cellular player of air pollutant-induced asthma exacerbation and development. Methods: We examined the distribution of innate immune cells in the murine models of asthma induced by house dust mite and DEP. Changes in immune cell profiles caused by DEP exposure were confirmed by flow cytometry and RNA-Seq analysis. The roles of sialic acid-binding, Ig-like lectin F (SiglecF)-positive neutrophils were further evaluated by adoptive transfer experiment and in vitro functional studies. Results: DEP exposure induced a unique population of lung granulocytes that coexpressed Ly6G and SiglecF. These cells differed phenotypically, morphologically, functionally, and transcriptionally from other SiglecF-expressing cells in the lungs. Our findings with murine models suggest that intratracheal challenge with DEPs induces the local release of adenosine triphosphate, which is a damage-associated molecular pattern signal. Adenosine triphosphate promotes the expression of SiglecF on neutrophils, and these SiglecF(+) neutrophils worsen type 2 and 3 airway inflammation by producing high levels of cysteinyl leukotrienes and neutrophil extracellular traps. We also found Siglec8-(which corresponds to murine SiglecF) expressing neutrophils, and we found it in patients with asthma-chronic obstructive pulmonary disease overlap. Conclusion: The SiglecF(+) neutrophil is a novel and critical player in airway inflammation and targeting this population could reverse or ameliorate asthma.	[Shin, Jae Woo; Kim, Jihyun; Kim, Hye Young] Seoul Natl Univ, Lab Mucosal Immunol, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 03080, South Korea; [Ham, Seokjin; Roh, Tae-Young] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Ham, Seokjin; Roh, Tae-Young] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Choi, Sun Mi; Lee, Chang-Hoon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Jung Chan] Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Ji Hyung] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Cho, Sang-Heon; Kang, Hye Ryun] Seoul Natl Univ, Coll Med, Div Allergy & Clin Immunol, Dept Internal Med, Seoul, South Korea; [Cho, Sang-Heon; Kang, Hye Ryun; Kim, Hye Young] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Coll Med, Seoul, South Korea; [Kim, You-Me] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Lab Immune Regulat, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Chung, Yeonseok] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea; [Bae, Yoe-Sik; Bae, Yong-Soo] Sungkyunkwan Univ, SRC Ctr Immune Res Nonlymphoid Organs, Dept Biol Sci, Suwon, South Korea; [Bae, Yoe-Sik; Bae, Yong-Soo] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Roh, Tae-Young] SysGenLab Inc, Pohang, South Korea; [Kim, Taesoo] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea University; Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Ewha Womans University	Kim, HY (corresponding author), Seoul Natl Univ, Lab Mucosal Immunol, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 03080, South Korea.	hykim11@snu.ac.kr		Ham, Seokjin/0000-0002-6950-2848; Roh, Tae-Young/0000-0001-5833-0844	Korea Healthcare Technology R&D Project of the Ministry of Health and Welfare, Korea [HI15C1736]; National Research Foundation of Korea; BK21-plus education program	Korea Healthcare Technology R&D Project of the Ministry of Health and Welfare, Korea; National Research Foundation of Korea(National Research Foundation of Korea); BK21-plus education program	This study was supported by grants from the Korea Healthcare Technology R&D Project of the Ministry of Health and Welfare, Korea (HI15C1736) and a grant from the National Research Foundation of Korea (NRF-2019R1A2C2087574 and SRC 2017R1A5A1014560) . Jae Woo Shin received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea.	Accomazzo MR, 2001, AM J RESP CRIT CARE, V163, P266, DOI 10.1164/ajrccm.163.1.9912019; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brandt EB, 2015, CURR OPIN PEDIATR, V27, P724, DOI 10.1097/MOP.0000000000000286; Brinkmann Volker, 2010, J Vis Exp, DOI 10.3791/1724; Castellani S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49419-z; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; D'Amato G, 2005, CLIN EXP ALLERGY, V35, P1113, DOI 10.1111/j.1365-2222.2005.02328.x; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Degroote RL, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03064; Dicker AJ, 2018, J ALLERGY CLIN IMMUN, V141, P117, DOI 10.1016/j.jaci.2017.04.022; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Grabcanovic-Musija F, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0221-7; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Iikura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123584; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim J, 2011, AM J PATHOL, V179, P2730, DOI 10.1016/j.ajpath.2011.08.008; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krishnamoorthy N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4747; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Lambrecht BN, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.MCHD-0053-2016; Lambrecht Bart N, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS236, DOI 10.1513/AnnalsATS.201405-218AW; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Lundback B, 2016, EXPERT REV RESP MED, V10, P39, DOI 10.1586/17476348.2016.1114417; Matsui M, 2020, BIOCHEM BIOPH RES CO, V526, P599, DOI 10.1016/j.bbrc.2020.03.122; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Murrison LB, 2019, J CLIN INVEST, V129, P1504, DOI 10.1172/JCI124612; Nadif R, 2016, EUR RESPIR J, V48, P1040, DOI 10.1183/13993003.00336-2016; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Parmentier CN, 2012, J ALLERGY CLIN IMMUN, V129, P1136, DOI 10.1016/j.jaci.2012.01.057; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pfirschke C, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108164; Pham DL, 2017, CLIN EXP ALLERGY, V47, P57, DOI 10.1111/cea.12859; Radermecker C, 2018, CURR OPIN IMMUNOL, V54, P28, DOI 10.1016/j.coi.2018.05.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Xia Y, 2017, J THORAC DIS, V9, P4798, DOI 10.21037/jtd.2017.11.113; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847	61	4	4	7	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1253	+		10.1016/j.jaci.2021.09.031	http://dx.doi.org/10.1016/j.jaci.2021.09.031			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3T5RO	34653517				2022-12-18	WOS:000840331500019
J	Straalen, KRV; Prens, EP; Gudjonsson, JE				Straalen, Kelsey R. van; Prens, Errol P.; Gudjonsson, Johann E.			Insights into hidradenitis suppurativa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Acne inversa; prevalence; lesion; pathogenesis; comor-bidities; treatment; target	INFLAMMATORY-BOWEL-DISEASE; SKIN MICROBIOTA; EXPRESSION; PREVALENCE; SYMPTOMS; LESIONS; RISK; MUTATIONS; SMOKERS; BURDEN	Hidradenitis suppurativa (HS) is a chronic, debilitating, inflammatory skin disorder with a prevalence of around 1% and a profound impact on patients' quality of life. Characteristic lesions such as inflammatory nodules, abscesses, and sinus tracts develop in the axillae, inguinal, and gluteal areas, typically during or after puberty. A complex interplay of genetic predisposition, hormonal factors, obesity, and smoking contributes to development and maintenance of the disease. HS is considered to arise from an intrinsic defect within the hair follicle, leading to follicular plugging, cyst formation, and subsequent rupture that in turn induce an acute inflammatory response characterized by elevated levels of IL-1b, IL-17, and TNF. Over time, acute lesions transition into chronic disease, with active draining sinus tracts accompanied by extensive fibrosis. HS is associated with other immune-mediated inflammatory diseases, metabolic and cardiovascular disorders, and psychiatric comorbidities. Treatment of HS often requires a combination of antibiotic or immunosuppressing therapies and surgical intervention. Nonetheless, the currently available treatments are not universally effective, and many drugs, which are often repurposed from other inflammatory diseases, are under investigation. Studies into the early stages of HS may yield treatments to prevent disease progression; yet, they are hampered by a lack of appropriate in vitro and animal models. (J Allergy Clin Immunol 2022;149:1150-61.)	[Straalen, Kelsey R. van; Prens, Errol P.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, 1910 Taubman Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Straalen, Kelsey R. van; Prens, Errol P.] Erasmus Univ, Med Ctr Rotterdam, Dept Dermatol, Rotterdam, Netherlands; Erasmus Univ, Med Ctr Rotterdam, Lab Expt Immunodermatol, Rotterdam, Netherlands	University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gudjonsson, JE (corresponding author), Univ Michigan, Dept Dermatol, 1910 Taubman Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	johanng@med.umich.edu		Gudjonsson, Johann/0000-0002-0080-0812				Ahn C, 2018, EXPERT REV CLIN IMMU, V14, P225, DOI 10.1080/1744666X.2018.1438269; Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Alikhan A, 2019, J AM ACAD DERMATOL, V81, P91, DOI 10.1016/j.jaad.2019.02.068; Andersen RK, 2020, INT J DERMATOL, V59, P216, DOI 10.1111/ijd.14651; Andersen RK, 2019, EXP DERMATOL, V28, P312, DOI 10.1111/exd.13885; Assan F, 2020, J ALLERGY CLIN IMMUN, V146, P452, DOI 10.1016/j.jaci.2020.01.045; Barrea L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010057; Bitan DT, 2020, J EUR ACAD DERMATOL, V34, P574, DOI 10.1111/jdv.15997; Blok JL, 2015, ACTA DERM-VENEREOL, V95, P994, DOI 10.2340/00015555-2186; Boer J, 2017, DERMATOLOGY, V233, P47, DOI 10.1159/000472252; Brandsma CA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-108; Byrd AS, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5908; Calao M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200683; Canoui-Poitrine F, 2013, J INVEST DERMATOL, V133, P1506, DOI 10.1038/jid.2012.472; Canoui-Poitrine F, 2009, J AM ACAD DERMATOL, V61, P51, DOI 10.1016/j.jaad.2009.02.013; Cao H, FRONT IMMUNOL, V12; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Carmona-Rivera C, 2022, J INVEST DERMATOL, V142, P924, DOI 10.1016/j.jid.2021.07.187; Castelli E, 2022, WIEN MED WOCHENSCHR, V172, P126, DOI 10.1007/s10354-021-00859-1; Cazzaniga S, J INVEST DERMATOL, V2021; Chandran NS, 2021, EXP DERMATOL, V30, P23, DOI 10.1111/exd.14340; Chen L, 2014, PLOS ONE, V9; Choi E, 2018, SKIN APPENDAGE DISOR, V4, P281, DOI 10.1159/000481836; Chu CB, 2021, BRIT J DERMATOL, V185, P1054, DOI 10.1111/bjd.20581; Cohen JM, 2022, INT J DERMATOL, V61, P84, DOI 10.1111/ijd.15578; Collier Erin K, 2020, Int J Womens Dermatol, V6, P372, DOI 10.1016/j.ijwd.2020.09.002; Danby FW, 2013, BRIT J DERMATOL, V168, P1034, DOI 10.1111/bjd.12233; Daxhelet M, 2020, DERMATOLOGY, V236, P431, DOI 10.1159/000507348; Deckers IE, 2017, J AM ACAD DERMATOL, V76, P49, DOI 10.1016/j.jaad.2016.08.031; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Duchatelet S, 2020, J INVEST DERMATOL, V140, P2085, DOI 10.1016/j.jid.2019.10.025; Dunstan RW, 2021, EXP DERMATOL, V30, P820, DOI 10.1111/exd.14273; Egeberg A, 2017, J INVEST DERMATOL, V137, P1060, DOI 10.1016/j.jid.2016.11.040; Egeberg A, 2016, JAMA DERMATOL, V152, P429, DOI 10.1001/jamadermatol.2015.6264; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Fauconier M, 2018, JOINT BONE SPINE, V85, P593, DOI 10.1016/j.jbspin.2017.09.005; Federico A, 2021, CLIN DERMATOL, V39, P496, DOI 10.1016/j.clindermatol.2021.01.002; Fernandez Jennifer M, 2020, Int J Womens Dermatol, V6, P368, DOI 10.1016/j.ijwd.2020.07.002; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Frew JW, 2019, BRIT J DERMATOL, V181, P566, DOI 10.1111/bjd.17695; Gadelha RD, 2020, AN BRAS DERMATOL, V95, P203, DOI 10.1016/j.abd.2019.02.012; Garcia-Gil MF, INT J DERMATOL, V2021, P25; Garcovich S, 2021, CLIN DERMATOL, V39, P240, DOI 10.1016/j.clindermatol.2020.10.016; Garg A, 2018, J AM ACAD DERMATOL, V79, P495, DOI 10.1016/j.jaad.2018.02.053; Georgin-Lavialle S, 2019, PRESSE MED, V48, P25; Giamarellos-Bourboulis EJ, 2016, J INVEST DERMATOL, V136, P1592, DOI 10.1016/j.jid.2016.04.021; Glatt S, 2021, JAMA DERMATOL, V157, P1279, DOI 10.1001/jamadermatol.2021.2905; Gonzalez-Lopez MA, 2021, POSTEP DERM ALERGOL, V38, P450, DOI 10.5114/ada.2021.107932; Gonzalez-Manso A, 2021, DERMATOLOGY, V237, P365, DOI 10.1159/000511045; Gonzalez-Villanueva I, 2018, BRIT J DERMATOL, V178, P984, DOI 10.1111/bjd.16264; Gotesman RD, INT J DERMATOL, V60, P433; Gudjonsson JE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139930; Hagan Paa Gyasi, 2020, JAAD Int, V1, P1, DOI 10.1016/j.jdin.2020.02.001; Hana A, 2007, LIFE SCI, V80, P2214, DOI 10.1016/j.lfs.2007.02.007; Hayama K, 2020, J DERMATOL, V47, P743, DOI 10.1111/1346-8138.15378; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Herbert D, 2018, J INVEST DERMATOL, V138, P1999, DOI 10.1016/j.jid.2018.03.1522; Hessam S, 2018, BRIT J DERMATOL, V178, P761, DOI 10.1111/bjd.16019; Hessam S, 2018, EUR J DERMATOL, V28, P449, DOI 10.1684/ejd.2018.3369; Hessam S, 2016, J DERMATOL SCI, V82, P166, DOI 10.1016/j.jdermsci.2016.02.009; Hoffman LK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203672; Hotz C, 2016, J INVEST DERMATOL, V136, P1768, DOI 10.1016/j.jid.2016.04.036; Huilaja L, 2018, J INVEST DERMATOL, V138, P46, DOI 10.1016/j.jid.2017.06.020; Hung CT, 2019, J DERMATOL, V46, P867, DOI 10.1111/1346-8138.15038; Ingram JR, 2018, BRIT J DERMATOL, V178, P917, DOI 10.1111/bjd.16101; Ingram JR, 2013, BRIT J DERMATOL, V168, P874, DOI 10.1111/bjd.12048; Jalenques I, 2020, J AM ACAD DERMATOL, V83, P542, DOI 10.1016/j.jaad.2020.03.041; Javorsky E, 2013, J AM ACAD DERMATOL, V68, pAB89; Jemec GBE, 1996, J AM ACAD DERMATOL, V35, P191, DOI 10.1016/S0190-9622(96)90321-7; Jfri A, 2021, JAMA DERMATOL, V157, P924, DOI 10.1001/jamadermatol.2021.1677; Jorgensen AHR, 2020, J EUR ACAD DERMATOL, V34, P565, DOI 10.1111/jdv.15904; Kaaz K, 2018, ACTA DERM-VENEREOL, V98, P757, DOI 10.2340/00015555-2967; Kelly G, 2015, BRIT J DERMATOL, V173, P1431, DOI 10.1111/bjd.14075; Kimball AB, 2016, NEW ENGL J MED, V375, P422, DOI 10.1056/NEJMoa1504370; Kirby JS, 2020, BRIT J DERMATOL, V182, P24, DOI 10.1111/bjd.18035; Kjaersgaard Andersen R, 2021, BRIT J DERMATOL; Kromann CB, 2014, BRIT J DERMATOL, V171, P819, DOI 10.1111/bjd.13090; Kromann CB, 2014, ACTA DERM-VENEREOL, V94, P553, DOI 10.2340/00015555-1800; Kurokawa I, 2015, J DERMATOL, V42, P747, DOI 10.1111/1346-8138.12881; Langan EA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041205; Lee JH, 2018, J EUR ACAD DERMATOL, V32, P1784, DOI 10.1111/jdv.15071; Leuenberger M, 2016, DERMATOLOGY, V232, P254, DOI 10.1159/000443648; Liang YT, 2021, J DERMATOL, V48, P613, DOI 10.1111/1346-8138.15811; Lindso Andersen P, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3464; List EK, 2019, ARCH DERMATOL RES, V311, P331, DOI 10.1007/s00403-019-01910-3; Loo CH, 2018, INT J DERMATOL, V57, P1454, DOI 10.1111/ijd.14210; Lopez-Candales Angel, 2017, J Nat Sci, V3; Lowe MM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139932; Maarouf M, 2019, AUSTRALAS J DERMATOL, V60, pE90, DOI 10.1111/ajd.12909; Machado MO, 2019, JAMA DERMATOL, V155, P939, DOI 10.1001/jamadermatol.2019.0759; Mancuso P, 2016, IMMUNOTARGETS THER, V5, P47, DOI 10.2147/ITT.S73223; Mariottoni P, FRONT MED-LAUSANNE, V8; Martorell-Calatayud A, 2015, J AM ACAD DERMATOL, V72, pAB150; Matusiak L, 2017, J AM ACAD DERMATOL, V76, P670, DOI 10.1016/j.jaad.2016.10.042; Matusiak L, 2010, J AM ACAD DERMATOL, V62, P706, DOI 10.1016/j.jaad.2009.09.021; McInnes IB, 2021, NAT REV IMMUNOL, V21, P680, DOI 10.1038/s41577-021-00603-1; Melibary YT, 2018, DERMATOL REP, V10, DOI 10.4081/dr.2018.7546; Micieli R, 2018, INT J DERMATOL, V57, P1471, DOI 10.1111/ijd.14173; Molinelli E, 2020, J AM ACAD DERMATOL, V83, P665, DOI 10.1016/j.jaad.2020.04.092; Montero-Vilchez T, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18136709; Moran B, 2017, J INVEST DERMATOL, V137, P2389, DOI 10.1016/j.jid.2017.05.033; Nadeem A, 2017, CYTOKINE, V97, P14, DOI 10.1016/j.cyto.2017.05.018; Naik HB, 2020, J INVEST DERMATOL, V140, P922, DOI 10.1016/j.jid.2019.08.445; Nakamizo S, J ALLERGY CLIN IMMUN, V2021; Nakashima C, 2019, EXP DERMATOL, V28, P1405, DOI 10.1111/exd.14014; Nelson AM, 2019, EXP DERMATOL, V28, P867, DOI 10.1111/exd.13973; Nguyen TV, 2021, J EUR ACAD DERMATOL, V35, P50, DOI 10.1111/jdv.16677; Nikolakis Georgios, 2021, Dermatology, V237, P673, DOI 10.1159/000509873; Nikolakis G, 2019, AM J CLIN DERMATOL, V20, P503, DOI 10.1007/s40257-019-00442-w; Omine T, 2020, J DERMATOL, V47, P855, DOI 10.1111/1346-8138.15411; Orvain C, 2020, J CLIN INVEST, V130, P3777, DOI 10.1172/JCI131180; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Pascual JC, 2016, BRIT J DERMATOL, V175, P1101, DOI 10.1111/bjd.14870; Penno CA, 2020, J INVEST DERMATOL, V140, P2421, DOI 10.1016/j.jid.2020.04.011; Phan K, 2020, J DERMATOL TREAT, V31, P615, DOI 10.1080/09546634.2019.1613483; Qiao P, 2019, J INVEST DERMATOL, V139, P1470, DOI 10.1016/j.jid.2018.12.019; Qiu FF, 2017, ONCOTARGET, V8, P268, DOI 10.18632/oncotarget.13613; Racanelli E, 2021, CANCERS, V13, DOI 10.3390/cancers13051153; Reddy S, 2019, JAMA DERMATOL, V155, P1284, DOI 10.1001/jamadermatol.2019.2610; Richette P, 2014, J RHEUMATOL, V41, P490, DOI 10.3899/jrheum.130977; Riddle A, 2021, DERMATOL SURG, V47, P349, DOI 10.1097/DSS.0000000000002892; Riis PT, 2019, BRIT J DERMATOL, V180, P774, DOI 10.1111/bjd.16998; Riis PT, 2017, BRIT J DERMATOL, V176, P1083, DOI 10.1111/bjd.14922; Riis PT, 2016, ACTA DERMATOVENER CR, V24, P239; Ring HC, 2017, CLIN EXP DERMATOL, V42, P261, DOI 10.1111/ced.13025; Ring HC, 2017, ACTA DERM-VENEREOL, V97, P208, DOI 10.2340/00015555-2503; Riverain-Gillet E, 2020, J INVEST DERMATOL, V140, P1847, DOI 10.1016/j.jid.2020.02.046; Sachdeva M, 2021, INT J DERMATOL, V60, pE459, DOI 10.1111/ijd.15677; Sandhu VK, 2020, BRIT J DERMATOL, V182, P1288, DOI 10.1111/bjd.18695; Schell SL, 2021, J AM ACAD DERMATOL, V85, P232, DOI 10.1016/j.jaad.2020.08.014; Schneider AM, 2020, J INVEST DERMATOL, V140, P716, DOI 10.1016/j.jid.2019.06.151; Schwob E, 2020, J EUR ACAD DERMATOL, V34, pE478, DOI 10.1111/jdv.16385; Seivright JR, 2022, DERMATOLOGY, V238, P260, DOI 10.1159/000517283; Shavit E, 2015, J EUR ACAD DERMATOL, V29, P371, DOI 10.1111/jdv.12567; Sherman S, 2021, J AM ACAD DERMATOL, V85, P1473, DOI 10.1016/j.jaad.2020.12.051; Shi ZR, 2020, J INVEST DERMATOL, V140, P1815, DOI 10.1016/j.jid.2020.01.020; Shlyankevich J, 2014, J AM ACAD DERMATOL, V71, P1144, DOI 10.1016/j.jaad.2014.09.012; Sivanand A, 2020, J CUTAN MED SURG, V24, P64, DOI 10.1177/1203475419874412; Slominski A, 2013, J STEROID BIOCHEM, V137, P107, DOI 10.1016/j.jsbmb.2013.02.006; SONNEX TS, 1988, BRIT J DERMATOL, V119, P653, DOI 10.1111/j.1365-2133.1988.tb03479.x; Stolwijk C, 2012, RHEUM DIS CLIN N AM, V38, P441, DOI 10.1016/j.rdc.2012.09.003; STONE OJ, 1976, ARCH DERMATOL, V112, P1142, DOI 10.1001/archderm.112.8.1142; Thompson AM, 2021, BRIT J DERMATOL, V185, P225, DOI 10.1111/bjd.19926; Thompson KG, 2020, J AM ACAD DERMATOL, V83, P942, DOI 10.1016/j.jaad.2020.01.042; Thorlacius L, 2018, J INVEST DERMATOL, V138, P52, DOI 10.1016/j.jid.2017.09.008; Tiri H, 2018, J INVEST DERMATOL, V138, P2672, DOI 10.1016/j.jid.2018.06.171; Tzellos T, 2015, BRIT J DERMATOL, V173, P1142, DOI 10.1111/bjd.14024; van der Zee HH, 2014, BRIT J DERMATOL, V171, P673, DOI 10.1111/bjd.13002; van der Zee HH, 2012, BRIT J DERMATOL, V166, P98, DOI 10.1111/j.1365-2133.2011.10643.x; van der Zee HH, 2015, J AM ACAD DERMATOL, V73, pS23, DOI 10.1016/j.jaad.2015.07.047; van Dijk SJ, 2015, INT J OBESITY, V39, P85, DOI 10.1038/ijo.2014.34; van Straalen KR, 2019, BRIT J DERMATOL, V181, P224, DOI 10.1111/bjd.17887; van Straalen KR, 2020, JAMA DERMATOL, V156, P1359, DOI 10.1001/jamadermatol.2020.3630; van Straalen KR, 2021, BRIT J DERMATOL; van Straalen KR, J AM ACAD DERMATOL, V84, P1401; Vanlaerhoven AMJD, 2018, DERMATOLOGY, V234, P232, DOI 10.1159/000491547; Vinkel C, 2017, INT J DERMATOL, V56, P811, DOI 10.1111/ijd.13603; von der Werth JM, 2000, J EUR ACAD DERMATOL, V14, P389, DOI 10.1046/j.1468-3083.2000.00087.x; von Laffert M, 2011, BRIT J DERMATOL, V164, P367, DOI 10.1111/j.1365-2133.2010.10034.x; Vossen ARJV, 2017, AM J CLIN DERMATOL, V18, P687, DOI 10.1007/s40257-017-0280-2; Vossen ARJV, 2017, J AM ACAD DERMATOL, V76, P155, DOI 10.1016/j.jaad.2016.07.024; Vural S, 2019, BRIT J DERMATOL, V180, P1459, DOI 10.1111/bjd.17466; Wang YJ, 2004, INT IMMUNOPHARMACOL, V4, P1675, DOI 10.1016/j.intimp.2004.07.028; Wang Z, DERMATOLOGY, V237, P698; Witte-Handel E, 2019, J INVEST DERMATOL, V139, P1294, DOI 10.1016/j.jid.2018.11.018; Wolk K, 2021, BRIT J DERMATOL, V185, P164, DOI 10.1111/bjd.19795; Wolk K, 2017, BRIT J DERMATOL, V177, P1385, DOI 10.1111/bjd.15424; Yao YQ, 2020, INT J DERMATOL, V59, P333, DOI 10.1111/ijd.14706; Yee Danielle, 2021, Int J Womens Dermatol, V7, P259, DOI 10.1016/j.ijwd.2020.10.010; YU CCW, 1990, BRIT J DERMATOL, V122, P763; 유혜린, 2016, [Korean Journal of Dermatology, 대한피부과학회지], V54, P723; Zhang XL, 2015, J INVEST DERMATOL, V135, P618, DOI 10.1038/jid.2014.399; Zong DD, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0311-8; Zouboulis CC, 2019, J EUR ACAD DERMATOL, V33, P19, DOI 10.1111/jdv.15233; Zouboulis CC, 2015, J EUR ACAD DERMATOL, V29, P619, DOI 10.1111/jdv.12966	175	4	4	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1150	1161		10.1016/j.jaci.2022.02.003	http://dx.doi.org/10.1016/j.jaci.2022.02.003			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0Z8PK	35189127				2022-12-18	WOS:000791333500001
J	Huang, HJ; Resch-Marat, Y; Casset, A; Weghofer, M; Zieglmayer, P; Zieglmayer, R; Lemell, P; Horak, F; Chen, KW; Potapova, E; Matricardi, PM; Pauli, G; Grote, M; Valenta, R; Vrtala, S				Huang, Huey-Jy; Resch-Marat, Yvonne; Casset, Anne; Weghofer, Margit; Zieglmayer, Petra; Zieglmayer, Rene; Lemell, Patrick; Horak, Friedrich; Chen, Kuan-Wei; Potapova, Ekaterina; Matricardi, Paolo M.; Pauli, Gabrielle; Grote, Monika; Valenta, Rudolf; Vrtala, Susanne			IgE recognition of the house dust mite allergen Der p 37 is associated with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Der p 37; house dust mite allergy; recombinant allergen; allergy diagnosis	MAJOR ALLERGEN; SENSITIZATION; PEPTIDES; BINDING; PROTEIN; CHITIN	Background: House dust mite (HDM) allergens are major elicitors of allergic reactions worldwide. Objective: Identification, characterization, and evaluation of diagnostic utility of a new important HDM allergen was performed. Methods: A cDNA coding for a new Dermatophagoides pteronyssinus (Dp) allergen, Der p 37, was isolated from a Dp expression library with allergic patients' IgE antibodies. Recombinant Der p 37 (rDer p 37) expressed in Escherichia coli was purified, then characterized by mass spectrometry, circular dichroism, and IgE reactivity by ImmunoCAP ISAC technology with sera from 111 clinically defined HDM-allergic patients. The allergenic activity of rDer p 37 was studied by basophil activation and CD4(+) T-cell responses by carboxyfluorescein diacetate succinimidyl ester dilution assays. Specific antibodies raised against rDer p 37 were used for the ultrastructural localization of Der p 37 in mites by immunogold transmission electron microscopy. Results: Der p 37, a 26 kDa allergen with homology to chitin binding proteins, is immunologically distinct from Der p 15, 18, and 23. It is located in the peritrophic membrane of fecal pellets. Der p 37 reacted with IgE antibodies from a third of HDM-allergic patients and induced specific basophil-and CD4+ T-cell activation. Der p 37 IgE-positive patients had significantly higher IgE levels to major HDM allergens, reacted with more HDM allergens, and had a higher risk (odds ratio 5 3.1) of asthma compared to Der p 37-negative patients. Conclusions: Der p 37, a new Dp allergen recognized by a third of HDM-allergic patients, may serve as a surrogate marker for severe HDM sensitization and asthma.	[Huang, Huey-Jy; Resch-Marat, Yvonne; Casset, Anne; Weghofer, Margit; Chen, Kuan-Wei; Valenta, Rudolf; Vrtala, Susanne] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Zieglmayer, Petra; Zieglmayer, Rene; Lemell, Patrick] Vienna Challenge Chamber, Vienna, Austria; [Horak, Friedrich] Allergy Ctr Vienna West, Vienna, Austria; [Potapova, Ekaterina; Matricardi, Paolo M.] Charite Univ Med Berlin, Dept Pediat Resp Med Immunol & Crit Care Med, Berlin, Germany; [Potapova, Ekaterina; Matricardi, Paolo M.] Free Univ Berlin, Berlin, Germany; [Potapova, Ekaterina; Matricardi, Paolo M.] Humboldt Univ, Berlin, Germany; [Pauli, Gabrielle] Hop Univ Strasbourg, Serv Pneumol, Strasbourg, France; [Grote, Monika] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Valenta, Rudolf] NRC Inst Immunol FMBA Russia, Moscow, Russia; [Valenta, Rudolf] Sechenov First Moscow State Med Univ, Lab Immunopathol, Dept Clin Immunol & Allergy, Moscow, Russia; [Zieglmayer, Petra; Valenta, Rudolf] Karl Landsteiner Univ, Krems, Austria	Medical University of Vienna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munster; NRC Institute of Immunology FMBA of Russia; Sechenov First Moscow State Medical University	Vrtala, S (corresponding author), Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	susanne.vrtala@meduniwien.ac.at		Valenta, Rudolf/0000-0001-5944-3365; Potapova, Ekaterina/0000-0003-4427-6335; Huang, Huey-Jy/0000-0001-5464-0132	Austrian Science Fund (FWF) [DK W 1248-B30, F4602, F4605]; Country of Lower Austria and the; Government of the Russian Federation [14.W03.31.0024]; Medical University of Vienna	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Country of Lower Austria and the; Government of the Russian Federation; Medical University of Vienna	This study was funded by the Austrian Science Fund (FWF; DK W 1248-B30, F4602, F4605), Country of Lower Austria and the Medical University of Vienna. R.V. is the recipient of a megagrant from the Government of the Russian Federation (grant 14.W03.31.0024).	Acevedo N, 2019, ALLERGY ASTHMA IMMUN, V11, P450, DOI 10.4168/aair.2019.11.4.450; Banerjee S, 2015, J INVEST DERMATOL, V135, P102, DOI 10.1038/jid.2014.271; Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biddulph P, 2010, EXP APPL ACAROL, V52, P449; Caraballo L, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100118; Chen KW, 2019, J ALLERGY CLIN IMMUN, V143, P1248, DOI 10.1016/j.jaci.2018.10.048; Chen ZG, 2019, INT ARCH ALLERGY IMM, V180, P17, DOI 10.1159/000499409; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Elisyutina O, 2019, ALLERGY, V74, P2525, DOI 10.1111/all.13931; Fernandez-Caldas E, 2014, CHEM IMMUNOL ALLERGY, V100, P234, DOI 10.1159/000358860; Focke M, 2004, CLIN EXP ALLERGY, V34, P1525, DOI 10.1111/j.1365-2222.2004.02081.x; Gronlund H, 2008, CLIN EXP ALLERGY, V38, P1275, DOI 10.1111/j.1365-2222.2008.03003.x; Hales BJ, 2013, INT ARCH ALLERGY IMM, V160, P233, DOI 10.1159/000339760; Halim A, 2015, MOL CELL PROTEOMICS, V14, P191, DOI 10.1074/mcp.M114.042614; Huang HJ, 2019, ALLERGY, V74, P2461, DOI 10.1111/all.13956; Huang HJ, 2018, J ALLERGY CLIN IMMUN, V142, P1656, DOI 10.1016/j.jaci.2018.07.010; Jacquet A, 2020, ALLERGY, V75, P33, DOI 10.1111/all.13940; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Li J, 2013, CLIN EXP ALLERGY, V43, P1171, DOI 10.1111/cea.12157; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Nakamura R, 2010, ALLERGY, V65, P1266, DOI 10.1111/j.1398-9995.2010.02363.x; Pomes A, 2019, J ALLERGY CLIN IMMUN, V144, P935, DOI 10.1016/j.jaci.2019.05.036; Posa D, 2017, J ALLERGY CLIN IMMUN, V139, P541, DOI 10.1016/j.jaci.2016.08.014; Resch Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160641; Resch Y, 2015, J ALLERGY CLIN IMMUN, V136, P1083, DOI 10.1016/j.jaci.2015.03.024; Rodr~iguez-Dominguez A, 2020, J ALLERGY CLIN IMMUN, P30479; Sanchez-Borges M, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0145-4; Sarzsinszky E, 2021, ALLERGY ASTHMA IMMUN, V13, P154, DOI 10.4168/aair.2021.13.1.154; Scala E, 2016, J ALLERGY CLIN IMMUN, V137, P629, DOI 10.1016/j.jaci.2015.07.009; Shakib F, 1998, IMMUNOL TODAY, V19, P313, DOI 10.1016/S0167-5699(98)01284-5; Siroux V, 2019, ALLERGY, V74, P824, DOI 10.1111/all.13676; Siroux V, 2017, J ALLERGY CLIN IMMUN, V139, P643, DOI 10.1016/j.jaci.2016.05.023; Soh WT, 2015, INT ARCH ALLERGY IMM, V168, P150, DOI 10.1159/000442176; Thomas WR, 2010, ASIAN PAC J ALLERGY, V28, P211; Valenta R, 2018, J ALLER CL IMM-PRACT, V6, P1845, DOI 10.1016/j.jaip.2018.08.032; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zakzuk J, 2014, INT ARCH ALLERGY IMM, V163, P119, DOI 10.1159/000356482	40	4	4	7	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1031	1043		10.1016/j.jaci.2021.07.040	http://dx.doi.org/10.1016/j.jaci.2021.07.040			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34419535	hybrid			2022-12-18	WOS:000765811400002
J	Scadding, GK; Scadding, GW				Scadding, Glenis K.; Scadding, Guy W.			Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic rhinosinusitis with nasal polyps; CRSwNP; biologics; omalizumab; SNOT-22; JAK-selective inhibitors			[Scadding, Glenis K.] UCL, Div Infect & Immun, Univ Coll Hosp London, Royal Natl ENT Hosp, London, England; [Scadding, Guy W.] Imperial Coll, Allergy & Clin Immunol, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London	Scadding, GK (corresponding author), Royal Natl ENT Hosp, Huntley St, London WC1E 6DG, England.	g.scadding@ucl.ac.uk						Blauvelt A, 2021, JAMA DERMATOL, V157, P1047, DOI 10.1001/jamadermatol.2021.3023; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2022, J ALLERGY CLIN IMMUN, V149, P957, DOI 10.1016/j.jaci.2021.07.045; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Laidlaw TM, 2020, ANN ALLERG ASTHMA IM, V124, P326, DOI 10.1016/j.anai.2019.12.001; Marcus S, 2020, INT FORUM ALLERGY RH, V10, P183, DOI 10.1002/alr.22454; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Scadding GK, 2021, J ALLER CL IMM-PRACT, V9, P1851, DOI 10.1016/j.jaip.2021.02.013; Traves PG, 2021, ANN RHEUM DIS, V80, P865, DOI 10.1136/annrheumdis-2020-219012; Yong M, 2021, INT FORUM ALLERGY RH, V11, P1626, DOI 10.1002/alr.22865	10	4	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					895	897		10.1016/j.jaci.2021.10.029	http://dx.doi.org/10.1016/j.jaci.2021.10.029			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34752829	Bronze			2022-12-18	WOS:000765938100016
J	Sliz, E; Huilaja, L; Pasanen, A; Laisk, T; Reimann, E; Magi, R; Hannula-Jouppi, K; Peltonen, S; Salmi, T; Koulu, L; Tasanen, K; Kettunen, J				Sliz, Eeva; Huilaja, Laura; Pasanen, Anu; Laisk, Triin; Reimann, Ene; Magi, Reedik; Hannula-Jouppi, Katariina; Peltonen, Sirkku; Salmi, Teea; Koulu, Leena; Tasanen, Kaisa; Kettunen, Johannes			Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; genome-wide association; DSC1; SERPINB7; FinnGen	LD SCORE REGRESSION; MUTATIONS; PATHOGENICITY; ASSOCIATION; PROTEIN; LOCI; RARE	Background: Atopic dermatitis (AD) is a common chronic inflammatory skin disease with high heritability. Previous genome-wide association studies have identified several loci predisposing to AD. These findings explain approximately 30% of the variance in AD susceptibility, suggesting that further work is required to fully understand the genetic underpinnings. Objective: We sought to gain additional understanding of the genetic contribution to AD risk by using biobank resources. Methods: We completed a genome-wide meta-analysis of AD in 796,661 individuals (N-cases = 22,474) from the FinnGen study, the Estonian Biobank, and the UK Biobank. We further performed downstream in silico analyses to characterize the risk variants at the novel loci. Results: We report 30 loci associating with AD (P < 5 x 10(-8)), 5 of which are novel. In 2 of the novel loci, we identified missense mutations with deleterious predictions in desmocollin 1 and serpin family B member 7, genes encoding proteins crucial to epidermal strength and integrity. Conclusions: These findings elucidate novel genetic pathways involved in AD pathophysiology. The likely involvement of desmocollin 1 and serpin family B member 7 in AD pathogenesis may offer opportunities for the development of novel treatment strategies for AD in the future.	[Sliz, Eeva; Kettunen, Johannes] Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Aapistie 5A,POB 5000, Oulu 90014, Finland; [Sliz, Eeva; Kettunen, Johannes] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Huilaja, Laura; Pasanen, Anu; Tasanen, Kaisa] Med Res Ctr Oulu, Dept Dermatol, PEDEGO Res Unit, Oulu, Finland; [Huilaja, Laura; Pasanen, Anu; Tasanen, Kaisa] Univ Hosp, Oulu, Finland; [Huilaja, Laura; Pasanen, Anu; Tasanen, Kaisa] Univ Oulu, Oulu, Finland; [Pasanen, Anu] Univ Oulu, PEDEGO Res Unit, Oulu, Finland; [Pasanen, Anu] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Pasanen, Anu] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Laisk, Triin; Reimann, Ene; Magi, Reedik] Univ Tartu, Estonian Genome Ctr, Inst Genom, Tartu, Estonia; [Hannula-Jouppi, Katariina] Univ Helsinki, ERN Skin Ctr, Dept Dermatol & Allergol, Helsinki, Finland; [Hannula-Jouppi, Katariina] Helsinki Univ Cent Hosp, Helsinki, Finland; [Hannula-Jouppi, Katariina] Folkhalsan Res Ctr, Helsinki, Finland; [Hannula-Jouppi, Katariina] Univ Helsinki, Res Programs Unit, Stem Cells & Metab Res Program, Helsinki, Finland; [Peltonen, Sirkku; Koulu, Leena] Univ Turku, Dept Dermatol & Venereol, Turku, Finland; [Peltonen, Sirkku; Koulu, Leena] Turku Univ Hosp, Dept Dermatol, Turku, Finland; [Peltonen, Sirkku] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol, Gothenburg, Sweden; [Peltonen, Sirkku] Sahlgrens Univ Hosp, Dept Dermatol & Venereol, Reg Vastra Gotaland, Gothenburg, Sweden; [Salmi, Teea] Tampere Univ, Fac Med & Hlth Technol, Celiac Dis Res Ctr, Tampere, Finland; [Salmi, Teea] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Tartu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Turku; University of Turku; University of Gothenburg; Sahlgrenska University Hospital; Tampere University; Tampere University; Tampere University Hospital	Sliz, E (corresponding author), Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Aapistie 5A,POB 5000, Oulu 90014, Finland.	eeva.sliz@oulu.fi	Peltonen, Sirkku/C-3133-2008	Peltonen, Sirkku/0000-0003-0990-1430; Salmi, Teea/0000-0001-7459-4938; Pasanen, Anu/0000-0001-7460-5086; Sliz, Eeva/0000-0002-2316-058X	Business Finland [HUS 4685/31/2016, UH 4386/31/2016]; AbbVie Inc; AstraZeneca UK Ltd; Biogen MA Inc; Celgene Corporation; Celgene International II Sarl; Genentech Inc; Merck Sharp Dohme Corp; Pfizer Inc; GlaxoSmithKline Intellectual Property Development Ltd; Sanofi US Services Inc; Maze Therapeutics Inc; Janssen Biotech Inc; Novartis AG; Sigrid Juselius Foundation; Academy of Finland [297338, 307247]; Novo Nordisk Foundation [NNF17OC0026062]; European Union through the European Regional Development Fund [2014-2020.4.01.15-0012, 2014-2020.4.01.16-0125]; European Union [810645]; Estonian Research Council [PRG687, PRG1291]	Business Finland; AbbVie Inc(AbbVie); AstraZeneca UK Ltd(AstraZeneca); Biogen MA Inc; Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); Celgene International II Sarl(Bristol-Myers SquibbCelgene Corporation); Genentech Inc(Roche HoldingGenentech); Merck Sharp Dohme Corp(Merck & Company); Pfizer Inc(Pfizer); GlaxoSmithKline Intellectual Property Development Ltd; Sanofi US Services Inc; Maze Therapeutics Inc; Janssen Biotech Inc(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis AG; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union through the European Regional Development Fund(European Commission); European Union(European Commission); Estonian Research Council(Estonian Research Council)	The FinnGen project is funded by 2 grants from Business Finland (grant nos. HUS 4685/31/2016 and UH 4386/31/2016) and the following industry partners: AbbVie Inc, AstraZeneca UK Ltd, Biogen MA Inc, Celgene Corporation, Celgene International II Sarl, Genentech Inc, Merck Sharp & Dohme Corp, Pfizer Inc, GlaxoSmithKline Intellectual Property Development Ltd, Sanofi US Services Inc, Maze Therapeutics Inc, Janssen Biotech Inc, and Novartis AG. This study was funded by the Sigrid Juselius Foundation (J.K.), the Academy of Finland (grant nos. 297338 and 307247 to J.K.), Novo Nordisk Foundation (grant no. NNF17OC0026062 to J.K.), the European Union through the European Regional Development Fund (project nos. 2014-2020.4.01.15-0012 and 2014-2020.4.01.16-0125), the European Union (through Horizon 2020 grant no. 810645), and the Estonian Research Council grants (grant nos. PRG687 and PRG1291).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bataille V, 2012, J EUR ACAD DERMATOL, V26, P1067, DOI 10.1111/j.1468-3083.2011.04444.x; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Beigi F, 2013, CIRC RES, V113, P372, DOI 10.1161/CIRCRESAHA.113.301075; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cai XY, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00174; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Cuellar-Partida G, 2019, BIORXIV518027; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Feingold KR, 2014, J INVEST DERMATOL, V134, P597, DOI 10.1038/jid.2013.440; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Fukaya T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01418; Hannula-Jouppi K, 2020, J AM ACAD DERMATOL, V83, P643, DOI 10.1016/j.jaad.2019.11.004; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Johansson A, 2019, HUM MOL GENET, V28, P4022, DOI 10.1093/hmg/ddz175; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kubo A, 2013, AM J HUM GENET, V93, P945, DOI 10.1016/j.ajhg.2013.09.015; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Mitt M, 2017, EUR J HUM GENET, V25, P869, DOI 10.1038/ejhg.2017.51; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pigors M, 2016, AM J HUM GENET, V99, P430, DOI 10.1016/j.ajhg.2016.06.004; Pradhan D, 2019, CANCERS, V11, P1; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y	40	4	4	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1105	+		10.1016/j.jaci.2021.07.043	http://dx.doi.org/10.1016/j.jaci.2021.07.043			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO6CI	34454985	hybrid, Green Published			2022-12-18	WOS:000765811400008
J	Beloglazov, V; Yatskov, I; Nikolaeva, A; Lavrenchuk, E; DuBuske, L				Beloglazov, Vladimir; Yatskov, Igor; Nikolaeva, A.; Lavrenchuk, E.; DuBuske, Lawrence			Cathepsin G in Patients with SARS-Cov-2 Infection of Various Degrees of Severity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									[Beloglazov, Vladimir; Yatskov, Igor; Nikolaeva, A.; Lavrenchuk, E.] Crimea Med Acad, Simferopol, Russia; [DuBuske, Lawrence] George Washington Univ, Sch Med, Immunol Res Inst New England, Washington, DC 20052 USA	George Washington University			Yatskov, Igor/ABD-1686-2021; Beloglazov, Vladimir A/P-8419-2015	Yatskov, Igor/0000-0002-5486-7262; Beloglazov, Vladimir A/0000-0001-9640-754X					0	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2		S		176	AB59	AB59						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0H8SE					2022-12-18	WOS:000778999300176
J	Rha, MS; Yoon, YH; Koh, JY; Jung, JH; Lee, H; Park, SK; Park, SH; Kim, YM; Rha, KS; Shin, EC				Rha, Min-Seok; Yoon, Young Hoon; Koh, June-Young; Jung, Jae Hyung; Lee, Ha Seok; Park, Soo Kyoung; Park, Su-Hyung; Kim, Yong Min; Rha, Ki-Sang; Shin, Eui-Cheol			IL-17A-producing sinonasal MAIT cells in patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; nasal polyp; mucosal-associated invariant T cells; MAIT cells; IL-17A; MAIT cells	INVARIANT T-CELLS; EOSINOPHILIC CHRONIC RHINOSINUSITIS; TISSUE-REPAIR; IN-VIVO; DISEASE; INFLAMMATION; IL-4; ACTIVATION; MICROBIOTA; ENDOTYPES	Background: Diverse immune cells contribute to the pathogenesis of chronic rhinosinusitis (CRS), an inflammatory disease of the nasal cavity and paranasal sinuses. However, whether mucosal-associated invariant T (MALT) cells are present in human sinonasal tissues remains unclear. Furthermore, the characteristics of sinonasal MALT cells have not been studied in patients with CRS. Objective: We investigated the phenotype, function, and clinical implications of MAIT cells in patients with CRS. Methods: Peripheral blood and sinonasal tissue were obtained from patients with CRS with (CRSwNP) or without nasal polyps (CRSsNP) and healthy controls. MAIT cells were analyzed by flow cytometry. Results: We found that MAIT cells are present in human sinonasal tissues from healthy controls and patients with CRS. The sinonasal MAIT cell population, but not peripheral blood MAIT cells, from patients with CRSsNP, noneosinophilic CRSwNP (NE-NP), or eosinophilic CRSwNP (E-NP) had a significantly higher frequency of activated cells marked by CD38 expression. In functional analysis, the sinonasal MAIT cell population from NE-NP and E-NP had a significantly higher frequency of IL-17A(+) cells but lower frequency of IFN-gamma(+) or TNF+ cells than control sinonasal tissues. Furthermore, CD38 expression and IL-17A production by sinonasal MAIT cells significantly correlated with disease extent evaluated by the Lund-Mackay computed tomography score in patients with E-NP. Conclusions: Sinonasal MAIT cells exhibit an activated phenotype and produce higher levels of IL-17A in patients with CRSwNP. These alterations are associated with the extent of disease in patients with E-NP.	[Rha, Min-Seok; Koh, June-Young; Jung, Jae Hyung; Lee, Ha Seok; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Rha, Min-Seok] Yonsei Univ, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea; [Yoon, Young Hoon; Park, Soo Kyoung; Kim, Yong Min; Rha, Ki-Sang] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Res Inst Med Sci, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea; [Kim, Yong Min] Chungnam Natl Univ, Dept Med Sci, Sch Med, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Chungnam National University; Chungnam National University	Kim, YM; Rha, KS (corresponding author), Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Res Inst Med Sci, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Lab Immunol & Infect Dis, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	entkym@cnu.ac.kr; ksrha@cnu.ac.kr; ecshin@kaist.ac.kr	Park, Su-Hyung/N-3514-2014	Park, Su-Hyung/0000-0001-6363-7736; Rha, Min-Seok/0000-0003-1426-7534	National Research Foundation, Republic of Korea [NRF-2018M3A9D3079498]; Ministry of Science and ICT (MSIT)	National Research Foundation, Republic of Korea(National Research Foundation of Korea); Ministry of Science and ICT (MSIT)(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation, Republic of Korea, Grant (NRF-2018M3A9D3079498), which is funded by the Ministry of Science and ICT (MSIT).	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Bachert C, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00218-1; Bose S, 2016, J ALLER CL IMM-PRACT, V4, P584, DOI 10.1016/j.jaip.2016.04.008; Bottcher K, 2018, HEPATOLOGY, V68, P172, DOI 10.1002/hep.29782; Boulouis C, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000644; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Cardell LO, 2020, J ALLERGY CLIN IMMUN, V145, P752, DOI 10.1016/j.jaci.2020.01.019; Chalermwatanachai T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26327-2; Cho SH, 2016, J ALLER CL IMM-PRACT, V4, P575, DOI 10.1016/j.jaip.2016.04.015; Choi EB, 2014, ALLERGY, V69, P517, DOI 10.1111/all.12374; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Delemarre T, 2020, J ALLERGY CLIN IMMUN, V146, P337, DOI 10.1016/j.jaci.2020.04.040; Derycke L, 2012, J CYST FIBROS, V11, P193, DOI 10.1016/j.jcf.2011.11.007; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gibbs A, 2017, MUCOSAL IMMUNOL, V10, P35, DOI 10.1038/mi.2016.30; Godfrey DI, 2019, NAT IMMUNOL, V20, P1110, DOI 10.1038/s41590-019-0444-8; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Hamilos DL, 2015, J ALLERGY CLIN IMMUN, V136, P1454, DOI 10.1016/j.jaci.2015.10.011; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hinks TSC, 2019, CELL REP, V28, P3249, DOI 10.1016/j.celrep.2019.07.039; Hinks TSC, 2016, AM J RESP CRIT CARE, V194, P1208, DOI 10.1164/rccm.201601-0002OC; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Jiang XD, 2011, AM J RHINOL ALLERGY, V25, pE171, DOI 10.2500/ajra.2011.25.3645; Jo J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004210; Kato A, 2013, J ALLERGY CLIN IMMUN, V131, P933, DOI 10.1016/j.jaci.2013.02.023; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Lamichhane R, 2019, CELL REP, V28, P3061, DOI 10.1016/j.celrep.2019.08.054; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leng TQ, 2019, CELL REP, V28, P3077, DOI 10.1016/j.celrep.2019.08.050; Lezmi G, 2019, J ALLERGY CLIN IMMUN, V144, P1714, DOI 10.1016/j.jaci.2019.08.003; Lezmi G, 2018, CLIN IMMUNOL, V188, P7, DOI 10.1016/j.clim.2017.11.009; LUND VJ, 1995, ANN OTO RHINOL LARYN, V104, P17, DOI 10.1177/000348949510410s02; Ma J, 2016, CLIN EXP ALLERGY, V46, P1162, DOI 10.1111/cea.12758; MAGGI E, 1992, J IMMUNOL, V148, P2142; Makihara S, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.014; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Ono N, 2012, ALLERGY RHINOL, V3, pE50, DOI 10.2500/ar.2012.3.0030; Paramasivan S, 2020, ALLERGY, V75, P2037, DOI 10.1111/all.14276; Parrot T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe1670; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Provine NM, 2020, ANNU REV IMMUNOL, V38, P203, DOI 10.1146/annurev-immunol-080719-015428; Rha MS, 2020, J HEPATOL, V73, P640, DOI 10.1016/j.jhep.2020.03.033; Rha MS, 2020, J ALLERGY CLIN IMMUN, V145, P1378, DOI 10.1016/j.jaci.2019.12.915; Ryu W, 2020, ALLERGY ASTHMA IMMUN, V12, P507, DOI 10.4168/aair.2020.12.3.507; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Saitoh T, 2010, INT ARCH ALLERGY IMM, V151, P8, DOI 10.1159/000232566; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Shaler CR, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001930; Skapenko A, 2004, J IMMUNOL, V172, P6427, DOI 10.4049/jimmunol.172.10.6427; Sobkowiak MJ, 2019, EUR J IMMUNOL, V49, P133, DOI 10.1002/eji.201847759; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Teufelberger AR, 2019, TRENDS MOL MED, V25, P696, DOI 10.1016/j.molmed.2019.05.003; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Van Crombruggen K, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00742-2018; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Wallington JC, 2018, J ALLERGY CLIN IMMUN, V141, P2182, DOI 10.1016/j.jaci.2017.08.009; Wang M, 2019, J ALLERGY CLIN IMMUN, V144, P1254, DOI 10.1016/j.jaci.2019.06.023; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Ye LY, 2020, J ALLERGY CLIN IMMUN, V145, P1469, DOI 10.1016/j.jaci.2019.12.891; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	74	4	4	3	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					599	+		10.1016/j.jaci.2021.07.037	http://dx.doi.org/10.1016/j.jaci.2021.07.037			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34403659				2022-12-18	WOS:000752623200019
J	Rosenkranz, MA; Dean, DC; Bendlin, BB; Jarjour, NN; Esnault, S; Zetterberg, H; Heslegrave, A; Evans, MD; Davidson, RJ; Busse, WW				Rosenkranz, Melissa A.; Dean, Douglas C., III; Bendlin, Barbara B.; Jarjour, Nizar N.; Esnault, Stephane; Zetterberg, Henrik; Heslegrave, Amanda; Evans, Michael D.; Davidson, Richard J.; Busse, William W.			Neuroimaging and biomarker evidence of neurodegeneration in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; dementia; diffusion-weighted imaging; neurodegeneration; inflammation; GFAP; NfL	MILD COGNITIVE IMPAIRMENT; NEURITE ORIENTATION DISPERSION; FIBRILLARY ACIDIC PROTEIN; HELPER 17 CELLS; ALZHEIMERS-DISEASE; PERMUTATION INFERENCE; PARKINSONS-DISEASE; HIPPOCAMPAL VOLUME; RISK; DEMENTIA	Background: Epidemiologic studies have shown that Alzheimer's disease (AD) and related dementias (ADRD) are seen more frequently with asthma, especially with greater asthma severity or exacerbation frequency. Objective: To examine the changes in brain structure that may underlie this phenomenon, we examined diffusion-weighted magnetic resonance imaging (dMRI) and blood-based biomarkers of AD (phosphorylated tau 181, p-Tau181), neurodegeneration (neurofilament light chain, NIL), and glial activation (glial fibrillary acidic protein, GFAP). Methods: dMRI data were obtained in 111 individuals with asthma, ranging in disease severity from mild to severe, and 135 healthy controls. Regression analyses were used to test the relationships between asthma severity and neuroimaging measures, as well as AD pathology, neurodegeneration, and glial activation, indexed by plasma p-Tau181, NIL, and GFAP, respectively. Additional relationships were tested with cognitive function. Results: Asthma participants had widespread and large-magnitude differences in several dMRI metrics, which were indicative of neuroinflammation and neurodegeneration, and which were robustly associated with GFAP and, to a lesser extent, NfL. The AD biomarker p-Tau181 was only minimally associated with neuroimaging outcomes. Further, asthma severity was associated with deleterious changes in neuroimaging outcomes, which in turn were associated with slower processing speed, a test of cognitive performance. Conclusions: Asthma, particularly when severe, is associated with characteristics of neuroinflammation and neurodegeneration, and may be a potential risk factor for neural injury and cognitive dysfunction. There is a need to determine how asthma may affect brain health and whether treatment directed toward characteristics of asthma associated with these risks can mitigate these effects.	[Rosenkranz, Melissa A.; Davidson, Richard J.] Univ Wisconsin, Dept Psychiat, Madison, WI 53703 USA; [Rosenkranz, Melissa A.; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, 625 W Washington Ave, Madison, WI 53703 USA; [Dean, Douglas C., III] Univ Wisconsin, Dept Pediat, Madison, WI 53703 USA; [Dean, Douglas C., III] Univ Wisconsin, Dept Med Phys, Madison, WI 53703 USA; [Dean, Douglas C., III] Univ Wisconsin, Waisman Ctr, Madison, WI 53703 USA; [Bendlin, Barbara B.; Jarjour, Nizar N.; Esnault, Stephane; Busse, William W.] Univ Wisconsin, Dept Med, Madison, WI 53703 USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53703 USA; [Bendlin, Barbara B.] Wisconsin Alzheimers Dis Res Ctr, Sch Med & Publ Hlth, Madison, WI USA; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Gothenburg, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik; Heslegrave, Amanda] UK Dementia Res Inst UCL, London, England; [Evans, Michael D.] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities	Rosenkranz, MA (corresponding author), Univ Wisconsin, Ctr Hlth Minds, 625 W Washington Ave, Madison, WI 53703 USA.	melissa.rosenkranz@wisc.edu	Rosenkranz, Melissa/AFU-7196-2022; Esnault, Stephane/AAO-4712-2020	Rosenkranz, Melissa/0000-0001-8432-9011; Esnault, Stephane/0000-0001-7238-8671; Davidson, Richard/0000-0002-8506-4964	National Heart, Lung, and Blood Institute [R01 HL123284, U10HL109168]; National Center for Complementary and Integrative Health [P01 AT004952]; National Institute of Child Health and Human Development [U54 HD090256]; UK Dementia Research Institute	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Complementary and Integrative Health; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UK Dementia Research Institute	This work was supported by funding from the National Heart, Lung, and Blood Institute R01 HL123284 toW.W.B. and U10HL109168 to N.N.J.; from the National Center for Complementary and Integrative Health P01 AT004952 to R.J.D.; and by a core grant to theWaisman Center from the National Institute of Child Health and Human Development U54 HD090256. H.Z. and A.H. acknowledge funding from the UK Dementia Research Institute. H.Z. is a Wallenberg Scholar.	Abdelhak A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33158-8; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badji A, 2019, AGEING RES REV, V53, DOI 10.1016/j.arr.2019.05.001; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Benussi A, 2020, J ALZHEIMERS DIS, V77, P1129, DOI 10.3233/JAD-200608; Beurel E, 2013, BIOL PSYCHIAT, V73, P622, DOI 10.1016/j.biopsych.2012.09.021; Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7; Brown CA, 2018, CORTEX, V104, P58, DOI 10.1016/j.cortex.2018.04.006; Brown ES, 2008, BIOL PSYCHIAT, V63, P705, DOI 10.1016/j.biopsych.2007.09.014; Brown ES, 2004, BIOL PSYCHIAT, V55, P538, DOI 10.1016/j.biopsych.2003.09.010; Budisavljevic S, 2017, CEREB CORTEX, V27, P1532, DOI 10.1093/cercor/bhv348; Caballero MAA, 2018, BRAIN, V141, P3065, DOI 10.1093/brain/awy229; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Chen GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21825; Chen J, 2020, FRONT AGING NEUROSCI, V12, P1; Chen MH, 2014, J AM MED DIR ASSOC, V15, P763, DOI 10.1016/j.jamda.2014.06.003; Chou RC, 2016, CNS DRUGS, V30, P1111, DOI 10.1007/s40263-016-0374-z; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cipollini V, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00095; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Derogatis L.R., 1994, SCL90 R ADM SCORING, V3rd; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Gitelman DR, 2013, ARTHRITIS RHEUM-US, V65, P2190, DOI 10.1002/art.38009; Gorus E, 2008, J GERIATR PSYCH NEUR, V21, P204, DOI 10.1177/0891988708320973; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grinde B, 2021, INT J CLIN PHARM-NET, V43, P541, DOI 10.1007/s11096-020-01160-8; Guo RB, 2013, EXP NEUROL, V247, P209, DOI 10.1016/j.expneurol.2013.04.008; Hajek T, 2006, EUR PSYCHIAT, V21, P123, DOI 10.1016/j.eurpsy.2005.01.005; Halliday G, 2017, LANCET NEUROL, V16, P862, DOI 10.1016/S1474-4422(17)30343-5; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hoffmeyer F, 2009, CURR OPIN ALLERGY CL, V9, P16, DOI 10.1097/ACI.0b013e32831d8144; Jang H, 2017, NEUROREPORT, V28, P242, DOI 10.1097/WNR.0000000000000740; Janson C, 1996, EUR RESPIR J, V9, P2132, DOI 10.1183/09031936.96.09102132; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jiskoot LC, 2018, ANN CLIN TRANSL NEUR, V5, P1025, DOI 10.1002/acn3.601; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Karahan E, 2019, J NEUROSCI, V39, P5910, DOI 10.1523/JNEUROSCI.2954-18.2019; Keatings VM, 1997, J ALLERGY CLIN IMMUN, V99, P693, DOI 10.1016/S0091-6749(97)70032-0; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Khakh BS, 2019, ANNU REV NEUROSCI, V42, P187, DOI 10.1146/annurev-neuro-070918-050443; KOIZUMI A, 1995, CLIN EXP IMMUNOL, V101, P468; Kroll JL, 2018, NEUROIMAGE-CLIN, V19, P213, DOI 10.1016/j.nicl.2018.04.012; Lahiri DK, 2010, EXP GERONTOL, V45, P291, DOI 10.1016/j.exger.2010.01.001; Lai J, 2014, NEUROCHEM INT, V75, P26, DOI 10.1016/j.neuint.2014.05.006; Lai JE, 2014, NEUROPHARMACOLOGY, V79, P707, DOI 10.1016/j.neuropharm.2014.01.011; Lee ES, 2016, ALZ DIS ASSOC DIS, V30, P289, DOI 10.1097/WAD.0000000000000143; Liu Z, 2019, BRAIN BEHAV IMMUN, V81, P630, DOI 10.1016/j.bbi.2019.07.026; Lu HN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00624-8; Luciano R, 2015, PEDIATRICS, V135, P1074, DOI 10.1542/peds.2014-2391; Lutsey PL, 2019, AM J RESP CRIT CARE, V199, P1385, DOI 10.1164/rccm.201807-1220OC; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Mayo CD, 2017, NEUROIMAGE-CLIN, V13, P330, DOI 10.1016/j.nicl.2016.12.012; Naji N, 2014, INT ARCH ALLERGY IMM, V165, P27, DOI 10.1159/000367789; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Passamonti L, 2019, J NEUROSCI, V39, P7218, DOI 10.1523/JNEUROSCI.2574-18.2019; Peng YH, 2015, J EPIDEMIOL COMMUN H, V69, P123, DOI 10.1136/jech-2014-204445; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Phillips M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065712; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Ramakrishnan RK, 2019, EXPERT REV RESP MED, V13, P1057, DOI 10.1080/17476348.2019.1666002; Rook GAW, 2007, T ROY SOC TROP MED H, V101, P1072, DOI 10.1016/j.trstmh.2007.05.014; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Rosenkranz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040921; Rusanen M, 2013, CURR ALZHEIMER RES, V10, P549, DOI 10.2174/1567205011310050011; Seifan A, 2015, NEUROEPIDEMIOLOGY, V45, P237, DOI 10.1159/000439568; Silkoff PE, 2004, J ALLERGY CLIN IMMUN, V114, P1241, DOI 10.1016/j.jaci.2004.08.042; Silver M, 2018, NEUROPSYCHOPHARMACOL, V43, P1573, DOI 10.1038/s41386-018-0023-y; Sisco SM, 2016, CLIN NEUROPSYCHOL, V30, P1104, DOI 10.1080/13854046.2016.1188989; Sofroniew MV, 2020, TRENDS IMMUNOL, V41, P758, DOI 10.1016/j.it.2020.07.004; Steinmann M, 2015, EUR J PEDIATR, V174, P519, DOI 10.1007/s00431-014-2423-2; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Su W, 2012, CLIN NEUROL NEUROSUR, V114, P372, DOI 10.1016/j.clineuro.2011.11.002; Tattersall MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204708; Tu MC, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00268; Tu MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175143; Tuleta I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186820; US Department of Health and Human Services National Institutes of Health National Institute on Aging, 2015, 2014 2015 ALZH DIS P; US Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation, NAT PLAN ADDR ALZH D; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Watanabe M, 2019, NEUROLOGY, V93, pE1299, DOI 10.1212/WNL.0000000000008160; Winkler AM, 2016, NEUROIMAGE, V141, P502, DOI 10.1016/j.neuroimage.2016.05.068; Winkler AM, 2016, HUM BRAIN MAPP, V37, P1486, DOI 10.1002/hbm.23115; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woods CP, 2015, EUR J ENDOCRINOL, V173, P633, DOI 10.1530/EJE-15-0608; Xia MX, 2014, J NEUROIMMUNOL, V273, P53, DOI 10.1016/j.jneuroim.2014.06.005; Xing LY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00023; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yin RH, 2015, J ALZHEIMERS DIS, V47, P495, DOI 10.3233/JAD-150139; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhuang TT, 2018, BRAIN RES BULL, V143, P194, DOI 10.1016/j.brainresbull.2018.09.006	102	4	4	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					589	+		10.1016/j.jaci.2021.09.010	http://dx.doi.org/10.1016/j.jaci.2021.09.010			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34536414	Green Published			2022-12-18	WOS:000752623200018
J	Terhorst-Molawi, D; Hawro, T; Grekowitz, E; Kiefer, L; Metz, M; Alvarado, D; Hawthorne, T; Merchant, K; Crew, L; Crowley, E; Heath-Chiozzi, M; Maurer, M				Terhorst-Molawi, Dorothea; Hawro, Tomasz; Grekowitz, Eva; Kiefer, Lea; Metz, Martin; Alvarado, Diego; Hawthorne, Thomas; Merchant, Kunal; Crew, Linda; Crowley, Elizabeth; Heath-Chiozzi, Margo; Maurer, Marcus			The Anti-KIT Antibody, CDX-0159, Reduces Mast Cell Numbers and Circulating Tryptase and Improves Disease Control in Patients with Chronic Inducible Urticaria (Cindu)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									[Terhorst-Molawi, Dorothea; Hawro, Tomasz; Grekowitz, Eva; Kiefer, Lea; Metz, Martin; Maurer, Marcus] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, Dermatol Allergol, Berlin, Germany; [Alvarado, Diego; Hawthorne, Thomas; Merchant, Kunal; Crew, Linda; Crowley, Elizabeth; Heath-Chiozzi, Margo] Celldex Therapeut, Hampton, NJ USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin			Kiefer, Lea/GPX-2352-2022; Maurer, Marcus/ABG-2174-2020	Maurer, Marcus/0000-0002-4121-481X					0	4	4	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2		S		534	AB178	AB178						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0H8SE					2022-12-18	WOS:000778999300532
J	Tsoi, LC; Patrick, MT; Shuai, S; Sarkar, MK; Chi, SY; Ruffino, B; Billi, AC; Xing, XY; Uppala, R; Zang, C; Fullmer, J; He, Z; Maverakis, E; Mehta, NN; White, BEP; Getsios, S; Helfrich, Y; Voorhees, JJ; Kahlenberg, JM; Weidinger, S; Gudjonsson, JE				Tsoi, Lam C.; Patrick, Matthew T.; Shuai, Shao; Sarkar, Mrinal K.; Chi, Sunyi; Ruffino, Bethany; Billi, Allison C.; Xing, Xianying; Uppala, Ranjitha; Zang, Cheng; Fullmer, Joseph; He, Zhi; Maverakis, Emanual; Mehta, Nehal N.; White, Bethany E. Perez; Getsios, Spiro; Helfrich, Yolanda; Voorhees, John J.; Kahlenberg, J. Michelle; Weidinger, Stephan; Gudjonsson, Johann E.			Cytokine responses in nonlesional psoriatic skin as clinical predictor to anti-TNF agents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Psoriasis; etanercept; cytokine response; PASI; drug response prediction	PERSONALIZED MEDICINE; BIOLOGIC THERAPIES; UNINVOLVED SKIN; IFN-GAMMA; ETANERCEPT; ALPHA; SAFETY; EXPRESSION; EFFICACY; DISEASE	Background: A major issue with the current management of psoriasis is our inability to predict treatment response. Objective: Our aim was to evaluate the ability to use baseline molecular expression profiling to assess treatment outcome for patients with psoriasis. Methods: We conducted a longitudinal study of 46 patients with chronic plaque psoriasis treated with anti-TNF agent etanercept, and molecular profiles were assessed in more than 200 RNA-seq samples. Results: We demonstrated correlation between clinical response and molecular changes during the course of the treatment, particularly for genes responding to IL-17A/TNF in keratinocytes. Intriguingly, baseline gene expressions in nonlesional, but not lesional, skin were the best marker of treatment response at week 12. We identified USP18, a known regulator of IFN responses, as positively correlated with Psoriasis Area and Severity Index (PASI) improvement (P = 9.8 X 10(-4)) and demonstrate its role in regulating IFN/TNF responses in keratinocytes. Consistently, cytokine gene signatures enriched in baseline nonlesional skin expression profiles had strong correlations with PASI improvement. Using this information, we developed a statistical model for predicting PASI75 (ie, 75% of PASI improvement) at week 12, achieving area under the receiver-operating characteristic curve value of 0.75 and up to 80% accurate PASI75 prediction among the top predicted responders. Conclusions: Our results illustrate feasibility of assessing drug response in psoriasis using nonlesional skin and implicate involvement of IFN regulators in anti-TNF responses.	[Tsoi, Lam C.; Patrick, Matthew T.; Shuai, Shao; Sarkar, Mrinal K.; Chi, Sunyi; Ruffino, Bethany; Billi, Allison C.; Xing, Xianying; Uppala, Ranjitha; Zang, Cheng; Fullmer, Joseph; Helfrich, Yolanda; Voorhees, John J.; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Tsoi, Lam C.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.; Chi, Sunyi; He, Zhi] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Shuai, Shao] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian, Shaanxi, Peoples R China; [Maverakis, Emanual] UC Davis Med Ctr, Sch Med, Dept Dermatol, Sacramento, CA USA; [Mehta, Nehal N.] NHLBI, Sect Inflammat & Cardiometab Dis, NIH, Bldg 10, Bethesda, MD 20892 USA; [White, Bethany E. Perez; Getsios, Spiro] Northwestern Univ, Dept Dermatol, Chicago, IL USA; [Kahlenberg, J. Michelle] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Campus Kiel, Kiel, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Air Force Military Medical University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwestern University; University of Michigan System; University of Michigan; University of Kiel; Schleswig Holstein University Hospital	Tsoi, LC; Gudjonsson, JE (corresponding author), Med Sci 1,1301 E Catherine St, Ann Ann, MI 48109 USA.	alextso@umich.edu; johanng@med.umich.edu	Chi, Sunyi/GXV-3605-2022	Tsoi, Lam Cheung/0000-0003-1627-5722; Helfrich, Yolanda/0000-0003-4957-3910; Chi, Sunyi/0000-0003-4112-2074; Sarkar, Mrinal/0000-0001-8505-4259	Amgen; Babcock Endowment Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR060802, P30-AR075043, AR072129]; National Institute of Allergy and Infectious Diseases [R01-AR069071]; A. Alfred Taubman Medical Research Institute; Taubman Medical Institute; Dermatology Foundation; Arthritis National Research Foundation; National Psoriasis Foundation Psoriasis Prevention Initiative	Amgen(Amgen); Babcock Endowment Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); A. Alfred Taubman Medical Research Institute; Taubman Medical Institute; Dermatology Foundation; Arthritis National Research Foundation(National Research Foundation of Korea); National Psoriasis Foundation Psoriasis Prevention Initiative	This work was supported by Amgen. L.C.T., M.K.S., and J.E.G. were supported by the Babcock Endowment Fund. The study also received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant nos. R01-AR060802 and P30-AR075043 to J.E.G. and grant no. AR072129 to L.C.T.), the National Institute of Allergy and Infectious Diseases (award no. R01-AR069071 to J.E.G.), the A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award (to J.E.G.), Taubman Medical Institute (J.E.G., J.M.K., and L.C.T.), the Dermatology Foundation (L.C.T.), the Arthritis National Research Foundation (L.C.T.), and the National Psoriasis Foundation Psoriasis Prevention Initiative (L.C.T., J.E.G., E.M., and J.M.K.).	Albanesi C, 1999, J IMMUNOL, V162, P494; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Arimoto K, 2017, NAT STRUCT MOL BIOL, V24, P279, DOI 10.1038/nsmb.3378; Aziz MA, 2017, CRIT REV ONCOL HEMAT, V118, P70, DOI 10.1016/j.critrevonc.2017.08.007; Blauvelt A, 2019, J EUR ACAD DERMATOL, V33, P546, DOI 10.1111/jdv.15258; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caldarola G, 2009, INT J IMMUNOPATH PH, V22, P961, DOI 10.1177/039463200902200411; Chan CWH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112423; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Conrad C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02466-4; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowlatshahi EA, 2013, BRIT J DERMATOL, V169, P266, DOI 10.1111/bjd.12355; Flamant M, 2018, THER ADV GASTROENTER, V11, P1, DOI 10.1177/1756283X17745029; Foulkes AC, 2017, BRIT J DERMATOL, V177, P344, DOI 10.1111/bjd.15691; Gisondi P, 2007, AUTOIMMUN REV, V6, P515, DOI 10.1016/j.autrev.2006.12.002; Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Horton I, 2017, J PERS MED, V7, DOI 10.3390/jpm7030007; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johnston A, 2014, BRIT J DERMATOL, V171, P97, DOI 10.1111/bjd.12937; Kaushik SB, 2019, J AM ACAD DERMATOL, V80, P27, DOI 10.1016/j.jaad.2018.06.057; Kaushik SB, 2019, J AM ACAD DERMATOL, V80, P43, DOI 10.1016/j.jaad.2018.06.056; Kavanaugh A, 2009, ARTHRITIS RHEUM-US, V60, P976, DOI 10.1002/art.24403; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kim-Hellmuth S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00366-1; Kivelevitch D, 2014, BIOL-TARGETS THER, V8, P169, DOI 10.2147/BTT.S41481; Klijn SL, 2018, BRIT J DERMATOL, V178, P1181, DOI 10.1111/bjd.16247; KRUEGER GG, 1981, J CLIN INVEST, V68, P1548, DOI 10.1172/JCI110409; Krueger GG, 2006, J AM ACAD DERMATOL, V54, pS112, DOI 10.1016/j.jaad.2005.10.054; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Le ST, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00589; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Loos AM, 2018, J AM ACAD DERMATOL, V79, P135, DOI 10.1016/j.jaad.2018.02.027; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Merleev AA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120682; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Noe MH, 2019, J DRUGS DERMATOL, V18, P745; Paller AS, 2010, J AM ACAD DERMATOL, V63, P762, DOI 10.1016/j.jaad.2010.04.004; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Sarkar MK, 2018, ANN RHEUM DIS, V77, P1653, DOI 10.1136/annrheumdis-2018-213197; Shaabani N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau2125; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034594; Tavakolpour S, 2017, IMMUNOL LETT, V190, P130, DOI 10.1016/j.imlet.2017.08.002; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Toh S, 2012, PHARMACOEPIDEM DR S, V21, P524, DOI 10.1002/pds.3238; Tsoi LC, 2020, J ALLERGY CLIN IMMUN, V145, P1406, DOI 10.1016/j.jaci.2019.11.047; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Tsoi LC, 2018, J ALLERGY CLIN IMMUN, V141, P805, DOI 10.1016/j.jaci.2017.07.054; Tsoi LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15382; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Tyring S, 2007, ARCH DERMATOL, V143, P719, DOI 10.1001/archderm.143.6.719; Vide J, 2017, AN BRAS DERMATOL, V92, P667, DOI 10.1590/abd1806-4841.20175603; Wu JJ, 2018, J DERMATOL TREAT, V29, P769, DOI 10.1080/09546634.2018.1466022; Ye L, 2014, J INVEST DERMATOL, V134, P2843, DOI 10.1038/jid.2014.205; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046	64	4	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					640	+		10.1016/j.jaci.2021.07.024	http://dx.doi.org/10.1016/j.jaci.2021.07.024			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34343561				2022-12-18	WOS:000752623200022
J	Benito-Villalvilla, C; Perez-Diego, M; Angelina, A; Kisand, K; Rebane, A; Subiza, JL; Palomares, O				Benito-Villalvilla, Cristina; Perez-Diego, Mario; Angelina, Alba; Kisand, Kai; Rebane, Ana; Luis Subiza, Jose; Palomares, Oscar			Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen-specific immunotherapy; allergoid-mannan conjugates; monocytes; tolerogenic dendritic cells; regulatory T cells; metabolism; epigenetics	REGULATORY T-CELLS; IMMUNOTHERAPY; DEXAMETHASONE; VITAMIN-D-3; MECHANISMS; INDUCTION; TOLERANCE; PATHWAYS; DELIVERY; STATE	Background: Allergoid-mannan conjugates are novel vaccines for allergen-specific immunotherapy being currently assayed in phase 2 clinical trials. Allergoid-mannan conjugates target dendritic cells (DCs) and generate functional forkhead box P3 (FOXP3)-positive Treg cells, but their capacity to reprogram monocyte differentiation remains unknown. Objective: We studied whether allergoid-mannan conjugates could reprogram monocyte differentiation into tolerogenic DCs and the underlying molecular mechanisms. Methods: Monocytes from nonatopic and allergic subjects were differentiated into DCs under conventional protocols in the absence or presence of allergoid-mannan conjugates. ELISA, real-time quantitative PCR, coculture, flow cytometry, and suppression assay were performed. Metabolic and epigenetic techniques were also used. Results: Monocyte differentiation from nonatopic and allergic subjects into DCs in the presence of allergoid-mannan conjugates yields stable tolerogenic DCs. Lipopolysaccharid-estimulated mannan-tolDCs show a significantly lower cytokine production, lower TNF-alpha/IL-10 ratio, and higher expression of the tolerogenic molecules PDL1, IDO, SOCS1, SOCS3, and IL10; and they induce higher numbers of functional FOXP3(+) Treg cells than conventional DC counterparts. Mannan-tolDCs shift glucose metabolism from Warburg effect and lactate production to mitochondrial oxidative phosphorylation. They also display epigenetic reprogramming involving specific histone marks within tolerogenic loci and lower expression levels of histone deacetylase genes. Mannan-tolDCs significantly increase the expression of the anti-inflammatory miRNA-146a/b and decrease proinflammatory miRNA-155. Conclusions: Allergoid-mannan conjugates reprogram monocyte differentiation into stable tolerogenic DCs via epigenetic and metabolic reprogramming. Our findings shed light on the novel mechanisms by which allergoid-mannan conjugates might contribute to allergen tolerance induction during allergen-specific immunotherapy.	[Benito-Villalvilla, Cristina; Perez-Diego, Mario; Angelina, Alba; Palomares, Oscar] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Madrid, Spain; [Kisand, Kai; Rebane, Ana] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Luis Subiza, Jose] Inmunotek, Madrid, Spain	Complutense University of Madrid; University of Tartu	Palomares, O (corresponding author), Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Ave Complutense S-N, Madrid 28040, Spain.	oscar.palomares@quim.ucm.es	Rebane, Ana/D-4279-2013	Rebane, Ana/0000-0001-6051-1361; Perez-Diego, Mario/0000-0002-9787-8922; Benito-Villalvilla, Cristina/0000-0002-5544-0199; Angelina, Alba/0000-0001-5282-9767	MINECO, Spain [SAF-2017-84978-R]; CDTI [IDI-20110410, IDI-20141131]; MINECO; FPU fellowship from MINECO; FPI fellowship from MINECO [SAF-2017-84978-R]; European Union through the European Regional Development Fund [2014-2020.4.01.15-0012]; Estonian Research Council grant [PRG1117]	MINECO, Spain(Spanish Government); CDTI; MINECO(Spanish Government); FPU fellowship from MINECO; FPI fellowship from MINECO(Spanish Government); European Union through the European Regional Development Fund(European Commission); Estonian Research Council grant(Estonian Research Council)	This work was supported by grants SAF-2017-84978-R to O.P. from MINECO, Spain, and by grants IDI-20110410 and IDI-20141131 to Inmunotek SL from CDTI and MINECO. C.B.-V. and M.P.-D. are recipients of FPU and FPI fellowships (SAF-2017-84978-R) , respectively, from MINECO. A.R. is funded by European Union through the European Regional Development Fund (Project no. 2014-2020.4.01.15-0012) and K.K. by Estonian Research Council grant PRG1117.	Ahad A, 2019, ISCIENCE, V19, P996, DOI 10.1016/j.isci.2019.08.024; Alvaro-Lozano M, 2020, PEDIAT ALLERG IMM-UK, V31, P1, DOI 10.1111/pai.13189; Anderson AE, 2017, CLIN EXP IMMUNOL, V187, P113, DOI 10.1111/cei.12870; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Bacher P, 2018, J ALLERGY CLIN IMMUN, V142, P1697, DOI 10.1016/j.jaci.2018.10.016; Benito-Villalvilla C, 2020, ALLERGY, V75, P648, DOI 10.1111/all.14036; Benito-Villalvilla C, 2018, ALLERGO J, V27, P34, DOI 10.1007/s40629-018-0069-8; Boonpiyathad T, 2020, ASIAN PAC J ALLERGY, V38, P139, DOI 10.12932/AP-030220-0754; Boonpiyathad T, 2019, SEMIN IMMUNOL, V44, DOI 10.1016/j.smim.2019.101326; Carreras-Badosa G, 2020, BIOMATERIALS, V262, DOI 10.1016/j.biomaterials.2020.120316; Cauwels A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00674; de Roock S, 2011, J ALLERGY CLIN IMMUN, V128, P1369, DOI 10.1016/j.jaci.2011.08.006; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Eljaszewicz A, 2021, J ALLERGY CLIN IMMUN, V147, P1865, DOI 10.1016/j.jaci.2020.08.042; Ferreira GB, 2012, J PROTEOME RES, V11, P941, DOI 10.1021/pr200724e; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frikeche J, 2012, EXP HEMATOL, V40, P783, DOI 10.1016/j.exphem.2012.06.008; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gonzalez JL, 2018, VET DERMATOL, V29, P449, DOI 10.1111/vde.12679; Hossenbaccus L, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-00436-y; Jensen-Jarolim E, 2020, ALLERGY, V75, P746, DOI 10.1111/all.14134; Knisz J, 2007, J ALLERGY CLIN IMMUN, V119, P739, DOI 10.1016/j.jaci.2006.12.620; Komlosi ZI, 2020, IMMUNOL ALLERGY CLIN, V40, P15, DOI 10.1016/j.iac.2019.09.010; Lee JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15569-1; Lopez-Abente J, 2021, EUR RESPIR J, P57; Mahler V, 2019, J ALLERGY CLIN IMMUN, V143, P813, DOI 10.1016/j.jaci.2019.01.024; Malinarich F, 2015, J IMMUNOL, V194, P5174, DOI 10.4049/jimmunol.1303316; Manzano AI, 2016, GLYCOCONJUGATE J, V33, P93, DOI 10.1007/s10719-015-9640-4; Mitchell LA, 2012, J IMMUNOL, V189, P5612, DOI 10.4049/jimmunol.1202151; Montagner S, 2013, IMMUNOL REV, V253, P12, DOI 10.1111/imr.12042; Morante-Palacios O, 2021, TRENDS IMMUNOL, V42, P59, DOI 10.1016/j.it.2020.11.001; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nijhuis L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00151; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Palomares O, 2017, IMMUNOL REV, V278, P219, DOI 10.1111/imr.12555; Pfaar O, 2019, ALLERGY, V74, P3, DOI 10.1111/all.14077; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Royce SG, 2012, J ASTHMA, V49, P121, DOI 10.3109/02770903.2011.648298; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Sim WJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/2636701; Sirvent S, 2016, J ALLERGY CLIN IMMUN, V138, P558, DOI 10.1016/j.jaci.2016.02.029; Soria I, 2018, ALLERGY, V73, P875, DOI 10.1111/all.13396; Steelant B, 2019, J ALLERGY CLIN IMMUN, V144, P1242, DOI 10.1016/j.jaci.2019.04.027; Suarez-Alvarez B, 2013, EPIGENETICS-US, V8, P694, DOI 10.4161/epi.25201; Svajger U, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106275; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Wan XL, 2019, BLOOD ADV, V3, P644, DOI 10.1182/bloodadvances.2018022756; Wang J, 2019, EUR REV MED PHARMACO, V23, P5168, DOI 10.26355/eurrev_201906_18181	50	4	4	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					212	+		10.1016/j.jaci.2021.06.012	http://dx.doi.org/10.1016/j.jaci.2021.06.012			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34153371	hybrid, Green Accepted			2022-12-18	WOS:000741453800004
J	Duraisamy, K; Singh, K; Kumar, M; Lefranc, B; Bonnafe, E; Treilhou, M; Leprince, J; Chow, BKC				Duraisamy, Karthi; Singh, Kailash; Kumar, Mukesh; Lefranc, Benjamin; Bonnafe, Elsa; Treilhou, Michel; Leprince, Jerome; Chow, Billy K. C.			P17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell-line activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cell activation; innate immunity; immune modulation; MRGPRX2; mast cells; monocytes; human-monocyte-derived macrophages (h-MDMs); monocyte recruitment; chemotaxis; cytokine release	PROTEIN-COUPLED RECEPTOR; ANTIMICROBIAL PEPTIDE LL-37; CHEMOATTRACTANT PROTEIN-1; CATHELICIDIN LL-37; HOST-DEFENSE; ANT VENOM; C-BETA; MRGPRX2; MACROPHAGES; GPCR	Background: P17, a peptide isolated from Tetramorium bicarinatum ant venom, is known to induce an alternative phenotype of human monocyte-derived macrophages via activation of an unknown G protein-coupled receptor (GPCR). Objective: We sought to investigate the mechanism of action and the immunomodulatory effects of P17 mediated through MRGPRX2 (Mas-related G protein-coupled receptor X2). Methods: To identify the GPCR for P17, we screened 314 GPCRs. Upon identification of MRGPRX2, a battery of in silico, in vitro, ex vivo, and in vivo assays along with the receptor mutation studies were performed. In particular, to investigate the immunomodulatory actions, we used beta-hexosaminidase release assay, cytokine releases, quantification of mRNA expression, cell migration and differentiation assays, immunohistochemical labeling, hematoxylin and eosin, and immunofluorescence staining. Results: P17 activated MRGPRX2 in a dose-dependent manner in beta-arrestin recruitment assay. In LAD2 cells, P17 induced calcium and beta-hexosaminidase release. Quercetin- and short hairpin RNA-mediated knockdown of MRGPRX2 reduced P17-evoked beta-hexosaminidase release. In silico and in vitro mutagenesis studies showed that residue Lys(8) of P17 formed a cation-pi interaction with the Phe(172) of MRGPRX2 and [Ala(8)] P17 lost its activity partially. P17 activated LAD2 cells to recruit THP-1 and human monocytes in Transwell migration assay, whereas MRGPRX2-impaired LAD2 cells cannot. In addition, P17-treated LAD2 cells stimulated differentiation of THP-1 and human monocytes, as indicated by the enhanced expression of macrophage markers cluster of differentiation 11b and TNF-alpha by quantitative RT-PCR. Immunohistochemical and immunofluorescent staining suggested monocyte recruitment in mice ears injected with P17. Conclusions: Our data provide novel structural information regarding the interaction of P17 with MRGPRX2 and intracellular pathways for its immunomodulatory action.	[Duraisamy, Karthi; Singh, Kailash; Kumar, Mukesh; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China; [Lefranc, Benjamin; Leprince, Jerome] Normandy Univ, IRIB, PRIMACEN, INSERM,U1239, Rouen, France; [Bonnafe, Elsa; Treilhou, Michel] Univ Fed Toulouse Midi Pyrenees, INU Champoll, EA7417,BTSB, Albi, France	University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China.; Leprince, J (corresponding author), INSERM, U1239, Rouen, France.	jerome.leprince@univ-rouen.fr; bkcc@hku.hk	Kumar, Mukesh/AGY-9400-2022	Kumar, Mukesh/0000-0001-8580-9332; Duraisamy, Karthi/0000-0001-5994-7133; Lefranc, Benjamin/0000-0002-0367-2414; Bonnafe, Elsa/0000-0002-2630-4876; Chow, Billy, KC/0000-0003-3390-0307; Leprince, Jerome/0000-0002-7814-9927	HK government Research Grants Council (RGC) grant [GRF 1711320, 17111421]; National Natural Science Foundation of China/RGC; University of Hong Kong seed fund for basic research [201910159222]; Institut National de la Sante et de la Recherche Medicale (Inserm); Normandy University (Rouen); Region Normandy; European Union (PHEDERCPG project); European Regional Development Fund; European Union (3R project)	HK government Research Grants Council (RGC) grant; National Natural Science Foundation of China/RGC(National Natural Science Foundation of China (NSFC)); University of Hong Kong seed fund for basic research; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Normandy University (Rouen); Region Normandy; European Union (PHEDERCPG project); European Regional Development Fund(European Commission); European Union (3R project)	This work was supported by the HK government Research Grants Council (RGC) grant (nos. GRF 1711320 and 17111421) , National Natural Science Foundation of China/RGC, and University of Hong Kong seed fund for basic research (grant no. 201910159222 to B.K.C.C.) ; Institut National de la Sante?et de la Recherche Me?dicale (Inserm) , the Normandy University (Rouen) , the Region Normandy, the European Union (PHEDERCPG and 3R projects) , and Europe gets involved in Normandy with European Regional Development Fund to J.L.	Agier J, 2015, CENT EUR J IMMUNOL, V40, P225, DOI 10.5114/ceji.2015.51359; Alkanfari I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040311; Alkanfari I, 2018, J IMMUNOL, V201, P343, DOI 10.4049/jimmunol.1701793; Almeida CR, 2016, STEM CELL REP, V6, P466, DOI 10.1016/j.stemcr.2016.02.012; Arifuzzaman M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0216; Ayudhya CCN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215247; Babina M., 2020, ITCH, V5, DOI [DOI 10.1097/ITX.0000000000000032, 10.1097/itx.0000000000000032]; Bader M, 2014, PHARMACOL REV, V66, P1080, DOI 10.1124/pr.113.008136; Bai J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222005; Basith S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00128; Benmoussa K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01650; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; Brinkman DJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070670; Campbell EM, 1999, J IMMUNOL, V163, P2160; Cardoso FC, 2020, BIOCHEM PHARMACOL, V181, DOI 10.1016/j.bcp.2020.114107; Carstens E, 2014, FRONT NEUROSCI, P1, DOI 10.1201/b16573; Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263; Che T, 2018, CELL, V172, P55, DOI 10.1016/j.cell.2017.12.011; Chen RF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-340; Ayudhya CCN, 2020, J DENT RES, V99, P882, DOI 10.1177/0022034520919107; Ciancetta A, 2015, TRENDS PHARMACOL SCI, V36, P878, DOI 10.1016/j.tips.2015.08.006; Ciemny M, 2018, DRUG DISCOV TODAY, V23, P1530, DOI 10.1016/j.drudis.2018.05.006; Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Danella Polli C, 2013, ISRN INFLAMM, V2013; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Deuis JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40883; Devine DA, 2004, MAMMALIAN HOST DEFEN; Diharce J, 2019, MOLECULES, V24, DOI 10.3390/molecules24071351; Ding J, 2009, METALLOMICS, V1, P471, DOI 10.1039/b913265a; Ding YY, 2019, INT IMMUNOPHARMACOL, V66, P185, DOI 10.1016/j.intimp.2018.11.025; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Eustache S, 2016, EXPERT OPIN DRUG DIS, V11, P771, DOI 10.1080/17460441.2016.1201058; Ferry X, 2002, PEPTIDES, V23, P1507, DOI 10.1016/S0196-9781(02)00090-6; Ferry X, 2001, J IMMUNOL, V167, P4805, DOI 10.4049/jimmunol.167.9.4805; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Golden DBK, 2007, IMMUNOL ALLERGY CLIN, V27, P261, DOI 10.1016/j.iac.2007.03.008; Gonzalez-Rey E, 2006, P NATL ACAD SCI USA, V103, P4228, DOI 10.1073/pnas.0508997103; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Gruber CW, 2010, CURR PHARM DESIGN, V16, P3071; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gupta K, 2015, ONCOTARGET, V6, P28573, DOI 10.18632/oncotarget.5611; Gupta Shiva, 2018, J Oral Maxillofac Pathol, V22, P239, DOI 10.4103/jomfp.JOMFP_113_16; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Penney EHJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00156; Jiang JH, 2018, PHARMACOL REP, V70, P355, DOI 10.1016/j.pharep.2017.09.004; Kapellos TS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02035; Karhu T, 2017, BBA-GEN SUBJECTS, V1861, P2530, DOI 10.1016/j.bbagen.2017.08.013; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kim Hwan Soo, 2020, F1000Res, V9, DOI 10.12688/f1000research.22037.1; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kumar M, 2020, MOLECULES, V25, DOI 10.3390/molecules25051028; Lafleur MA, 2020, J IMMUNOTOXICOL, V17, P110, DOI 10.1080/1547691X.2020.1757793; Lai NY, 2017, J INTERN MED, V282, P5, DOI 10.1111/joim.12591; Lang HN, 2016, MOL THER, V24, P2000, DOI 10.1038/mt.2016.174; Lansu K, 2017, NAT CHEM BIOL, V13, P529, DOI [10.1038/NCHEMBIO.2334, 10.1038/nchembio.2334]; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Liu R, 2017, BIOCHEM PHARMACOL, V146, P214, DOI 10.1016/j.bcp.2017.09.017; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu L, 2017, J LEUKOCYTE BIOL, V102, P237, DOI 10.1189/jlb.3RU1216-539R; Lukic A, 2017, FASEB J, V31, P4370, DOI 10.1096/fj.201700319R; Lupala CS, 2018, J BIOMOL STRUCT DYN, V36, P2436, DOI 10.1080/07391102.2017.1357503; Mak SOK, 2019, FASEB J, V33, P5389, DOI 10.1096/fj.201801732RR; MAX SI, 1993, J NEUROSCI, V13, P4293; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meital LT, 2019, J IMMUNOL METHODS, V472, P75, DOI 10.1016/j.jim.2019.04.005; Mencarelli A, 2020, J LEUKOCYTE BIOL, V107, P797, DOI 10.1002/JLB.3MA1219-210RR; Mendel HC, 2020, BIOCHEM PHARMACOL, V181, DOI 10.1016/j.bcp.2020.114129; Mortari MR, 2007, BRIT J PHARMACOL, V151, P860, DOI 10.1038/sj.bjp.0707275; Muratspahic E, 2019, TRENDS PHARMACOL SCI, V40, P309, DOI 10.1016/j.tips.2019.03.004; Muto Y, 2014, J INVEST DERMATOL, V134, P2728, DOI 10.1038/jid.2014.222; Negus SS, 2006, BIOCHEM PHARMACOL, V71, P1663, DOI 10.1016/j.bcp.2005.12.038; Neveu C, 2014, BRIT J PHARMACOL, V171, P4425, DOI 10.1111/bph.12808; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39; On JSW, 2015, MOL BIOL EVOL, V32, P2048, DOI 10.1093/molbev/msv087; Ong SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01761; Ou YQ, 2009, ACTA PHARMACOL SIN, V30, P435, DOI 10.1038/aps.2009.21; Palgan K, 2015, INT J IMMUNOPATH PH, V28, P119, DOI 10.1177/0394632015572566; Paulsen K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538786; Pennington MW, 2018, BIOORGAN MED CHEM, V26, P2738, DOI 10.1016/j.bmc.2017.09.029; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Porebski G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03027; Reddy VB, 2017, J ALLERGY CLIN IMMUN, V140, P1726, DOI 10.1016/j.jaci.2017.05.046; Reinholz M, 2012, ANN DERMATOL, V24, P126, DOI 10.5021/ad.2012.24.2.126; Rifflet A, 2012, PEPTIDES, V38, P363, DOI 10.1016/j.peptides.2012.08.018; Robas N, 2003, J BIOL CHEM, V278, P44400, DOI 10.1074/jbc.M302456200; Ruytinx P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01930; RYAN KC, 1994, J WILDERNESS MED, V5, P263, DOI 10.1580/0953-9859-5.3.263; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149359; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Starr T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193601; Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Tatemoto K, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12655; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Tene N, 2016, PEPTIDES, V79, P103, DOI 10.1016/j.peptides.2016.04.001; Tene N, 2014, FOOD CONTROL, V42, P202, DOI 10.1016/j.foodcont.2014.02.026; Thapaliya M, 2021, CURR ALLERGY ASTHM R, V21, DOI 10.1007/s11882-020-00979-5; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305; Touchard A, 2020, J PROTEOME RES, V19, P1800, DOI 10.1021/acs.jproteome.0c00048; Touchard A, 2018, J PROTEOME RES, V17, P3503, DOI 10.1021/acs.jproteome.8b00452; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Varricchi G, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00299; Vianello E, 2016, NUTR METAB CARDIOVAS, V26, P246, DOI 10.1016/j.numecd.2015.12.005; Vujicic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24706-3; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Waddell LA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02246; Wang G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01388; Yamada K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020112; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yu YY, 2017, INT IMMUNOPHARMACOL, V49, P6, DOI 10.1016/j.intimp.2017.05.016; Zamani F, 2013, ADV PHARM BULL, V3, P329, DOI 10.5681/apb.2013.053; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang T, 2017, EUR J IMMUNOL, V47, P1949, DOI 10.1002/eji.201746951; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551; Zhu YJ, 2017, INT J MOL MED, V40, P281, DOI 10.3892/ijmm.2017.3022	129	4	4	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					275	291		10.1016/j.jaci.2021.04.040	http://dx.doi.org/10.1016/j.jaci.2021.04.040			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34111449	hybrid			2022-12-18	WOS:000741453800009
J	Gauthier, M; Kale, SL; Oriss, TB; Scholl, K; Das, S; Yuan, HJ; Hu, SM; Chen, J; Camiolo, M; Ray, P; Wenzel, S; Ray, A				Gauthier, Marc; Kale, Sagar Laxman; Oriss, Timothy B.; Scholl, Kathryn; Das, Sudipta; Yuan, Huijuan; Hu, Sanmei; Chen, Jie; Camiolo, Matthew; Ray, Prabir; Wenzel, Sally; Ray, Anuradha			Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CXCR3; CXCL9; CXCL10; CCL5; CCR5; IFN-gamma; severe asthma; maraviroc	GAMMA-INDUCIBLE PROTEIN-10; IFN-GAMMA; AIRWAY HYPERRESPONSIVENESS; CHEMOKINE RECEPTORS; MOUSE MODEL; MAST-CELL; T-CELLS; EXPRESSION; AXIS	Background: Many patients with severe asthma (SA) fail to respond to type 2 inflammation-targeted therapies. We previously identified a cohort of subjects with SA expressing type 1 inflammation manifesting with IFN-gamma expression and variable type 2 responses. Objective: We investigated the role of the chemotactic receptors C-X-C chemokine receptor 3 (CXCR3) and C-C chemokine receptor 5 (CCR5) in establishing type 1 inflammation in SA. Methods: Bronchoalveolar lavage microarray data from the Severe Asthma Research Program I/II were analyzed for pathway expression and paired with clinical parameters. Wild-type, Cxcr3(-/-) and Ccr5(-/-) mice were exposed to a type 1-high SA model with analysis of whole lung gene expression and histology. Wild-type and Cxcr3(-/-) mice were treated with a US Food and Drug Administration-approved CCR5 inhibitor (maraviroc) with assessment of airway resistance, inflammatory cell recruitment by flow cytometry, whole lung gene expression, and histology. Results: A cohort of subjects with increased IFN-gamma expression showed higher asthma severity. IFN-gamma expression was correlated with CXCR3 and CCR5 expression, but in Cxcr3(-/- )and Ccr5(-/-) mice type 1 inflammation was preserved in a murine SA model, most likely owing to compensation by the other pathway. Incorporation of maraviroc into the experimental model blunted airway hyperreactivity despite only mild effects on lung inflammation. Conclusions: IFNG expression in asthmatic airways was strongly correlated with expression of both the chemokine receptors CXCR3 and CCR5. Although these pathways provide redundancy for establishing type 1 lung inflammation, inhibition of the CCL5/CCR5 pathway with maraviroc provided unique benefits in reducing airway hyperreactivity. Targeting this pathway may be a novel approach for improving lung function in individuals with type 1-high asthma.	[Gauthier, Marc; Kale, Sagar Laxman; Oriss, Timothy B.; Scholl, Kathryn; Das, Sudipta; Yuan, Huijuan; Hu, Sanmei; Chen, Jie; Camiolo, Matthew; Ray, Prabir; Wenzel, Sally; Ray, Anuradha] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Oriss, Timothy B.; Ray, Prabir; Ray, Anuradha] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Wenzel, Sally] Univ Pittsburgh, Sch Environm & Occupat Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gauthier, M; Ray, A (corresponding author), UPMC Montefiore, 628NW,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	gauthierm@upmc.edu; raya@pitt.edu	Kale, Sagar/I-7107-2019; Yuan, Huijuan/ABD-1037-2021	Yuan, Huijuan/0000-0002-9589-0098; Gauthier, Marc/0000-0001-5037-2804	National Institutes of Health [AI 106684, F32 HL137089, HL113956, AI048927]; Parker B. Francis Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation	Supported by the National Institutes of Health (grants AI 106684 [to A.R. and S.E.W.]), F32 HL137089 [to M.G.]), HL113956 [to A.R.]), and AI048927 [to A.R.]) and through the Parker B. Francis Foundation (to M.G.).	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Antonelli A, 2008, AUTOIMMUN REV, V8, P18, DOI 10.1016/j.autrev.2008.07.017; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; Camiolo MJ, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108974; Camiolo MJ, 2021, CURR OPIN IMMUNOL, V72, P66, DOI 10.1016/j.coi.2021.03.004; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Fuchimoto Y, 2011, AM J RESP CELL MOL, V45, P1248, DOI 10.1165/rcmb.2010-0465OC; Gauthier M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94580; Kato Y, 2006, INT ARCH ALLERGY IMM, V139, P245, DOI 10.1159/000091170; Kobayashi Y, 2019, CLIN EXP ALLERGY, V49, P853, DOI 10.1111/cea.13382; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Lazarus SC, 2019, NEW ENGL J MED, V380, P2009, DOI 10.1056/NEJMoa1814917; Lin Yi, 2011, Respir Res, V12, P123, DOI 10.1186/1465-9921-12-123; Liu ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162905; McGregor MC, 2019, AM J RESP CRIT CARE, V199, P433, DOI 10.1164/rccm.201810-1944CI; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Modena BD, 2017, AM J RESP CRIT CARE, V195, P1449, DOI 10.1164/rccm.201607-1407OC; Muehling LM, 2020, J ALLERGY CLIN IMMUN, V146, P555, DOI 10.1016/j.jaci.2020.03.037; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; O'Connell D, 2015, AM J PHYSIOL-LUNG C, V309, pL348, DOI 10.1152/ajplung.00099.2015; Oriss TB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91019; Pejler G, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00685-2019; Perez-Martinez L, 2018, TRANSL RES, V196, P17, DOI 10.1016/j.trsl.2018.01.004; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Robinson DS, 2004, J ALLERGY CLIN IMMUN, V114, P58, DOI 10.1016/j.jaci.2004.03.034; Salomonsson M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00321; Sauty A, 1999, J IMMUNOL, V162, P3549; Takaku Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-138; Tan JQ, 2000, J IMMUNOL, V165, P1548, DOI 10.4049/jimmunol.165.3.1548; Wisniewski JA, 2018, J ALLERGY CLIN IMMUN, V141, P2048, DOI 10.1016/j.jaci.2017.08.020; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598	36	4	4	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					113	+		10.1016/j.jaci.2021.05.044	http://dx.doi.org/10.1016/j.jaci.2021.05.044			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YJ5AM	34146578				2022-12-18	WOS:000744544500021
J	Gross, M; Speckmann, C; May, A; Gajardo-Carrasco, T; Wustrau, K; Maier, SL; Panning, M; Huzly, D; Agaimy, A; Bryceson, YT; Choo, S; Chow, CW; Duckers, G; Fasth, A; Fraitag, S; Grawe, K; Haxelmans, S; Holzinger, D; Hudowenz, O; Hubschen, JM; Khurana, C; Kienle, K; Klifa, R; Korn, K; Kutzner, H; Lammermann, T; Ledig, S; Lipsker, D; Meeths, M; Naumann-Bartsch, N; Rascon, J; Schanzer, A; Seidl, M; Tesi, B; Vauloup-Fellous, C; Vollmer-Kary, B; Warnatz, K; Wehr, C; Neven, B; Vargas, P; Sepulveda, FE; Lehmberg, K; Schmitt-Graeff, A; Ehl, S				Gross, Miriam; Speckmann, Carsten; May, Annette; Gajardo-Carrasco, Tania; Wustrau, Katharina; Maier, Sarah Lena; Panning, Marcus; Huzly, Daniela; Agaimy, Abbas; Bryceson, Yenan T.; Choo, Sharon; Chow, C. W.; Dueckers, Gregor; Fasth, Anders; Fraitag, Sylvie; Graewe, Katja; Haxelmans, Sabine; Holzinger, Dirk; Hudowenz, Ole; Huebschen, Judith M.; Khurana, Claudia; Kienle, Korbinian; Klifa, Roman; Korn, Klaus; Kutzner, Heinz; Laemmermann, Tim; Ledig, Svea; Lipsker, Dan; Meeths, Marie; Naumann-Bartsch, Nora; Rascon, Jelena; Schaenzer, Anne; Seidl, Maximilian; Tesi, Bianca; Vauloup-Fellous, Christelle; Vollmer-Kary, Beate; Warnatz, Klaus; Wehr, Claudia; Neven, Benedicte; Vargas, Pablo; Sepulveda, Fernando E.; Lehmberg, Kai; Schmitt-Graeff, Annette; Ehl, Stephan			Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cytotoxicity; rubella virus; live vaccine; granuloma; primary immunodeficiency; hemophagocytic lymphohistiocytosis; Griscelli syndrome type 2	LYMPHOCYTE-MEDIATED CYTOTOXICITY; DENDRITIC CELL-MIGRATION; T-CELLS; PARTIAL ALBINISM; NATURAL-KILLER; PERFORIN; VIRUS; MECHANISMS; MICE; INFECTION	Background: Rubella virus-induced granulomas have been described in patients with various inborn errors of immunity. Most defects impair T-cell immunity, suggesting a critical role of T cells in rubella elimination. However, the molecular mechanism of virus control remains elusive. Objective: This study sought to understand the defective effector mechanism allowing rubella vaccine virus persistence in granulomas. Methods: Starting from an index case with Griscelli syndrome type 2 and rubella skin granulomas, this study combined an international survey with a literature search to identify patients with cytotoxicity defects and granuloma. The investigators performed rubella virus immunohistochemistry and PCR and T-cell migration assays. Results: This study identified 21 patients with various genetically confirmed cytotoxicity defects, who presented with	[Gross, Miriam; Speckmann, Carsten; Graewe, Katja; Ehl, Stephan] Univ Med Ctr Freiburg, Fac Med, Ctr Chron Immunodeficiency, Inst Immunodeficiency, Freiburg, Germany; [Warnatz, Klaus] Univ Med Ctr Freiburg, Fac Med, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Warnatz, Klaus; Wehr, Claudia; Schmitt-Graeff, Annette] Univ Med Ctr Freiburg, Fac Med, Ctr Chron Immunodeficiency, Freiburg, Germany; [Gross, Miriam] Univ Freiburg, Fac Biol, Freiburg, Germany; [Haxelmans, Sabine] Univ Freiburg, Life Imaging Ctr, Freiburg, Germany; [Speckmann, Carsten] Univ Med Ctr Freiburg, Fac Med, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Panning, Marcus; Huzly, Daniela] Univ Med Ctr Freiburg, Fac Med, Inst Virol, Freiburg, Germany; [Wehr, Claudia] Univ Med Ctr Freiburg, Fac Med, Dept Med 1, Freiburg, Germany; [May, Annette; Seidl, Maximilian; Vollmer-Kary, Beate] Univ Med Ctr Freiburg, Fac Med, Inst Surg Pathol, Freiburg, Germany; [Gajardo-Carrasco, Tania; Sepulveda, Fernando E.] Inst Natl Sante & Rech Med INSERM, Mol Basis Altered Immune Homeostasis Lab, Unite Mixte Rech UMR 1163, Paris, France; [Neven, Benedicte] Univ Paris, INSERM UMR 1163, Lab Immunogenet Pediat Autoimmun, Paris, France; [Gajardo-Carrasco, Tania; Neven, Benedicte; Sepulveda, Fernando E.] Univ Paris, Imagine Inst, Paris, France; [Wustrau, Katharina; Maier, Sarah Lena; Ledig, Svea; Lehmberg, Kai] Univ Med Ctr Hamburg Eppendorf, Div Pediat Stem Cell Transplantat & Immunol, Hamburg, Germany; [Agaimy, Abbas] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany; [Korn, Klaus] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Virol, Erlangen, Germany; [Bryceson, Yenan T.] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden; [Meeths, Marie] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Meeths, Marie; Tesi, Bianca] Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden; [Bryceson, Yenan T.] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway; [Choo, Sharon] Royal Childrens Hosp, Dept Allergy & Immunol, Melbourne, Vic, Australia; [Chow, C. W.] Royal Childrens Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Dueckers, Gregor] Zentrum Kinder & Jugendmed, Helios Klinikum Krefeld, Krefeld, Germany; [Fasth, Anders] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Sahlgrenska Acad, Gothenburg, Sweden; [Fraitag, Sylvie] Necker Enfants Malad Hosp, Dept Pathol, Paris, France; [Holzinger, Dirk] Univ Duisburg Essen, Dept Pediat Hematol Oncol, Essen, Germany; [Hudowenz, Ole] Justus Liebig Univ Giessen, Dept Rheumatol Immunol Osteol & Phys Med, Campus Kerckhoff, Bad Nauheim, Germany; [Huebschen, Judith M.] Luxembourg Inst Hlth, World Hlth Org European Reg Reference Lab Measles, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Khurana, Claudia] Univ Bielefeld, Childrens Ctr Bethel, Dept Pediat Hematol & Oncol, Univ Hosp Ostwestfalen Lippe OWL, Bielefeld, Germany; [Kienle, Korbinian; Laemmermann, Tim] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Klifa, Roman] Assistance Publ Hop Paris AH PH, Immunol & Pediat Hematol Dept, Paris, France; [Kutzner, Heinz] The Dermatopathology, Friedrichshafen, Germany; [Lipsker, Dan] Univ Strasbourg, Fac Med, Strasbourg, France; [Lipsker, Dan] Hop Univ, Clin Dermatol, Strasbourg, France; [Meeths, Marie] Karolinska Univ Hosp, Theme Childrens Hlth, Stockholm, Sweden; [Tesi, Bianca] Karolinska Univ Hosp, Karolinska Univ Lab, Dept Clin Genet, Stockholm, Sweden; [Naumann-Bartsch, Nora] Univ Hosp Erlangen, Dept Pediat, Div Pediat Hematol & Oncol, Erlangen, Germany; [Rascon, Jelena] Vilnius Univ Hosp, Ctr Pediat Oncol & Hematol, Santaros Klin, Vilnius, Lithuania; [Rascon, Jelena] Vilnius Univ, Fac Med, Vilnius, Lithuania; [Schaenzer, Anne] Justus Liebig Univ Giessen, Inst Neuropathol, Giessen, Germany; [Seidl, Maximilian] Heinrich Heine Univ, Inst Pathol, Dusseldorf, Germany; [Seidl, Maximilian] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Vauloup-Fellous, Christelle] Univ Paris Saclay, Dept Virol, World Hlth Org Rubella Natl Reference Lab, INSERM U1193,Hop Paul Brousse,AP HP,Grp Rech Infe, Villejuif, France; [Neven, Benedicte] Hop Necker Enfants Malad, Assistance Publ Hop Paris AP HP, Pediat Hematol Immunol & Rheumatol Dept, Paris, France; [Vargas, Pablo] Paris Sci & Lettres Res Univ, Ctr Natl Rech Sci CNRS UMR 144, Inst Curie, Paris, France; [Vargas, Pablo] Paris Sci & Lettres Res Univ, Inst Pierre Gilles de Gennes, Paris, France; [Vargas, Pablo] Paris Sci & Lettres Res Univ, Inst Curie, INSERM U932 Immunite & Canc, Paris, France; [Sepulveda, Fernando E.] Ctr Natl La Rech Sci CNRS, Paris, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Bergen; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Helios Kliniken; University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Duisburg Essen; Justus Liebig University Giessen; Luxembourg Institute of Health; University of Bielefeld; Max Planck Society; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Erlangen Nuremberg; Vilnius University Hospital Santariskiu Klinikos; Vilnius University; Justus Liebig University Giessen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Ehl, S (corresponding author), Univ Med Ctr Freiburg, Inst Immunodeficiency, Breisacher Str 115, D-79104 Freiburg, Germany.	stephan.ehl@uniklinik-freiburg.de	Sepulveda, Fernando/O-7803-2016; VARGAS, Pablo/HHM-4543-2022; Seidl, Maxmilian/ABF-3322-2021; Vauloup-Fellous, Christelle/AAE-5567-2021; Rascon, Jelena/AAD-9514-2022; Rascon, Jelena/E-5513-2012	Sepulveda, Fernando/0000-0001-5865-4929; VARGAS, Pablo/0000-0002-6475-494X; Seidl, Maxmilian/0000-0002-5559-4980; Rascon, Jelena/0000-0003-4420-6943; Huzly, Daniela/0000-0002-1641-5943; Fasth, Anders/0000-0002-0033-740X; Lipsker, Dan/0000-0003-4675-0336	Deutsche Forschungsgemeinschaft [SFB1160, DKS 2016.04, DKS 2018.11]; French State funding from the Agence Nationale de la Recherche under "Investissements d'avenir'' program [ANR-10-IAHU-01]; Fondation Bettencourt Schueller; Grand Duchy of Luxembourg through the Ministry of Health; Grand Duchy of Luxembourg through the Ministry of Education and Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); French State funding from the Agence Nationale de la Recherche under "Investissements d'avenir'' program(French National Research Agency (ANR)); Fondation Bettencourt Schueller; Grand Duchy of Luxembourg through the Ministry of Health; Grand Duchy of Luxembourg through the Ministry of Education and Research	M.G., A.M., K.G., B.V.K., A.S.G., and S.E. were supported by the Deutsche Forschungsgemeinschaft (SFB1160, TPA1 and Z1). This work was further supported by the Deutsche Kinderkrebsstiftung (DKS 2016.04 and DKS 2018.11). T.G.C. was supported by the French State funding from the Agence Nationale de la Recherche under ``Investissements d'avenir'' program (ANR-10-IAHU-01) and the ``Fondation Bettencourt Schueller.'' J.M.H. was financially supported by the Grand Duchy of Luxembourg through the Ministries of Health and of Higher Education and Research.	Akyol S, 2020, J PEDIAT HEMATOL ONC, V42, pE627, DOI 10.1097/MPH.0000000000001589; Ammann S, 2017, J CLIN IMMUNOL, V37, P770, DOI 10.1007/s10875-017-0443-1; Aung S, 2001, J VIROL, V75, P9918, DOI 10.1128/JVI.75.20.9918-9924.2001; Bender NR, 2020, AM J DERMATOPATH, V42, P455, DOI 10.1097/DAD.0000000000001598; Bodemer C, 2014, CLIN MICROBIOL INFEC, V20, pO656, DOI 10.1111/1469-0691.12573; Brisse E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01102; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Buchbinder D, 2019, J CLIN IMMUNOL, V39, P81, DOI 10.1007/s10875-018-0581-0; Capece T, 2017, J CELL BIOL, V216, P3817, DOI 10.1083/jcb.201609072; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Deripapa E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00807; Dhossche J, 2019, JAMA DERMATOL, V155, P859, DOI 10.1001/jamadermatol.2019.0814; Dix RD, 2003, J VIROL, V77, P3402, DOI 10.1128/JVI.77.6.3402-3408.2003; Eyer D, 1998, ANN DERMATOL VENER, V125, P727; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Franciszkiewicz K, 2014, J IMMUNOL, V193, P4952, DOI 10.4049/jimmunol.1401184; Franco MA, 1997, J VIROL, V71, P479, DOI 10.1128/JVI.71.1.479-486.1997; Frey S, 2008, J VIROL, V82, P11619, DOI 10.1128/JVI.00375-08; Gather R, 2020, EUR J IMMUNOL, V50, P1770, DOI 10.1002/eji.201948123; Gotesman R, 2021, PEDIATR DERMATOL, V38, P194, DOI 10.1111/pde.14370; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Heeg M, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27344; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Jessen B, 2011, BLOOD, V118, P4620, DOI 10.1182/blood-2011-05-356113; KAGI D, 1995, IMMUNOL REV, V146, P95, DOI 10.1111/j.1600-065X.1995.tb00686.x; Kagi D, 1995, EUR J IMMUNOL, V25, P3256, DOI 10.1002/eji.1830251209; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; Kuo PT, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00271; Leclerc-Mercier S, 2019, J EUR ACAD DERMATOL, V33, P1412, DOI 10.1111/jdv.15568; Lin MT, 1997, J VIROL, V71, P383, DOI 10.1128/JVI.71.1.383-391.1997; Makino K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121548; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Mullbacher A, 1999, J VIROL, V73, P1665; Murphy MJ, 2010, J CUTAN PATHOL, V37, P907, DOI 10.1111/j.1600-0560.2009.01465.x; Navarrete CL, 2016, INT J DERMATOL, V55, P804, DOI 10.1111/ijd.13147; Neven B, 2017, CLIN INFECT DIS, V64, P83, DOI 10.1093/cid/ciw675; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pagan AJ, 2018, ANNU REV IMMUNOL, V36, P639, DOI 10.1146/annurev-immunol-032712-100022; Perelygina L, 2020, CURR OPIN ALLERGY CL, V20, P574, DOI 10.1097/ACI.0000000000000694; Perelygina L, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008080; Perelygina L, 2016, J ALLERGY CLIN IMMUN, V138, P1436, DOI 10.1016/j.jaci.2016.06.030; Robert-Koch-Institut, 2019, EPIDEMIOLOGISCHES B; Rossi CP, 1998, J VIROL, V72, P4515; Saez PJ, 2018, METHODS MOL BIOL, V1749, P361, DOI 10.1007/978-1-4939-7701-7_26; Sepulveda FE, 2013, BLOOD, V121, P595, DOI 10.1182/blood-2012-07-440339; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Singh RK, 2012, J CELL SCI, V125, P1652, DOI 10.1242/jcs.100438; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Tam PYI, 2014, PEDIATR INFECT DIS J, V33, P117, DOI 10.1097/INF.0000000000000073; Terrell CE, 2013, BLOOD, V121, P5184, DOI 10.1182/blood-2013-04-495309; Tesi B, 2018, J ALLERGY CLIN IMMUN, V142, P317, DOI 10.1016/j.jaci.2018.02.031; TSUGE I, 1987, J CLIN LAB IMMUNOL, V23, P7; Usherwood EJ, 1997, J GEN VIROL, V78, P2025, DOI 10.1099/0022-1317-78-8-2025; Vargas P, 2016, J IMMUNOL METHODS, V432, P30, DOI 10.1016/j.jim.2015.12.005; Vargas P, 2014, JOVE-J VIS EXP, DOI 10.3791/51099	58	4	4	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					388	+		10.1016/j.jaci.2021.05.007	http://dx.doi.org/10.1016/j.jaci.2021.05.007			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	34033843	Green Submitted			2022-12-18	WOS:000747922700008
J	Kitagawa, Y; Kawasaki, Y; Yamasaki, Y; Kambe, N; Takei, S; Saito, MK				Kitagawa, Yohko; Kawasaki, Yuri; Yamasaki, Yuichi; Kambe, Naotomo; Takei, Syuji; Saito, Megumu K.			Anti-TNF treatment corrects IFN-gamma-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Blau syndrome; anti-TNF treatment; NF-kappa B; autoinflammatory loop; disease-specific iPS cells	EARLY-ONSET SARCOIDOSIS; KAPPA-B ACTIVATION; CARD15 MUTATIONS; NOD2; PROTECTION; INHIBITORS; ARTHRITIS; PROTEIN	Background: Blau syndrome (BS) is an autoinflammatory disease associated with mutations in nucleotide-binding oligomerization domain 2. Although treatments with anti-TNF agents have been reported to be effective, the underlying molecular mechanisms remain unclear. Objective: We aimed to elucidate the mechanisms of autoinflammation in patients with BS and to clarify how anti-TNF treatment controls the disease phenotype at the cellular level in clinical samples. Methods: Macrophages were differentiated from monocytes of 7 BS patients, and global transcriptional profiles of 5 patients were analyzed with or without IFN-gamma stimulation. Macrophages were also generated from BS-specific induced pluripotent stem cells (iPSCs), and their transcriptome was examined for comparison. Results: Aberrant inflammatory responses were observed upon IFN-gamma stimulation in macrophages from untreated BS patients, but not in those from patients treated with anti-TNF. iPSC-derived macrophages carrying a disease-associated mutation also showed IFN-gamma-dependent accelerated inflammatory responses. Comparisons of peripheral blood- and iPSC-derived macrophages revealed the upregulation of nuclear factor kappa-light-chain enhancer of activated B cells (NF-kappa B) targets in unstimulated macrophages as a common feature. Conclusions: IFN-gamma stimulation is one of the key signals driving aberrant inflammatory responses in BS-associated macrophages. However, long-term treatment with anti-TNF agents ameliorates such abnormalities even in the presence of IFN-gamma stimulation. Our data thus suggest that preexposure to TNF or functionally similar cytokines inducing NF-kappa B-driven proinflammatory signaling during macrophage development is a prerequisite for accelerated inflammatory responses upon IFN-gamma stimulation in BS.	[Kitagawa, Yohko; Kawasaki, Yuri; Saito, Megumu K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan; [Yamasaki, Yuichi; Takei, Syuji] Kagoshima Univ Hosp, Dept Pediat, Kagoshima, Japan; [Kambe, Naotomo] Kansai Med Univ, Dept Dermatol, Hirakata, Osaka, Japan; [Kambe, Naotomo] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto, Japan	Kyoto University; Kagoshima University; Kansai Medical University; Kyoto University	Saito, MK (corresponding author), Kyoto Univ, Dept Clin Applicat, Cen R iPS Cell Res & Applicat, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	msaito@cira.kyoto-u.ac.jp	Kambe, Naotomo/H-3987-2017	Kambe, Naotomo/0000-0001-9610-4952	Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine from the Japan Agency for Medical Research and Development (AMED) [JP21bm0104001]; Acceleration Program for Intractable Diseases Research Utilizing Disease-Specific iPS Cells from AMED [17935244]; Practical Research Project for Rare/Intractable Diseases from AMED [17929899, 18J02122]; JSPS [17K10243, 19K08784]; Ministry of Health, Labour and Welfare, Japan	Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Acceleration Program for Intractable Diseases Research Utilizing Disease-Specific iPS Cells from AMED; Practical Research Project for Rare/Intractable Diseases from AMED; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Funding was provided from the Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine (JP21bm0104001) from the Japan Agency for Medical Research and Development (AMED; to M.K.S.) , the Acceleration Program for Intractable Diseases Research Utilizing Disease-Specific iPS Cells from AMED (17935244 to M.K.S.) , Practical Research Project for Rare/Intractable Dis-eases from AMED (17929899 to M.K.S.) , Grants-in-Aid for Japanese Society for the Promotion of Science (JSPS) fellows (18J02122 to Y. Ki.) , JSPS Grants-in-Aid for Scientific Research C (17K10243 to Y. Ka. and 19K08784 to N.K.) , anda research grant from Ministry of Health, Labour and Welfare, Japan (to N.K.) .	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; BLAU EB, 1985, J PEDIATR-US, V107, P689, DOI 10.1016/S0022-3476(85)80394-2; Bloemendaal FM, 2018, J CROHNS COLITIS, V12, P1122, DOI 10.1093/ecco-jcc/jjy075; Chen J, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2017-5; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Gerrick KY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208602; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Harada J, 2016, PEDIATR DERMATOL, V33, pE385, DOI 10.1111/pde.12908; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HETHERINGTON S, 1982, AM J DIS CHILD, V136, P13, DOI 10.1001/archpedi.1982.03970370015002; Ikeda K, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4533; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kuo D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8587; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu L, 2018, SEMIN ARTHRITIS RHEU, V47, P727, DOI 10.1016/j.semarthrit.2017.09.010; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Matsuda T, 2020, ANN RHEUM DIS, V79, P1492, DOI 10.1136/annrheumdis-2020-217320; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Moll M, 2013, CLIN IMMUNOL, V147, P242, DOI 10.1016/j.clim.2013.04.008; Nagakura T, 2017, J RHEUMATOL, V44, P536, DOI 10.3899/jrheum.160672; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; Okafuji I, 2009, ARTHRITIS RHEUM-US, V60, P242, DOI 10.1002/art.24134; Otsubo Y, 2017, MOD RHEUMATOL, V27, P169, DOI 10.3109/14397595.2014.964388; Simonini G, 2013, ARTHRITIS RHEUM-US, V65, P513, DOI 10.1002/art.37776; Takada S, 2018, J ALLERGY CLIN IMMUN, V141, P339, DOI 10.1016/j.jaci.2017.04.013; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamashita M, 2019, CELL STEM CELL, V25, P357, DOI 10.1016/j.stem.2019.05.019; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Yotsumoto S, 2000, J AM ACAD DERMATOL, V43, P969, DOI 10.1067/mjd.2000.103754; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	41	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					176	+		10.1016/j.jaci.2021.05.030	http://dx.doi.org/10.1016/j.jaci.2021.05.030			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34175136				2022-12-18	WOS:000741453800001
J	Le Joncour, A; Desbois, AC; Leroyer, AS; Tellier, E; Regnier, P; Maciejewski-Duval, A; Comarmond, C; Barete, S; Arock, M; Bruneval, P; Launay, JM; Fouret, P; Blank, U; Rosenzwajg, M; Klatzmann, D; Jarraya, M; Chiche, L; Koskas, F; Cacoub, P; Kaplanski, G; Saadoun, D				Le Joncour, Alexandre; Desbois, Anne-Claire; Leroyer, Aurelie S.; Tellier, Edwige; Regnier, Paul; Maciejewski-Duval, Anna; Comarmond, Cloe; Barete, Stephane; Arock, Michel; Bruneval, Patrick; Launay, Jean-Marie; Fouret, Pierre; Blank, Ulrich; Rosenzwajg, Michelle; Klatzmann, David; Jarraya, Mohamed; Chiche, Laurent; Koskas, Fabien; Cacoub, Patrice; Kaplanski, Gilles; Saadoun, David			Mast cells drive pathologic vascular lesions in Takayasu arteritis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Large vessel vasculitis; mast cell; vascular remodeling; Takayasu	ANGIOGENESIS; PERMEABILITY; INFLAMMATION; ASSOCIATE; TH17	Background: Takayasu arteritis (TAK) is a large vessel vasculitis resulting in artery wall remodeling with segmental stenosis and/or aneurysm formation. Mast cells (MCs) are instrumental in bridging cell injury and inflammatory response. Objectives: This study sought to investigate the contribution of MCs on vessel permeability, angiogenesis, and fibrosis in patients with TAK. Methods: MC activation and their tissue expression were assessed in sera and in aorta from patients with TAK and from healthy donors (HDs). In vivo permeability was assessed using a modified Miles assay. Subconfluent cultured human umbilic vein endothelial cells and fibroblasts were used in vitro to investigate the effects of MC mediators on angiogenesis and fibrogenesis. Results: This study found increased levels of MC activation markers (histamine and indoleamine 2,3-dioxygenase) in sera of patients with TAK compared with in sera of HDs. Marked expression of MCs was shown in aortic lesions of patients with TAK compared with in those of noninflammatory aorta controls. Using Miles assay, this study showed that sera of patients with TAK significantly increased vascular permeability in vivo as compared with that of HDs. Vessel permeability was abrogated in MC-deficient mice. MCs stimulated by sera of patients with TAK supported neoangiogenesis (increased human umbilic vein endothelial cell proliferation and branches) and fibrosis by inducing increased production of fibronectin, type 1 collagen, and a-smooth muscle actin by fibroblasts as compared to MCs stimulated by sera of HD. Conclusions: MCs are a key regulator of vascular lesions in patients with TAK and may represent a new therapeutic target in large vessel vasculitis.	[Le Joncour, Alexandre; Desbois, Anne-Claire; Regnier, Paul; Maciejewski-Duval, Anna; Comarmond, Cloe; Rosenzwajg, Michelle; Klatzmann, David; Cacoub, Patrice; Saadoun, David] Univ Paris 06, Dept Immunol Immunopathol Immunotherapy, Univ Paris 06, Unite Mixte Rech UMR S959,INSERM,Sorbonne Univ, Paris, France; [Le Joncour, Alexandre; Desbois, Anne-Claire; Regnier, Paul; Maciejewski-Duval, Anna; Comarmond, Cloe; Rosenzwajg, Michelle; Klatzmann, David; Cacoub, Patrice; Saadoun, David] Hop La Pitie Salpetriere, Dept Biotherapy, Paris, France; [Arock, Michel] Hop La Pitie Salpetriere, Lab Hematol Biol, Paris, France; [Le Joncour, Alexandre; Desbois, Anne-Claire; Comarmond, Cloe; Barete, Stephane; Rosenzwajg, Michelle; Klatzmann, David; Cacoub, Patrice; Saadoun, David] Grp Hosp Pitie Salpetriere, AP HP, Dept Internal Med & Clin Immunol,Ctr Natl Referen, Ctr Natl References Malad Autoimmunes & Syst Rare, Paris, France; [Fouret, Pierre] Grp Hosp Pitie Salpetriere, AP HP, Lab Anatomopathol, Paris, France; [Chiche, Laurent; Koskas, Fabien] Grp Hosp Pitie Salpetriere, AP HP, Serv Chirurg Vasc, Paris, France; [Barete, Stephane] Grp Hosp Pitie Salpetriere C Foix, Dept Dermatol DMU3ID, Unite Fonct Dermatol, Paris, France; [Arock, Michel] Ctr Rech Cordeliers, UMRS1138, INSERM, Cell Death & Drug Resistance Lymphoproliferat Dis, Paris, France; [Bruneval, Patrick] Hop Europeen Georges Pompidou, Lab Anatomopathol, Paris, France; [Launay, Jean-Marie] INSERM, UMR S 942, F-75010 Paris, France; [Blank, Ulrich] Univ Paris, Ctr Res Inflammat, INSERM UMR 51149, Sorbonne Paris Cite,Lab Excellence INFLAMEX, Paris, France; [Blank, Ulrich] Univ Paris, CNRS, Expt Res Lab 8252, Sorbonne Paris Cite,Lab Excellence INFLAMEX, Paris, France; [Jarraya, Mohamed] Hop St Louis, Banque Tissus Humains, Paris, France; [Leroyer, Aurelie S.; Tellier, Edwige; Kaplanski, Gilles] Aix Marseille Univ, Inrae 1260, INSERM, Ctr Rech CardioVasc & Nutr,U1263, Marseille, France; [Kaplanski, Gilles] Ctr Hosp Univ Conception, AP HM, Serv Med Interne, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Saadoun, D (corresponding author), Sorbonne Univ, Lab I3 Immunol Immunopathol Immunotherapy, UMR 7211, INSERM,U959,Hop Pitie Salpetriere, 47-83 Blvd Hop, F-75013 Paris, France.	david.saadoun@aphp.fr		Regnier, Paul/0000-0002-9713-1132	Fondation pour la RechercheMedicale; INSERM	Fondation pour la RechercheMedicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	A.C. Desbois was supported by grant from the Fondation pour la RechercheMedicale. A. Le Joncour was supported by grant from INSERM.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Arock M, 2018, HAEMATOLOGICA, V103, P1760, DOI 10.3324/haematol.2018.195867; Bachelet I, 2006, IMMUNOL ALLERGY CLIN, V26, P407, DOI 10.1016/j.iac.2006.05.007; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Bradding P, 2018, IMMUNOL REV, V282, P198, DOI 10.1111/imr.12626; Brown M, 2019, CLIN EXP IMMUNOL, V195, P310, DOI 10.1111/cei.13238; Chung JW, 2007, J VASC SURG, V45, P906, DOI 10.1016/j.jvs.2007.01.016; Cid MC, 2000, ARTHRITIS RHEUM-US, V43, P184, DOI 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N; Conti P, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12475; Danelli L, 2017, J IMMUNOL, V198, P2374, DOI 10.4049/jimmunol.1601282; de Souza DA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122674; Deng JS, 2010, CIRCULATION, V121, P906, DOI 10.1161/CIRCULATIONAHA.109.872903; Garbuzenko E, 2002, CLIN EXP ALLERGY, V32, P237, DOI 10.1046/j.1365-2222.2002.01293.x; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Inder SJ, 2000, ANGIOLOGY, V51, P565, DOI 10.1177/000331970005100705; Izadi D, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay0370; Kaiser M, 1999, AM J PATHOL, V155, P765, DOI 10.1016/S0002-9440(10)65175-9; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Kurata A, 2019, MOD RHEUMATOL, V29, P992, DOI 10.1080/14397595.2019.1570999; Legere SA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00580; Levick SP, 2011, CARDIOVASC RES, V89, P12, DOI 10.1093/cvr/cvq272; LEVISCHAFFER F, 1995, CHEM IMMUNOL, V61, P161; Mayranpaa MI, 2008, CLIN EXP RHEUMATOL, V26, pS63; Mayranpaa MI, 2009, J VASC SURG, V50, P388, DOI 10.1016/j.jvs.2009.03.055; Nian JB, 2020, CELL CYCLE, V19, P1132, DOI 10.1080/15384101.2020.1749402; Numano F, 2000, LANCET, V356, P1023, DOI 10.1016/S0140-6736(00)02701-X; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Regnier P, 2020, ANN RHEUM DIS, V79, P951, DOI 10.1136/annrheumdis-2019-216900; Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010; Saadoun D, 2015, ARTHRITIS RHEUMATOL, V67, P1353, DOI 10.1002/art.39037; Saleh R, 2014, BLOOD, V124, P111, DOI 10.1182/blood-2013-10-534685; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; SORBO J, 1994, INT J EXP PATHOL, V75, P43; Swedenborg J, 2011, ARTERIOSCL THROM VAS, V31, P734, DOI 10.1161/ATVBAHA.110.213157; Weiskirchen R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111429	37	4	4	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					292	+		10.1016/j.jaci.2021.05.003	http://dx.doi.org/10.1016/j.jaci.2021.05.003			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	33992671	Green Submitted			2022-12-18	WOS:000747922700001
J	Akenroye, AT; Brunetti, T; Romero, K; Daya, M; Kanchan, K; Shankar, G; Chavan, S; Boorgula, MP; Ampleford, EA; Fonseca, HF; Hawkins, GA; Teixeira, HMP; Campbell, M; Rafaels, N; Winters, A; Bleecker, ER; Cruz, AA; Barreto, ML; Meyers, DA; Ortega, VE; Figueiredo, CA; Barnes, KC; Checkley, W; Hansel, NN; Mathias, RA				Akenroye, Ayobami T.; Brunetti, Tonya; Romero, Karina; Daya, Michelle; Kanchan, Kanika; Shankar, Gautam; Chavan, Sameer; Boorgula, Meher Preethi; Ampleford, Elizabeth A.; Fonseca, Hellen Freitas; Hawkins, Gregory A.; Teixeira, Helena Mariana Pitangueira; Campbell, Monica; Rafaels, Nicholas; Winters, Alexandra; Bleecker, Eugene R.; Cruz, Alvaro A.; Barreto, Mauricio L.; Meyers, Deborah A.; Ortega, Victor E.; Figueiredo, Camila A.; Barnes, Kathleen C.; Checkley, William; Hansel, Nadia N.; Mathias, Rasika A.			Genome-wide association study of asthma, total IgE, and lung function in a cohort of Peruvian children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; immunoglobulin E; lung function; admixture; genome wide association analyses; Peru; ancestry; allergy; Abbreviations used; Populations	PUERTO-RICAN; ADMIXTURE; ANCESTRY; DIVERSE; LOCI; METAANALYSIS; INFERENCE; VARIANTS; AMERICAN; ALLERGEN	Background: Genetic ancestry plays a role in asthma health disparities. Objective: Our aim was to evaluate the impact of ancestry on and identify genetic variants associated with asthma, total serum IgE level, and lung function. Methods: A total of 436 Peruvian children (aged 9-19 years) with asthma and 291 without asthma were genotyped by using the Illumina Multi-Ethnic Global Array. Genome-wide proportions of indigenous ancestry populations from continental America (NAT) and European ancestry from the Iberian populations in Spain (IBS) were estimated by using ADMIXTURE. We assessed the relationship between ancestry and the phenotypes and performed a genome-wide association study. Results: The mean ancestry proportions were 84.7% NAT (case patients, 84.2%; controls, 85.4%) and 15.3% IBS (15.8%; 14.6%). With adjustment for asthma, NAT was associated with higher total serum IgE levels (P < .001) and IBS was associated with lower total serum IgE levels (P < .001). NAT was associated with higher FEV1 percent predicted values (P < .001), whereas IBS was associated with lower FEV1 values in the controls but not in the case patients. The HLA-DR/DQ region on chromosome 6 (Chr6) was strongly associated with total serum IgE (rs3135348; P = 3.438 x 10-10) and was independent of an association with the haplotype HLA-DQA1-HLA-DQB1:04.01-04.02 (P = 1.55 x 10-05). For lung function, we identified a locus (rs4410198; P = 5.536 x 10-11) mapping to Chr19, near a cluster of zinc finger interacting genes that colocalizes to the long noncoding RNA CTD-2537I9.5. This novel locus was replicated in an independent sample of pediatric case patients with asthma with similar admixture from Brazil (P = .005). Conclusion: This study confirms the role of HLA in atopy, and identifies a novel locus mapping to a long noncoding RNA for lung function that may be specific to children with NAT. (J Allergy Clin Immunol 2021;148:1493-504.)	[Akenroye, Ayobami T.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD 21224 USA; [Romero, Karina; Checkley, William; Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA; [Kanchan, Kanika; Shankar, Gautam; Winters, Alexandra; Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA; [Brunetti, Tonya; Daya, Michelle; Chavan, Sameer; Boorgula, Meher Preethi; Campbell, Monica; Rafaels, Nicholas; Barnes, Kathleen C.] Univ Colorado, Div Biomed Informat & Personalized Med, Denver, CO 80202 USA; [Romero, Karina] AB PRISMA, Lima, Peru; [Ampleford, Elizabeth A.; Ortega, Victor E.] Wake Forest Sch Med, Ctr Precis Med, Dept Internal Med, Winston Salem, NC 27101 USA; [Fonseca, Hellen Freitas; Teixeira, Helena Mariana Pitangueira; Figueiredo, Camila A.] Univ Fed Bahia UFBA, Inst Ciencias Saude, Salvador, BA, Brazil; [Hawkins, Gregory A.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27101 USA; [Bleecker, Eugene R.; Meyers, Deborah A.] Univ Arizona, Dept Med, Tucson, AZ USA; [Cruz, Alvaro A.] Fundacao ProAR, Salvador, BA, Brazil; [Barreto, Mauricio L.] Fiocruz MS, Ctr Integracao Dados & Conhecimento Saude, Salvador, BA, Brazil; [Checkley, William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Colorado System; University of Colorado Denver; Wake Forest University; Universidade Federal da Bahia; Wake Forest University; University of Arizona; Fundacao Oswaldo Cruz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hansel, NN (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.; Mathias, RA (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	nhansel1@jhmi.edu; rmathias@jhmi.edu	Boorgula, Meher Preethi/AAC-6252-2022; Chavan, Sameer/AAU-2285-2021; Fonseca, Héllen/AAJ-4629-2021; Figueiredo, Camila Alexandrina/H-3525-2015	Chavan, Sameer/0000-0002-0220-0845; Figueiredo, Camila Alexandrina/0000-0003-1356-6188	National Institute of Environmental Health Sciences, National Institutes of Health [R01ES018845, R01ES018845-S1, NHLBI R01 HL142992]; National Institute of Allergy and Infectious Diseases T32 Research Training Grant in Pediatric Allergy and Immunology [2T32AI007007-41]; Johns Hopkins University Provost's Postdoctoral Award; Fogarty Global Health [5R25TW009340]; National Heart, Lung, and Blood Institute, National Institutes of Health [R00HL096955]	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases T32 Research Training Grant in Pediatric Allergy and Immunology; Johns Hopkins University Provost's Postdoctoral Award; Fogarty Global Health; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institute of Environmental Health Sciences, National Institutes of Health (grants R01ES018845 and R01ES018845-S1 and NHLBI R01 HL142992). A.T.A was supported by the National Institute of Allergy and Infectious Diseases T32 Research Training Grant in Pediatric Allergy and Immunology (grant no. 2T32AI007007-41) and the Johns Hopkins University Provost's Postdoctoral Award. K.R. was a Fogarty Global Health Fellow through the consortium comprising the University of North Carolina, Johns Hopkins University, Morehouse School of Medicine, and Tulane University during the conduct of this work (through grant 5R25TW009340) W.C. was supported by Pathway to Independence Award R00HL096955 from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Abe K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0322-y; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Asher MI, 1998, EUR RESPIR J, V12, P315; Bermejo JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006756; Bien SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167758; Brehm JM, 2015, AM J RESP CRIT CARE, V192, P634, DOI 10.1164/rccm.201501-0047LE; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Centers for Disease Control and Prevention, 2012, ASTHM IMP NAT; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Cruz AA, 2020, RESP MED, V161, DOI 10.1016/j.rmed.2019.105817; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Daya M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08469-7; Forno E, 2017, J ALLERGY CLIN IMMUN, V140, P996, DOI 10.1016/j.jaci.2016.12.967; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Galanter JM, 2014, J ALLERGY CLIN IMMUN, V134, P295, DOI 10.1016/j.jaci.2013.08.055; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Groot Michael, 2018, JSM Bioinform Genom Proteom, V3; Hansel NN, 2019, ANN AM THORAC SOC, V16, P348, DOI 10.1513/AnnalsATS.201807-448OC; Harris DN, 2018, P NATL ACAD SCI USA, V115, pE6526, DOI 10.1073/pnas.1720798115; Jafarzadeh M, 2020, GENOMICS, V112, P2615, DOI 10.1016/j.ygeno.2020.02.012; Kanchan K, 2021, J ALLERGY CLIN IMMUN, V147, P15, DOI 10.1016/j.jaci.2020.10.039; Kim JH, 2018, ALLERGY ASTHMA IMMUN, V10, P397, DOI 10.4168/aair.2018.10.4.397; Koczulla AR, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-29; Kontakioti E, 2014, HUM IMMUNOL, V75, P930, DOI 10.1016/j.humimm.2014.06.022; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; Levin AM, 2013, J ALLERGY CLIN IMMUN, V131, P1176, DOI 10.1016/j.jaci.2012.10.002; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P751, DOI 10.1016/j.jaci.2004.12.1138; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; Mersha TB, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00292; Moffatt MF, 2001, EUR J HUM GENET, V9, P341, DOI 10.1038/sj.ejhg.5200636; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Movahedi M, 2008, IRAN J ALLERGY ASTHM, V7, P215, DOI 07.04/ijaai.215220; Mubarak B, 2017, IRAN J ALLERGY ASTHM, V16, P313; Pappas DJ, 2016, HUM IMMUNOL, V77, P283, DOI 10.1016/j.humimm.2015.12.006; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P1502, DOI 10.1016/j.jaci.2014.10.033; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Potaczek DP, 2012, CLIN EXP ALLERGY, V42, P852, DOI 10.1111/j.1365-2222.2011.03953.x; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S.C.C, PLINK 1 9; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; R Core Team, 2021, R LANG ENV STAT COMP; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Schoettler N, 2019, J ALLERGY CLIN IMMUN, V144, P1495, DOI 10.1016/j.jaci.2019.10.023; Shih JW, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0358-4; Shrine N, 2019, NAT GENET, V51, P481, DOI 10.1038/s41588-018-0321-7; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Takejima P, 2017, INT ARCH ALLERGY IMM, V172, P150, DOI 10.1159/000458151; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Turner S.D., 2014, J OPEN SOURCE SOFTW, DOI [DOI 10.1101/005165, 10.1101/005165, DOI 10.1101/005165.V1]; Upham JW, 2004, J ALLERGY CLIN IMMUN, V114, P1202, DOI 10.1016/j.jaci.2004.06.051; Vergara C, 2013, GENET EPIDEMIOL, V37, P393, DOI 10.1002/gepi.21702; Wallace C, 2013, GENET EPIDEMIOL, V37, P802, DOI 10.1002/gepi.21765; World Health Organization, 2017, ASTHM FACT SHEET; Wu AC, 2014, J ALLERGY CLIN IMMUN, V133, P723, DOI 10.1016/j.jaci.2013.09.037; Wu X, 2018, ANTIOXID REDOX SIGN, V29, P922, DOI 10.1089/ars.2017.7293; Yan Q, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01505-2016; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044; Yizhak K, 2019, SCIENCE, V364, P970, DOI 10.1126/science.aaw0726; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zheng Xiuwen, 2018, Methods Mol Biol, V1802, P163, DOI 10.1007/978-1-4939-8546-3_11	70	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1493	1504		10.1016/j.jaci.2021.02.035	http://dx.doi.org/10.1016/j.jaci.2021.02.035		DEC 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO	33713768	Green Accepted			2022-12-18	WOS:000728634000016
J	Darlenski, R; Kozyrskyj, AL; Fluhr, JW; Caraballo, L				Darlenski, Razvigor; Kozyrskyj, Anita L.; Fluhr, Joachim W.; Caraballo, Luis			Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: Unmet needs and open questions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergic; atopy; asthma; allergic rhinitis; atopic march; phenotype; transepidermal water loss; hydration; Staphylococcus; epigenetic; interleukin	STAPHYLOCOCCUS-AUREUS; FOOD SENSITIZATION; STRATUM-CORNEUM; FILAGGRIN MUTATIONS; HAY-FEVER; ALLERGY; COLONIZATION; EXPRESSION; DISEASE; ECZEMA	Atopic diathesis encompassing atopic dermatitis (AD), allergic rhinoconjunctivitis, food allergy, eosinophilic esophagitis, and asthma is a widely prevalent condition with a broad heterogeneity in clinical course, age of onset, and lifespan persistence. A primary event in AD is the commonly inherited epidermal barrier dysfunction. Together with the hostmicrobiome interactions, barrier defect and allergen exposure modulate both innate and adaptive immunity, thus triggering and maintaining the inflammatory response. Microbiome diversity, together with the host's contact with nonpathogenic microbes in childhood, is a prerequisite for functional maturation of the immune system, which is in part mediated by microbiome-induced epigenetic changes. Yet, whether microbiome alterations are the result or the reason for barrier impairment and inflammatory response of the host is unclear. Exposure to locally prevalent microbial species could contribute to further modification of the disease course. The objective of this review is to reveal the link between changes in the skin microbiota, barrier dysfunction, and inflammation in AD. Addressing unmet needs includes determining the genetic background of AD susceptibility; the epigenetic modifications induced by the microbiota and other environmental factors; the role of globally diverse provoking factors; and the implementation of personalized, phenotype-specific therapies such as a epidermal barrier restoration in infancy and microbiota modulation via systemic or topical interventions, all of which open gaps for future research. (J Allergy Clin Immunol 2021;148:1387-93.)	[Darlenski, Razvigor] ACC Tokuda Hosp, Dept Dermatovenerol, Sofia, Bulgaria; [Darlenski, Razvigor] Trakia Univ, Dept Dermatovenerol, Stara Zagora, Bulgaria; [Kozyrskyj, Anita L.] Edmonton Clin Hlth Acad, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada; [Fluhr, Joachim W.] Charit Univ Med Berlin, Dept Dermatol Venereol & Allergol, Berlin, Germany; [Caraballo, Luis] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia	Trakia University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena	Darlenski, R (corresponding author), ACC Tokuda Hosp, Dept ment Dermatol, 51B Nikola Vaptsarov Blvd, Sofia 1407, Bulgaria.	darlenski@gmail.com		Darlenski, Razvigor/0000-0002-4220-8040				Abuabara K, 2018, ALLERGY, V73, P696, DOI 10.1111/all.13320; Acevedo N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74798-z; Al Kindi A, 2021, J ALLERGY CLIN IMMUN, V147, P1354, DOI 10.1016/j.jaci.2020.09.023; Alduraywish SA, 2016, ALLERGY, V71, P77, DOI 10.1111/all.12784; Allen HB, 2014, JAMA DERMATOL, V150, P260, DOI 10.1001/jamadermatol.2013.8627; Altunbulakli C, 2018, J ALLERGY CLIN IMMUN, V142, P1643, DOI 10.1016/j.jaci.2018.07.005; Apfelbacher CJ, 2011, ALLERGY, V66, P206, DOI 10.1111/j.1398-9995.2010.02464.x; Archer NK, 2019, J ALLERGY CLIN IMMUN, V143, P1426, DOI 10.1016/j.jaci.2018.08.042; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Babina M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010102; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Baurecht H, 2018, J ALLERGY CLIN IMMUN, V141, P1668, DOI 10.1016/j.jaci.2018.01.019; Bawany F, 2020, J ALLER CL IMM-PRACT, V8, P860, DOI 10.1016/j.jaip.2019.12.005; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Bieber T, 2017, J ALLERGY CLIN IMMUN, V139, pS58, DOI 10.1016/j.jaci.2017.01.008; Bin LH, 2021, ALLERGY, V76, P2510, DOI 10.1111/all.14762; Brauweiler AM, 2020, J INVEST DERMATOL, V140, P915, DOI 10.1016/j.jid.2019.09.004; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Callewaert C, 2021, COMPUT STRUCT BIOTEC, V19, P624, DOI 10.1016/j.csbj.2021.01.001; Callewaert C, 2020, J INVEST DERMATOL, V140, P191, DOI 10.1016/j.jid.2019.05.024; Cau L, 2021, J ALLERGY CLIN IMMUN, V147, P955, DOI 10.1016/j.jaci.2020.06.024; Chalmers JR, 2020, LANCET, V395, P962, DOI 10.1016/S0140-6736(19)32984-8; Chen CC, 2016, PEDIAT ALLERG IMM-UK, V27, P254, DOI 10.1111/pai.12522; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Cheung GYC, 2014, FEMS MICROBIOL REV, V38, P698, DOI 10.1111/1574-6976.12057; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P269, DOI 10.1067/mai.2001.117455; Czarnowicki T, 2019, J ALLERGY CLIN IMMUN, V143, P1, DOI 10.1016/j.jaci.2018.10.032; Darlenski R, 2014, CLIN DERMATOL, V32, P409, DOI 10.1016/j.clindermatol.2013.11.007; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Di Domenico EG, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090301; Elias MS, 2017, J ALLERGY CLIN IMMUN, V140, P1299, DOI 10.1016/j.jaci.2017.01.039; Emmert H, 2021, EXP DERMATOL, V30, P1398, DOI 10.1111/exd.14185; Feuillie C, 2018, MBIO, V9, DOI 10.1128/mBio.01184-18; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Fyhrquist N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12253-y; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Hamilton JD, 2021, CLIN EXP ALLERGY, V51, P915, DOI 10.1111/cea.13954; Hata TR, 2010, BRIT J DERMATOL, V163, P659, DOI 10.1111/j.1365-2133.2010.09892.x; Hill DA, 2018, J ALLER CL IMM-PRACT, V6, P1528, DOI 10.1016/j.jaip.2018.05.010; Horimukai K, 2016, ALLERGOL INT, V65, P103, DOI 10.1016/j.alit.2015.09.004; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Igawa S, 2017, J INVEST DERMATOL, V137, P449, DOI 10.1016/j.jid.2016.10.015; Jun SH, 2017, CLIN EXP ALLERGY, V47, P85, DOI 10.1111/cea.12851; Karpathiou G, 2021, PATHOL RES PRACT, V223, DOI 10.1016/j.prp.2021.153477; Kelleher MM, 2016, J ALLERGY CLIN IMMUN, V137, P1111, DOI 10.1016/j.jaci.2015.12.1312; Kezic S, 2012, J ALLERGY CLIN IMMUN, V129, P1031, DOI 10.1016/j.jaci.2011.12.989; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Kim JH, 2021, EXP MOL MED, V53, P907, DOI 10.1038/s12276-021-00627-6; Kim JE, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040444; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Koplin JJ, 2014, ALLERGY, V69, P1639, DOI 10.1111/all.12487; Kramer ON, 2017, CLIN DERMATOL, V35, P344, DOI 10.1016/j.clindermatol.2017.03.005; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li L, 2019, AM J CLIN DERMATOL, V20, P367, DOI 10.1007/s40257-018-0404-3; Li S, 2017, BRIT J DERMATOL, V177, pE125, DOI 10.1111/bjd.15409; Liang YS, 2019, J ALLERGY CLIN IMMUN, V144, P1025, DOI 10.1016/j.jaci.2019.06.011; Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; Margolis DJ, 2012, J ALLERGY CLIN IMMUN, V130, P912, DOI 10.1016/j.jaci.2012.07.008; Marschall P, 2021, J ALLERGY CLIN IMMUN, V147, P1778, DOI 10.1016/j.jaci.2020.10.006; Martin MJ, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040442; Meylan P, 2017, J INVEST DERMATOL, V137, P2497, DOI 10.1016/j.jid.2017.07.834; Mlitz V, 2012, J EUR ACAD DERMATOL, V26, P983, DOI 10.1111/j.1468-3083.2011.04198.x; Moberg C, 2006, BRIT J DERMATOL, V155, P557, DOI 10.1111/j.1365-2133.2006.07372.x; Nakagawa S, 2017, CELL HOST MICROBE, V22, P667, DOI 10.1016/j.chom.2017.10.008; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Nakatsuji T, 2016, J INVEST DERMATOL, V136, P2192, DOI 10.1016/j.jid.2016.05.127; Nomura T, 2020, J ALLER CL IMM-PRACT, V8, P1840, DOI 10.1016/j.jaip.2020.02.022; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P26, DOI 10.1016/j.jaci.2018.11.015; Parm U, 2018, J PERINATOL, V38, P1503, DOI 10.1038/s41372-018-0220-x; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Prescott SL, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0160-5; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Ruokolainen L, 2017, CLIN EXP ALLERGY, V47, P665, DOI 10.1111/cea.12895; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schmidt AD, 2021, EXP DERMATOL, V30, P1150, DOI 10.1111/exd.14392; Silverberg JI, 2022, J ALLERGY CLIN IMMUN, V149, P977, DOI 10.1016/j.jaci.2021.07.036; Simpson EL, 2018, J INVEST DERMATOL, V138, P2224, DOI 10.1016/j.jid.2018.03.1517; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Skjerven HO, 2020, LANCET, V395, P951, DOI 10.1016/S0140-6736(19)32983-6; Sonesson A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08046-2; Stefanovic N, 2021, CURR TREAT OPTION AL, V8, P222, DOI 10.1007/s40521-021-00289-9; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tan-Lim CSC, 2021, PEDIAT ALLERG IMM-UK, V32, P1255, DOI 10.1111/pai.13514; Tham EH, 2020, BIOTECHNOL J, V15, DOI 10.1002/biot.201900322; Towell AM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014444118; Traisaeng S, 2019, TOXINS, V11, DOI 10.3390/toxins11060311; Tun HM, 2021, GASTROENTEROLOGY, V161, P94, DOI 10.1053/j.gastro.2021.03.016; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Williams MR, 2017, CELL HOST MICROBE, V22, P579, DOI 10.1016/j.chom.2017.10.015; Zhang L, 2021, J DERMATOL, V48, P1877, DOI 10.1111/1346-8138.16126	100	4	4	6	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1387	1393		10.1016/j.jaci.2021.10.002	http://dx.doi.org/10.1016/j.jaci.2021.10.002		DEC 2021	7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO	34688495				2022-12-18	WOS:000728634000004
J	Martinez, A; de la Rosa, R; Mujahid, M; Thakur, N				Martinez, Adali; de la Rosa, Rosemarie; Mujahid, Mahasin; Thakur, Neeta			Structural racism and its pathways to asthma and atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Racism; health disparities; asthma; allergic dermatitis; atopy	ADVERSE CHILDHOOD EXPERIENCES; SOCIOECONOMIC-STATUS; RESIDENTIAL SEGREGATION; GALA II; PERCEIVED DISCRIMINATION; CHRONIC INFLAMMATION; PSYCHOSOCIAL STRESS; ECZEMA PREVALENCE; ALLOSTATIC LOAD; AIR-POLLUTION	Black, Latinx, and Indigenous people in the United States experience a disproportionate burden of asthma and atopic dermatitis. The study of these disease disparities has focused on proximal socioenvironmental exposures and on the biomechanistic (including genetic) differences between racial and ethnic groups. Although biomedical research in allergy and immunology stands to benefit from the inclusion of diverse study populations, the narrow focus on biologic mechanisms disregards the complexity of interactions across biologic and structural factors, including the effects of structural racism. Structural racism is the totality of ways in which society fosters discrimination by creating and reinforcing inequitable systems through intentional policies and practices sanctioned by government and institutions. It is embedded across multiple levels, including the economic, educational, health care, and judicial systems, which are manifested in inequity in the physical and social environment. In this review, we present a conceptual framework and pull from the literature to demonstrate how structural racism is a root cause of atopic disease disparities by way of residential segregation, socioeconomic position, and mass incarceration, which may lead to aberrations in the innate and adaptive immune response and the augmentation of physiologic stress responses, contributing to a disproportionate disease burden for racial and ethnic populations. (J Allergy Clin Immunol 2021;148:1112-20.)	[Martinez, Adali; Thakur, Neeta] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [de la Rosa, Rosemarie; Mujahid, Mahasin] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Thakur, N (corresponding author), Univ Calif San Francisco, Dept Med, 500 Parnassus Ave,Box 0841, San Francisco, CA 94143 USA.	Neeta.Thakur@ucsf.edu			University of California President's Postdoctoral Fellowship; National Heart, Lung and Blood Institute [K23-HL125551-01A1]	University of California President's Postdoctoral Fellowship(University of California System); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a University of California President's Postdoctoral Fellowship (to R.D.) and the National Heart, Lung and Blood Institute (career development award K23-HL125551-01A1 [to N.T.]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abuabara K, 2020, J ALLERGY CLIN IMMUN, V145, P192, DOI 10.1016/j.jaci.2019.06.044; Alcala E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152683; Alexander D, 2017, J HEALTH ECON, V55, P186, DOI 10.1016/j.jhealeco.2017.07.003; Alexander Michelle, 2010, NEW JIM CROW MASS IN; [Anonymous], 2021, ASTHM AM IND AL NAT; [Anonymous], 2016, RAC JUST NEWS NAT AM; [Anonymous], 2019, NATL ASTHM DAT; Bacon SL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-125; Bailey ZD, 2021, NEW ENGL J MED, V384, P768, DOI 10.1056/NEJMms2025396; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Balakirski G, 2021, CURR OPIN ALLERGY CL, V21, P368, DOI 10.1097/ACI.0000000000000759; Bhan N, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2013-000016; Bombay A, 2014, TRANSCULT PSYCHIATRY, V51, P320, DOI 10.1177/1363461513503380; Brewer M, 2017, HEALTH PLACE, V44, P86, DOI 10.1016/j.healthplace.2017.01.006; Brockie TN, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/410395; Brody GH, 2014, CHILD DEV, V85, P989, DOI 10.1111/cdev.12213; Brunner PM, 2019, ANN ALLERG ASTHMA IM, V122, P449, DOI 10.1016/j.anai.2018.11.015; Burke LM, 2021, HOUSING REDLINING IT; Cardenas A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11058-3; Carlson S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179091; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chen E, 2016, PSYCHOSOM MED, V78, P1043, DOI 10.1097/PSY.0000000000000392; Chen W, 2013, AM J RESP CRIT CARE, V187, P584, DOI 10.1164/rccm.201210-1789OC; Cheon CY, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.27591; Chung J, 2019, ANN ALLERG ASTHMA IM, V122, P360, DOI 10.1016/j.anai.2018.12.017; Clausing ES, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.696827; Cohen DA, 2000, PREV MED, V30, P146, DOI 10.1006/pmed.1999.0609; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Conching AKS, 2019, SOC SCI MED, V230, P74, DOI 10.1016/j.socscimed.2019.04.001; Cooper HLF, 2015, SUBST USE MISUSE, V50, P1188, DOI 10.3109/10826084.2015.1007669; Crouch E, 2019, CHILD ABUSE NEGLECT, V92, P209, DOI 10.1016/j.chiabu.2019.04.010; Daya M, 2019, ANN ALLERG ASTHMA IM, V122, P456, DOI 10.1016/j.anai.2019.02.009; Delfino RJ, 2014, EPIDEMIOLOGY, V25, P48, DOI 10.1097/EDE.0000000000000016; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Frank JW, 2013, AM J PUBLIC HEALTH, V103, pE38, DOI 10.2105/AJPH.2013.301255; Fuxench ZCC, 2019, J INVEST DERMATOL, V139, P583, DOI 10.1016/j.jid.2018.08.028; Garcia-Marcos L, 2014, INT J EPIDEMIOL, V43, P1846, DOI 10.1093/ije/dyu145; Gaskin DJ, 2012, HEALTH SERV RES, V47, P2353, DOI 10.1111/j.1475-6773.2012.01417.x; Goel C, 2015, IMMUNOBIOLOGY, V220, P1113, DOI 10.1016/j.imbio.2015.05.010; Goosby BJ, 2013, SOCIOL COMPASS, V7, P630, DOI 10.1111/soc4.12054; Gurung B., 2014, POLICY DISCUSSION PA; Hanifin IM, 2007, DERMATITIS, V18, P82, DOI 10.2310/6620.2007.06034; Harb H, 2015, J ALLERGY CLIN IMMUN, V135, P15, DOI 10.1016/j.jaci.2014.11.009; Holguin F, 2005, AM J RESP CRIT CARE, V171, P103, DOI 10.1164/rccm.200402-143OC; Hua T, 2018, ANN ALLERG ASTHMA IM, V121, P622, DOI 10.1016/j.anai.2018.07.019; Huang HW, 2013, NEUROIMMUNOMODULAT, V20, P1, DOI 10.1159/000343099; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Hughes HK, 2017, ACAD PEDIATR, V17, P127, DOI 10.1016/j.acap.2016.11.011; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Iqbal S, 2014, AM J PUBLIC HEALTH, V104, pS175, DOI 10.2105/AJPH.2013.301509; Kanchongkittiphon W, 2015, ENVIRON HEALTH PERSP, V123, P6, DOI [10.1289/ehp.1307922, 10.1289/ehp.123-A6]; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Keet CA, 2017, J ALLERGY CLIN IMMUN, V140, P822, DOI 10.1016/j.jaci.2017.01.036; Kim Dasom, 2018, Chronic Dis Transl Med, V4, P75, DOI 10.1016/j.cdtm.2018.03.003; Kim Y, 2019, J INVEST DERMATOL, V139, P827, DOI 10.1016/j.jid.2018.10.029; Krieger N, 2020, ANNU REV PUBL HEALTH, V41, P37, DOI 10.1146/annurev-publhealth-040119-094017; Kroner JD, 2018, J ALLERGY CLIN IMMUN, V142, P1669, DOI 10.1016/j.jaci.2018.07.019; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Lee RD, 2017, CHILD ABUSE NEGLECT, V69, P40, DOI 10.1016/j.chiabu.2017.04.004; Lee RD, 2013, PEDIATRICS, V131, pE1188, DOI 10.1542/peds.2012-0627; Liberman AC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00235; Logan JR, 2013, CITY COMMUNITY, V12, P160, DOI 10.1111/cico.12021; Lowe AA, 2018, ANN AM THORAC SOC, V15, P745, DOI 10.1513/AnnalsATS.201708-674PS; Ma L, 2014, J EUR ACAD DERMATOL, V28, P1079, DOI 10.1111/jdv.12288; Margolis DJ, 2019, JAMA DERMATOL, V155, P1269, DOI 10.1001/jamadermatol.2019.1946; McCauley K, 2019, J ALLERGY CLIN IMMUN, V144, P1187, DOI 10.1016/j.jaci.2019.05.035; McKenzie C, 2019, ANN ALLERG ASTHMA IM, V123, P173, DOI 10.1016/j.anai.2019.05.014; Mcquaid EL, 2017, ACHIEVING RESP HLTH; Meduri GU, 2004, ANN NY ACAD SCI, V1024, P24, DOI 10.1196/annals.1321.004; Miller GE, 2006, P NATL ACAD SCI USA, V103, P5496, DOI 10.1073/pnas.0506312103; Miller GE, 2018, PEDIATR PULM, V53, P710, DOI 10.1002/ppul.23983; Milner AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147158; Misra S, 2021, HEALTH EDUC BEHAV, V48, P332, DOI 10.1177/10901981211010676; Mitchell B, 2018, REDLINING MAPS PERSI; Morello-Frosch R, 2006, ENVIRON RES, V102, P181, DOI 10.1016/j.envres.2006.05.007; Nardone A, 2020, LANCET PLANET HEALTH, V4, pE24, DOI 10.1016/S2542-5196(19)30241-4; Nardone A, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0782-x; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Odlum M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25134; Pomes A, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0694-1; Purser JL, 2008, BIOMARK MED, V2, P335, DOI 10.2217/17520363.2.4.335; Quillian L, 2020, RACE SOC PROBL, V12, P13, DOI 10.1007/s12552-019-09276-x; Ramirez F, 1996, J IMMUNOL, V156, P2406; Ray A, 2020, PHYSIOL REV, V100, P983, DOI 10.1152/physrev.00023.2019; Remigio-Baker RA, 2015, LUNG, V193, P885, DOI 10.1007/s00408-015-9777-8; Rosenbaum E, 2008, J HEALTH SOC BEHAV, V49, P131, DOI 10.1177/002214650804900202; Rosenberg SL, 2014, J ALLERGY CLIN IMMUN, V134, P1009, DOI 10.1016/j.jaci.2014.07.005; Rothstein R., 2017, COLOR LAW FORGOTTEN; Salinas C, 2019, J LAT EDUC, V18, P302, DOI 10.1080/15348431.2017.1390464; Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001; Semega J., 2019, CURRENT POPULATION S; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Silverberg JI, 2014, DERMATITIS, V25, P107, DOI 10.1097/DER.0000000000000034; Silverberg JI, 2013, JAMA PEDIATR, V167, P554, DOI 10.1001/jamapediatrics.2013.1319; Simons RL, 2018, DEV PSYCHOL, V54, P1993, DOI 10.1037/dev0000511; Snow SJ, 2018, TOXICOL SCI, V164, P9, DOI 10.1093/toxsci/kfy129; Stempel H, 2019, PAEDIATR RESPIR REV, V32, P10, DOI 10.1016/j.prrv.2019.07.001; Sullivan K, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-0899-6; Tackett KJ, 2020, PEDIATR DERMATOL, V37, P142, DOI 10.1111/pde.14058; Thakur N, 2019, J ALLERGY CLIN IMMUN, V143, P1914, DOI 10.1016/j.jaci.2018.12.1015; Thakur N, 2017, CHEST, V151, P804, DOI 10.1016/j.chest.2016.11.027; Thakur N, 2014, J ASTHMA, V51, P720, DOI 10.3109/02770903.2014.905593; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Theall KP, 2012, AM J EPIDEMIOL, V176, pS164, DOI 10.1093/aje/kws185; Tiotiu AI, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176212; Wagner P, 2015, PRISON POLICY INITIA; Wang EA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-290; Washington DM, 2018, J RACIAL ETHN HEALTH, V5, P928, DOI 10.1007/s40615-017-0441-2; Wechsler ME, 2019, NEW ENGL J MED, V381, P1227, DOI 10.1056/NEJMoa1905560; Wegienka G, 2012, CLIN EXP ALLERGY, V42, P909, DOI 10.1111/j.1365-2222.2011.03946.x; Whittemore AH, 2017, J PLAN LIT, V32, P16, DOI 10.1177/0885412216683671; Williams DR, 2019, HEALTH SERV RES, V54, P1374, DOI 10.1111/1475-6773.13222; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750; Williams DR, 2016, HEALTH PSYCHOL, V35, P407, DOI 10.1037/hea0000242; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Wing R, 2015, ANN ALLERG ASTHMA IM, V114, P379, DOI 10.1016/j.anai.2015.02.019; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008; Wright RJ, 2005, J ALLERGY CLIN IMMUN, V116, P1301, DOI 10.1016/j.jaci.2005.09.050; Xiang LB, 2013, INT IMMUNOPHARMACOL, V17, P556, DOI 10.1016/j.intimp.2013.07.019; Xu LX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/983149; Yonas MA, 2012, CURR OPIN ALLERGY CL, V12, P202, DOI 10.1097/ACI.0b013e32835090c9; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1; Zheng XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138146; Zhu YQ, 2021, J INVEST DERMATOL, V141, P1855, DOI 10.1016/j.jid.2020.12.022; Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006; Zullo SW, 2019, J AM ACAD DERMATOL, V81, pAB133	132	4	4	3	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1112	1120		10.1016/j.jaci.2021.09.020	http://dx.doi.org/10.1016/j.jaci.2021.09.020		NOV 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	WV7LX	34743832	Green Accepted, hybrid			2022-12-18	WOS:000717415000003
J	Fragoulis, GE; Brock, J; Basu, N; McInnes, IB; Siebert, S				Fragoulis, George E.; Brock, James; Basu, Neil; McInnes, Iain B.; Siebert, Stefan			The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						JAK inhibitors; randomized controlled trials; biologics; rheumatoid arthritis; psoriasis; inflammatory bowel disease	SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR INHIBITORS; JANUS KINASE INHIBITOR; DOUBLE-BLIND; INADEQUATE RESPONSE; MAINTENANCE THERAPY; TOFACITINIB MONOTHERAPY; ULCERATIVE-COLITIS; RANDOMIZED-TRIAL; CLINICAL-TRIALS	JAK inhibitors (JAKIs) are a new class of targeted therapy that have entered clinical practice for the treatment of immune-mediated rheumatic conditions. JAKIs can block the signaling activity of a variety of proinflammatory cytokines and therefore have the potential to mediate therapeutic benefits across a wide range of immune-mediated conditions. Several JAKIs are licensed, and many more are undergoing clinical trials. Here we provide a narrative review of the current and upcoming JAKIs for adult immune-mediated rheumatic and related conditions, with a specific focus on efficacy in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, psoriasis, and inflammatory bowel disease. The overall safety profile of JAKIs appears largely comparable to that of existing biologic cytokine-targeting agents, particularly, TNF inhibitors, apart from risk of herpes zoster, which is increased for JAKIs. Importantly however, unresolved safety concerns remain, particularly relating to increased venous thromboembolism. (J Allergy Clin Immunol 2021;148:941-52.)	[Fragoulis, George E.; Brock, James; Basu, Neil; McInnes, Iain B.; Siebert, Stefan] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Fragoulis, George E.] Natl & Kapodistrian Univ Athens, Dept Propaedeut Internal Med 1, Laiko Gen Hosp, Athens, Greece	University of Glasgow; Laiko General Hospital; National & Kapodistrian University of Athens	Siebert, S (corresponding author), Inst Infect Immun & Inflammat, 4th Floor,Sir Graeme Davies Bldg,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	stefan.siebert@glasgow.ac.uk						AGENCY EM, 2020, EMA925172020; Al-Bawardy B, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.651415; Angelini J, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10071002; [Anonymous], 2021, XELJANZ TOFACITINIB; [Anonymous], 2019, FDA UPADACITINIB RIS; Avci AB, 2021, RHEUMATOLOGY, V60, pii11, DOI [10.1093/rheumatology/keaa893, DOI 10.1093/RHEUMATOLOGY/KEAA893, DOI 10.1093/RHEUMAT0L0GY/KEAA893]; Bachelez H, 2015, LANCET, V386, P552, DOI 10.1016/S0140-6736(14)62113-9; Banerjee S, 2017, DRUGS, V77, P521, DOI 10.1007/s40265-017-0701-9; Bechman K, 2019, RHEUMATOLOGY, V58, P1755, DOI 10.1093/rheumatology/kez087; Boehncke WH, 2018, CLIN REV ALLERG IMMU, V55, P295, DOI 10.1007/s12016-017-8634-3; Brown MA, 2017, BEST PRACT RES CL RH, V31, P763, DOI 10.1016/j.berh.2018.09.005; Burmester GR, 2018, LANCET, V391, P2503, DOI 10.1016/S0140-6736(18)31115-2; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Choy E, 2019, ARTHRITIS RHEUMATOL, V71; Cohen Stanley B, 2020, RMD Open, V6, DOI 10.1136/rmdopen-2020-001395; Combe B, 2021, ANN RHEUM DIS, V80, P848, DOI 10.1136/annrheumdis-2020-219214; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Curtis JR, 2017, CLIN EXP RHEUMATOL, V35, P614; Curtis JR, 2016, ANN RHEUM DIS, V75, P1843, DOI 10.1136/annrheumdis-2016-209131; Damsky W, 2018, NEW ENGL J MED, V379, P2540, DOI 10.1056/NEJMoa1805958; Machado MAD, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1539-6; De Wilde K, 2017, ANN RHEUM DIS, V76, P585, DOI 10.1136/annrheumdis-2016-209454; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Deodhar A, 2021, ANN RHEUM DIS, V80, P1004, DOI 10.1136/annrheumdis-2020-219601; Dougados M, 2017, ANN RHEUM DIS, V76, P88, DOI 10.1136/annrheumdis-2016-210094; El Jammal T, 2021, EXPERT OPIN PHARMACO, V22, P205, DOI 10.1080/14656566.2020.1822325; Evangelatos G, 2020, THER ADV MUSCULOSKEL, V12, DOI 10.1177/1759720X20930116; Feagan Brian G, 2021, Lancet, V397, P2372, DOI 10.1016/S0140-6736(21)00666-8; Felson D, 2007, ARTHRIT RHEUM-ARTHR, V57, P193, DOI 10.1002/art.22552; Fleischmann R, 2019, ARTHRITIS RHEUMATOL, V71, P1788, DOI 10.1002/art.41032; Fleischmann R, 2017, LANCET, V390, P457, DOI 10.1016/S0140-6736(17)31618-5; Fleischmann R, 2017, ARTHRITIS RHEUMATOL, V69, P506, DOI 10.1002/art.39953; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Fleischmann RM, 2015, ARTHRITIS RHEUMATOL, V67, P334, DOI 10.1002/art.38949; Forman SB, 2020, J INVEST DERMATOL, V140, P2359, DOI 10.1016/j.jid.2020.03.962; Fragoulis GE, 2019, RHEUMATOLOGY, V58, P43, DOI 10.1093/rheumatology/key276; Fragoulis GE, 2016, ANNU REV MED, V67, P337, DOI 10.1146/annurev-med-051914-021944; Furumoto Y, 2017, ARTHRITIS RHEUMATOL, V69, P148, DOI 10.1002/art.39818; Genovese MC, 2019, JAMA-J AM MED ASSOC, V322, P315, DOI 10.1001/jama.2019.9055; Genovese MC, 2018, LANCET, V391, P2513, DOI 10.1016/S0140-6736(18)31116-4; Genovese MC, 2016, NEW ENGL J MED, V374, P1243, DOI 10.1056/NEJMoa1507247; Genovese MC, 2016, ARTHRITIS RHEUMATOL, V68, P46, DOI 10.1002/art.39473; Ghoreschi K, 2021, LANCET, V397, P754, DOI 10.1016/S0140-6736(21)00184-7; Gladman D, 2017, NEW ENGL J MED, V377, P1525, DOI 10.1056/NEJMoa1615977; Hammitzsch A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.591176; Harigai M, 2019, RHEUMATOLOGY, V58, P34, DOI 10.1093/rheumatology/key287; Harrington R, 2020, J INFLAMM RES, V13, P519, DOI 10.2147/JIR.S219586; Huang JF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.017; Jamilloux Y, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102390; Kivitz AJ, 2018, SEMIN ARTHRITIS RHEU, V48, P406, DOI 10.1016/j.semarthrit.2018.07.006; Komai T, 2018, SCAND J RHEUMATOL, V47, P505, DOI 10.1080/03009742.2017.1387673; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Kvist-Hansen A, 2020, DERMATOLOGY THER, V10, P29, DOI 10.1007/s13555-019-00347-w; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Lee JJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0435-y; Lee YH, 2020, Z RHEUMATOL, V79, P785, DOI 10.1007/s00393-020-00750-1; Lefevre PLC, 2020, J CROHNS COLITIS, V14, pS725, DOI 10.1093/ecco-jcc/jjaa014; Liew SH, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.028; Mahieu MA, 2016, LUPUS, V25, P1122, DOI 10.1177/0961203316652492; McInnes IB, 2021, NEW ENGL J MED, V384, P1227, DOI 10.1056/NEJMoa2022516; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease P, 2018, LANCET, V392, P2367, DOI 10.1016/S0140-6736(18)32483-8; Mease Philip J, 2021, Ann Rheum Dis, V80, P312, DOI 10.1136/annrheumdis-2020-218870; Meshkov AD, 2019, ANN RHEUM DIS, V78, DOI 10.1136/annrheumdis-2018-213554; Nash P, 2021, ANN RHEUM DIS, V80, P71, DOI 10.1136/annrheumdis-2020-218398; Nash P, 2020, RHEUMATOL THER, V7, P553, DOI 10.1007/s40744-020-00209-4; Nogueira M, 2020, DRUGS, V80, P341, DOI 10.1007/s40265-020-01261-8; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Panes J, 2017, GUT, V66, P1049, DOI 10.1136/gutjnl-2016-312735; Papp KA, 2015, BRIT J DERMATOL, V173, P949, DOI 10.1111/bjd.14018; Papp K, 2018, NEW ENGL J MED, V379, P1313, DOI 10.1056/NEJMoa1806382; Papp KA, 2016, BMC DERMATOL, V16, DOI 10.1186/s12895-016-0051-4; Rajasimhan S, 2020, DRUG AGING, V37, P551, DOI 10.1007/s40266-020-00775-w; Maneiro JR, 2017, SEMIN ARTHRITIS RHEU, V47, P149, DOI 10.1016/j.semarthrit.2017.02.007; ROTENBERG C, 2018, EUR RESPIR J, P52; Rubbert-Roth A, 2020, NEW ENGL J MED, V383, P1511, DOI 10.1056/NEJMoa2008250; Sandborn WJ, 2020, J CROHNS COLITIS, V14, P1202, DOI 10.1093/ecco-jcc/jjaa049; Sandborn WJ, 2020, GASTROENTEROLOGY, V158, P2139, DOI 10.1053/j.gastro.2020.02.030; Sandborn WJ, 2017, NEW ENGL J MED, V376, P1723, DOI 10.1056/NEJMoa1606910; Sands BE, 2020, ALIMENT PHARM THER, V51, P271, DOI 10.1111/apt.15555; Sands BE, 2018, J CROHNS COLITIS, V12, P1158, DOI 10.1093/ecco-jcc/jjy085; Sepriano A, 2020, ANN RHEUM DIS, V79, P760, DOI 10.1136/annrheumdis-2019-216653; Sideris Nikolaos, 2020, Mediterr J Rheumatol, V31, P137, DOI 10.31138/mjr.31.1.137; Smolen JS, 2019, LANCET, V393, P2303, DOI 10.1016/S0140-6736(19)30419-2; Smolen JS, 2019, J RHEUMATOL, V46, P7, DOI 10.3899/jrheum.171361; Strand V, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2018-000808; Strand V, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2018-000806; Sunzini F, 2020, THER ADV MUSCULOSKEL, V12, DOI 10.1177/1759720X20936059; Takeuchi T, 2019, ANN RHEUM DIS, V78, P1305, DOI 10.1136/annrheumdis-2019-215164; Tanaka Y, 2022, MOD RHEUMATOL, V32, P1, DOI 10.1080/14397595.2021.1902617; Tanaka Y, 2019, ANN RHEUM DIS, V78, P1320, DOI 10.1136/annrheumdis-2019-215163; Taylor PC, 2019, ARTHRITIS RHEUMATOL, V71, P1042, DOI 10.1002/art.40841; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; van der Heijde D, 2019, LANCET, V394, P2108, DOI 10.1016/S0140-6736(19)32534-6; van der Heijde D, 2018, LANCET, V392, P2378, DOI 10.1016/S0140-6736(18)32463-2; van der Heijde D, 2017, ANN RHEUM DIS, V76, P1340, DOI 10.1136/annrheumdis-2016-210322; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van Vollenhoven RF, 2020, ARTHRITIS RHEUMATOL, V72, P761, DOI 10.1002/art.41179; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Vermeire S, 2017, LANCET, V389, P266, DOI 10.1016/S0140-6736(16)32537-5; Vieira MC, 2016, CLIN THER, V38, P2628, DOI 10.1016/j.clinthera.2016.11.004; Wallace DJ, 2018, LANCET, V392, P222, DOI 10.1016/S0140-6736(18)31363-1; Westhovens R, 2021, ANN RHEUM DIS, V80, P727, DOI 10.1136/annrheumdis-2020-219213; Winthrop KL, 2021, ANN RHEUM DIS, V80, P134, DOI 10.1136/annrheumdis-2020-218992; Winthrop KL, 2020, ANN RHEUM DIS, V79, P1290, DOI 10.1136/annrheumdis-2019-216852; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wollenhaupt J, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1866-2; Xie FL, 2016, ARTHRITIS RHEUMATOL, V68, P2612, DOI 10.1002/art.39761; You HX, 2020, CLIN REV ALLERG IMMU, V59, P334, DOI 10.1007/s12016-020-08786-6; You HX, 2019, ANN RHEUM DIS, V78, P1441, DOI 10.1136/annrheumdis-2019-215455; Zhang H, 2018, CIRCULATION, V137, P1934, DOI 10.1161/CIRCULATIONAHA.117.030423	111	4	4	2	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					941	952		10.1016/j.jaci.2021.08.010	http://dx.doi.org/10.1016/j.jaci.2021.08.010		OCT 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34450118				2022-12-18	WOS:000705023300003
J	Jansen, K; Wirz, OF; van de Veen, W; Tan, G; Mirer, D; Sokolowska, M; Satitsuksanoa, P; Message, SD; Kebadze, T; Glanville, N; Mallia, P; Skiepko, R; Eljaszewicz, A; Moniuszko, M; Cardoso, C; Gern, JE; Papadopoulos, NG; Akdis, CA; Johnston, SL; Nadeau, KC; Akdis, M				Jansen, Kirstin; Wirz, Oliver F.; van de Veen, Willem; Tan, Ge; Mirer, David; Sokolowska, Milena; Satitsuksanoa, Pattraporn; Message, Simon D.; Kebadze, Tatiana; Glanville, Nicholas; Mallia, Patrick; Skiepko, Roman; Eljaszewicz, Andrzej; Moniuszko, Marcin; Cardoso, Carlos; Gern, James E.; Papadopoulos, Nikolaos G.; Akdis, Cezmi A.; Johnston, Sebastian L.; Nadeau, Kari C.; Akdis, Muebeccel			Loss of regulatory capacity in Treg cells following rhinovirus infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Treg cells; rhinovirus 16; RV-A16; rhinovirus infection; allergic asthma; experimental infection; suppressive capacity; anti-viral response; interferon-induced genes; proinflammatory cytokines	T-CELLS; RESPIRATORY ILLNESS; TYPE-2 INFLAMMATION; IMMUNE-RESPONSES; IFN-ALPHA; ASTHMA; DEFICIENT; CYTOKINES; DIFFERENTIATION; EXACERBATIONS	Background: Respiratory infections with rhinoviruses (RV) are strongly associated with development and exacerbations of asthma, and they pose an additional health risk for subjects with allergy. Objective: How RV infections and chronic allergic diseases are linked and what role RV plays in the breaking of tolerance in regulatory T (Treg) cells is unknown. Therefore, this study aims to investigate the effects of RV on Treg cells. Methods: Treg cells were isolated from subjects with asthma and controls after experimental infection with the RV-A16 (RV16) and analyzed with next-generation sequencing. Additionally, suppression assays, quantitative PCR assays, and protein quantifications were performed with Treg cells after in vitro RV16 infection. Results: RV16 induced a strong antiviral response in Treg cells from subjects with asthma and controls, including the upregulation of IFI44L, MX1, ISG15, IRF7, and STAT1. In subjects with asthma, the inflammatory response was exaggerated and showed a dysregulated immune response compared with that in the controls. Furthermore, subjects with asthma failed to upregulate several immunosuppressive molecules such as CTLA4 and CD69, and they upregulated the inflammasome-related genes PYCARD and AIM2. Additionally, RV16 reduced the suppressive capacity of Treg cells from healthy subjects and subjects with asthma in vitro and increased TH2 cell-type cytokine production. Conclusions: Treg cells from healthy subjects and subjects with asthma displayed an antiviral response after RV infection and showed reduced suppressive capacity. These data suggest that Treg cell function might be altered or impaired during RV infections, which might play an important role in the association between RV and the development of asthma and asthma exacerbations.	[Jansen, Kirstin; Wirz, Oliver F.; van de Veen, Willem; Tan, Ge; Mirer, David; Sokolowska, Milena; Satitsuksanoa, Pattraporn; Akdis, Cezmi A.; Akdis, Muebeccel] Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland; [van de Veen, Willem; Akdis, Cezmi A.] Christine Kiihne Ctr Allergy Res & Educ, Davos, Switzerland; [Tan, Ge] ETH Zurich Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Message, Simon D.; Kebadze, Tatiana; Glanville, Nicholas; Mallia, Patrick; Johnston, Sebastian L.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Skiepko, Roman; Eljaszewicz, Andrzej; Moniuszko, Marcin] Med Univ Bialystok, Dept Regenerat Med & Immune Regulat, Bialystok, Poland; [Cardoso, Carlos] Hochgebirgsklin Davos, Pneumonol Dept, Davos, Switzerland; [Gern, James E.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Papadopoulos, Nikolaos G.] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Papadopoulos, Nikolaos G.] Univ Athens, Pediat Clin 2, Allergy Dept, Athens, Greece; [Nadeau, Kari C.] Stanford Univ, Dept Med, Sean N Parker Ctr Allergy & Asthma Res, Palo Alto, CA USA	Swiss Institute of Allergy & Asthma Research; University of Zurich; Imperial College London; Medical University of Bialystok; University of Wisconsin System; University of Wisconsin Madison; University of Manchester; National & Kapodistrian University of Athens; Stanford University	Akdis, M (corresponding author), Swiss Inst Allergy & Asthma Res, Herman Burchard Str 9, CH-7265 Davos, Switzerland.	akdism@siat.uzh.ch		Wirz, Oliver/0000-0003-0377-6464; Moniuszko, Marcin/0000-0001-7183-3120	Swiss National Science Foundation [320030-159870/310030-179428, 310030-156823, 310030_189334/1]; PREDICTA [260895]; Sean N. Parker Center for Allergy and Asthma Research at Stanford University; Christine Kuhne Center for Allergy Research and Education; GSK; Medical Research Council Clinical Research Fellowship; British Medical Association H.C. Roscoe Fellowship; British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program [P00/2]; Asthma UK [02/027, 05/067, CH11SJ]; Welcome Trust [063717, 083567/Z/07/Z]; National Institute for Health Research Biomedical Research Center; MRC Centre [G1000758]; Asthma UK Centre [AUK-BC-2015-01]; European Research Council [788575]; National Institutes of Health [U19 AI104317, U19 AI104209, U01 AI140498, R01 AI140134]; Naddisy Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); PREDICTA; Sean N. Parker Center for Allergy and Asthma Research at Stanford University; Christine Kuhne Center for Allergy Research and Education; GSK(GlaxoSmithKline); Medical Research Council Clinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Medical Association H.C. Roscoe Fellowship; British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program; Asthma UK; Welcome Trust(Wellcome Trust); National Institute for Health Research Biomedical Research Center(National Institute for Health Research (NIHR)); MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK Centre; European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Naddisy Foundation	M.A. has received research support from the Swiss National Science Foundation (grant 320030-159870/310030-179428) and PREDICTA (grant 260895) and the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. C.A.A. is employed by the Swiss Institute of Allergy and Asthma Research, University of Zurich, and supported by the Swiss National Science Foundation (grant 310030-156823) and the Christine Kuhne Center for Allergy Research and Education. M.S. received research grants from the Swiss National Science Foundation (grant 310030_189334/1) and from GSK. The experimental infection study was supported by a Medical Research Council Clinical Research Fellowship (to S.D.M.), a British Medical Association H.C. Roscoe Fellowship (to S.D.M.), the British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program (grant P00/2), Asthma UK (grants 02/027 and 05/067), the Welcome Trust (grants 063717 and 083567/Z/07/Z) for the Centre for Respiratory Infection, Imperial College, and the National Institute for Health Research Biomedical Research Center funding scheme. S.L.J. is the Asthma UK Clinical Professor (grant CH11SJ); he is an National Institute for Health Research Emeritus Senior Investigator, and he was supported by the MRC Centre (grant G1000758), the Asthma UK Centre (grant AUK-BC-2015-01), and European Research Council (advanced grant 788575). J.E.G. is supported by the National Institutes of Health (grant U19 AI104317 [Asthma and Allergic Diseases Cooperative Research Center]). K.C.N. is supported by the National Institutes of Health (grant U19 AI104209 [Asthma and Allergic Diseases Cooperative Research Center] and grants U01 AI140498 and R01 AI140134) and the Naddisy Foundation.	Aab A, 2017, ALLERGY, V72, P232, DOI 10.1111/all.12931; Agache I, 2019, J CLIN INVEST, V129, P1493, DOI 10.1172/JCI124611; Atsaves V, 2019, CANCERS, V11, DOI 10.3390/cancers11071037; Bandukwala HS, 2013, NAT IMMUNOL, V14, P201, DOI 10.1038/ni.2546; Bedoya F, 2013, J IMMUNOL, V190, P6115, DOI 10.4049/jimmunol.1203302; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Boonpiyathad T, 2020, ALLERGY, V75, P84, DOI 10.1111/all.13967; Bossios A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-114; Brincks EL, 2013, J IMMUNOL, V190, P3438, DOI 10.4049/jimmunol.1203140; Chen TT, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/3096183; Contoli M, 2015, ALLERGY, V70, P910, DOI 10.1111/all.12627; Deane JA, 2012, J IMMUNOL, V188, P2179, DOI 10.4049/jimmunol.1102752; DeDiego ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01159-19; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gern JE, 2015, CLIN EXP ALLERGY, V45, P32, DOI 10.1111/cea.12428; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Han MY, 2019, MUCOSAL IMMUNOL, V12, P958, DOI 10.1038/s41385-019-0172-2; Hansel TT, 2017, EBIOMEDICINE, V19, P128, DOI 10.1016/j.ebiom.2017.03.033; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ieven M, 2018, CLIN MICROBIOL INFEC, V24, P1158, DOI 10.1016/j.cmi.2018.02.004; Ilarraza R, 2013, J ALLERGY CLIN IMMUN, V131, P395, DOI 10.1016/j.jaci.2012.11.041; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jartti T, ALLERGY EUR J ALLERG, V76, P247; Jartti T, 2017, J ALLERGY CLIN IMMUN, V140, P895, DOI 10.1016/j.jaci.2017.08.003; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jung HE, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020109; Kolar P, 2009, ARTHRITIS RHEUM-US, V60, P123, DOI 10.1002/art.24181; Kondo M, 2016, J IMMUNOL, V196, P563, DOI 10.4049/jimmunol.1501429; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee WM, 2015, METHODS MOL BIOL, V1221, P25, DOI 10.1007/978-1-4939-1571-2_3; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin PH, 2018, MUCOSAL IMMUNOL, V11, P1239, DOI 10.1038/s41385-018-0004-9; Mehta AK, 2018, ALLERGY, V73, P1415, DOI 10.1111/all.13390; Menzel M, 2019, SCI REP-UK, V9, P1; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Meyer K, 2015, SCI REP-UK, V5, P1; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315; Muehling LM, 2016, J IMMUNOL, V197, P3214, DOI 10.4049/jimmunol.1600663; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Narayan S, 2011, IMMUNOLOGY, V134, P33, DOI 10.1111/j.1365-2567.2011.03462.x; Papadopoulos Nikolaos G, 2004, Paediatr Respir Rev, V5, P255, DOI 10.1016/j.prrv.2004.04.002; Piconese S, 2015, CYTOKINE GROWTH F R, V26, P133, DOI 10.1016/j.cytogfr.2014.10.012; Prill MM, 2018, CLIN INFECT DIS, V66, P1528, DOI 10.1093/cid/cix1034; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roh YS, 2018, AM J PATHOL, V188, P2574, DOI 10.1016/j.ajpath.2018.07.011; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tanwar S, 2020, J AUTOIMMUN, V115, DOI 10.1016/j.jaut.2020.102525; Veerati PC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00974; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang YG, 2010, J IMMUNOL, V184, P1589, DOI 10.4049/jimmunol.0901582; Wildenbeest JG, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.022; Wirz OF, 2020, ALLERGY, V75, P3147, DOI 10.1111/all.14445; Xi Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.27; Yamaguchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30124; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0927-9; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zaheer RS, 2014, MUCOSAL IMMUNOL, V7, P1127, DOI 10.1038/mi.2013.128; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003	73	4	4	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					1016	+		10.1016/j.jaci.2021.05.045	http://dx.doi.org/10.1016/j.jaci.2021.05.045		OCT 2021	30	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34153372				2022-12-18	WOS:000705023300012
J	Reyes-Angel, J; Han, YY; Litonjua, AA; Celedon, JC				Reyes-Angel, Jessica; Han, Yueh-Ying; Litonjua, Augusto A.; Celedon, Juan C.			Diet and asthma: Is the sum more important than the parts?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Diet; asthma; nutrients; vitamins	FOLLOW-UP; TRIAL; RISK		[Reyes-Angel, Jessica; Han, Yueh-Ying; Celedon, Juan C.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pulm Med, Dept Pediat, Pittsburgh, PA USA; [Litonjua, Augusto A.] Univ Rochester, Univ Rochester Med Ctr, Div Pulmonol, Dept Pediat, Rochester, NY 14627 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester	Celedon, JC (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Pediat Pulm Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	juan.celedon@chp.edu			US National Institutes of Health [HL117191, HL119952, MD011764]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health (grant nos. HL117191, HL119952, and MD011764) .	Alwarith J, 2020, NUTR REV, V78, P928, DOI 10.1093/nutrit/nuaa005; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Chen LW, 2020, AM J CLIN NUTR, V111, P440, DOI 10.1093/ajcn/nqz297; Forno E, 2020, JAMA-J AM MED ASSOC, V324, P752, DOI 10.1001/jama.2020.12384; Han YY, 2020, ANN AM THORAC SOC, V17, P293, DOI 10.1513/AnnalsATS.201908-629OC; Han YY, 2018, J ALLER CL IMM-PRACT, V6, P834, DOI 10.1016/j.jaip.2017.12.029; Han YY, 2013, LANCET RESP MED, V1, P813, DOI 10.1016/S2213-2600(13)70126-7; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Litonjua AA, 2020, NEW ENGL J MED, V382, P525, DOI 10.1056/NEJMoa1906137; Ma J, 2016, EUR RESPIR J, V47, P122, DOI 10.1183/13993003.00591-2015	10	4	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					706	707		10.1016/j.jaci.2021.04.030	http://dx.doi.org/10.1016/j.jaci.2021.04.030		SEP 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33965429	Green Accepted, Bronze			2022-12-18	WOS:000695242900012
J	Roumeau, I; Coutu, A; Navel, V; Pereira, B; Baker, JS; Chiambaretta, F; Bremond-Gignac, D; Dutheil, F				Roumeau, Ines; Coutu, Adrien; Navel, Valentin; Pereira, Bruno; Baker, Julien S.; Chiambaretta, Frederic; Bremond-Gignac, Dominique; Dutheil, Frederic			Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Chronic disease; immunomodulators; topical drugs; atopy; inflammation; pediatrics	TOPICAL 2-PERCENT CYCLOSPORINE; IMPRESSION CYTOLOGY SPECIMENS; EYE-DROPS; CROMOLYN SODIUM; DOUBLE-BLIND; LODOXAMIDE 0.1-PERCENT; TACROLIMUS OINTMENT; NEDOCROMIL SODIUM; CLINICAL FINDINGS; OCULAR SURFACE	Background: Vernal keratoconjunctivitis (VKC) is a severe type of allergic conjunctivitis for which treatment strategies are still under debate. Objectives: This study sought to conduct a systematic review and meta-analysis to evaluate the efficacy of medical treatments for VKC. Methods: The PubMed, Cochrane Library, Embase, and ScienceDirect databases were searched to assess the efficacy of treatments for VKC. Random-effect meta-analyses on changes in clinical scores of symptoms and signs between baseline and after treatment, stratified on treatment classes, were computed. Meta-regressions were searched for potential influencing parameters. Results: Included were 45 studies (27 randomized controlled trials and 18 prospective cohort studies), 1749 patients (78% were men; mean age, 11.2 years), and 12 different treatment classes. Mast cell stabilizers (MCSs; usually considered as firstline therapy), cyclosporine, and tacrolimus were the most studied drugs (in three-quarters of studies). Overall, all clinical scores improved. Total symptom and sign score decreased for MCSs (effect size, -3.19; 95% CI, -4.26 to -2.13), cyclosporine (effect size, -2.06; 95% CI, -2.72 to -1.40), and tacrolimus (effect size, -2.39; 95% CI, -3.36 to -1.43). No significant differences were shown depending on treatment classes, concentration, age, sex, baseline activity scores, and atopy. Sensitivity analyses demonstrated similar results. Conclusions: This study confirms the efficacy of MCSs in the treatment of VKC. Efficacy of cyclosporine and tacrolimus did not differ, suggesting that tacrolimus is a good alternative to cyclosporine for severe cases of VKC. Further studies are needed to compare other drugs and their precise place in treatment strategy.	[Roumeau, Ines; Coutu, Adrien; Navel, Valentin; Chiambaretta, Frederic] CHU Clermont Ferrand, Ophthalmol Dept, Clermont Ferrand, France; [Dutheil, Frederic] CHU Clermont Ferrand, Univ Hosp Clermont Ferrand, Prevent & Occupat Med Dept, Clermont Ferrand, France; [Pereira, Bruno] Univ Hosp Clermont Ferrand, Clin Res & Innovat Direct, Biostat Unit, Clermont Ferrand, France; [Navel, Valentin; Chiambaretta, Frederic] Univ Clermont Auvergne, INSERM, Translat Approach Epithelial Injury & Repair Dept, CNRS,Genet Reprod Dev, Clermont Ferrand, France; [Dutheil, Frederic] Univ Clermont Auvergne, CNRS, Physiol & Psychosocial Stress Dept, Lab Psychol Sociale & Cognit, Clermont Ferrand, France; [Baker, Julien S.] Hong Kong Baptist Univ, Ctr Hlth & Exercise Sci Res Phys Educ & Hlth, Hong Kong, Peoples R China; [Bremond-Gignac, Dominique] Univ Hosp Necker Enfants Malades, Ophthalmol Dept, Paris, France; [Bremond-Gignac, Dominique] Sorbonne Paris Cite Univ, INSERM, Team Physiopathol Ocular Dis Clin Dev 17, Unite Mixte Rech S1138,Cordeliers Search Ctr, Paris, France; [Dutheil, Frederic] Australian Catholic Univ, Sch Exercise Sci, Fac Hlth, Melbourne, Vic, Australia	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Hong Kong Baptist University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Australian Catholic University	Navel, V (corresponding author), CHU Clermont Ferrand, Ophthalmol, 58 Rue Montalembert, F-63000 Clermont Ferrand, France.	vnavel@chu-clermontferrand.fr		Navel, Valentin/0000-0001-6317-345X				Addis H, 2018, CLIN OPHTHALMOL, V12, P119, DOI 10.2147/OPTH.S129552; Akpek EK, 2000, OPHTHALMOLOGY, V107, P263, DOI 10.1016/S0161-6420(99)00096-2; Al-Amri AM, 2016, MIDDLE EAST AFR J OP, V23, P135, DOI 10.4103/0974-9233.164616; Avunduk AM, 2001, OPHTHALMOLOGICA, V215, P290, DOI 10.1159/000050876; Avunduk AM, 2000, OPHTHALMOLOGY, V107, P1333, DOI 10.1016/S0161-6420(00)00089-0; Ben-Eli H, 2018, CURR OPIN ALLERGY CL, V18, P411, DOI 10.1097/ACI.0000000000000473; Benichou T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195166; Bielory L, 2002, DRUGS, V62, P1611, DOI 10.2165/00003495-200262110-00004; BLEIK JH, 1991, OPHTHALMOLOGY, V98, P1679; Bonini S, 2000, OPHTHALMOLOGY, V107, P1157, DOI 10.1016/S0161-6420(00)00092-0; Bremond-Gignac D, 2008, BRIT J OPHTHALMOL, V92, P1097, DOI 10.1136/bjo.2007.117812; Bremond-Gignac D, 2016, OPHTHALMOLOGY, V123, P435, DOI 10.1016/j.ophtha.2015.07.012; Centofanti M, 1996, EYE, V10, P422, DOI 10.1038/eye.1996.93; Citrome L, 2014, INT J CLIN PRACT, V68, P533, DOI 10.1111/ijcp.12435; Corum I, 2005, J OCUL PHARMACOL TH, V21, P400, DOI 10.1089/jop.2005.21.400; D'Angelo G, 2003, GRAEF ARCH CLIN EXP, V241, P192, DOI 10.1007/s00417-002-0612-6; d'Azy CB, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.3.38; De Smedt SK, 2012, OPHTHALMOLOGY, V119, P1766, DOI 10.1016/j.ophtha.2012.03.041; Doan S, 2007, J FR OPHTALMOL, V30, P697, DOI 10.1016/S0181-5512(07)91357-1; Doan S, 2017, OPHTHALMOL THER, V6, P195, DOI 10.1007/s40123-016-0074-2; EASTY D L, 1972, Clinical Allergy, V2, P99, DOI 10.1111/j.1365-2222.1972.tb01274.x; ELHENNAWI M, 1994, BRIT J OPHTHALMOL, V78, P365, DOI 10.1136/bjo.78.5.365; Esposito S, 2016, PEDIATR DRUGS, V18, P347, DOI 10.1007/s40272-016-0185-1; Feizi S, 2021, OCUL SURF, V19, P282, DOI 10.1016/j.jtos.2020.10.005; FOSTER CS, 1980, AM J OPHTHALMOL, V90, P175, DOI 10.1016/S0002-9394(14)74850-0; FOSTER CS, 1988, OPHTHALMOLOGY, V95, P194; Ghasemi H, 2019, J OPHTHAL VIS RES, V14, P398, DOI 10.18502/jovr.v14i4.5435; Gokhale NS, 2016, INDIAN J OPHTHALMOL, V64, P145, DOI 10.4103/0301-4738.179727; Gunduz K, 1996, OPHTHALMIC RES, V28, P80; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Heffler E, 2016, JAMA OPHTHALMOL, V134, P461, DOI 10.1001/jamaophthalmol.2015.5679; Hida Wilson Takashi, 2006, Arq. Bras. Oftalmol., V69, P851, DOI 10.1590/S0004-27492006000600013; Iovieno A, 2008, GRAEF ARCH CLIN EXP, V246, P435, DOI 10.1007/s00417-007-0682-6; Jain Arun K., 2006, Indian Journal of Ophthalmology, V54, P111; Keklikci U, 2008, JPN J OPHTHALMOL, V52, P357, DOI 10.1007/s10384-008-0577-z; Keklikci U, 2014, ADV CLIN EXP MED, V23, P455, DOI 10.17219/acem/37145; Kheirkhah A, 2011, EYE, V25, P871, DOI 10.1038/eye.2011.75; Kilic A, 2006, CAN J OPHTHALMOL, V41, P693, DOI 10.3129/i06-061; Kumar S, 2009, ACTA OPHTHALMOL, V87, P133, DOI 10.1111/j.1755-3768.2008.01347.x; Kumari R, 2017, NEPAL J OPHTHALMOL, V9, P128, DOI 10.3126/nepjoph.v9i2.19257; Labcharoenwongs P, 2012, ASIAN PAC J ALLERGY, V30, P177; Lallemand F, 2017, EUR J PHARM BIOPHARM, V117, P14, DOI 10.1016/j.ejpb.2017.03.006; Lambiase A, 2003, ARCH OPHTHALMOL-CHIC, V121, P615, DOI 10.1001/archopht.121.5.615; Lambiase A, 2009, OPHTHAL EPIDEMIOL, V16, P38, DOI 10.1080/09286580802573177; Leonardi A, 2007, BRIT J OPHTHALMOL, V91, P1662, DOI 10.1136/bjo.2007.117515; Leonardi A, 1997, BRIT J OPHTHALMOL, V81, P23, DOI 10.1136/bjo.81.1.23; Leonardi A, 2019, OPHTHALMOLOGY, V126, P671, DOI 10.1016/j.ophtha.2018.12.027; Leonardi A, 2013, OPHTHALMOL THER, V2, P73, DOI 10.1007/s40123-013-0019-y; Leonardi A, 2013, AM J OPHTHALMOL, V155, P796, DOI 10.1016/j.ajo.2012.11.018; Mahdy RAR, 2012, CORNEA, V31, P525, DOI 10.1097/ICO.0b013e3181eae270; Mantelli F, 2007, BRIT J OPHTHALMOL, V91, P1656, DOI 10.1136/bjo.2007.122044; MEYER E, 1987, BRIT J OPHTHALMOL, V71, P497, DOI 10.1136/bjo.71.7.497; Muller EG, 2017, ARQ BRAS OFTALMOL, V80, P154, DOI 10.5935/0004-2749.20170038; Muller GG, 2014, EYE CONTACT LENS, V40, P79, DOI 10.1097/ICL.0000000000000001; Navel V, 2019, OCUL SURF, V17, P655, DOI 10.1016/j.jtos.2019.06.004; Nebbioso M, 2019, CLIN OPHTHALMOL, V13, P1147, DOI 10.2147/OPTH.S181811; Nebbioso M, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/1061276; Norris MR, 2020, CURR OPIN ALLERGY CL, V20, P609, DOI 10.1097/ACI.0000000000000692; Occasi F, 2017, PEDIAT ALLERG IMM-UK, V28, P503, DOI 10.1111/pai.12737; Oner V, 2012, JPN J OPHTHALMOL, V56, P312, DOI 10.1007/s10384-012-0152-5; Oray M, 2013, CORNEA, V32, P1149, DOI 10.1097/ICO.0b013e31828ffdf8; Pucci N, 2002, ANN ALLERG ASTHMA IM, V89, P298, DOI 10.1016/S1081-1206(10)61958-8; Pucci N, 2015, PEDIAT ALLERG IMM-UK, V26, P256, DOI 10.1111/pai.12360; Sayed KM, 2019, GRAEF ARCH CLIN EXP, V257, P1989, DOI 10.1007/s00417-019-04389-w; SECCHI AG, 1990, AM J OPHTHALMOL, V110, P641, DOI 10.1016/S0002-9394(14)77061-8; Sharma Ashok, 1997, Indian Journal of Ophthalmology, V45, P177; Spadavecchia L, 2006, PEDIAT ALLERG IMM-UK, V17, P527, DOI 10.1111/j.1399-3038.2006.00427.x; Tesse R, 2010, PEDIAT ALLERG IMM-UK, V21, P330, DOI 10.1111/j.1399-3038.2009.00948.x; Turan-Vural E, 2012, OCUL IMMUNOL INFLAMM, V20, P125, DOI 10.3109/09273948.2012.656877; Verin P, 2001, EUR J OPHTHALMOL, V11, P120, DOI 10.1177/112067210101100203; Verin PH, 1999, CLIN EXP ALLERGY, V29, P529; Vichyanond P, 2004, J ALLERGY CLIN IMMUN, V113, P355, DOI 10.1016/j.jaci.2003.10.065; Wan Q, 2018, OPHTHALMIC RES, V59, P126, DOI 10.1159/000478704; Zanjani H, 2017, CORNEA, V36, P675, DOI 10.1097/ICO.0000000000001200; Zicari AM, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0656-4	75	4	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					822	834		10.1016/j.jaci.2021.03.026	http://dx.doi.org/10.1016/j.jaci.2021.03.026		SEP 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33819510	Bronze			2022-12-18	WOS:000695242900031
J	Tamari, M; Trier, AM; Kim, BS				Tamari, Masato; Trier, Anna M.; Kim, Brian S.			Emerging targeted therapeutics underscore immunologic heterogeneity of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Alarmin; asthma; IL-25; IL-33; TSLP; JAK			[Tamari, Masato; Trier, Anna M.; Kim, Brian S.] Washington Univ, Sch Med, 660 South Euclid Ave,CB8123, St Louis, MO 63110 USA	Washington University (WUSTL)	Kim, BS (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,CB8123, St Louis, MO 63110 USA.	briankim@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161; Trier, Anna/0000-0001-7957-2180				Braithwaite IE, 2021, J ALLERGY CLIN IMMUN, V148, P783, DOI 10.1016/j.jaci.2021.02.042; Doroudchi A, 2020, ANN ALLERG ASTHMA IM, V124, P44, DOI 10.1016/j.anai.2019.10.016; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Frossing L, 2021, J ALLER CL IMM-PRACT, V9, P1267, DOI 10.1016/j.jaip.2020.09.051; Kaur R, 2019, J ALLERGY CLIN IMMUN, V144, P1, DOI 10.1016/j.jaci.2019.05.031; Kelsen SG, 2021, J ALLERGY CLIN IMMUN, V148, P790, DOI 10.1016/j.jaci.2021.03.044; Kim BS, 2020, J ALLERGY CLIN IMMUN, V145, P572, DOI 10.1016/j.jaci.2019.08.042; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Menzies-Gow A, 2021, NEW ENGL J MED, V384, P1800, DOI 10.1056/NEJMoa2034975; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006	10	4	4	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					719	721		10.1016/j.jaci.2021.07.008	http://dx.doi.org/10.1016/j.jaci.2021.07.008		SEP 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	34310926	Bronze			2022-12-18	WOS:000695242900017
J	Beaufils, F; Esteves, P; Enaud, R; Germande, O; Celle, A; Marthan, R; Trian, T; Fayon, M; Berger, P				Beaufils, Fabien; Esteves, Pauline; Enaud, Raphael; Germande, Ophelie; Celle, Alexis; Marthan, Roger; Trian, Thomas; Fayon, Michael; Berger, Patrick			Mitochondria are involved in bronchial smooth muscle remodeling in severe preschool wheezers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; children; bronchial remodeling; mitochondrial biogenesis; calcium	ASTHMA; PROLIFERATION; INFLAMMATION; BIOGENESIS	Background: Bronchial remodeling is a key feature of asthma that is already present in preschoolers with wheezing. Moreover, bronchial smooth muscle (BSM) remodeling at preschool age is predictive of asthma at school age. However, the mechanism responsible for BSM remodeling in preschoolers with wheezing remains totally unknown. In contrast, in adult asthma, BSM remodeling has been associated with an increase in BSM cell proliferation related to increased mitochondrial mass and biogenesis triggered by an altered calcium homeostasis. Indeed, BSM cell proliferation was decreased in vitro by the calcium channel blocker gallopamil. Objective: Our aim was to investigate the mechanisms involved in BSM cell proliferation in preschoolers with severe wheezing, with special attention to the role of mitochondria and calcium signaling. Methods: Bronchial tissue samples obtained from 12 preschool controls without wheezing and 10 preschoolers with severe wheezing were used to measure BSM mass and establish primary BSM cell cultures. BSM cell proliferation was assessed by manual counting and flow cytometry, ATP content was assessed by bioluminescence, mitochondrial respiration was assessed by using either the Seahorse or Oroboros technique, mitochondrial mass and biogenesis were assessed by immunoblotting, and calcium response to carbachol was assessed by confocal microscopy. The effect of gallopamil was also evaluated. Results: BSM mass, cell proliferation, ATP content, mitochondrial respiration, mass and biogenesis, and calcium response were all increased in preschoolers with severe wheezing compared with in the controls. Gallopamil significantly decreased BSM mitochondrial biogenesis and mass, as well as cell proliferation. Conclusion: Mitochondria are key players in BSM cell proliferation in preschoolers with severe wheezing and could represent a potential target to treat BSM remodeling at an early stage of the disease. (J Allergy Clin Immunol 2021;148:645-51.)	[Beaufils, Fabien; Esteves, Pauline; Enaud, Raphael; Germande, Ophelie; Celle, Alexis; Marthan, Roger; Trian, Thomas; Fayon, Michael; Berger, Patrick] Univ Bordeaux, Bordeaux, France; [Beaufils, Fabien; Esteves, Pauline; Enaud, Raphael; Germande, Ophelie; Celle, Alexis; Marthan, Roger; Trian, Thomas; Fayon, Michael; Berger, Patrick] Ctr Rech Cardiothorac Bordeaux, U1045, INSERM, CIC 1401, Bordeaux, France; [Beaufils, Fabien; Enaud, Raphael; Marthan, Roger; Fayon, Michael; Berger, Patrick] CHU Bordeaux, Serv Pediat Med, Serv Explorat Fonct Resp, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Berger, P (corresponding author), Ctr Rech Cardiothorac Bordeaux, INSERM, U1045, PTIB Hop Xavier Arnozan, Ave Haut Leveque, F-33600 Pessac, France.	patrick.berger@u-bordeaux.fr	Fayon, Michael/HDN-7887-2022; Berger, Patrick/D-8779-2012	Fayon, Michael/0000-0002-1238-2128; Berger, Patrick/0000-0003-4702-0343; trian, thomas/0000-0002-2567-4867	French Ministry of Health [B10122230, 2010A0113435]	French Ministry of Health	Supported by a research grant from the French Ministry of Health (grant B10122230; 2010A0113435) .	Allard B, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02998; [Anonymous], 2009, J PEDIAT PUERICULTUR, V22, P286; Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; Beasley R, 2000, J ALLERGY CLIN IMMUN, V105, P7; Castro-Rodriguez JA, 2018, PEDIATR PULM, V53, P824, DOI 10.1002/ppul.23968; Deshane JS, 2020, FRONT MED, V7, P16; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Esteves P, 2020, REV MAL RESPIR, V37, P201, DOI 10.1016/j.rmr.2020.02.004; Fayon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122446; Girodet PO, 2015, AM J RESP CRIT CARE, V191, P876, DOI 10.1164/rccm.201410-1874OC; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Lezmi G, 2015, AM J RESP CRIT CARE, V192, P164, DOI 10.1164/rccm.201411-1958OC; Midulla F, 2003, EUR RESPIR J, V22, P698, DOI 10.1183/09031936.02.00113202; O'Reilly R, 2013, J ALLERGY CLIN IMMUN, V131, P1024, DOI 10.1016/j.jaci.2012.08.044; Ramos-Barbon D, 2010, AM J RESP CRIT CARE, V182, P317, DOI 10.1164/rccm.200905-0745OC; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Trian T, 2016, J ALLERGY CLIN IMMUN, V137, P1717, DOI 10.1016/j.jaci.2015.10.031	21	4	4	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					645	+		10.1016/j.jaci.2021.03.027	http://dx.doi.org/10.1016/j.jaci.2021.03.027		AUG 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33819511				2022-12-18	WOS:000687104900017
J	Buchheit, KM; Laidlaw, TM; Levy, JM				Buchheit, Kathleen M.; Laidlaw, Tanya M.; Levy, Joshua M.			Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Aspirin-exacerbated respiratory disease; respiratory biologic; IgE; IL-5R alpha; IL-4R alpha; nasal polyp; mepolizumab; benralizumab; omalizumab; dupilumab			[Buchheit, Kathleen M.; Laidlaw, Tanya M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Buchheit, Kathleen M.; Laidlaw, Tanya M.] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA; [Buchheit, Kathleen M.] Emory Univ, Dept Otolaryngol Head & Neck Surg, Atlanta, GA 30322 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Emory University	Buchheit, KM (corresponding author), Brigham & Womens Hosp, 60 Fenwood Rd,Suite 5002H, Boston, MA 02445 USA.	kbuchheit@bwh.harvard.edu			National Institutes of Health [U19AI095219, K23AI139352, R01HL128241]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the National Institutes of Health (grants U19AI095219, K23AI139352, and R01HL128241) and by generous contributions from the Vinik and Kaye families.	Bavaro N, 2021, J ALLER CL IMM-PRACT, V9, P2910, DOI 10.1016/j.jaip.2021.02.020; Buchheit KM, 2021, J ALLERGY CLIN IMMUN, V148, P574, DOI 10.1016/j.jaci.2021.05.043; Buchheit KM, 2020, J ALLERGY CLIN IMMUN, V145, P1574, DOI 10.1016/j.jaci.2020.02.035; Han JK, 2021, LANCET RESP MED, V9, P1141, DOI 10.1016/S2213-2600(21)00097-7; Hayashi H, 2016, J ALLERGY CLIN IMMUN, V137, P1585, DOI 10.1016/j.jaci.2015.09.034; Laidlaw TM, 2019, J ALLER CL IMM-PRACT, V7, P2462, DOI 10.1016/j.jaip.2019.03.044; Laidlaw TM, 2019, LARYNGOSCOPE, V129, pE61, DOI 10.1002/lary.27564; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Scott WC, 2021, J ALLERGY CLIN IMMUN, V147, P1318, DOI 10.1016/j.jaci.2020.11.001; White AA, 2018, NEW ENGL J MED, V379, P1060, DOI 10.1056/NEJMra1712125	10	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					348	350		10.1016/j.jaci.2021.06.019	http://dx.doi.org/10.1016/j.jaci.2021.06.019		AUG 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	34174296	Bronze, Green Accepted			2022-12-18	WOS:000684625700010
J	Cahill, KN				Cahill, Katherine N.			Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Aspirin-exacerbated respiratory disease; aspirin therapy; cyclooxygenase; mast cell; cysteinyl leukotrienes; prostaglandin; immunology			[Cahill, Katherine N.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	Vanderbilt University	Cahill, KN (corresponding author), Vanderbilt Univ, Med Ctr, 2525 West Enda Ave,Suite 450, Nashville, TN 37203 USA.	Katherine.cahill@vumc.org		Cahill, Katherine/0000-0002-8549-1835	National Institutes of Health [U01 AI 155299]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the National Institutes of Health (grant U01 AI 155299).	Boyce JA, 2019, J ALLERGY CLIN IMMUN, V144, P875, DOI 10.1016/j.jaci.2019.08.022; Cahill KN, 2019, AM J RESP CRIT CARE, V200, P704, DOI 10.1164/rccm.201809-1755OC; Cahill KN, 2019, J ALLERGY CLIN IMMUN, V143, P799, DOI 10.1016/j.jaci.2018.10.007; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; Cavagnero KJ, 2021, ANN ALLERG ASTHMA IM, V126, P135, DOI 10.1016/j.anai.2020.09.011; Katial RK, 2010, J ALLERGY CLIN IMMUN, V126, P738, DOI 10.1016/j.jaci.2010.06.036; Laidlaw TM, 2019, J ALLERGY CLIN IMMUN, V143, P316, DOI 10.1016/j.jaci.2018.06.001; Sousa AR, 2002, NEW ENGL J MED, V347, P1493, DOI 10.1056/NEJMoa013508; Stevens WW, 2021, J ALLERGY CLIN IMMUN, V147, P827, DOI 10.1016/j.jaci.2020.10.043; Tyrak KE, 2021, CLIN EXP ALLERGY, V51, P1046, DOI 10.1111/cea.13886	10	4	4	15	31	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					344	347		10.1016/j.jaci.2021.06.009	http://dx.doi.org/10.1016/j.jaci.2021.06.009		AUG 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	34144108				2022-12-18	WOS:000684625700009
J	Eid, R; Yan, CH; Stevens, W; Doherty, TA; Borish, L				Eid, Ryan; Yan, Carol H.; Stevens, Whitney; Doherty, Taylor A.; Borish, Larry			Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aspirin-exacerbated respiratory disease; mast cells; basophils; eosinophils; innate lymphoid cells; type 2 inflammation; IgE	CHRONIC RHINOSINUSITIS; LYMPHOID-CELLS; NASAL POLYPS; PROSTAGLANDIN D-2; CUTTING EDGE; MAST-CELLS; LEUKOTRIENE; EXPRESSION; ASTHMA; EOSINOPHILS	Aspirin-exacerbated respiratory disease (AERD) is a complex inflammatory disorder that is not generally viewed as a disease involving the adaptive immune system but instead one largely driven by the innate immune system. This article focuses on the cellular dysregulation involving 4 central cell types: eosinophils, basophils, mast cells, and innate lymphoid type 2 cells. AERD can be envisioned as involving a self-perpetuating vicious circle in which mediators produced by a differentiated activated epithelial layer, such as IL-25, IL-33, and thymic stromal lymphopoietin, engage and activate each of these innate immune cells. The activation of these innate immune cells with their production of additional cytokine/chemokine and lipid mediators leads to further recruitment and activation of these innate immune cells. More importantly, numerous mediators produced by these innate immune cells provoke the epithelium to induce further inflammation. This self-perpetuating cycle of inflammation partially explains both current interventions suggested to ameliorate AERD (eg, aspirin desensitization, leukotriene modifiers, anti-IL-5/IL-5 receptor, anti-IL-4 receptor, and anti-IgE) and invites exploration of novel targets as specific therapies for this condition (prostaglandin D2 antagonists or cytokine antagonists [IL-25, IL-33, thymic stromal lymphopoietin]). Several of these interventions currently show promise in small retrospective analyses but now require definite clinical trials.	[Eid, Ryan; Borish, Larry] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA; [Yan, Carol H.] Univ Calif San Diego, Div Otolaryngol Head & Neck Surg, Dept Surg, San Diego, CA USA; [Stevens, Whitney] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60208 USA; [Stevens, Whitney] Northwestern Univ, Dept Otolaryngol, Chicago, IL 60208 USA; [Doherty, Taylor A.] Univ Calif San Diego, Div Rheumatol, Dept Med Allergy & Immunol, San Diego, CA USA; [Doherty, Taylor A.] Vet Affairs San Diego Hlth Care Syst, La Jolla, CA USA; [Borish, Larry] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA	University of Virginia; University of California System; University of California San Diego; Northwestern University; Feinberg School of Medicine; Northwestern University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Virginia	Borish, L (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA.	lb4m@virginia.edu			National Institutes of Health [UO1 AI123337, R21 AI151496, UG1 HL139126, K23 AI141694, AI 070535]; Veterans Affairs BLRD Award [BX005073]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs BLRD Award	This study was supported by the National Institutes of Health (grant nos. UO1 AI123337, R21 AI151496, and UG1 HL139126 to L.B.; grant no. K23 AI141694 to W.S.; and grant no. AI 070535 to T.A.D.) and Veterans Affairs BLR&D Award (grant no. BX005073 to T.A.D.).	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; ARM JP, 1989, AM REV RESPIR DIS, V140, P148, DOI 10.1164/ajrccm/140.1.148; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bandeira-Melo C, 2003, PROSTAG LEUKOTR ESS, V69, P135, DOI 10.1016/S0952-3278(03)00074-7; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Buchheit KM, 2021, ANN ALLERG ASTHMA IM, V126, P127, DOI 10.1016/j.anai.2020.09.016; Buchheit KM, 2020, J ALLERGY CLIN IMMUN, V145, P1574, DOI 10.1016/j.jaci.2020.02.035; Buchheit KM, 2016, J ALLERGY CLIN IMMUN, V137, P1566, DOI 10.1016/j.jaci.2015.10.020; Cahill KN, 2019, AM J RESP CRIT CARE, V200, P704, DOI 10.1164/rccm.201809-1755OC; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Cahill KN, 2017, J ALLERGY CLIN IMMUN, V139, P764, DOI 10.1016/j.jaci.2016.09.025; Cahill KN, 2016, AM J RESP CELL MOL, V54, P34, DOI 10.1165/rcmb.2014-0486OC; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Celejewska-Wojcik N, 2020, ALLERGY, V75, P831, DOI 10.1111/all.14141; Chang JE, 2014, J ALLERGY CLIN IMMUN, V133, P899, DOI 10.1016/j.jaci.2013.09.020; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Delemarre T, 2020, J ALLERGY CLIN IMMUN, V146, P337, DOI 10.1016/j.jaci.2020.04.040; Doherty TA, 2019, ALLERGOL INT, V68, P9, DOI 10.1016/j.alit.2018.11.001; Doherty TA, 2018, J ALLERGY CLIN IMMUN, V141, P1587, DOI 10.1016/j.jaci.2018.02.034; Doherty TA, 2015, J LEUKOCYTE BIOL, V97, P455, DOI 10.1189/jlb.5BT0814-374R; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Dwyer DF, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb7221; Eastman JJ, 2017, J ALLERGY CLIN IMMUN, V140, P101, DOI 10.1016/j.jaci.2016.11.023; Eid RC, 2020, ANN ALLERG ASTHMA IM, V124, P102, DOI 10.1016/j.anai.2019.09.023; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Feng X, 2016, J ALLERGY CLIN IMMUN, V138, P1089, DOI 10.1016/j.jaci.2016.04.042; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Hayashi H, 2020, AM J RESP CRIT CARE, V201, P1488, DOI 10.1164/rccm.201906-1215OC; Hayashi H, 2016, J ALLERGY CLIN IMMUN, V137, P1585, DOI 10.1016/j.jaci.2015.09.034; Jakiela B, 2021, J ALLERGY CLIN IMMUN, V147, P1269, DOI 10.1016/j.jaci.2020.08.007; Jerschow E, 2017, J ALLER CL IMM-PRACT, V5, P998, DOI 10.1016/j.jaip.2016.11.021; Karta MR, 2018, J ALLERGY CLIN IMMUN, V141, P329, DOI 10.1016/j.jaci.2017.03.010; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kohanski MA, 2018, J ALLERGY CLIN IMMUN, V142, P460, DOI 10.1016/j.jaci.2018.03.019; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Laidlaw TM, 2019, J ALLER CL IMM-PRACT, V7, P2462, DOI 10.1016/j.jaip.2019.03.044; Laidlaw TM, 2019, LARYNGOSCOPE, V129, pE61, DOI 10.1002/lary.27564; Laidlaw TM, 2014, J ALLERGY CLIN IMMUN, V133, P1692, DOI 10.1016/j.jaci.2013.12.1034; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Lang DM, 2018, ANN ALLERG ASTHMA IM, V121, P98, DOI 10.1016/j.anai.2018.05.007; Lee JU, 2017, RESP MED, V123, P71, DOI 10.1016/j.rmed.2016.11.020; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Liu T, 2018, J IMMUNOL, V200, P915, DOI 10.4049/jimmunol.1700603; Liu T, 2015, J IMMUNOL, V195, P3537, DOI 10.4049/jimmunol.1500905; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; Lund SJ, 2017, J IMMUNOL, V199, P1096, DOI 10.4049/jimmunol.1601569; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Mahdavinia M, 2014, J ALLERGY CLIN IMMUN, V133, P1759, DOI 10.1016/j.jaci.2013.12.1092; Maric J, 2019, J ALLERGY CLIN IMMUN, V143, P2202, DOI 10.1016/j.jaci.2018.10.069; Maric J, 2018, J ALLERGY CLIN IMMUN, V141, P1761, DOI 10.1016/j.jaci.2017.09.050; Martin H, 2021, J ALLER CL IMM-PRACT, V9, P1384, DOI 10.1016/j.jaip.2020.09.007; Martin HC, 2021, ANN ALLERG ASTHMA IM, V126, P120, DOI 10.1016/j.anai.2020.11.002; Miljkovic D, 2014, ALLERGY, V69, P1154, DOI 10.1111/all.12440; Mita H, 2004, CLIN EXP ALLERGY, V34, P1262, DOI 10.1111/j.1365-2222.2004.02034.x; Mitsui C, 2016, J ALLERGY CLIN IMMUN, V137, P400, DOI 10.1016/j.jaci.2015.05.041; Miyata J, 2019, ALLERGY, V74, P1113, DOI 10.1111/all.13726; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Olze H, 2006, RHINOLOGY, V44, P145; Orlandi RR, 2021, INT FORUM ALLERGY RH, V11, P213, DOI 10.1002/alr.22741; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pal K, 2019, ANN ALLERG ASTHMA IM, V123, P503, DOI 10.1016/j.anai.2019.09.003; Pan DX, 2019, J ALLERGY CLIN IMMUN, V143, P1047, DOI 10.1016/j.jaci.2018.06.033; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Payne SC, 2011, LARYNGOSCOPE, V121, P2262, DOI 10.1002/lary.21969; Perez-Novo CA, 2005, J ALLERGY CLIN IMMUN, V115, P1189, DOI 10.1016/j.jaci.2005.02.029; Perez-Novo CA, 2004, INT ARCH ALLERGY IMM, V133, P255, DOI 10.1159/000076832; Persson EK, 2019, SCIENCE, V364, P751, DOI 10.1126/science.aaw4295; Poposki JA, 2017, IMMUN INFLAMM DIS, V5, P233, DOI 10.1002/iid3.161; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; Salimi M, 2017, J ALLERGY CLIN IMMUN, V140, P1090, DOI 10.1016/j.jaci.2016.12.958; Schneider TR, 2018, J ALLER CL IMM-PRACT, V6, P825, DOI 10.1016/j.jaip.2017.10.011; Scott WC, 2021, J ALLERGY CLIN IMMUN, V147, P1318, DOI 10.1016/j.jaci.2020.11.001; Sestini P, 1996, AM J RESP CRIT CARE, V153, P572, DOI 10.1164/ajrccm.153.2.8564100; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Steiner UC, 2020, RHINOLOGY, V58, P544, DOI 10.4193/Rhin19.423; Steinke JW, 2016, IMMUNOL ALLERGY CLIN, V36, P719, DOI 10.1016/j.iac.2016.06.008; Steinke JW, 2014, J IMMUNOL, V193, P41, DOI 10.4049/jimmunol.1301753; Steinke JW, 2013, J ALLERGY CLIN IMMUN, V132, P856, DOI 10.1016/j.jaci.2013.05.008; Steinke JW, 2003, J ALLERGY CLIN IMMUN, V111, P342, DOI 10.1067/mai.2003.67; Stevens WW, 2021, J ALLERGY CLIN IMMUN, V148, P439, DOI 10.1016/j.jaci.2021.02.045; Stevens WW, 2021, J ALLERGY CLIN IMMUN, V147, P827, DOI 10.1016/j.jaci.2020.10.043; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Suzuki N, 2021, ENT-EAR NOSE THROAT, V100, p738S, DOI 10.1177/0145561320902858; Takabayashi T, 2019, ALLERGY, V74, P1307, DOI 10.1111/all.13677; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Takahashi T, 2017, J ALLERGY CLIN IMMUN, V140, P720, DOI 10.1016/j.jaci.2017.01.022; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Tsuda T, 2019, INT IMMUNOL, V31, P33, DOI 10.1093/intimm/dxy061; Tuttle KL, 2018, J ALLER CL IMM-PRACT, V6, P1045, DOI 10.1016/j.jaip.2018.01.038; van der Ploeg EK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd3489; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Ying S, 2006, J ALLERGY CLIN IMMUN, V117, P312, DOI 10.1016/j.jaci.2005.10.037; Yun Y, 2020, ALLERGOL INT, V69, P232, DOI 10.1016/j.alit.2019.11.002; Zhou WS, 2016, AM J RESP CRIT CARE, V193, P31, DOI 10.1164/rccm.201410-1793OC	112	4	4	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					309	318		10.1016/j.jaci.2021.06.016	http://dx.doi.org/10.1016/j.jaci.2021.06.016		AUG 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	34364539	Green Accepted			2022-12-18	WOS:000684625700005
J	Nakamizo, S; Honda, T; Sato, T; Al Mamun, M; Chow, Z; Duan, KB; Lum, J; Tan, KJ; Tomari, K; Sato, R; Kitoh, A; Tay, ASL; Common, JEA; Guan, NL; Setou, M; Ginhoux, F; Kabashima, K				Nakamizo, Satoshi; Honda, Tetsuya; Sato, Tomohito; Al Mamun, Md.; Chow, Zachary; Duan, Kaibo; Lum, Josephine; Tan, Kahbing Jasmine; Tomari, Kaori; Sato, Reiko; Kitoh, Akihiko; Tay, Angeline S. L.; Common, John E. A.; Guan, Ng Lai; Setou, Mitsutoshi; Ginhoux, Florent; Kabashima, Kenji			High-fat diet induces a predisposition to follicular hyperkeratosis and neutrophilic folliculitis in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						High-fat diet; fatty acids; folliculitis; CXCL1; CXCL2; CXCR2; neutrophil; palmitic acid; hair follicle; acne; hidradenitis suppurativa	PROTEIN-KINASE-C; ACNE-VULGARIS; ATOPIC-DERMATITIS; RNA-SEQ; INFLAMMATION; CELLS; DIFFERENTIATION; KERATINOCYTES; REVEALS; DISEASE	Background: Neutrophilic folliculitis is an inflammatory condition of hair follicles. In some neutrophilic folliculitis, such as in patients with acne and hidradenitis suppurativa, follicular hyperkeratosis is also observed. Neutrophilic folliculitis is often induced and/or exacerbated by a high-fat diet (HFD). However, the molecular mechanisms by which an HFD affects neutrophilic folliculitis are not fully understood. Objective: Our aim was to elucidate how an HFD promotes the development of neutrophilic folliculitis. Methods: Mice were fed an HFD, and their skin was subjected to histologic, RNA sequencing, and imaging mass spectrometry analyses. To examine the effect of an HFD on neutrophil accumulation around the hair follicles, phorbol 12-myristate 13-acetate (PMA) was used as an irritant to the skin. Results: Histologic analysis revealed follicular hyperkeratosis in the skin of HFD-fed mice. RNA sequencing analysis showed that genes related to keratinization, especially in upper hair follicular keratinocytes, were significantly upregulated in HFD-fed mice. Application of PMA to the skin induced neutrophilic folliculitis in HFD-fed mice but not in mice fed a normal diet. Accumulation of neutrophils in the skin and around hair follicles was dependent on CXCR2 signaling, and CXCL1 (a CXCR2 ligand) was produced mainly by hair follicular keratinocytes. Imaging mass spectrometry analysis revealed an increase in fatty acids in the skin of HFD-fed mice. Application of these fatty acids to the skin induced follicular hyperkeratosis and caused PMA-induced neutrophilic folliculitis even in mice fed a normal diet. Conclusion: An HFD can facilitate the development of neutrophilic folliculitis with the induction of hyperkeratosis of hair follicles and increased neutrophil infiltration around the hair follicles via CXCR2 signaling.	[Nakamizo, Satoshi; Duan, Kaibo; Lum, Josephine; Tan, Kahbing Jasmine; Sato, Reiko; Guan, Ng Lai; Ginhoux, Florent; Kabashima, Kenji] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, 8A Biomed Grove,IMMUNOS Bldg, Singapore 138648, Singapore; [Nakamizo, Satoshi; Chow, Zachary; Tan, Kahbing Jasmine; Tay, Angeline S. L.; Common, John E. A.; Ginhoux, Florent; Kabashima, Kenji] Agcy Sci Technol & Res, Skin Res Inst Singapore, Biopolis, Singapore, Singapore; [Nakamizo, Satoshi; Honda, Tetsuya; Tomari, Kaori; Sato, Reiko; Kitoh, Akihiko; Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto, Japan; [Honda, Tetsuya] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan; [Sato, Tomohito; Al Mamun, Md.; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS); Kyoto University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, 8A Biomed Grove,IMMUNOS Bldg, Singapore 138648, Singapore.; Honda, T; Kabashima, K (corresponding author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	hontetsu@kuhp.kyoto-u.ac.afn; Florent_Ginhoux@immunol.a-star.edu.sg; kaba@kuhp.kyoto-u.ac.jp	Common, John/Q-6412-2018; Chow, Zachary/GXG-8693-2022; Nakamizo, Satoshi/ABH-2121-2021; MAMUN, MD AL/GOV-3518-2022	Common, John/0000-0002-3280-7365; Nakamizo, Satoshi/0000-0001-9332-0369; MAMUN, MD AL/0000-0001-9274-3386	Singapore Immunology Network; Agency for Science, Technology and Research [H17/01/a0/004]; Skin Research Institute of Singapore; Japan Society for the Promotion of Science [JP19K08790, JP15H05906, 263395]; Takeda Sci-ence Foundation; Japan Agency for Medical Research and Develop-ment [16ek0410011h0003, 16he0902003h0002, JP19gm1210006]; Uehara Memorial Foundation; SRIS core funding	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Skin Research Institute of Singapore(Agency for Science Technology & Research (A*STAR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Sci-ence Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Develop-ment(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); SRIS core funding	Supported by Singapore Immunology Network and SRIS core funding; the Agency for Science, Technology and Research (grant H17/01/a0/004) ; the Skin Research Institute of Singapore; grants from the Japan Society for the Promotion of Science (grants JP19K08790 and JP15H05906 [to T.H.] and grant 263395 [to K.K.] ) , the Takeda Sci-ence Foundation [to K.K.] , and the Japan Agency for Medical Research and Develop-ment (grants 16ek0410011h0003, 16he0902003h0002, and JP19gm1210006 [to K.K.] ) . S.N. is supported by the Uehara Memorial Foundation.	Admani S, 2013, DERMATOL THER, V26, P462, DOI 10.1111/dth.12108; [Anonymous], 2020, GPLOTS VARIOUS R PRO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhate K, 2013, BRIT J DERMATOL, V168, P474, DOI 10.1111/bjd.12149; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Blok JL, 2016, BRIT J DERMATOL, V174, P1392, DOI 10.1111/bjd.14371; Burris J, 2014, J ACAD NUTR DIET, V114, P384, DOI 10.1016/j.jand.2013.11.010; Clemmensen A, 2009, EXP DERMATOL, V18, P979, DOI 10.1111/j.1600-0625.2009.00921.x; Cordain L, 2002, ARCH DERMATOL, V138, P1584, DOI 10.1001/archderm.138.12.1584; Danby FW, 2015, J AM ACAD DERMATOL, V73, pS52, DOI 10.1016/j.jaad.2015.07.042; Dawson AL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2634; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; DIAZGUERRA MJM, 1991, J BIOL CHEM, V266, P23568; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; Ewald DA, 2017, J ALLERGY CLIN IMMUN, V139, P562, DOI 10.1016/j.jaci.2016.08.029; Frishberg A, 2016, BIOINFORMATICS, V32, P3842, DOI 10.1093/bioinformatics/btw535; Grossi E, 2016, J EUR ACAD DERMATOL, V30, P96, DOI 10.1111/jdv.12878; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Herbert D, 2018, J INVEST DERMATOL, V138, P1999, DOI 10.1016/j.jid.2018.03.1522; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Kanemaru K, 2015, EXP DERMATOL, V24, P436, DOI 10.1111/exd.12691; Korbecki J, 2019, INFLAMM RES, V68, P915, DOI 10.1007/s00011-019-01273-5; Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Li WH, 2017, ARCH DERMATOL RES, V309, P529, DOI 10.1007/s00403-017-1747-y; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Mai K, 2006, J CLIN ENDOCR METAB, V91, P1501, DOI 10.1210/jc.2005-2069; Mirshahpanah P, 2007, CUTAN OCUL TOXICOL, V26, P195, DOI 10.1080/15569520701502815; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Nakamizo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14292-1; Nakano K, 2007, SKIN PHARMACOL PHYS, V20, P29, DOI 10.1159/000096169; O'Neill AM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0558-5; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; Pastore S, 1997, J CLIN INVEST, V99, P3009, DOI 10.1172/JCI119496; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; San Jose I, 2001, J ANAT, V198, P399, DOI 10.1046/j.1469-7580.2001.19840399.x; Sanford JA, 2019, J IMMUNOL, V202, P1767, DOI 10.4049/jimmunol.1800893; Shaw James C, 2002, Am J Clin Dermatol, V3, P571, DOI 10.2165/00128071-200203080-00007; SHMUELI E, 1993, J INTERN MED, V234, P397, DOI 10.1111/j.1365-2796.1993.tb00761.x; Simonart T, 2013, AM J CLIN DERMATOL, V14, P429, DOI 10.1007/s40257-013-0042-8; Smith Mallory K, 2017, F1000Res, V6, P1272, DOI 10.12688/f1000research.11337.1; Smith RN, 2007, AM J CLIN NUTR, V86, P107, DOI 10.1093/ajcn/86.1.107; Storer M A, 2018, Int J Womens Dermatol, V4, P198, DOI 10.1016/j.ijwd.2018.08.009; Tan JKL, 2001, J AM ACAD DERMATOL, V44, P439, DOI 10.1067/mjd.2001.111340; Taylor M, 2011, EUR J DERMATOL, V21, P323, DOI 10.1684/ejd.2011.1357; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Vos T, 2013, LANCET, V381, P628; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Yazici K, 2004, J EUR ACAD DERMATOL, V18, P435, DOI 10.1111/j.1468-3083.2004.00946.x; Yiu ZZN, 2015, CLIN EXP DERMATOL, V40, P383, DOI 10.1111/ced.12540; Zhang YW, 2015, IMMUNITY, V42, P953, DOI 10.1016/j.immuni.2015.04.016; Zhou M, 2018, BRIT J DERMATOL, V179, P732, DOI 10.1111/bjd.16655; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	58	4	4	4	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					473	+		10.1016/j.jaci.2021.02.032	http://dx.doi.org/10.1016/j.jaci.2021.02.032		AUG 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33713763				2022-12-18	WOS:000684625700024
J	Annesi-Maesano, I; Maesano, CN; Biagioni, B; D'Amato, G; Cecchi, L				Annesi-Maesano, Isabella; Maesano, Cara Nichole; Biagioni, Benedetta; D'Amato, Gennaro; Cecchi, Lorenzo			Call to action: Air pollution, asthma, and allergy in the exposome era	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; allergy; air pollution; climate; exposome			[Annesi-Maesano, Isabella; Maesano, Cara Nichole] INSERM, Desbrest Inst Epidemiol & Publ Hlth, 641 Ave Doyen Gaston Giraud, F-34093 Montpellier, France; [Annesi-Maesano, Isabella; Maesano, Cara Nichole] Montpellier Univ, Montpellier, France; [Biagioni, Benedetta] IRCCS Azienda Osped Univ Bologna, Div Internal Med, Allergy Outpatient Clin, Bologna, Italy; [D'Amato, Gennaro] Univ Naples Federico II, Cardarelli Hosp, High Specialty A, Div Resp & Allerg Dis,Dept Chest Dis, Naples, Italy; [D'Amato, Gennaro] Univ Naples Federico II, Med Sch Specializat Resp Dis, Naples, Italy; [Cecchi, Lorenzo] Univ Florence, Ctr Bioclimatol, Florence, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Antonio Cardarelli Hospital; University of Naples Federico II; University of Naples Federico II; University of Florence	Annesi-Maesano, I (corresponding author), Montpellier Univ, URC, 641 Ave Doyen Gaston Giraud, F-34093 Montpellier, France.	isabella.annesi-maesano@inserm.fr						Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Annesi-Maesano I, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02981-2020; Baluch N, 2020, ANN ALLERG ASTHMA IM, V125, P639, DOI 10.1016/j.anai.2020.09.006; Cecchi L, 2018, J ALLERGY CLIN IMMUN, V141, P846, DOI 10.1016/j.jaci.2018.01.016; Celedon Juan C, 2014, Ann Am Thorac Soc, V11, P473, DOI 10.1513/AnnalsATS.201402-059PS; Pfeffer PE, 2021, CHEST, V159, P1346, DOI 10.1016/j.chest.2020.10.053; Soomro MH, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP1829, 10.1289/ehp1829]; Thurston GD, 2020, ANN AM THORAC SOC, V17, P387, DOI 10.1513/AnnalsATS.202001-046ST; Vernet C, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1015; Whyand T, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0785-0	10	4	4	7	17	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					70	72		10.1016/j.jaci.2021.05.026	http://dx.doi.org/10.1016/j.jaci.2021.05.026		JUL 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	34238507	Bronze			2022-12-18	WOS:000669906700008
J	Liu, T; Barrett, NA; Nagai, J; Lai, JY; Feng, CL; Boyce, JA				Liu, Tao; Barrett, Nora A.; Nagai, Jun; Lai, Juying; Feng, Chunli; Boyce, Joshua A.			Leukotriene D-4 paradoxically limits LTC4-driven platelet activation and lung immunopathology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Platelets; leukotrienes; CysLT(2)R; mast cells; eosinophils; AERD	EXACERBATED RESPIRATORY-DISEASE; INFLAMMATORY CELLS; AIRWAY RESPONSIVENESS; RECEPTOR; EXPRESSION; PROTEIN; CYSLT(1); E-4; 5-LIPOXYGENASE; HISTAMINE	Background: The 3 cysteinyl leukotrienes (cysLTs), leukotriene (LT) C-4 (LTC4), LTD4, and LTE4, have different biologic half-lives, cellular targets, and receptor specificities. CysLT(2)R binds LTC4 and LTD4 in vitro with similar affinities, but it displays a marked selectivity for LTC4 in vivo. LTC4, but not LTD4, strongly potentiates allergen-induced pulmonary eosinophilia in mice through a CysLT(2)R-mediated, platelet- and IL-33-dependent pathway. Objective: We sought to determine whether LTD4 functionally antagonizes LTC4 signaling at CysLT(2)R. Methods: We used 2 different in vivo models of CysLT(2)R-dependent immunopathology, as well as ex vivo activation of mouse and human platelets. Results: LTC4-induced CD62P expression; HMGB1 release; and secretions of thromboxane A(2), CXCL7, and IL-33 by mouse platelets were all were blocked by a selective CysLT(2)R antagonist and inhibited by LTD4. These effects did not depend on CysLT(1)R. Inhaled LTD4 blocked LTC4-mediated potentiation of ovalbumin-induced eosinophilic inflammation; recruitment of platelet-adherent eosinophils; and increases in IL-33, IL-4, IL-5, and IL-13 levels in lung tissue. In contrast, the effect of administration of LTE4, the preferred ligand for CysLT(3)R, was additive with LTC4. The administration of LTD4 to Ptges(-/-) mice, which display enhanced LTC4 synthesis similar to that in aspirin-exacerbated respiratory disease, completely blocked the physiologic response to subsequent lysine-aspirin inhalation challenges, as well as increases in levels of IL-33, type 2 cytokines, and biochemical markers of mast cell and platelet activation. Conclusion: The conversion of LTC4 to LTD4 may limit the duration and extent of potentially deleterious signaling through CysLT(2)R, and it may contribute to the therapeutic properties of desensitization to aspirin in aspirin-exacerbated respiratory disease.	[Liu, Tao; Barrett, Nora A.; Nagai, Jun; Lai, Juying; Feng, Chunli; Boyce, Joshua A.] Brigham & Womens Hosp, Dept Med, Div Clin Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Liu, Tao; Barrett, Nora A.; Nagai, Jun; Lai, Juying; Feng, Chunli; Boyce, Joshua A.] Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA USA; [Barrett, Nora A.; Nagai, Jun; Boyce, Joshua A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Boyce, JA (corresponding author), Brigham & Womens Hosp, Jeff & Penny Vinik Ctr Allerg Dis Res, Div Clin Immunol & Allergy, Dept Med, Hale Bldg Transformat Med,60 Fenwood Rd, Boston, MA 02115 USA.	jboyce@rics.bwh.harvard.edu			Vinik Family; Kaye Family; National Institutes of Health [AI078908, HL111113, HL117945, R37AI052353, R01AI136041, R01HL136209, R01AI130109, U19AI095219]	Vinik Family; Kaye Family; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by generous contributions from the Vinik Family and the Kaye Family, as well as by National Institutes of Health grants AI078908, HL111113, HL117945, R37AI052353, R01AI136041, R01HL136209, R01AI130109, and U19AI095219.	Aharony D, 1998, AM J RESP CRIT CARE, V157, pS214, DOI 10.1164/ajrccm.157.6.mar-2; ARM JP, 1990, AM REV RESPIR DIS, V142, P1112, DOI 10.1164/ajrccm/142.5.1112; ARM JP, 1989, AM REV RESPIR DIS, V140, P148, DOI 10.1164/ajrccm/140.1.148; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Bankova LG, 2016, P NATL ACAD SCI USA, V113, P6242, DOI 10.1073/pnas.1605957113; Barrett NA, 2012, J IMMUNOL, V189, P4556, DOI 10.4049/jimmunol.1201865; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Cahill KN, 2019, AM J RESP CRIT CARE, V200, P704, DOI 10.1164/rccm.201809-1755OC; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; CHRISTIE PE, 1993, EUR RESPIR J, V6, P1468; Corrigan C, 2005, J ALLERGY CLIN IMMUN, V115, P316, DOI 10.1016/j.jaci.2004.10.051; Cummings HE, 2013, J IMMUNOL, V191, P5807, DOI 10.4049/jimmunol.1302187; DAVIDSON AB, 1987, AM REV RESPIR DIS, V135, P333; DRAZEN JM, 1992, AM REV RESPIR DIS, V146, P104, DOI 10.1164/ajrccm/146.1.104; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; Hasegawa S, 2010, PLATELETS, V21, P253, DOI 10.3109/09537101003615394; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hui YQ, 2001, J BIOL CHEM, V276, P47489, DOI 10.1074/jbc.M107556200; Israel E, 2002, J ALLERGY CLIN IMMUN, V110, P847, DOI 10.1067/mai.2002.129413; ISRAEL E, 1993, AM REV RESPIR DIS, V148, P1447, DOI 10.1164/ajrccm/148.6_Pt_1.1447; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Johansson MW, 2012, AM J RESP CRIT CARE, V185, P498, DOI 10.1164/rccm.201109-1712OC; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Laitinen A, 2005, J ALLERGY CLIN IMMUN, V115, P259, DOI 10.1016/j.jaci.2004.10.021; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lazarinis N, 2018, J ALLERGY CLIN IMMUN, V142, P1080, DOI 10.1016/j.jaci.2018.02.024; LEE CW, 1983, IMMUNOLOGY, V48, P27; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P4922, DOI 10.1073/pnas.81.15.4922; Liu MC, 1996, J ALLERGY CLIN IMMUN, V98, P859, DOI 10.1016/S0091-6749(96)80002-9; Liu T, 2019, MUCOSAL IMMUNOL, V12, P679, DOI 10.1038/s41385-019-0134-8; Liu T, 2018, J IMMUNOL, V200, P915, DOI 10.4049/jimmunol.1700603; Liu T, 2015, J IMMUNOL, V195, P3537, DOI 10.4049/jimmunol.1500905; Liu T, 2015, J IMMUNOL, V194, P5061, DOI 10.4049/jimmunol.1402959; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Maekawa A, 2010, J IMMUNOL, V185, P1846, DOI 10.4049/jimmunol.1001131; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Oyoshi MK, 2012, P NATL ACAD SCI USA, V109, P4992, DOI 10.1073/pnas.1203127109; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Pillai SG, 2004, PHARMACOGENETICS, V14, P627, DOI 10.1097/00008571-200409000-00007; REID GK, 1990, J BIOL CHEM, V265, P19818; Shi ZZ, 2001, MOL CELL BIOL, V21, P5389, DOI 10.1128/MCB.21.16.5389-5395.2001; Sousa AR, 2002, NEW ENGL J MED, V347, P1493, DOI 10.1056/NEJMoa013508; Takeda T, 2016, J ALLERGY CLIN IMMUN, V138, P1395, DOI 10.1016/j.jaci.2016.01.032; Thompson MD, 2003, PHARMACOGENETICS, V13, P641, DOI 10.1097/00008571-200310000-00008; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; White A, 2006, ANN ALLERG ASTHMA IM, V97, P688, DOI 10.1016/S1081-1206(10)61101-5; Zhu L, 2005, AM J RESP CELL MOL, V33, P531, DOI 10.1165/rcmb.2005-0124OC	63	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					195	+		10.1016/j.jaci.2020.10.041	http://dx.doi.org/10.1016/j.jaci.2020.10.041		JUL 2021	19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IW	33285161	Green Accepted			2022-12-18	WOS:000669908500002
J	Rook, GAW; Bloomfield, SF				Rook, Graham A. W.; Bloomfield, Sally F.			Microbial exposures that establish immunoregulation are compatible with targeted hygiene	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunoregulation; microbiota; microbial exposures; hygiene; evolution; T(H)2-adjuvant; vaccine; hygiene hypothesis	ATOPIC-DERMATITIS; HAY-FEVER; RISK; LIFE; ENVIRONMENT; INFECTIONS; ALLERGY; HEALTH; ASTHMA; CARE	It is often suggested that hygiene is not compatible with the microbial exposures that are necessary for establishment of the immune system in early life. However, when we analyze the microbial exposures of modern humans in the context of human evolution and history, it becomes evident that whereas children need exposure to the microbiotas of their mothers, other family members, and the natural environment, exposure to the unnatural microbiota of the modern home is less relevant. In addition, any benefits of exposure to the infections of childhood within their household setting are at least partly replaced by the recently revealed nonspecific effects of vaccines. This article shows how targeting hygiene practices at key risk moments and sites can maximize protection against infection while minimizing any impact on essential microbial exposures. Moreover, this targeting must aim to reduce direct exposure of children to cleaning agents because those agents probably exert T(H)2-adjuvant effects that trigger allergic responses to normally innocuous antigens. Finally, we need to halt the flow of publications in the scientific literature and the media that blame hygiene for the increases in immunoregulatory disorders. Appropriately targeted hygiene behavior is compatible with a healthy lifestyle that promotes exposure to essential microorganisms.	[Rook, Graham A. W.] UCL Univ Coll London, Dept Infect, Ctr Clin Microbiol, London, England; [Bloomfield, Sally F.] London Sch Hyg & Trop Med, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Rook, GAW (corresponding author), 94 Hemingford Rd, London N1 1DD, England.	g.rook@ucl.ac.uk						Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 2020, NAT REV IMMUNOL, V20, P464, DOI 10.1038/s41577-020-0338-x; Adams K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228462; Adams RI, 2016, BUILD ENVIRON, V109, P224, DOI 10.1016/j.buildenv.2016.09.001; Aiello AE, 2008, AM J INFECT CONTROL, V36, pS128, DOI 10.1016/j.ajic.2008.09.008; Akdis CA, 2021, NAT REV IMMUNOL, V21, P739, DOI 10.1038/s41577-021-00538-7; Andersson MA, 1998, APPL ENVIRON MICROB, V64, P4767; Benn CS, 2020, LANCET INFECT DIS, V20, pE274, DOI 10.1016/S1473-3099(19)30742-X; Benn CS, 2004, BRIT MED J, V328, P1223, DOI 10.1136/bmj.38069.512245.FE; Bloomfield SF, 2019, PERSPECT PUBLIC HEAL, V139, P285, DOI 10.1177/1757913919878367; Bloomfield SF, 2017, GMS HYG INFECT CONTR, V12, DOI 10.3205/dgkh000293; Bloomfield SF, 2016, PERSPECT PUBLIC HEAL, V136, P213, DOI 10.1177/1757913916650225; Bremner SA, 2008, ALLERGY, V63, P274, DOI 10.1111/j.1398-9995.2007.01599.x; Brito IL, 2019, NAT MICROBIOL, V4, P964, DOI 10.1038/s41564-019-0409-6; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Dunder T, 2007, ARCH PEDIAT ADOL MED, V161, P972, DOI 10.1001/archpedi.161.10.972; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Finlay BB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2010217118; Flandroy L, 2018, SCI TOTAL ENVIRON, V627, P1018, DOI 10.1016/j.scitotenv.2018.01.288; Florsheim EB, 2021, CELL, V184, P1440, DOI 10.1016/j.cell.2020.12.007; Galazzo G, 2020, GASTROENTEROLOGY, V158, P1584, DOI 10.1053/j.gastro.2020.01.024; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Hesselmar B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208472; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; International Scientific Forum on Home Hygiene, 2018, CONT BURD INF DIS EV; Johnson Katerina V-A, 2020, Hum Microb J, V15, pNone, DOI 10.1016/j.humic.2019.100069; Kirjavainen PV, 2019, NAT MED, V25, P1089, DOI 10.1038/s41591-019-0469-4; Lemire P, 2020, ENVIRON INT, V144, DOI 10.1016/j.envint.2020.106017; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Maillard JY, 2020, AM J INFECT CONTROL, V48, P1090, DOI 10.1016/j.ajic.2020.04.011; McCall LI, 2020, NAT MICROBIOL, V5, P108, DOI 10.1038/s41564-019-0593-4; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Netea MG, 2019, CELL HOST MICROBE, V25, P13, DOI 10.1016/j.chom.2018.12.006; Palmer M., 2020, MAILONLINE; Parajuli A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00084; Pullinger EJ, 1936, J HYG-CAMBRIDGE, V36, P456, DOI 10.1017/S0022172400043783; Renz H, 2021, NAT REV IMMUNOL, V21, P177, DOI 10.1038/s41577-020-00420-y; Rook G, 2017, LANCET, V390, P521, DOI 10.1016/S0140-6736(17)30566-4; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; Roslund MI, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba2578; Roswall J, 2021, CELL HOST MICROBE, V29, P765, DOI 10.1016/j.chom.2021.02.021; Sahlberg B, 2010, SCAND J PUBLIC HEALT, V38, P232, DOI 10.1177/1403494809350517; Salo MJ, 2019, J APPL MICROBIOL, V127, P1135, DOI 10.1111/jam.14369; Sasaki E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02171; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; SCOTT E, 1984, J HYG-CAMBRIDGE, V92, P193, DOI 10.1017/S0022172400064214; Scudellari M, 2017, P NATL ACAD SCI USA, V114, P1433, DOI 10.1073/pnas.1700688114; Sherriff A, 2002, ARCH DIS CHILD, V87, P30, DOI 10.1136/adc.87.1.30; Sherriff A, 2002, ARCH DIS CHILD, V87, P26, DOI 10.1136/adc.87.1.26; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thompson Derek, 2020, THEATLANTIC; von Hertzen L, 2015, ANN MED, V47, P218, DOI 10.3109/07853890.2015.1010226; Weber J, 2015, AM J RESP CRIT CARE, V191, P522, DOI 10.1164/rccm.201410-1899OC	56	4	4	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					33	39		10.1016/j.jaci.2021.05.008	http://dx.doi.org/10.1016/j.jaci.2021.05.008		JUL 2021	7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	34033844	Green Published			2022-12-18	WOS:000669906700003
J	Soumana, IH; Carlsten, C				Soumana, Illiassou Hamidou; Carlsten, Christopher			Air pollution and the respiratory microbiome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Air pollution; respiratory microbiome; lung microbiome			[Soumana, Illiassou Hamidou; Carlsten, Christopher] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada	University of British Columbia	Carlsten, C (corresponding author), Vancouver Gen Hosp, Gordon & Leslie Diamond Hlth Care Ctr, Lung Ctr, 2775 Laurel St,7th Floor, Vancouver, BC V5Z 1M9, Canada.	carlsten@mail.ubc.ca			Michael Smith Foundation for Health Research; British Columbia Lung Association; Mitacs	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Lung Association; Mitacs	Supported by the Michael Smith Foundation for Health Research, British Columbia Lung Association, and Mitacs.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; Brown RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01803-x; Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472; Glencross DA, 2020, FREE RADICAL BIO MED, V151, P56, DOI 10.1016/j.freeradbiomed.2020.01.179; Jiang XQ, 2016, J THORAC DIS, V8, pE31, DOI 10.3978/j.issn.2072-1439.2015.11.50; Liu JG, 2019, J THORAC DIS, V11, P2617, DOI 10.21037/jtd.2019.05.77; Mao YX, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.104936; Piyadasa H, 2018, AM J RESP CRIT CARE, V197, P1358, DOI 10.1164/rccm.201708-1714LE; van der Valk JPM, 2021, J OCCUP ENVIRON MED, V63, pE163, DOI 10.1097/JOM.0000000000002143; Xue YF, 2020, TOXICOL LETT, V334, P14, DOI 10.1016/j.toxlet.2020.09.007	10	4	4	13	30	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					67	69		10.1016/j.jaci.2021.05.013	http://dx.doi.org/10.1016/j.jaci.2021.05.013		JUL 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	34048853	Bronze			2022-12-18	WOS:000669906700007
J	Stafford, A; Patel, N; Turner, PJ				Stafford, Aisling; Patel, Nandinee; Turner, Paul J.			Anaphylaxis-moving beyond severity...	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Anaphylaxis; food allergy; severity score			[Stafford, Aisling; Patel, Nandinee; Turner, Paul J.] Imperial Coll London, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England	Imperial College London	Turner, PJ (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England.	p.turner@imperial.ac.uk		Turner, Paul/0000-0001-9862-5161	National Institute for Health Research Biomedical Research Centre based at the Imperial College Healthcare National Health Service Trust and Imperial College London	National Institute for Health Research Biomedical Research Centre based at the Imperial College Healthcare National Health Service Trust and Imperial College London	Supported through the National Institute for Health Research Biomedical Research Centre based at the Imperial College Healthcare National Health Service Trust and Imperial College London [to N.P. and P.J.T.]. The views expressed in this article are those of the author(s) and do not necessarily reflect those of the National Health Service, National Institute for Health Research, or Department of Health.	Anagnostou K, 2019, ARCH DIS CHILD, V104, P83, DOI 10.1136/archdischild-2018-314867; Arasi S, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100493; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Cardona V, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100472; Dribin TE, J ALLERGY CLIN IMMUN, V2021, P173; Eller E, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0215-x; Muraro A, 2018, ALLERGY, V73, P1792, DOI 10.1111/all.13408; Roberts G, 2019, CLIN EXP ALLERGY, V49, P1558, DOI 10.1111/cea.13516; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Turner PJ, 2016, ALLERGY, V71, P1241, DOI 10.1111/all.12924	10	4	4	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					83	85		10.1016/j.jaci.2021.04.017	http://dx.doi.org/10.1016/j.jaci.2021.04.017		JUL 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	33901514	Bronze, Green Submitted			2022-12-18	WOS:000669906700013
J	Moecking, J; Laohamonthonkul, P; Chalker, K; White, MJ; Harapas, CR; Yu, CH; Davidson, S; Hrovat-Schaale, K; Hu, DL; Eng, C; Huntsman, S; Calleja, DJ; Horvat, JC; Hansbro, PM; O'Donoghue, RJJ; Ting, JP; Burchard, EG; Geyer, M; Gerlic, M; Masters, SL				Moecking, Jonas; Laohamonthonkul, Pawat; Chalker, Katelyn; White, Marquitta J.; Harapas, Cassandra R.; Yu, Chien-Hsiung; Davidson, Sophia; Hrovat-Schaale, Katja; Hu, Donglei; Eng, Celeste; Huntsman, Scott; Calleja, Dale J.; Horvat, Jay C.; Hansbro, Phil M.; O'Donoghue, Robert J. J.; Ting, Jenny P.; Burchard, Esteban G.; Geyer, Matthias; Gerlic, Motti; Masters, Seth L.			NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NLRP1; inflammasome; asthma; DPP9; SNP	AIRWAY HYPERRESPONSIVENESS; INTERLEUKIN-18 LEVELS; KIDNEY-DISEASE; MURINE MODEL; IL-18; EXPRESSION; SERUM; IL-1-BETA; CYTOKINES; RISK	Background: NLRP1 is an innate immune sensor that can form cytoplasmic inflammasome complexes. Polymorphisms in NLRP1 are linked to asthma; however, there is currently no functional or mechanistic explanation for this. Objective: We sought to clarify the role of NLRP1 in asthma pathogenesis. Methods: Results from the GALA II cohort study were used to identify a link between NLRP1 and asthma in Mexican Americans. In vitro and in vivo models for NLRP1 activation were applied to investigate the role of this inflammasome in asthma at the molecular level. Results: We document the association of an NLRP1 haplotype with asthma for which the single nucleotide polymorphism rs11651270 (M1184V) individually is the most significant. Surprisingly, M1184V increases NLRP1 activation in the context of N-terminal destabilization, but decreases NLRP1 activation on dipeptidyl peptidase 9 inhibition. In vitro studies demonstrate that M1184V increases binding to dipeptidyl peptidase 9, which can account for its inhibitory role in this context. In addition, in vivo data from a mouse model of airway inflammation reveal a protective role for NLRP1 inflammasome activation reducing eosinophilia in this setting. Conclusions: Linking our in vitro and in vivo results, we found that the NLRP1 variant M1184V reduces inflammasome activation in the context of dipeptidyl peptidase 9 inhibition and could thereby increase asthma severity. Our studies may have implications for the treatment of asthma in patients carrying this variant of NLRP1.	[Moecking, Jonas; Laohamonthonkul, Pawat; Chalker, Katelyn; Harapas, Cassandra R.; Yu, Chien-Hsiung; Davidson, Sophia; Hrovat-Schaale, Katja; Calleja, Dale J.; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Moecking, Jonas; Laohamonthonkul, Pawat; Chalker, Katelyn; Harapas, Cassandra R.; Yu, Chien-Hsiung; Davidson, Sophia; Hrovat-Schaale, Katja; Calleja, Dale J.; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Moecking, Jonas; Geyer, Matthias] Univ Bonn, Inst Biol Struct, Venusberg Campus 1, Bonn, Germany; [White, Marquitta J.; Hu, Donglei; Eng, Celeste; Huntsman, Scott; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Horvat, Jay C.; Hansbro, Phil M.] Hunter Med Res Inst, Prior Res Ctr Healthy Lungs, New Lambton, Australia; [Horvat, Jay C.; Hansbro, Phil M.] Univ Newcastle, Callaghan, NSW, Australia; [Hansbro, Phil M.] Centenary Inst, Ctr Inflammat, Sydney, NSW, Australia; [Hansbro, Phil M.] Univ Technol Sydney, Fac Sci, Ultimo, Australia; [O'Donoghue, Robert J. J.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Ting, Jenny P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Gerlic, Motti] Tel Aviv Univ, Dept Clin Microbiol & Immunol, Sackler Fac Med, Tel Aviv, Israel	Walter & Eliza Hall Institute; University of Melbourne; University of Bonn; University of California System; University of California San Francisco; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney; University of Melbourne; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Tel Aviv University; Sackler Faculty of Medicine	Masters, SL (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	masters@wehi.edu.au	Hansbro, Phil/G-7486-2013; Gerlic, Motti/U-3484-2017; Davidson, Sophia/AAA-4581-2022	Hansbro, Phil/0000-0002-4741-3035; Gerlic, Motti/0000-0001-9518-1833; Yu, Chien-Hsiung Alan/0000-0003-1744-3791; Geyer, Matthias/0000-0002-7718-5002; Horvat, Jay/0000-0002-8526-0631; Moecking, Jonas/0000-0001-5914-1359	National Heart, Lung, and Blood Institute; TOPMed Data Coordinating Center [3R01HL-120393-02S1, HHSN268201800001I]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); TOPMed Data Coordinating Center	We thank R. Crawley and S. Russo for outstanding animal husbandry. We also acknowledge the Trans-Omics in Precision Medicine (TOPMed) program imputation panel (freeze 5) supported by the National Heart, Lung, and Blood Institute accessed through the Michigan Imputation Server. The panel was constructed and implemented by the TOPMed Informatics Research Center at the University of Michigan (3R01HL-117626-02S1; contract HHSN268201800002I). The TOPMed Data Coordinating Center (3R01HL-120393-02S1; contract HHSN268201800001I) provided additional data management, sample identity checks, and overall program coordination and support. The Graphical Abstract was prepared using Biorender. We gratefully acknowledge the studies and participants who provided biological samples and data for TOPMed.	Abdi H, 2007, BONFERONNI AND SIDAK; Altinova AE, 2008, CYTOKINE, V42, P217, DOI 10.1016/j.cyto.2008.02.006; Anders HJ, 2016, J AM SOC NEPHROL, V27, P2564, DOI 10.1681/ASN.2016020177; Bhardwaj S, 2017, CYTOKINE, V91, P153, DOI 10.1016/j.cyto.2016.12.014; Bornelov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080080; Bradding Peter, 2008, Allergy Asthma Clin Immunol, V4, P84, DOI 10.1186/1710-1492-4-2-84; Cho YS, 2001, FEBS LETT, V501, P139, DOI 10.1016/S0014-5793(01)02652-7; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Cirelli KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003927; Clipman SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192378; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Leal VNC, 2018, MOL IMMUNOL, V93, P64, DOI 10.1016/j.molimm.2017.11.006; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; DIMITROVA N, 2017, PLOS ONE, V32, P736, DOI DOI 10.1371/J0URNAL.P0NE.0178059; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Egger C, 2017, EUR J PHARMACOL, V809, P64, DOI 10.1016/j.ejphar.2017.05.022; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Gao C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-570; Geldhoff M, 2013, IMMUNOGENETICS, V65, P9, DOI 10.1007/s00251-012-0653-x; Gorfu G, 2014, MBIO, V5, DOI 10.1128/mBio.01117-13; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Griswold AR, 2019, ACS CHEM BIOL, V14, P2424, DOI 10.1021/acschembio.9b00462; Harms RZ, 2015, MOL IMMUNOL, V64, P306, DOI 10.1016/j.molimm.2014.12.012; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Ho LP, 2002, CHEST, V121, P1421, DOI 10.1378/chest.121.5.1421; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Kaplanov I, 2019, P NATL ACAD SCI USA, V116, P1361, DOI 10.1073/pnas.1812266115; Kobayashi T, 2013, AM J RESP CELL MOL, V49, P989, DOI 10.1165/rcmb.2012-0444OC; Kodama T, 2000, J ALLERGY CLIN IMMUN, V105, P45, DOI 10.1016/S0091-6749(00)90176-3; Konno S, 1996, INT ARCH ALLERGY IMM, V109, P73, DOI 10.1159/000237234; Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Kuribayashi K, 2002, CLIN EXP ALLERGY, V32, P641, DOI 10.1046/j.0954-7894.2002.01346.x; Laddha NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107020; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lei YT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01223; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu XY, 2018, ONCOL LETT, V15, P6265, DOI 10.3892/ol.2018.8166; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Magana J, 2020, BIODATA MIN, V13, DOI 10.1186/s13040-020-00218-7; Mak ACY, 2018, AM J RESP CRIT CARE, V197, P1552, DOI 10.1164/rccm.201712-2529OC; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Monteleone G, 1999, J IMMUNOL, V163, P143; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakatani-Okuda A, 2005, AM J PHYSIOL-LUNG C, V289, pL280, DOI 10.1152/ajplung.00380.2004; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Nogueira LG, 2015, CYTOKINE, V73, P79, DOI 10.1016/j.cyto.2015.01.037; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Oroz J, 2016, J BIOL CHEM, V291, P19487, DOI 10.1074/jbc.M116.741082; Nunes MCP, 2018, CIRCULATION, V138, pE169, DOI 10.1161/CIR.0000000000000599; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Pontillo A, 2016, J MED VIROL, V88, P1646, DOI 10.1002/jmv.24514; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian NF, 2010, J CANCER RES CLIN, V136, P709, DOI 10.1007/s00432-009-0710-5; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Santos MLS, 2016, INFECT GENET EVOL, V40, P162, DOI 10.1016/j.meegid.2016.02.038; Schofield L, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0883-8; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; SHER ME, 1995, AM J SURG, V169, P133, DOI 10.1016/S0002-9610(99)80121-4; Singh KP, 2018, MOL IMMUNOL, V97, P82, DOI 10.1016/j.molimm.2018.03.019; Soares JLS, 2018, CLIN IMMUNOL, V187, P46, DOI 10.1016/j.clim.2017.10.003; Sumpter KM, 2011, PEDIATR DIABETES, V12, P656, DOI 10.1111/j.1399-5448.2011.00761.x; Sun XX, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/7405120; Tanaka H, 2001, J ALLERGY CLIN IMMUN, V107, P331, DOI 10.1067/mai.2001.112275; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Wang Y, 2019, MBIO, V10; Wang YC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0465-7; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wenzel, 2012, DRUG DISCOV TODAY DI, V9, pE75, DOI DOI 10.1016/j.ddmec.2012.09.001; White MJ, 2016, IMMUNOGENETICS, V68, P391, DOI 10.1007/s00251-016-0914-1; Witola WH, 2011, INFECT IMMUN, V79, P756, DOI 10.1128/IAI.00898-10; Wong CK, 2007, CLIN EXP IMMUNOL, V149, P123, DOI 10.1111/j.1365-2249.2007.03389.x; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zwijnenburg PJG, 2003, J NEUROIMMUNOL, V138, P31, DOI 10.1016/S0165-5728(03)00088-2; Zwijnenburg PJG, 2003, J IMMUNOL, V170, P4724, DOI 10.4049/jimmunol.170.9.4724	93	4	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2134	+		10.1016/j.jaci.2020.12.636	http://dx.doi.org/10.1016/j.jaci.2020.12.636		JUN 2021	32	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33378691	Green Published, hybrid			2022-12-18	WOS:000657814800018
J	Salomon, JJ; Albrecht, T; Graeber, SY; Scheuermann, H; Butz, S; Schatterny, J; Mairbaurl, H; Baumann, I; Mall, MA				Salomon, Johanna J.; Albrecht, Tobias; Graeber, Simon Y.; Scheuermann, Heike; Butz, Simone; Schatterny, Jolanthe; Mairbaeurl, Heimo; Baumann, Ingo; Mall, Marcus A.			Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis with nasal polyps; nasal epithelium; Ca2+-activated Cl- channel; TMEM16A; epithelial Cl- secretion	TRANSEPITHELIAL ION-TRANSPORT; CYSTIC-FIBROSIS; MUCIN SECRETION; CELLS; CHANNEL; TMEM16A; INTERLEUKIN-13; PATHOGENESIS; EXPRESSION; CALCIUM	Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is one of the most common chronic disorders with limited therapeutic options. However, the pathogenesis of CRSwNP remains poorly understood. Objective: We sought to determine the role of abnormalities in nasal epithelial ion transport in primary epithelial cultures and patients with CRSwNP. Methods: We studied epithelial ion transport and transcript levels of the Cl- channels cystic fibrosis transmembrane conductance regulator and transmembrane protein 16A (TMEM16A) in human primary nasal epithelial cultures of patients with CRSwNP and healthy controls. Furthermore, we determined expression levels of proinflammatory cytokines that have been implicated in the regulation of epithelial ion channels (IL-1 beta, INF-gamma, TNF-alpha, IL-13) and studied effects of the key T(H)2 signaling molecule IL-13 in CRSwNP and control nasal epithelial cultures. Finally, we measured in vivo nasal potential difference to compare epithelial ion transport in patients with CRSwNP and controls. Results: Bioelectric studies demonstrated that Ca2+-activated Cl- secretion was reduced in CRSwNP versus control nasal epithelial cultures. Transcript levels of IL-13 and the Ca2+-activated Cl- channel TMEM16Awere increased in CRSwNP cultures. Stimulation with IL-13 increased TMEM16A expression and restored Ca2+-activated Cl- secretion in CRSwNP cultures. Nasal potential difference measurements demonstrated reduced Ca2+-activated Cl- transport in patients with CRSwNP versus controls. Conclusions: This study demonstrates that TMEM16Amediated Ca2+-activated Cl- secretion is reduced in primary nasal epithelial cultures and nasal epithelia of patients with CRSwNP. Our data suggest that the Ca2+-activated Cl- channel TMEM16A may be implicated in the pathogenesis and serve as a novel therapeutic target in patients with CRSwNP.	[Salomon, Johanna J.; Graeber, Simon Y.; Scheuermann, Heike; Butz, Simone; Schatterny, Jolanthe; Mairbaeurl, Heimo; Mall, Marcus A.] Heidelberg Univ, Dept Translat Pulmonol, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Albrecht, Tobias; Baumann, Ingo] Heidelberg Univ, Dept Otolaryngol Head & Neck Surg, Heidelberg, Germany; [Graeber, Simon Y.; Mall, Marcus A.] Charite Univ Med Berlin, Dept Pediat Pulmonol Immunol & Crit Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany; [Graeber, Simon Y.; Mall, Marcus A.] Berlin Inst Hlth BIH, Berlin, Germany; [Graeber, Simon Y.; Mall, Marcus A.] German Ctr Lung Res DZL, Associated Partner Site, Berlin, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Mall, MA (corresponding author), Charite Univ Med Berlin, Dept Pediat Pulmonol Immunol & Crit Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	Marcus.Mall@charite.de	Graeber, Simon/AGX-6006-2022; Mall, Marcus A./AAA-1498-2022	Mall, Marcus A./0000-0002-4057-2199; Graeber, Simon Y./0000-0002-1666-8924	German Federal Ministry of Education and Research [82DZL004A1]; German Research Foundation [CRC 1449 A01, CRC 1449 Z02]; Einstein Foundation Berlin [EP2017-393]; Charite - Universitatsmedizin Berlin; BIH	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Einstein Foundation Berlin; Charite - Universitatsmedizin Berlin; BIH	This study was supported in part by grants from the German Federal Ministry of Education and Research (grant no. 82DZL004A1), the German Research Foundation (grant nos. CRC 1449 A01 and Z02), and the Einstein Foundation Berlin (grant no. EP2017-393). S.Y.G. is participant of the Berlin Institute of Health (BIH)-Charit~e Clinician Scientist Program funded by the Charite -Universitatsmedizin Berlin and the BIH.	Akdis C, 2015, GLOBAL ATLAS ALLERGI; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Anagnostopoulou P, 2012, J CLIN INVEST, V122, P3629, DOI 10.1172/JCI60429; Baumann I, 2009, HNO, V57, P873, DOI 10.1007/s00106-009-1972-6; Baumann I, 2007, RHINOLOGY, V45, P268; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Danahay HL, 2020, AM J RESP CRIT CARE, V201, P946, DOI 10.1164/rccm.201908-1641OC; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Fritzsching B, 2017, J ALLERGY CLIN IMMUN, V140, P190, DOI 10.1016/j.jaci.2016.09.045; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Galietta LJV, 2000, AM J PHYSIOL-LUNG C, V278, pL1186, DOI 10.1152/ajplung.2000.278.6.L1186; Galietta Luis J V, 2004, Proc Am Thorac Soc, V1, P62, DOI 10.1513/pats.2306017; Graeber SY, 2018, AM J RESP CRIT CARE, V197, P1433, DOI 10.1164/rccm.201710-1983OC; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Gurrola J, 2017, J ALLERGY CLIN IMMUN, V140, P1499, DOI 10.1016/j.jaci.2017.10.006; Hahn A, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13290; Kim MD, 2020, AM J RESP CRIT CARE, V201, P313, DOI 10.1164/rccm.201905-0990OC; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Li HY, 2017, CURR OPIN PHARMACOL, V34, P91, DOI 10.1016/j.coph.2017.10.002; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Paradiso AM, 2003, J PHYSIOL-LONDON, V548, P203, DOI 10.1113/jphysiol.2002.034447; Park SJ, 2013, J ALLERGY CLIN IMMUN, V131, P772, DOI 10.1016/j.jaci.2012.12.671; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Rowe SM, 2011, METHODS MOL BIOL, V741, P69, DOI 10.1007/978-1-61779-117-8_6; Rudmik L, 2011, CURR ALLERGY ASTHM R, V11, P247, DOI 10.1007/s11882-010-0175-2; Salomon JJ, 2016, AM J PHYSIOL-LUNG C, V310, pL593, DOI 10.1152/ajplung.00321.2015; Sasaki S, 2018, NUCLEIC ACID THER, V28, P1, DOI 10.1089/nat.2017.0696; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Seo Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155771; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; STUTTS MJ, 1995, AM J PHYSIOL-CELL PH, V268, pC425, DOI 10.1152/ajpcell.1995.268.2.C425; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xu W, 1999, J MEMBRANE BIOL, V171, P117, DOI 10.1007/s002329900564; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; YANKASKAS JR, 1985, AM REV RESPIR DIS, V132, P1281; Zhang Y, 2015, ALLERGY ASTHMA IMMUN, V7, P367, DOI 10.4168/aair.2015.7.4.367	52	4	4	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2191	+		10.1016/j.jaci.2021.02.008	http://dx.doi.org/10.1016/j.jaci.2021.02.008		JUN 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33609628	Bronze			2022-12-18	WOS:000657814800024
J	Khodoun, MV; Morris, SC; Shao, WH; Potter, C; Angerman, E; Kiselev, A; Yarawsky, AE; Herr, AB; Klausz, K; Otte, A; Peipp, M; Finkelman, FD				Khodoun, Marat, V; Morris, Suzanne C.; Shao, Wen-Hai; Potter, Crystal; Angerman, Elizabeth; Kiselev, Artem; Yarawsky, Alexander E.; Herr, Andrew B.; Klausz, Katja; Otte, Anna; Peipp, Matthias; Finkelman, Fred D.			Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-Fc epsilon RI alpha mAbs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mouse; humanized; mast cell; desensitization; Syk; cross-linking; IL-4; IgG(1); IgG4	PROTEIN-TYROSINE KINASE; MAST-CELL; IN-VIVO; MONOCLONAL-ANTIBODY; IMMUNE-COMPLEXES; B-CELLS; AFFINITY; RECEPTOR; EXPRESSION; DESENSITIZATION	Background: Mast cell and basophil activation by antigen cross linking of Fc epsilon RI-bound IgE is central to allergy pathogenesis. We previously demonstrated global suppression of this process by rapid desensitization with anti-Fc epsilon RI alpha mAbs. Objectives: We sought to determine whether use of monovalent (mv) anti-Fc epsilon RI alpha mAbs increases desensitization safety without loss of efficacy. Methods: mv anti-human (hu) Fc epsilon RI alpha mAbs were produced with mouse-derived immunoglobulin variable regions and huIgG(1) or huIgG(4) C regions and were used to suppress murine IgE-mediated anaphylaxis and food allergy. mAbs were administered as a single dose or as serially increasing doses to mice that express hu instead of mouse Fc epsilon RI alpha; mice that additionally have an allergy-promoting IL-4Ra mutation; and hu cord blood-reconstituted immunodeficient, hu cytokinesecreting, mice that have large numbers of activated hu mast cells. Anaphylaxis susceptibility was sometimes increased by treatment with IL-4 or a b-adrenergic receptor antagonist. Results: mv anti-hu Fc epsilon RI alpha mAbs are considerably less able than divalent mAbs are to induce anaphylaxis and deplete mast cell and basophil IgE, but mv mAbs still strongly suppress IgEmediated disease. The mv mAbs can be safely administered as a single large dose to mice with typical susceptibility to anaphylaxis, while a rapid desensitization approach safely suppresses disease in mice with increased susceptibility. Our huIgG(4) variant of mv anti-huFc epsilon RI alpha mAb is safer than our huIgG(1) variant is, apparently because reduced interactions with Fc epsilon Rs decrease ability to indirectly cross-link Fc epsilon RI. Conclusions: mv anti-Fc epsilon RI alpha mAbs more safely suppress IgEmediated anaphylaxis and food allergy than divalent variants of the same mAbs do. These mv mAbs may be useful for suppression of huIgE-mediated disease.	[Khodoun, Marat, V; Morris, Suzanne C.; Shao, Wen-Hai; Potter, Crystal; Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Allergy Immunol & Rheumatol, Cincinnati, OH USA; [Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Angerman, Elizabeth; Yarawsky, Alexander E.; Herr, Andrew B.; Finkelman, Fred D.] Russian Acad Sci, Div Immunobiol, St Petersburg, Russia; [Herr, Andrew B.] Russian Acad Sci, Div Infect Dis, Cincinnati Childrens Hosp Med Ctr, St Petersburg, Russia; [Kiselev, Artem] Russian Acad Sci, Inst Cytol, St Petersburg, Russia; [Klausz, Katja; Otte, Anna; Peipp, Matthias] Univ Kiel, Univ Hosp Schleswig Holstein, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; University of Kiel; Schleswig Holstein University Hospital	Finkelman, FD (corresponding author), Apartment 79,26 Sderot Nitza, IL-4226259 Netanya, Israel.	finkelfd@ucmail.uc.edu	Peipp, Matthias/A-8775-2013; Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Langner, Anna/0000-0002-4011-9650; Peipp, Matthias/0000-0002-5088-3804; Yarawsky, Alexander/0000-0002-5973-5058	US National Institutes of Health [R01AI130103, R01AI113162, R01-DK116789]; Mildred-Scheel-Professorship program of German Cancer Aid; DFG Excellence Cluster "Precision Medicine in Chronic Inflammation"; Cincinnati Digestive Health Center	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mildred-Scheel-Professorship program of German Cancer Aid; DFG Excellence Cluster "Precision Medicine in Chronic Inflammation"(German Research Foundation (DFG)); Cincinnati Digestive Health Center	Supported by grants R01AI130103 (to F.D.F.) , R01AI113162 (to F.D.F.) , R01-DK116789 (to W.-H.S.) from the US National Institutes of Health; the Mildred-Scheel-Professorship program of German Cancer Aid (to M.P.) ; the DFG Excellence Cluster "Precision Medicine in Chronic Inflammation" (to M.P.) ; and the Cincinnati Digestive Health Center (to F.D.F.) .	ALTMAN LC, 1981, MED CLIN N AM, V65, P941, DOI 10.1016/S0025-7125(16)31482-1; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Cambier JC, 2010, IMMUNOL LETT, V128, P6, DOI 10.1016/j.imlet.2009.09.006; Cernadas JR, 2010, ALLERGY, V65, P1357, DOI 10.1111/j.1398-9995.2010.02441.x; Clay CD, 2018, J ALLERGY CLIN IMMUN, V141, P1373, DOI 10.1016/j.jaci.2017.05.027; Dekkers G, 2017, MABS-AUSTIN, V9, P767, DOI 10.1080/19420862.2017.1323159; Dombrowicz D, 1996, J IMMUNOL, V157, P1645; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; EMLEN W, 1982, J EXP MED, V155, P1210, DOI 10.1084/jem.155.4.1210; Eray M, 1998, INT IMMUNOL, V10, P1573, DOI 10.1093/intimm/10.10.1573; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; Finkelman FD, 2001, J ALLERGY CLIN IMMUN, V107, P772, DOI 10.1067/mai.2001.114989; Finkelman Fred, 2003, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0628s54; GOROFF DK, 1988, J IMMUNOL, V140, P2919; GRACE SA, 1982, IMMUNOLOGY, V47, P221; GRENCIS RK, 1993, PARASITE IMMUNOL, V15, P55, DOI 10.1111/j.1365-3024.1993.tb00572.x; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; Holowka D, 1996, ANNU REV BIOPH BIOM, V25, P79; Iikura M, 2001, INT ARCH ALLERGY IMM, V124, P470, DOI 10.1159/000053782; Incorvaia C, 2014, DRUG DES DEV THER, V8, P197, DOI 10.2147/DDDT.S49409; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Khodoun MV, 2020, J ALLERGY CLIN IMMUN, V145, P907, DOI 10.1016/j.jaci.2019.12.003; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V131, P1555, DOI 10.1016/j.jaci.2013.02.043; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KURLANDER RJ, 1984, J IMMUNOL, V133, P855; Lantz CS, 1997, J IMMUNOL, V158, P2517; Laue TM, 1992, ANAL ULTRACENTRIFUGA, P90, DOI [10.1007/s00249-009-0425-1, DOI 10.1007/S00249-009-0425-1]; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; MacGlashan D, 2012, CLIN EXP ALLERGY, V42, P1060, DOI 10.1111/j.1365-2222.2012.04013.x; Macglashan Donald Jr., 1998, Frontiers in Bioscience, V3, pD746; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; MATSUDA H, 1990, J IMMUNOL, V144, P259; Matsuda K, 2005, J ALLERGY CLIN IMMUN, V116, P1357, DOI 10.1016/j.jaci.2005.08.042; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Morris SC, 2000, J IMMUNOL, V164, P3035, DOI 10.4049/jimmunol.164.6.3035; ODONOVAN WJ, 1946, LANCET, V251, P444; Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Sancho-Serra MD, 2011, EUR J IMMUNOL, V41, P1004, DOI 10.1002/eji.201040810; SCHARENBERG AM, 1994, J ALLERGY CLIN IMMUN, V94, P1142, DOI 10.1016/0091-6749(94)90323-9; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah M, 2018, INT J PHARMACEUT, V552, P1, DOI 10.1016/j.ijpharm.2018.09.049; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; SULLIVAN TJ, 1982, J ALLERGY CLIN IMMUN, V69, P500, DOI 10.1016/0091-6749(82)90174-9; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; Vilen BJ, 2002, J IMMUNOL, V168, P4344, DOI 10.4049/jimmunol.168.9.4344; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2014, BLOOD, V123, pE134, DOI 10.1182/blood-2014-02-556340; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Zhang K, 2019, J IMMUNOL, V203, P2777, DOI 10.4049/jimmunol.1900112; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	60	4	4	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1838	+		10.1016/j.jaci.2020.10.045	http://dx.doi.org/10.1016/j.jaci.2020.10.045		MAY 2021	21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33326804	Green Accepted			2022-12-18	WOS:000651594300005
J	Kury, P; Staniek, J; Wegehaupt, O; Janowska, I; Eckenweiler, M; Korinthenberg, R; Japaridze, N; Pendziwiat, M; Helbig, I; Verhoeyen, E; Jung, J; de Oteyza, ACG; Proietti, M; Phirtskhalaishvili, T; Rtskhiladze, I; Nielsen, PJ; Ehl, S; Speckmann, C; Rizzi, M				Kury, Patrick; Staniek, Julian; Wegehaupt, Oliver; Janowska, Iga; Eckenweiler, Matthias; Korinthenberg, Rudolf; Japaridze, Natia; Pendziwiat, Manuela; Helbig, Ingo; Verhoeyen, Els; Jung, Johannes; de Oteyza, Andres Caballero Garcia; Proietti, Michele; Phirtskhalaishvili, Tamar; Rtskhiladze, Irakli; Nielsen, Peter J.; Ehl, Stephan; Speckmann, Carsten; Rizzi, Marta			Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MULTIPLE STAGES		[Kury, Patrick; de Oteyza, Andres Caballero Garcia; Proietti, Michele; Ehl, Stephan; Speckmann, Carsten] Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency, Inst Immunodeficiency,Med Ctr, Freiburg, Germany; [Kury, Patrick; Staniek, Julian] Univ Freiburg, Fac Biol, Freiburg, Germany; [Staniek, Julian; Janowska, Iga; Rizzi, Marta] Univ Freiburg, Med Ctr, Dept Rheumatol & Clin Immunol, Fac Med, Freiburg, Germany; [Wegehaupt, Oliver; Eckenweiler, Matthias; Speckmann, Carsten] Univ Freiburg, Med Ctr, Ctr Pediat & Adolescent Med, Fac Med, Freiburg, Germany; [Korinthenberg, Rudolf] Univ Freiburg, Med Ctr, Div Neuropediat & Muscular Disorders, Dept Pediat & Adolescent Med,Fac Med, Freiburg, Germany; [Japaridze, Natia; Pendziwiat, Manuela] Univ Kiel, Univ Med Ctr Schleswig Holstein, Childrens Hosp, Dept Neuropediat, Kiel, Germany; [Pendziwiat, Manuela; Helbig, Ingo] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Helbig, Ingo] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Helbig, Ingo] Childrens Hosp Philadelphia, Epilepsy NeuroGenet Initiat, Philadelphia, PA 19104 USA; [Helbig, Ingo] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat DBHi, Philadelphia, PA 19104 USA; [Helbig, Ingo] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Verhoeyen, Els] Univ Lyon, CIRI, Lyon, France; [Verhoeyen, Els] INSERM, U1111, Lyon, France; [Verhoeyen, Els] ENS Lyon, Lyon, France; [Verhoeyen, Els] Univ Lyon, Lyon, France; [Verhoeyen, Els] CNRS, UMR 5308, Lyon, France; [Verhoeyen, Els] Univ Cote dAzur, INSERM, C3M, Nice, France; [Jung, Johannes] Univ Freiburg, Fac Med, Dept Med Hematol Oncol & Stem Cell Transplantat 1, Med Ctr, Freiburg, Germany; [Phirtskhalaishvili, Tamar; Rtskhiladze, Irakli] Med Ctr Mrcheveli, Tbilisi, Georgia; [Nielsen, Peter J.] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland; [Rizzi, Marta] Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg	Speckmann, C (corresponding author), Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency, Inst Immunodeficiency,Med Ctr, Freiburg, Germany.; Rizzi, M (corresponding author), Univ Freiburg, Med Ctr, Dept Rheumatol & Clin Immunol, Fac Med, Freiburg, Germany.; Speckmann, C (corresponding author), Univ Freiburg, Med Ctr, Ctr Pediat & Adolescent Med, Fac Med, Freiburg, Germany.; Rizzi, M (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.	carsten.speckmann@uniklinik-freiburg.de; marta.rizzi@uniklinik-freiburg.de	Verhoeyen, Els/AAW-4853-2021; Helbig, Ingo/G-8467-2018	Verhoeyen, Els/0000-0001-9224-5491; Helbig, Ingo/0000-0001-8486-0558; Rizzi, Marta/0000-0002-5153-6089; Wegehaupt, Oliver/0000-0002-9391-0761; Caballero Garcia de Oteyza, Andres/0000-0002-8892-1255; Jung, Johannes/0000-0003-0137-7929	German Research Foundation (DFG) [SFB1160]; DFG under Germany`s Excellence Strategy [CIBSS-EXC-2189, 390939984]; Children's Hospital of Philadelphia through the Epilepsy NeuroGenetics Initiative; DFG [HE5415/5-1, HE5415/6-1, FOR2715 (HE5415/7-1)]; Else Kroner-Fresenius-Stiftung	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG under Germany`s Excellence Strategy(German Research Foundation (DFG)); Children's Hospital of Philadelphia through the Epilepsy NeuroGenetics Initiative; DFG(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung	Supported by a grant from the German Research Foundation (DFG) (SFB1160: B02 [to M.R.] and A01 [to S.E.]). S.E. was supported by the DFG under Germany`s Excellence Strategy (CIBSS-EXC-2189; Project identifier 390939984). The research was also supported by intramural funds of the Children's Hospital of Philadelphia through the Epilepsy NeuroGenetics Initiative, the DFG (HE5415/5-1 and HE5415/6-1 [to I.H.]), the DFG Research Unit FOR2715 (HE5415/7-1 [to I.H.]), and the Else Kroner-Fresenius-Stiftung (personal grant to J.J.). The authors are responsible for the contents of this publication.	Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Malone CS, 2002, J IMMUNOL, V168, P3369, DOI 10.4049/jimmunol.168.7.3369; Minuzzo S, 2005, BRIT J HAEMATOL, V130, P878, DOI 10.1111/j.1365-2141.2005.05699.x; Samardzic T, 2002, MOL CELL BIOL, V22, P8320, DOI 10.1128/MCB.22.23.8320-8331.2002; Samardzic T, 2002, EUR J IMMUNOL, V32, P2481, DOI 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Siegel R, 2006, CELL, V125, P761, DOI 10.1016/j.cell.2006.03.036; Stauss D, 2016, EMBO J, V35, P881, DOI 10.15252/embj.201591459	9	4	4	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1977	1980		10.1016/j.jaci.2021.01.027	http://dx.doi.org/10.1016/j.jaci.2021.01.027		MAY 2021	4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZE	33571536	hybrid, Green Published			2022-12-18	WOS:000651594000007
J	Sahlen, P; Spalinskas, R; Asad, S; Das Mahapatra, K; Hojer, P; Anil, A; Eisfeldt, J; Srivastava, A; Nikamo, P; Mukherjee, A; Kim, KH; Bergman, O; Stahle, M; Sonkoly, E; Pivarcsi, A; Wahlgren, CF; Nordenskjold, M; Taylan, F; Bradley, M; Tapia-Paez, I				Sahlen, Pelin; Spalinskas, Rapolas; Asad, Samina; Das Mahapatra, Kunal; Hojer, Pontus; Anil, Anandashankar; Eisfeldt, Jesper; Srivastava, Ankit; Nikamo, Pernilla; Mukherjee, Anaya; Kim, Kyu-Han; Bergman, Otto; Stahle, Mona; Sonkoly, Eniko; Pivarcsi, Andor; Wahlgren, Carl-Fredrik; Nordenskjold, Magnus; Taylan, Fulya; Bradley, Maria; Tapia-Paez, Isabel			Chromatin interactions in differentiating keratinocytes reveal novel atopic dermatitis- and psoriasis-associated genes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; psoriasis; Capture Hi-C; AFG1L; CLINT1; ADO; LINC00302; 1	GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; TERMINAL DIFFERENTIATION; CANDIDATE GENES; KLF4; DISCOVERY; VARIANTS; COMPLEX; STATES	Background: Hundreds of variants associated with atopic dermatitis (AD) and psoriasis, 2 common inflammatory skin disorders, have previously been discovered through genomewide association studies (GWASs). The majority of these variants are in noncoding regions, and their target genes remain largely unclear. Objective: We sought to understand the effects of these noncoding variants on the development of AD and psoriasis by linking them to the genes that they regulate. Methods: We constructed genomic 3-dimensional maps of human keratinocytes during differentiation by using targeted chromosome conformation capture (Capture Hi-C) targeting more than 20,000 promoters and 214 GWAS variants and combined these data with transcriptome and epigenomic data sets. We validated our results with reporter assays, clustered regularly interspaced short palindromic repeats activation, and examination of patient gene expression from previous studies. Results: We identified 118 target genes of 82 AD and psoriasis GWAS variants. Differential expression of 58 of the 118 target genes (49%) occurred in either AD or psoriatic lesions, many of which were not previously linked to any skin disease. We highlighted the genes AFG1L, CLINT1, ADO, LINC00302, and RP1-140J1.1 and provided further evidence for their potential roles in AD and psoriasis. Conclusions: Our work focused on skin barrier pathology through investigation of the interaction profile of GWAS variants during keratinocyte differentiation. We have provided a catalogue of candidate genes that could modulate the risk of AD and psoriasis. Given that only 35% of the target genes are the gene nearest to the known GWAS variants, we expect that our work will contribute to the discovery of novel pathways involved in AD and psoriasis. (J Allergy Clin Immunol 2021;147:1742-52.)	[Sahlen, Pelin; Spalinskas, Rapolas; Hojer, Pontus; Anil, Anandashankar] KTH Royal Inst Technol, Sch Chem Biotechnol & Hlth, Sci Life Lab, Stockholm, Sweden; [Asad, Samina; Das Mahapatra, Kunal; Srivastava, Ankit; Nikamo, Pernilla; Mukherjee, Anaya; Stahle, Mona; Sonkoly, Eniko; Pivarcsi, Andor; Wahlgren, Carl-Fredrik; Bradley, Maria; Tapia-Paez, Isabel] Karolinska Inst, Dermatol & Venereol Div, Dept Med Solna, Stockholm, Sweden; [Eisfeldt, Jesper; Nordenskjold, Magnus; Taylan, Fulya] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Stockholm, Sweden; [Sonkoly, Eniko; Pivarcsi, Andor] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Kim, Kyu-Han] AmorePacific Corp, Res & Dev Unit, Basic Res & Innovat Div, Yongin, South Korea; [Bergman, Otto] Karolinska Inst, Ctr Mol Med, Dept Med Solna, Div Cardiovasc Med, Stockholm, Sweden; [Bergman, Otto] Karolinska Univ Hosp, Solna, Sweden; [Eisfeldt, Jesper; Nordenskjold, Magnus; Taylan, Fulya] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Pivarcsi, Andor] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Sonkoly, Eniko; Bradley, Maria] Karolinska Univ Hosp, Dermatol Unit, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Sahlen, P (corresponding author), Sci Life Lab, Tomtebodavagen 23A, S-17165 Stockholm, Sweden.	pelin.akan@scilifelab.se	Taylan, Fulya/V-7121-2019; Tapia-Páez, Isabel/ABD-7197-2021; Das Mahapatra, Kunal/AAE-2530-2022	Taylan, Fulya/0000-0002-2907-0235; Srivastava, Ankit/0000-0001-5328-7509; Spalinskas, Rapolas/0000-0002-1648-6426; Tapia-Paez, Isabel/0000-0002-0535-4233; Nordenskjold, Magnus/0000-0002-4974-425X	Swedish Research Council (Vetenskapsradet) [78081, 201805973]; Swedish Skin Foundation [2544, 2968, 2709, 2948]; Sanofi Genzyme Award for Type 2 Innovation Grant 2018; Swedish Cancer Society [CAN 2018/801]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Skin Foundation; Sanofi Genzyme Award for Type 2 Innovation Grant 2018; Swedish Cancer Society(Swedish Cancer Society)	Supported by the Swedish Research Council (Vetenskapsradet, grant 78081) and the Swedish Skin Foundation (grants 2544 and 2968) . M.B. and I.T.P. received the Sanofi Genzyme Award for Type 2 Innovation Grant 2018 for this study. A.P. was funded by Swedish Skin Foundation (grants 2709 and 2948) and the Swedish Cancer Society (grant CAN 2018/801) . The computations and data handling were made possible byresources provided by the Swedish National Infrastructure for Computing at Rackham (UPPMAX) , which was partially funded by the Swedish Research Council through grant agreement 201805973.	Akerborg O, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002353; Anil A, 2018, BIOINFORMATICS, V34, P675, DOI 10.1093/bioinformatics/btx625; Arvanitis M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14843-7; Atlasi Y, 2019, NAT CELL BIOL, V21, P568, DOI 10.1038/s41556-019-0310-9; Baxter JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03411-9; Bos JD, 2010, EXP DERMATOL, V19, P325, DOI 10.1111/j.1600-0625.2009.01024.x; Boxer LD, 2014, GENE DEV, V28, P2013, DOI 10.1101/gad.246579.114; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cannon ME, 2018, AM J HUM GENET, V103, P637, DOI 10.1016/j.ajhg.2018.10.001; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Cookson WOCM, 2001, J AM ACAD DERMATOL, V45, pS7, DOI 10.1067/mjd.2001.117026; Damm A, 2016, EUR J IMMUNOL, V46, P1959, DOI 10.1002/eji.201646401; Dao LTM, 2017, NAT GENET, V49, P1073, DOI 10.1038/ng.3884; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Flister MJ, 2013, GENOME RES, V23, P1996, DOI 10.1101/gr.160283.113; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Grafe F, 2004, EUR J PHARM BIOPHARM, V57, P337, DOI 10.1016/j.ejpb.2003.10.010; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Guttman-Yassky E, 2017, CURR OPIN IMMUNOL, V48, P68, DOI 10.1016/j.coi.2017.08.008; Hartmann H, 2013, GENOME RES, V23, P181, DOI 10.1101/gr.139881.112; Hibino T, 2016, J DERMATOL SCI, V84, pE69; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Janeke G, 2003, J INVEST DERMATOL, V121, P354, DOI 10.1046/j.1523-1747.2003.12366.x; Kim Gyu-han, 2016, ACOMPOSITION SKIN BA; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lange SS, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800048; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loset M, 2019, DERMATOLOGY, V235, P355, DOI 10.1159/000500402; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Malin J, 2013, NUCLEIC ACIDS RES, V41, P6828, DOI 10.1093/nar/gkt374; Martin P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10069; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Pasquali L, 2019, ACTA DERM-VENEREOL, V99, P196, DOI 10.2340/00015555-3066; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Rajarajan P, 2018, SCIENCE, V362, P1269, DOI 10.1126/science.aat4311; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Sahlen P, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0727-9; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455; Therianou A, 2019, EXP DERMATOL, V28, P72, DOI 10.1111/exd.13831; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Villarreal-Martinez A, 2016, EXP THER MED, V11, P1217, DOI 10.3892/etm.2016.3066; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Yu WC, 2020, BURNS, V46, P1128, DOI 10.1016/j.burns.2019.11.016; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	59	4	4	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1742	1752		10.1016/j.jaci.2020.09.035	http://dx.doi.org/10.1016/j.jaci.2020.09.035		MAY 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33069716	Green Published, hybrid			2022-12-18	WOS:000647680800023
J	Gattinger, P; Bidovec-Stojkovic, U; Zidarn, M; Korosec, P; Valenta, R; Mittermann, I				Gattinger, Pia; Bidovec-Stojkovic, Urska; Zidarn, Mihaela; Korosec, Peter; Valenta, Rudolf; Mittermann, Irene			Glycosylation enhances allergenic activity of major bee venom allergen Api m 1 by adding IgE epitopes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GRASS-POLLEN ALLERGEN; HONEYBEE VENOM; CARBOHYDRATE; DETERMINANTS; REACTIVITY; EXPRESSION		[Gattinger, Pia; Valenta, Rudolf; Mittermann, Irene] Med Univ Vienna, Div Immunopathol, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Bidovec-Stojkovic, Urska; Zidarn, Mihaela; Korosec, Peter] Univ Clin Resp & Allerg Dis, Golnik, Slovenia; [Zidarn, Mihaela] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Valenta, Rudolf] Fed Biomed Agcy Russia, NRC Inst Immunol, Moscow, Russia; [Valenta, Rudolf] Sechenov First Moscow State Med Univ, Dept Clin Immunol & Allergy, Immunopathol Lab, Moscow, Russia; [Valenta, Rudolf] Karl Landsteiner Univ Hlth Sci, Krems, Austria	Medical University of Vienna; University of Ljubljana; NRC Institute of Immunology FMBA of Russia; Sechenov First Moscow State Medical University	Mittermann, I (corresponding author), Med Univ Vienna, Div Immunopathol, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria.	irene.mittermann@meduniwien.ac.at		Valenta, Rudolf/0000-0001-5944-3365; Mittermann, Irene/0000-0002-6240-6730; Gattinger, Pia/0000-0001-6724-8543	Austrian Science Fund [P26728, F4605]; HVD Biotech, Vienna, Austria; Viravaxx, Vienna, Austria	Austrian Science Fund(Austrian Science Fund (FWF)); HVD Biotech, Vienna, Austria; Viravaxx, Vienna, Austria	This study was supported by grants from the Austrian Science Fund (P26728 and F4605) and from HVD Biotech, Vienna, Austria and Viravaxx, Vienna, Austria. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball T, 2005, FEBS J, V272, P217, DOI 10.1111/j.1432-1033.2004.04403.x; Blank S, 2011, PROTEIN PEPTIDE LETT, V18, P415, DOI 10.2174/092986611794653923; Burtin D, 2009, CLIN EXP ALLERGY, V39, P760, DOI 10.1111/j.1365-2222.2009.03201.x; Do DC, 2017, IMMUN INFLAMM DIS, V5, P386, DOI 10.1002/iid3.145; Dorofeeva Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50854-1; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Gattinger P, 2019, EBIOMEDICINE, V39, P33, DOI 10.1016/j.ebiom.2018.12.002; Gieras A, 2007, J ALLERGY CLIN IMMUN, V119, P384, DOI 10.1016/j.jaci.2006.09.034; Glesner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022223; Hemmer W, 2018, J ALLERGY CLIN IMMUN, V141, P372, DOI 10.1016/j.jaci.2017.04.028; Jakob T, 2012, J ALLERGY CLIN IMMUN, V130, P276, DOI 10.1016/j.jaci.2012.03.048; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; MULLER UR, 1995, J ALLERGY CLIN IMMUN, V96, P395, DOI 10.1016/S0091-6749(95)70059-5; Platts-Mills TAE, 2015, IMMUNOL ALLERGY CLIN, V35, P247, DOI 10.1016/j.iac.2015.01.009; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Villazala-Merino S, 2020, J ALLERGY CLIN IMMUN, V145, P958, DOI 10.1016/j.jaci.2019.11.019; Zafred D, 2013, J ALLERGY CLIN IMMUN, V132, P696, DOI 10.1016/j.jaci.2013.03.021; Zahirovi A, 2019, J ALLERGY CLIN IMMUN, V143, P791, DOI 10.1016/j.jaci.2018.10.003	20	4	4	4	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1502	+		10.1016/j.jaci.2020.10.002	http://dx.doi.org/10.1016/j.jaci.2020.10.002		APR 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	33045279	hybrid			2022-12-18	WOS:000647154500015
J	Godon, O; Hechler, B; Jonssson, F				Godon, Ophelie; Hechler, Beatrice; Jonssson, Friederike			The role of IgG subclasses and platelets in experimental anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Experimental anaphylaxis; mouse models; IgG sub-classes; platelets; FcgRs			[Godon, Ophelie; Jonssson, Friederike] Inst Pasteur, INSERM UMR1222, Unit Antibodies Therapy & Pathol, 25 Rue Docteur Roux, F-75015 Paris, France; [Hechler, Beatrice] Etab Francais Sang EFS Grand Est, INSERM UMR S1255, F-67065 Strasbourg, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jonssson, F (corresponding author), Inst Pasteur, INSERM UMR1222, Unit Antibodies Therapy & Pathol, 25 Rue Docteur Roux, F-75015 Paris, France.	joensson@pasteur.fr	Jönsson, Friederike/H-7525-2014	Jönsson, Friederike/0000-0002-1667-8065	Jeunes Chercheuses/Jeunes Chercheurs grant from the Agence National de la Recherche [ANR16-CE15-0012-01]; French Society of Allergology (SFA); Centre National de la Recherche Scientifique	Jeunes Chercheuses/Jeunes Chercheurs grant from the Agence National de la Recherche(French National Research Agency (ANR)); French Society of Allergology (SFA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Some of the work mentioned in this article has been supported by a Jeunes Chercheuses/Jeunes Chercheurs grant from the Agence National de la Recherche (grant no. ANR16-CE15-0012-01) and a subvention by the French Society of Allergology (SFA). F.J. is an employee of Centre National de la Recherche Scientifique.	Beutier H, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan5997; Beutier H, 2017, J ALLERGY CLIN IMMUN, V139, P269, DOI 10.1016/j.jaci.2016.03.028; Cloutier N, 2018, P NATL ACAD SCI USA, V115, pE1550, DOI 10.1073/pnas.1720553115; Epp A, 2018, J ALLERGY CLIN IMMUN, V141, P399, DOI 10.1016/j.jaci.2017.06.021; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Jonsson F, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat1479; Karhausen J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6314; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V132, P1375, DOI 10.1016/j.jaci.2013.09.008; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016	10	4	4	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1209	1211		10.1016/j.jaci.2021.01.009	http://dx.doi.org/10.1016/j.jaci.2021.01.009		APR 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33493556	Bronze, Green Submitted			2022-12-18	WOS:000637368900009
